cell_line_id,drug_id,response,predictions
MOLP-8,11612883,2.388158793316403,2.083169026593735
MDST8,654092,-1.4293910300938224,-0.2578495701161778
RKO,52947716,-6.611161073849914,-2.6480572480088638
RKO,56963564,0.5825206420774123,-0.07732838453896299
Granta-519,107970,1.5911312599666134,1.8597477708117855
HEL,12003241,-0.3954740832299299,-1.353147698592409
SK-HEP-1,445091,4.514173662724111,4.329949399581355
SK-CO-1,vorinostat-carboplatin (1-1 mol-mol),2.626947191906058,3.302730079199774
SU-DHL-1,JQ-1-vorinostat (2-1 mol-mol),1.047000957100153,0.8423793420308303
PaTu 8902,selumetinib-navitoclax (8-1 mol-mol),2.7909772109313677,1.8181581730160503
HCC15,24775005,4.257174534281358,3.7293114927413695
HuP-T3,6450551,3.7588607556856006,3.088859648957989
SaOS-2,72376,-1.862865015628177,-1.436357837386754
HARA [Human squamous cell lung carcinoma],9911830,2.811378702432749,2.6047061842825685
Panc 02.03,3062316,2.5231792980774,0.706455210383022
MOLP-8,6918837,-6.2821371699611515,-4.121205048743838
SW48,1242560,3.5610164041067645,3.4025853293875823
RCC10RGB,3062316,3.7206614033239833,0.7193857727634739
IA-LM,25262965,-3.1838216959830796,-1.4733101589696804
BICR 22,3038522,1.9324211832044784,3.227004118118586
SW1573,4096211,3.236722527011662,2.3864426419372453
LS180,navitoclax-pluripotin (1-1 mol-mol),-0.4771322903655018,-0.8678301445897451
NCI-H2452,2733526,3.4563089712221,3.880161787795207
WM115,44197249,3.814304480361476,4.392284933223226
HARA [Human squamous cell lung carcinoma],ISOX-bortezomib (250-1 mol-mol),0.5382016887520487,0.8046408260310993
Granta-519,JQ-1-UNC0638 (2-1 mol-mol),-1.2323689665878552,-0.05086912654269959
SW948,216345,3.8478701746280506,3.693084852258997
RKN,2858523,3.2318364946727653,3.0966386193510766
HARA [Human squamous cell lung carcinoma],11507802,1.3937860028408913,1.7182907280142137
LCLC-97TM1,17759555,4.8791087487812606,3.501377905074473
ALL-SIL,24771867,-3.516684419884963,-1.6110058468670951
WM115,11455910,0.9860510612095932,1.4599321750610388
MOLP-8,11485656,1.8270206697288176,1.6937561843222202
MOLM-13,9866186,-0.4750218873797177,0.18481554211944715
Daudi,445091,3.707432883595851,3.8520624533301566
RERF-LC-MS,9907093,3.840365222907794,4.282226089783142
LCLC-97TM1,selumetinib-decitabine (4-1 mol-mol),4.710076676704391,2.6123203972291402
IA-LM,49836020,4.225846480888235,3.110556290700395
IA-LM,JQ-1-navitoclax (2-1 mol-mol),0.4623829149690596,0.8385502138791441
HuP-T3,445643,4.0158423100173986,4.080181410402536
RKO,5351362,1.5688417029382893,1.1278570219845863
SU-DHL-1,25262965,-0.1887460090186497,-2.059879218831429
MOLP-8,3552672,2.5417747800161483,2.596451474118882
Daudi,selumetinib-UNC0638 (4-1 mol-mol),2.5339399670169827,2.672627364578273
HCC15,24771867,-1.1106317715549263,2.5627908840217257
HARA [Human squamous cell lung carcinoma],16115403,-4.2638303939611335,-3.8647072461717595
COR-L95,25161177,5.647598761093448,3.913893355325557
BFTC-909,16219061,3.736019824418232,3.429029984619941
LCLC-97TM1,3503,2.904492448420953,2.313618773247784
RKN,5287620,-2.679516494579474,-1.9717750422887517
IA-LM,5281321,-0.2514769440259956,-1.174460474694937
SK-HEP-1,24964624,3.121305411780932,2.6646094227575468
SaOS-2,9884685,-0.6485333929619777,0.6915717729297356
MOLP-8,44566777,0.3680572795114795,-0.22423323385942473
K-562,3081361,1.217245739162405,1.9502066601884729
HuP-T3,53392493,2.0684681956337654,2.680115405867616
SW48,11404337,-1.6842588085779022,-0.1998823032903826
RKO,24771867,6.323343540042099,-0.5642706770810851
MDST8,11497983,4.366208744407351,4.53060754445032
Daudi,6918638,-1.8107043721369585,-0.6563072299970496
RERF-LC-MS,107970,3.001301355490032,2.4620468546612475
NCI-H2452,56963564,2.315469414243469,0.6264621429904657
MOLP-8,JQ-1-UNC0638 (2-1 mol-mol),-1.954296009625891,0.36729014396900944
MOLM-13,4259181,-1.5110532495146267,-0.3792762898647149
RERF-LC-MS,5566,3.05978093065268,3.129712114181205
HEL,44607531,1.529117499700861,1.052495939988683
BFTC-909,25262965,-1.7887871070762158,-1.1776646769800279
ML-1 [Human thyroid carcinoma],26596,-0.6105391992480588,-0.5960624971968178
BICR 31,46191454,1.7584497327325264,1.7963004336750172
UACC-812,426756,4.999419351863596,4.203110475287333
SW1271,9911463,3.695583497273472,4.046784777081191
COR-L105,219104,4.205860409291191,4.070963701734496
MOLP-8,46943432,-0.8980695552897974,0.514864131008143
MOLM-13,11626560,-0.3289224093786886,0.6955706082533278
SU-DHL-1,73707398,0.2992121771474305,1.1114435005189989
HCC15,doxorubicin-navitoclax (2-1 mol-mol),-1.4188615279170478,-0.7879285591326675
HCC1500,9907093,4.182225492860836,4.077960532188413
SW1573,JQ-1-vorinostat (2-1 mol-mol),2.32143209708559,1.3742694449773327
LS180,serdemetan-SCH-529074 (1-1 mol-mol),1.4143670518957836,2.0667190560963844
NCI-H1568,5746,-0.0019321539800122,1.2904152708958738
SW1271,navitoclax-birinapant (1-1 mol-mol),0.1602834101021188,1.693835068180777
HEL,10385095,1.0320529067741009,0.9914531681307815
P31/FUJ,374536,-2.654779926412406,1.0115647456132948
KU-19-19,119607,4.136898976237774,5.345075420317183
HCC1500,11656518,1.3375266797474916,1.5337615341708999
NCI-H1568,44819697,-2.651253194329211,-0.23671161318354336
COR-L105,6918328,0.8369476830507139,0.3107441763487822
PaTu 8988t,1750826,2.46453979570572,-1.1534101270202555
NCI-H1568,vorinostat-navitoclax (4-1 mol-mol),0.9474025116898376,1.2247341210949196
HCC1500,6438330,2.8683818740810088,2.10269669861418
HEL,11214940,0.9295508638766669,1.2332327341056668
HCC15,104842,-2.640027553911029,-2.4249749091241957
BICR 22,53495165,-1.022289455565369,0.6697148602372917
SK-HEP-1,JQ-1-vorinostat (2-1 mol-mol),1.4434630535263555,1.2415684936820621
SW948,11167602,-0.1815305116238505,2.233269019510195
SaOS-2,119607,5.401113896800015,5.349158918872172
SW1271,444795,4.935671262335122,4.509805510953254
LS411N,107970,2.4864618038552724,2.0783507225900366
RERF-LC-MS,3025944,4.157794890121567,4.27720813559686
IGROV-1,5282054,3.614574021382022,3.92756007038955
MOLP-8,5284373,1.9803114216772224,1.902806735923345
SW1271,46907787,1.639327018501732,2.4952138443391276
K-562,tretinoin-carboplatin (2-1 mol-mol),5.512334561910439,3.501278682580312
IA-LM,carboplatin-UNC0638 (2-1 mol-mol),4.065848381548882,3.349015570554095
ALL-SIL,5351362,0.9273092220520184,0.8591943977719632
MDST8,docetaxel-tanespimycin (2-1 mol-mol),-2.250770682375198,-1.8188363510141123
LCLC-97TM1,54618164,4.1848187977728,4.081710541354688
SK-HEP-1,123631,3.617013696107864,2.7059317685754785
LS180,1641662,3.031869457755623,3.4928575721154504
LCLC-97TM1,46199207,3.402623883365983,3.3095525297606883
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384,-0.48525122362711187
ALL-SIL,168312962,1.491579787235829,0.41999860387201304
IGROV-1,135398516,1.9751898057484376,2.1692196369656522
SK-OV-3,4261,3.2658157069367615,1.7944226485580037
Panc 02.03,11707110,-0.717341284128793,0.9860649980754556
P31/FUJ,4261,-0.12536828191131,0.4660430179855939
Daudi,53481919,2.490259403593742,3.2703248209803917
MDST8,navitoclax-birinapant (1-1 mol-mol),-0.9553214738186762,1.4021921557124104
ML-1 [Human thyroid carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),2.9053104812744186,1.9246748078572589
SW1573,12003241,-0.6702221198842615,-1.2172410710141088
COR-L95,11238147,1.8523673489534709,2.5230613236403916
SW48,452548,-3.152923699933953,0.523437678050261
ALL-SIL,46224516,1.508509192124363,1.774193894395827
COR-L105,selumetinib-MK-2206 (8-1 mol-mol),1.6265269022274589,2.4551527248779412
HARA [Human squamous cell lung carcinoma],46199207,3.289640650109998,3.222309740859353
UACC-812,docetaxel-tanespimycin (2-1 mol-mol),-4.467025086254145,-2.3751616585641204
ML-1 [Human thyroid carcinoma],24856436,-1.6469735215058778,1.0509566715439158
Daudi,6918837,-6.333799665630375,-4.3807040801314825
K-562,57330099,5.557476297558147,3.8064058902448594
MOLM-13,3038522,-2.559283473550591,2.3521561391565924
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841,-0.2907888198054242
SU-DHL-6,9903786,1.8029536633965553,1.9939157457496024
Daudi,151289,0.3893937359913983,0.6266529840828529
MOLP-8,51037431,3.96461280344528,2.833742294883099
BICR 31,11152667,-0.7818812516610519,-0.6638332657948479
LS180,46907787,-0.2837252988913812,1.8355623955762146
PaTu 8902,16725315,5.393152185048805,4.476404365772574
Panc 02.03,6914657,-4.005158687469553,-3.5694005855645474
HuP-T3,54613361,5.307179038572215,0.23785344637320585
PaTu 8902,107970,2.826401466277882,2.306275327403411
RKO,25183872,-1.1635703485572924,-1.1303368683756359
RCC10RGB,135659046,5.776465120313546,3.9065932709858955
BICR 31,16725315,5.360398456728244,4.341239283911048
IA-LM,216239,1.6797579071033788,2.272602858554811
LCLC-97TM1,selumetinib-navitoclax (8-1 mol-mol),3.8256626967827385,1.6732004368889717
COR-L105,6610216,4.21117605455994,4.326356131867195
COR-L105,10427712,4.508625829006449,4.412914793044876
NCI-H2452,6610355,4.992583267176856,4.786001713863382
PaTu 8988t,11364421,0.0778741703331701,-2.0063917408696863
RKN,3552672,1.948192158503618,2.954593672375612
Granta-519,46174525,4.2506809125564615,2.8898798192280055
SW1271,44819697,-0.8585090240358869,-0.7071553839335771
WM115,44486219,4.206639028474801,4.16943022823299
MOLP-8,6918736,-3.613498069188207,-2.2568033399567775
LS411N,navitoclax-pluripotin (1-1 mol-mol),0.0808011312818899,-1.0205957115008815
LS411N,49836020,4.501659667614969,2.8597099385388516
WM115,9927531,5.125567810288171,4.887931801786358
SW1271,24797083,1.5469513987685792,1.4285224606942322
HCC1500,1566236,1.5057997400762737,1.9922555324966038
SK-OV-3,serdemetan-SCH-529074 (1-1 mol-mol),2.3877296872918334,2.2173341432661857
LCLC-97TM1,5566,3.3253657103683976,3.037768611218033
NCI-H1568,1242560,2.6554382745340046,3.68121930577481
RKO,11717001,3.92417498432234,4.029704428720833
SW1271,11612883,2.3755529899406604,2.992978873440399
Daudi,11396600,1.6595042173405945,2.3146677627154015
P31/FUJ,60700,-1.8341903870446763,-1.4759848034524705
MOLM-13,JQ-1-MK-0752 (1-1 mol-mol),-1.5133138249776965,0.10380517096759694
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649,0.5523303214456433
ML-1 [Human thyroid carcinoma],2858523,3.273643216387516,3.18481918974016
IGROV-1,3552672,2.134472496867482,3.0410139936275336
Granta-519,637858,1.0013506713179747,0.9181641238850575
RERF-LC-MS,24753719,5.208830602571573,4.435550590703667
BICR 22,10385095,0.7738978245677988,1.6893946389133578
IA-LM,216468,5.467489395679956,1.9091632363906168
HARA [Human squamous cell lung carcinoma],46398810,2.9743064800682912,2.728190765211922
ML-1 [Human thyroid carcinoma],JQ-1-navitoclax (2-1 mol-mol),0.5559974390910295,1.2058499450844404
SK-HEP-1,5738263,4.7811273930471065,3.5139545180366047
SU-DHL-1,44632017,-0.1440136540504316,0.9440698988900167
HEL,selumetinib-navitoclax (8-1 mol-mol),-0.2593426680751931,0.08025595439585471
PaTu 8902,11152667,1.2355675895718252,-0.4231849762531191
RCC10RGB,53245473,3.741106102916085,3.315772495435265
RERF-LC-MS,637858,3.156110522031532,2.4812162215124234
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858,1.9221163850582315
HuP-T3,selumetinib-MK-2206 (8-1 mol-mol),2.743935040601299,1.8930760247246499
MOLP-8,23635314,-4.658988245687028,-2.821785838173536
HCC1500,241158,4.347158152842418,3.9853701439461844
NCI-H1568,16065773,2.3280951044534923,2.513307437001153
COR-L105,24771867,3.297975412837562,3.043710290193786
COR-L105,11625818,4.2515796910784385,4.595551159592118
RERF-LC-MS,JQ-1-MK-0752 (1-1 mol-mol),3.600892214686445,2.170474170926807
IGROV-1,2841722,3.834853118277962,4.499924330463793
SaOS-2,51039095,1.985897726070115,2.6281523339183352
LS180,navitoclax-sorafenib (1-1 mol-mol),3.51212583776398,1.719473968954013
COR-L105,44589607,3.154557065472522,3.140458108174556
HARA [Human squamous cell lung carcinoma],54626689,4.600126869473187,4.542975055028768
LS411N,9911463,4.267700407985282,3.4329163374084875
IGROV-1,4378219,2.016502068118561,2.457453906231601
Daudi,135659046,3.1156448500687923,3.1573408397021567
KU-19-19,16722836,2.3762239171314894,1.8405749479009454
IGROV-1,10410894,3.2660402181528263,3.368290199065291
Panc 02.03,49793307,-1.288996397670963,-2.6871470231194308
HuP-T3,SNX-2112-bortezomib (250-1 mol-mol),0.0780901353743998,-1.0625303190166748
MOLM-13,3136844,3.815118683612459,3.5257090200261882
MOLP-8,6914657,-3.275680842626438,-4.649986024988161
K-562,9887053,4.062685534067952,3.036603009786843
ML-1 [Human thyroid carcinoma],16038120,1.3266996549374028,1.3536527243983207
NCI-H1568,52947716,-4.502411459776945,-0.46208812623281437
BFTC-909,11178236,-2.4757289909406683,-3.0906122156431377
Daudi,6610355,3.6984054922795906,3.9996478318749813
HuP-T3,10184653,2.026243337908569,1.2637026474503905
IA-LM,36462,3.5803800151684384,2.237034882910333
SU-DHL-6,46907787,-0.6700724490980451,-0.28897080447260276
HCC15,10231331,4.227224330005602,1.9644739089029428
LS180,135398516,1.9815935031047112,2.0103449846639974
MDST8,53495165,-1.6914230136545845,0.4020488731066274
SW48,135411,0.1882785626851766,0.8382463226968848
COR-L105,11485656,1.8131666015075352,2.49936303256186
HCC15,1239801,5.074899811919598,4.243853813622216
SK-CO-1,11497983,-2.036472499029009,4.317854696093654
Granta-519,2742550,3.255820788990773,3.1653541886765852
ALL-SIL,16720766,-0.6951675656481376,-0.8824797727460859
COR-L105,11175137,3.2551565890936165,2.7914330336677553
RCC10RGB,decitabine-navitoclax (2-1 mol-mol),2.143538063867694,1.928592072461197
BICR 22,ISOX-bortezomib (250-1 mol-mol),1.660291867951594,0.688822245329761
IGROV-1,409805,5.990596261907717,5.0859923261478475
Panc 02.03,11485656,5.602754460209725,2.5210086395981763
Granta-519,54619267,3.910643053444693,3.382818666771197
COR-L95,navitoclax-gemcitabine (1-1 mol-mol),-4.597005855092225,-1.2074056863925582
BICR 22,6252,-0.1324642168432157,1.3290727260292459
MDST8,11404337,0.5498361952050128,0.14463072481274514
SaOS-2,60750,-3.1697993298632183,-1.9481531417713505
SW948,11717001,4.275182691709766,3.9090020600233437
MDST8,11175137,2.5746086097463974,2.6827285285002596
IGROV-1,322968,4.140599241163106,3.7603739231454636
HCC1500,1242560,3.704354238917139,3.846954304372858
MOLM-13,9911830,-0.5537570191991712,1.7455388524397513
COR-L105,16038120,1.5247864010803889,1.2530261335069421
COR-L105,45279963,3.905008730311125,3.582526548165348
WM115,148198,-2.543343591950365,-2.9963407994799622
IGROV-1,2749,2.0319044408234954,2.0765294812669244
K-562,4477,-0.1635303329058878,0.6309935023915801
SK-HEP-1,25227462,1.4628952719758763,0.5451771130845323
Panc 02.03,23582824,1.3457270338170706,0.8062023991168041
SK-HEP-1,241158,4.116654148222159,3.9475388265922082
SK-CO-1,168313047,0.9150038640573646,2.5243218210040705
Granta-519,9823820,3.571742016367909,2.7624371098218337
SK-CO-1,159324,2.1120355222347738,3.1082157432730657
SK-CO-1,10385095,1.4661007046294967,1.4746343240947157
NCI-H2452,71304818,2.7948147605911218,2.6788875881059666
MOLP-8,4578,4.125075782233611,3.8504942425520614
NCI-H2452,11455910,0.7111396076654327,1.243042858005695
HARA [Human squamous cell lung carcinoma],6917907,-4.425737266076785,-4.678991591633975
LS180,10074640,3.3464344717087333,3.0610095119608705
MDST8,71466578,3.80352554053155,4.22728347282733
LS411N,6184667,3.0967158778150465,2.4624561228461985
SW948,11317348,1.1175502037929408,1.8377891108945135
MDST8,119607,4.705186592802013,5.37926050241285
SW48,11507802,0.6466338181730511,1.7652970650697597
IA-LM,alisertib-navitoclax (2-1 mol-mol),-2.012462769104639,0.35206028832817454
WM115,5702613,3.6693021536028367,3.2072544629621262
SK-CO-1,23725625,2.337747507524157,5.189414397419521
K-562,2749,1.8349792189296796,1.1753390475437375
IA-LM,3825829,4.571991496451351,3.598825742100061
KU-19-19,104842,-1.861779032385676,-2.259126869941891
SK-HEP-1,12001922,2.448252559355595,2.0004613544982663
HEL,135440466,1.1488755358131115,1.4898074215534345
Panc 02.03,6918328,1.3018368822202735,0.219168321942094
SaOS-2,72734382,4.901362762899978,4.631366094330086
HuP-T3,135421197,1.625440100707307,2.0121278553343953
HCC1500,3384730,2.626558190955656,2.967372838426482
IGROV-1,51037431,5.669320749085174,3.372667066451289
BFTC-909,4917,2.929839520827846,3.265253310546348
WM115,637858,1.77843641117838,2.097727293290351
MDST8,44589607,2.007770745404649,2.6645996020174927
LCLC-97TM1,5282054,3.1900504557345664,3.3711277883218473
HuP-T3,46199207,3.4499209547515433,3.390014385273813
BICR 31,25262965,-3.4333038857773093,-1.0453725965367135
LCLC-97TM1,6914657,-1.7973267784986633,-3.5486132013694665
MOLM-13,9823820,-0.5140029045699521,2.2821943636398188
RCC10RGB,327653,3.228661308812885,3.408696472135477
NCI-H1568,4705,2.022283964907955,3.2149307527082023
SW948,selumetinib-MK-2206 (8-1 mol-mol),-0.5060345185709773,1.974921681977523
RKO,6914657,-2.9196237708628505,-4.3519575907969035
WM115,72734382,5.455243998512052,4.725574876261273
SW48,46398810,2.2376864399879,2.6002907881151383
LS411N,2945648,3.381909997555915,2.595246748125559
LS411N,JQ-1-UNC0638 (2-1 mol-mol),1.029472619372517,1.3227150227268765
SaOS-2,selumetinib-PLX-4032 (8-1 mol-mol),4.990111037976576,3.7538426728470125
ALL-SIL,421610,2.937759224643201,2.5038116237001438
COR-L95,11404337,0.1032061359669597,-0.3056408899271325
WM115,11427553,3.734660617826416,2.559777025321687
HCC15,122327,4.313110702061898,4.915982533943278
Daudi,9444,3.424690286905087,3.2898148621543175
Granta-519,4521392,4.382822475618979,3.753375199659804
SW48,31703,-4.626106549902408,-0.7291687878244925
RKN,10127622,5.371150210721622,4.045550841792558
ALL-SIL,71466445,2.2002248480614925,2.1443423211188413
MDST8,656346,0.9697505348816438,1.409008303942879
Daudi,71680916,3.7291665773697,3.593803441461936
HEL,135398516,1.4688857829361923,1.1971313046019052
HARA [Human squamous cell lung carcinoma],168312962,2.6720428895447412,2.0532851355974095
P31/FUJ,9936388,-7.166815071220185,-5.019415006641346
HARA [Human squamous cell lung carcinoma],42611257,3.5357302300548716,3.5235605284000213
HCC15,11625818,4.624206979967606,4.50914240793949
LCLC-97TM1,42611257,3.4642891468760957,3.3830800251431246
LCLC-97TM1,5311,1.9621633752287055,1.1474323754619196
RERF-LC-MS,52912189,3.970931922009392,2.323172297270159
BICR 22,9915743,0.3047863731286212,-0.20824133893286606
Granta-519,11612883,3.2575401906490895,1.70610103129415
LCLC-97TM1,vorinostat-carboplatin (1-1 mol-mol),3.53516680468747,2.754713940233194
NCI-H2452,3543504,4.306818718463235,4.708637728701792
SK-CO-1,676352,2.6575015884388704,2.1020350725640675
COR-L105,docetaxel-tanespimycin (2-1 mol-mol),0.3286281168811693,-2.625834749689755
RKN,71304818,2.008207131108322,2.516704909946003
IGROV-1,67156097,0.1763939852409119,-0.40374941143380794
IGROV-1,51039095,1.7163430299301403,3.0570294897981
P31/FUJ,JQ-1-MK-0752 (1-1 mol-mol),-0.1535880671922636,0.0018871986853222999
IGROV-1,72193861,2.0623829231433293,1.693572387789145
Daudi,tretinoin-navitoclax (4-1 mol-mol),3.599991807714322,1.087295752705027
NCI-H1568,11167602,1.5259281753697294,2.5257515145415597
NCI-H1568,52912189,3.4016367932827563,2.3008072561784836
SU-DHL-1,107985,-3.306496987383706,-3.459603559007776
P31/FUJ,73707386,2.311695228129917,2.2464715278408796
WM115,9884685,-1.925323313513864,0.6666620700692671
SaOS-2,16722836,0.8662367041162377,1.766300495309542
PaTu 8902,46843906,4.340257675131653,3.2432274202265385
BFTC-909,656346,-0.1018552101429806,1.0387689782408422
COR-L95,54618305,4.5292428127427575,4.02397767861062
PaTu 8988t,selumetinib-MK-2206 (8-1 mol-mol),3.0176221561167096,2.5755091901117013
Daudi,24772860,-3.9771177154169304,-2.65850848201499
BFTC-909,9911463,4.114346930944119,3.989420085487418
LCLC-97TM1,44197249,3.7483906325702545,3.921674934613745
BFTC-909,6918837,-1.9878509916437357,-2.3235383874197892
RERF-LC-MS,24797083,0.2985814331764478,1.5111222492705494
P31/FUJ,135928012,4.893710575363991,3.7876958847492284
P31/FUJ,53232,3.343897726239282,2.6344881109561347
K-562,navitoclax-MST-312 (1-1 mol-mol),0.8745280332695038,0.6965225301829284
MOLP-8,25062766,1.6722099464266416,1.8394916055364265
PaTu 8902,JQ-1-vorinostat (2-1 mol-mol),2.024407809701968,1.0843107560587295
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308,-0.524968839617762
SK-CO-1,262093,3.1807391377127376,2.9979744842437244
LS180,72376,-2.8322202153843703,-2.139201168253758
SK-CO-1,carboplatin-etoposide (40-17 mol-mol),1.570074747334896,3.1209307391881747
KU-19-19,6918328,0.0154884073180988,0.20508451645596104
SK-HEP-1,107985,-2.2891993358893856,-3.284253530990934
PaTu 8988t,216239,1.832862266271042,2.3660779077630254
SW1573,vorinostat-navitoclax (4-1 mol-mol),1.892054443323453,1.689263288427613
PaTu 8902,156414,2.7243668654536206,1.512857924275265
Daudi,16659841,2.946181230411034,2.3579710457678895
LS180,123631,2.1427319304120624,2.2967315862660915
BFTC-909,10385095,0.9839595624316404,1.3998029114557715
NCI-H1568,241158,1.943489424131273,3.9623362801246436
UACC-812,44589607,1.3537953197929582,2.792082816748013
Granta-519,11960529,3.2261057296158593,3.3595998493074664
LCLC-97TM1,25062766,2.2139494005881293,2.0941179603800295
LCLC-97TM1,5291,3.6350350305332424,3.7217518370788634
MOLM-13,44491742,3.7695621371445975,3.7367912265839562
P31/FUJ,3025986,-2.3655111331800067,-1.4821579414493338
PaTu 8988t,2749,1.558615062570056,1.9001931763084174
IGROV-1,2113511,5.982902824257526,5.721841787840134
Daudi,54639126,5.221444108043,2.5635582365560174
HuP-T3,selumetinib-PLX-4032 (8-1 mol-mol),4.085577653340594,3.2498736605918195
HCC15,9868037,2.5640614102548556,3.521917506987434
PaTu 8902,6918837,-2.118913626513807,-2.1182220444100768
ALL-SIL,23725625,2.2136327630148736,3.4033743256716558
COR-L105,11455910,0.425998653780944,1.4340279585777989
K-562,16013152,3.768503882504226,3.1157821038415308
Daudi,67156097,-2.7448600083467163,-2.500419826117843
SW48,6610216,4.461301788418361,4.3233946164547135
BICR 22,11977753,-1.1105881150796446,-1.4561163653905291
Daudi,753704,2.787779434331829,3.9189235227565047
COR-L105,46943432,2.471907312248233,2.8009839646762087
IA-LM,16736978,1.926640001137528,1.5730677250705025
IGROV-1,176870,1.8349827429681411,3.6136362308393126
SK-CO-1,148198,-1.1611262776602205,-3.4544446198571546
HARA [Human squamous cell lung carcinoma],219104,4.732621852676119,4.086418278089277
IGROV-1,46943432,4.105714883822214,2.307620880792428
LS411N,168312962,3.224541058203402,1.200540893370777
LS411N,1641662,3.6634193785306337,3.30031515479966
HEL,vorinostat-navitoclax (4-1 mol-mol),-0.226382947191329,-0.07766285296827323
LCLC-97TM1,26596,-2.266692800551727,-1.6359768731547384
HEL,151289,0.2321343459174182,0.43680346203568093
Daudi,1285940,3.7558538743643792,2.6612212713525616
MOLP-8,2749,1.3302247490678565,0.9715939933905902
RERF-LC-MS,10427712,4.250983789220692,4.393295592199063
WM115,16725315,4.630500047502962,4.433576447055023
Granta-519,9840324,5.864872193260208,5.5013118278801345
HuP-T3,25262965,3.989652761156405,-1.61308934460392
NCI-H2452,11719255,2.41462187851326,3.7313873086590883
COR-L105,1641662,3.72017777917812,3.6680636629309147
SaOS-2,89928392,1.2892186505806515,1.4582299774763772
LS411N,969516,3.2917111714105647,2.3732790978303178
Panc 02.03,carboplatin-etoposide (40-17 mol-mol),3.971241945633474,3.2468015415957
NCI-H2452,327653,3.049758242791241,3.3973543064242966
LS180,4521392,3.9983682640735094,4.292992728020597
IA-LM,2113511,5.955012720035456,5.622845399562614
HCC15,11167602,2.587200682435675,2.659462995471857
RCC10RGB,9911830,4.5526597563763795,2.963986468720209
P31/FUJ,168312962,2.530788243280419,0.5196416574455588
ML-1 [Human thyroid carcinoma],136227331,5.904689393841422,3.94965134834001
ML-1 [Human thyroid carcinoma],11609586,2.006327876020203,2.963729229446449
Granta-519,9933475,1.54115480203428,1.519953387790548
HuP-T3,73707398,1.153693297692098,1.2443791743540746
SaOS-2,409805,5.764413924489168,4.575368647148794
KU-19-19,984333,-0.867877464903324,0.548886183917007
HARA [Human squamous cell lung carcinoma],5351362,1.123570314509272,1.6653381225636752
LCLC-97TM1,selumetinib-PLX-4032 (8-1 mol-mol),3.0304859741823944,3.537146656951585
P31/FUJ,navitoclax-pluripotin (1-1 mol-mol),-1.7547710657643,-2.3120548886648593
SW48,6918837,-4.354568378072889,-2.964368702446956
LCLC-97TM1,16741245,5.12826814210941,4.018154407913802
NCI-H2452,11507802,3.578778888517491,1.7495789232240142
HEL,11175137,3.15338888234114,1.6143875224018336
BICR 22,60750,-4.532323865382038,-0.9077322907605953
Granta-519,44491742,4.018752292224149,3.690883084244802
SK-HEP-1,12003241,-1.7510835313415607,-1.5391461749428472
SU-DHL-6,36314,1.1358641594844867,-2.9696528138898786
HuP-T3,11152667,0.3145958176635,-0.822785662166296
Granta-519,15547703,2.599412791530534,2.505867920814556
IA-LM,25126798,4.097105087874825,3.689934588761293
MOLP-8,119182,-1.11255726511749,-1.8680429065610655
BICR 31,65064,5.259646525120305,5.034207205674165
COR-L105,6917907,-5.504495586582428,-5.01831066805913
LCLC-97TM1,11238147,1.840896458617422,2.555490603811235
HEL,51039095,2.698396554100347,2.2067697736385314
PaTu 8902,44185566,2.9137350944736653,2.6971172441226856
Daudi,53495165,-3.885820769064659,-2.149046276463039
BICR 31,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7385932494474976,4.010619394147792
MOLP-8,439501,-2.9296652389863267,-2.2983888817077816
Panc 02.03,4259181,2.0313571914007604,0.5553031927954923
PaTu 8902,126941,-2.2828817630557228,-2.893666353558454
RKN,5328940,2.201806852003849,1.8442133503815545
PaTu 8988t,SNX-2112-bortezomib (250-1 mol-mol),-1.5745385961478635,-0.8970720404257108
HARA [Human squamous cell lung carcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.5629845870291592,1.8971024646543364
COR-L95,246676,4.317733637680926,3.7872540293538037
K-562,135928012,4.4390204871751004,3.972213881671118
MOLP-8,56946209,-6.528820954061854,-4.481897285174291
SW948,selumetinib-decitabine (4-1 mol-mol),0.3455932815007744,1.3622861435784817
COR-L105,135421197,1.9442341701951136,1.9682102323605204
HARA [Human squamous cell lung carcinoma],374536,3.8012573814376567,2.338847694945954
IA-LM,selumetinib-MK-2206 (8-1 mol-mol),3.1087327611966185,2.246748313283765
ML-1 [Human thyroid carcinoma],56649450,4.029501942502391,3.6799528575007083
RCC10RGB,5280436,4.525748645562069,3.4677025476961085
NCI-H1568,31703,-1.6950574450364193,-0.6042483353449967
SW1271,148198,-2.630785543453804,-3.0982309804085393
Granta-519,11964036,1.5223427206827596,0.20994890117800086
MOLM-13,16725315,3.788691115651132,3.3467436283707652
Panc 02.03,1716436,3.766168811644757,3.1178205879277043
SaOS-2,JQ-1-UNC0638 (2-1 mol-mol),1.2943206739427773,1.678650345490897
K-562,1566236,1.8179642124055264,1.5872427518002865
RCC10RGB,409805,6.020159348453613,5.444945551932627
HuP-T3,navitoclax-MST-312 (1-1 mol-mol),0.8342028342455182,0.9786475608370624
HCC1500,11175137,2.755904594476177,2.7575594619246395
HCC1500,11494412,1.8019649514762912,2.086055309075908
HCC15,10127622,3.735977541508184,3.8897224499627314
HARA [Human squamous cell lung carcinoma],4096211,1.410240196225579,2.3145212348356576
SK-HEP-1,168312962,-1.3309808369359073,2.100411139901452
COR-L105,24180719,3.693037976394381,3.6237507628019636
Daudi,46943432,0.8866201698678313,0.7368310302347407
HCC15,BRD-K27188169-navitoclax (2-1 mol-mol),-0.2430288225821102,2.5890322467883613
Granta-519,24180125,1.2477770260094014,2.172001825967601
RKN,9967941,2.6996754619948065,3.811427716011053
RKN,135398516,1.9656218312143572,1.9782463941545803
KU-19-19,16115403,-3.194116920729502,-4.026449709515719
SW948,56949517,5.5880132005349505,4.130659682653628
NCI-H1568,44632017,0.9967277604489184,1.4834081625615898
COR-L95,11175137,2.52315362607855,2.37217944383399
NCI-H1568,676352,1.7505105304855018,2.155356368294267
NCI-H2452,126941,-2.0674603287446964,-2.71115774308622
NCI-H2452,4477,0.2060981637085811,0.6130079567407902
SaOS-2,vorinostat-navitoclax (4-1 mol-mol),1.3300754000959574,1.1905667772035373
LS411N,vorinostat-carboplatin (1-1 mol-mol),2.115093899053651,2.531757930583893
BICR 31,11647372,2.8607835505972035,1.2265488392271862
WM115,52912189,2.2242444616857417,2.3221643667974714
COR-L105,2729026,3.0417945234466863,2.8226980813911955
COR-L95,65064,3.24172080303354,4.430329851906391
IGROV-1,54613361,1.0826132998561049,0.1557422853607155
NCI-H1568,53232,2.5527200815554587,3.150379807349479
IGROV-1,9884685,-0.088911709267569,0.8377935348219152
HARA [Human squamous cell lung carcinoma],104842,-3.702627319243614,-2.703569825076747
SW948,16720766,3.3510678765666517,0.3430387246558552
ALL-SIL,135928012,2.5698772014589992,3.8108177348691346
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701,0.7943088986556494
COR-L95,56946209,-6.902335125637694,-4.249730979306537
IA-LM,49867926,4.185996432673056,3.571364375489064
SW948,11625818,3.962309646097391,3.7065564744807817
IA-LM,4259181,2.3536383664390734,-0.0268310680062906
NCI-H1568,4259181,0.5766231269303183,0.28723568112461456
SW948,6438330,3.286047925562068,2.2088657581219153
P31/FUJ,15547703,2.950164329068843,2.6474065238232254
COR-L95,1750826,-0.7485912803642704,-1.5013561780065567
HEL,51037431,1.91843497941606,2.761647859927666
BICR 22,vorinostat-navitoclax (4-1 mol-mol),0.9224898382798205,1.009746195503623
Granta-519,462382,0.1364457210972633,0.5373378039443857
LCLC-97TM1,11719255,2.8064116850649774,3.014448410570594
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266,-0.9646876389943604
MOLP-8,1242560,2.9421278446513393,2.9760632209169016
WM115,9911463,2.5241618652619007,3.927256865928336
RKO,3025986,-0.6013959236761957,-1.4720656432211836
PaTu 8902,5335621,4.440333682211631,4.663624500339171
NCI-H2452,19582717,3.9299005055458793,4.446093438961339
NCI-H2452,171352865,2.832902682703541,3.379020453471779
COR-L105,5566,3.258554573596101,3.1089196992361376
BFTC-909,11647372,1.2423847125416496,1.5462358104226892
Daudi,3503,0.8148417795144576,1.7841600935821205
COR-L105,25183872,-0.7403581245059931,-0.3596426077068003
ALL-SIL,375860,-1.552794194023853,-0.5299809909502619
HuP-T3,72193861,3.3106720937076233,1.7492308250043442
NCI-H1568,ISOX-bortezomib (250-1 mol-mol),0.1016439372832729,0.7191242803669283
SW1271,6438330,2.1351654373433764,2.0507370489947605
SU-DHL-6,25262965,-2.983432395440536,-2.599642798664232
SU-DHL-1,serdemetan-SCH-529074 (1-1 mol-mol),1.762662031403703,1.5206527379896835
BICR 22,JQ-1-UNC0638 (2-1 mol-mol),1.3883099593452988,1.8809806438788685
SU-DHL-1,44489367,4.533806271256096,4.492127500069079
MDST8,31703,-1.4422735490012837,-0.5919441997681747
ML-1 [Human thyroid carcinoma],568763,0.2556406277244685,0.6767593361164636
IA-LM,10302451,4.177351274859187,2.960333596731912
SW48,11214940,3.1705360221414134,1.8295650166326172
RCC10RGB,10074640,3.4095283906874956,3.2620266952846166
HCC1500,carboplatin-UNC0638 (2-1 mol-mol),3.485346920824326,3.1019719534117915
COR-L105,25227462,0.5095099099095757,0.5656585354753343
COR-L95,66577038,3.0490878420221934,2.873787090659578
LS180,46191454,1.5509574675684803,1.7640308071814683
RCC10RGB,65064,5.251967206688168,5.053548932011689
IGROV-1,72376,-2.111352545322758,-1.6879770905404266
MOLM-13,89183176,2.661461024404157,2.932574145431163
LCLC-97TM1,doxorubicin-navitoclax (2-1 mol-mol),-1.1891183752031609,-1.0019292975164567
RKO,3384730,1.0492755436091918,1.7021674326113094
SW948,11656518,-0.9054812480406104,1.7146625478475748
ALL-SIL,2949965,1.286096946783907,2.1444633572841436
ML-1 [Human thyroid carcinoma],selumetinib-tretinoin (2-1 mol-mol),1.8296865613090936,3.7755251031799957
RERF-LC-MS,selumetinib-BRD-A02303741 (4-1 mol-mol),3.278081284431068,3.9713681798811087
K-562,5287620,-0.244838249137823,-2.152276464051764
Granta-519,3825829,3.4773445434270243,3.3955213278067946
MOLP-8,10385095,0.909191851453096,0.9514851362375631
COR-L95,135928012,3.4969711227856397,3.917028963428466
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251,1.4910821872675806
UACC-812,25161177,3.457735095549926,3.9382748497081996
SK-HEP-1,11178236,-5.847785565222589,-3.4202696490696733
SW1573,16741245,2.047879460545898,3.966080185474873
K-562,vorinostat-navitoclax (4-1 mol-mol),0.9167311998987592,0.5152722034933681
K-562,89183176,3.981701702250952,3.0818057112444275
P31/FUJ,9915743,-0.8907797257006451,0.21947309719534083
WM115,3503,1.3325075362119865,2.346034005159828
PaTu 8988t,44202524,3.9754310935930968,2.0701350213837704
SW948,9952709,2.6604018004594514,2.744900590718882
Granta-519,56946209,-6.359988120178517,-4.947455442635607
NCI-H1568,navitoclax-piperlongumine (1-1 mol-mol),1.526760839095053,1.796454036610347
Daudi,613000,1.9882519691431488,2.5124195048723292
RERF-LC-MS,374536,3.716253113618047,2.5950073442406665
LS180,72734382,4.032476699930466,4.533000768999199
Daudi,1566236,1.0534301581716357,1.5556720470009568
BFTC-909,9868037,3.24226767674478,3.548529395687578
HuP-T3,107985,-4.90392348596967,-3.3238178740295523
BICR 22,crizotinib-PLX-4032 (2-1 mol-mol),2.04605335326416,1.9444212291520648
IGROV-1,168312962,3.022863957843741,2.126383507735494
IGROV-1,3081361,0.99973562532788,2.3027074237930676
BFTC-909,5311,1.6846521587280363,1.4590564404691058
NCI-H2452,2841722,4.2339337769073175,4.273130425637934
NCI-H1568,navitoclax-gemcitabine (1-1 mol-mol),-4.7036832419339865,-0.5974830842538721
RERF-LC-MS,5278396,3.382202757419261,3.7181004213985718
COR-L95,44607531,1.1147625805359247,1.4020359803297295
SaOS-2,135440466,1.1747227113697256,2.0134469184496377
RCC10RGB,285033,2.114091727684993,-1.0085314684713844
SW1573,448949,2.6434946381292703,2.2099065350983036
SK-CO-1,11964036,1.41955554287601,1.3231493564241128
SK-HEP-1,24901704,5.545234809796251,3.463289095615703
RERF-LC-MS,71751553,4.213964581210796,4.579478828305246
SW1573,11178236,-2.507507612037206,-3.2438343720116616
HCC15,6450551,1.6627728253820353,3.1202479892912707
SU-DHL-1,54619267,3.144461009217004,3.9390281238280704
P31/FUJ,11626560,0.2148563033664798,0.8781081943784826
COR-L105,119607,5.370152891195211,5.3424134614997305
NCI-H2452,11427553,2.818972077820031,2.8160147662116155
HuP-T3,2871966,0.5817483683031975,0.777467167029715
Granta-519,439501,-6.00499370561019,-2.3469055546831057
RCC10RGB,JQ-1-UNC0638 (2-1 mol-mol),2.5689754136574425,1.748551537790552
SW948,navitoclax-sorafenib (1-1 mol-mol),1.76041571963915,1.3149083214728958
BICR 22,2945648,3.5832925483527625,2.7548414718205874
NCI-H1568,11228183,4.140816994678141,2.6174247120483596
COR-L95,89928392,1.3878824566143364,0.9416796525628394
BICR 22,2871966,0.0284401826322965,0.8104772544631575
HEL,46199207,2.3973871372245372,2.766110640549152
HCC1500,52912189,2.5783780690097857,2.425021209904856
KU-19-19,52947716,-4.518413756843173,0.5723376180724766
ML-1 [Human thyroid carcinoma],5280436,5.01828711367565,3.7698847169490857
NCI-H1568,7326481,2.864470016727109,3.0852111393830284
RKN,53232,2.2291100881655037,2.8322107345628758
KU-19-19,4477,-0.0533500132034658,0.6603104861305686
SK-OV-3,107970,2.5604111984812152,2.4366017419648367
BICR 22,1242560,3.7933374150058015,3.456941433875904
ALL-SIL,5738263,2.854339564213428,2.5146507162859355
HEL,5329102,1.6539669706420914,1.3524201653173724
LS411N,selumetinib-BRD-A02303741 (4-1 mol-mol),3.2423717644429577,3.611540219258772
SaOS-2,3854666,0.6354016080385003,1.9380519046269926
P31/FUJ,107985,-4.114404549725097,-4.040753114097999
SK-HEP-1,54619267,4.307302877095537,4.200332632702259
MOLP-8,11213558,1.2108381509164672,1.4018855135184705
LS180,6914657,-4.58065814502937,-4.119941463299248
HEL,71466380,3.121887792191312,3.712750042338458
COR-L105,25154868,4.769445801979145,4.582461587129852
LCLC-97TM1,25105715,3.527934306265534,3.2659440216172855
SW1271,16013152,5.485365595141675,4.036246676346543
ALL-SIL,1750826,-2.8707446972397483,-3.3183731813056916
SW48,44632017,-0.021210675828241,1.3759299449222038
NCI-H1568,4578,4.166510450069308,4.592375757132516
SW948,24180125,1.460789729891403,2.431313184356122
COR-L105,25161177,3.712985248467103,4.0876251078860495
P31/FUJ,57519531,1.451496749892495,1.5329980309208688
ALL-SIL,6918837,-4.772645295536399,-4.53361938100799
RKO,16720766,-1.2722083569090707,-0.05501986602093115
Daudi,11707110,2.6257952816009498,0.9454718862509407
PaTu 8988t,24785538,3.127280515757933,1.8065075391359278
PaTu 8988t,selumetinib-vorinostat (8-1 mol-mol),4.764605515620316,2.5504639949729304
HEL,46174525,3.393297616528365,2.89987879610084
MDST8,17759555,5.018522859633252,3.7447594027649105
SW1271,53392493,2.79081275696651,2.7000404475089472
COR-L95,carboplatin-UNC0638 (2-1 mol-mol),3.064030034312791,3.2836597040333
SU-DHL-1,9927531,2.969590320438058,4.44618288101595
Daudi,445455,3.7530002864178416,3.8732676974723006
SW948,24951314,0.7675285489701543,0.693288150613551
IA-LM,JQ-1-carboplatin (1-1 mol-mol),4.993034474620053,0.7255961363936814
SK-CO-1,9866186,-0.7388742913087788,0.9574590934409377
RERF-LC-MS,60700,0.497286081450591,0.01028849886321486
BFTC-909,11364421,-5.034674750215906,-1.7839911066215905
SW1573,49766530,-2.79322841384178,-0.19807654993123702
COR-L105,vorinostat-carboplatin (1-1 mol-mol),4.069993227019241,3.3196270496061056
MDST8,25126798,3.890491738661291,3.877899240603216
HCC1500,3543504,4.272332537756205,4.3093712975392195
COR-L95,25062766,3.209944577871265,2.0251473223237766
ML-1 [Human thyroid carcinoma],5351362,1.4214743835970418,1.7797635280023376
SK-CO-1,44632017,0.9847861620501556,1.5694007068211544
NCI-H2452,navitoclax-piperlongumine (1-1 mol-mol),2.2697751233857058,1.8320253249962861
NCI-H2452,445455,4.8000860101003235,4.725632559032792
ML-1 [Human thyroid carcinoma],446155,2.0206180645356766,2.777611023003581
HuP-T3,439501,-2.469428626730465,-2.1348516072703045
RERF-LC-MS,9884685,0.4531053665233772,0.8140174365444096
RKO,5281321,1.9988379902215376,-1.9536209800705857
NCI-H2452,10410894,4.350169635958685,3.574136686844976
HuP-T3,24951314,1.4235135044150102,1.6016057084216333
SaOS-2,71466445,4.363709574185696,3.406451323088344
BICR 31,44185566,3.0664042381745946,2.6058209771939405
NCI-H1568,11625818,3.359978935972883,4.752316492947621
BICR 31,3552672,2.13577451695998,3.150137263899193
P31/FUJ,decitabine-carboplatin (1-1 mol-mol),1.8939659397992608,-0.19975661734717456
HARA [Human squamous cell lung carcinoma],11640390,3.0925981241806983,3.5732947680140086
ML-1 [Human thyroid carcinoma],55283,2.9349831464401936,2.8821170477803753
LCLC-97TM1,119182,-0.294501899208461,-0.7606418824341875
ALL-SIL,52947716,-0.7216046839402591,-3.515820600388865
RKO,11640390,5.295981617059328,2.7654388016743976
RKO,25150857,2.5785304193211247,1.7809587837884893
RKO,erlotinib-PLX-4032 (2-1 mol-mol),3.5689359084165124,3.1869304829468
ALL-SIL,1716436,3.0252724323132374,2.5494043062688703
RCC10RGB,262093,2.8343922904091134,3.1396229056868368
HARA [Human squamous cell lung carcinoma],135411,-0.5831763791629045,0.6061124623363274
SK-HEP-1,439501,-2.4482777943885856,-1.8390639105239037
RKN,71466380,6.199959456698308,4.553106528362382
HARA [Human squamous cell lung carcinoma],19582717,3.08314824082211,4.310879914442636
RERF-LC-MS,1242560,3.610791422912421,3.747591339074918
SK-CO-1,ISOX-bortezomib (250-1 mol-mol),-0.2509608033573304,0.7810555696321676
Panc 02.03,66577038,3.3089612685646985,3.0195111171072075
LCLC-97TM1,52947716,-3.0616129604635565,0.3562938579352482
SU-DHL-1,20959075,-3.3128713931491087,-2.807929633139458
BICR 22,2113511,7.552062733189383,5.611700632439271
SW948,25126798,3.357341035223679,3.767024924344016
HEL,3854666,0.8085723321900852,0.6819616281234522
HCC15,168313047,3.1265794948701338,2.581411793880126
WM115,107985,-2.5041726579949857,-3.3307209092894317
WM115,42611257,-0.3600732192588895,2.8760760636246983
HCC15,60700,-1.3823438115431317,-0.17274537307521814
COR-L95,alisertib-navitoclax (2-1 mol-mol),-1.2067075871406427,-0.4362724738824332
PaTu 8902,navitoclax-MST-312 (1-1 mol-mol),2.8235677032410873,1.3197606237821327
SW48,60750,-4.2221568193195225,-2.0315428947679686
NCI-H1568,262093,2.8880881470868585,2.9702745334983702
PaTu 8902,53392493,3.316041661234319,2.8864422887842447
Granta-519,11647372,1.7523915142224398,0.13269660116668475
SK-HEP-1,8515,5.0523689066797495,4.07215347581578
SW1271,decitabine-navitoclax (2-1 mol-mol),4.244493551272361,2.0423473984267044
LS180,702558,5.586038369213652,5.192584344176305
IGROV-1,15983966,1.7101486625531308,-0.9508504724994747
SK-CO-1,6505803,-2.970063061644963,-1.0147499620541043
SaOS-2,navitoclax-piperlongumine (1-1 mol-mol),1.6017048786640289,1.460379892175229
PaTu 8988t,11485656,1.82057121616084,2.4574340544094273
KU-19-19,2874250,6.302627434426347,4.4238222361661235
MOLM-13,11175137,0.3158641445144168,1.6572592672211164
WM115,644241,2.021542714802758,2.395101165707487
SW48,52947716,1.8444935422046616,-0.9402311579485821
NCI-H1568,10302451,3.040030486332468,3.209344208064554
COR-L95,44185566,2.2555949878605484,2.2184350836137194
LS411N,16725315,5.1123164266785714,3.9767765165753963
BICR 22,25195348,4.085059979970886,3.3885202344679084
SaOS-2,5311281,0.944453452900516,2.135399919488927
SW1271,613753,3.197731710568041,3.3069371537759684
IA-LM,9840324,5.344700856558617,5.7244477994016165
LCLC-97TM1,439501,-2.367039612081251,-2.120630703135164
LS180,9825149,2.508714096118433,2.062437927237682
COR-L105,9911830,1.908645944756667,2.7956961476952995
Granta-519,25126798,3.857539921377872,3.5640671086940574
K-562,11238147,1.4367734907149323,2.1371635870743493
SK-CO-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6721111669479054,-1.4202752831941328
IGROV-1,4705,3.3098412390054603,3.189035102484666
RERF-LC-MS,1716436,4.437154842045929,3.274907549203546
COR-L95,6918638,0.5429028056483723,-0.12406991382438698
BICR 22,11507802,1.0844954054416946,2.1150176514291177
Daudi,54626689,2.8292455243221264,4.231495311948687
COR-L105,148124,3.589067174421039,-1.9050717678410138
HEL,selumetinib-JQ-1 (4-1 mol-mol),-0.6322408734916383,-0.666659136583353
IGROV-1,9825149,2.5588021380929553,2.1292487390413584
LS180,2113511,7.0742493322433955,5.692752501405274
MOLP-8,16038120,-1.6086793301450355,0.3027027505077745
KU-19-19,67291369,2.2261044123877656,2.978422842250217
COR-L105,carboplatin-etoposide (40-17 mol-mol),5.23047829437091,3.185136850289891
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029,-0.5587107058243376
MDST8,navitoclax-gemcitabine (1-1 mol-mol),0.2783653553106409,-1.3103336231552578
Granta-519,44462760,4.300929542453815,2.4326084376872195
MDST8,tretinoin-navitoclax (4-1 mol-mol),1.0614057430446846,2.5049660014165647
KU-19-19,17755052,6.06318579738538,2.046486952962066
MDST8,11214940,-0.3312007430689519,1.9506286003758655
SaOS-2,57519531,1.7793183342968584,2.5999202930974423
BFTC-909,erlotinib-PLX-4032 (2-1 mol-mol),4.45664321306644,3.2068039959928973
LCLC-97TM1,44493528,4.18527882332477,4.29922935102408
LS180,decitabine-navitoclax (2-1 mol-mol),3.265284502098727,1.963922103751407
SW48,10231331,-2.95597966611556,1.6268501917738372
SW948,24797083,1.9027092264791332,1.6371758842941893
IGROV-1,11238147,2.1723642292765084,3.126229405097642
COR-L95,17755052,2.817022282186957,1.7242914747156473
LS180,25126798,3.79328534931886,3.8144645402048236
IGROV-1,71304818,2.4878074097553378,2.5117204965560673
SK-HEP-1,10302451,4.165168773877425,3.177441935575999
HCC15,25102847,1.68346873279249,2.4989214929041648
SK-OV-3,15983966,-3.6834707194333927,-1.0872779458085309
HCC1500,54143018,1.195335139641603,0.9609598816679233
COR-L105,11364421,-0.5536252833264237,-0.4947785764024162
RKN,148198,-1.0178445286580065,-2.9501188138174297
KU-19-19,400769,-0.482585358097733,-0.720868376751173
COR-L105,7326481,3.3886978035876547,3.0681217106519796
COR-L105,44819697,1.466179589978979,-0.01608467386621382
SW1271,5281672,5.179464513143849,4.469558822189017
PaTu 8988t,3634881,3.651211463421112,3.0718877978515065
IA-LM,11404337,0.4340662777154989,-0.3631294892748606
NCI-H1568,5287969,-2.4053225408736405,-1.7328426522487512
ML-1 [Human thyroid carcinoma],60750,0.2716917716617745,-1.4309508325399007
COR-L105,54619267,4.07987987500145,4.177738023437142
SK-OV-3,9907093,4.994966956142975,4.205674395554454
ALL-SIL,11167602,0.1759872916057691,1.9853633885555513
MOLM-13,49836020,-0.1965532240483963,2.3332549680783456
HCC15,52947716,3.127529556956005,0.2811909165175619
SW1573,4261,3.544037815747042,1.971781864370766
MOLM-13,6184667,1.666374934082413,2.007631955404896
SK-HEP-1,3854666,3.0622551399292264,2.374765564808431
Granta-519,241158,3.1692083740262373,2.5132201958510354
MOLP-8,5978,-7.284134927472065,-2.7343072862070574
LS180,10302451,1.4669812473297774,2.935779839603151
RKO,16065773,3.3120716405166615,2.0007366703369605
MOLM-13,24964624,0.892926396159225,1.1890928896012456
KU-19-19,11427553,3.4053411651543035,3.0057517399959526
SK-CO-1,44137675,3.0714779264964074,3.5759263406571
P31/FUJ,6852167,1.016015239887951,1.4406367877292399
HCC1500,5351362,1.2955308259083285,1.4553971672886972
ML-1 [Human thyroid carcinoma],11964036,2.920411614995081,1.4287688264469653
MOLM-13,252682,7.80657372951634,6.323623728114466
HARA [Human squamous cell lung carcinoma],57330099,4.527264318285619,4.250720933648221
HCC1500,44607530,1.2894809747133489,1.7458943196916854
SW1271,3025944,4.184087558749553,4.33557686780912
HCC15,44493528,4.34604946513687,4.242640159783831
P31/FUJ,6918736,-1.9353169891324984,-2.4062482369122336
ML-1 [Human thyroid carcinoma],168313016,5.516575315061805,4.955024600035491
K-562,24856436,0.0017034666231649,-0.25069480974965697
LS180,216468,-0.2416288368660945,2.9568512052597153
SU-DHL-6,11507802,0.7208159532280615,0.5266725423540762
SW948,5291,4.046310039203204,3.609629251885754
ML-1 [Human thyroid carcinoma],46398810,2.1486791434985344,2.7907345567880157
HCC15,11152667,0.1037945221143532,-0.3906136026835649
K-562,selumetinib-GDC-0941 (4-1 mol-mol),2.3648746020483284,1.0513771596607038
Daudi,piperlongumine-MST-312 (1-1 mol-mol),0.9306925214047892,1.2962508093352423
SaOS-2,49766530,0.3706728408995327,-0.7190664398414555
SU-DHL-1,168313016,5.361416197440646,4.212562276709991
HCC15,168312962,2.4994502868710677,2.0819927699598733
IGROV-1,24797083,1.5319862293819655,1.3920657903930913
WM115,71751553,4.133313051647094,4.575521880485783
SW1271,24951314,2.0404240106098723,1.3580574953524127
Granta-519,SNX-2112-bortezomib (250-1 mol-mol),-3.1352941908416243,-2.6823842282599792
SaOS-2,676352,2.2074841133021432,2.0756372041707847
P31/FUJ,322968,1.4419696378870497,2.2832660443557327
SU-DHL-1,10127622,2.7675483211751466,2.744270997273568
COR-L105,44137675,1.808161252080405,3.8218600366002624
PaTu 8988t,11625818,4.482422780967983,4.528999394363512
HARA [Human squamous cell lung carcinoma],156414,2.353598180094054,1.6893867970597949
Panc 02.03,16038120,1.606654693103348,1.344894652369352
BICR 22,3854666,0.9977305103930704,2.240703697702084
Daudi,46398810,1.6020476162665716,1.594829360336245
COR-L95,984333,1.162546188419483,0.2323022009432953
WM115,1317464,3.7806694387813753,2.7263348917203523
K-562,71680916,4.727537128358906,3.992714164984506
BICR 31,25183872,-0.4870171412848909,-0.5728324602940018
COR-L105,11626560,2.2911739511823503,2.0196590091008932
SW1271,9936388,2.2656701786136315,-0.9124055318999921
MOLM-13,135421197,0.945680487717708,1.3265650683298662
SK-HEP-1,136227924,3.6301481247272287,2.950019605513918
K-562,375860,-0.3542925626582329,-0.36194408188632815
SK-OV-3,9887053,4.42879128381072,4.085036047073723
LS180,9936388,-5.017955750811216,-2.123631666160051
SW48,9935249,1.3330175828473068,2.8553397775217877
SW1271,11214940,1.5931636594582963,1.7703885550942398
BICR 31,serdemetan-SCH-529074 (1-1 mol-mol),3.0027631707479467,2.1506687726903118
RKO,67156097,-1.3338800856316015,-1.8125660875248943
LCLC-97TM1,51039095,2.799665973949055,2.947933618720256
MOLM-13,54143018,-1.3895840664016086,-0.6753672250755125
Granta-519,5738263,2.4520737989935246,2.6314529675928005
SW1271,2828334,6.430891789984985,6.272514933578321
COR-L105,salermide-PLX-4032 (12-1 mol-mol),5.562133960836907,5.052567523976968
HCC15,3136844,4.306118753112888,4.52576503793315
IGROV-1,54454,2.453541831966438,2.6735071520264673
BICR 22,9935249,5.2884064452137585,3.0093600176190365
BICR 22,72376,-2.4643814155147634,-1.6115973593597948
HARA [Human squamous cell lung carcinoma],71304818,2.9544117211144147,2.5196599878157557
ML-1 [Human thyroid carcinoma],selumetinib-MK-2206 (8-1 mol-mol),-0.7620404937141786,2.563982653870352
SK-OV-3,25022340,0.9085118587340768,3.0942561285997847
HARA [Human squamous cell lung carcinoma],11167602,3.2969276962649823,2.2823527080766444
P31/FUJ,11238147,2.0504580426090286,1.955058117778234
NCI-H2452,44607531,1.7526351480007742,1.4859853492908448
SW48,selumetinib-navitoclax (8-1 mol-mol),-2.7874089121789662,1.7064818547094753
WM115,119607,3.834781850796951,5.4504832843207005
IGROV-1,71466445,2.3758001916617797,3.940901008041378
SaOS-2,54618164,4.337585482929099,4.106274208225351
SaOS-2,46843906,2.56299568717197,2.871968777525672
SW1573,navitoclax-sorafenib (1-1 mol-mol),1.0822173392973782,1.9668567187905321
LCLC-97TM1,2841722,4.284298549740087,4.138400801778863
LS411N,36462,3.380504085081747,1.6932506408701837
COR-L95,637858,1.3348673917451612,1.3212795750987936
HuP-T3,10113978,4.191114511390656,3.6540996723375434
Daudi,selumetinib-vorinostat (8-1 mol-mol),1.8930359660265372,1.5457561909333095
MOLM-13,24772860,-4.1681928866236415,-2.929472882541737
WM115,9823820,4.472944540337913,4.244380695743135
MOLM-13,3676137,4.483658238026924,4.038324035344054
MOLP-8,49766530,-0.668776240648524,-1.903305726715979
SW1271,107970,2.3235168881670285,2.3290247642199593
PaTu 8988t,16065773,3.154821962511545,2.508585383797636
Daudi,tretinoin-carboplatin (2-1 mol-mol),4.019264736178175,3.406794882838781
SK-OV-3,JQ-1-UNC0638 (2-1 mol-mol),4.235651526458717,1.4770573977272972
Panc 02.03,selumetinib-UNC0638 (4-1 mol-mol),4.3993780952510955,2.9774362118526296
RERF-LC-MS,selumetinib-PLX-4032 (8-1 mol-mol),2.4830780225250413,3.711112853941002
NCI-H2452,11364421,-0.8742390414707,-1.5276807752383343
NCI-H2452,4788,5.30317679490816,5.844996217816669
P31/FUJ,11396600,3.188193103342261,2.7665339619516356
SW48,2130404,2.4705566813277215,3.4218617585548277
SU-DHL-6,322968,0.8712022459195665,2.0620114933008815
BICR 22,107985,-3.867593954539223,-3.345624595090968
COR-L105,46215462,2.588599789838095,2.1112794138053936
PaTu 8988t,5287969,-2.0890298278516513,-1.5742713023364672
SaOS-2,9866186,1.0217998308229927,1.0497242878873172
SW948,16065773,2.2305150921307653,2.176686309953392
RERF-LC-MS,tretinoin-carboplatin (2-1 mol-mol),4.86238533641819,5.080016566325718
WM115,10127622,-0.9383410403940764,3.1816650054624653
WM115,2733526,4.043531113233861,3.551830964597629
PaTu 8902,49850262,5.593248228762752,3.77051341581469
HCC1500,54613361,2.498230028210423,0.00045171915379446756
SaOS-2,ISOX-bortezomib (250-1 mol-mol),1.126416426166952,0.42539614071202353
Daudi,5746,-2.3170879531966273,0.07004639242866738
MDST8,6610355,3.7892287954147457,4.8465756383729035
SK-OV-3,219104,6.736269406359778,3.947945134185707
MOLP-8,49793307,-5.094504062696007,-3.831445757864436
NCI-H1568,54626689,4.298451601405369,4.710622435879428
IGROV-1,156414,1.4212019235656712,1.3359143972344043
Daudi,4477,-0.8111056564008632,0.4767904615010197
K-562,135398738,1.706304792848783,2.333293008194774
MOLM-13,57330099,4.105312173478173,3.6652938927079033
SW1271,42642645,0.8738549597199083,1.0236168287336533
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823,-0.9133467986973878
NCI-H1568,decitabine-carboplatin (1-1 mol-mol),4.2821372470380545,4.4363878462941635
ML-1 [Human thyroid carcinoma],selumetinib-vorinostat (8-1 mol-mol),1.7610539005616883,2.576166937468051
Granta-519,16725315,3.130545070245978,3.335721907767291
ML-1 [Human thyroid carcinoma],73707386,3.645367416812384,2.597534225858766
RKO,3854666,1.2691133577357363,1.1593707131434312
SaOS-2,119182,-1.602754826097209,-0.4995760227903056
ML-1 [Human thyroid carcinoma],49793307,-2.0238665574613024,-1.721588783785879
Granta-519,9843750,4.294258272153345,2.7620934963903823
MDST8,5329102,2.639161266907228,2.1447166152383144
Daudi,selumetinib-JQ-1 (4-1 mol-mol),0.1373274073902578,0.06471307165568041
SW48,36314,-6.6979677874770065,-0.8132188737068384
RKO,9825149,2.459088339864112,1.9672482865312733
MOLM-13,9911463,2.5287579203643986,3.0442809167886513
RERF-LC-MS,44566777,0.4059341966526995,0.7400533854094735
SK-OV-3,10184653,1.9718742380811307,0.9884824928869655
HCC1500,16219061,2.7461663809715375,3.378931970065696
SK-HEP-1,9926054,1.934364320328667,1.9076643017696824
IGROV-1,24901704,3.0789156375765936,3.5450309172648753
BICR 31,9933475,1.7480026685414405,1.8984764482864673
COR-L95,3552672,1.407232830890507,2.589197300579946
NCI-H2452,ISOX-bortezomib (250-1 mol-mol),1.6045376494936,0.8149365046068173
COR-L105,66577038,3.4359280481345755,3.088843493747963
COR-L105,24753719,4.356648297258706,4.399798217585122
ALL-SIL,24978538,-2.389127379896269,-0.8953543624995818
SU-DHL-1,3025986,-2.176216514163443,-1.315195077623919
IA-LM,3062316,1.9598487648076035,1.3022781754751747
MOLP-8,448949,2.0087568721459146,1.382755079104662
HCC15,89928392,2.045660123087396,1.9669231236530078
SK-CO-1,16720766,-0.9325558438762483,1.0940277450028157
IGROV-1,11485656,1.900409616013456,2.407133758040317
HCC15,44137675,4.493981948720765,3.6775889941077016
SaOS-2,5284373,3.659507244236858,2.981000940985883
COR-L95,44589607,1.7004659608333377,2.549679108083607
PaTu 8988t,16659841,4.413190590676007,3.8706200370857466
MDST8,5311,1.1196330054843209,1.5980010951694772
HARA [Human squamous cell lung carcinoma],3825829,3.0637384073868787,4.124440990913744
K-562,168313200,4.769830643466651,2.6638455275450577
SU-DHL-1,36314,4.070517798024083,-1.7519477779122388
COR-L95,219104,2.3748233222255144,3.0151951431230093
Granta-519,44566777,1.2837383493022634,-0.4727870674535319
WM115,45279963,3.6868070952026506,3.7711172968221462
HuP-T3,10127622,4.169685865232827,3.440182899854695
SaOS-2,54454,3.299905279612609,2.5842912342234796
COR-L105,71466445,5.452991683251573,3.9946808940688663
SK-HEP-1,crizotinib-PLX-4032 (2-1 mol-mol),2.841663753001873,1.9081180247808391
COR-L105,19582717,3.403236730524823,4.324881716503148
K-562,11625818,4.129982389727392,3.7435568500603926
LCLC-97TM1,3384730,2.793888789676347,2.505147431044201
BICR 31,4917,3.733916426719056,3.22923652220143
PaTu 8902,54619267,4.2510877724746585,4.19504608384514
ALL-SIL,25102847,-0.1309610459144975,1.6076151373792136
MOLM-13,23939,5.7894293981406,3.4898506163387544
COR-L95,2828334,5.963676169995917,6.0444405538342885
PaTu 8988t,44137675,4.243997881661858,3.834958725172226
HARA [Human squamous cell lung carcinoma],675434,4.319126364052166,4.473299242292256
SW948,5978,-3.22198817122066,-1.5362084825180258
RKN,375860,0.0559819210079563,-0.33657798387693766
NCI-H1568,49836020,3.1231470101883336,2.522479783527506
NCI-H1568,12001922,1.1909466973303815,1.9011164837958574
HuP-T3,135411,0.8125735513868637,0.8174216710196767
NCI-H1568,119607,3.825066299684422,5.362266435906044
WM115,9825149,1.8328544820090609,2.2430582483467263
WM115,104842,-0.2362637011987665,-2.1806259927658123
P31/FUJ,327653,2.543614095842417,2.486543108812243
RKO,11396600,3.504834935214814,2.8726930427165875
SK-CO-1,135440466,-1.3303352220830715,2.4244300633263887
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885,0.6595368480556643
P31/FUJ,23635314,-1.6494447832357666,-2.7650473987338775
RERF-LC-MS,carboplatin-etoposide (40-17 mol-mol),1.469978322286411,2.970384567028887
SW1271,46215462,2.0233113088179406,1.97333273769102
MOLP-8,969516,1.8716619229833695,2.1863406283753024
K-562,135999136,3.657737204061429,2.8595268564434475
SW1271,9866186,1.0057234740027048,0.8266515089406758
BICR 31,5278396,4.450921628721945,3.597438176350455
HuP-T3,462382,0.4397112913332706,0.510303146182773
SW48,44202524,0.7134579720144102,2.02667151045479
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233,-1.1187693797121905
HARA [Human squamous cell lung carcinoma],6610216,4.810637550807952,4.380715274330995
LCLC-97TM1,3025944,4.079230434060959,4.146705982020686
SW48,46174525,4.111785915347283,4.426423558602105
HCC15,11396600,3.725702968544969,3.9064019459789323
SaOS-2,2949965,2.5764816921436067,2.936598469080857
COR-L95,selumetinib-navitoclax (8-1 mol-mol),1.0752689694736437,0.9832819343597832
NCI-H1568,10296883,3.9462373745058863,4.041723474106825
COR-L105,SNX-2112-bortezomib (250-1 mol-mol),-1.6644703388391169,-1.015176492617012
Panc 02.03,216345,4.682043945218969,4.192578683483842
Daudi,26596,-3.612902475241139,-2.488124179858917
NCI-H2452,262093,3.2163720661137942,3.1175969861097723
PaTu 8902,9936388,2.1491039356268966,-0.4611552541584429
SaOS-2,4477,0.5134457679146515,0.6220670802442708
RERF-LC-MS,4096211,1.8582313750529689,2.2191951927027387
SK-HEP-1,53232,2.505434368946379,2.5320973689426776
SaOS-2,crizotinib-PLX-4032 (2-1 mol-mol),1.6526017036303646,2.019068421714778
KU-19-19,439501,-2.2192304341921205,-1.899024170798125
SW48,11222830,1.1015320686905217,1.6260319719668541
P31/FUJ,71680916,4.420716560192731,3.9174144997051172
IGROV-1,73707398,0.8848064516600974,1.3051500570258667
BICR 31,176870,3.2718013899021607,3.30127362147899
PaTu 8902,72193861,3.6637635590803384,2.155342376033854
SW48,10427712,4.323791553226545,4.369379586748725
HuP-T3,5470400,-0.4965810223867313,-0.15541995563367844
BFTC-909,3385,6.578023483143935,4.4447045241972205
LS411N,5278396,4.113687735714835,3.0947006261650425
WM115,carboplatin-etoposide (40-17 mol-mol),5.807621476943687,2.6019151926325126
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404,0.768535957224659
P31/FUJ,36462,-0.6599401629031103,0.06917341105778543
IA-LM,24964624,2.660053298461781,1.9411026769804591
Granta-519,4477,0.7960263088071861,0.6341017081825723
WM115,675434,4.127717546006753,4.539091909852722
SW48,2708,3.1864056833879726,4.988976725172111
P31/FUJ,11964036,1.0580497047985076,0.2922421550831051
SK-CO-1,4096211,1.2314360568652074,2.1547641114898957
Granta-519,24748573,3.0643863299071668,1.4224407734807412
HCC1500,salermide-PLX-4032 (12-1 mol-mol),5.277831355050616,4.501156756387359
MDST8,6918736,-3.3936356144084066,-1.1093889921421287
IGROV-1,3062316,-2.2361832227909075,1.6322442111955615
Daudi,136227331,3.813653547789358,3.2359383724585125
MDST8,3385,6.506797592159471,4.355449235460864
MOLP-8,3101542,4.39402228569031,1.8284184166537343
PaTu 8988t,19582717,5.440280671607156,4.3579270867545485
ALL-SIL,54618771,-0.3818526805852408,-0.19830585692952096
SW948,9911463,3.099005262739027,3.3707205649577205
NCI-H1568,navitoclax-pluripotin (1-1 mol-mol),-0.6791877741589081,-0.4266568803530587
HEL,4259181,-1.3539346499127438,-0.42835498971620356
Panc 02.03,702558,5.477624163348055,5.495300250457598
RCC10RGB,9911463,4.415558893727306,4.011646116238162
P31/FUJ,2828334,6.241721397046506,5.610633619813419
BFTC-909,53232,2.9810373365160316,2.7013127711000027
KU-19-19,1750826,-1.6748688873644846,-1.1816257603108695
WM115,54454,3.1744679186495963,2.532868654239707
LS180,5329102,2.7428602070947266,2.0360956769491128
K-562,25102847,1.0686863962440132,1.861343358864022
NCI-H2452,51039095,3.311280338748592,2.9311559561928617
SaOS-2,107985,-4.209612864808627,-3.5357116806755413
RERF-LC-MS,24180719,3.6010609924552455,3.8288397832953645
P31/FUJ,9967941,3.859476565836545,3.210122623489917
ALL-SIL,19582717,3.9660864037028793,2.8618261651856924
BICR 31,448949,3.395825088667814,2.1333258004834845
IGROV-1,9926054,1.8111808945519428,2.0700745522430752
MOLM-13,44632017,0.3571286974750209,0.84578866641451
RKO,984333,1.1849980625737155,-0.013276445911665017
BICR 31,tretinoin-carboplatin (2-1 mol-mol),5.271330190091957,5.092169069920313
LS180,5311281,2.3621140012684014,2.569323572819162
IGROV-1,5328940,0.347812751869877,1.8569330540365891
SU-DHL-1,126941,-4.504729002827146,-2.6951507304899365
LS180,49850262,4.041689005821524,3.841392397118877
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435,1.2702427552999822
SW48,10113978,2.97157913395206,3.2180659058143926
COR-L95,227681,2.232633220711044,2.770780298197059
P31/FUJ,carboplatin-etoposide (40-17 mol-mol),0.2579285765316561,0.6063276105769316
SW1271,65064,3.2018268639765908,4.833505556565159
Daudi,2733487,3.89488184101632,5.393579497609064
MDST8,4096211,1.945430248625456,2.1249555055260143
MOLM-13,56963564,-0.6687647359934185,-0.15682350740081172
HEL,navitoclax-birinapant (1-1 mol-mol),-0.6071790485634636,0.23452688545379735
Daudi,216468,0.1519487612341026,1.099382174878907
COR-L105,11494412,3.277457630260471,1.7826695720125398
BICR 31,31703,-0.4867862372580436,-0.6112160270772646
P31/FUJ,49793307,-4.015617000908982,-3.9945874828795955
ALL-SIL,6450551,-1.4599471288533186,1.1682953963315703
LS411N,selumetinib-JQ-1 (4-1 mol-mol),-0.8055713738039206,0.061809026370514004
SW1271,36462,1.4389686814792042,2.189350479717275
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251,1.4910821872675806
SW1271,17755052,4.188603356762487,2.1626769261729204
HARA [Human squamous cell lung carcinoma],9444,4.21141613858085,4.305446022646267
Granta-519,9967941,4.009641048767512,3.209972043917822
HCC1500,25105715,3.368057340132644,3.4603773412623315
Daudi,ISOX-bortezomib (250-1 mol-mol),-0.1612683603405773,-0.06384874802511817
HEL,2858523,2.985624119180162,2.5469619758313558
SaOS-2,3543504,4.845259948636094,4.23653765821912
HEL,71466578,3.2881122758034413,2.428449177376615
MOLM-13,44185566,-0.1979234147827578,1.6363318818317503
RKO,46215462,1.869666408515056,1.4607907716186859
PaTu 8988t,16720766,0.7633491404380248,0.6488910573729904
MDST8,17755052,0.7758841708349149,1.8906747112404272
SW948,doxorubicin-navitoclax (2-1 mol-mol),-0.3830277458226139,-0.7614869465731487
Granta-519,16741245,4.459375532286075,3.4592823199718112
LCLC-97TM1,36462,0.8347023875377979,2.3477500259766275
HEL,24785538,4.025400084811953,0.052032478300235455
SU-DHL-1,piperlongumine-MST-312 (1-1 mol-mol),0.8193437205412945,1.690078620135042
SK-CO-1,54613361,-1.1953747905350511,-0.20327431763745757
HCC1500,selumetinib-GDC-0941 (4-1 mol-mol),3.80127350150034,1.4544297483921975
Daudi,25105715,2.455657378323054,2.995675634365239
SK-CO-1,3038522,3.74499401693701,2.9902789642244807
LS411N,11625818,4.428513603720294,3.7755757064515416
SW948,445643,4.022773961540602,3.932976048559825
COR-L105,135984461,4.336047626093702,4.118181695316869
NCI-H1568,71466578,4.264938806787537,4.681281782339045
HuP-T3,11364421,1.6783982807514195,-1.0048913782151447
Daudi,49867926,3.659415180241599,2.7287808225194454
HARA [Human squamous cell lung carcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.7875744304636512,-0.7237363395920788
SW948,11404337,1.0073661261070797,-0.3929381171475803
SU-DHL-6,5278396,3.0928075812605123,3.1538251260082846
SW48,JQ-1-vorinostat (2-1 mol-mol),0.3555995079043024,1.0995003997494726
PaTu 8988t,24964624,3.238300662516523,2.7295130811901425
Granta-519,135411,0.2246473977843227,-0.05942906156299955
LS411N,3025986,-2.0648766502168843,-0.8911720743737729
HEL,BRD-K58730230,4.651487565209977,3.3105192022243286
K-562,148124,-7.41486725283878,-3.400409306867159
K-562,10302451,0.1323934402367818,2.639127707732845
K-562,1641662,2.591871767435193,2.9689201605455584
ML-1 [Human thyroid carcinoma],54618164,4.279062995535924,4.115763487323238
Daudi,156422,2.1936092532092295,3.010806155171528
BFTC-909,44491742,4.0640318167931255,4.412200885660971
PaTu 8988t,doxorubicin-navitoclax (2-1 mol-mol),-0.3664110079346409,-1.2052614356346356
MOLP-8,135398744,7.476327693514706,4.348063586908906
IGROV-1,54618164,4.2184521751950115,4.116342011868635
HCC1500,selumetinib-vorinostat (8-1 mol-mol),2.561295167839282,2.5860301306938887
PaTu 8988t,4259181,-1.3402011211504403,0.011481479983099483
RCC10RGB,selumetinib-navitoclax (8-1 mol-mol),2.731385168920209,2.311777627228066
KU-19-19,31703,-0.69897788572983,-0.7445628433228109
SK-HEP-1,5460769,6.10306620405049,2.802233493542042
K-562,11404337,1.5978316825317844,-0.973377252711691
NCI-H2452,9840324,6.282829349463256,6.001730999721502
HEL,JQ-1-carboplatin (1-1 mol-mol),-0.4400207777249079,-0.4530837210993644
KU-19-19,11214940,3.3843502872937106,1.911509103375022
MOLM-13,3815108,3.4784839929418343,2.0184761924354593
IGROV-1,16065773,3.3717508464278585,2.5047677474328047
Daudi,6252,0.2227136884944618,-2.2680142237117904
SK-OV-3,1641662,4.382504296977698,3.622688790482288
MOLP-8,11238147,1.6731293567937424,2.1288889738661076
K-562,44462760,3.6560426907742896,2.9191263804448595
RKO,9911463,3.963116579454927,3.128997454873369
KU-19-19,387447,-3.0100561484626738,-4.262672608995864
LS180,219104,3.901138037988577,3.8772293138167147
SaOS-2,selumetinib-UNC0638 (4-1 mol-mol),4.750362941139615,3.051452483075893
LS180,11609586,3.254650235567635,2.6538804592110568
RKO,3025944,4.391654014934833,4.1325128553168184
ML-1 [Human thyroid carcinoma],16720766,0.621696324806819,0.7055900892290505
SW1573,11640390,3.5338327701281176,3.6302477985562933
ML-1 [Human thyroid carcinoma],6917907,-7.443362541349426,-3.3866470676340925
NCI-H2452,navitoclax-pluripotin (1-1 mol-mol),-1.4411429928004444,-0.7026161344648603
LCLC-97TM1,2708,5.63991197078878,4.459880626637779
HuP-T3,262093,3.018266583248783,2.916133093161114
PaTu 8902,3503,3.0706473844938422,2.412170991474204
HCC15,6918328,-0.0257689511183662,0.4022092084244857
COR-L105,24797083,1.0360227961267732,1.5435475148915105
P31/FUJ,9887053,2.876589254443052,2.629729593676535
WM115,446155,1.535185995815247,2.546086601429141
COR-L105,613753,3.1601590793812,3.2631539999105876
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021,-0.7510727651768943
IGROV-1,10385095,1.0670946713416192,1.3092806502326177
NCI-H2452,6252,4.582294901932163,1.0676513157115899
MOLP-8,72193861,1.011292170776,0.401288763137658
LS411N,JQ-1-vorinostat (2-1 mol-mol),0.7731890132640523,-0.01356734942424495
IGROV-1,26596,2.910298792762654,-0.6900814895688018
RERF-LC-MS,11640390,2.8932892314821927,3.785701058085477
SW1573,selumetinib-piperlongumine (8-1 mol-mol),4.823355107887568,3.398745438907633
ML-1 [Human thyroid carcinoma],9444,3.622178437751676,4.279448464146382
MOLP-8,carboplatin-etoposide (40-17 mol-mol),0.4522049028656168,0.9045616727815831
RKO,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7729264296394276,3.5357974566936257
SK-OV-3,168313047,2.892407732266751,2.523507574494999
Daudi,9926054,1.7776420054693636,1.6407166210637254
COR-L105,2749,1.1758378373045044,2.269224456343593
SK-CO-1,6918837,-2.3986996753086305,-2.9317082764772913
IGROV-1,12003241,-2.0122972114546904,-1.0946002226754457
HCC15,9866186,0.9811967871114916,0.7301318840989957
MOLP-8,selumetinib-decitabine (4-1 mol-mol),-1.0628389373049278,0.657827668978457
WM115,9887053,3.7520086754622657,4.344660388180134
COR-L105,9933475,1.7212192557919994,2.0384863733362977
MDST8,9967941,4.864965348465847,3.652741919902188
KU-19-19,5566,3.5813761109507154,3.0015084993718375
MDST8,navitoclax-pluripotin (1-1 mol-mol),-0.7687489339577367,-0.9102557706317181
ALL-SIL,168313016,2.945013463521221,3.8806195517254287
RKN,JQ-1-vorinostat (2-1 mol-mol),1.810431860868636,0.990753924251655
LCLC-97TM1,216239,3.3274661005628636,2.3155287079594586
UACC-812,9935249,3.1921366544842,2.787205432813705
KU-19-19,46398810,3.059016393641159,2.7740510968879017
HCC15,selumetinib-vorinostat (8-1 mol-mol),1.4639379045779866,2.600994318027867
Daudi,24901704,1.6931015271472445,2.0984160914703995
UACC-812,navitoclax-sorafenib (1-1 mol-mol),2.1784288698451473,1.6642189467646435
SU-DHL-1,135440466,0.4118800450630493,2.04471641166867
IGROV-1,5311,1.0068816368200209,1.4883649963058938
RERF-LC-MS,5329102,2.8374518121885637,2.2125536513524633
LS180,selumetinib-UNC0638 (4-1 mol-mol),1.869156071766359,2.5950996159101622
Granta-519,10302451,3.667767303482806,2.631480955563478
HCC1500,alisertib-navitoclax (2-1 mol-mol),-1.6435253227103,0.47347881823452087
NCI-H1568,4096211,1.8643847121139272,2.2551194842643376
ML-1 [Human thyroid carcinoma],11612883,2.523942692100722,3.246895604810817
LS180,44487872,4.564049669792266,4.437779208244104
ALL-SIL,JQ-1-vorinostat (2-1 mol-mol),0.0034804556832889,-0.6603971312275214
SW948,135411,1.551236240082995,0.5608310445518808
PaTu 8988t,216345,4.148994433618168,4.058342806737102
LS180,9935249,3.57280690269837,3.0652675649321117
UACC-812,46926350,-4.425607795744521,-4.1451507290874705
K-562,46224516,3.0237589268452396,2.2024269209703244
SW948,16013152,4.211275799279611,3.265547376696174
BICR 22,10074640,3.373223414806136,3.061587754394357
Granta-519,54618164,3.794628352719798,3.4742335739194856
K-562,49793307,-5.346924391172112,-4.056482352987943
IGROV-1,54678924,1.4704159748793169,2.257635956571808
COR-L105,selumetinib-tretinoin (2-1 mol-mol),2.682328410307197,3.767657998876304
IA-LM,24785538,2.950939703376364,0.5170525398255567
HARA [Human squamous cell lung carcinoma],5278396,3.775794457804869,3.5654503313437083
ALL-SIL,262093,0.6753795238054565,1.5235974805847095
SK-HEP-1,49793307,-1.6219654789172164,-1.966946970052641
UACC-812,9915743,-6.921665690083625,-0.8287058858145371
MOLP-8,24964624,0.5129160642166024,1.2474724431614974
SW48,16725315,4.089936042929296,4.300542085379889
P31/FUJ,25102847,1.6695774391929423,2.0566986404429954
MOLM-13,216468,0.0785275755512733,1.037308969696387
HCC1500,135421197,1.2704457907642457,1.9482438865115748
COR-L95,445643,4.015431140089913,3.760934584665916
Granta-519,9826308,-1.279512827450026,-0.39668708772276695
HARA [Human squamous cell lung carcinoma],9549297,1.8946305959472185,2.426672798833132
HCC15,44589607,3.4730057914725005,3.047970777581453
SK-CO-1,73707398,0.894037962240185,1.631376179405836
RERF-LC-MS,46191454,1.934559197398404,2.1762973051805967
PaTu 8902,44491742,4.263402068757711,4.308586773230338
PaTu 8902,53481919,4.066569856261274,3.9225797317897655
HCC1500,4521392,5.662319691471263,4.27174896593041
BICR 22,11364421,-5.708558910936986,-1.447049185341148
LCLC-97TM1,6610216,4.478615539127516,4.102228002662279
BICR 22,52912189,1.443997008169696,2.3935629095546433
SW1271,11404337,-3.6050810245472382,-0.2702121651735158
IGROV-1,969516,2.460805405371151,2.860621637421576
LS411N,25062766,1.7796504921777256,1.8878956970891647
IGROV-1,11977753,-2.2284230058029433,-1.372718786368373
SW48,JQ-1-UNC0638 (2-1 mol-mol),0.4200169651809782,1.4652211745445056
IA-LM,54618164,4.43488746250501,4.0217256544056745
SU-DHL-1,135398738,3.5570959576905983,3.942424300927519
HCC1500,23725625,5.012282150953445,5.17121375144894
SW948,56973724,2.5267361451247647,2.3735502325882516
COR-L105,2742550,3.8597521863519257,4.098718920015807
HCC1500,selumetinib-navitoclax (8-1 mol-mol),0.8768646792211049,1.5452220685220175
SW948,11485656,1.7814283284456571,1.9311464896050652
LS180,56963564,-0.4927248320174067,0.40320001469391753
RKO,9866186,0.3829002704071885,0.466047028059698
Daudi,44202524,1.1056351253600936,1.3077509445050195
NCI-H1568,11964036,0.8982081488420575,1.370617700852863
MOLM-13,9915743,0.7456385275428815,0.40699018854158125
Panc 02.03,4788,6.040807258084593,5.82463729807674
SU-DHL-1,10410894,1.885737679840171,3.047123943510718
WM115,3062316,1.2654694678882143,1.2182563836754283
HuP-T3,148198,-3.5090934063696153,-2.9737428259124896
HCC1500,24748573,2.217224851211772,2.348684854552016
RKN,44185566,3.394049733904779,2.6810041561319946
WM115,73707371,4.316198918387243,5.039120438889669
HARA [Human squamous cell lung carcinoma],2749,1.5155233624959286,2.1711467089665977
COR-L95,119607,5.444677320305195,4.97750385922939
SW1271,3543504,5.279434126076659,4.497122296865913
RKN,613753,3.037549827357118,3.375876880428768
MOLP-8,9933475,1.6461417731910544,1.5401299677256
SU-DHL-1,374536,2.32669265560356,1.673544593997583
NCI-H2452,11222830,1.0864314168284432,1.7604302500437372
BICR 31,16736978,1.5520316002325725,1.7671611613139657
BFTC-909,11656518,3.71751997684089,1.98669931645427
SW48,49793307,-4.357023521296349,-2.8052942672010266
HCC15,676352,2.734399334153108,2.1829107864623336
K-562,9933475,1.5582186007451084,1.451861712938265
COR-L105,1716436,2.5827881779858797,3.0668343761997208
MOLP-8,71751553,4.257415338539138,3.6262921652075364
MOLP-8,11427553,-1.470461076327197,1.4771613527842902
HARA [Human squamous cell lung carcinoma],5329102,2.385019760073336,2.0836795342046837
HCC1500,65064,3.4319990575629484,4.772128283456913
BICR 22,54678924,2.835542995017498,2.090957128601842
SaOS-2,52947716,3.1327874038156636,-0.8258941982538229
RERF-LC-MS,327653,4.17889189356682,3.320907047902972
RERF-LC-MS,216468,3.2358353560937267,3.5143706423235996
LS180,637858,2.1359320280537704,1.8439986336238605
ALL-SIL,navitoclax-PLX-4032 (1-1 mol-mol),-1.20714893159784,-0.6082501156540864
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404,3.0355113378692717
HCC15,25154868,4.699010678354358,4.392755876539486
BFTC-909,1716436,3.115342072857748,3.2283129779829305
WM115,208908,3.0871953707393662,1.948663387089693
COR-L95,5287969,-1.974656124599848,-1.8155842582610857
MOLP-8,9907093,3.7363465424365567,3.5144924552728787
RCC10RGB,5738263,4.593697299478501,3.7700864699816714
SU-DHL-1,446155,1.7989638936827528,2.47606157545277
Granta-519,51037431,4.032962229357369,2.7286363668764917
BFTC-909,24771867,4.730369684143592,2.9244284350708325
SW1271,9926054,1.9992649208496855,2.2676729017607316
IA-LM,46843906,4.034671652936036,2.06959514093245
PaTu 8902,3634881,3.736044150449037,3.2054374950493423
HARA [Human squamous cell lung carcinoma],5311281,2.4258881489706217,2.773693607958466
COR-L105,89928392,1.7234999745886912,1.714876479521442
Panc 02.03,6917907,-5.450554920776264,-4.767352012856444
ALL-SIL,216345,2.7239648031314108,2.8006835823234195
Granta-519,5311281,1.2060114833285496,1.5226647797134247
RKN,25150857,2.829513348324473,2.5526579996674514
RERF-LC-MS,702558,6.005509402748126,5.416998733296539
Granta-519,44202524,0.8355806814666445,1.3139271343187096
IGROV-1,65064,4.920352624378345,4.841164369053413
HCC15,82146,4.430619158397189,3.840454982410062
IGROV-1,135984461,4.285945029851472,4.1031515960476765
SW1573,tretinoin-navitoclax (4-1 mol-mol),3.744579099862024,2.9971129885024097
RKN,25183872,-1.1518449365963386,-0.886041840481576
SW1271,6450551,2.703162256598128,2.8435764507502523
COR-L95,SNX-2112-bortezomib (250-1 mol-mol),-1.5926355912839212,-1.2918623301207046
RKN,656346,1.677354805367284,1.0145071049149657
MOLP-8,3503,1.781914224283778,1.9519776910878508
COR-L105,2828334,6.248355208389406,6.183087230541755
BFTC-909,docetaxel-tanespimycin (2-1 mol-mol),0.450361572300305,-2.474736334960105
MOLP-8,135875424,3.0291075959050233,3.183834559556539
HCC15,24748573,2.004363812639911,2.3983745291974126
RERF-LC-MS,selumetinib-MK-2206 (8-1 mol-mol),2.1861340415515076,2.5120696452022555
HARA [Human squamous cell lung carcinoma],89928392,1.691456490518517,1.7310680851067146
IGROV-1,56649450,0.515518984822669,3.2181654586172375
KU-19-19,9444,4.28834999434395,4.323799040420938
Granta-519,3552672,2.198733357723822,2.2836950930723816
SW948,66577038,2.9537896679300655,2.827237562154871
NCI-H2452,119607,5.591396796149955,5.467121774403341
RKN,selumetinib-tretinoin (2-1 mol-mol),7.09288474093864,3.854494522489899
HuP-T3,2729026,2.9922624267509317,2.7098774417523805
SK-HEP-1,71466578,6.341226391578653,4.651450563488796
Daudi,24785538,-0.3082535888445589,0.5584250818252194
IGROV-1,5280436,3.2616766817665086,3.555995529565654
RERF-LC-MS,7251185,3.4578262740878976,2.943820705919353
HCC15,156414,2.365134958139565,1.730170961838659
BICR 22,piperlongumine-MST-312 (1-1 mol-mol),1.342404351806,1.9071179868502512
BICR 31,10127622,3.719060323270891,3.8215046369001455
SaOS-2,15547703,3.066966974063678,3.509044082151435
Daudi,decitabine-carboplatin (1-1 mol-mol),0.1639659484946293,0.06595529944185734
HCC15,alisertib-navitoclax (2-1 mol-mol),-2.6533611611755177,1.014573896868417
SU-DHL-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.028973070586865,3.818012512818985
SU-DHL-1,3689413,-2.511818154735677,0.1884199111105702
COR-L105,56946209,-4.798718381888378,-3.70908634185411
IGROV-1,5978,-1.5618214380165825,-1.9577572946424362
BFTC-909,11222830,1.7098036316197358,1.8018520640834976
IGROV-1,216239,2.21703825410177,2.4082261550866075
MDST8,135440466,3.3221976295713342,2.5512585455790986
P31/FUJ,44632017,0.6534437162154956,0.9306363930811237
IGROV-1,219104,3.803083685328391,3.8923286145611575
SaOS-2,637858,1.716758511666406,1.9638758266656142
WM115,crizotinib-PLX-4032 (2-1 mol-mol),-0.0688201401017855,1.741999158850224
COR-L95,24753719,4.203119149122614,3.8724309122397558
HCC1500,3025944,3.928139296588046,4.1750734071687114
Panc 02.03,56946209,-4.513446270471167,-4.037413220149545
HuP-T3,25126798,3.926602492728053,3.7976372566734797
PaTu 8988t,3011155,4.341218756124128,4.103687727053882
SW48,20959075,-3.67297247887529,-2.6115593630232947
HCC1500,JQ-1-navitoclax (2-1 mol-mol),-0.2605650300766051,0.4453669306366714
BICR 22,44486219,3.936553836391045,4.341240455817964
RERF-LC-MS,6918736,-1.8242544668906209,-1.6221569746885676
NCI-H2452,selumetinib-PLX-4032 (8-1 mol-mol),3.036066268275686,3.6604995673375
RKO,44137675,4.282234128328841,3.108760792394752
IA-LM,11626560,2.8197095065502515,1.272854637651151
SW948,2746,1.2183078272507333,2.5130251468284546
NCI-H1568,168313200,3.516432771095034,3.028845126552448
IA-LM,262093,2.9896562434219627,2.4232655154289535
MOLP-8,4261,-0.435327551985223,0.34237669102957546
HEL,2708,3.2519957529556716,3.417244755662968
BICR 31,selumetinib-tretinoin (2-1 mol-mol),0.9632535907950592,3.732938158397182
LCLC-97TM1,erlotinib-PLX-4032 (2-1 mol-mol),2.856806725221915,3.0081615810160063
MOLM-13,51039095,-0.7255439577713276,1.9584242176165378
IGROV-1,426756,6.142776526139055,4.402996869120184
NCI-H2452,25154868,4.866167054223791,4.58393790049028
PaTu 8902,4705,3.6244040622068256,3.125342352473776
ML-1 [Human thyroid carcinoma],25105715,3.821272786179671,3.523052552209859
Daudi,135421197,0.2989842149032058,1.285387223070526
IGROV-1,10427712,3.944243047938238,4.32058165933701
COR-L95,24978538,-1.547703636473998,0.5098796064245357
SaOS-2,52912189,2.036463757447864,2.3105734231968986
PaTu 8902,452548,0.9739796251952438,0.4200864194051585
IGROV-1,52912189,2.3966568144845666,2.13162294633244
SU-DHL-1,387447,-5.562438756444553,-4.517980340786561
HCC15,135398516,2.1695814103654696,2.1228749908050535
SK-CO-1,6610216,4.838209270425191,4.216342134249775
MOLM-13,5351362,0.6925875902125201,1.0870122494985919
HCC15,46191454,1.8626809755345697,2.119815658996004
SW948,9825149,1.8114941973110277,2.1329734976228845
Daudi,54639665,4.383406013207389,3.007202839456674
HEL,2828334,6.1216048061751795,5.596217136745039
BICR 22,71466445,3.433479198461154,3.5531623837690485
ALL-SIL,9826308,-0.8056632694679019,-0.17632385118694946
NCI-H2452,57519531,1.3990882913061125,2.67895856360677
BICR 22,54613361,0.4978505675466737,0.4439022378391842
SK-OV-3,135440466,2.5162908691834405,2.3509026267765027
SW48,JQ-1-MK-0752 (1-1 mol-mol),-0.7749163681319219,1.8336343016367165
SW48,6852167,2.2630322871527913,2.871914567783901
RKO,11404337,-0.3534280477619294,-0.5717903483339373
ALL-SIL,5291,-1.9713425457655045,2.985950329245516
K-562,salermide-PLX-4032 (12-1 mol-mol),5.074335009677914,4.794409207309669
IGROV-1,24771867,1.9944882740161016,2.4485577301598
MOLM-13,46224516,1.6904951862054391,1.9587066889618265
SW48,119607,5.387394946551996,5.1849991477289
Panc 02.03,ISOX-bortezomib (250-1 mol-mol),1.22897027092613,0.722180616328917
BICR 22,49836020,2.6142262300183305,1.9930355821059627
BICR 22,16720766,0.4876582946813295,1.2015392910950056
HARA [Human squamous cell lung carcinoma],159324,3.9851922367796937,3.1672838445706093
SK-CO-1,123631,1.846760097113305,2.3181965436886536
BFTC-909,36462,4.374665451212183,2.522088589399791
LS180,vorinostat-carboplatin (1-1 mol-mol),3.0396864380779327,3.1308774700372304
RKO,5328940,1.7974237645790871,1.2686595017180768
RCC10RGB,ISOX-bortezomib (250-1 mol-mol),1.8255695347909304,0.8710103434974585
ALL-SIL,5281321,-2.461016259028612,-2.7830905857788726
P31/FUJ,568763,-0.9310646254211032,-0.3558035550799594
HuP-T3,selumetinib-UNC0638 (4-1 mol-mol),3.11768337000848,3.1423177235174955
HCC15,crizotinib-PLX-4032 (2-1 mol-mol),0.980759868979001,1.9834010145808458
WM115,3081361,1.7542351340434374,2.4227860189143917
Panc 02.03,676352,3.0262590525496895,2.1566163693425526
Panc 02.03,44462760,5.147948611944762,3.7237989361850112
COR-L95,11228183,-1.8408108773608771,1.5446783508256439
WM115,56973724,4.208743527700851,3.3634146693605556
KU-19-19,vorinostat-carboplatin (1-1 mol-mol),2.5196906513135913,3.447072778649666
HEL,65628,4.10911337005638,3.2696305436620383
Daudi,11612883,1.1925703345745973,1.8588462566212265
RCC10RGB,24856436,4.070420512574028,0.9944676863149993
COR-L105,46199207,3.6604959991625825,3.3854438044507185
Granta-519,25195348,3.9328442274761217,2.603663415904173
NCI-H1568,1750826,-3.116085482779225,-0.9647275139994332
IA-LM,12001922,1.9531449792239188,2.0032888266642432
IGROV-1,19582717,6.764352444432722,4.226148063629635
HCC15,10113978,2.260363506948615,3.4205400674822495
SK-HEP-1,10074640,3.7857764861964935,3.292861694215643
PaTu 8988t,6918328,1.905296387062238,0.12126027395998724
HuP-T3,24785538,1.540895569713237,1.6573792415995894
BICR 31,5281321,1.1837918014475457,-0.9360835763521544
MOLM-13,216345,0.0865178974102724,2.6652709190542896
HCC15,448949,2.8674184346568414,1.9139675358613761
K-562,44566777,1.311822236929868,0.23279490732599975
HEL,452548,-1.769607447996444,-2.7411715508070307
SU-DHL-1,11507802,0.9378608618407872,1.6736269284321341
SU-DHL-6,2113511,5.89050983447184,4.266258369068085
SaOS-2,54613361,0.0035364978270003,-0.0019987059998766
SaOS-2,24748573,1.7294478830476196,2.033134967448948
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713,3.4086673095157263
HuP-T3,49766530,1.2218451996302029,-0.7508582669495512
HEL,262093,2.3252232523203995,1.639130407495641
SaOS-2,tretinoin-navitoclax (4-1 mol-mol),2.244909484198112,2.6928538600061467
MOLP-8,675434,3.835070621627746,3.984855951635025
RKN,16725315,3.256745916563384,4.080150482847724
RERF-LC-MS,5746,1.1068525081764873,1.6291568221095023
SaOS-2,11964036,0.5086023979470407,1.3910330362684435
COR-L105,selumetinib-navitoclax (8-1 mol-mol),1.996235021345007,2.111201686373396
LCLC-97TM1,126941,-2.218385477362075,-2.1235943222552636
HCC15,54618771,1.6567762934530044,1.3573709920248658
RKO,2113511,4.623772297498578,5.212010144836353
RKN,9929138,7.419607622812729,5.682920206777975
HCC1500,5460769,5.1304942195737935,2.707332692442673
COR-L95,31703,-3.0462560513884203,-1.1133998262246347
HCC1500,46224516,1.0534131743048871,2.495353475008756
Panc 02.03,5328940,2.397017671249583,1.7793334894053734
LCLC-97TM1,11404337,-1.4043223473519348,-0.20236908029805462
HCC1500,42642645,1.451455976812008,1.0517228281672941
IGROV-1,51037431,5.669320749085174,3.372667066451289
SW1573,107970,2.0608182724975266,2.380183369710694
SW948,46191454,4.338482378206047,1.4860264340723466
Granta-519,11455910,0.302072347623865,0.45367424621087765
COR-L105,2113511,6.080993735084838,5.712605743292722
SW948,ISOX-bortezomib (250-1 mol-mol),0.2235113953706366,0.6283601776745293
IGROV-1,448949,2.098499309472767,2.0128443325029064
NCI-H1568,107970,1.680617581032042,2.5526977721698088
SK-OV-3,24797083,1.6169926593639932,1.3685436127916766
ML-1 [Human thyroid carcinoma],vorinostat-navitoclax (4-1 mol-mol),0.5480043604957033,1.4590249412758276
SW948,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.798210383310514,3.5874974850631345
IGROV-1,4259181,0.1937358171291443,0.15288196952912805
LS180,135875424,4.384751932486372,3.8887066080166175
UACC-812,54765302,2.961863639252158,3.965032138229529
SW1271,49867926,6.0238397416149345,4.488416684423334
SU-DHL-1,3025944,3.851371371046294,4.093688908158508
SW48,9967941,4.423983829284398,3.6957108752292624
SW1573,11609586,3.686627979451031,3.1371738732481362
Panc 02.03,16065773,3.1661848504472023,2.427613848902214
RCC10RGB,135421197,4.393109316582631,2.377612876212117
IGROV-1,24785538,1.106246320450551,1.6166589033607972
HuP-T3,5278396,4.193223405360703,3.663569759362903
IA-LM,24901704,3.940918836251392,2.7924934059423325
SK-HEP-1,11214940,1.8009666315936252,1.9956823165079944
K-562,11364421,-5.792707438494169,-4.135506900912916
LS411N,3384730,4.573317632228089,1.79170964516247
LCLC-97TM1,568763,-0.0784771886342085,0.3305365771708063
HCC1500,9936388,-2.5304598124234365,-1.5977320000215547
HCC15,5311,0.7792586953300233,1.4626744211363525
SU-DHL-1,54686904,3.5039759810509676,3.0676763919624817
PaTu 8988t,11626560,2.010870886496287,2.169451665626065
HuP-T3,2749,2.009482044490881,2.126175842368575
RKO,60750,-2.2331483998906654,-2.8531741514434903
HCC15,5287620,-1.6098111318920385,-1.864314715989109
HEL,654092,-1.523294365181231,-1.0257585327565493
SK-HEP-1,71304818,1.6350171624170464,2.658798497205435
SU-DHL-1,448949,1.2808073887625644,1.7463102320711767
K-562,5281321,0.5422415972342122,-2.064683745730826
NCI-H1568,selumetinib-JQ-1 (4-1 mol-mol),2.397330498930178,1.9202200978169734
LCLC-97TM1,5351362,1.316382729979947,1.3875982662763733
MOLP-8,5460769,1.8843864880791628,2.5183110994312794
SaOS-2,56963564,-0.1924881408966614,0.6072542199230943
RKN,446155,3.7628691651204234,2.607944825834777
HEL,doxorubicin-navitoclax (2-1 mol-mol),-1.6523771973343595,-2.4272287382432793
NCI-H1568,16038120,0.8714631615296456,1.3350298029102854
Daudi,25102847,1.3031740879242997,1.9503330749087007
LS411N,25154868,4.929077040033465,4.127170128807224
SW1573,crizotinib-PLX-4032 (2-1 mol-mol),2.8041804107820796,2.054769433862698
ML-1 [Human thyroid carcinoma],54649381,4.324070376451948,4.02527481692911
LS411N,9915743,2.8294092926119028,0.530097719677189
Panc 02.03,BRD-K55473186,4.513191364064351,4.310294465785847
SW1271,JQ-1-vorinostat (2-1 mol-mol),1.5175672893366323,1.1624171250272066
SK-HEP-1,selumetinib-navitoclax (8-1 mol-mol),3.029292695644022,2.1050912722515407
SU-DHL-6,4917,2.9501994456287792,2.7591668444553066
Daudi,16741245,3.410771008602035,3.6516181078648247
MOLP-8,3062316,1.3489297980566397,0.811802812935928
NCI-H2452,selumetinib-UNC0638 (4-1 mol-mol),4.804967854809725,3.402282436979156
RERF-LC-MS,25183872,-0.4545636564638026,-0.4006146401497762
HEL,JQ-1-UNC0638 (2-1 mol-mol),-0.0647820501822815,-0.34699610657640767
MOLP-8,60700,-2.8082015295780858,-1.34356800687457
NCI-H2452,637858,1.8545349692582156,2.1925042351886654
LCLC-97TM1,11626560,0.938916298027116,1.6378706421261284
HuP-T3,136227924,2.888640375816574,3.008017721104578
IA-LM,5284329,5.1954673618886655,2.899596786173632
RKO,104842,-2.5196749638548,-3.675128552240708
SaOS-2,11494412,0.4895123820960489,1.6202749083209997
IA-LM,9926054,3.212619063516659,1.7166347675765072
MOLM-13,doxorubicin-navitoclax (2-1 mol-mol),-5.382475006616194,-2.596851079711042
MDST8,23635314,-2.200660522590374,-0.877171872647498
SaOS-2,alisertib-navitoclax (2-1 mol-mol),-0.6198148244275179,-0.23666334912964612
RKN,4261,1.529955054772996,1.7078387599561102
SW48,11396600,3.829401994456863,3.843201978746981
LS411N,JQ-1-navitoclax (2-1 mol-mol),0.3997266798331875,0.3206022502726937
HCC1500,16659841,5.303826701580757,3.828125436248877
HARA [Human squamous cell lung carcinoma],24901704,2.881552784728447,3.5159165329205835
BICR 31,JQ-1-vorinostat (2-1 mol-mol),1.378421076759701,1.2734816861520033
MOLP-8,10231331,1.2198029486879254,0.85499441096974
COR-L95,16725315,5.004914745056217,3.86748932602778
HEL,16115403,-4.756245139541522,-4.853253871412083
WM115,11717001,-1.1241138002933555,3.740189988216087
SaOS-2,11626560,1.1465195781021866,1.9769500847921455
BFTC-909,9907093,4.635414583134371,4.349278616897309
HCC1500,66577038,2.9555971550997935,3.0621289379441725
IA-LM,285033,0.5092837727748464,-2.0446646942272784
IA-LM,4917,4.737499942891754,2.876631888201668
BICR 22,44632017,0.9263322393180023,1.1694439944533979
RKN,navitoclax-pluripotin (1-1 mol-mol),0.1191364332542713,-0.9782480638915872
HARA [Human squamous cell lung carcinoma],docetaxel-tanespimycin (2-1 mol-mol),-6.628155731353656,-3.0632544625388958
SW1573,89928392,2.032641459256584,1.8276575061151388
MOLP-8,119607,5.472499710124238,4.401420284542108
COR-L105,46398810,3.2483226376094194,2.652735609878521
HCC15,decitabine-navitoclax (2-1 mol-mol),0.0974547037094189,2.2363584858637076
HCC1500,135999136,4.086589117257826,3.8452306230956426
WM115,11497983,4.51521868458229,3.8765678521371263
SK-HEP-1,46926350,-4.110479335135347,-3.953600977127875
RKO,322968,3.8471310775605216,2.7649845811176066
LS180,25262965,-0.0916364033105869,-1.1844868993711106
HCC1500,246676,4.424448695399937,4.111007393217115
COR-L105,104842,-0.9230389281504464,-2.094510861140735
SK-HEP-1,navitoclax-piperlongumine (1-1 mol-mol),1.24584260367843,1.979293379518223
SK-CO-1,6610355,4.767157937449789,4.3738253125992745
IGROV-1,676352,2.310492141650647,2.090319519678702
SW48,262093,2.726859331273406,3.0863160063979707
HCC15,55508,3.481008151195261,3.6741091505188552
HCC1500,2126,3.801078614960916,4.560465879144771
PaTu 8988t,24951314,3.0808050806085188,1.43649208250709
RKN,11455910,3.815213247766997,1.338871364458192
SW1573,3062316,2.075650426956439,1.314043154796088
SK-HEP-1,5287620,-1.0463187584720948,-1.7094838560596923
HARA [Human squamous cell lung carcinoma],25102847,2.0322740825170555,2.5787035450851454
MOLP-8,24779724,4.381900106399647,3.072920035915082
Panc 02.03,107985,-4.238430695688479,-3.427201213818321
IA-LM,322968,2.7570489193637018,3.0238586345249576
K-562,448949,1.070656561881704,1.5573274415534897
LS180,54649381,3.823257143411622,3.795681492567571
IGROV-1,5281321,-1.4962463697398798,-1.292575032624836
NCI-H1568,42642645,1.4281976900349445,1.0702427081260504
SK-HEP-1,selumetinib-GDC-0941 (4-1 mol-mol),2.75141710768083,1.6554774164233317
K-562,44185566,1.8580861510177096,1.8902885870734514
SW48,637858,1.3097623359774897,2.109635422114455
SK-HEP-1,613753,3.3794099216210203,3.398074895476435
ML-1 [Human thyroid carcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.412069402111766,3.899360011937765
COR-L105,11234052,4.539846823478364,4.41433761785826
IGROV-1,72193861,2.0623829231433293,1.693572387789145
SW1271,3503,3.0280256153278606,2.2695668421421353
NCI-H1568,57330099,4.373464200171548,4.151708691778908
MOLM-13,1750826,-3.2515027143289728,-3.1408118930322337
SW1271,11222830,1.3106603955640226,1.6780687020616498
RERF-LC-MS,445091,4.218142840499499,4.3991998419238385
BICR 31,3062316,-1.406162609577698,0.46488100333575644
HEL,25126798,0.3968700607761156,3.313092128078156
COR-L95,5738263,2.419040765220329,3.157829438376857
SK-CO-1,36462,0.7476665664464673,2.3698931843196505
WM115,49766530,-0.6421157759153451,0.07108858961420948
SW1271,ISOX-bortezomib (250-1 mol-mol),1.0601498198738095,0.6633681468711086
BFTC-909,46901937,4.445112058189045,3.2145163080919326
SW1271,136227331,4.376300443457216,3.9961059106748924
COR-L95,25262965,1.4716002732306153,-1.5306148971135531
COR-L105,5281672,4.46136628199001,4.619381720700196
WM115,73707398,1.178086440828875,1.2381960677805224
Granta-519,6852167,2.2648312753409887,1.370077378955128
RERF-LC-MS,46174525,5.020740506928848,4.50866443768514
SW48,navitoclax-PLX-4032 (1-1 mol-mol),2.4409762203438117,2.069712386822239
RCC10RGB,44202524,4.922768729279552,2.7215697136544734
BFTC-909,BRD-K27188169,5.152610673434624,3.6383686835848024
ML-1 [Human thyroid carcinoma],44607530,1.6401891623478355,1.940099415835529
IA-LM,439501,-4.16745845294267,-2.208003024228271
RKN,25262965,-0.5506090189051945,-1.2672010105747904
SW48,3385,1.919145280274203,3.882786647752105
RERF-LC-MS,12001922,2.43602915295576,2.0492806286588863
IGROV-1,568763,0.665047061839467,0.2933852095702169
P31/FUJ,10385095,1.5135865779060806,0.9530929914437084
HuP-T3,12001922,2.3367896101102907,1.9180201428043597
HCC1500,1641662,3.3816027924522487,3.6045083280916
HARA [Human squamous cell lung carcinoma],25195348,4.01900560130828,3.1818394283462434
P31/FUJ,1242560,3.8275456086274127,3.0497770090562906
NCI-H1568,57519531,1.3161148530355309,2.605262683505417
SW1271,42611257,4.308869978455437,3.2200774326049175
Daudi,10184653,1.026270071695755,0.5650830222437798
K-562,2858523,2.745068324935018,2.7303576255397353
IA-LM,crizotinib-PLX-4032 (2-1 mol-mol),2.5646441197957555,1.4471228285249311
HARA [Human squamous cell lung carcinoma],11152667,-1.8717886502550631,-0.5090928467396232
BICR 22,12001922,2.2523981699696165,1.8241638315289668
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719,-0.17807561572556097
UACC-812,5978,-2.554443854158195,-1.1765405294290205
MOLP-8,753704,3.0200894206550877,3.9597262487223888
ALL-SIL,5394,4.4345454375843625,3.145070051758592
RCC10RGB,navitoclax-PLX-4032 (1-1 mol-mol),2.769034348653669,1.7058227258603909
WM115,selumetinib-navitoclax (8-1 mol-mol),-2.2824841087283954,2.09210817087007
NCI-H2452,44137675,2.6709050374584846,3.789582425934224
BICR 31,52912189,2.5113420173615464,2.595628365714701
WM115,72199292,4.562209520612744,0.3040466496402101
BICR 22,25154868,5.114547534217177,4.528104217678393
SW48,25262965,-0.5589271325062998,-1.5124802088210243
IGROV-1,4705,3.3098412390054603,3.189035102484666
LS180,SNX-2112-bortezomib (250-1 mol-mol),-0.5067570232278682,-1.5217437714343347
COR-L95,11955716,-2.3894028875885778,-1.4983638603940879
BICR 31,241158,4.31214680273537,4.0659460481661425
RCC10RGB,25062766,2.0619451400109265,2.08771832351597
HCC1500,25262965,-5.244904140838402,-1.0974692753398998
PaTu 8988t,285033,-2.1993510069972215,-1.5889616277575118
PaTu 8988t,44566777,-0.8532538772982161,0.9374336852423519
SW948,71466445,3.954398511848749,3.0393862950326076
IGROV-1,6610216,4.310938387105607,4.340934058643816
PaTu 8902,11497983,4.394920409770125,4.181811203118593
SW48,11612883,0.3553002535249436,2.8008370180504016
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188,-0.6394726418645371
HEL,9868037,2.50949616555346,1.6575429437359803
HEL,11178236,-0.8324730036537664,-3.480960241603754
RERF-LC-MS,60750,-4.1612389836176,-1.971925773159693
Granta-519,carboplatin-etoposide (40-17 mol-mol),-0.2598184919405968,0.07488949125281724
SaOS-2,24901704,3.518814077302041,3.2992730794204412
COR-L95,6914657,-4.192308975603822,-4.339947623738318
COR-L105,262093,2.940873643596252,3.094700560333988
LS180,44486219,4.325065743764261,4.284204354532092
RKN,10074640,3.313081701902331,3.3239662555687928
BFTC-909,5746,0.5111824642409613,1.3671862343822172
K-562,8515,4.039482215632923,3.3569814201306274
PaTu 8988t,31703,0.1373281877500042,-0.7742206737720722
MDST8,135984461,4.124255066625015,3.8149525503644446
WM115,107970,1.780812210779262,2.51083404373867
HARA [Human squamous cell lung carcinoma],44507138,3.9193587835112,2.6141913190661517
IGROV-1,327653,3.667792542405671,3.1425166650252603
P31/FUJ,89183176,3.539325961528454,2.84743518057644
RCC10RGB,6438330,2.9900078425794385,2.2639122899822137
RKN,5280436,4.161667428331563,3.6371752132829527
COR-L105,445455,4.3186388426275535,4.778861825378489
LS411N,24785538,0.7817075732213645,0.57081986967552
Daudi,11152667,-2.9472151872913104,-2.0311092529097485
P31/FUJ,448949,2.0159916590055067,1.255880757314798
Daudi,11609586,-0.3532025604686024,1.7364976434191846
SW948,46926350,-4.641976408237662,-4.063221774044148
SW1271,72193861,2.914678902909763,1.6354959270965745
PaTu 8902,25126798,4.210533326596683,3.819505644841137
COR-L105,11955716,-2.257823880116287,-1.4714294845291551
HCC15,46224516,2.679221759698836,2.632091017805191
HCC15,135423438,2.37991378319322,2.414124915370439
Daudi,421610,1.7509728437935097,2.5099098802838715
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276,2.23113021609918
SaOS-2,11238147,2.85636627636287,2.8024593713361754
IGROV-1,374536,0.7022324251593053,2.4218057119229237
SU-DHL-1,51039095,1.7422871999086744,2.341874951415426
IA-LM,72193861,3.820444995189443,0.4621163265868516
HEL,5738263,3.378820716395454,2.547671517435317
RCC10RGB,BRD9876-MK-1775 (4-1 mol-mol),3.486807022828034,1.0055125935753577
SW948,6852167,2.188206161672083,2.475365246243656
K-562,71751553,5.367911183247371,4.121025723870583
BFTC-909,71304818,3.116417285157316,2.801086117211034
SW948,25227462,-0.2382390684396511,-0.08631004169558419
SK-OV-3,637858,3.830307013284548,2.1419887845379706
RKN,49766530,-3.8574490235665584,-0.637609115527888
NCI-H1568,9933475,1.8521331470520848,2.081534443628694
BFTC-909,decitabine-navitoclax (2-1 mol-mol),5.107856917496857,2.111635064659311
KU-19-19,17759555,3.7275461226555566,3.6165428358737386
LS411N,44589607,3.372730635507476,2.126142136513705
RKO,vorinostat-carboplatin (1-1 mol-mol),4.42147496708757,2.232376560832239
SW1271,5278396,3.101008990901291,3.5500183268341186
LCLC-97TM1,46398810,1.8633773855233131,2.283647359946443
SK-CO-1,6852167,2.111498553552754,2.8501336127525003
SW1573,5479543,3.675213844165782,3.682026383053948
COR-L95,12003241,2.921570030601445,-0.5929038847029333
Panc 02.03,9911463,4.953148943637795,4.006544365535655
P31/FUJ,crizotinib-PLX-4032 (2-1 mol-mol),0.7828925550397006,0.9125677567096853
RERF-LC-MS,3384730,3.247206310046507,3.127176278628615
IGROV-1,51039095,1.7163430299301403,3.0570294897981
KU-19-19,89928392,2.8864230284497747,1.6841713664004976
SK-CO-1,216468,0.6363757446548435,3.3696707511838495
LCLC-97TM1,3038522,2.979698040139259,3.176190687565478
BICR 22,6914657,-3.057028291966878,-2.7763418717455126
MDST8,3815108,3.655140825789689,2.6501532512012274
HEL,11364421,-3.0976744543470067,-4.4095848061491285
SW1573,10074640,3.956421484938757,3.335647903019726
LS180,6610355,3.640469161520063,4.289031259030752
Daudi,2858523,2.224035136584194,2.807316907527581
BICR 22,135875424,4.925705128316808,3.902431338718598
SK-OV-3,23582824,0.9299959314677436,0.8903623286655697
K-562,5282054,3.5952240521498062,2.892854360922575
NCI-H2452,44589607,3.0010828964799208,3.318592235629588
LS180,638278,3.5544678930796656,3.1964128121174635
MOLP-8,426756,3.5390437920539117,3.992721919625992
HARA [Human squamous cell lung carcinoma],11964036,1.505983259630614,1.5970795777516877
SaOS-2,selumetinib-MK-2206 (8-1 mol-mol),3.420103401204114,2.388605843049171
SK-HEP-1,selumetinib-PLX-4032 (8-1 mol-mol),4.995301598954557,2.780004333376789
BICR 31,71466380,5.422644788319504,4.623723847385446
PaTu 8988t,53392493,3.5279637137541524,2.7789657420329337
UACC-812,6610216,4.947422623598504,4.304129730526259
SW1271,16038120,0.5203426502283315,0.947252964295481
IGROV-1,67156097,0.1763939852409119,-0.40374941143380794
UACC-812,216239,2.3945159107119767,2.449560532397078
HCC15,serdemetan-SCH-529074 (1-1 mol-mol),2.4880259252589543,2.14845940814811
ALL-SIL,36462,-1.376242093473402,-0.39840367879841443
BICR 31,1750826,0.6511109819152475,-0.9979528087678183
IGROV-1,56649450,0.515518984822669,3.2181654586172375
HARA [Human squamous cell lung carcinoma],66577038,3.5726698245106445,3.2045689494601532
PaTu 8988t,6918837,-0.8891471976747255,-2.274928779913728
ML-1 [Human thyroid carcinoma],9936388,-4.434207119356507,-0.44010612974698254
NCI-H1568,2828334,5.9155051642717,6.283110744715981
MOLP-8,56973724,1.5171827826362807,1.9254439773540717
MOLP-8,2729026,2.779201693602774,2.2238603976035893
P31/FUJ,753704,3.2802738483106766,4.137932404379106
SaOS-2,25183872,-0.102413301755783,-0.7603862002420273
NCI-H2452,decitabine-navitoclax (2-1 mol-mol),4.538424362545292,2.2976900115004124
LCLC-97TM1,9825149,1.404394440199107,2.2068609568354973
WM115,9929138,6.7694003006369226,5.978813513865394
RERF-LC-MS,2746,3.2731211053052647,3.4260564962832842
COR-L95,5351362,0.837381680047442,1.2219734804231948
HCC15,ISOX-bortezomib (250-1 mol-mol),1.036560789961647,0.8627168697434108
RCC10RGB,3101542,4.48788654191394,3.633423807953376
BICR 31,44566777,1.4466588952743178,0.8639998002233998
WM115,5746,-0.962904812763719,1.4810284828263705
HEL,9903786,1.206049982415758,1.4379359380535572
NCI-H1568,44486219,3.435494584556288,4.424171056673737
SK-CO-1,124202324,2.795373404058925,2.2446507791248935
MOLM-13,5329102,-5.212236525427112,1.3302689598759776
SaOS-2,10427712,4.893681366378875,4.185336058552953
SW48,409805,3.4729287041870127,4.768239341860797
HCC15,216345,4.3772403070959705,3.982059525535684
NCI-H2452,46215462,2.291566037713401,1.973460540100489
SU-DHL-1,55283,1.0511806970329092,2.453262910092582
SW48,navitoclax-birinapant (1-1 mol-mol),1.0401381719181744,1.4633307471372152
HARA [Human squamous cell lung carcinoma],56946209,-3.7436646215458182,-3.9192844158127444
MDST8,24821094,3.627663013095859,2.6061540260795355
HCC15,9911463,3.642862209488471,4.018744050886868
BICR 31,navitoclax-gemcitabine (1-1 mol-mol),3.844959889456845,-0.6725441551002526
SW948,11178236,-0.7120713487548671,-2.871855220533804
HCC1500,5329102,1.6369795361395487,2.080319270189827
SU-DHL-1,11364421,-4.160715855029451,-2.2310022539262864
SU-DHL-1,176870,3.225718242496366,3.005784457100351
WM115,2742550,3.774256401917875,3.8930582953313926
SW48,12003241,-0.9746028071684796,-0.9581882486198281
NCI-H1568,11494412,0.631822071405162,1.8856893036634963
WM115,25102847,1.9091464851380515,2.529370076909091
COR-L105,23725625,5.8274909459435165,5.377331159121598
Granta-519,9956119,4.186560294974692,2.680893979793536
COR-L95,72193861,1.6807669427950571,0.9509758992153565
IA-LM,6917907,0.442667441503668,-4.6400810859966946
SW1573,53232,-0.4627324496874346,2.854729559764158
Panc 02.03,19582717,5.117031119305748,4.433116551390942
RCC10RGB,227681,3.758665689171896,3.439261260034195
WM115,24901704,3.629786211252992,3.4659318631190303
HARA [Human squamous cell lung carcinoma],4477,-0.0807211341972061,0.6723417088604531
K-562,637858,1.3097643671251342,1.1111323793209298
SW948,613753,3.0653891790249617,3.064917165157017
Granta-519,9926054,1.8135939424605243,1.6642632991033628
SK-CO-1,55508,3.57241133457179,3.3225342929833492
HCC1500,5426,4.174536858194301,3.525308916469295
IGROV-1,4521392,5.131794979216607,4.195859275452879
UACC-812,6918878,3.827620339158657,3.016396911236404
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906,0.7259775784488979
KU-19-19,72193861,2.401782330602402,2.0181985062381087
WM115,5281321,0.1495893125543727,-0.9786958626448036
ML-1 [Human thyroid carcinoma],3038522,3.665928761402901,3.5031974941844646
P31/FUJ,31703,-2.5575864334968976,-2.6400398795797106
HEL,decitabine-navitoclax (2-1 mol-mol),-1.4855622179945482,-0.9047791927957111
ALL-SIL,44589607,0.5481515481681011,1.707295425653828
PaTu 8988t,11955716,-2.6731660557009267,-1.491788131063697
IGROV-1,5738263,4.037832478240785,3.447646965006121
HARA [Human squamous cell lung carcinoma],126941,-2.554285063423382,-2.932245568921037
BFTC-909,650361,3.8112149600795706,3.662849839036055
SW948,16725315,5.2631267850751335,3.8266357828816098
Panc 02.03,25102847,3.3458680072040603,2.663316966914822
BICR 31,216239,4.655547148927136,2.456936035864045
SK-HEP-1,51039095,3.60670356936783,2.8945084701892654
IGROV-1,9907093,2.687959785702283,4.158546814920735
ML-1 [Human thyroid carcinoma],126941,-2.044263255039902,-2.3212568847173216
LCLC-97TM1,49766530,0.6419783818490065,-0.7724312099029759
Granta-519,2113511,5.634502761977105,4.5294093743003465
COR-L95,322968,2.331837213900703,2.9795635094617943
RKO,ISOX-bortezomib (250-1 mol-mol),0.9877489052510549,0.181671292633897
SW48,60700,-1.9747801062936423,-0.4825954569111501
SaOS-2,46907787,1.5905885991562354,2.5199654638058213
LS411N,5311,1.0830647686053458,0.8536485384843394
NCI-H1568,5278396,3.684546625455108,3.628343279814709
P31/FUJ,2858523,2.921593087757198,2.8178602480922605
MOLP-8,25102847,1.798391543473315,1.9647335851628316
HCC15,57330099,4.175732386995395,4.024140966759637
LCLC-97TM1,16013152,5.423690206414697,3.911242707692906
SW1271,16065773,2.6188234772001886,2.6239966481097254
RERF-LC-MS,52947716,-5.597592816818683,0.40438027729350295
MOLM-13,11167602,-1.7638454235436123,1.7491788637903682
NCI-H2452,vorinostat-carboplatin (1-1 mol-mol),3.5311802496777576,3.1265064654136956
Granta-519,3038522,1.8764454398289976,2.427633711833405
SW1573,54626689,3.958399976383255,4.616837298517341
K-562,445455,4.202279962055385,3.992143566765864
SK-CO-1,25262965,-3.291258197582341,-1.2981765999545283
Granta-519,54618771,-0.1786557603441652,-0.13505990148898991
ML-1 [Human thyroid carcinoma],216345,4.790115930225849,4.273409262076382
HuP-T3,42642645,1.566786855324099,1.1614223328469993
MOLM-13,44589607,2.917529465117915,2.1256961675836092
ML-1 [Human thyroid carcinoma],10385095,1.881738472046862,1.630861205567923
SU-DHL-6,753704,4.418086475877281,4.036250116598174
SU-DHL-6,6918837,-4.716152603392634,-4.728536695380531
P31/FUJ,46199207,2.4446101047156215,2.721061773216162
SaOS-2,156422,4.313289259132858,3.912104104295531
BFTC-909,5282054,4.21714099973987,3.914661383654482
RCC10RGB,9803433,4.221770064596342,4.578208136402153
Granta-519,UNC0638-navitoclax (1-1 mol-mol),-1.1089217343766455,-0.3164904772302288
RKN,89183176,6.327700475537756,4.646887555510487
BFTC-909,16038120,1.74161234898449,1.390208599968867
HCC1500,71466445,3.970736335461394,3.5798409162607006
Granta-519,25062766,1.8322611726564384,1.6047931935890107
SK-OV-3,216345,4.761928129554225,4.089155970308136
Granta-519,11609586,-2.485330170292811,1.5477843246119585
SK-HEP-1,6918878,4.4325993547595655,3.1014537541624385
P31/FUJ,676352,1.6175160353980318,1.6896810150605106
UACC-812,25227462,-0.2916299121927669,0.3937519926612035
RERF-LC-MS,54596558,4.400747096440468,4.567965599997381
Daudi,9911830,-0.0057102646081846,1.9267484024428458
COR-L95,72376,-2.5853838467146493,-2.4626028347857845
LCLC-97TM1,135875424,3.9585615026829823,4.07006706204967
P31/FUJ,49850262,2.7073676452568427,2.664353086841496
HEL,10410894,1.686960620182283,2.7574822570186597
LS180,10127622,1.4423864514133429,3.165126015423861
LS411N,16038120,1.458068935835204,0.6224148324055359
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506,3.041646986137967
IGROV-1,11214940,1.360660548899077,1.8197937209888602
Panc 02.03,969516,3.806573436208542,2.889254373929224
BICR 22,JQ-1-navitoclax (2-1 mol-mol),1.0465005615278271,1.0330754399630369
SW48,656346,-0.2718986936332406,0.9435228484664063
SW948,285033,-0.875487938395224,-1.862723901413869
Panc 02.03,4261,3.516583077320981,1.655061288048505
SW48,49766530,3.606492941369466,-0.3001982403692278
SW48,16038120,-1.7922421690180796,1.229230789944056
RKN,navitoclax-MST-312 (1-1 mol-mol),0.5631499209413128,0.835086528614513
ML-1 [Human thyroid carcinoma],46199207,3.5690585114534024,3.343323715458502
WM115,2945648,2.5851994154769025,2.916823173815713
BFTC-909,vorinostat-carboplatin (1-1 mol-mol),0.6014624935477999,3.4644018457532995
BICR 22,25227462,-3.180570489875023,0.5724570191950267
IGROV-1,5460769,1.6083174601829917,2.748117465139342
K-562,753704,4.7227938780788525,3.97306749067886
K-562,ISOX-bortezomib (250-1 mol-mol),0.3376370593793573,0.4499196813849433
HuP-T3,4788,5.894927949545096,5.732394713425232
SK-OV-3,42642645,1.640931292575566,1.043700762639971
PaTu 8988t,11222830,1.761666424308375,1.7504222054445784
BFTC-909,448949,2.818327130228084,2.0698287032636578
HEL,serdemetan-SCH-529074 (1-1 mol-mol),2.278758279722759,1.4845222019133992
WM115,5281672,6.287836255113029,4.481265262812992
Daudi,3384730,1.441294292217556,1.4825065131470125
SaOS-2,navitoclax-pluripotin (1-1 mol-mol),-0.5587106095561101,-0.8246276537626719
LS180,6252,-0.5438897009285958,1.080384069043915
SaOS-2,3025944,4.435896212894107,4.285522809900883
SaOS-2,25161177,4.43427627730954,3.803143043087121
LS180,JQ-1-UNC0638 (2-1 mol-mol),0.673634242684319,1.2308166219083987
HARA [Human squamous cell lung carcinoma],6918328,1.494996835192892,0.38657745060535764
BFTC-909,11228183,3.298719229946038,2.4189525234837435
Panc 02.03,navitoclax-sorafenib (1-1 mol-mol),3.063115591562286,1.7054358919602688
Granta-519,135659046,3.900512348834848,3.027299445874582
LS180,126941,-2.6871715133008385,-2.7273006688538475
MOLM-13,3081361,0.9632978577503784,1.5170921826348729
WM115,9936388,-1.175666523167262,-1.2302637853912648
HARA [Human squamous cell lung carcinoma],119182,-1.5549760643936197,-0.31655840653814465
IGROV-1,15953870,2.712793598656007,3.703804828106351
RKN,10410894,1.511663597063748,3.4487876363121845
IA-LM,6918638,0.61198230609435,0.479571832988556
SW1271,56946209,-4.174123648346971,-4.0371204053204
BICR 22,67156097,-1.5899611273150889,0.2469880998420328
SW1271,2749,2.846909316544141,1.8448373188494835
KU-19-19,65628,4.405271017285275,4.29051703790763
MOLM-13,5566,2.591289759721003,2.9066332190304682
HCC1500,89928392,1.0051530188155344,1.452988525140044
SW948,25102847,1.6816963863778185,2.2901841933653064
ALL-SIL,10427712,3.5706749567785625,3.64637897849502
IGROV-1,2749,2.0319044408234954,2.0765294812669244
LS411N,selumetinib-piperlongumine (8-1 mol-mol),1.1466452951203283,2.176216556186276
HCC15,SNX-2112-bortezomib (250-1 mol-mol),-3.246727097806559,-1.273801575314191
SaOS-2,1242560,3.6046854082724034,3.6363036334911327
RCC10RGB,123631,3.672101761387351,2.53667680559255
SaOS-2,JQ-1-MK-0752 (1-1 mol-mol),2.214313979092396,1.9034254854872632
SW48,carboplatin-etoposide (40-17 mol-mol),-0.9429596789262168,2.8853224766690118
ML-1 [Human thyroid carcinoma],400769,0.4240275581269139,-0.4188797421873522
MOLM-13,23725625,2.3173082013566204,3.5432825425838894
SK-CO-1,15547703,3.920131639479481,3.150675648643085
SK-CO-1,navitoclax-pluripotin (1-1 mol-mol),-0.9841338872717872,-0.7105828842692995
SaOS-2,71729975,2.29546286795302,1.794022192320522
KU-19-19,12003241,-0.0608702413973226,-1.1979201704992115
SK-CO-1,568763,0.0338205510733868,0.5536517066527709
SU-DHL-1,984333,1.5848171755072842,0.3652971685912833
RERF-LC-MS,49766530,0.7744144603938863,-0.336410702863736
SU-DHL-6,11152667,-4.5064226702829,-2.037443559450104
HCC15,2130404,2.6093174666871293,3.525034164923614
RKN,11626560,2.593417875894138,1.8394471587360899
NCI-H1568,navitoclax-MST-312 (1-1 mol-mol),0.8258625122307741,1.01613158116631
Daudi,44137675,1.0044684727898117,2.863224419028339
SW948,54619267,3.654776559833868,3.765387435106706
MOLP-8,selumetinib-UNC0638 (4-1 mol-mol),0.7931432464838661,2.1365593773899114
RCC10RGB,4259181,1.719089746142662,0.5630905987256324
SU-DHL-1,9887053,2.0473441666614156,3.8368485401279484
SK-OV-3,9911463,4.2249846626647125,4.039870266580927
HCC15,49766530,0.5190445493569186,-0.4729415461259294
Granta-519,3385,2.090684083959823,2.282065279240072
RKO,54613361,0.2998145946125954,-0.23677616518204433
HEL,3384730,1.593743887858678,1.3943089262825428
NCI-H1568,11977753,-3.4091025242198696,-1.1840490005247581
SK-OV-3,285033,-0.1977879636486448,-1.684866937715371
Daudi,3385,1.70419989930712,2.5031440142952586
NCI-H1568,9825149,1.6639399446813206,2.2245521203424716
IGROV-1,654092,-1.340387623873854,-0.05737214387753925
SW1271,126941,-2.215477966101826,-2.863402784800572
IGROV-1,6852167,1.5305143027352028,2.9153480234562
HEL,11626560,1.0872099702081388,0.5041108585227698
SW948,126941,-3.436390914894009,-2.2765390418975184
RKN,107985,-3.0900461086436404,-3.0660240205953766
P31/FUJ,12001922,1.6134382673725098,1.47916698782931
Daudi,11404337,-3.064654238522792,-1.1389769869383117
SaOS-2,6438330,2.0981522234577064,2.0508229981977117
LS411N,126941,-2.790198017582557,-2.6278195160357427
HCC1500,10302451,3.7658874637842135,3.4063764660262605
BICR 31,4259181,2.3774772051226685,0.6619696305491923
MOLM-13,11656518,1.5202718128538335,0.5072437599469942
COR-L95,148124,-0.3758104123213183,-2.740379662071791
MOLP-8,53232,1.5052202963885184,2.4952810730335795
NCI-H2452,3038522,3.3601174997652725,3.2189520121860546
HCC1500,erlotinib-PLX-4032 (2-1 mol-mol),3.588293308391856,2.9420261260351204
SW948,16722836,1.2939108289094092,1.319061432057556
HEL,439501,-2.350875236844296,-2.4298430082365896
NCI-H2452,445091,5.08182727911324,4.3622554209004525
RKO,9840324,5.302067215897717,5.6354157195776144
SaOS-2,44489675,3.960447273667139,4.104253051805405
ML-1 [Human thyroid carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.479159740244691,2.1112442107561424
BICR 22,46901937,4.667354689676901,3.2795144175978357
LCLC-97TM1,2746,2.92478275020961,3.0608170810905118
P31/FUJ,selumetinib-JQ-1 (4-1 mol-mol),-1.737174960648273,-0.4616188027794894
Daudi,44491742,3.5549145676591314,4.001868858965279
BICR 31,374536,2.383890315264743,2.430224976974584
NCI-H2452,17759555,4.398260875691204,3.8123461868953616
LS411N,25183872,0.0970121311419586,-0.5334161827069965
Panc 02.03,23725625,6.172373492037936,5.193921412825502
Granta-519,65064,2.9178387202883735,3.9288732760184155
COR-L105,11222830,1.704570553497338,1.6804325796841497
NCI-H1568,5394,4.198509108960074,3.9669489777964473
P31/FUJ,135984461,4.1454221372139894,2.925901802943361
K-562,49836020,4.414855158615189,3.326773320057322
HEL,4788,5.03605552733545,4.962442988499576
HEL,selumetinib-GDC-0941 (4-1 mol-mol),3.377819044796062,0.4879619224338823
LS411N,6610216,4.962940577428159,4.019630404922414
NCI-H1568,23635314,-3.8228905075414055,-1.549342305202263
HCC1500,5328940,1.924598719414512,1.8133434924920269
BFTC-909,44589607,3.3115887945185496,3.0411296673992583
MOLM-13,5281321,-2.338854439084819,-2.4148965748904305
MOLP-8,71466380,3.4619880715079603,3.546076400479937
K-562,439501,-2.3563528898814905,-2.3738343379323568
LCLC-97TM1,44819697,0.4394946813834864,0.11689770276824599
HCC1500,9956119,4.194319271525248,3.486131950126195
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356,1.672708809765638
HCC1500,6505803,-1.3038553273576796,-0.6444045607353105
SK-CO-1,16038120,-1.5377645940979283,1.1503641914931826
MOLP-8,46398810,1.7248083632166018,2.107722356794929
RKN,73707386,3.296207724675486,2.3469527143845537
HuP-T3,6918638,1.0959798369911515,0.5508740410575359
SK-CO-1,72734382,5.327408257337546,4.6315783729122435
P31/FUJ,alisertib-navitoclax (2-1 mol-mol),-2.72541188794455,-1.434740832948826
SU-DHL-1,23725625,3.354193732931358,4.816253437092659
SW948,4378219,2.7444419460246716,2.2290806772545224
Granta-519,6610216,4.381057854502396,3.734455402690739
SaOS-2,25126798,4.16568157244383,3.8726838121793232
MOLP-8,11719255,2.3085103352777057,2.4358809846186267
SU-DHL-1,969516,2.44648475018104,2.6334808534450214
HuP-T3,9884685,1.9355517940144655,1.0535173802396733
SU-DHL-1,54618164,3.660876980117255,3.7814055104901843
P31/FUJ,4788,5.1911977113578285,4.923775465401642
IGROV-1,10074640,3.2681490579824426,3.155200994027916
LS180,46224516,3.8200366067107714,2.453847774551308
K-562,24753719,4.107201496626299,3.4853359079722934
HCC1500,46926350,-3.99988450675712,-4.075664907391211
LS411N,11175137,2.6624545374598,2.069897595736176
IGROV-1,71466578,4.017291197092763,4.697054331920044
Granta-519,10184653,0.998312657126817,0.45268152634352943
MDST8,selumetinib-MK-2206 (8-1 mol-mol),0.7033297936486181,2.3474530511824065
MOLP-8,6918328,-3.583816044173495,-1.0469515981591757
SW948,56649450,1.940604714075546,2.806490548227342
BFTC-909,374536,2.594742723017773,2.6078130298639737
KU-19-19,44185566,3.361767971446376,2.5974467083326345
NCI-H2452,1750826,0.2631697114156899,-1.5319313731038289
LCLC-97TM1,24180719,3.1823264447338837,3.349430325931966
SW1573,docetaxel-tanespimycin (2-1 mol-mol),2.3053158054818077,-2.0113068434744843
KU-19-19,navitoclax-piperlongumine (1-1 mol-mol),2.9388781180521124,2.007370267168603
RKO,675434,4.252493680505022,4.196895855176669
RERF-LC-MS,vorinostat-navitoclax (4-1 mol-mol),1.7393887492524955,1.6316534480553648
HCC15,25105715,3.3758270019314147,3.4659489876679777
HuP-T3,6610216,4.722811341582641,4.226764109692042
MOLP-8,156422,3.6985484587412394,3.219906632708594
SK-HEP-1,6917907,-0.2672796642005143,-3.677866266525559
SW948,984333,0.954004982504914,0.38174127312158956
PaTu 8988t,51039095,3.672985699080835,2.7656673134492684
Granta-519,selumetinib-BRD-A02303741 (4-1 mol-mol),7.197937797796196,3.5744952871313553
MOLM-13,10385095,0.2048351805935088,0.8720547239982062
WM115,2842253,4.366205978966029,5.481924879669618
NCI-H1568,navitoclax-birinapant (1-1 mol-mol),1.7942101393430023,1.5337918134885749
IGROV-1,135423438,0.764137689665023,2.3607359803383217
RKO,16725315,5.119694523443236,3.7260308070534087
MDST8,11609586,4.829072296940778,2.9122968130289797
COR-L95,7251185,1.1216187825494426,1.940988773865672
RERF-LC-MS,51039095,3.2453184174795324,2.6964577746914027
P31/FUJ,17759555,3.626728737883383,3.180193971576658
HCC1500,5113032,4.590685122922873,5.086879595169068
P31/FUJ,16741245,4.043144814115882,3.6339034359442848
HCC15,5746,0.6503914795852271,1.3175556686499936
RKO,10074640,2.8357111382750646,3.0206887718610926
WM115,10322450,3.651827454662003,4.166871640851809
LS180,11404337,-0.0678179476465551,-0.29275192996152766
Daudi,46191454,-0.8094751773550651,-0.06119090001028212
P31/FUJ,selumetinib-tretinoin (2-1 mol-mol),-0.8330243559244562,2.2517362789366997
P31/FUJ,44202524,1.0280075167408849,1.5300923865896996
ALL-SIL,44185566,1.0410692737439569,1.6137213854427666
PaTu 8902,54618164,4.284638344065584,4.18923074383184
COR-L95,46224516,1.2687748324677306,2.222950945098786
COR-L105,56949517,4.666554440626914,4.330685033027944
BICR 31,piperlongumine-MST-312 (1-1 mol-mol),1.564015805040982,2.0994815672351317
BICR 22,45279963,3.757910341256097,3.5729823648175145
HEL,9911463,3.4775133545177774,3.17863407569481
HCC1500,navitoclax-PLX-4032 (1-1 mol-mol),-0.625964193644412,1.088096009183265
BICR 22,JQ-1-MK-0752 (1-1 mol-mol),2.0389244155422577,1.7717945889302638
Granta-519,5287969,-2.420005986832857,-2.2283746860816267
IGROV-1,71466578,4.017291197092763,4.697054331920044
Daudi,1323703,3.9745876209629354,2.119583739628105
COR-L95,9956119,3.960527548011759,3.186625007474194
SW48,15953870,2.1672009909649415,3.4759375344379166
SW48,5278396,2.530949009900888,3.354003146677605
WM115,10296883,3.9273376390568138,3.9807060248074624
NCI-H2452,10302451,4.286596307748033,3.2689402328590416
SW948,9915743,1.1952390119197474,0.6585145962978889
SW1271,9903786,4.005340236032604,2.9537392890480585
LS411N,49793307,-3.1894754739686455,-3.3579495794348198
Daudi,126941,-4.413815937813151,-3.1059194281563594
SU-DHL-1,89183176,5.662525063156772,3.091888529371612
BICR 31,SNX-2112-bortezomib (250-1 mol-mol),-2.620347476140509,-0.8898053885727226
SK-CO-1,216239,2.5779715954988656,2.336122224304445
SaOS-2,24889392,3.914866726590468,4.148474550576955
LS180,3025944,4.8838055311701805,4.122916234757401
SW48,11626560,-0.4765255311776857,1.8373169031002348
RKN,168313047,2.366456695786382,2.4810348484526816
NCI-H1568,4788,5.820003751306211,5.538229665270731
RKN,65628,4.337575078598336,4.327214926173829
LS411N,5311281,3.759327828108219,2.4413202611600417
RKN,23725625,4.172652901782409,4.977976849526828
BFTC-909,168312962,2.436518653578315,2.27042721141013
K-562,56946209,-4.819463057676977,-4.516832816973922
K-562,navitoclax-piperlongumine (1-1 mol-mol),1.084720053726158,1.0262112357755309
Daudi,11647372,-0.1839602824658907,0.1732151050925193
SW948,5479543,0.3482839273666757,2.928978287841451
SU-DHL-1,11626560,-1.697644171575415,1.4142643835969377
BICR 22,71466380,4.042212978424107,4.43012006905062
HCC1500,selumetinib-UNC0638 (4-1 mol-mol),3.968035032331931,3.0035504610548274
MOLP-8,BRD-A02303741-navitoclax (2-1 mol-mol),3.766843844868067,1.1551350034274472
MOLP-8,9967941,2.6295638429027206,3.1427793146846335
SW1271,piperlongumine-MST-312 (1-1 mol-mol),2.322149279280664,1.809116557931434
NCI-H2452,25183872,0.970145395005522,-0.5777353152587316
RCC10RGB,navitoclax-MST-312 (1-1 mol-mol),1.0881941253840328,0.912527663633901
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996,1.157988117994003
HCC15,8515,2.8931769079597767,3.9470920723263987
SK-HEP-1,7251185,3.0945137710223687,2.8564909417487088
HuP-T3,3689413,-1.422602865458103,0.507368382767887
HCC1500,2113511,4.626117550925971,5.371388550071003
HARA [Human squamous cell lung carcinoma],445091,4.978549366904043,4.404491956271634
SW1573,5351362,2.395315345585997,1.7151979334486347
SaOS-2,16725315,3.258166087647875,3.975436071820556
SK-HEP-1,44566777,0.1035402456781041,0.5190812276574538
ML-1 [Human thyroid carcinoma],9887053,4.856845998315694,4.1687691451777935
NCI-H2452,54618771,2.226699645078912,1.1630001212639582
RKN,5329102,3.127163305072316,1.9822586788887164
BFTC-909,JQ-1-vorinostat (2-1 mol-mol),1.4357033395957943,1.4408179930669913
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276,2.23113021609918
NCI-H1568,5287620,-3.0605655272876104,-1.6750836346462874
IGROV-1,5329102,1.2794664511054334,1.987571123357046
SU-DHL-1,71680916,6.473574001994787,4.426136377483335
COR-L105,25262965,-4.3344847799771,-1.2678147967255138
SW48,3503,2.2068347221848605,2.388298375320574
BICR 31,36462,3.088359748996336,2.6411806173946326
SK-HEP-1,24753719,4.401042857593667,4.4578741585367405
RCC10RGB,navitoclax-gemcitabine (1-1 mol-mol),-0.0681716439191075,-0.761353612357839
IA-LM,16659841,3.92216274325252,2.9852289778120813
WM115,24771867,3.628628048718056,3.264145257856404
SK-CO-1,67156097,0.6545128366700663,-0.17560270777084913
RKN,selumetinib-vorinostat (8-1 mol-mol),2.829001792073934,2.532789680421791
SaOS-2,navitoclax-sorafenib (1-1 mol-mol),2.1552340524690843,1.6715061150773887
IGROV-1,71466380,4.863636874274779,4.474542635633177
HCC1500,selumetinib-piperlongumine (8-1 mol-mol),2.4825259194039173,3.0018781407752697
Daudi,5281321,-4.970506938945455,-2.577389033152256
BFTC-909,12003241,-0.8371396827795129,-1.1819048791732183
SaOS-2,44185566,3.018169617675811,2.631234847593382
SW48,54619238,4.554849733994691,4.422601813178863
Granta-519,25227462,-6.0432717278136066,-2.62320646858565
HCC1500,72376,-0.7270592073375387,-1.7489042094212548
SK-OV-3,3689413,0.6002437290843657,0.021589344139954506
HARA [Human squamous cell lung carcinoma],122327,4.478573115200279,4.864738804098389
COR-L105,71466380,4.962997689396809,4.470565935799456
K-562,56649450,4.352548214039191,2.8318613292249064
ALL-SIL,2828334,5.780519190951295,5.547964566621354
MOLP-8,5746,-0.9490954024297016,0.028615232299919625
LS411N,9935249,3.5378716054356927,1.8053654000819597
KU-19-19,148198,-3.572091199224797,-3.1650853906119334
Granta-519,navitoclax-piperlongumine (1-1 mol-mol),-0.8573381901716745,-0.5362180576663262
Granta-519,navitoclax-MST-312 (1-1 mol-mol),-0.2022371646874937,-0.4610045137742572
RERF-LC-MS,54619267,3.9836959677109354,4.2390966110936885
RKO,piperlongumine-MST-312 (1-1 mol-mol),2.2495159802497864,1.5265260912525767
SK-CO-1,445455,4.388752059403359,4.663681467155883
ML-1 [Human thyroid carcinoma],42611257,2.85876832372032,3.653965049051511
BFTC-909,6914657,-4.61933610547547,-3.9241559759954456
IGROV-1,54619267,3.9701367924453455,4.281961532194618
NCI-H2452,6918289,-3.5458030779688277,2.770109919100875
SW48,654092,0.3720639788768654,0.07786578840794324
LS180,10184653,1.1411409682713576,0.7693879620891748
SW1573,4259181,2.0061423198913766,0.2213135572949371
BICR 22,5978,-3.054007840707858,-0.6859142234219118
SK-CO-1,446155,2.509492168961503,2.9596676779798154
HuP-T3,piperlongumine-MST-312 (1-1 mol-mol),1.4346079723069378,1.715733051981644
MOLP-8,6917907,-6.199761218038622,-5.204744841053245
WM115,6610216,3.675624927368402,4.316735242850566
BICR 22,11964036,1.4111698106068242,1.2476205384238896
IGROV-1,135440466,0.9791523710816318,2.284449928959934
SU-DHL-1,46224516,1.9664047258697153,1.8937132332363578
ML-1 [Human thyroid carcinoma],656346,1.1399678324227185,1.3384016149379634
NCI-H2452,156422,4.888821376667332,4.25723748277306
BICR 22,446155,3.7361559304721106,2.702138776077549
BFTC-909,3038522,3.685618431455981,3.225012366597801
RKO,46907787,4.104881837237831,0.47937269811492234
IGROV-1,123631,1.7694522866439453,2.261876270867159
LS411N,5280436,4.183720769167266,3.0850537271335043
HARA [Human squamous cell lung carcinoma],15983966,-4.087930187377121,-1.5735946698914276
HEL,5311,0.0816485968486221,0.42356262923042054
SU-DHL-1,327653,2.51842673185387,2.6634300808828653
MOLM-13,8515,0.8268618162227004,3.0353855080137175
MOLP-8,25183872,-1.6811002192977054,-2.0011366186877315
Granta-519,11228183,-2.3490545548585335,0.13283156770741533
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776,0.9215208733245812
SaOS-2,5470400,4.204063595869918,0.007579888369541808
BFTC-909,5738263,3.1091802601858185,3.416826941896428
SK-CO-1,20959075,-3.269929661945314,-2.709806969785757
SK-OV-3,9956119,5.08600620496794,3.7701178515230134
WM115,tretinoin-navitoclax (4-1 mol-mol),3.8155470378280008,2.659322747852847
BICR 31,5978,2.6862960741960693,-1.3544623497738137
RERF-LC-MS,375860,-0.2896823379882159,-0.180720379023648
SK-OV-3,selumetinib-piperlongumine (8-1 mol-mol),4.999927979817729,3.6896312238658795
COR-L105,44202524,4.8543272504702895,2.53050901962694
MOLP-8,44137675,1.775364766844489,3.0900571302009343
IGROV-1,9907093,2.687959785702283,4.158546814920735
LCLC-97TM1,10385095,1.2595894653665305,1.1316611331265556
HCC1500,serdemetan-SCH-529074 (1-1 mol-mol),0.9549823890456136,2.1020904014158663
P31/FUJ,3038522,3.230912995410489,2.470338715500044
PaTu 8988t,5281321,0.6032906637165831,-0.7351455955709544
HEL,9866186,-1.054303819018661,0.1794332912387709
HCC15,carboplatin-etoposide (40-17 mol-mol),1.5999978710207647,2.971712702328749
SW948,2708,5.7755473109613265,4.254064172353661
PaTu 8988t,3025944,4.261130932115319,4.227246702423205
SK-HEP-1,3689413,-2.4602386660304143,0.018341079226524268
SU-DHL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.3225967046124065,3.0443678596600274
ML-1 [Human thyroid carcinoma],24771867,3.392643461506865,3.2888672370762695
RKO,6252,0.5352436981906653,-0.6064709873373055
SU-DHL-1,4521392,5.192178694848648,4.129140236343257
Daudi,72376,-4.854665282210012,-3.7678910657352334
RKN,4259181,0.9508926940780028,0.017458097841596597
ML-1 [Human thyroid carcinoma],4096211,3.147888642031647,2.33829487928277
HARA [Human squamous cell lung carcinoma],44819697,3.9048868362328264,-0.3562403045163797
SW1271,36314,-4.053350989931705,-1.7103843497542446
COR-L105,1750826,-1.9007119452090728,-0.8209459857215826
HuP-T3,salermide-PLX-4032 (12-1 mol-mol),5.718732466752557,4.885248572528818
Granta-519,46215462,0.9491023197189584,1.029618598549543
SW1271,3676137,4.713113076263269,4.633556739212281
IA-LM,5278396,3.9030690758091904,3.3552380479716577
NCI-H2452,24775005,5.579264227156813,3.7412294580987884
K-562,23635314,-4.3400265171433725,-2.7787627722559787
COR-L105,6852167,2.71981320036177,3.1217666515887696
Panc 02.03,16741245,4.354855972582246,4.167810574960901
SU-DHL-1,2733487,6.186604270067288,5.99662449118773
Granta-519,26596,-3.6955660538224784,-2.6473683561949395
SW1271,JQ-1-UNC0638 (2-1 mol-mol),1.8151113798618133,1.7728567343109023
ALL-SIL,176870,2.444675771693443,2.399349456725628
LCLC-97TM1,19582717,4.783105330370089,3.657714463629524
HuP-T3,119607,5.841541098284191,5.391074787545542
RKN,selumetinib-UNC0638 (4-1 mol-mol),3.946775123673676,3.247929608117332
P31/FUJ,637858,0.7903103947120294,0.9897560036149352
COR-L95,5329102,1.6379635813529434,1.789274447948873
BICR 31,5291,3.978522058600436,3.7833906061240885
LS180,6852167,2.255231171645259,2.836804512122218
IA-LM,89928392,1.436934436501384,0.7590099360258757
RKO,docetaxel-tanespimycin (2-1 mol-mol),-5.095252166768177,-4.431807647656803
BICR 22,9903786,3.2901982519836213,2.7931620383455633
SK-CO-1,3384730,3.2619898650330272,3.364359180217468
SW48,17755052,-0.4852421045975616,1.6733077573540114
COR-L105,568763,0.9810834095142736,0.5458757339405184
HCC1500,9866186,3.137309558941867,1.2219476877084805
HCC15,124202324,2.163317754038658,2.487123248479635
HCC1500,6917907,-5.345696307345718,-4.311016036643937
HCC1500,23635314,-1.1425681705854864,-1.2349870794437718
Granta-519,126941,-4.311277898608593,-3.2612832065908623
SU-DHL-1,tretinoin-carboplatin (2-1 mol-mol),3.205630539300333,4.096729805267705
SW948,24771867,-2.1331828785420166,-0.019404140844497278
HARA [Human squamous cell lung carcinoma],638278,3.613202989039307,3.19438580219687
LCLC-97TM1,10410894,3.7243046596553344,3.4248946718744504
COR-L95,11609586,-0.6075050167057128,2.198948737643514
MOLM-13,9952709,2.652499766566874,1.9353751376060229
HCC15,24951314,1.20775234306688,1.415262273616933
BFTC-909,11175137,1.859642091823866,2.849166711518234
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567,-0.5439737198536589
SaOS-2,9444,4.299296809659387,4.248229381707407
Daudi,71576739,4.751042411789338,3.541902428859968
SU-DHL-1,6505803,-0.92520479323989,-0.731558589345189
SU-DHL-1,11214940,-0.4959690036226346,1.8299782197454721
IA-LM,71466578,5.490140561499378,3.6904151753042016
RERF-LC-MS,262093,3.104487938727744,3.1838235333474376
SW1271,71466380,4.990835020791986,4.416483036683781
Panc 02.03,135411,0.8368106867561712,0.9033273582393754
RERF-LC-MS,8515,3.770178660744851,4.195386930189195
HCC15,45100309,5.717971650422449,2.895155779914017
COR-L95,54618771,1.9587299059916856,1.1266234363461098
LCLC-97TM1,16736978,1.4629436365964008,1.4164570290835257
IGROV-1,9825149,2.5588021380929553,2.1292487390413584
IGROV-1,227681,3.5439813498262347,3.3366371887172748
RERF-LC-MS,44489675,3.7548789887197183,4.128030116312055
MOLP-8,3136844,3.797428854524256,3.6663075386767603
COR-L95,5746,-1.1189080553056585,0.5077494352738148
BICR 22,135398516,2.7677082767193117,2.253964734142037
KU-19-19,tanespimycin-gemcitabine (1-1 mol-mol),1.208542786585586,-0.6643720419518919
ALL-SIL,57330099,4.126515702027515,3.6465793336494743
SW48,135398738,2.3509294796071454,4.5999509976449025
WM115,2113511,5.303490143807845,5.369276013746217
Daudi,2729026,1.2833432455886875,2.3143179706536077
P31/FUJ,100016,5.4217002529902185,4.940553351139773
IGROV-1,71466445,2.3758001916617797,3.940901008041378
ALL-SIL,6918878,-0.682122479171039,0.23722367213775325
Daudi,73707371,3.866210661620395,3.483625322778355
ML-1 [Human thyroid carcinoma],60700,-3.146668380067059,0.401106816308021
SW48,11364421,-4.967269122022574,-1.5614323353189237
HCC15,selumetinib-JQ-1 (4-1 mol-mol),1.0945511889039805,1.6325001920325208
LS411N,135411,0.7383506227122603,0.07778740690243365
K-562,3634881,3.4419902111623473,2.8357602502583252
KU-19-19,969516,2.8919422545546043,2.9745383486693915
Daudi,135999136,4.063293138043838,2.6340067710425097
SU-DHL-1,12001922,1.0574025128990867,1.5557934064807728
HCC15,carboplatin-UNC0638 (2-1 mol-mol),3.871381279129182,3.4546987813684265
MDST8,11427553,3.108888701151444,2.9506505756170083
COR-L95,navitoclax-pluripotin (1-1 mol-mol),-0.7248049337705845,-0.8279538708225
HuP-T3,9840324,6.187364891887578,5.723394933842738
RERF-LC-MS,5281321,-2.2570738048063257,-0.9972271342063821
UACC-812,16725315,4.601797708491857,4.119391428692806
WM115,53481919,3.625694730030069,3.869904084792359
WM115,3136844,4.4781621433894925,4.5159336131707155
SK-HEP-1,135999136,5.290710201924687,4.317701385677306
SK-OV-3,72734382,4.397767647147488,4.770134970789586
SU-DHL-1,4096211,0.0680701310214702,1.900221248206553
SK-CO-1,2749,0.8616454488616467,2.1303501522112454
COR-L105,4477,0.3499366832640422,0.4250153558382751
SW948,24785538,-1.2786696026485709,0.6683904711909381
BICR 22,25161177,4.685384367036766,4.1219064470318765
Granta-519,11955716,-3.0537796337487064,-2.1565948102517076
ALL-SIL,10127622,5.469150259822909,3.215224019877713
SK-CO-1,11238147,1.2924304468719774,3.0205628980593757
IGROV-1,11427553,2.926316692603687,2.9384621058314075
BICR 22,54618164,4.171441086739322,3.814442331954032
BFTC-909,57519531,3.2286550647211025,2.7242187992274114
SaOS-2,1750826,-1.0374385524430834,-1.2863048016949044
SU-DHL-1,71466445,3.7763473385017994,2.9360020112291823
SW1271,6852167,3.737297660761554,3.064403383256846
SW948,9549297,1.722924191719054,2.229199896673834
BICR 31,72376,-0.802396523967939,-1.3945918978023055
SK-HEP-1,56946209,-4.57873882670014,-3.8745833631404514
RKO,24964624,3.0430796891613903,1.5354594388259348
NCI-H2452,54143018,0.9899128272921088,0.8807332278734821
SU-DHL-6,60750,-4.821248170588626,-3.64297011225919
HEL,44259,1.31343744649104,0.8992567829690215
MDST8,3038522,4.546677862508445,3.0743928405763903
Daudi,72193861,0.2314245956601211,0.21589782008578215
NCI-H2452,4096211,2.487981551988898,2.1303452960094043
LCLC-97TM1,carboplatin-etoposide (40-17 mol-mol),1.252125961208134,3.175812706777929
Daudi,208908,1.616008502166041,2.055172326489148
LS411N,46191454,1.665967132338862,1.310976955742178
Panc 02.03,262093,3.467425891303458,3.150051006985803
COR-L95,462382,0.8255977399878551,0.5310673005734978
IGROV-1,16736978,0.1982875499977011,1.6092112192968986
MDST8,107985,-3.301997074358414,-3.8641434932891663
COR-L105,navitoclax-gemcitabine (1-1 mol-mol),-0.9402734681791266,-0.6555040295313285
ML-1 [Human thyroid carcinoma],65064,4.907366569161651,5.047361121968362
RKO,54618164,4.0326978900214705,3.8045997655008303
MOLP-8,5311,0.4432260076750803,0.31862125098375765
SK-HEP-1,5291,4.1108608913621545,3.7034870129436617
SaOS-2,107970,2.235066344736828,2.429679167910628
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905,2.453656886942944
Granta-519,6252,-5.172240666242431,-1.896001923522255
IGROV-1,285033,-1.3538783590767758,-1.8582456625246297
RKO,serdemetan-SCH-529074 (1-1 mol-mol),2.0344925203933006,1.7249708712058467
NCI-H1568,46191454,1.7726304550427152,2.0502688408985583
PaTu 8902,24856436,4.585148807200659,0.5249803211819094
WM115,5351362,0.9981168658111552,1.7876107204296472
IA-LM,387447,-4.406032561698067,-3.9077170015786855
MOLM-13,656346,-0.3431029585418202,0.2647791041097438
COR-L105,637858,2.3247583240908405,2.3198974632150096
Daudi,448949,1.1283153338590814,1.38119275068424
SW948,42642645,-0.386998084672917,0.3500297230646514
BFTC-909,JQ-1-carboplatin (1-1 mol-mol),5.2410563732595845,2.1929381768786977
HCC1500,52947716,-7.376885049387286,-0.7534359078567432
MDST8,439501,-2.351670240427255,-1.912678667506332
RERF-LC-MS,25161177,4.303824118845859,4.425412072300757
SU-DHL-1,3634881,1.9377929493272257,2.668419512443664
RKO,46398810,2.934390735401444,2.0596147133214386
BFTC-909,carboplatin-etoposide (40-17 mol-mol),3.649517561488253,3.1238051452330557
HCC15,159324,2.6315252421023536,3.0025240243739533
PaTu 8988t,serdemetan-SCH-529074 (1-1 mol-mol),3.002094874495684,2.269086304662137
HARA [Human squamous cell lung carcinoma],11612883,2.0711773248440783,3.090304314885958
Daudi,2949965,1.2926680931891954,2.088310294775484
RKO,23725625,3.9986828157613616,3.88593418427786
HEL,16722836,0.561669465799647,0.47771117055969325
Panc 02.03,11175137,3.7353172411310696,2.7447296280818616
KU-19-19,6918878,0.8609723302141853,3.2374915295603683
Granta-519,docetaxel-tanespimycin (2-1 mol-mol),-8.26947994699302,-5.16218360086756
SW48,3854666,0.5343434371102147,2.3453825470698324
SK-HEP-1,11626560,2.7034566874481745,1.940725027950202
ML-1 [Human thyroid carcinoma],navitoclax-sorafenib (1-1 mol-mol),2.2930044306717954,1.966945233920171
NCI-H2452,3825829,3.8827569930751937,4.1897110672146685
BFTC-909,126941,-2.0975077483758415,-2.401012657924106
NCI-H2452,24951314,1.9717681393720747,1.560860431900242
HCC15,54454,0.5186235809490349,2.7019136061272384
BICR 31,4096211,1.2121831781068038,2.3290011401881503
SK-CO-1,6914657,-1.8836208914019363,-3.6077550659112068
SW48,44493528,3.8128145383765992,4.263340879724326
COR-L95,BRD-A02303741-navitoclax (2-1 mol-mol),0.0270607892224954,1.0769130217974918
SW1271,168312962,3.6054980890180746,1.755755660335994
HARA [Human squamous cell lung carcinoma],5566,3.127581032716584,3.01600104153321
Panc 02.03,135440466,3.0724615257354153,2.3191981222597473
PaTu 8988t,navitoclax-piperlongumine (1-1 mol-mol),3.1694697801552025,1.7492881807296476
BFTC-909,11427553,2.7610941057010754,2.7885984414175122
LS411N,ISOX-bortezomib (250-1 mol-mol),0.5408045393266885,0.6687553409621746
SW1271,44493528,4.286060334293371,4.537271272122563
Granta-519,JQ-1-MK-0752 (1-1 mol-mol),-0.0004173872761687,-0.5351229867590057
LS180,49836020,0.6204023867713871,2.0314426422251497
HEL,148198,-3.399100076616297,-4.056084480156659
ML-1 [Human thyroid carcinoma],19582717,3.041392892734857,4.618979418981361
Granta-519,3543504,5.0961511485487705,3.5994061155473167
HCC1500,3038522,2.0060085934463108,2.9250630622953313
RKO,4917,3.097539294413192,2.8693533283680046
RCC10RGB,168312962,4.335962117924443,2.536170343587314
SaOS-2,104842,-4.966916923279438,-2.750059727613297
Panc 02.03,753704,5.09544361232119,5.054025678237268
PaTu 8988t,439501,-3.4446792284706347,-1.9204363503595874
LS180,5282054,4.115839158247494,3.963041942382054
IA-LM,5287620,-0.8479822353163541,-1.9904577452635233
RCC10RGB,6610216,4.531223922644925,4.4780531031744975
SK-OV-3,vorinostat-carboplatin (1-1 mol-mol),3.580838266034329,3.3421238302093275
HuP-T3,selumetinib-tretinoin (2-1 mol-mol),3.9566869559335585,3.305429591795982
SW1271,9911830,2.7072275961126997,2.6820414539427073
WM115,11719255,3.1992621528929166,3.5113257947597596
RCC10RGB,42642645,2.104174802814935,1.3424362816005333
K-562,72376,-2.627875463605781,-3.357832215945077
KU-19-19,selumetinib-vorinostat (8-1 mol-mol),1.3262473417693337,2.571655521004969
HCC1500,9549297,1.8848953505663728,2.304434743532569
HCC1500,44241473,4.374636754710865,4.6683348323091485
HuP-T3,2708,5.229598766149438,5.017430764692158
P31/FUJ,9866186,-0.5408158091236333,0.13689576096430683
RERF-LC-MS,11657048,4.330866638894723,4.191795557638411
HEL,119182,-2.1951032337756935,-2.6999094839178532
RCC10RGB,10296883,4.350673741830848,3.987210960050135
MDST8,10385095,1.2575537617816142,1.3169431413266621
SK-CO-1,23635314,-1.3218098525260824,-0.8279880639640922
BICR 22,72199289,4.441607504718354,3.451009412973398
MOLP-8,9911830,1.992368688928045,2.00474320777162
SW48,24772860,-4.097111396936187,-1.838837264815307
COR-L105,8515,4.561371818511258,4.135602138699206
IGROV-1,15547703,3.339928221860449,3.2606816145955144
SU-DHL-1,656346,-0.4085927723055031,1.1317576014483637
COR-L105,168313200,3.683873258385797,2.9319868020752864
Daudi,46224516,0.8162026590632436,2.299924187654005
Granta-519,5287620,-2.8216901996678985,-1.9821669700376898
P31/FUJ,JQ-1-vorinostat (2-1 mol-mol),-0.2741289026450685,-0.6627731765284731
UACC-812,11640390,4.086462739167014,2.8723801843234917
K-562,17755052,3.8994339695870326,1.1347649441791037
BICR 31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0760223515380139,1.5882992162787035
LS180,656346,-0.0089884994203474,0.8346642086080932
LS411N,selumetinib-UNC0638 (4-1 mol-mol),2.4499191002493315,2.957164469264122
SU-DHL-1,5311281,2.996662642824561,2.1923045004890507
RCC10RGB,25161177,5.612412997721579,4.1632310771726795
K-562,3854666,0.2872946014041473,0.9554505761032074
P31/FUJ,9825149,2.400010374644864,1.8886657424161408
SW1271,11964036,1.1602803966527862,1.657075416295454
LCLC-97TM1,176870,1.9757247403033509,2.7306045446439295
K-562,168313016,4.482960220744853,4.110230519357711
BICR 22,selumetinib-PLX-4032 (8-1 mol-mol),3.113612897977895,2.7691127360131986
SW1573,285033,-0.3175288260868649,-1.4361150093477404
BICR 31,4788,6.181654669045445,5.80963047315259
LS411N,11404337,-0.9351547419605356,-0.4250868853949061
RERF-LC-MS,9967941,1.5454786965180345,3.876532631603747
Granta-519,56973724,1.8473061894805545,1.6631943585017361
K-562,11507802,0.4095176942133114,0.6876110091751447
SW1271,1750826,-3.093550008900348,-1.441726452777859
P31/FUJ,135398738,-0.0291234665218711,2.164455622548094
WM115,5329102,1.7959886386080517,2.1118117026890384
MOLM-13,5470400,-0.3466627309634489,-0.15246870756502515
WM115,navitoclax-PLX-4032 (1-1 mol-mol),-0.9695757520165332,2.1512108048977256
Granta-519,44607531,0.7355881041308102,1.2567799283665453
RCC10RGB,5566,3.997570642857795,3.1306089849555083
KU-19-19,24964624,3.8522438290321768,2.6506290627869804
WM115,1641662,3.4019570651475557,3.6473542744820406
BICR 22,5282054,4.223594396310054,3.8242355284126237
BICR 31,10231331,3.776464743887352,2.2020415500603185
RKO,3825829,4.017808531984142,3.5543469663730947
Daudi,10322450,2.3131627402631905,3.165054770934177
BICR 22,285033,-4.068757657270757,-1.2093888658074292
SU-DHL-1,5281321,-1.7372628502658949,-1.1159462212973381
RKO,5287620,-1.9975210326345276,-2.230629438333517
Panc 02.03,53232,6.367991743549877,2.8992941889495603
SaOS-2,9826308,0.4955218987390744,0.6751561114560721
HuP-T3,10074640,3.8159838645365807,3.1983179349480433
SW948,4259181,0.2292867461834122,-0.18790549288032443
HARA [Human squamous cell lung carcinoma],11222830,1.4006503885864872,1.7098963655277206
IGROV-1,568763,0.665047061839467,0.2933852095702169
ALL-SIL,decitabine-carboplatin (1-1 mol-mol),-0.0286812837112609,-0.8366152175067276
MOLM-13,322968,2.556875190594409,2.2933761993496065
ALL-SIL,9903786,1.532435199339551,1.883997286479384
SW1573,409805,6.568626512075582,4.742394737498392
LS180,1750826,1.061711606063746,-0.6729994691170039
HuP-T3,46191454,1.9484889201022677,1.766502592264971
ML-1 [Human thyroid carcinoma],24901704,3.6288922396747743,3.441632471110995
HEL,216345,3.87635579429504,3.1983018744547795
BICR 31,2749,2.2358137088107033,2.381926277782837
SaOS-2,3385,7.1536746080698395,4.242557856525654
WM115,11626560,1.643291568999912,1.937104336206398
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922,1.731643457779102
ML-1 [Human thyroid carcinoma],36462,0.3533243941090192,2.6601073537710858
Granta-519,24964624,2.975569692960617,1.3007179152320862
HARA [Human squamous cell lung carcinoma],16038120,0.7093520184689783,1.1438383290770242
COR-L105,6918638,0.8528151020185122,0.8200697411134308
RCC10RGB,9825149,2.634802111166888,2.4323717351818703
HCC1500,44493528,4.240662848371031,4.480607559041605
COR-L105,44489675,3.747818158649104,4.057689813305381
SK-CO-1,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1356145956067642,3.094915883108408
P31/FUJ,selumetinib-piperlongumine (8-1 mol-mol),0.6855922532418997,2.1499207461370773
BICR 31,2746,4.041774334142006,3.561201467709613
MDST8,51037431,3.453193232905579,3.2805403352951368
K-562,676352,1.515837042857868,1.8791136736686676
LCLC-97TM1,73707386,3.587652793939767,2.9235514212723306
SK-CO-1,54618164,4.180915062416914,4.009453276449903
SaOS-2,5329102,1.942826181308244,2.149384617885247
SU-DHL-1,doxorubicin-navitoclax (2-1 mol-mol),-3.969153330724774,-2.2894606776021775
LCLC-97TM1,151289,0.9235530786043882,1.1834467305556453
BICR 22,400769,0.1100780529561809,-0.33450467488810676
Panc 02.03,docetaxel-tanespimycin (2-1 mol-mol),-0.6813802759264704,-3.111073071377804
SK-CO-1,400769,-0.6897300489229926,-0.6637583284376177
SW1271,56973724,2.58013716529859,3.2255344052257
LCLC-97TM1,2945648,2.6479910997037934,2.602368034807498
SU-DHL-1,439501,-2.3864560258185916,-2.219157123880448
NCI-H1568,148198,-4.9953315451672005,-3.1658281840179883
RKO,11507802,1.7455765117352984,0.9886997582655639
Panc 02.03,216239,3.7763245170365183,2.245875422409958
HCC1500,9825149,1.9829642871568696,2.1271270158189157
NCI-H2452,53232,3.5381177646863837,2.7917311345931766
MOLP-8,11494412,0.4734092912657368,0.6534801666422955
Granta-519,9911463,3.5000933341892733,3.011716614810695
SK-CO-1,10410894,3.775604170297083,3.4168493397595925
Granta-519,navitoclax-pluripotin (1-1 mol-mol),-1.5381813072816537,-2.634852848624921
MDST8,5328940,2.138158341424683,1.830609322330125
SaOS-2,1716436,3.427239396926117,2.9590556110155135
HuP-T3,9887053,4.07990532641299,4.08635753001722
NCI-H1568,24772860,2.3104914540479324,-1.7380286916830567
LCLC-97TM1,135999136,4.356650968290631,3.7024527804417566
IGROV-1,4378219,2.016502068118561,2.457453906231601
BICR 22,46199207,3.899734747403315,3.1205353258636332
BICR 31,9915743,-0.3251640044425866,0.5340161005885262
NCI-H2452,613753,2.817247196569438,3.3516962713364262
P31/FUJ,46174525,2.51911302821391,3.023031882536452
P31/FUJ,5335621,3.2282922271331613,4.009869300370913
IGROV-1,5278396,3.119031774261392,3.708710792992051
HuP-T3,16038120,1.51216352382263,1.2773368170944037
LCLC-97TM1,17755052,0.1986775459223547,1.8765992376515421
PaTu 8988t,66577038,3.1818565141070625,3.1474068536592545
PaTu 8988t,54618771,0.599962301527202,1.3465904864243663
SK-CO-1,46191454,1.747962727561699,1.4775592789713692
SW48,46907787,-1.5740012638710297,2.176237850041035
ALL-SIL,11485656,1.390704841990788,1.6740013444564221
RERF-LC-MS,selumetinib-piperlongumine (8-1 mol-mol),3.579320132644808,3.7239434618124223
SK-CO-1,4788,5.843658659854095,5.784400574051745
IGROV-1,16725315,4.890680859998698,4.40231224292975
SW1271,24821094,3.627509655063773,2.8836074458739334
Daudi,navitoclax-pluripotin (1-1 mol-mol),-3.474702671481659,-2.0122573622001005
WM115,216468,3.848857711215856,3.3402789821678835
SaOS-2,24779724,4.377738848523283,4.126380051049068
HCC15,675434,4.852455641097197,4.574264125916722
SK-CO-1,46398810,2.9216967746168625,2.626794661199546
LS180,JQ-1-vorinostat (2-1 mol-mol),0.4669519655203766,1.1664667405241147
Panc 02.03,123631,3.5560371664842325,2.238626290674569
SK-CO-1,448949,1.9523830928265349,2.146883179823674
RKO,285033,-2.0365968290915393,-2.6652943786878796
SW48,2749,0.8385534684858028,2.093536426042327
IA-LM,navitoclax-gemcitabine (1-1 mol-mol),-0.1598122581920494,-1.0819265290770905
HCC1500,54618164,3.7944844711277264,4.107553692875226
Panc 02.03,2858523,3.458791746781272,3.199762260785054
PaTu 8902,piperlongumine-MST-312 (1-1 mol-mol),2.709357535529884,2.0515022399859553
COR-L95,4261,0.3666433774913241,1.005559986441731
HEL,126941,-3.7945695708983664,-2.957368344379542
HCC1500,54596490,4.413271545106012,4.66675098415057
BFTC-909,375860,-1.1901103647211757,-0.009620525834821708
COR-L95,9866186,0.0204391385842873,0.71121988989119
BICR 22,66577038,2.5300885228037813,2.762303054561717
SW948,9826308,0.2428169991227084,0.17221373724515526
MOLM-13,73707440,5.976327057082507,4.177431666295311
PaTu 8902,5291,3.72219732976082,3.6081479676891273
RERF-LC-MS,5470400,2.5584942331402623,-0.07013996149152109
SW1573,16725315,3.253832365815957,4.109435736683956
SU-DHL-1,3552672,1.9257473882600096,2.8497516291546425
HCC15,60750,0.68669542572171,-2.2119827140050887
SW48,5328940,0.1162920415883012,1.699745607205811
PaTu 8988t,4378219,1.99751885903338,2.56778910491837
HEL,241158,3.370113308144609,2.399667442545564
MOLP-8,53495165,-2.6639864548579535,-1.7929158818099091
LS411N,46943432,5.879073426568822,1.3663272980032135
LS180,ISOX-bortezomib (250-1 mol-mol),0.5409757723847333,0.7390131764912715
SK-HEP-1,selumetinib-UNC0638 (4-1 mol-mol),4.697700742307761,3.1615955179886948
Panc 02.03,4521392,4.25988041093388,4.329778974321208
SW1271,5951923,6.143368489838077,4.437492165063232
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903,3.5053648385492835
HARA [Human squamous cell lung carcinoma],44185566,2.9912273208606552,2.751107706382513
RERF-LC-MS,11717001,4.567893424272946,4.112442060646677
NCI-H1568,25102847,1.8020479238639409,2.5818435753717592
MOLM-13,44137675,1.768154079183361,2.815030833225428
RKO,10427712,4.823698606341804,3.9035859089291005
BICR 22,6852167,2.9570859917106533,2.3629111655987454
ALL-SIL,vorinostat-navitoclax (4-1 mol-mol),-1.3745471945547945,-0.5677203505814749
SW1271,124202324,3.327062905972079,2.4004108452315207
WM115,400769,0.2375153529743729,-0.5369125295273001
RKN,3038522,4.332475047921768,3.3425939485882292
SW1271,4096211,3.040458805184357,2.0205317233305
BICR 31,60700,1.4006980690412227,0.11211652183842784
Granta-519,448949,1.64880276038625,1.2439552906625757
HEL,11964036,0.787171767074348,0.0726247580105955
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881,2.412204420727991
BICR 22,11485656,1.7887481250962165,2.405790624186825
HEL,44202524,1.7623585771552046,1.5722715336498885
COR-L105,3503,2.4932686195421625,2.463820095490307
LS180,4788,5.917574515812926,5.687655058881051
IGROV-1,219104,3.803083685328391,3.8923286145611575
IGROV-1,11152667,-1.4116509977729443,-0.31935735731425263
LCLC-97TM1,JQ-1-MK-0752 (1-1 mol-mol),0.5638595279312849,1.6282039846536214
HuP-T3,11485656,3.0565489144797224,2.471676018123975
NCI-H1568,9907093,3.7800753982052697,4.221926945368386
LCLC-97TM1,10184653,1.174063194948861,1.417715376784208
MDST8,16038120,1.9679009346440888,1.23545870531939
MDST8,navitoclax-PLX-4032 (1-1 mol-mol),-1.0125849451326647,1.7102670378308995
NCI-H1568,216239,1.54277692538335,2.337704399734718
LCLC-97TM1,5280436,3.0011603005672804,3.509159978932976
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563,3.524978670496088
Granta-519,5281321,-3.900138103622144,-2.433686901875395
NCI-H2452,6917907,-3.4621989648593696,-4.966466611260104
HCC1500,135659046,2.9858139057826905,3.791915068830115
P31/FUJ,3825829,3.1586120375796516,3.367357474154868
NCI-H1568,selumetinib-piperlongumine (8-1 mol-mol),3.9234194964704185,3.141676148991321
SW1271,JQ-1-navitoclax (2-1 mol-mol),1.3503657606474289,1.1080372547410584
SK-HEP-1,7326481,2.0213225214426505,2.9500676047400516
PaTu 8988t,JQ-1-navitoclax (2-1 mol-mol),1.798415555135888,0.8001427905589715
HCC1500,3634881,3.181593200231373,3.3834122037900416
HuP-T3,5311,2.274555641774389,1.614287105996134
P31/FUJ,969516,2.490551298955204,2.1359788205374177
LCLC-97TM1,25183872,-1.9138026924081315,-0.788720697270517
WM115,54619267,3.5599503094850244,4.197225045044534
HARA [Human squamous cell lung carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),3.6972893846800545,3.12152898916401
SaOS-2,17755052,-0.5339241699834809,1.8904541847697687
SW948,decitabine-navitoclax (2-1 mol-mol),2.8681609289857155,1.2642482706405214
SaOS-2,19582717,4.316823865856345,4.3605771389048025
COR-L105,25105715,3.731140483220641,3.436226200633223
SK-HEP-1,5278396,4.037206436677834,3.6856976214903447
HCC15,erlotinib-PLX-4032 (2-1 mol-mol),4.047611661511117,3.0681521001995593
COR-L105,6918837,-2.1114263163326177,-2.183934996311973
IGROV-1,25262965,-3.18785020602057,-1.2138745119320755
HuP-T3,6505803,1.3238670991795596,-0.5090914759826611
NCI-H1568,11214940,1.6761106979183067,1.9663081701559222
HCC15,44543605,4.452652862359365,3.9720815655079527
SW48,46199207,2.9489751610364405,3.1081732143030387
P31/FUJ,104842,-4.465734156959207,-4.256779028040157
MOLM-13,24180719,3.226510234308061,2.9951471465302704
HCC15,12003241,-1.0460858766179792,-0.8870029116046324
IGROV-1,10231331,1.9104831176724932,1.5851922755901198
IGROV-1,107970,2.287061680908213,2.3184544208724875
LCLC-97TM1,46907787,1.8795083111860824,1.0567553676043828
IGROV-1,5278396,3.119031774261392,3.708710792992051
SK-CO-1,5329102,2.034917542642271,1.9851599250621623
SK-HEP-1,11152667,2.375581084403437,-0.10755881790714128
WM115,2126,3.806678244062894,4.596535001120012
SW1271,selumetinib-decitabine (4-1 mol-mol),1.699127774006886,3.631395191733294
K-562,6918736,-3.666344542032524,-1.8756525775482575
Granta-519,6450551,1.162651959279597,1.3126642828725985
NCI-H2452,5479543,3.804245584293823,3.699419090621399
Daudi,11497983,1.6119133198716458,0.08570559226257995
WM115,4521392,4.32247006400087,4.272329160832684
MOLM-13,24901704,-2.733844077576574,2.17235852592465
Daudi,56973724,1.9677776982823123,1.663030702673548
HCC1500,613753,3.153964202511791,3.225117308874872
Granta-519,5460769,2.1422187145203897,2.1949141401161523
RCC10RGB,53495165,3.554009618530711,1.1599203563791443
PaTu 8902,3854666,4.137852419807088,2.4040330299329624
Granta-519,151289,0.2062194994497177,0.5460723151000978
MOLP-8,5479543,3.0970965636903327,2.51400434558813
LCLC-97TM1,4096211,1.6170661636178802,1.852837861929435
LCLC-97TM1,SNX-2112-bortezomib (250-1 mol-mol),-1.5766290939625012,-1.119441746631111
SW48,9907093,2.826389946725867,3.975846646557146
MOLP-8,5281672,3.2641398124752063,4.106446000375522
SW948,6610355,3.913576061403015,4.2081147744123015
SU-DHL-1,5746,-2.2023974745237815,0.18154750696053365
MOLM-13,10410894,3.311191932806664,2.4377595463326793
SW1573,3384730,1.5192292760027193,3.2167975949576966
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032,1.7113102748171272
NCI-H2452,54649381,5.966732082850981,3.9797350347412146
COR-L105,JQ-1-navitoclax (2-1 mol-mol),0.1739680576486409,1.0832092303090335
BFTC-909,9444,3.603329432205708,4.224830790777407
RERF-LC-MS,SNX-2112-bortezomib (250-1 mol-mol),-2.268317507970671,-0.9228508165546471
SW1271,9952709,3.6093754742197706,3.174914406044321
IGROV-1,4788,5.801051990484709,5.547821369904159
K-562,3825829,2.9396673791475587,3.4610091733567026
COR-L105,53232,1.738169806280081,3.0553168119449996
Daudi,25195348,1.3194617548918357,2.3239060324861573
NCI-H1568,46199207,1.8853593558521984,3.327355088052485
RCC10RGB,135440466,4.497503570362309,2.46125312952313
SU-DHL-1,navitoclax-birinapant (1-1 mol-mol),1.3479254816656925,0.6463396824489225
NCI-H1568,3062316,1.133797551734723,0.9572048975458898
Panc 02.03,56649450,3.905458120664549,3.3263484621295163
RKN,44589607,3.09715941328701,3.087642588784592
MOLM-13,568763,-0.9067431163570788,-0.45906831061946873
MOLP-8,444795,3.9342801961368417,2.8705066096316214
RCC10RGB,navitoclax-piperlongumine (1-1 mol-mol),1.8990680206310235,1.8525133042648145
COR-L95,selumetinib-piperlongumine (8-1 mol-mol),2.799372777395438,2.599693810279214
COR-L105,vorinostat-navitoclax (4-1 mol-mol),0.9761778131002136,1.3271961161635155
IGROV-1,6918878,1.6706182189896102,2.952297664639945
BFTC-909,piperlongumine-MST-312 (1-1 mol-mol),1.831832453388112,1.845079300401337
BICR 22,5280436,0.2666608642372045,3.473876817755125
BFTC-909,3081361,3.110656330811392,2.4423635435568958
PaTu 8988t,45279963,4.21642269895433,3.732273690255839
MDST8,613753,3.2461287764543085,3.4106448384699792
LS411N,6917907,-5.419583860239815,-5.2222681103782636
HCC15,5335621,5.428336568471036,4.8329053423384885
SW48,71466380,4.3724837890251935,4.48129800655199
SK-OV-3,66577038,3.416512813520814,3.106304131398221
RCC10RGB,49766530,-1.6086406954404375,-0.5014044282816722
HuP-T3,16722836,1.72068374216493,1.7866299454815928
MOLM-13,168313016,3.5509192860421592,3.8746943339625255
SU-DHL-1,675434,3.83709506639581,4.2230376511718015
P31/FUJ,9911463,3.6551866379259743,2.9689826583082866
P31/FUJ,445455,5.725867195241275,3.8439138013707153
MOLP-8,285033,-4.447286141218139,-3.250896497770573
RKN,107970,2.600341318615175,2.219752132177413
IA-LM,4788,5.899787929501101,5.801880451053674
RKO,71680916,5.910552922648844,3.938719133339001
K-562,9825149,1.660902694463834,1.8896354397923871
RCC10RGB,4261,3.441062261939301,1.9284753860682264
IGROV-1,387447,-3.9508602289798658,-4.142152440505946
WM115,54618164,3.776567993994872,4.161033996698415
LS180,44607531,1.744731406430345,1.3373569519213158
NCI-H2452,123631,2.1406097245383062,2.520911112868971
K-562,262093,3.1056763935044813,2.1233574655746175
MDST8,24180719,2.4870372971011374,3.1526197713317226
WM115,66577038,2.911239385644133,2.840041339852577
SU-DHL-1,6918328,-0.7249486298416586,-1.4986828935566465
NCI-H2452,135999136,4.5117873079445205,4.069884034903783
ML-1 [Human thyroid carcinoma],9823820,3.655965927562111,4.149445054014991
PaTu 8902,11609586,3.6092581559147185,3.036630187429594
IGROV-1,11497983,4.37450324471555,4.3012985413141624
RKN,387447,-2.9807645129134066,-4.183856770281863
LS180,6184667,4.288388758455988,3.070433005811195
RKO,JQ-1-vorinostat (2-1 mol-mol),0.9623246898976432,0.3945386520171027
NCI-H1568,5460769,1.1324377767406906,2.5614007671898253
ML-1 [Human thyroid carcinoma],374536,-3.4857090018028956,2.6459193737171973
HuP-T3,3025986,0.0333046209415895,-0.6489133065137603
IGROV-1,11625818,2.877471533668122,4.483061927301121
SaOS-2,122327,5.211292969638739,4.749607974838532
BICR 31,46943432,4.176233154169203,2.5611322120503455
HCC1500,10427712,5.196976599700856,4.209184314310565
K-562,9866186,0.7861847855254385,0.134525003757424
RKO,10231331,2.816804700080647,1.6273428604065676
NCI-H1568,126941,-1.411149621431801,-2.588122062186908
HCC1500,9933475,1.9677534910437375,1.9948998783720284
ALL-SIL,53245473,2.8781179496967666,2.9847474023731233
K-562,135423438,0.8826240773524879,1.4545845957420998
BFTC-909,9956119,4.255413767268681,3.676501473855674
HCC1500,9884685,1.9086372211674376,0.7779948845374607
P31/FUJ,71304818,2.235751993715144,2.080706880395923
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342,-0.3809091289433145
MOLP-8,5470400,0.1664110443814662,-0.4296513262403295
ML-1 [Human thyroid carcinoma],9967941,2.6659391926085183,3.9896608437356127
SW48,44819697,-2.186530212001632,-0.4705257667415429
SW48,12001922,1.4259296039497584,1.798072899146937
NCI-H1568,24951314,0.6613293075425478,1.6507561889880162
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057,2.4256725866155433
SW1573,51039095,4.568767182944777,2.9265656792891646
BFTC-909,46224516,1.8849058086882595,2.617234895154102
SU-DHL-1,52947716,-4.8688827763192135,-2.4009161860102495
IGROV-1,262093,3.169376516915595,3.060433070739888
MOLM-13,selumetinib-PLX-4032 (8-1 mol-mol),2.341131850097057,2.4729836389805713
WM115,24821094,1.6911725066550027,3.200438856199826
COR-L105,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9364869385558905,4.275065457427549
SaOS-2,53325874,4.45514535643454,4.406461410650384
SaOS-2,4261,1.4562926555721387,1.7699128885217044
Daudi,selumetinib-BRD-A02303741 (4-1 mol-mol),4.766499662103581,4.105429729863337
SK-CO-1,9907093,3.652313916117519,4.300174561959616
SaOS-2,613753,3.192322830330122,3.326248986440115
BFTC-909,148198,-2.03933057080943,-2.9364159508118264
MOLM-13,49793307,-4.691237884437231,-3.971833948250816
ML-1 [Human thyroid carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-2.7240522304333763,-0.5250514629087308
COR-L105,135411,0.974173137304268,0.8106096153334709
RERF-LC-MS,135411,0.496828330774242,0.8359652540919739
SK-OV-3,16725315,5.283554915030345,4.242282385614081
SK-CO-1,3854666,3.8596661393399927,2.6130920798979447
LS180,51039095,2.999333495393298,2.978918759285767
RERF-LC-MS,135440466,2.007932851474071,2.5140934002311557
SW1271,SNX-2112-bortezomib (250-1 mol-mol),-1.3790138823522573,-1.3861660086968712
LS411N,446155,3.6642844723827266,2.7654870129042526
HCC15,72193861,-0.2523453521741511,1.896743354490824
BFTC-909,52947716,3.1995758728854224,0.5602652773354935
SK-HEP-1,9933475,2.440596541444364,2.046499181480445
MOLM-13,702558,4.671896667990455,3.6158268602935477
P31/FUJ,375860,-1.2092771030706315,-0.4402745124486311
Panc 02.03,57519531,5.330694472788803,2.7555549670863244
COR-L105,selumetinib-decitabine (4-1 mol-mol),2.222127008727221,3.543504559149306
HCC1500,11238147,3.2515653100317023,2.967986777371514
RKO,11427553,3.456895276763714,1.748846461432481
HARA [Human squamous cell lung carcinoma],24771867,-1.145662696893675,2.860420397600225
HCC15,9927531,3.758901572486559,4.7952848450609915
Panc 02.03,107970,3.0394503344184214,2.392533305652068
BICR 22,6917907,-5.724798000333263,-2.9233882453150106
P31/FUJ,219104,1.0946129740431632,2.345710935745074
MOLP-8,selumetinib-BRD-A02303741 (4-1 mol-mol),0.9308410221976412,3.337106387968425
ML-1 [Human thyroid carcinoma],421610,2.367130129227347,3.377578444480278
P31/FUJ,SNX-2112-bortezomib (250-1 mol-mol),-3.0882098716957223,-2.8000783449245694
COR-L105,23582824,0.3539942370445449,0.7775427695094589
RERF-LC-MS,selumetinib-vorinostat (8-1 mol-mol),2.5829848762682865,2.842153773642806
NCI-H1568,135999136,4.3721543597322405,4.250927385086644
HuP-T3,11404337,1.0495167124251128,-0.30421438976990406
MOLM-13,2729026,2.3347481789683564,2.2639832578717365
IGROV-1,9935249,3.330117761231163,3.2233843191007328
IGROV-1,16038120,0.2864038103759729,1.1799962627950906
NCI-H2452,11167602,2.565240148317103,2.539352586417806
Granta-519,4788,5.939837006566146,4.954467961296498
HARA [Human squamous cell lung carcinoma],9935249,3.837366541191349,3.1672838445706093
Daudi,2842253,3.640131040983124,3.444952277932785
PaTu 8988t,9911463,4.367264855700764,3.896695086475612
IA-LM,613753,3.1957676281974328,3.1475529561689997
HCC1500,168312962,0.9454061370050444,2.1170299878628485
Granta-519,52912189,-1.096728840522365,-0.030238845934594912
K-562,67291369,1.5957287334193675,0.8793377512695922
HuP-T3,1750826,-1.878047057258104,-0.8479394600309027
RCC10RGB,24180125,2.398663234613943,2.979961278215199
SW1271,5566,3.0013167075914344,3.1110167074171073
P31/FUJ,126941,-4.476387704672624,-2.9865525989402952
ML-1 [Human thyroid carcinoma],UNC0638-navitoclax (1-1 mol-mol),2.518264645027629,1.9205916726401342
HCC1500,44486219,3.883233561942222,4.455704131501829
SW1573,24964624,5.100144587499453,2.7212132560686757
LCLC-97TM1,crizotinib-PLX-4032 (2-1 mol-mol),1.007977471964547,1.746081373460139
Daudi,42642645,-0.8700738631175318,-0.07672682359537007
COR-L95,carboplatin-etoposide (40-17 mol-mol),-0.214243666427535,1.683237169099752
HARA [Human squamous cell lung carcinoma],5746,1.191361240850758,1.2127310311190274
SW1271,969516,2.705669665349302,2.763751938137068
COR-L95,6918837,-4.56092327324237,-3.8095348289935176
SK-CO-1,25154868,4.619527339846263,4.15292968173047
RKO,159324,3.5523933893017583,1.6838444346625625
HCC1500,168313200,1.6452616775244175,2.8404748928232504
IGROV-1,4788,5.801051990484709,5.547821369904159
KU-19-19,5746,1.6270456089520258,1.1167615516889955
RERF-LC-MS,46398810,3.3112335021243977,2.7483577225113187
IGROV-1,6438330,2.7487580937365683,2.3349405757638646
PaTu 8988t,123631,3.803217986992814,2.5014689884213066
LCLC-97TM1,5278396,4.167561166456711,3.252302627700924
WM115,71680916,4.535911767348542,4.883918653798546
NCI-H2452,322968,3.869715934392993,4.12326852019574
NCI-H1568,2708,3.449118605167301,5.021230388025697
Daudi,5470400,3.6690588756853706,0.44936278738173946
NCI-H1568,3038522,2.281352774411324,3.3315236600417917
K-562,24951314,0.9405452740645998,0.5468109860768644
BICR 31,44137675,3.031084694210408,3.858499332524926
SaOS-2,82146,4.466197629976123,3.6261798288169986
ALL-SIL,BRD-A02303741-navitoclax (2-1 mol-mol),-0.9236991288199824,-0.07731303711902374
HuP-T3,5738263,4.055810266621769,3.6300998286375012
COR-L95,11494412,1.7619372096243109,1.0901044515831038
Granta-519,11507802,0.4974969144595386,0.8259162227910042
WM115,2949965,2.619280368742809,2.835156220852478
HCC15,613753,3.363668001401703,3.3499906449800743
HCC1500,107985,-3.8501888791364034,-3.6643202669641886
WM115,54678924,1.8194282087981308,2.3175141410000846
Daudi,135398516,-0.2737475793919353,1.2795999218932
PaTu 8902,5280436,5.000479378124589,3.6830408730499995
RKN,439501,-1.5558449248177562,-2.2601897356480283
RCC10RGB,5287620,-0.3857243809023412,-1.5376136668223057
Daudi,5566,2.2518803351891616,2.8934769664616415
COR-L105,31703,0.0245204691354453,-0.336212535542618
LS180,44507138,3.917968702075208,2.4203195606124326
Daudi,11964036,0.3747037141940179,0.3776644066902825
K-562,16659841,3.212428083743772,2.727834744054444
MOLM-13,54618771,-0.6841479707721928,-0.023781755297424254
NCI-H1568,49793307,-3.5648882234860895,-2.344678450760118
SK-HEP-1,navitoclax-gemcitabine (1-1 mol-mol),-0.1291553978520299,-1.5960454484052047
BFTC-909,vorinostat-navitoclax (4-1 mol-mol),1.5579626952552863,1.2759059790437914
KU-19-19,selumetinib-decitabine (4-1 mol-mol),2.1660518976484853,3.7606342939825446
SW1271,107985,-2.924919788256343,-3.39725467403705
COR-L95,2746,2.78697970441755,2.4884946389608134
IGROV-1,104842,-1.6690343627553987,-2.402863708835066
COR-L95,16038120,0.5843691628917023,0.39876464297073416
HARA [Human squamous cell lung carcinoma],73707398,1.6371281450925783,1.3987335931323506
HCC1500,123631,1.5682585338280497,2.0338629649145874
PaTu 8902,322968,4.547287257097872,4.026891949825771
HARA [Human squamous cell lung carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.4213259806317335,2.2408166897071373
Daudi,11167602,1.0022899570414256,1.7839096233094807
ALL-SIL,10074640,-0.3353589360570669,2.443858317308527
COR-L95,57519531,1.325264870307383,2.21463474017467
LCLC-97TM1,46191454,0.3820919964810073,2.029889500796908
ALL-SIL,439501,-2.349752310116714,-2.4783481969384935
IGROV-1,25126798,3.9275606774720817,3.884923200959396
WM115,24753719,4.6734048968266775,4.290397615887739
HCC15,36314,-6.084589216701663,-1.7723064972139333
HEL,16720766,-1.3120587580234824,-0.671022721834211
SU-DHL-1,11222830,1.179409628644554,1.6127933005975092
HuP-T3,3634881,3.0028113890745707,3.2596127596455893
K-562,5738263,2.3545721599917027,2.6835584872084177
SK-CO-1,16725315,3.5012946679092853,4.502126866275544
RKN,327653,3.2518035953304434,3.3001872651946496
RKO,24772860,-3.046302255649564,-2.3968028300730246
HARA [Human squamous cell lung carcinoma],1750826,2.2891380116234616,-0.5495058214711164
NCI-H1568,piperlongumine-MST-312 (1-1 mol-mol),1.2489252589958966,2.184240662627036
SK-CO-1,15953870,2.1343083972614725,3.472015800999486
BICR 22,71751553,4.276876209585518,4.454434220026844
K-562,24964624,2.9615918690112717,1.4722147885492287
RKO,11222830,1.6656419736189183,1.5075711154815121
RCC10RGB,25105715,3.76392637454814,3.4615131720821335
ALL-SIL,54618164,3.625474128679928,3.3734380767459218
HARA [Human squamous cell lung carcinoma],25183872,-0.077265330214196,-0.5641100126579746
SU-DHL-1,49793307,-4.256389272054101,-3.864749069097501
SK-HEP-1,9915743,2.4580731883892293,1.4400329904891092
SaOS-2,10410894,2.56650375580144,3.4187734263830087
ML-1 [Human thyroid carcinoma],9926054,2.0491703403306056,2.204835126304285
COR-L95,44491742,4.146782751375218,4.194288143912827
SK-OV-3,44137675,2.687297746540291,3.796913894594781
SU-DHL-1,4477,-0.6876815909262691,0.43953442937202264
RKN,5311,1.8833679583763572,1.562214989674395
COR-L105,11640390,3.408966388045623,3.7416775714645096
RCC10RGB,637858,2.3286326267725084,2.488363140062004
HARA [Human squamous cell lung carcinoma],16722836,2.4020375260133595,1.7040048485784869
ML-1 [Human thyroid carcinoma],54454,2.7684179569761422,2.6898391257853
NCI-H1568,serdemetan-SCH-529074 (1-1 mol-mol),1.1632168234026012,2.150544241584981
SU-DHL-1,6852167,2.266746993939426,2.543831175395623
HARA [Human squamous cell lung carcinoma],2945648,3.3865607820212316,2.8619163318069627
HuP-T3,49793307,-5.3581383477853555,-2.608662546538509
SK-CO-1,5282054,3.655593178279643,4.074212705929234
RKO,2841722,4.522769482159767,3.880889096971357
Granta-519,65628,2.6603144373939154,3.1058132848601154
SU-DHL-1,637858,0.6782178889909583,1.8861899154455282
RKN,9911830,3.6623648245681744,2.525195436213051
ALL-SIL,tretinoin-navitoclax (4-1 mol-mol),0.1560826957318693,-0.43908418856903203
MDST8,ISOX-bortezomib (250-1 mol-mol),1.0361241685592786,0.5983867543158103
BICR 22,9884685,0.2149660223226223,0.8354444287749452
COR-L105,46907787,0.7742744471044445,2.5005032111864187
RCC10RGB,navitoclax-sorafenib (1-1 mol-mol),2.209619948834929,1.9491250752159095
RKO,54618771,2.3159310195777985,1.1982206368674866
HCC1500,6450551,2.2317386689521816,2.874320397676464
BICR 22,10296883,3.888864516393213,3.8469482810680584
Daudi,10302451,1.2926011902861492,2.546828552380561
Daudi,tanespimycin-gemcitabine (1-1 mol-mol),-4.635562978503933,-2.687332177878092
SaOS-2,JQ-1-carboplatin (1-1 mol-mol),1.527244446829994,2.549135882194952
Granta-519,216239,2.502983600228736,1.7802530506966654
RERF-LC-MS,selumetinib-JQ-1 (4-1 mol-mol),1.7940148785234815,1.7149722687480997
NCI-H2452,4521392,4.554150979099382,4.319402818327735
IGROV-1,123631,1.7694522866439453,2.261876270867159
IGROV-1,5566,3.174346862827938,3.1398780763426486
MDST8,72193861,1.790495642839322,2.053499486111245
COR-L95,400769,-0.6446482680437077,-0.6762381515297834
SaOS-2,5287620,-1.8033063725700844,-2.016222233883764
COR-L95,6917907,-5.619348954097505,-4.788708721723065
WM115,9840324,5.544544164897635,5.911301603679083
COR-L105,selumetinib-UNC0638 (4-1 mol-mol),1.9595144972930605,3.2993358487473405
SW948,10322450,3.138867511839475,3.275356162416646
K-562,25126798,3.746183025237492,3.540139032758372
LS180,5335621,4.412574333730147,4.367100761195876
SK-CO-1,9911830,2.5560928673864676,2.5340014654429757
BICR 31,selumetinib-vorinostat (8-1 mol-mol),3.0204654665417237,2.6023399756253345
SK-CO-1,9825149,2.4273154495027147,2.0806810744636035
HuP-T3,tretinoin-navitoclax (4-1 mol-mol),4.772875046445671,3.2394581762918784
KU-19-19,10074640,3.725362653690234,3.212351790790594
NCI-H1568,24901704,3.012455129702266,3.4213337437585074
PaTu 8902,216345,4.855612410794221,4.094294862876795
LCLC-97TM1,44202524,1.0559659544617075,2.168518063508654
MOLP-8,9884685,-1.6145757941110517,-0.11647001527042625
SaOS-2,11656518,3.53164758658959,1.9107992881027889
ALL-SIL,5280436,2.610850174870569,2.5456761373833086
ML-1 [Human thyroid carcinoma],10231331,4.187669502210677,2.0914742017025882
HARA [Human squamous cell lung carcinoma],JQ-1-vorinostat (2-1 mol-mol),2.5839829159057848,1.2895406461528187
COR-L105,16659841,4.469572921203622,4.056430329242705
SW48,11625818,2.5740084903132914,4.2294478151633905
COR-L95,135875424,3.0866900102445816,3.5979678018097743
NCI-H2452,10074640,3.4255764700713685,3.3169658490742364
SK-CO-1,60750,-4.4937571478067495,-1.3030433438814575
BICR 22,374536,2.9550889228261386,2.2428744219817074
MOLP-8,2126,5.134995770793403,3.7898229906148115
NCI-H2452,5566,2.960608772215372,3.1254307812609885
Daudi,54618771,-0.114332288085178,0.6444556476921253
NCI-H1568,44137675,2.485428235347338,3.684598011062596
BICR 31,24771867,6.325583215176513,3.091897519272045
HCC1500,135875424,3.5744445956281483,3.8854044001446355
K-562,vorinostat-carboplatin (1-1 mol-mol),2.490945525629646,1.9690150649780862
IGROV-1,753704,6.461140333581179,5.010315971281263
SW48,11497983,-4.007853458767396,3.859159369045668
MOLM-13,25195348,1.114215790958376,2.3785369788029027
Daudi,441298,1.3514709590925575,2.3114065914087565
SK-OV-3,124202324,3.0713957973247186,2.50654395987632
BFTC-909,23635314,-1.3241610546701814,-1.6054672769768703
COR-L95,71304818,2.943301589855332,2.3973766889997976
SW1271,44607530,2.17277245139498,2.1155675109455556
RERF-LC-MS,219104,4.628133490361187,4.05054420345836
NCI-H2452,31703,-0.2834256058580119,-0.642431161850334
Daudi,462382,-0.0525304302162242,0.557855692758091
SU-DHL-1,25183872,-2.297532702486321,-1.7677125027131075
K-562,54618164,3.946994253297547,3.718546508331957
SK-HEP-1,568763,1.0235069184223942,0.5348643130361106
SW48,docetaxel-tanespimycin (2-1 mol-mol),-8.123886258687621,-2.4429905049949343
Daudi,BRD-A02303741-navitoclax (2-1 mol-mol),3.127125631555358,0.8368423585325729
Panc 02.03,2828334,6.385741192046609,6.149659662728709
HCC15,5702613,2.8473188935914835,3.046456836292356
PaTu 8902,11625818,4.430115392870615,4.611971389877304
COR-L105,53392493,2.0389615313780256,2.9596458909781402
RKN,3062316,2.6330403907451863,0.6957478769857957
UACC-812,6505803,-4.59801553223132,-0.41804721924204796
UACC-812,16736978,0.0217391388778129,1.683348668398137
BFTC-909,5278396,3.473037688340168,3.7487186007097937
SW948,73707398,1.7510146080607218,0.8906231171200472
BICR 22,107970,2.71438120007047,2.3402986157715997
SW1271,984333,0.5174855517327741,0.7557227204778627
IGROV-1,9967941,2.9735049794712545,3.694129530235999
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693,-0.7613475805363459
SW948,135984461,4.375312800732864,3.013648967316155
LS180,5280436,4.14000298943632,3.6180226624826357
MOLP-8,219104,2.0853040324344536,2.219125874141741
MOLP-8,1716436,2.7387406442001287,2.4285501462578982
MOLM-13,171352865,4.594115651620468,2.6041817685267734
KU-19-19,10127622,1.068304480617998,3.7472543293687193
KU-19-19,5460769,4.3332822587900255,3.040028979435344
LS180,675434,4.417044491450032,4.434266930841485
RERF-LC-MS,vorinostat-carboplatin (1-1 mol-mol),3.78748525663286,3.5148331967445414
SK-HEP-1,66577038,3.45712203265648,2.982422434960059
SW1271,3689413,-1.2412691685690602,-0.4332198836283524
COR-L95,10296883,4.074268886544182,3.4817871335189143
HCC1500,5287620,-3.8084705838741306,-1.4721860164976692
RCC10RGB,JQ-1-navitoclax (2-1 mol-mol),1.088443536961304,1.0452260454362936
WM115,serdemetan-SCH-529074 (1-1 mol-mol),1.0432203411705916,2.096763473420887
SW948,vorinostat-navitoclax (4-1 mol-mol),1.0335682598311662,0.8905543651649372
SW1271,46843906,3.0036733058278298,3.1135664850603195
SW1271,10184653,2.439662406391272,1.5352046557862218
SK-CO-1,31703,-2.259601900898513,-0.34603577034244615
COR-L105,10074640,3.626128603914542,3.2604095936730624
MOLP-8,11152667,-1.9226575172330305,-1.7865936053380584
SW948,56646779,5.261847054930003,2.9124380054335988
MOLP-8,9825149,0.6088991704164435,1.5246371559440872
ALL-SIL,piperlongumine-MST-312 (1-1 mol-mol),1.1188007214876046,1.1230330685933445
RKN,1641662,3.781184529562369,3.5491103943770157
Daudi,1750826,-5.008838903624334,-3.4567019037022475
RERF-LC-MS,24856436,0.2419222597799965,0.6037520085528493
COR-L105,6184667,3.4155069342084916,3.0926532507621745
HARA [Human squamous cell lung carcinoma],151289,0.6137813450564443,1.1154193149447695
MOLP-8,568763,-0.8505432933185847,-0.17434344199520216
Granta-519,piperlongumine-MST-312 (1-1 mol-mol),1.116794346695572,1.1609792189688237
SK-OV-3,54618771,2.5849230632376923,1.486169833411384
SW1271,135398516,2.256973153183445,2.2750486079989303
MOLM-13,44819697,-1.7672663076184636,-1.1366323693069205
LCLC-97TM1,24748573,2.1629406196043894,1.8743709190351694
NCI-H1568,10113978,1.8126489257310032,3.522034563696729
ALL-SIL,SNX-2112-bortezomib (250-1 mol-mol),-3.319111432428944,-2.7741007932722295
COR-L95,1566236,1.7351682171374878,1.844456635396954
PaTu 8988t,54619267,4.243668204976347,4.175359820959489
BICR 31,73707398,2.635299985295534,1.3772920910285913
P31/FUJ,24978538,-1.1674360999825653,-0.240351510682017
HuP-T3,25227462,0.1487181406442073,0.5287290735646912
Daudi,439501,-2.973914496380735,-2.537541420669022
NCI-H1568,67156097,-1.7914617240991686,-0.19471047449504447
WM115,36314,3.85550299796777,-0.9105190574529931
MOLP-8,409805,3.552664043240888,3.7143238946319403
SW48,24753719,4.052743892866938,4.303872018687263
SW48,3825829,3.1303188593692854,4.028921479529981
PaTu 8988t,54613361,0.5051194448617704,0.1869733448164695
SK-CO-1,44493528,4.973545843770428,4.227640228944081
MOLP-8,44202524,1.1617664844294235,1.5982912769153506
P31/FUJ,11656518,-0.8295634521320199,0.578868877992712
HARA [Human squamous cell lung carcinoma],11625818,4.840804819194981,4.624700055027553
LS180,36314,2.4476112429633403,-1.1081872323723558
SK-CO-1,119182,-2.3548964470523974,-0.42748789279552574
LS411N,72376,-2.6969507034435236,-2.9976458587730868
BICR 31,51037431,4.633533363663127,3.615328127808931
ML-1 [Human thyroid carcinoma],72376,-3.175400377997246,-1.4626421293580385
HCC1500,46907787,2.786329845885891,2.0074441595002432
MOLP-8,2708,2.5820066460748015,3.5013343662510654
HEL,10113978,2.6394190696879662,2.105987943279222
HEL,1641662,3.192273244328466,2.783403358566097
LS411N,12001922,2.0246848718715604,1.5984148517849663
ALL-SIL,56963564,-1.2928564241979046,-0.23824553138693272
ALL-SIL,168313047,1.973173862571291,1.779894106594272
COR-L95,3038522,2.051786867518871,3.0188579851875725
LS411N,25102847,2.9606059837222767,2.2696474227242134
SW48,5566,2.216391660090734,2.9130888223114937
HARA [Human squamous cell lung carcinoma],637858,2.3831379320922728,2.2036040984882943
SW48,6917907,-5.957551707769467,-4.568939245138888
RKN,246676,4.414592383854902,4.3072037552882945
IGROV-1,285033,-1.3538783590767758,-1.8582456625246297
PaTu 8988t,11609586,2.9135578891851233,2.9132612646349436
P31/FUJ,19582717,2.23583270668625,2.8741153784841447
SK-OV-3,71304818,3.289226671933847,2.6939599442837228
SW48,9903786,0.6824641791663469,2.953847351923274
SW48,107985,-4.220376672084107,-3.6070408865242234
ALL-SIL,49836020,-3.56746653346715,2.9655461855548135
HARA [Human squamous cell lung carcinoma],24772860,-1.3203429479269333,-1.99925362568043
MOLM-13,7326481,3.309466894819375,2.600382088037406
PaTu 8988t,387447,-4.215036300164339,-3.5325773707512975
IGROV-1,10231331,1.9104831176724932,1.5851922755901198
NCI-H1568,salermide-PLX-4032 (12-1 mol-mol),5.036103452561945,4.962830276118325
WM115,6852167,1.3860811523021286,2.904349828994869
SW48,11175137,0.8049020199472112,2.8243197269354865
NCI-H1568,6918837,-3.937828464321892,-2.659462461777206
ALL-SIL,409805,3.511042482554543,3.664058735373288
BFTC-909,11485656,2.882750602975944,2.6134761169967855
HCC1500,6610216,3.984830656845064,4.21929080990098
MDST8,46191454,-0.3052251724831438,1.7571472464042512
NCI-H2452,52947716,2.3907771066336543,-0.2989283104547093
COR-L95,135411,0.6709946332822974,0.4672752861595944
RERF-LC-MS,11497983,4.204546577264711,4.437590853800654
MDST8,3025986,-2.3601391308628368,-0.38224659951568773
K-562,10113978,1.9599198523990544,2.393223089516022
MDST8,66577038,3.4472401917824387,2.811223125068621
RCC10RGB,6917907,3.54732574828972,-3.584827011584035
SU-DHL-1,54618305,4.34503505735179,3.5552651645028424
RERF-LC-MS,selumetinib-navitoclax (8-1 mol-mol),2.77400767356552,2.307121221384514
RERF-LC-MS,navitoclax-piperlongumine (1-1 mol-mol),3.552905574656644,2.1532073215628817
WM115,448949,1.6539360415615445,2.2249196072159454
ALL-SIL,216239,1.0502640873271551,1.862837412229431
HuP-T3,docetaxel-tanespimycin (2-1 mol-mol),1.3630986120545014,-3.036356994604546
IA-LM,53325874,6.131967715828746,4.036451933458469
ML-1 [Human thyroid carcinoma],16219061,3.525142786131821,3.739976747484799
P31/FUJ,119182,-2.8125390579467244,-3.1975149246198367
SU-DHL-1,11717001,3.585470860794662,3.1716252289898663
MOLP-8,168313016,3.7646553629166304,3.753208654312989
ML-1 [Human thyroid carcinoma],11485656,3.567697107596816,2.620739888819499
SW1271,9823820,4.369434873409536,4.045105086359845
SK-CO-1,51037431,2.025162533854422,3.168309509340813
SW48,11964036,-0.90016316876993,1.3230727491050425
Granta-519,702558,4.9740995052838874,3.681824395029092
ALL-SIL,UNC0638-navitoclax (1-1 mol-mol),-1.2077799570565213,-0.9281637064272388
NCI-H1568,6918328,-2.169641972219076,0.3336488250123599
Daudi,637858,0.7785119720749748,1.0189715226696419
SW948,53495165,0.2015090818079991,-1.4834687156189699
SW1573,46398810,3.5765453048302933,2.7653053551065923
MOLP-8,637858,0.6022882265593398,1.0549963726681577
NCI-H1568,3825829,3.749474944576795,4.069509857042338
MOLM-13,4788,4.00969340257961,5.157127563343603
SU-DHL-1,135398516,1.716785738144405,1.643671176841165
HCC1500,2945648,3.001490751925554,3.0755157966826556
SaOS-2,SNX-2112-bortezomib (250-1 mol-mol),-2.769432838518552,-1.1919388215074707
HEL,46943432,0.8947528664895825,0.9139850757740139
RKN,3689413,-4.085525957083088,-0.3072394951021273
COR-L95,45279963,4.007720953160328,3.0775287880851265
LS180,11364421,-2.9792456594346945,-1.5548865983142612
SW948,51039095,-2.1737453378627567,2.7192159926506094
HEL,135421197,2.810551353794614,1.4087426978067485
SK-OV-3,doxorubicin-navitoclax (2-1 mol-mol),-0.6082867931514424,-1.0131034154506195
HuP-T3,5351362,1.4959503226370765,1.4112110194013652
P31/FUJ,selumetinib-decitabine (4-1 mol-mol),-0.417260560947631,-0.2704882006381484
SU-DHL-1,6623618,1.9512254956144048,2.1565908248805292
BICR 22,31703,-2.104947288409208,-0.5326577872875147
P31/FUJ,BRD-A02303741-navitoclax (2-1 mol-mol),0.458289206697817,0.5133662392519406
IA-LM,17755052,4.247702528352723,2.172404851536574
IGROV-1,17755052,-1.0246415273055465,1.5250418868973012
WM115,navitoclax-birinapant (1-1 mol-mol),2.982568846631371,1.6526008235560203
IGROV-1,3503,2.453392942972796,2.3608553436351696
BICR 31,10302451,2.0763164615496232,2.6171530645035066
COR-L95,JQ-1-vorinostat (2-1 mol-mol),1.1858087423050925,0.7300941512873331
MOLM-13,2841722,4.084965304911922,3.805315792911296
COR-L105,9549297,5.541569761250669,2.713973792429398
COR-L95,4705,3.007858501345706,2.791241956162077
SK-HEP-1,54626689,5.252317432323977,4.704088903475852
BICR 22,24964624,2.8366894332481127,2.3449000226513657
K-562,3384730,2.2830550335302555,1.734721879501844
RKN,46224516,3.695788234754723,2.676109437807966
Panc 02.03,44607531,1.9299895981807216,1.5601515800388552
MOLM-13,11317348,-4.1893096196029465,1.1265498747740879
LS411N,60700,1.793788628592944,-0.6123188207820222
ALL-SIL,9967941,3.4348481015027628,3.0348264092666706
SK-HEP-1,46907787,5.1061569205326505,2.462970041164772
RKN,5351362,2.529766574998156,1.5205533295066045
HuP-T3,31703,0.4675615226322689,-0.5348827953632778
SaOS-2,6610355,4.596244040557677,4.698817902704487
BICR 31,25195348,4.130650271984148,3.514262649406858
MOLP-8,73707438,3.908454567487333,4.194911930658927
MDST8,3503,3.3556251865549065,2.5661087750907563
COR-L95,439501,-1.1523844892623298,-2.2218854869081683
HARA [Human squamous cell lung carcinoma],selumetinib-piperlongumine (8-1 mol-mol),4.925037100159097,3.5871874445574026
P31/FUJ,5281321,-2.503740446113486,-2.390268646372426
BICR 22,selumetinib-piperlongumine (8-1 mol-mol),3.0599254943264116,2.728082398754999
BICR 22,2729026,3.062923067871907,2.5688067399040415
SW1573,51037431,1.8928004764191728,3.3079734410806507
ML-1 [Human thyroid carcinoma],285033,-2.470992399828971,-1.1668384537837404
RERF-LC-MS,16741245,3.282184197465347,3.7195540024045646
ML-1 [Human thyroid carcinoma],71466380,5.169213277707957,4.770618659807716
SK-HEP-1,11427553,3.604603983851784,2.9823439005446972
SW948,alisertib-navitoclax (2-1 mol-mol),-1.9206127672365017,0.20319451973935343
SaOS-2,36462,1.0480120523183942,2.1495629194140333
IGROV-1,124202324,2.2563058955522157,2.2596011761485273
P31/FUJ,54618771,-0.1557090961755644,0.02713000350042752
HCC15,6918837,-3.491973763742546,-2.6205357221417773
RERF-LC-MS,10302451,4.085913110869725,3.510808197745043
WM115,9866186,1.4274901944164853,1.207837874989531
RCC10RGB,3634881,4.1231622503065495,3.3996936448117263
MOLP-8,tretinoin-carboplatin (2-1 mol-mol),4.454701733266676,3.15736705823785
SK-OV-3,56946209,-2.3996417591607235,-3.736616361567794
Daudi,9907093,2.3595872536278977,3.212759313605604
UACC-812,135421197,0.8848266315498433,2.0976046585785997
COR-L105,11707110,-2.3960237918310967,0.16259173181041933
NCI-H2452,crizotinib-PLX-4032 (2-1 mol-mol),2.3217431804401607,1.9922717727209187
RKN,selumetinib-GDC-0941 (4-1 mol-mol),1.8547441727402172,1.4788641331923518
BICR 22,5287620,-2.2777736835755076,-1.917575853078175
HEL,135398738,1.3240045179008624,2.01199996485487
SK-CO-1,3825829,3.015639513793665,4.1607875290078224
BFTC-909,135398516,3.047749913114312,2.3769486810396976
Granta-519,252682,6.242071482699392,6.323429791577229
RERF-LC-MS,piperlongumine-MST-312 (1-1 mol-mol),1.31949560405159,2.012343902590168
SU-DHL-1,241158,1.6235055790866513,3.6978883863913903
PaTu 8988t,8515,4.36808886077581,4.08789500501554
NCI-H1568,44489675,3.7863062268563064,4.073110825679828
MDST8,135875424,6.383148165610491,3.92777177799384
IA-LM,24771867,1.1290385026114922,-0.17817572139814808
PaTu 8902,12001922,1.8953174279693872,2.0588909057653053
HCC1500,8515,5.3989297102528715,4.179232747727428
MDST8,4259181,0.8851574645315519,0.34479326050636094
SK-OV-3,16038120,1.745962946040546,1.36362536575536
SK-CO-1,25126798,3.6561952188996503,3.9110974715559137
HCC1500,4261,0.9221319619811188,1.4111588392096996
WM115,613753,3.1291419252746877,3.343419079858174
IGROV-1,6505803,-0.2382223795960626,-0.3013979829039265
KU-19-19,49766530,0.1366302187334878,-0.2807781496803877
BICR 22,11494412,0.8036857209518554,1.6383376480194403
HCC1500,11955716,2.281516197797272,-1.2842939003053093
MOLP-8,71680916,4.479993680298279,4.025595840299804
ML-1 [Human thyroid carcinoma],3025944,4.339456842576773,4.2917254945569985
BICR 22,15983966,-4.391384426150851,-0.7183905829637958
SK-HEP-1,selumetinib-tretinoin (2-1 mol-mol),6.787404934084747,3.4748414443088103
RERF-LC-MS,9866186,0.0636323256725951,0.7653107606002314
IGROV-1,54613361,1.0826132998561049,0.1557422853607155
K-562,4259181,-0.7813149193344907,-0.3755175578232407
SW48,6438330,1.214777505056659,2.036430060675018
LS180,54618305,4.3130332958468385,4.305010446576739
K-562,5746,1.9738407973257048,0.3839493631262634
COR-L95,3081361,3.577896308939448,2.2199948462883032
KU-19-19,ISOX-bortezomib (250-1 mol-mol),0.6477518582997711,0.704632830128917
MOLM-13,navitoclax-sorafenib (1-1 mol-mol),-4.200053856490793,0.6076144780855008
HARA [Human squamous cell lung carcinoma],2113511,5.545523050638764,5.58205734585857
NCI-H2452,alisertib-navitoclax (2-1 mol-mol),-1.045230676490147,0.574664216266015
K-562,53495165,-1.204911447319433,-1.577035855329598
SK-CO-1,JQ-1-vorinostat (2-1 mol-mol),1.937629549480178,1.1635652496333035
HCC15,3676137,4.952150033317278,4.558440828068547
PaTu 8988t,46398810,3.220252132938068,2.5264249435097685
IA-LM,ISOX-bortezomib (250-1 mol-mol),0.3247346059672509,0.42753026698242536
BFTC-909,9927531,5.31835549136936,4.959782154451705
Panc 02.03,16722836,2.9028860212849565,1.8114510824964847
NCI-H1568,doxorubicin-navitoclax (2-1 mol-mol),-2.631367093813306,-1.0204949451502265
Granta-519,3011155,5.044202810550695,2.0706382045401064
IGROV-1,3825829,4.144093606877803,4.050375676881746
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891,0.0017480154609928911
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014,-1.088077872399287
WM115,11238147,1.7518250261640556,2.9591117065652917
HEL,6610355,4.700351008256091,3.9026014883235463
COR-L105,10410894,5.46795970795096,3.3208756418489536
K-562,135421197,2.032823128578147,1.2825358639636366
HuP-T3,25105715,3.756943800954468,3.445660693527513
BICR 22,11717001,4.533318725499836,3.903264625977464
ML-1 [Human thyroid carcinoma],168313047,1.965548883908303,2.5141270535918223
BICR 22,176870,3.0604023761484154,2.83508945812262
COR-L105,9823820,3.977631180290917,4.011381541205592
P31/FUJ,66577038,3.0536576112540916,2.52712337879163
HuP-T3,11612883,3.639610964764467,2.983841796509377
PaTu 8988t,12001922,2.536714978511883,2.0607510916471785
P31/FUJ,24771867,-2.604308550432203,-1.1621784942951228
P31/FUJ,3634881,2.159990781463395,2.616852746362662
SW1271,11640390,3.706316930576478,3.887712774858638
Granta-519,984333,0.7513060576966085,-1.079413747670119
COR-L95,46398810,2.3153378536205036,2.5901143647514084
NCI-H2452,4259181,1.4154165902225178,0.223801679907869
HCC15,docetaxel-tanespimycin (2-1 mol-mol),-6.454135481670954,-2.624454229001704
RERF-LC-MS,3503,1.2198018250646854,2.561935742508469
BFTC-909,168313047,1.967772312792883,2.377126610948076
NCI-H1568,49766530,-3.205306991379519,-0.2067925070608088
SW948,selumetinib-JQ-1 (4-1 mol-mol),-0.7293969321677569,0.2973852885999361
IGROV-1,44491742,4.406671418311328,4.289477941259691
SaOS-2,54596490,5.687426160237218,4.517267841774113
Granta-519,46843906,0.846372381562089,1.3693564082792542
SK-OV-3,46398810,2.6339706660379205,2.639333307733507
WM115,25154868,2.4497388117539773,4.365197247676341
K-562,navitoclax-gemcitabine (1-1 mol-mol),-0.2101297783462078,-1.946673728866772
BICR 31,123631,1.818021308876907,2.2688734237643082
HuP-T3,60750,3.212181181151216,-1.31759203401127
WM115,71304818,2.065667497969779,2.380431272262089
SU-DHL-1,11964036,1.0253922980362349,1.5067941419590187
SW1271,9444,4.046685913234064,4.056228376422422
IA-LM,1716436,3.827820678542469,2.983315466920132
HARA [Human squamous cell lung carcinoma],3854666,0.7328632401261175,2.2327786075037106
Granta-519,selumetinib-decitabine (4-1 mol-mol),1.299817261369256,0.2681008326324441
SW48,44137675,1.8984167228990951,3.3552456593176823
IGROV-1,11364421,-2.1205062036040982,-1.35739912526052
PaTu 8902,3465537,3.540732953494624,2.5049792856512143
HCC1500,54618771,1.4039271563223086,1.330751773481007
NCI-H1568,23725625,5.336887169251221,5.246889632017652
BICR 31,9936388,2.7244047649519074,-0.3078923944990552
IGROV-1,49850262,4.068828647042517,3.7860402529089083
HCC15,5280436,4.320878094694944,3.66687343076602
COR-L95,46215462,1.6156782364555438,1.5070550923714947
SW948,25022340,4.946878477600784,1.8201020291284609
P31/FUJ,3025944,3.8644283212627895,3.860848019530047
SK-CO-1,5978,-3.732613512446313,-1.4047022762022596
LS411N,19582717,5.192972758226466,3.192484837122271
SaOS-2,26596,-1.8442798913702467,-0.8895929144366397
MOLM-13,6610216,4.131122051839403,3.9018965571819786
KU-19-19,3025944,4.41555498235696,4.300849573673884
HCC15,11497983,1.686538707374479,3.9111178466324366
HCC1500,216468,3.3608861469702735,3.067536962237253
NCI-H2452,56649450,2.972344092085675,3.691854261789225
SK-OV-3,25262965,0.4953902890441227,-1.189410686594963
HCC15,10184653,1.3258142209068642,1.573422917638946
SU-DHL-1,3825829,2.249840075454991,3.7738981588521883
WM115,49867926,3.8689880289876446,4.605274412210997
K-562,285033,-3.792012978388577,-2.9437566738965852
Granta-519,53495165,-2.785106410212646,-2.106376270287652
SU-DHL-1,5335621,3.5965276677583846,4.342071176929306
NCI-H1568,1566236,1.6523344134899465,2.550836335415415
HCC15,25195348,3.62058364960133,3.375033586866013
LCLC-97TM1,7326481,3.961997196958484,2.9754589971135226
SU-DHL-1,JQ-1-UNC0638 (2-1 mol-mol),2.5998168320155712,0.2793342323803278
LS411N,9887053,4.348393626170801,2.9745803930454313
LS180,208908,2.3350670945107783,1.7295278971329933
IA-LM,54454,3.681506421747591,2.540999259220625
RKN,4378219,1.9905206425028277,2.7126052631909765
WM115,selumetinib-tretinoin (2-1 mol-mol),-1.0607687385354925,2.6996911148442617
ML-1 [Human thyroid carcinoma],2949965,3.680012286367402,3.083962581786411
IGROV-1,216345,3.498629789107092,3.7489676682799655
SW948,5282054,2.5738720751419746,3.086414568014029
PaTu 8902,66577038,3.2739824602509304,3.0421527014181375
COR-L105,1566236,2.352597865521479,2.5021300776012514
MDST8,selumetinib-piperlongumine (8-1 mol-mol),2.2463644977006423,3.238883803254285
MOLM-13,46191454,-2.5774836063329905,0.070387502830426
HCC15,72734382,4.010055800269774,4.786504514144671
SU-DHL-1,navitoclax-MST-312 (1-1 mol-mol),0.7019716882253797,0.4585838649529933
SaOS-2,53232,1.3253237607162072,2.6674211330290585
KU-19-19,9936388,2.972521935644637,-0.027804476786575938
BFTC-909,selumetinib-JQ-1 (4-1 mol-mol),1.1253035869238386,1.933712771144812
PaTu 8988t,selumetinib-PLX-4032 (8-1 mol-mol),6.546714585900996,3.7744340766295066
SU-DHL-6,445643,2.4790626422724107,3.4256786956067162
ML-1 [Human thyroid carcinoma],89183176,4.271882086089193,4.761626845170503
HCC1500,208908,1.6399748300125228,1.8541079395817286
P31/FUJ,4917,2.744589019426067,2.6478236464766587
HuP-T3,241158,3.8412641522091144,4.019738848744399
SaOS-2,46224516,2.521923040225463,2.3409966036002237
LS180,54618771,0.643112685351952,0.9722411440513007
Daudi,23725625,2.2816125857144978,3.2613918596928992
Panc 02.03,25227462,-1.0518848939229315,0.3906372459966621
WM115,462382,0.0353255606914336,0.518555267971445
SaOS-2,135875424,3.0421388786055727,3.8144185802843635
Granta-519,10113978,3.360346958971763,2.175226616924125
SU-DHL-1,51037431,2.2415500634191763,2.6499754579836092
SW1271,135440466,1.7072517695379112,2.310215509735758
BICR 31,208908,2.9880095911503983,1.8781998277134797
NCI-H1568,11719255,3.5544275615483087,3.53251436433098
SU-DHL-1,4259181,-1.4222017445817885,0.0053514330315658975
NCI-H1568,135984461,4.216726883570129,4.176832800646833
Daudi,navitoclax-piperlongumine (1-1 mol-mol),0.8768236288563281,0.34966692550001516
K-562,25195348,2.6278567451650394,2.659649137355375
SW948,6918638,-0.8188756331889222,0.22481263414387176
UACC-812,216345,3.8515167014354152,3.6384150391526457
PaTu 8988t,446155,5.325372031764619,2.6381726107505927
RERF-LC-MS,selumetinib-tretinoin (2-1 mol-mol),3.2790865080217397,3.827273124644276
NCI-H1568,54618771,0.8004506686595156,1.6728821330282537
HCC15,9823820,3.975711917882334,4.182726444873867
RCC10RGB,9935249,3.9754060705766943,3.4415969734790806
SK-OV-3,3854666,3.321518045263264,2.1217677814425264
Daudi,135928012,2.6114481479622516,3.87697093027415
RERF-LC-MS,selumetinib-UNC0638 (4-1 mol-mol),2.6397170445300433,3.447364878484036
HCC1500,44491742,3.6723474636183537,4.2842487212167475
K-562,54626689,4.3954029102592145,4.3740213533824885
SW948,11152667,-0.307089718187717,-0.6758138496463181
NCI-H1568,984333,0.7198134332239758,0.944281084446411
Granta-519,selumetinib-tretinoin (2-1 mol-mol),5.148474908350203,2.5252317605318795
IGROV-1,44507138,2.359177395411688,2.774715187469184
COR-L105,44566777,0.9614143121394376,0.6417764513085712
HCC1500,25126798,3.9309577641895137,3.8190957032428536
LS411N,5470400,-0.4509258648896809,-0.19584445135057837
PaTu 8902,11427553,3.388107623793881,2.9714812727588593
BICR 31,JQ-1-carboplatin (1-1 mol-mol),2.1121797103281876,2.5785057820500983
LS411N,11364421,-0.88941081068058,-2.8559131861010245
Panc 02.03,6918638,1.5939476449475074,0.5495068199336044
IA-LM,73707398,1.4255919606814562,0.7509360715498338
Granta-519,54613361,-0.5306815642640709,-1.0380318548935583
IGROV-1,176870,1.8349827429681411,3.6136362308393126
SK-OV-3,24821094,3.4952627197751744,3.0546387055125597
SaOS-2,5566,3.2892304449964125,2.9011422295844524
BFTC-909,44486219,4.380685277356905,4.337939403836384
SW1271,52947716,2.875834451056303,-1.1614238531586536
LS180,20959075,-3.038194424999374,-2.929168572545625
BICR 22,2708,5.160276397343071,4.8314539920025785
LS411N,24856436,0.7977520405714393,0.5496575975887035
RKO,3062316,2.656751778030552,1.3083445218237169
IGROV-1,2841722,3.834853118277962,4.499924330463793
SW948,9967941,3.223093544556301,3.1921896676049504
WM115,5291,3.6779708977342263,3.7048498005325063
ML-1 [Human thyroid carcinoma],262093,3.5917492591420737,3.1994524543033283
NCI-H2452,11152667,-1.2581393219211725,-0.19968493859394296
SK-HEP-1,54454,2.662573207119838,2.4536429626776295
PaTu 8902,46398810,2.87785673961289,2.5805534641163392
MOLM-13,4096211,0.3628379797080729,0.9616006365954634
SaOS-2,31703,-1.4545352226195103,-1.0235170213664775
NCI-H2452,89928392,1.3829077368930702,1.6726228379414068
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482,1.077840740777491
SU-DHL-1,216468,2.865615091111303,2.277210133137511
BFTC-909,5335621,5.263558209813896,4.788777980432356
IGROV-1,984333,0.6618578113050116,0.4678212342190562
SaOS-2,53393127,5.00574224434263,4.138321459304819
LS180,26596,-1.3053249122689552,-1.2078871311964108
PaTu 8902,216239,3.2515461693373946,2.2374131919304294
RERF-LC-MS,216239,1.5111459083459036,2.352042149780023
IGROV-1,327653,3.667792542405671,3.1425166650252603
MDST8,25062766,1.7641764997703038,2.073095567062726
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853,-0.5796278878492773
SW948,9911830,2.1163810502856344,2.2877967400272197
SW948,25262965,-4.786935998048743,-1.171112437874481
Granta-519,17755052,3.698735089058188,0.18568447737657404
HARA [Human squamous cell lung carcinoma],969516,2.3775549977258836,2.8991610602259663
SW1271,navitoclax-MST-312 (1-1 mol-mol),1.6729617215063168,1.0087421196426565
BICR 31,65628,4.368112552275168,4.459976943085663
LS411N,1716436,3.6051806229528394,2.821847035637678
HEL,31703,-1.5815868160580933,-2.2308270267387527
ALL-SIL,46191454,0.8221974593607395,-0.0920472771541741
IGROV-1,46843906,3.392503571349757,2.9499594766180235
MDST8,52912189,0.1558018738717314,2.0499474215377145
SK-HEP-1,73707398,1.730256970360003,1.3776104129432647
NCI-H2452,969516,2.821538204226011,2.9480474564982178
Daudi,9825149,1.5190393381512124,1.5669003289003434
HEL,49766530,-2.395534265113236,-2.0300748150062136
SU-DHL-1,445643,3.1136870030048116,3.4076792671419764
Granta-519,25102847,2.235988678650905,2.1842000786936078
SU-DHL-1,8515,3.677486404661737,3.5863689760897812
SK-CO-1,decitabine-carboplatin (1-1 mol-mol),2.301340396249523,4.175872024076773
NCI-H1568,73707398,1.0000031751048108,1.578871771695587
RKN,44607531,3.612700906890815,1.6780023028657964
RKO,448949,2.722052887717566,1.5394769104171595
SaOS-2,123631,3.143555798261004,2.23914949115648
RERF-LC-MS,docetaxel-tanespimycin (2-1 mol-mol),-5.54075092456557,-3.072134770764544
HCC15,445455,6.40486213649735,4.678345960113479
ML-1 [Human thyroid carcinoma],54639126,4.430736107428324,4.217573226134388
MOLM-13,16720766,-3.0154852550238473,-0.6566989451894887
SU-DHL-1,52912189,2.819399061651446,1.9066014402501172
IGROV-1,6918328,-0.5330006254346346,0.2736142315058619
HARA [Human squamous cell lung carcinoma],67156097,-1.978765302962937,-0.7979678730840412
Granta-519,168312962,2.8455100129937447,0.26234431303651223
RCC10RGB,24748573,3.544482176439233,2.3705163208733433
NCI-H1568,71576739,4.4464222538448075,3.837998449363354
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701,0.7943088986556494
MOLP-8,3025944,3.977744021049233,3.951718004366623
MDST8,navitoclax-sorafenib (1-1 mol-mol),0.2125187849150193,1.7619635762809773
SW48,3025944,3.8378875325919513,4.187563602121692
P31/FUJ,5460769,2.718083541162644,2.2036838016429443
PaTu 8902,56946209,-3.5225671286307585,-3.6919906635607482
IGROV-1,11964036,-0.1609353030421705,1.096345993159766
HCC1500,327653,2.623652361439541,3.1893323436924534
BICR 22,11640390,3.3009766271386014,3.262242723160722
IGROV-1,400769,-0.5589612210030486,-0.4622747788433413
HuP-T3,24821094,3.9398095537443023,2.911738429029583
HuP-T3,BRD-A02303741-navitoclax (2-1 mol-mol),4.136817383870447,2.6062529856049985
RKN,54618771,1.93479648501244,1.3271120768301463
Daudi,BRD-A02303741-carboplatin (1-1 mol-mol),4.3065470056962765,3.8633620974496945
PaTu 8988t,73707398,1.170719580837983,1.439221801482825
HARA [Human squamous cell lung carcinoma],10113978,3.460603354098383,3.6141752279823134
Panc 02.03,10231331,3.962628244123872,2.2838834021743173
HCC1500,387447,-5.435802195710178,-3.8341942124382813
K-562,25150857,2.2256112733235978,1.8451758002841918
COR-L95,135398516,3.161482452438301,2.0699356840377665
MOLP-8,46191454,-2.2442719810217984,0.11456092169092484
HEL,BRD-A02303741-navitoclax (2-1 mol-mol),-1.272488077546847,0.45080618688986784
BICR 22,4259181,0.3497439952553443,0.29595510268232494
SU-DHL-1,49836020,5.336381428124731,2.337007705466854
P31/FUJ,246676,3.344572915959865,3.6990823752380653
MOLP-8,UNC0638-navitoclax (1-1 mol-mol),1.623066033495539,0.29653088984400805
WM115,JQ-1-MK-0752 (1-1 mol-mol),1.4273161009607245,1.6717477321134735
WM115,carboplatin-UNC0638 (2-1 mol-mol),3.608353626656174,3.3487738103829754
SK-CO-1,135875424,3.678629656731489,3.684430785795403
SW948,3552672,1.903682389315955,2.504900166132752
NCI-H1568,selumetinib-BRD-A02303741 (4-1 mol-mol),5.032258587314436,4.42467316105002
NCI-H2452,JQ-1-navitoclax (2-1 mol-mol),0.3722844908497442,1.0084055737632185
HCC15,selumetinib-decitabine (4-1 mol-mol),4.297917027036863,3.9801688155951824
P31/FUJ,6610355,3.438139996915945,3.9301989394357952
NCI-H1568,446155,2.3736727750277455,2.844979128602596
HCC15,107985,-2.9906891972859415,-3.306107243383498
Daudi,6918328,-3.006382851838594,-1.3230317459445218
Daudi,25161177,4.237474374185298,3.7558133893549153
LS180,selumetinib-navitoclax (8-1 mol-mol),0.5338849490491672,1.575324173581819
RCC10RGB,vorinostat-carboplatin (1-1 mol-mol),4.3210323450827275,3.419559818357554
HCC1500,374536,2.8802619944250765,2.084736492505787
SU-DHL-1,400769,-1.357151076144479,-1.059742756033939
MOLP-8,16725315,4.20287759788283,3.6429130327171237
K-562,SNX-2112-bortezomib (250-1 mol-mol),-3.0816368014715434,-2.4908343348938105
MDST8,24753719,4.799692184779076,4.467587136295593
Panc 02.03,25195348,3.9334722209588735,3.3514214543862675
IA-LM,5328940,2.67230513268953,1.5363670207901192
HARA [Human squamous cell lung carcinoma],387447,-4.146769649621688,-3.784289211518798
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905,2.453656886942944
Granta-519,676352,1.633141874861156,1.6817894739941754
HCC15,49793307,-2.657858659953827,-2.3292549512302694
K-562,16065773,1.923835638804153,1.9816443024075143
RERF-LC-MS,23582824,0.1470987082457378,0.654592597744523
SW948,9907093,4.923675844906718,3.7344571723494213
HuP-T3,374536,4.193584653265312,2.5261509896692718
WM115,11396600,2.8854117577089378,3.7370423986885637
IGROV-1,16722836,0.856484234547582,1.6422796517085059
LS411N,89183176,4.7846004508379085,3.3009937862640726
LS411N,selumetinib-MK-2206 (8-1 mol-mol),1.1332062725089502,1.7799873876685481
HCC15,6917907,-3.7751611818797897,-3.33086707086687
NCI-H1568,637858,1.7833024505225796,2.17399668079614
PaTu 8902,5329102,2.5341846500240246,2.0048355779737195
Daudi,54765302,2.540510911033338,3.6026983840591043
RERF-LC-MS,100016,6.56071523320666,6.3829059770718395
NCI-H1568,387447,-3.95080818095812,-3.647273065697616
HARA [Human squamous cell lung carcinoma],168313047,3.4416690801744574,2.4659753505647197
SaOS-2,11612883,2.0316436721768087,2.8902506814432685
SK-OV-3,135411,1.6318689765112546,0.9285211052905425
IGROV-1,208908,2.822483792004996,1.9303790645205174
RKN,51037431,2.467401650082352,3.073128124553376
MOLM-13,3025944,3.8428716966726992,3.964461942891329
PaTu 8902,135421197,2.3024316473658004,1.914020323682375
MDST8,969516,2.598297465814476,3.0112648106495112
MOLM-13,60750,-4.5529472050787545,-2.8494362814068195
SK-CO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.9815172513006872,1.0825953578621859
IGROV-1,9915743,-0.4757488934941289,1.1352927303967488
BICR 31,56946209,-4.213875977630207,-3.8528827744650744
MDST8,124202324,2.333625526818204,2.144413162153281
BFTC-909,46907787,2.3649992203474515,2.01401979819894
Daudi,12003241,-4.903510386182724,-1.315439449760026
PaTu 8902,969516,4.108056616445131,2.9388937753722906
RKO,24951314,1.467797052763695,0.47520322586096275
SW48,439501,-2.266376314928653,-2.052585940780315
IGROV-1,5311281,3.3250623444804206,2.5509606637575413
BFTC-909,9825149,2.463033939289578,2.4950618678342273
LS180,2858523,3.002923184305197,3.0171153733228557
HEL,decitabine-carboplatin (1-1 mol-mol),0.001071059904297,0.1924064278942981
ALL-SIL,selumetinib-navitoclax (8-1 mol-mol),-0.8393067870593486,0.25417669543751326
PaTu 8902,10074640,3.6154267469790304,3.1744440305024657
LS180,135421197,1.2375553911833763,1.699016492355569
ML-1 [Human thyroid carcinoma],3081361,2.035617561629102,2.549225797854056
HuP-T3,4259181,1.3598984416642497,0.46760941317506927
MOLM-13,9840324,5.573129737038137,5.339439603673786
NCI-H2452,docetaxel-tanespimycin (2-1 mol-mol),0.4791468482228301,-3.03882963288788
RCC10RGB,7251185,2.312506998895348,2.8094932397492745
LCLC-97TM1,23725625,2.954034200595367,4.730257177659497
RKO,24797083,0.8657042008278414,1.0719054041664033
RKN,selumetinib-piperlongumine (8-1 mol-mol),3.808395082066658,3.5717474837350944
HARA [Human squamous cell lung carcinoma],45100309,5.833200435543825,3.023769629584444
ALL-SIL,24951314,0.1921049921473096,0.07302277139803387
NCI-H1568,tretinoin-navitoclax (4-1 mol-mol),4.46686431300974,3.000764086031901
K-562,16725315,4.409558206085648,3.737354149020533
ML-1 [Human thyroid carcinoma],9825149,3.1128843906344117,2.49028785265762
SU-DHL-1,9915743,1.482861419138649,0.8821430513196815
SW1271,4917,2.7806051488376293,3.041047476842914
Granta-519,vorinostat-carboplatin (1-1 mol-mol),1.7690430171361815,1.889042597345108
COR-L95,3062316,3.2830028596837217,1.069882886185917
MDST8,10074640,3.541716125988611,3.1945278902702228
IGROV-1,44185566,2.2104732991243248,2.641154670810692
SU-DHL-6,57519531,1.2127003418717253,1.6140847885333498
SK-CO-1,241158,4.831010946536929,4.005999023152438
SW948,46843906,2.6248020109336023,2.30861914085128
RERF-LC-MS,6610216,4.063402980130349,4.383920507171871
RERF-LC-MS,46843906,4.323049782377064,3.130866421703077
NCI-H1568,selumetinib-UNC0638 (4-1 mol-mol),2.7760221243911016,3.4267127688836463
LCLC-97TM1,piperlongumine-MST-312 (1-1 mol-mol),1.3069230942291734,1.7780571847999247
RCC10RGB,selumetinib-vorinostat (8-1 mol-mol),3.237241333738756,2.956971906125757
HCC15,24180719,4.303391195547382,3.541250709998004
RKO,selumetinib-navitoclax (8-1 mol-mol),2.1856811512057885,1.2805903062048531
MOLP-8,6505803,0.6382990348001342,-1.0387590897451924
Daudi,5278396,2.816567405543214,3.0837408751912623
RKO,66577038,3.1469091340303637,2.6894630045863024
MOLP-8,54143018,0.5860183196437395,-0.4484145076310876
SaOS-2,24856436,0.4386880001360848,0.5064533991760019
BICR 31,9866186,1.254760755448308,0.7873301860793682
RCC10RGB,11257553,3.6405008146732434,1.7947903229294815
SW48,JQ-1-navitoclax (2-1 mol-mol),-0.920123495664676,0.7733471276233853
RKO,57330099,4.8516025997257275,3.5700651171635065
P31/FUJ,54649500,4.423311343715707,3.212684520297844
SW948,10302451,4.082058519290096,2.791074502292503
WM115,2746,3.2273654457979957,3.3910339138625427
KU-19-19,654092,0.6096416345891582,-0.16792113062776237
PaTu 8988t,10296883,3.999790485906541,3.9433974194618413
BICR 22,54143018,1.1733542553992964,0.8483567641960275
MDST8,71466445,2.0942740576673593,3.428741756914258
PaTu 8902,36462,3.471634301287976,2.4671674461242326
LS411N,44632017,5.0127460000138,1.490435008204767
COR-L95,9911830,2.1813921058815553,2.2542015450114965
ALL-SIL,9911830,-2.857836139869332,1.8731844772764945
WM115,3465537,1.2344570371137795,2.5495800457389777
NCI-H2452,navitoclax-birinapant (1-1 mol-mol),2.13598555906201,1.7262540173296426
SU-DHL-1,54454,0.0220955119836291,2.438761253141327
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245,4.7958328819972005
MOLP-8,24821094,3.654707766369703,2.481232913380565
MOLP-8,6852167,0.8455390099609336,1.71362584072026
Panc 02.03,11222830,1.865607722872823,1.635058115925625
MDST8,2746,2.514425635914287,3.3493283442256994
Granta-519,1716436,2.7310795448836904,2.51786874351406
Daudi,selumetinib-tretinoin (2-1 mol-mol),4.819941209079035,2.4859754950319175
RERF-LC-MS,11625818,4.251014876931036,4.660944056839617
P31/FUJ,4378219,1.2412027933720209,1.8275601001358361
HCC15,3062316,2.729530034687651,1.1501566441289808
LS180,9903786,2.2166672873522857,2.7035091784279017
PaTu 8902,16065773,3.37985868216597,2.4376676685025513
LS411N,9911830,3.118029057589745,1.8736614905167799
LCLC-97TM1,6438330,3.0238187505324885,2.3363330014535157
KU-19-19,25062766,2.9321374053838807,2.032646558264369
HCC1500,10074640,2.968051262406446,3.022365445342869
P31/FUJ,6505803,0.2535639265329721,-0.5816336831630755
NCI-H2452,387447,-3.2957708741809975,-4.248291003498246
MOLM-13,11228183,-2.7074565632423546,0.31529662623934024
SU-DHL-6,5566,0.7122829809928822,2.899134208558879
COR-L95,24785538,1.0654849938174582,0.9356391716760537
RERF-LC-MS,ISOX-bortezomib (250-1 mol-mol),0.403542566479009,0.9581297242797262
WM115,4578,4.221194502857287,4.553912853679859
COR-L105,4578,4.590840204947243,4.509939874406574
K-562,374536,0.780579010414565,1.0993818806868711
COR-L105,60700,0.1425021915553204,-0.0608324537032304
K-562,46926350,-4.162486097405079,-4.431621933881673
SW1573,4705,3.887877577681455,3.350410897807692
LCLC-97TM1,637858,1.4157632634757724,1.8477933619587708
WM115,46926350,-4.284670953339827,-3.7980655379492716
RERF-LC-MS,15547703,2.8085711207925015,3.356945875119656
NCI-H1568,11497983,3.872384435522252,4.3561814817485605
MDST8,4788,5.889593740712007,5.767801166086372
IGROV-1,8515,2.1861539315976053,4.0537811392479695
RKN,24772860,-0.333409077824626,-1.9811988793300077
PaTu 8988t,322968,4.849886698333752,3.792776440959632
RERF-LC-MS,16720766,0.5604118097796991,0.524682437964941
SW948,6505803,-1.4287073835677784,-0.9414805662083855
BICR 22,462382,1.3729135623232431,0.5511159368246067
LS180,322968,4.435040308321651,3.77034495788259
SaOS-2,11152667,-0.1732170298835725,-0.0649612789157231
ML-1 [Human thyroid carcinoma],49846579,3.632639122540709,2.110276086357878
HCC1500,227681,1.895909952215359,3.05153780146348
SU-DHL-1,57330099,3.736750567984075,3.8882770877999984
PaTu 8902,crizotinib-PLX-4032 (2-1 mol-mol),2.4716529657314252,1.893295570193257
COR-L95,11977753,-0.4790698517891548,-1.230527266550632
HARA [Human squamous cell lung carcinoma],6450551,1.1333007709837388,2.9470493938417075
SW1573,11427553,4.057369297610019,2.799143859417949
LS411N,selumetinib-decitabine (4-1 mol-mol),2.113542613262742,1.0677360613981108
LS180,12001922,1.7594619366424422,1.8994582728637095
SaOS-2,12001922,2.1147367002170494,1.932114838854314
SU-DHL-1,3543504,3.7817510655567625,4.157241549832675
BICR 31,24901704,3.914024172074534,3.5424218055012062
MOLM-13,5287620,-2.884996470216499,-2.1064756878925484
BICR 31,25102847,2.842271629600241,2.6616239364650043
COR-L95,10113978,3.7452762075447104,2.7685992214985604
LS180,selumetinib-GDC-0941 (4-1 mol-mol),-1.227348326224306,1.080357977603651
MOLP-8,vorinostat-navitoclax (4-1 mol-mol),0.8660372331148116,0.4567899594750557
ML-1 [Human thyroid carcinoma],1750826,-1.3031865689994189,-1.14881371136335
MOLP-8,decitabine-carboplatin (1-1 mol-mol),0.1349258094123646,0.25754909965174655
COR-L105,168312962,3.0410731046381065,2.7405424931016773
LCLC-97TM1,10322450,3.85878970197106,3.5965258353868306
HCC1500,25161177,4.357780519617112,3.9576612759386767
SK-CO-1,9967941,1.837567054996146,3.7016564015029485
COR-L95,5311,1.4789786210040632,1.1671297702809298
ML-1 [Human thyroid carcinoma],2733526,3.914729894927785,3.8723036570496405
LCLC-97TM1,72193861,0.688846554638978,1.2793353974928028
SW48,4096211,0.1208358665406906,2.0548525990286803
LS411N,135875424,4.300305751936665,3.3477012149223504
SK-CO-1,42642645,0.466262192383588,1.1148319149093775
IGROV-1,1566236,2.765820903157784,2.252257691426523
HCC15,10410894,4.508285516741203,3.2334797622418834
IGROV-1,6450551,2.579641476451469,2.799216977446231
IGROV-1,452548,0.0422661560146271,0.623318352354204
COR-L95,216345,3.729430833860697,3.3342844452338904
Daudi,navitoclax-gemcitabine (1-1 mol-mol),-4.251556973738435,-2.6270688034319387
LS180,2945648,3.723684880750219,3.0902452006310717
RKO,9936388,0.8183869926163714,-3.99346631356646
HuP-T3,10231331,2.6811135289001236,2.0289190052249055
PaTu 8902,44493528,4.360494725244959,4.43057992417452
Panc 02.03,45279963,4.323488067826322,3.6299037719753993
MDST8,BRD-K27188169-navitoclax (2-1 mol-mol),-1.2819787508049554,2.651868719076076
BFTC-909,44507138,2.8704731321552734,2.7243252099404827
ALL-SIL,49766530,-2.347000417785464,-1.7886588350866464
SU-DHL-1,6918289,4.3249644726818275,1.257262871357488
NCI-H2452,54626689,4.879011133008654,4.781449117065213
HCC1500,4917,1.9149154714535184,2.989183243572005
LCLC-97TM1,15547703,3.011827246330581,3.116156928417277
MOLM-13,71304818,2.1544936448447873,1.9119568936198115
SU-DHL-1,4917,2.4666047815714154,2.69780287379063
NCI-H2452,56946209,-3.558178980562316,-3.9515276115830864
RKN,1750826,-6.055252220387113,-1.5984173182031938
RKO,25105715,3.388469834531371,3.2858799342312763
RCC10RGB,46191454,4.887818963424851,2.2123715002292665
LS411N,3815108,3.549037613932863,2.371198431082688
HEL,56946209,-4.040477533762366,-4.657485222551987
BICR 22,122327,5.571410232221064,4.84564146588504
BFTC-909,969516,2.723005004244225,2.929176607753137
KU-19-19,selumetinib-JQ-1 (4-1 mol-mol),-0.4288095691894706,1.276239298561755
RKO,24856436,0.2423564692967549,0.05743795859719
SU-DHL-6,5746,-1.2123840023346684,-0.6204848768041394
SU-DHL-1,135411,-2.10627226052293,0.7266766485008955
SK-OV-3,1716436,3.636442167288748,3.0423355004098456
IGROV-1,44543605,3.88270235241076,3.8721360436808077
K-562,6914657,-3.91828110768511,-4.740845975673604
HARA [Human squamous cell lung carcinoma],9866186,-0.525705997781229,0.7961608768254382
NCI-H2452,25262965,-3.6663688304344695,-1.259909321902181
HARA [Human squamous cell lung carcinoma],navitoclax-MST-312 (1-1 mol-mol),0.8639589641874816,1.2024022159436094
MOLM-13,11404337,-1.791363376051536,-1.0391808851914066
RKO,36462,3.4370564574699185,1.669235387196135
IGROV-1,446155,3.750396425244744,2.6311435388319815
COR-L95,72734382,4.117898969233179,4.004386345749711
K-562,11396600,3.7562155275673415,2.7512621702916222
LCLC-97TM1,4705,3.0319662392534057,3.0760216534544003
Daudi,2130404,3.4806417402967993,2.0265529004384835
UACC-812,vorinostat-navitoclax (4-1 mol-mol),1.8866466886365112,1.0429509022616414
MDST8,327653,3.1544218347658375,3.0955145464831615
SK-CO-1,11656518,0.968890652064466,1.8779736821455095
K-562,5311281,3.9022564066083967,2.3757396093201617
ALL-SIL,carboplatin-etoposide (40-17 mol-mol),-0.158708138675103,0.05927502755285312
MOLP-8,selumetinib-PLX-4032 (8-1 mol-mol),1.1163083218110827,3.324428651444216
RKO,445091,4.342692134156949,4.077959767685104
MOLM-13,9935249,2.7939558009041283,1.593744969438343
SK-CO-1,selumetinib-navitoclax (8-1 mol-mol),-1.2361376975305869,1.3890951113418655
RCC10RGB,selumetinib-JQ-1 (4-1 mol-mol),3.398592660488386,1.9673338175715043
SU-DHL-1,124202324,2.3695119203399906,2.0478251952316
COR-L105,9884685,2.6443959528770167,0.9647669042863659
BICR 31,10113978,4.990782635230478,3.7579546349357313
HEL,crizotinib-PLX-4032 (2-1 mol-mol),1.5778515450818191,0.8012289296565259
MOLP-8,6610355,3.5622833697709178,3.623780659964281
LCLC-97TM1,2749,2.4194398786749067,1.8948730667091582
Daudi,5311,0.1794409230409946,0.5807196755453204
HuP-T3,2113511,6.036487802507154,5.758605177742546
P31/FUJ,452548,-2.598049093653093,-2.961382210759857
SaOS-2,16065773,3.691866894593861,2.5019545820481515
RERF-LC-MS,65064,5.274588293813746,5.169696647780992
HuP-T3,89928392,1.747135585577409,1.4681289255410157
P31/FUJ,56963564,-0.6738396792941169,-0.10910483453787795
LS180,5746,0.8609008276830991,1.069903342174247
BICR 22,11707110,-2.2145574606059912,0.2463964527719941
Daudi,9952709,2.2307089742515713,1.9562890983314711
SW48,3543504,4.30466926238752,4.277989246538437
SW48,11427553,0.5193301330840923,2.8809969678757907
WM115,56649450,1.7070260970326938,3.5104877905410636
IGROV-1,89928392,1.4824233552493276,1.4294661646462787
SW1271,72376,-1.909620961604672,-1.6150222751827314
SaOS-2,5278396,3.8495121754699686,3.5759961224677754
K-562,42642645,-0.9952706094252596,-0.18976183659224152
Panc 02.03,446155,2.721578883226381,2.9277187102322775
RERF-LC-MS,44462760,4.251912039026111,4.0065036330952095
BFTC-909,3503,3.411270469206907,2.523029311978693
MOLM-13,104842,-5.846939346357726,-3.949855304696751
K-562,11656518,1.1460195934444493,1.0620211654493306
HCC15,76446078,6.244123044550032,3.6246797040438774
COR-L95,6438330,1.555078701387849,1.575155632614011
COR-L95,9926054,2.0133423062539726,2.0027439142095766
BICR 31,462382,1.217928478873545,0.5003209202140082
UACC-812,46199207,3.606176782545976,3.2766373691650483
SW1271,16725315,3.214819296898604,4.057800380817486
BICR 22,3385,1.594485383262216,4.018738298519645
HEL,11234052,1.6482548628813194,3.0449459442225604
SW1271,49793307,-1.6735159246770874,-2.071793318342054
HEL,3025944,4.107185950107739,3.680483586786811
SK-CO-1,1641662,2.678789461404506,3.5917901023894507
RKN,71680916,6.446363106372924,4.772589341382291
IA-LM,25183872,-0.4633226224219731,-0.80728888032648
IGROV-1,6918837,-2.9804518885508635,-2.4065444723806624
HEL,252682,5.808471376099282,6.364832031002282
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351,-0.23653294992290486
MOLM-13,374536,0.9670025892080272,1.2524711588656183
NCI-H2452,168313047,2.588327036215806,2.611140546441703
Granta-519,4917,3.021022166883331,2.5914550416213236
ML-1 [Human thyroid carcinoma],JQ-1-UNC0638 (2-1 mol-mol),2.6444298637243167,1.8785122339809817
MOLM-13,selumetinib-GDC-0941 (4-1 mol-mol),-1.09695682780189,0.4958868450363333
BICR 31,262093,3.397835562493394,3.002501185903954
LS411N,12003241,-0.0946051023392001,-0.6309979509525888
HCC1500,5282054,2.2651950194203323,3.8744668968515343
HCC15,322968,4.854333863324092,3.922815954932994
RCC10RGB,9936388,2.3235560801623465,-0.26118672547913585
NCI-H2452,46199207,3.026577128215497,3.2764977366449393
Granta-519,9444,3.3091580955395146,3.673228124948909
IGROV-1,53392493,2.352084848618059,2.5170664773420874
COR-L95,151289,3.0372683791028705,0.7758320896441424
NCI-H1568,216468,4.700562763036761,3.426592028894579
WM115,25195348,4.859937697346287,3.457415042095698
SaOS-2,2858523,3.094677154220442,2.9584933361017653
SW1271,421610,4.471416490511734,3.4491238897601773
BICR 31,637858,2.611871003184785,2.243351817975661
SW948,11175137,1.686043515242534,2.2992458966762084
MDST8,11625818,2.7981930885976705,4.759311705434474
Panc 02.03,11609586,3.3931905350155915,3.084631953807338
Granta-519,selumetinib-UNC0638 (4-1 mol-mol),2.20466638812085,2.0603244696926337
PaTu 8902,9825149,2.767587999144615,2.2743317762533364
HCC1500,6918837,-4.362896894201754,-3.2453865349296103
BFTC-909,navitoclax-PLX-4032 (1-1 mol-mol),3.5024450661652153,2.3273130032702527
SaOS-2,5282054,3.07206551989859,3.7526134976545675
SK-OV-3,navitoclax-birinapant (1-1 mol-mol),-5.0727238052406705,1.9995934566843296
SK-CO-1,72376,-3.2194985981528808,-1.5907872968237995
Panc 02.03,carboplatin-UNC0638 (2-1 mol-mol),5.105759320304772,3.578188261323765
WM115,10302451,3.6553280898048905,3.0738099313068634
Granta-519,613000,2.2510291651452143,2.3504851977710395
SaOS-2,11222830,1.0878926350484104,1.6332897359434804
IA-LM,54678924,1.6007306497128662,1.538078032339975
HEL,119607,4.922739390517752,4.367072406783966
HCC1500,6918328,-0.2689126411143879,0.007175326005540836
HuP-T3,crizotinib-PLX-4032 (2-1 mol-mol),2.5650363225974315,1.7633346399941863
LS180,3062316,2.327440880417239,0.9900397015806561
LCLC-97TM1,11317348,1.7152030009838672,2.653565560502309
SaOS-2,6918736,-1.8799034133096575,-1.6444933385282794
SaOS-2,12003241,-0.699813042979073,-1.1792288664137598
LS180,10113978,3.7861477365363383,3.125883403978065
SW48,54618359,4.4319552735559,1.95572051170652
PaTu 8902,ISOX-bortezomib (250-1 mol-mol),1.241492124971151,0.9527169511437923
HEL,387447,-4.961191552031455,-5.062256829823573
RKN,6610216,4.220445612403551,4.322991492623555
P31/FUJ,656346,-0.3707458386499477,0.42278448044077005
Granta-519,selumetinib-JQ-1 (4-1 mol-mol),0.6993639444129659,-0.2645459943381546
PaTu 8902,navitoclax-gemcitabine (1-1 mol-mol),4.2969329187245,-0.9881984479011915
MOLP-8,9952709,2.638563783306324,1.9896004098094042
SaOS-2,11455910,0.8777485884783317,1.2183287538360705
K-562,10184653,1.719293175029272,1.1335938044772795
Granta-519,4259181,-0.7648884727300508,-0.35803896412196534
BICR 22,4521392,3.4098909359208625,4.0678375115070615
HCC15,2874250,4.519421691404506,4.325384081935971
SaOS-2,6918638,1.2055090485954645,0.305815186495384
MOLM-13,9868037,0.9756233042827712,1.8026343236875786
HCC15,navitoclax-sorafenib (1-1 mol-mol),0.4047669070332462,1.9494742105539142
MOLP-8,16659841,2.203571056365997,2.458864370711131
LS411N,656346,4.206497662771029,0.5822589312092045
RKO,5460769,5.660789679983863,2.3365118959066193
BICR 31,6610355,4.797647038745592,4.680240994156224
ML-1 [Human thyroid carcinoma],17755052,4.154119256233629,1.9958380880741395
RKO,11964036,1.8153618806471208,0.4455934096779241
NCI-H2452,7326481,3.286880233884326,2.8789821362879415
RCC10RGB,44491742,5.1484686760969645,4.477314916038944
IGROV-1,50905018,6.092412272559071,4.325845249049362
BICR 31,9884685,0.303781088019613,0.894017338991226
Panc 02.03,3081361,3.1546648300373357,2.4492839990811945
BFTC-909,25126798,3.8219929141120166,3.8020597028555816
MOLM-13,66890843,1.9738756301734208,1.6284439859476425
HCC1500,24180125,3.164669305988548,3.009033135585956
SK-HEP-1,53392493,3.66906541895257,2.791596248014029
RERF-LC-MS,2945648,2.437954541344266,3.0526345665543135
HEL,25150857,2.447529551071105,1.6272297371028122
BICR 22,65064,5.333446499438452,4.9197518368220985
PaTu 8988t,carboplatin-UNC0638 (2-1 mol-mol),3.665220724432894,3.342582682888034
P31/FUJ,123631,2.0303759233077017,2.1037373639775465
HCC1500,tanespimycin-gemcitabine (1-1 mol-mol),2.493780816473477,-1.2994770698065474
IGROV-1,11175137,1.8411496230681277,2.7065929054668003
KU-19-19,44241473,5.030815161961597,4.7638051103231875
SW48,72193861,-0.4534629909928462,1.8057041217691432
NCI-H2452,selumetinib-vorinostat (8-1 mol-mol),3.054936641040398,2.6639509535448207
MOLM-13,5311281,1.6146001182421037,1.5953458178019653
HCC1500,9915743,1.9340540182592263,0.3267005802270048
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392,-0.1434208239865686
SW1271,crizotinib-PLX-4032 (2-1 mol-mol),1.7792866548085249,1.9057554515219615
LS180,4096211,2.1975503712063604,1.7872088381845608
NCI-H2452,66577038,3.355972963473848,3.180363914551864
WM115,JQ-1-UNC0638 (2-1 mol-mol),1.9415560976310364,1.4771573449892303
HCC15,11175137,3.485795641541794,2.7797507433009367
K-562,navitoclax-pluripotin (1-1 mol-mol),-4.5842278555306395,-1.6532862286937149
HuP-T3,2945648,2.5475895191101197,3.01490497889378
Panc 02.03,6450551,4.166761052507323,2.992194118418137
K-562,2708,5.362475494708341,3.564148828582094
RKN,219104,3.4277527780329096,3.758578127778257
RKO,16722836,2.0172870973895085,1.1491122138722623
UACC-812,439501,-1.4243957864326813,-2.1317378485416443
MOLP-8,11222830,0.9410853080031706,1.042930850437377
WM115,1239801,4.563824386797348,4.114349511588149
Daudi,11717001,4.763561920962392,3.8693954876328127
HARA [Human squamous cell lung carcinoma],24785538,-0.0579889747329333,1.9382032417438075
COR-L95,16736978,-0.5228132160938015,1.304306641380743
IGROV-1,11213558,0.52356811652227,1.6937531297679704
MDST8,44202524,1.4033794041893788,2.501173615278912
SU-DHL-6,10113978,2.1190356124222194,2.221148189223807
SK-HEP-1,4917,3.764636353681369,3.1479886669883395
HCC15,452548,-2.1001752731425727,0.5717386263549986
SW48,46191454,-0.9829938197758128,1.4650826662398857
MOLM-13,4521392,4.5803067712490115,3.95993255349009
HuP-T3,25062766,2.4453672011464023,2.0799420787538985
COR-L105,107985,-4.244896937866387,-3.297508829964226
SU-DHL-1,89928392,0.4021872915525221,1.5100828825736963
BICR 22,55508,4.44611517999926,2.993986488576675
ML-1 [Human thyroid carcinoma],135659046,3.731165476589243,3.852913667878496
MOLM-13,675434,3.665195693175508,4.048769875857201
SK-HEP-1,6610216,4.694225049802747,4.36439084134952
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032,1.7113102748171272
SU-DHL-1,49766530,-4.824875359994143,0.1697574354417225
HEL,12001922,1.658840092002429,1.5121139048210677
HCC15,46398810,2.6134237903958093,2.736121617280354
NCI-H1568,3136844,4.658915015928919,4.472564047384157
NCI-H2452,24821094,3.1123469452418537,3.0841635585583744
LS180,3543504,4.376890558116308,4.26764792353798
ALL-SIL,9927531,4.600523700119875,4.095952083897504
BICR 31,11167602,4.451308398956488,2.622713127278851
SW1271,16219061,4.25548468975063,3.5613156789622598
PaTu 8988t,448949,1.751499890417066,2.109571807372294
WM115,2858523,2.9957579985597467,2.9847980117196657
RCC10RGB,11364421,1.2845393833467151,-0.37344285634985425
SK-CO-1,984333,1.8899562330111348,0.9133663980399719
COR-L105,72376,-1.002534224494363,-1.4976935368290585
NCI-H1568,168312962,2.190321562510239,2.63628260970713
SaOS-2,2746,3.4161371679978436,3.28825710865926
Panc 02.03,51039095,3.661030142872421,3.175044688768324
SK-CO-1,65628,3.554197618459022,4.534349243781371
COR-L105,16725315,5.297524124299076,4.594766035397881
LCLC-97TM1,JQ-1-carboplatin (1-1 mol-mol),1.024195349701644,1.1383727971441453
RCC10RGB,46224516,2.231293839634299,2.744076634979387
RKN,9956119,4.4432647969313,3.6089405618487325
RKN,16065773,2.958619348149216,2.5016939770628794
WM115,17755052,0.4002517605741686,1.6096219637326652
WM115,168313200,2.1363369230808593,2.845717200700843
BICR 31,ISOX-bortezomib (250-1 mol-mol),1.0654896454992784,0.6845296688046233
WM115,navitoclax-MST-312 (1-1 mol-mol),0.1056862983661574,1.199462467925274
LCLC-97TM1,9903786,1.8016114643921617,2.8195956897390437
SaOS-2,49867926,4.146129188416838,4.368916490091065
RKO,25126798,4.002843113400742,3.435487359524713
ALL-SIL,219104,1.1543769867483644,2.1324696493062825
Granta-519,tretinoin-navitoclax (4-1 mol-mol),0.0394078475475117,-0.03728730273942753
SK-OV-3,3062316,0.5292744016150154,1.194010365500142
SK-OV-3,11178236,-2.424602318267421,-3.0218503172160096
LS180,9887053,3.1718141126704618,4.133108448235544
BFTC-909,25183872,0.7872065650622051,-0.6825288743866202
NCI-H1568,2945648,2.136721092573253,3.085644361877087
RKO,1716436,3.795795915163565,2.5952149514048504
SW948,65064,5.291153994733523,4.865472521913079
PaTu 8988t,salermide-PLX-4032 (12-1 mol-mol),5.538923116384137,4.994356342778583
SK-CO-1,16115403,-4.417233339728943,-4.020398817996692
SaOS-2,400769,-0.6660591873157414,-0.5680653373787439
SW1271,2733526,3.2893803459487594,3.6470796926084588
BICR 31,4521392,4.267019749412992,4.176767006070734
P31/FUJ,25154868,4.728907139536709,4.098554035450875
HEL,676352,2.4086189638079643,1.7731041221986206
PaTu 8902,BRD-K27188169,4.434214541500356,3.7567906454962285
KU-19-19,44607531,3.044914521934579,1.559060246491516
RKO,selumetinib-tretinoin (2-1 mol-mol),2.520120690265609,2.9823457559359867
SK-CO-1,72193861,-0.1340038294528125,1.7931572723365266
HCC15,selumetinib-UNC0638 (4-1 mol-mol),3.167456472626372,3.182509440239984
WM115,135423438,3.926483426744841,2.556224724520447
RERF-LC-MS,135875424,2.839581382146162,4.176653561004878
PaTu 8988t,46926350,-4.145321949318386,-3.9966532520739793
Daudi,23582824,-0.638376916275564,0.6048272943328383
Panc 02.03,168313200,4.226618217059218,3.0522784552901783
NCI-H1568,11175137,2.3278621292073067,2.8068468117826706
COR-L105,11152667,-0.3968124554752262,-0.44131930194561925
IA-LM,5281672,4.428935042775787,4.567187355893076
IGROV-1,3062316,-2.2361832227909075,1.6322442111955615
SU-DHL-1,5281672,4.30860315799997,4.348817848555607
HuP-T3,tretinoin-carboplatin (2-1 mol-mol),5.021357813866161,4.964544733633041
BICR 31,11625818,3.9395546041344858,4.7075822730056105
ML-1 [Human thyroid carcinoma],5311281,2.103239185945236,2.6551642020278705
NCI-H1568,445643,3.6093957886383814,3.7855531659500765
NCI-H1568,4477,0.3996701755478256,0.4741901035181498
RKO,36314,-4.63858923378885,-2.3829110107617213
Daudi,675434,3.694219652985114,4.072650948260688
MDST8,60750,-4.217127024403589,-1.3858388373630242
WM115,9903786,3.894434750277636,2.7631275290386434
RCC10RGB,5282054,3.6705963985990993,3.9805927913721955
HCC1500,262093,2.85046563878574,2.948453683303392
BFTC-909,4259181,-0.0277162117211437,0.30113267544063815
COR-L95,252682,6.347695054422412,6.487908165185046
LS180,9911463,3.681535048080384,3.7728430901698364
SK-HEP-1,1566236,1.7725788045776691,2.5303973641321535
LCLC-97TM1,6918736,-2.1743152466595626,-1.5264201912685758
SW948,10231331,-0.4116197219649379,1.5956492309075165
COR-L105,selumetinib-vorinostat (8-1 mol-mol),2.277448874031188,2.677887251580705
KU-19-19,52912189,3.155674258646967,2.2675116978141
PaTu 8988t,44185566,3.1955818251601493,2.6362624137643627
ALL-SIL,31703,-2.84181702758724,-3.124138090581119
MOLP-8,67156097,-2.505693621695456,-2.2169276192709133
P31/FUJ,12003241,-0.93015536828776,-1.4940717699071535
HARA [Human squamous cell lung carcinoma],44607531,1.5873617953354324,1.564619591245178
HuP-T3,72376,-1.771653200109272,-1.894718177849295
COR-L95,vorinostat-carboplatin (1-1 mol-mol),3.640391778924097,2.7720530287987675
ML-1 [Human thyroid carcinoma],3062316,-4.511354956700351,1.2214084383144606
SK-CO-1,54649381,3.727346200170898,3.9639604760369633
BICR 31,4578,4.306546690441069,4.564582631379706
HEL,24856436,0.2549549224561803,-0.4593045501577008
K-562,selumetinib-vorinostat (8-1 mol-mol),2.188537608414777,1.6649522603342688
Granta-519,selumetinib-vorinostat (8-1 mol-mol),1.614961732306094,1.4895721439299305
NCI-H1568,568763,0.1547040002068053,0.717112190434118
SaOS-2,10184653,1.5674189620168135,1.684084703141651
BICR 22,carboplatin-etoposide (40-17 mol-mol),1.4257688352427802,3.051575684647004
SK-CO-1,10127622,-1.7782095442547816,2.650586911331128
RKO,6450551,2.9764230599456782,1.7173479301125798
RCC10RGB,11222830,2.1708629162803654,1.8539036154070458
MOLM-13,439501,-2.531564352317227,-2.5435493972624084
KU-19-19,5328940,2.592216165266187,1.7192098234380222
SK-CO-1,BRD-A02303741-navitoclax (2-1 mol-mol),1.7439599678595026,2.0209870428379215
KU-19-19,navitoclax-pluripotin (1-1 mol-mol),-0.1990402991745543,-0.7953572225179488
LS411N,46224516,2.772468105753273,2.6582358108540074
COR-L95,3465537,1.5360689669151406,2.2146411870810256
NCI-H2452,650361,3.725817753027947,3.785907110673436
MOLP-8,135423438,1.7176055832456645,1.4207584667485689
Daudi,15953870,2.3174310256528017,2.9311950253181367
HEL,25062766,1.0860006913119025,1.4820997634481445
LS411N,9866186,0.9541786681011424,0.5879257278236786
NCI-H2452,72193861,1.1802568558602904,2.0088673489950626
SW1573,104842,-2.57352069349058,-2.520733690653249
SW48,1750826,1.3136286655933227,-0.5482755507447534
HCC15,25262965,-1.0400697166295236,-1.2186327925756137
SW948,156414,1.6424995325300082,0.7855963128969192
HEL,49793307,-3.822273429090704,-3.8026327206264843
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345,1.7967324475641147
KU-19-19,15983966,3.017543110767297,-0.487672092641178
Granta-519,445643,4.101892829369416,3.362086804108118
WM115,44462760,-6.607584862322745,2.9767719850507395
COR-L95,16722836,1.6737270586986386,1.4605593296904547
HuP-T3,19582717,-4.617931701404403,4.319713317480502
MOLP-8,135984461,3.690365922940533,2.9279277221983033
WM115,25105715,3.143290836206988,3.4258066112965815
SU-DHL-1,6610355,4.337111630655639,4.311325035274207
P31/FUJ,107970,2.0437014771117425,1.8854873078291507
BICR 31,9903786,2.10396775229317,2.962315876840993
HCC15,119607,5.6213928119464285,5.291748516661974
K-562,53392493,1.9280012389180945,1.7656576298251334
Granta-519,erlotinib-PLX-4032 (2-1 mol-mol),4.2552857521313925,2.860174651675158
ML-1 [Human thyroid carcinoma],4788,6.371899932480547,5.785682681536445
SaOS-2,6184667,2.75971928345779,3.0422608231694817
HCC1500,49867930,4.391361036771465,4.786767568113387
HCC1500,156422,3.756088196252004,4.1387603313816665
LS180,2729026,2.858515315971793,2.7268366731891405
UACC-812,9926054,1.7122964049751828,2.1664015096218434
BFTC-909,2945648,3.347829093032643,2.9691721203491244
RCC10RGB,piperlongumine-MST-312 (1-1 mol-mol),2.4761046612469944,2.5331187175441006
COR-L95,10427712,3.3507411292398315,3.9654559786329004
HCC1500,73707371,6.057238887548947,5.206625993935655
SU-DHL-1,5566,2.363543718324467,2.8275924621769826
RCC10RGB,navitoclax-pluripotin (1-1 mol-mol),0.1501865832808995,-0.7312593328389394
SW1271,44137675,2.993655891868926,3.8594148227127136
PaTu 8988t,10385095,1.1295524511895831,1.225462484364002
IGROV-1,107970,2.287061680908213,2.3184544208724875
LCLC-97TM1,3081361,3.200154540210029,2.276512388167641
MDST8,24797083,1.659668465713326,1.2768357921209779
MOLM-13,100016,3.967621300341963,4.794788930556145
SW48,6914657,-5.582748420606011,-3.6094673853666093
RKN,54454,2.1815674244706407,2.648342312320632
SW1271,54686904,4.077781574312711,3.977898185729498
MDST8,tanespimycin-gemcitabine (1-1 mol-mol),1.2757210463641129,0.07685176510973762
LCLC-97TM1,11152667,-1.9849905525936635,-0.4271052385596337
RKO,6610355,5.147293026177706,4.104660865697897
HuP-T3,11234052,4.425621489915021,4.366029595945194
BICR 31,11485656,2.9684140094972387,2.50020935448272
HCC15,445643,3.643779771767104,4.046566190470558
BFTC-909,alisertib-navitoclax (2-1 mol-mol),3.1464879320843635,0.6657820284889954
Granta-519,6918878,0.9437787040623058,0.3616390818055038
SU-DHL-1,16720766,-1.7997333167058054,0.42595484028630315
COR-L95,navitoclax-MST-312 (1-1 mol-mol),0.0334777259745642,0.1587857492316763
RKO,11626560,1.596896929931414,0.966766777960388
IGROV-1,44589607,3.0909001492794377,2.8335783919096684
HEL,168313047,1.7739787927154282,2.0474154541492466
IGROV-1,11964036,-0.1609353030421705,1.096345993159766
SK-HEP-1,969516,2.3030983588134917,3.0497500412642857
LS411N,68056272,3.648680202626129,3.2209837813935382
WM115,navitoclax-piperlongumine (1-1 mol-mol),2.2126166903364037,1.8098716453364938
HEL,2749,1.5352641298417238,1.0183522865536785
MOLM-13,135398516,0.1807695197937267,1.4783649505908734
Daudi,176870,1.9898427065198672,2.6374615230571856
HEL,10427712,4.076538081897971,3.7798458489643747
SW948,24772860,-2.2115718578693495,-1.7946728438958608
Granta-519,2729026,1.8472912754822493,2.2208530271239897
COR-L95,5394,4.313147278509764,3.753753515560224
LS411N,46907787,0.8939335106347707,0.19196142497040658
ML-1 [Human thyroid carcinoma],2841722,5.015074505803474,4.271110711343522
KU-19-19,11485656,2.7576201496249264,2.297920655744657
IGROV-1,2858523,3.196384505087132,3.0074301539774746
SW948,702558,5.163408425848839,4.267836674093214
RERF-LC-MS,72734382,4.885789692793362,4.666890046265376
NCI-H1568,JQ-1-navitoclax (2-1 mol-mol),1.9826778797664537,0.8107398449425667
RERF-LC-MS,11964036,1.6707185338079893,1.5344698872633256
ML-1 [Human thyroid carcinoma],25154868,4.839556149748317,4.579781996484247
SW48,3038522,2.575519148977434,2.980807748524215
IGROV-1,11364421,-2.1205062036040982,-1.35739912526052
Daudi,24753719,1.7041863717102288,3.2690385019977275
MOLM-13,selumetinib-BRD-A02303741 (4-1 mol-mol),2.2135360458532216,2.4949527558214957
SW1271,73707438,3.2742940196229022,4.028479076912094
MOLM-13,44487061,4.373293273870424,3.1042214382287137
SaOS-2,568763,0.7449819257203903,0.6960710174859069
SaOS-2,168313200,1.7182390433527042,2.9660306171474637
K-562,15547703,3.09098547046412,2.807158968263889
BICR 22,24785538,-0.3286106781648999,2.021857812988177
IGROV-1,9936388,2.10108466287406,-1.0080455805804374
BICR 22,4477,1.559722374810713,0.3944165323234677
LCLC-97TM1,navitoclax-birinapant (1-1 mol-mol),-0.5917483578052505,1.9418563795986616
BICR 22,16038120,1.2563245393113998,1.4515479142244592
PaTu 8988t,56649450,4.324867884259214,3.5996056548371063
PaTu 8988t,135411,1.3050507330755643,0.7914240967839185
NCI-H2452,12001922,2.2907278374018296,1.957775168687546
RKO,44185566,2.4837284923488063,1.5282914286747988
K-562,9826308,0.1842141800186153,0.05089243941177021
RCC10RGB,5311281,4.058856975975892,2.7967599974771518
WM115,5460769,2.9023963298546507,3.023063285061513
HCC15,119182,0.1055567812373319,-0.6403853033445566
BICR 22,44607531,1.5270609291983028,1.3784077408870372
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245,-0.9729862044145645
NCI-H1568,25262965,-4.225307409424958,-0.8447532062345947
SW948,5328940,1.2304763256018572,1.4195052124153533
IA-LM,10296883,4.25848729020474,3.5432171321975874
LCLC-97TM1,11964036,0.9095700511944136,1.0237432266518953
SK-OV-3,10074640,3.759507235638381,3.3367740180699736
BFTC-909,25062766,1.7422044094415416,1.9186132497528285
MOLM-13,44202524,0.8413416322030352,1.2834364652826884
P31/FUJ,44137675,3.225768708166513,3.034826751573595
PaTu 8902,42642645,2.254917267204718,1.0702745491414292
RKO,53232,4.485666667988006,2.5999302642990574
MDST8,51039095,3.753808380930837,2.8223581034557577
ALL-SIL,25150857,1.7729123360103365,1.6056825252215077
KU-19-19,136227924,3.1447471190609217,2.985027607577613
BICR 22,9911830,2.5765146499323497,2.633840733523337
SW48,26596,-2.356334812614481,-0.7238607661995683
WM115,8515,4.149615392892544,4.010023695835365
SaOS-2,3025986,-1.3703894596366477,-0.7019528158195663
LS411N,6623618,2.410312404439064,2.293902730796162
RKO,2749,1.3580925102381314,1.2979657286031965
SW1271,9915743,1.6128868969613257,1.4541317204367994
SaOS-2,44589607,3.1014372869468736,2.8744458359926055
BICR 31,9908783,4.390198834476992,5.2321000829945685
RERF-LC-MS,1641662,3.403538628142178,3.7201330520285096
SW948,168313200,2.3052543991742933,2.981034784177774
BFTC-909,16720766,-0.0189955240044846,0.7754990930536514
HCC1500,46843906,3.5664723036358703,3.233717718032643
BFTC-909,5291,3.495280995080932,3.806281308527309
PaTu 8902,5287620,-1.817962379422155,-1.829274276086499
Granta-519,24772860,-2.616849709254195,-2.939310760322799
SW48,selumetinib-decitabine (4-1 mol-mol),-2.392622848847121,3.088629595394995
MOLM-13,2858523,2.990787770243497,2.500415517954341
MOLP-8,73707398,-1.5200522985211378,0.4908412579981064
WM115,4788,5.364989483250021,5.602466984516322
KU-19-19,11717001,1.9129980214779312,4.197103193982666
PaTu 8988t,3854666,2.839522644305469,2.0806255853028413
MOLM-13,vorinostat-navitoclax (4-1 mol-mol),-0.987195893966014,0.040086655041729174
RKN,11222830,1.5707482267531538,1.675446899834913
SK-HEP-1,5978,1.689065603838291,-1.8160287154368748
LS180,374536,-1.6764778169414856,2.431696963935334
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286,0.9074879998612776
RCC10RGB,46199207,3.760684270246491,3.372959328463187
SW1271,49836020,-1.4027167140646708,1.8435575070108516
BFTC-909,2130404,3.366307483642889,3.353561192072707
SW1271,3384730,3.1846503121443144,2.783908254311728
HARA [Human squamous cell lung carcinoma],selumetinib-MK-2206 (8-1 mol-mol),2.6906074312139676,2.241191615192102
SW1573,selumetinib-PLX-4032 (8-1 mol-mol),4.4065207246272005,3.612475780798154
SaOS-2,285033,-3.099559966451384,-2.212399010265032
LS180,71466578,4.68838045718991,4.576150956462526
LCLC-97TM1,2126,5.523539990092585,4.547434014705337
NCI-H1568,9936388,-8.53108348301746,-1.2937024586893713
Panc 02.03,6505803,-1.93196111296706,-0.5757422338953835
BICR 22,9926054,1.8271931211135617,2.0541892226153227
SW1573,54618164,4.339091959582753,4.132518659628903
COR-L95,9907093,4.309721999642839,3.746312892280142
LCLC-97TM1,9911830,3.2250615193472085,2.5317506917766623
K-562,151289,0.3703020531314545,0.6070724694150554
HCC1500,24821094,2.4557115965701257,2.318959871683428
ALL-SIL,11222830,0.8263932665864424,1.1580845070440653
ALL-SIL,44490293,5.541636788423512,1.8764719069972997
BFTC-909,15547703,3.647732910564925,3.4000614455407976
PaTu 8988t,11175137,3.61207596874577,2.6393294205411424
COR-L95,44566777,1.612039010223373,0.7553715719479831
RKO,navitoclax-PLX-4032 (1-1 mol-mol),2.3429049321543083,1.281032953713884
SW48,9444,3.3118033011757806,4.099558954130925
COR-L105,52947716,1.1539739817838972,-0.21060382205107517
HARA [Human squamous cell lung carcinoma],11228183,1.9492387662676105,2.799150749663497
SW1573,16013152,3.6979705228045354,4.217422588427394
SW1573,17759555,4.342323370433329,3.752380276026799
SW1271,11609586,3.768986685585146,2.871455633719141
K-562,3552672,6.190745251508109,2.7157014174298384
ML-1 [Human thyroid carcinoma],151289,2.136095657957592,1.173429061111843
SW48,vorinostat-carboplatin (1-1 mol-mol),1.7573438485405597,3.2736221577660354
COR-L95,selumetinib-BRD-A02303741 (4-1 mol-mol),6.0949369940274645,3.9185983784389538
IGROV-1,57519531,2.639098862164858,2.4710801258699124
IGROV-1,1716436,3.2816872421007375,2.9937015843939423
ML-1 [Human thyroid carcinoma],11222830,1.0897337620982457,1.7845695969415072
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308,-0.2796627198019264
IGROV-1,2828334,6.070696247039626,6.169976079333005
SW1271,53495165,2.774319130141937,0.06788522523132594
SW948,67291369,3.8063591597957593,1.793281297723097
Daudi,11507802,0.3815953316544085,0.7118393725649067
RERF-LC-MS,2708,5.106155932743474,5.068486028581413
SW1573,52912189,3.9296893768173065,2.648356089090846
SU-DHL-1,25154868,3.5324679540942165,4.2695950027059775
BICR 31,24772860,-2.497965982707089,-1.7739755879408614
K-562,11719255,4.077642177046201,2.4837174382378127
WM115,5470400,-1.5377493662522326,0.265676986203203
KU-19-19,44589607,3.6813877406069246,3.022795020449158
LS180,11626560,1.7567799331145733,1.9852638259957223
Daudi,11427553,0.4642664556868584,1.326005797726216
HCC1500,44607531,1.3781074542184104,1.6808092366073994
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528,0.44534769960099674
PaTu 8902,4259181,0.9791956381618654,0.3998830616983341
SaOS-2,216345,4.363902597199754,3.961306511656549
BFTC-909,100016,5.8134150302243865,6.2476177806585955
BICR 22,56963564,0.2615280103832354,0.9055633894058929
COR-L95,selumetinib-MK-2206 (8-1 mol-mol),3.988992383923742,2.299453359784863
LS180,613753,3.1711720082363337,3.2510582799629084
BICR 22,3825829,4.259881935728516,3.95962362596211
P31/FUJ,25262965,-1.897985536240049,-1.9460282924659447
RKO,15953870,3.3462063589818034,3.2894364782838377
ALL-SIL,26596,-3.0181503922951674,-2.508905939452692
SW1271,4788,5.888244914590778,5.696190733957378
COR-L105,25150857,2.68968810352953,2.6895721041371647
RKO,24753719,3.882573791668401,3.6527898030075607
ML-1 [Human thyroid carcinoma],11719255,2.5461185366109453,3.774308786215613
Granta-519,selumetinib-PLX-4032 (8-1 mol-mol),6.800610624755647,3.3927287978647205
P31/FUJ,selumetinib-PLX-4032 (8-1 mol-mol),0.7192847011043231,3.031360573480445
PaTu 8902,613753,4.768885644214674,3.2904642740903034
PaTu 8902,44589607,3.762990171329796,2.982776712600306
MOLP-8,176870,4.692998654081846,2.5145633758603516
MOLP-8,216468,0.300035377459394,1.4043957513027672
NCI-H1568,1641662,3.419317894706959,3.5715866079790874
HCC1500,11626560,1.5792444837322512,2.0677123404375295
HCC1500,3689413,-1.6712109221216571,-0.23388968281100536
RKN,984333,1.094463938199557,0.6317591488696734
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405,3.901342726457222
COR-L105,4788,5.897633886873905,5.810306755472521
HuP-T3,carboplatin-etoposide (40-17 mol-mol),4.278227331004969,3.280835957957812
PaTu 8988t,136227924,2.49705731140334,3.0692666368338113
LCLC-97TM1,3634881,2.947438100526324,3.258040007723725
RCC10RGB,53392493,3.4706572822964072,2.8139376830224165
Panc 02.03,10385095,1.3097039910351371,1.357453271694641
RERF-LC-MS,445455,4.41080153827665,4.607116577800099
PaTu 8988t,6918638,2.256433939948275,0.8514459660438664
KU-19-19,24951314,1.2793314486163916,1.4421975519609203
MDST8,25183872,-0.5549651899708961,-0.45022918651727956
COR-L95,JQ-1-MK-0752 (1-1 mol-mol),5.448110634286577,1.067812186873663
WM115,navitoclax-sorafenib (1-1 mol-mol),1.4633730841087864,1.899478874430847
COR-L95,9908783,4.358103020890871,4.314798094801046
COR-L105,3552672,2.0991572824292435,3.10659068532276
SK-CO-1,5566,2.706069596509063,2.8235491622215165
RERF-LC-MS,969516,2.2498421794663095,3.111993604170257
HCC15,JQ-1-UNC0638 (2-1 mol-mol),2.9546017932515256,1.8855594114232457
HARA [Human squamous cell lung carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.8572824243778725,2.1634012989425666
NCI-H2452,452548,0.0358025934468,0.45747338790556513
Daudi,409805,3.686040208403983,3.7043119797671773
BFTC-909,5287620,-2.871557478653834,-1.8376669321275587
UACC-812,25183872,-0.2383295665292847,-0.6037942337920296
SW48,36462,-1.5563073788110886,2.2520329899956817
SK-CO-1,327653,3.1822308576162692,3.0903586402622705
MOLP-8,11507802,0.9747707839930404,0.8484296347119583
SW48,55508,1.9258231187784565,3.450425875370474
ML-1 [Human thyroid carcinoma],5329102,1.4103281602713895,2.3792001604178097
COR-L105,16065773,2.993283969068687,2.596045018420711
ML-1 [Human thyroid carcinoma],53495165,2.320007555236624,0.9938350729073353
LS180,451668,4.827094473942733,4.008414844216682
IGROV-1,36462,2.313632721410001,2.244860031269744
RCC10RGB,selumetinib-piperlongumine (8-1 mol-mol),4.460336891472633,3.5933407276264613
COR-L95,navitoclax-piperlongumine (1-1 mol-mol),-0.3992176902442844,0.29435826862299014
MDST8,11719255,3.580824685094748,3.425615099975362
BICR 22,135984461,4.376718251500639,3.4775714335627517
BFTC-909,selumetinib-MK-2206 (8-1 mol-mol),3.672772019831091,2.448552768615116
Granta-519,2871966,-2.0442685638601947,-0.559184078934399
Panc 02.03,136227924,3.0839082623333387,3.131358448277065
IA-LM,10074640,3.892343788144062,3.2916061456279953
HuP-T3,navitoclax-piperlongumine (1-1 mol-mol),2.1493116178026157,1.7286044193324048
BICR 22,10231331,2.1949493731732095,2.1188508442006566
PaTu 8902,carboplatin-UNC0638 (2-1 mol-mol),3.7190209158995273,3.5194504353127645
NCI-H2452,10127622,4.466077980380041,4.089124667154651
PaTu 8902,11178236,-2.9840755573739943,-3.0945651966918306
MDST8,6918837,-2.3764765121755,-2.2857091853319376
HCC15,1716436,2.8917896521916537,2.9361512074079545
Daudi,5351362,0.314899635949887,0.9348719624482004
IGROV-1,1750826,-3.124548162001242,-0.895717491318491
SW1271,24779724,6.290779023739936,3.99559345905427
SW948,216468,0.513065020542466,1.8361662610025271
HCC15,5738263,4.375256926251463,3.40919698409583
Granta-519,25183872,-2.24080905771406,-1.8120543439638555
MOLM-13,selumetinib-navitoclax (8-1 mol-mol),-1.2398703731830696,0.7386153561217657
SaOS-2,46926350,-4.2820912559124995,-4.1780829544522335
COR-L105,49766530,-0.5480688242609842,-0.24424363899461782
HEL,2874250,-2.245656223692803,3.7401460625895715
K-562,45279963,2.402740503794971,3.174814008591464
SW1271,441298,2.7117876410913073,2.3896643993213673
Daudi,46215462,1.1016280052611975,1.2487782012977668
BFTC-909,9915743,2.0959000942543025,1.462571120323944
Granta-519,55508,1.5366901224911111,2.9343333239729232
ML-1 [Human thyroid carcinoma],11507802,1.1504003941708354,1.9034356223696878
SU-DHL-1,445455,4.339452591135178,4.184667609030848
Granta-519,11222830,0.944926764715042,1.0725673468987806
SK-HEP-1,135421197,3.339831791709741,2.2754321500307126
COR-L105,11719255,5.177770829400177,3.558436569828535
SaOS-2,49793307,-3.0698778362667807,-2.0985403067892
SU-DHL-1,54618771,0.3433661921186922,0.4668762184441489
SaOS-2,navitoclax-PLX-4032 (1-1 mol-mol),2.865443862493463,1.8437581308529518
IGROV-1,54618164,4.2184521751950115,4.116342011868635
ML-1 [Human thyroid carcinoma],44507138,2.4759759240399206,2.6831036177938388
HCC15,4259181,-0.5021574884501439,0.3182674259636963
PaTu 8902,5311,1.4468060231693458,1.5795830685592944
SaOS-2,11609586,3.464015551213678,2.9925102011122586
BFTC-909,26596,-1.7437210940555867,-0.8736135331352868
RKO,3385,4.410917651107157,2.7687927017599288
SW48,5282054,3.4229655251352984,3.9220587259092916
HEL,3025986,1.4059985389197358,-1.4801694222262756
HCC15,2749,2.6993987110059456,2.1496053423849792
RCC10RGB,serdemetan-SCH-529074 (1-1 mol-mol),2.3426493996230424,2.290263953305808
MOLM-13,2733526,3.3430267495988693,3.3895203885443435
HCC1500,71466380,5.203984730888507,4.515709829892751
SK-HEP-1,104842,-1.0887000355540395,-2.4529639664747838
SW948,5566,3.1149649258053107,2.949545563362575
Daudi,11234052,2.508646185471885,2.9799713248167223
WM115,tanespimycin-gemcitabine (1-1 mol-mol),-2.08510571323105,-0.3949385803111467
SW48,208908,0.7661322887377208,2.054920919076807
SW48,24978538,0.0148337391131729,1.3154913968793727
P31/FUJ,9926054,1.2698752833949425,1.6392563861284901
Daudi,5287620,-2.5355659158885167,-2.2004825063200637
BICR 31,53325874,4.467091056736401,4.673567878525927
LS411N,400769,-0.3072623933562745,-0.7295243181165063
HCC15,7326481,6.13295321500094,3.0895057235989487
LS180,6610216,4.524725364990245,4.329048007576479
BICR 31,11609586,2.804864928293696,2.968173110176226
NCI-H1568,5351362,0.9370615420718584,1.677772375545044
NCI-H1568,selumetinib-PLX-4032 (8-1 mol-mol),3.6289743773432463,3.6594173515315935
HCC1500,26596,-0.8174609850015592,-1.005331972134031
Daudi,JQ-1-UNC0638 (2-1 mol-mol),-1.821496210426365,0.6171518908925451
Granta-519,salermide-PLX-4032 (12-1 mol-mol),5.521121579042541,4.514282912047738
BICR 31,5311281,1.899563489561116,2.5420500223221114
HuP-T3,11964036,1.9148977928601396,1.4148011953244242
HuP-T3,6918328,0.6989696425214073,0.10881914520655062
IA-LM,56963564,0.8197284064300991,0.2577433491622347
K-562,25227462,-1.535473545694956,-1.0574271925094088
HARA [Human squamous cell lung carcinoma],68056272,4.667757023830857,3.9343263197090432
P31/FUJ,6438330,0.60015264799364,1.275261096021529
NCI-H1568,54143018,1.7330311939537375,0.9296944589226315
MOLM-13,10184653,-1.0304513474260102,0.8202754291249857
COR-L105,3081361,0.7591954413754667,2.5944991238574033
SW48,3465537,3.829258919586145,2.4391518794567584
SK-CO-1,135398516,1.0451560562277196,2.1672954627481307
RKO,selumetinib-vorinostat (8-1 mol-mol),2.2625933360113826,1.91209851176269
BICR 31,11222830,2.7999268343872603,1.8302078004416882
P31/FUJ,1750826,-3.787471607079622,-3.0960910558022605
MOLM-13,124202324,0.9453642044256088,1.0256432851387212
LS180,445091,4.461419397707798,4.370300752315025
K-562,4578,4.401657334703153,4.006143284266873
BFTC-909,31703,-0.9928331583982526,-0.5776952703418773
Daudi,54618164,3.154466747848232,3.69633004893573
HCC1500,375860,0.1348683063529126,0.34401419904044095
MOLM-13,3385,-0.0516453787728095,2.5743897199247106
Daudi,123631,1.6174763425926726,1.9411387945121457
SW1573,6610355,4.129027118562099,4.653477819748502
K-562,44589607,2.662527895237601,1.981698132706035
SW948,24964624,1.7910099631647045,1.7039040933462777
LS180,387447,-4.2321913932512185,-4.18174364061228
SW1271,445091,4.3767610709371025,4.50999421948838
LS411N,5328940,2.1913370268343324,1.1442708689498908
ALL-SIL,46199207,2.4207183231317826,2.660614636683086
BFTC-909,644241,3.062866082016443,2.3585068559887894
SK-CO-1,5738263,3.1381077819263954,3.535415649150467
HCC1500,selumetinib-BRD-A02303741 (4-1 mol-mol),5.277663522211575,3.2773671431530045
PaTu 8902,3385,6.504553614083827,4.32053811858064
SW1271,5328940,1.739297434861375,1.9245687294020553
Daudi,444795,4.05018196872557,2.985487496608195
SaOS-2,9887053,4.468769125876902,4.094157348490413
ML-1 [Human thyroid carcinoma],6610355,5.061552725322464,4.9132648790005025
MOLP-8,9936388,3.4211096692910052,-4.8146614535848204
SaOS-2,5746,3.648398890023908,1.387775459512046
PaTu 8988t,135875424,4.8815767191826325,3.9298565962500236
SaOS-2,25195348,4.111342507306749,3.371891897198066
NCI-H1568,135398738,4.732110826035958,4.653577722082496
RKO,5329102,2.192208184281935,1.6437550175814015
ML-1 [Human thyroid carcinoma],122327,4.584045367066115,4.821784760758
WM115,11612883,3.668907379861532,2.846582367945325
HCC1500,24785538,2.8337652504333817,2.049352564366426
ALL-SIL,3854666,-1.067048731148745,0.7426524100046435
WM115,11494412,2.975341542339242,1.9130623244832534
Granta-519,9884685,-0.5481626961732873,-0.42376973817774555
LS411N,selumetinib-vorinostat (8-1 mol-mol),0.590504538579532,1.7281798597998879
KU-19-19,5287620,-2.913600334543538,-1.8527138896442847
HCC1500,25227462,-1.134185511373382,0.6949680942864805
SK-OV-3,9936388,2.038842599711319,-1.229002056720395
HARA [Human squamous cell lung carcinoma],5113032,5.077717215414557,5.099251945123735
HARA [Human squamous cell lung carcinoma],46191454,0.0255281814012309,2.013980769642154
COR-L95,9840324,5.902997789616562,5.71265362995765
SK-OV-3,159324,5.082712026660022,3.290295116361605
COR-L105,5426,4.419968019169297,3.8015251075739145
HARA [Human squamous cell lung carcinoma],carboplatin-UNC0638 (2-1 mol-mol),4.127490867447662,3.7153773385265025
HuP-T3,44491742,4.372770131484514,4.441935540924443
HEL,navitoclax-gemcitabine (1-1 mol-mol),-3.418603962504733,-2.053373037668849
MOLM-13,5978,-4.923441638627742,-3.052854856437638
KU-19-19,9911463,4.338553857034003,3.945328903506978
LS411N,SNX-2112-bortezomib (250-1 mol-mol),-2.160208901072175,-1.795249222766272
MDST8,9956119,3.20428794924567,3.7019430471430814
IGROV-1,44137675,1.8406125640672395,3.5953789890030556
NCI-H1568,24771867,2.7621066837370156,2.1470150048449903
SW1573,3503,1.662872296112478,2.4412152565029386
ALL-SIL,54143018,-1.6646130342073118,-0.7472333680522226
KU-19-19,9903786,4.470072542277405,2.854908743129368
Granta-519,67291369,2.669151289874282,0.537054567122426
HuP-T3,126941,-4.07371973001698,-2.278629569721158
IGROV-1,11175137,1.8411496230681277,2.7065929054668003
LCLC-97TM1,3543504,4.4040963352609825,4.225767055242476
PaTu 8988t,10184653,1.9115764380070437,1.5361103605565993
BICR 31,10184653,-1.3652350776002238,0.7591858357902518
PaTu 8988t,4917,3.9515789700022728,3.1059185815907657
LS411N,9967941,4.95978669187673,3.226390940159361
SW948,6918837,-5.2716912634433815,-3.411135699477518
Granta-519,19582717,3.2223711893143796,2.779678234374139
HuP-T3,753704,5.56041062328625,5.04989567558351
SW948,BRD-A02303741-navitoclax (2-1 mol-mol),3.1746461495638867,2.0563593149128327
HuP-T3,44819697,0.7007171788005963,-0.3422101323439869
Daudi,49766530,-5.535187194073846,-2.085293928287473
RKO,168313047,1.9322709085928884,1.9666868779873135
HEL,451668,-1.9900462993769088,-0.5736966753858919
BICR 22,selumetinib-tretinoin (2-1 mol-mol),2.504585066651982,2.2912369202644403
ALL-SIL,637858,0.2842777242368783,1.0350960554178243
SW48,375860,-0.9823609780883206,-0.10673006075830133
Granta-519,426756,3.1337304970475865,3.87443605701555
LS411N,3038522,4.360410119835835,3.1356429340614103
BICR 22,SNX-2112-bortezomib (250-1 mol-mol),-1.3459249311621435,-1.3696752100951475
NCI-H2452,11626560,1.8431584922948163,1.9811876957523094
SW48,135398516,1.3232406127849534,2.0163641819872287
SW48,5329102,0.4162536894409948,1.9240323662568917
ML-1 [Human thyroid carcinoma],322968,3.685498672876688,4.236697321343595
BICR 22,11427553,3.133254296040306,2.9185692131935097
NCI-H2452,72376,-3.519434001557919,-1.3647815299993247
ML-1 [Human thyroid carcinoma],11238147,1.6119243998814434,3.322013638876009
K-562,135984461,3.2548026411837787,3.1346463061900596
SaOS-2,BRD-A02303741-navitoclax (2-1 mol-mol),3.697295369553163,2.3879968186871268
Daudi,73707398,-0.7942959168982594,0.333344150565863
NCI-H2452,46398810,2.3683678826725387,2.7935632561332944
PaTu 8902,5738263,4.741832860910815,3.503988478773831
MOLP-8,10322450,4.082153801594249,3.116792360227054
HARA [Human squamous cell lung carcinoma],54618164,4.558968644978708,4.166143384335586
SW48,5287620,-2.9796019172473747,-1.8886366957455767
COR-L95,navitoclax-birinapant (1-1 mol-mol),-1.5627413747354164,0.2909438840466778
MOLP-8,56963564,0.2564931281605764,-0.1658876134491933
Granta-519,375860,-0.9367901929922506,-0.6445287384748333
SK-CO-1,656346,-0.6691405855346803,1.2830280372829863
RCC10RGB,44607531,1.912198544747903,1.5067392054537532
RKO,9823820,5.913042612438718,2.650354133980999
SW1271,25262965,-0.6695626057691765,-1.058191901001143
SaOS-2,2742550,4.001711578380083,3.9690657198416917
SW948,44491742,3.910317363967626,4.0469454308808785
K-562,25105715,3.3934107563871088,3.171924644181505
K-562,3689413,1.0071697658281389,-1.2875771587672489
NCI-H1568,9911830,1.3917537385715242,2.575724452130686
IGROV-1,42642645,0.3750175292659389,1.1722186176257043
MOLP-8,53392493,1.8438027475223988,1.7039694298911696
BICR 22,4788,5.9489186959823845,5.6255289099098915
IGROV-1,5287620,-1.5394168430569777,-1.5773345963411503
IGROV-1,446155,3.750396425244744,2.6311435388319815
LS180,15983966,-3.417830365026362,-1.0553177503553743
MDST8,5566,3.234550965497495,2.8412235457678854
K-562,644241,-4.86229706466587,0.8291061519442696
SU-DHL-1,135421197,1.1384736779813156,1.637039839918138
KU-19-19,44507138,1.5611189443326865,2.7654135100598034
Panc 02.03,5281321,1.7682996743542674,-0.8483040288646972
SW948,44607531,1.464462944366021,1.3684658119031703
KU-19-19,54649381,3.8760376098429616,3.931376677516734
Daudi,25062766,1.1734245449662122,1.6364582597578567
IGROV-1,56946209,-4.416985130578084,-3.97998974791757
ML-1 [Human thyroid carcinoma],49766530,-1.1158595986885904,-0.2692934203658421
NCI-H2452,11238147,5.37150149846425,2.876626358904769
HARA [Human squamous cell lung carcinoma],vorinostat-navitoclax (4-1 mol-mol),1.9090977342000552,1.487614384141406
HEL,3689413,-2.191477482826257,-1.3621929968029638
WM115,285033,-0.1832916587196474,-1.671521115954305
SaOS-2,piperlongumine-MST-312 (1-1 mol-mol),1.0729634254150997,1.8152231385578448
SU-DHL-1,426756,3.3694285311129777,3.8086724807826267
WM115,135999136,1.8466122948256136,4.112821409008118
IA-LM,45279963,4.638115534107364,3.1617600315444396
MDST8,JQ-1-UNC0638 (2-1 mol-mol),2.369730621007783,1.6552509597086718
SW948,4917,3.7157271581620166,2.9627257821674773
Granta-519,119182,-4.107570420442856,-2.7406301058040685
MDST8,56946209,-2.145438357732055,-3.649103522439988
HuP-T3,9927531,4.952379772704904,4.882304203081967
RCC10RGB,72967,3.7162805539485775,3.3970449124095525
P31/FUJ,vorinostat-carboplatin (1-1 mol-mol),1.4493920018144175,1.8940371492847095
COR-L105,25126798,3.974391104898093,3.9272409177189527
IGROV-1,676352,2.310492141650647,2.090319519678702
MOLM-13,11640390,3.605079146985929,2.558074270722663
SW1271,10302451,1.5832525718610488,3.456868384335627
HEL,123631,2.2046071754004553,1.8702680872711348
Daudi,9887053,0.4273795924431001,2.373242688499261
HCC15,53232,1.2438342439906054,2.77907244818629
KU-19-19,crizotinib-PLX-4032 (2-1 mol-mol),2.7637212964945745,2.0284409080240273
MOLP-8,107970,1.7976582890286323,1.8793847713611855
COR-L105,12003241,-1.8759508779616432,-0.915991463328409
SW948,11222830,1.2602033369542562,1.7144690408035035
LS411N,60750,3.4958773713368725,-1.8349750324052285
SK-HEP-1,selumetinib-decitabine (4-1 mol-mol),7.187577119098816,3.5736589381911448
COR-L95,11152667,-1.0192155235937173,-0.3949925988447436
RCC10RGB,136227924,3.611686331312014,3.193289252510125
Granta-519,46398810,1.929291860170987,1.7815677276218804
SW1271,135999136,4.614562085611917,3.7473119676270743
IGROV-1,53232,2.4872106086763393,2.6507707211962583
SW1271,5329102,1.7502689549650896,1.8607154267758645
Granta-519,136227924,1.3333863896282263,2.3089537581922817
HCC15,11213558,1.313690011959325,1.8241486390078796
BICR 22,54619267,3.924840101579574,3.8954335945300573
MDST8,9907093,2.778674083883115,4.475007195966164
P31/FUJ,11175137,-0.7372235608093404,1.8456321195326943
MDST8,36314,1.6029219233562175,-0.4744279250375032
PaTu 8902,2746,3.932313359375791,3.423860772977705
P31/FUJ,3543504,4.167476980253382,3.684118874152757
MOLM-13,selumetinib-decitabine (4-1 mol-mol),-2.0497039310535548,-0.21620603708237007
HCC1500,2749,1.6972528944159595,2.071152227793539
HCC1500,2858523,2.9580940168196372,2.968062316717604
P31/FUJ,241158,2.9181679480161997,2.619117528720143
IGROV-1,44202524,1.8303703172382677,2.367386691159152
COR-L95,24856436,0.3013384579313291,0.3407808670529358
Daudi,15983966,-4.480185591931726,-3.9795087432506073
MDST8,9903786,2.958137426904596,3.163632486498251
SU-DHL-1,57519531,0.9649766396601452,2.4717253603724374
IGROV-1,25262965,-3.18785020602057,-1.2138745119320755
MOLM-13,135411,-0.7080955458923358,0.1553679321336
HCC15,24901704,2.315976175325417,3.0774908749365277
SW1573,656346,0.5263129478884733,1.2129291848061785
SW1573,11238147,3.4967804964098517,3.18220121558322
MOLM-13,6918837,-5.322581124261525,-4.380535471696979
MOLM-13,444795,-0.8871401586886155,2.693965672332841
HARA [Human squamous cell lung carcinoma],2733526,3.2699742840947414,3.8692800288547056
SW948,44486219,4.202726475674803,3.9480055637075195
ML-1 [Human thyroid carcinoma],10302451,5.152653454280482,3.487922277716902
SK-HEP-1,4259181,0.3926762831937545,0.47928567364936564
MOLM-13,11152667,-8.249378694414048,-1.9360536649608315
HCC15,46199207,3.454904957256138,3.211565366736386
COR-L95,BRD-K55473186,4.076833088818027,3.80300231653341
SK-HEP-1,11612883,3.763210558313423,3.0307837035899268
SW48,54619267,2.8192087316830587,3.8137780981449563
COR-L95,448949,2.666065821382702,1.7559945925875766
SW1271,31703,-2.541706035799043,-1.0054234943060252
SW48,374536,2.9137455711630365,2.1872229785447543
HuP-T3,25183872,-1.5149537087973208,-0.5746178005144027
BICR 31,71466578,6.11729815776394,4.688666307891463
PaTu 8902,JQ-1-UNC0638 (2-1 mol-mol),3.325968686418886,1.7337161072418745
SW48,135440466,-0.9616456131279733,2.198007849892819
Granta-519,322968,2.3569390760499234,1.8898760670116435
RCC10RGB,25227462,3.0929907596871646,1.1548650304166128
P31/FUJ,6917907,-6.201167718101803,-5.616066257192745
PaTu 8988t,49793307,-2.0749757720441164,-1.9002209707686446
HARA [Human squamous cell lung carcinoma],9884685,2.402658407469787,1.1039564871979584
Granta-519,12001922,1.093482575381039,1.6344783196772052
SaOS-2,54649381,4.670802712896813,3.825705636305356
BICR 31,11213558,1.307666782243681,1.783582607859116
NCI-H1568,crizotinib-PLX-4032 (2-1 mol-mol),1.1920351291695386,2.1724611290258875
RKO,selumetinib-UNC0638 (4-1 mol-mol),2.378322605916553,2.289415147871995
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982,-0.3416564893488119
SW1573,216468,2.7570678542174294,3.56830160219142
WM115,selumetinib-UNC0638 (4-1 mol-mol),-1.6649688708670054,2.368425761397481
LCLC-97TM1,441298,2.906797889353979,2.479724564169183
LS180,24753719,4.21554861148433,4.375534359316588
ALL-SIL,65064,2.797289094590348,3.2957279004055717
BICR 22,67291369,2.228219380635809,2.68619126916238
RERF-LC-MS,168313200,3.896073258981905,3.0381860260105076
SK-HEP-1,9444,4.343802313850578,4.2830759864955645
PaTu 8988t,5328940,1.37213408852796,1.6838600665280834
BICR 22,5311,1.9321946929787237,1.7224316722548965
BICR 31,219104,4.339385963743166,4.023055629548847
IA-LM,navitoclax-birinapant (1-1 mol-mol),0.9661669112911666,1.055647064101627
ALL-SIL,4477,0.1906678465210559,0.3412119376330925
K-562,25154868,2.7747166739598264,4.170823723466069
SK-HEP-1,16065773,3.000790971898234,2.612748534820608
PaTu 8902,11364421,1.1100050491651887,-1.6144030682123789
NCI-H1568,3081361,2.134244125445247,2.353247929157087
HCC1500,11640390,3.4842141291887234,3.3461546139697163
BFTC-909,11626560,2.2197507332783735,1.9741625936982894
SW948,107970,1.650733689507072,2.243634938803755
RKN,15983966,-2.847635435689191,-1.2453672689490867
P31/FUJ,11455910,0.7543092217738059,0.44121222061595305
MDST8,71466380,4.4925072325945825,4.54041271383355
HuP-T3,44185566,3.047929926499308,2.6972795516629198
WM115,24772860,-3.130789858430774,-1.696844294365841
COR-L95,327653,2.664763845896721,3.0297594001482917
BICR 31,46398810,2.284799792972812,2.7519379383546205
MDST8,46199207,3.2831338438462545,3.156314626745701
P31/FUJ,54143018,-1.089453758548118,-0.5456970280383946
RKN,119607,5.106543735080002,5.342419330513354
COR-L105,5746,2.3338049438674933,1.5877178964450758
ALL-SIL,alisertib-navitoclax (2-1 mol-mol),-3.0899588817168286,-2.0314393099812365
MOLM-13,5738263,2.9100103684660237,2.6424147444308352
RERF-LC-MS,216345,4.25766275770173,4.187120902129147
P31/FUJ,10322450,3.023071845081992,3.2106568223831347
BICR 22,16065773,3.2562595111068933,2.5886500039726754
HARA [Human squamous cell lung carcinoma],3136844,4.042885024123848,4.492359393488433
RCC10RGB,2858523,3.1824977664847833,3.1392164390543655
HEL,3634881,2.3660153954756,2.679940301533051
BICR 31,4705,2.7587837218207194,3.091686634214203
Daudi,16736978,-0.1290294552432643,1.051243218270035
HCC1500,409805,3.5957056987066407,4.825416527099985
COR-L95,11497983,3.7904455836505977,2.0866136602610665
NCI-H1568,erlotinib-PLX-4032 (2-1 mol-mol),1.5802949352112503,3.1438584951819295
HuP-T3,123631,3.4682236131630213,2.2136449291175055
MOLM-13,6918736,-1.7098661921605196,-2.4566062054512714
MOLM-13,46943432,-0.154947866345158,0.7232160234330709
HCC1500,219104,2.0821347677363473,3.7726561359961983
WM115,salermide-PLX-4032 (12-1 mol-mol),1.9364726172790967,4.561956831815953
NCI-H1568,65064,3.2204713254113373,4.876737415839144
SW1271,16720766,0.8044088826386648,0.4961949219304214
Daudi,119607,3.8512151262400978,4.491463967737284
HCC1500,72193861,2.243893882523798,1.8290155131173964
K-562,5328940,0.7651330448756731,1.172918355982609
SaOS-2,644241,2.5011234622868415,2.5690458007784622
HEL,60700,-1.2821695146150829,-1.4400898978056034
RERF-LC-MS,25227462,0.8140348385016122,0.9441872577288716
COR-L95,4521392,4.944619543772989,3.935428438778498
KU-19-19,16720766,1.6427063989874335,0.48986241242675344
SK-OV-3,3025944,4.375754256809385,4.366898427670128
P31/FUJ,36314,-5.221113398603202,-1.7756316750350656
Panc 02.03,568763,0.7660787595735656,0.7413285739722388
PaTu 8988t,60700,1.4149082605005396,-0.15536451031876808
BFTC-909,421610,2.763760389372973,3.2643278861172664
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163,3.25710475268586
RERF-LC-MS,123631,2.7610356359897104,2.5811418653268903
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225,3.5534008323469037
RKN,10385095,1.0188882527918253,1.2382817655671834
K-562,carboplatin-etoposide (40-17 mol-mol),2.706166377048538,1.6201119926330418
SW1271,selumetinib-vorinostat (8-1 mol-mol),1.620526536353516,2.320127777557223
Daudi,44486219,3.679556481815833,3.7575690946788445
SK-CO-1,JQ-1-carboplatin (1-1 mol-mol),4.771818519750647,2.3425214258049656
P31/FUJ,159324,1.227532336429348,1.2353743613001005
SK-CO-1,6252,-1.3434891204218062,0.9556179266016955
LCLC-97TM1,656346,0.6605690440583806,0.6533249909365092
Panc 02.03,SNX-2112-bortezomib (250-1 mol-mol),-0.27502478347835,-1.2755848980949906
RERF-LC-MS,675434,4.646232548137413,4.650764495496386
KU-19-19,123631,3.236221278135049,2.2898521653646657
MOLM-13,15983966,-4.417403089755366,-4.125169652925803
HuP-T3,4917,3.663340719397695,3.097851877900374
LS180,44185566,1.7571027497277631,2.408634369377884
P31/FUJ,11228183,-0.9086595542209992,0.5989805377820159
WM115,9933475,1.7795579913266513,1.8537609684923857
RCC10RGB,445643,3.986839371383198,3.779761220559371
LS180,11238147,1.5426585727528574,2.81555873646939
SK-OV-3,6918328,0.3966751205296329,0.4015152150730578
SU-DHL-1,71466578,4.395132834723917,3.466750279898344
ALL-SIL,135421197,0.8278001934093618,1.2456370816609241
BICR 31,2858523,3.440938149330432,3.122876013230498
NCI-H1568,72734382,4.159676082420196,4.728592609238129
BICR 31,10427712,4.26091650049326,4.368471994867845
K-562,5351362,1.2059406782397044,1.0796259814336642
HEL,44589607,2.8579344181758164,1.9696685106966914
RERF-LC-MS,89928392,3.2509495975064193,1.7555836759925052
K-562,4705,3.481256778033869,2.829568605527001
SW948,400769,-0.4902020150535968,-0.6740305512229006
RKO,46199207,3.448070090368443,3.1576681105947775
HuP-T3,10410894,4.484643398072658,3.366267521718909
BICR 31,969516,3.644181632779252,2.8956292593015887
WM115,54618771,0.9043395114740442,1.4081155981503606
MDST8,2749,2.5181508528519365,2.175887447679933
SW1271,4378219,1.9495591217614856,2.6885323853966576
RERF-LC-MS,12003241,-0.3897829713203344,-0.9464825393335953
ML-1 [Human thyroid carcinoma],11683005,4.957719989216769,3.5404710434944344
PaTu 8902,44620216,3.796821774118314,4.173311687522227
MOLP-8,4378219,3.751203523477959,2.1165158477107497
PaTu 8988t,11152667,-0.7220641758089987,-0.40612547184949954
SK-OV-3,navitoclax-gemcitabine (1-1 mol-mol),0.2321972175274424,-1.076652025866502
SK-OV-3,60700,0.4435128165358443,0.0006716648253190694
LS180,168313047,2.515878081381246,2.343112433416833
K-562,400769,-0.7978860959413716,-1.2850816856409057
Panc 02.03,126941,-0.7071805078882285,-2.2986837600709227
NCI-H1568,3634881,3.2529386900783024,3.3146373004119134
LCLC-97TM1,24821094,3.5658031163211996,2.9816461763845425
LS411N,11485656,1.6093796612349578,1.852802882281792
HCC15,16736978,2.153897232237977,1.5946029069541328
LCLC-97TM1,6610355,3.6494140877324273,4.43594298668023
IA-LM,serdemetan-SCH-529074 (1-1 mol-mol),2.9054360397422387,1.865201748835179
IGROV-1,9911830,1.9130562323799436,2.7859972508442272
LS411N,159324,3.2133975478450005,1.8053654000819597
COR-L105,selumetinib-PLX-4032 (8-1 mol-mol),2.5098576733785705,3.469480676913516
SaOS-2,322968,3.970591848140582,3.71098366356255
BICR 31,216345,4.54975912567895,4.1316223179190406
HEL,3825829,3.033394475732853,3.324870282674142
COR-L105,46191454,3.4168297701439223,1.8975992941301445
K-562,5113032,4.649240406472478,4.353446156676487
BICR 22,156414,1.4774483319728589,0.4161688904599522
SW1573,135875424,1.8143158468632437,3.990196434585351
WM115,12003241,-3.303596686294694,-0.6821707917994165
RKN,11640390,3.613472996393559,3.692764410229098
HEL,23725625,2.914554844202699,3.462736100398281
COR-L95,36462,-0.8944975018350346,1.1767153340639844
HARA [Human squamous cell lung carcinoma],53232,3.05929528970331,2.9004547563307774
HuP-T3,11977753,3.281021154274905,-1.145535335443836
SK-HEP-1,400769,0.2777482831309371,-0.5576265430343931
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645,3.1407263490831343
SU-DHL-1,246676,5.693727803678488,3.874592087565462
HARA [Human squamous cell lung carcinoma],11626560,1.1307601374566012,2.058404582808491
PaTu 8902,selumetinib-JQ-1 (4-1 mol-mol),5.2969208566894075,1.590852672052165
RCC10RGB,44507138,4.147954700367582,2.887859028642273
LS411N,123631,3.048490743589503,1.7363417542668806
MOLM-13,11213558,-2.3442824820578347,0.8150393902372264
MOLP-8,selumetinib-tretinoin (2-1 mol-mol),3.5259628447658495,2.37660708587367
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766,-0.5522325459581283
PaTu 8988t,444795,4.288290341819835,4.8258703935935365
SK-CO-1,66577038,1.9378658470267984,3.132393473152829
SW48,24771867,-3.897611921368264,2.3862572199732113
NCI-H2452,9907093,3.826391051371518,4.244259147056901
SW1271,171352865,2.2565348875691624,3.289497063486732
SU-DHL-1,11152667,-1.9410189761528236,-0.347097887303711
SK-HEP-1,148124,3.734435411699081,-1.6927082650831338
RERF-LC-MS,107985,-3.0933260647006215,-3.0708810205864854
HARA [Human squamous cell lung carcinoma],44589607,3.368220225067554,2.988264623186826
ML-1 [Human thyroid carcinoma],36314,-4.393977809452653,-0.24133816051216317
RCC10RGB,10184653,2.2305820416370965,1.4551872032166338
LS411N,17755052,2.4732315703899226,1.5572605717696204
Granta-519,decitabine-navitoclax (2-1 mol-mol),-1.3661382782873654,-1.611015752066452
KU-19-19,24753719,4.40371401160258,4.361560770733785
PaTu 8902,72376,-1.694582331183855,-1.6858625950507102
HEL,72376,-3.0304513894944933,-3.346603012216051
ML-1 [Human thyroid carcinoma],25150857,2.4072078224567486,2.74702019545207
SW948,9884685,3.1398548031465525,0.08301189546828015
Daudi,24748573,1.578133478161721,1.4469225134230368
COR-L95,4917,3.3160135329409406,2.771195481503187
SK-CO-1,2708,2.7526164010571152,4.9386678791810334
Daudi,5479543,1.606221989903471,2.859490237174964
PaTu 8902,vorinostat-navitoclax (4-1 mol-mol),1.8599454099065449,1.4250728750419852
MOLP-8,44632017,0.8356757219547752,0.8200386635395396
SW1271,9868037,2.9396003878324857,3.5441439254525218
COR-L95,11455910,1.0154509596480157,0.9008464612957866
IGROV-1,445091,5.8777802446160825,4.427736738205771
IA-LM,107970,1.9308025720075177,2.202503616652105
BICR 31,15953870,5.115358479555731,3.7862149057325047
HEL,135984461,1.7610482730169696,2.486727267733457
HCC15,vorinostat-carboplatin (1-1 mol-mol),2.4228610420151853,3.243407571156946
PaTu 8988t,5311,3.6038975682992422,1.6880779759393745
MOLP-8,navitoclax-pluripotin (1-1 mol-mol),-0.3360266341011599,-1.8894455672918615
RCC10RGB,BRD-A02303741-navitoclax (2-1 mol-mol),1.3031528560505037,2.3031103908723223
SK-CO-1,11228183,0.9546983133897222,2.4619235398911496
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345,1.7967324475641147
NCI-H1568,selumetinib-vorinostat (8-1 mol-mol),2.593817270705759,2.5848495722743445
ML-1 [Human thyroid carcinoma],441298,2.939924630100921,2.8530682822005144
BICR 22,42642645,1.569820729256039,1.3803260769308061
RERF-LC-MS,387447,-4.351660250848144,-3.8381174788410424
SU-DHL-1,carboplatin-etoposide (40-17 mol-mol),-0.8202872264800385,1.1268102408593785
RKO,676352,2.3070338313311547,1.7512344909250612
HEL,66577038,3.4935326109734217,2.5593562341959855
RERF-LC-MS,25062766,1.7296886540377192,2.0085336198569426
RKN,52947716,-5.912196482956353,0.22863701326687916
SW48,56973724,0.919295357428288,3.3515625057221103
LS180,66577038,2.8527700320727725,3.043343069830237
K-562,7251185,2.894408284149289,1.532204886585733
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456,-1.0946206081173886
ML-1 [Human thyroid carcinoma],3025986,-0.9166044093803444,-0.12514299999462863
MOLM-13,6918878,-0.6248914400619264,0.626524683716452
IGROV-1,135421197,1.96820638017286,1.7559993558303173
RKN,11404337,0.6786980557761386,-0.4081160405734836
SU-DHL-1,6918878,1.5556600104975795,2.311453305458537
MOLM-13,176870,1.4073018577806429,2.117771907108265
SaOS-2,44566777,0.9896093397626105,0.662011953468881
COR-L105,5470400,0.2171168006478052,-0.09332482462037188
LS180,44632017,0.4358481157568056,1.1384077026299688
RCC10RGB,16065773,4.176477311044804,2.831645676494629
BICR 31,156414,0.5699919561712937,0.9178742087136214
SW1271,tanespimycin-gemcitabine (1-1 mol-mol),1.3087817847802907,-0.25568673398258657
HCC15,JQ-1-navitoclax (2-1 mol-mol),-0.7343032708143507,1.1613998921402666
Daudi,54596490,4.948926549609605,4.3825097055936135
NCI-H2452,11317348,1.7824301660124695,3.3896999388008116
IGROV-1,60700,0.4424479122017752,0.007133556445412319
IA-LM,135421197,2.370501142960713,1.564637490872968
NCI-H2452,135423438,1.816833708086427,2.4826202865903553
NCI-H2452,6918837,-2.3246752526945413,-2.193709292318668
HuP-T3,409805,5.703463345532586,4.965719459537249
Daudi,UNC0638-navitoclax (1-1 mol-mol),1.2047563677281543,0.147133249942151
WM115,3025944,4.015069634557516,4.186435566512103
BICR 22,10127622,2.812639951672956,3.1146019318625067
RCC10RGB,16741245,4.755009504271123,3.8478396884581736
MOLM-13,selumetinib-JQ-1 (4-1 mol-mol),-6.008931443997215,-0.7709249242064871
BFTC-909,1641662,3.805506520632872,3.6560402099607527
SK-HEP-1,3136844,5.506062707172487,4.483646700514334
MOLM-13,5335621,3.915836728943439,3.9253215333118754
ALL-SIL,6918736,-2.784980550106597,-2.1799986638266033
NCI-H2452,selumetinib-navitoclax (8-1 mol-mol),2.20402438215903,2.207168877260395
SK-OV-3,5311,1.582209129738937,1.6183778726964335
NCI-H1568,4378219,1.8995328874154,2.939248129305381
PaTu 8988t,135440466,2.5529183901912456,2.4040667408395255
P31/FUJ,208908,3.0114989034455415,1.9034496417147748
MOLM-13,55508,1.530825081139479,2.593273390380458
ALL-SIL,15983966,-4.919474478826657,-4.237304734464534
ALL-SIL,72193861,-0.8088702984298154,-0.03362621432016499
Granta-519,135875424,2.983761714085865,3.1578281758418245
Panc 02.03,25062766,3.7424097220448207,2.250012219703667
LS411N,5282054,4.11513360382112,2.8611949329917286
WM115,9956119,3.8110537513046423,3.5852025292439293
Daudi,10077130,1.7104594990439606,2.063239866130256
PaTu 8902,54618771,-1.3103145579416535,1.3002666177616664
LS411N,6610355,5.174673905344729,4.235829851607266
HARA [Human squamous cell lung carcinoma],446155,2.5576922800664006,2.850392582542229
Daudi,11364421,-5.814557541528941,-4.618714025923582
SW48,10090485,5.377611493091081,4.176090017192076
RERF-LC-MS,252682,6.464777279315186,6.450786701325676
RERF-LC-MS,25195348,2.310586589861769,3.452340959162594
LS411N,57330099,4.386912904802011,3.737446222518597
RERF-LC-MS,5351362,3.2669953777859493,1.6087691141452343
SaOS-2,5281321,-2.1045144226453134,-1.1549816648710944
SW948,navitoclax-gemcitabine (1-1 mol-mol),0.2837649103664914,-0.9390991171718334
HCC1500,15953870,3.698430879415157,3.474013617195024
BICR 31,107985,-2.559614665868775,-3.2674785596919533
SU-DHL-1,5978,-4.006589870739168,-2.988521393020098
SK-HEP-1,387447,-3.995016034956776,-3.7732704293724355
HARA [Human squamous cell lung carcinoma],11609586,3.326388879496588,3.012774571588817
BICR 22,44491742,3.912327775797625,4.218817934062637
NCI-H2452,10113978,2.1292579793865167,3.5527702823272453
SW1271,selumetinib-MK-2206 (8-1 mol-mol),0.1264422257766406,2.3924258775164935
HCC1500,JQ-1-vorinostat (2-1 mol-mol),1.1801971963023554,0.9232172183686369
MDST8,JQ-1-vorinostat (2-1 mol-mol),0.5745237647612197,1.1437848871642857
PaTu 8988t,10074640,3.912219918984309,3.2104737580001923
RKO,25102847,3.0524897378806033,2.2178261312024365
K-562,446155,2.553560117982406,2.587266185501557
HuP-T3,3062316,-3.5835263694309862,0.916030208487623
BICR 31,selumetinib-piperlongumine (8-1 mol-mol),5.193629730371027,3.6289423570549393
HCC15,selumetinib-MK-2206 (8-1 mol-mol),0.2516850341197869,2.095198717722143
COR-L105,9915743,-1.8659407955600968,1.1945777475776622
SU-DHL-1,676352,1.6127382742380425,1.7373230957263024
SK-CO-1,15983966,-2.8914318783251733,0.06964637568608449
BFTC-909,6450551,3.0302116860685886,2.9773752696884417
HEL,salermide-PLX-4032 (12-1 mol-mol),3.70170985200322,4.492905930650768
LCLC-97TM1,6852167,1.822160840349085,2.702662550511821
K-562,1716436,3.607306146681396,2.6324279349527706
ALL-SIL,6917907,-6.413711962559719,-5.498991116391514
SW48,44505237,4.455085659285412,3.0117654890433467
MOLP-8,4788,5.509648062033256,5.177248870678437
KU-19-19,49793307,-2.3409308252506777,-2.286958161663118
IGROV-1,46843906,3.392503571349757,2.9499594766180235
LS411N,selumetinib-navitoclax (8-1 mol-mol),0.3933540744124401,1.6765148532487633
NCI-H1568,23582824,0.2708211860244319,0.877975334439807
P31/FUJ,156414,0.8249508749632878,0.6808076293955202
HCC1500,vorinostat-carboplatin (1-1 mol-mol),3.9041081325977616,2.9799870149503658
Panc 02.03,24951314,2.3006835537528585,1.6413298758754544
RERF-LC-MS,46199207,3.61094494328213,3.3857794731499244
MOLM-13,docetaxel-tanespimycin (2-1 mol-mol),-6.839014739935568,-4.5915099092992655
IGROV-1,25102847,1.7007012555618253,2.672822091147125
COR-L95,9884685,1.274087436172542,0.37007665779806587
RKO,5738263,3.4166283525852523,2.602702923149638
BICR 31,446155,3.004688823756655,3.0163283167222312
MOLP-8,3081361,3.002632255231731,1.9200789286140472
KU-19-19,124202324,2.2262797687523266,2.552477021573102
COR-L95,241158,4.468160037389037,3.502324490942955
PaTu 8902,selumetinib-UNC0638 (4-1 mol-mol),4.723826632745484,2.966075697427994
SK-OV-3,9926054,2.1800400954819716,1.9893100705389657
NCI-H2452,285033,-1.1649166052412432,-1.81334204659469
MDST8,SNX-2112-bortezomib (250-1 mol-mol),-1.5360671270430672,-1.0193317701159714
SaOS-2,3136844,3.967600163436525,4.625449237430365
Granta-519,36462,-1.2340392932323463,-0.24263226158666218
Granta-519,24785538,0.1958729752370936,0.06539334398028093
WM115,5566,2.8846390038255127,2.730283540512243
IGROV-1,31703,-1.792518264692263,-0.8190036919556748
HCC1500,3025986,-0.5847488606379614,-1.0236834260812495
K-562,2828334,5.968313970587813,5.758088660825491
HCC15,navitoclax-gemcitabine (1-1 mol-mol),-0.4507382221714274,-0.7766704071536068
LS411N,72193861,2.8187845663214848,0.5093934189318253
SU-DHL-6,11964036,-0.1529025297927845,0.5201658393516622
LS180,6918837,-2.789669873343886,-3.0753358275957106
Granta-519,445455,5.050402748491994,3.921179300889175
LS411N,9926054,1.9376785020428349,1.8418173616615194
MOLM-13,135398738,2.371405234005272,1.7373738648106607
BICR 22,53392493,3.288173891171126,2.6227572518462012
SU-DHL-1,crizotinib-PLX-4032 (2-1 mol-mol),-1.5954357785960134,1.2811974640707013
HARA [Human squamous cell lung carcinoma],2126,5.112984415511083,4.656045318641174
MOLP-8,9823820,3.862667538801475,2.948559639142174
SW948,219104,3.4463785749905886,3.042397052368991
Daudi,56649450,2.7731175257265757,2.67999595378055
RKO,446155,4.170579555483674,2.3338911185099986
COR-L95,2708,4.088828930735336,4.2657796451326435
HARA [Human squamous cell lung carcinoma],11427553,0.5044011516017802,3.0266125962002395
SW948,6610216,4.184431800680971,3.9394217360963437
SU-DHL-1,vorinostat-navitoclax (4-1 mol-mol),1.2163104495485748,0.7163875735509577
MDST8,24978538,-1.5034064763640302,1.0866323786839318
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508,-0.5131482306282918
Granta-519,vorinostat-navitoclax (4-1 mol-mol),-1.0034104350750142,-0.7949439841318015
RERF-LC-MS,44607531,1.5104561529736475,1.6008754439938493
MDST8,16065773,2.461320056751215,2.3833019246613834
Daudi,11955716,-2.451420398730992,-2.1951611696879607
Daudi,44566777,-1.3909109996970672,-0.1464612928835709
WM115,53495165,2.3633352174150155,1.0043164886809963
MOLM-13,10077130,2.656845569256352,2.47670567193172
LCLC-97TM1,11364421,-5.841421445385269,-2.0108260930857
MOLM-13,9887053,0.5396890830211841,2.42532559260915
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191,1.9829276011296735
IGROV-1,46191454,1.3777495915525844,1.8059670541081718
Granta-519,5328940,0.7430401080732436,0.7618412561873575
SW1271,54618305,4.440463475812739,4.509578004908641
COR-L95,23725625,3.551891881441416,4.23179534698539
RCC10RGB,46843906,4.246883034106686,3.407810928497041
Granta-519,2945648,2.528276278220214,2.1484861655258656
Granta-519,11977753,-6.302388202708452,-2.134669850922403
SU-DHL-6,15953870,2.4587311871536315,2.9615645220999456
MOLM-13,10322450,2.9930800125873045,3.154326556809109
LCLC-97TM1,6505803,0.2281876141434561,-0.9459134898810144
WM115,9967941,2.88500943866673,3.8074074707393373
K-562,44202524,1.302888790519651,1.5785593920064664
K-562,252682,6.220409267483573,6.4805935442735505
HCC15,49867926,4.259454552862098,4.406939768479062
BICR 22,25183872,-0.1596442578279089,-0.5061992010406878
RKO,17755052,3.988455753476612,1.7027800035089293
IA-LM,selumetinib-piperlongumine (8-1 mol-mol),4.519292467442182,2.876774361270157
PaTu 8988t,5566,2.9380975134161553,3.058186313818467
K-562,219104,3.3686951285077273,2.7396752877989097
UACC-812,BRD-A02303741-carboplatin (1-1 mol-mol),6.034191295751065,3.46390542365696
WM115,100016,7.477930972064711,6.259593396003501
BICR 22,serdemetan-SCH-529074 (1-1 mol-mol),1.6325628481893268,1.797866297992106
SU-DHL-6,46191454,-0.3846699961999978,0.032179926518210625
LS180,124202324,2.088899784140079,2.264699399993942
KU-19-19,navitoclax-MST-312 (1-1 mol-mol),0.8014531944430209,0.8901683151578261
K-562,4261,1.1039684536741017,0.8197112551724963
NCI-H2452,5282054,2.993265650723398,3.9144258865708723
MOLP-8,168312962,1.5743557083321402,0.7287600829461708
Granta-519,969516,1.9567849087702365,2.130805594028505
NCI-H1568,25062766,1.9660972036535989,2.185824876887568
MOLM-13,448949,-0.3738099635599754,1.236707079309735
SW48,11647372,-0.0986138935854908,0.9321417058711379
MOLP-8,selumetinib-piperlongumine (8-1 mol-mol),0.460809914604767,1.986578249120093
SW1573,selumetinib-vorinostat (8-1 mol-mol),4.856763743237327,2.5662453045167983
RERF-LC-MS,11977753,-0.575574044510787,-1.1981238094658202
LS180,49793307,-3.6014942577594415,-3.0009320562450137
SW948,3854666,3.050289300885683,1.7470694068353592
HARA [Human squamous cell lung carcinoma],4917,3.022180747101803,3.0893924780631856
SW1271,navitoclax-PLX-4032 (1-1 mol-mol),5.386120495356167,2.238432569452375
WM115,5278396,3.4301399168519153,3.723056552990423
HCC1500,JQ-1-carboplatin (1-1 mol-mol),3.891416287519206,2.170337769633381
HCC1500,11485656,2.6610961572019103,2.337137734143107
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992,-0.05974576133123262
Daudi,2945648,2.1407869976239087,2.241881835539077
MOLM-13,3689413,-2.8005667715254017,-1.5529086890952866
RKN,3543504,4.234888347098623,4.3680107810829405
IGROV-1,24964624,0.5052308994941754,2.283020793972891
PaTu 8988t,676352,1.787056590779638,2.234494447349844
RERF-LC-MS,10385095,0.7812016081678173,1.4482052653118294
WM115,4259181,1.0090630393378868,0.41240710416793097
MOLP-8,navitoclax-gemcitabine (1-1 mol-mol),-4.985488409488958,-1.7758736022284176
SaOS-2,1239801,5.3522865443092575,4.301610148972687
Granta-519,44137675,2.975150065736677,3.0406134968281884
Daudi,11455910,-1.173613913103254,0.5361766058407291
UACC-812,11152667,2.562952126743398,0.5064638082826142
SaOS-2,16219061,3.147835700454569,3.44394095457473
P31/FUJ,erlotinib-PLX-4032 (2-1 mol-mol),2.316286260335057,2.5856420462216523
SaOS-2,71304818,3.198114510015862,2.7017277795051613
IGROV-1,57330099,4.391385744785918,4.030676549023622
LCLC-97TM1,2729026,2.4668071198749555,2.768966465531317
HCC1500,5281672,4.190998095776345,4.4631677751956484
NCI-H1568,9884685,-0.6579514975056241,0.7007552499836538
ML-1 [Human thyroid carcinoma],53392493,2.260380394132801,2.925564457092065
LS411N,107985,-2.091782559178726,-3.4315775485791367
COR-L95,42642645,0.7279572059378924,0.5015580392667345
LS180,5566,2.7460265721966897,2.809596547556574
COR-L95,104842,-6.859012992539376,-3.360374438773375
K-562,702558,5.364922414830515,4.096485938675979
NCI-H2452,vorinostat-navitoclax (4-1 mol-mol),0.733087868835974,1.5257002506752864
LCLC-97TM1,9929138,5.774162864206733,5.69031021916741
LS411N,31703,0.7183186901084707,-0.8099447032477388
WM115,23725625,4.964211357698685,5.121269199761973
HEL,piperlongumine-MST-312 (1-1 mol-mol),1.46077164854103,1.2114150143376163
SaOS-2,24978538,2.44958290959275,1.3589634242619213
HCC15,UNC0638-navitoclax (1-1 mol-mol),-0.269925552433359,1.9508591924802756
PaTu 8902,2858523,3.3217981805434196,2.920091568134564
HARA [Human squamous cell lung carcinoma],135398516,1.8495805389969304,2.31908320055868
SW48,65628,3.988389614478155,4.364790380299138
Granta-519,9903786,1.2937892753152922,1.839998660259246
IGROV-1,71304818,2.4878074097553378,2.5117204965560673
COR-L95,25105715,3.673741872436949,3.2179247104870523
HuP-T3,6918837,-1.8626358392084263,-2.4834906148673084
PaTu 8988t,72376,-1.956580109455481,-1.773595633418109
NCI-H2452,46907787,3.091101876271566,2.5821370914713566
SW948,23725625,5.544404993552476,3.9880659688365303
K-562,25062766,2.5223735702376753,1.837262802318508
SaOS-2,753704,5.53840358060444,4.801934728257729
NCI-H2452,56973724,2.8465784993073564,3.3091509096421685
Granta-519,71466578,4.383489061930637,2.6357682174858157
SW948,11609586,2.9863433458317714,2.237054058706598
HEL,71466445,1.5745300131733593,2.3406423095409803
Daudi,5329102,1.2784768117884069,1.3414036316519051
HCC15,409805,6.461768980239098,4.972947715600306
Daudi,2871966,-2.2343916463272873,-0.4877675426271289
HCC15,selumetinib-piperlongumine (8-1 mol-mol),4.822467978355287,2.8984820237132243
RERF-LC-MS,135421197,1.554065103888189,2.0285950793385497
SW1271,selumetinib-tretinoin (2-1 mol-mol),2.7817516989696855,3.3883090815956813
RKN,serdemetan-SCH-529074 (1-1 mol-mol),2.47980812948558,2.181582338643506
PaTu 8988t,25150857,2.5954794764360343,2.5515014537019614
P31/FUJ,11152667,-2.5755274762926095,-2.123193710095157
BFTC-909,ISOX-bortezomib (250-1 mol-mol),1.0929987126714282,0.554124895001645
BICR 31,2828334,6.263113325647995,6.172624519056999
MDST8,selumetinib-GDC-0941 (4-1 mol-mol),0.8218915121525238,1.7627014341898886
IGROV-1,11507802,1.5049911819213722,1.7036640170659783
Daudi,11485656,1.7254760898020216,1.6217147363165136
Granta-519,11152667,-3.975154363660797,-2.0095001914731236
SW48,11640390,-0.422464249163724,3.614310114519484
IA-LM,2828334,6.3387056990337705,5.726052258182347
HEL,36462,0.8349109175120154,0.06854750754662751
LS411N,4477,1.0450277541726452,0.7369643367521495
NCI-H2452,16219061,3.733701707144141,3.6579674874451498
RKO,16741245,1.399079485469943,3.66903766503564
NCI-H1568,445455,4.330931204553833,4.892475101714444
K-562,15983966,-4.450185495623787,-3.4366775729481756
HCC1500,4096211,2.7054358198440345,2.2620915360423264
SU-DHL-1,46191454,-0.3713761809994262,1.2343087661126964
IGROV-1,387447,-3.9508602289798658,-4.142152440505946
NCI-H1568,71751553,3.6437596116554887,4.6236189130295635
HARA [Human squamous cell lung carcinoma],selumetinib-vorinostat (8-1 mol-mol),4.369788913914824,2.3708522864918287
WM115,46199207,3.650123600055899,3.334363807084563
SaOS-2,71680916,4.865393442781168,4.867528731786497
COR-L95,9823820,4.611798945344124,3.4952945569453004
HuP-T3,44589607,2.433680498088492,2.808238265479301
SK-HEP-1,vorinostat-navitoclax (4-1 mol-mol),1.9601053638256545,1.4037901204883476
IGROV-1,3634881,2.769147818550815,3.2454497017594157
COR-L105,54626689,5.0742986339862926,4.681179740566033
HEL,176870,2.3693727744318887,2.094632294192943
LCLC-97TM1,9549297,2.332709006301325,2.4940727197005317
COR-L105,24180125,3.5925931777332676,3.08213739358775
MOLP-8,89928392,0.1045876418070581,0.43645926270588764
BICR 22,3025986,-2.8899356497226756,-0.7582203928550855
ALL-SIL,400769,-0.758162988868875,-1.439722762490101
BFTC-909,71466380,5.267829049221599,4.608302019460736
MOLM-13,24951314,-0.2336633009541456,0.28431453650906957
MOLP-8,3038522,2.029025514425164,2.644832426311105
RKN,16741245,1.555254881894904,3.751974916337452
COR-L105,71751553,4.255827287979035,4.535231225556035
MOLP-8,60750,-8.573260651984995,-2.8662980456953897
HCC15,navitoclax-birinapant (1-1 mol-mol),-0.4439511388855052,1.6217956849041066
BICR 22,24772860,-1.3590035600374548,-1.337772885135735
LCLC-97TM1,5470400,0.2889153362640624,-0.6206384659697557
BICR 31,53232,3.653430995715962,2.764960428092584
BICR 31,8515,4.104799625743522,4.305467208064427
COR-L105,10127622,2.236200578684094,3.7213990722744437
NCI-H1568,5328940,0.3466597705312412,1.736584133609929
MOLP-8,135421197,1.7506124789909805,1.3119018266887301
SW1573,54454,1.176648172779268,2.7788952232269755
NCI-H2452,11964036,2.1879069513719087,1.7730373092712333
MOLM-13,44493528,3.9608078939228175,4.20215072656839
SK-HEP-1,11396600,5.84824704867975,3.856983837563835
WM115,46215462,1.6800224060395437,1.9866107171720926
Granta-519,23939,5.101725753715152,3.6626294970891116
BICR 22,46907787,3.4905986586009843,2.2162297562200943
HEL,10184653,1.0835446596032057,0.47269528726178633
LS411N,9903786,3.6806866285220017,2.4721489216068706
SW48,9840324,6.311735261945371,5.758288209640828
HCC15,24753719,5.171121417544096,4.32354434569088
SW948,11507802,1.163064588903486,1.2694583939392874
COR-L105,2733487,7.427108299628283,5.906232629988434
SaOS-2,439501,-2.8243657156627724,-2.3551332200209902
UACC-812,5287969,-2.4803922230812527,-1.4856517449241438
Granta-519,66577038,2.6663435544296346,2.6424334482312215
RERF-LC-MS,6918837,-3.051376318733669,-2.475117780191068
NCI-H1568,11152667,-1.392140833696634,0.03623454386386828
KU-19-19,49850262,4.263742487880845,3.822083760640359
BICR 31,selumetinib-navitoclax (8-1 mol-mol),2.9853512378124023,2.029506780720817
SaOS-2,156414,1.509432711545826,1.4822413903703033
KU-19-19,navitoclax-gemcitabine (1-1 mol-mol),-0.4466146105667509,-1.300145493115315
Granta-519,216468,0.2159572219264565,0.9290405009496712
P31/FUJ,3136844,4.357504973194935,3.5668501824507564
MOLP-8,6918638,-1.572747132532541,-0.7143622456970418
LS411N,445643,4.311506480272609,3.924365231222873
MOLM-13,25126798,1.909946064109967,3.361506211891536
BICR 22,9927531,5.395078942533075,4.582973870312404
SU-DHL-6,3385,2.96945431954736,2.6623354187393464
SW948,49766530,-0.6875988061214425,-1.4218932827964286
MOLP-8,5287620,-5.023262566828496,-2.14901600006189
SW48,selumetinib-JQ-1 (4-1 mol-mol),-4.010422232345994,1.5040967164955412
SW1271,5746,1.8306286254207629,1.1339700097720142
SU-DHL-1,4788,5.095368657375766,5.171060879454911
UACC-812,44607531,-0.3950460021726514,1.1858620300384224
SK-CO-1,10074640,3.0297361304753143,3.2047449565585335
IGROV-1,65064,4.920352624378345,4.841164369053413
P31/FUJ,9444,3.558733501871851,3.621824533939959
MOLP-8,16722836,0.6223558214261112,0.936768767482211
LCLC-97TM1,11647372,-0.3650454903758569,1.069755523510689
COR-L95,9911463,4.18924595414168,3.457541190707695
MOLM-13,3634881,2.324290549736021,2.6652988589345927
IGROV-1,1242560,3.902441161940491,3.735910289756535
LS411N,702558,5.325144902608101,4.0304457114301435
MOLM-13,969516,1.839627080728713,2.1052703542414446
IGROV-1,50905018,6.092412272559071,4.325845249049362
SaOS-2,5311,1.6246857228566176,1.5316681941415755
ML-1 [Human thyroid carcinoma],5287620,-1.9113881956575816,-1.8352513520095732
BICR 31,11178236,-3.7191700347439176,-2.894896429087672
IGROV-1,16736978,0.1982875499977011,1.6092112192968986
HEL,54613361,-1.063581606127445,-0.7987066994608935
LS411N,409805,5.900990799691521,4.145433847202011
RKN,44819697,0.8547407464301948,-0.32004472582875887
SaOS-2,7326481,3.920515261577408,3.1596576058566876
HCC15,135411,0.5020362424433897,0.7574686214260944
SW1271,135875424,3.8663800475620542,3.910860029106228
SW948,5281321,-2.986965028390854,-1.869960961938461
ML-1 [Human thyroid carcinoma],52947716,-0.2471601623530622,1.4561910000472862
ALL-SIL,16722836,0.4684239096852854,0.6554360887205567
BICR 22,3384730,2.588423009806214,3.1288289542295713
SU-DHL-1,5282054,2.781862093779865,3.5749406021078936
COR-L105,10385095,2.1444085139831643,1.504477225189953
Panc 02.03,409805,5.9877775932277615,4.827173947115902
RERF-LC-MS,11707110,3.327368501952155,1.0655914268772806
Daudi,46199207,1.9328464692742409,2.7497646700785423
SK-HEP-1,9907093,4.5474965014619455,4.291347069917509
NCI-H2452,6918736,-2.096990091914002,-1.6274953224260131
SW948,25062766,2.473025838261029,2.119412074115092
SW1573,73707398,2.4757839790774123,1.4934346876815294
WM115,19582717,5.070140237856123,4.038164656879309
LCLC-97TM1,9926054,1.7367616025320842,2.0926498519007626
Granta-519,46907787,0.1510211143130647,-0.45824717703467605
HCC1500,JQ-1-MK-0752 (1-1 mol-mol),3.680434993229653,1.5328769626833856
Daudi,9866186,0.2429325896096028,0.17856880175404208
HCC15,19582717,3.4575202036464665,4.284510666453432
BICR 22,3136844,4.306912771504561,4.267752182415792
PaTu 8988t,15983966,3.5024124287376477,-1.3837803735704464
WM115,24964624,1.5810045411950775,2.4099138172313137
Daudi,5335621,3.7832010435602568,4.025379437266299
KU-19-19,selumetinib-PLX-4032 (8-1 mol-mol),2.356754737959246,3.1699084188010245
HCC1500,67156097,1.177976655162538,-0.2931984393513949
LS180,6918878,3.4964027843545775,2.782169821689851
MOLP-8,4096211,1.580191863417666,1.0811887537965192
P31/FUJ,6252,0.489412050489878,-2.0606993457057863
RERF-LC-MS,6505803,-0.6931241555509828,-0.28827091996686055
IGROV-1,24821094,1.720998716331183,3.094545867208243
BICR 31,5311,2.2783252682939876,1.7423960805069416
K-562,6438330,2.2742899368871123,1.6639203712859263
HCC15,71466578,3.4480874510133708,4.5842345523064605
RKO,5566,3.2270609816668308,2.8539080043075034
MOLM-13,BRD-A02303741-navitoclax (2-1 mol-mol),-0.0183785057987459,1.2093654030768173
Panc 02.03,24785538,2.724480470289088,1.6286556172011597
Granta-519,3025986,-4.58955813375105,-1.4665636498920986
BICR 22,6918837,-3.531862368916405,-2.1615941704466897
MDST8,25262965,-2.668035259531665,-0.9726284885340892
IA-LM,5329102,2.7310604185474654,1.7481279834267849
SK-HEP-1,3385,5.476337571299632,4.450720973006803
LS180,16722836,2.063998190370722,1.4981844870954566
HuP-T3,tanespimycin-gemcitabine (1-1 mol-mol),2.6296169541858694,-0.8053432133910263
LS180,2749,2.025296960861402,1.852662475106056
WM115,25262965,-0.2525217612691299,-1.3189026086732523
PaTu 8988t,5287620,-2.232870102756846,-2.0037928496044133
BICR 22,1641662,3.554805763515046,3.730575866527392
HEL,11152667,-1.5416892011653274,-1.5964744077477726
COR-L105,doxorubicin-navitoclax (2-1 mol-mol),-0.4088475134066937,-0.7570675438538168
ML-1 [Human thyroid carcinoma],219104,3.7281299088831386,4.142737742501299
Granta-519,9907093,4.568904425758597,3.3774458726209304
HuP-T3,56946209,-4.563482636842077,-4.050448271644
COR-L95,2126,5.99033959567007,4.02282473480676
WM115,216239,1.6966934324307903,2.58928439991732
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837,3.1009073580169737
BICR 31,6918837,-2.993188010662521,-2.3111348416450084
WM115,3676137,5.1484929308777225,4.640733524135035
COR-L105,5113032,4.587192003158758,5.059830188597988
NCI-H2452,23635314,-2.1133256000938596,-1.6468556648861294
RKN,9887053,4.324470541002337,4.130117366219888
RCC10RGB,11427553,3.4421917630858387,3.0560399400092275
SK-HEP-1,3025944,4.243935374614092,4.2159473617358785
HEL,613753,3.431831043675297,2.8315627506033882
LS180,navitoclax-birinapant (1-1 mol-mol),0.3756173230443141,1.8311702456822134
ML-1 [Human thyroid carcinoma],135411,-0.343606028350642,1.0381645974076856
WM115,6450551,3.3231751041078086,2.997102186937737
LS180,11178236,-2.7486494175863703,-2.9664374232644963
SU-DHL-1,53232,0.8595699071174782,2.485651283364555
LCLC-97TM1,2742550,3.525188493197443,3.5941451748411115
Daudi,1716436,1.8661291896859675,2.498407095630352
SK-OV-3,11964036,1.753508425012185,1.5458663449705443
LS411N,10385095,1.4098978051841675,1.3072598868003127
P31/FUJ,54613361,-1.6350280742113157,-0.8405499812176379
SU-DHL-1,638278,2.888532213305057,3.087179410740947
SW48,11228183,0.7765992306729816,2.3715351616278717
Daudi,54596558,3.73872893191344,4.056788130291549
IGROV-1,44543605,3.88270235241076,3.8721360436808077
SK-OV-3,16722836,0.9083609759186712,1.7220084829866489
HARA [Human squamous cell lung carcinoma],tretinoin-navitoclax (4-1 mol-mol),0.6020182307201102,3.1647819918540563
P31/FUJ,168313047,1.7496121138347704,2.1118885857848118
RCC10RGB,969516,5.025939213907113,3.1167078361698968
COR-L95,tanespimycin-gemcitabine (1-1 mol-mol),-2.183473735098961,-1.2172754615738237
Daudi,selumetinib-MK-2206 (8-1 mol-mol),2.382051987434729,1.7852635811805257
HCC1500,crizotinib-PLX-4032 (2-1 mol-mol),2.666541156679824,2.12614866737729
LS180,11507802,1.428529607587261,1.677351110435827
SW1271,2746,3.8382249001906814,3.3834564453184686
RERF-LC-MS,navitoclax-pluripotin (1-1 mol-mol),0.4193939180883417,-0.7156657551625827
SW48,6918328,-0.3603149144304291,0.17616959889552283
RKN,11214940,-1.342915177510304,1.6920559997852271
NCI-H1568,24180719,2.911739165396745,3.5729675321560355
BICR 22,selumetinib-JQ-1 (4-1 mol-mol),1.538481754600391,1.5251975062690866
K-562,11234052,2.2960989815513013,3.0915468357474505
SU-DHL-1,107970,1.234326472603969,2.037248992433137
RERF-LC-MS,5280436,-0.2566098032119844,3.756313323217077
HARA [Human squamous cell lung carcinoma],10074640,3.2082861236873814,3.2760002916857927
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482,1.8032383466333102
WM115,6184667,1.9705044508079528,3.144196002816013
P31/FUJ,26596,-2.2448149587984836,-2.3140240771981224
RCC10RGB,216345,4.504390062805713,3.7607779665767005
WM115,3634881,2.5774509186458183,2.817108264393302
COR-L105,5328940,1.3778120925573558,1.8775733037519082
NCI-H2452,135440466,3.051805385291023,2.4521877801670513
P31/FUJ,51039095,1.7212337572708742,2.1578620661927355
Daudi,135398738,3.444692827115736,2.1051891998111563
MDST8,753704,4.923832713886697,5.030791102306775
Granta-519,23725625,1.8582588361990624,3.308394331197404
IGROV-1,6438330,2.7487580937365683,2.3349405757638646
BFTC-909,51037431,4.63288955594681,3.2954596215533054
LS411N,262093,3.2594677855419456,2.3474192298840264
Daudi,12001922,0.8334324910861088,1.5499429666447826
LS411N,10074640,3.3220574057236876,3.1686094261244455
COR-L105,6438330,3.2365890454650867,2.488206412302591
LS180,3689413,1.3392854552239355,0.43198801040063806
IGROV-1,53495165,1.3981720287668329,0.7395224239416884
RKO,10296883,4.075814636405189,3.4068176039902425
MOLP-8,24951314,0.5243645664323562,0.03242648812422535
IGROV-1,25126798,3.9275606774720817,3.884923200959396
BFTC-909,5281321,-1.6266730162675118,-1.2415396462493204
MOLP-8,123631,3.0356710048833446,2.0011923658565167
LCLC-97TM1,selumetinib-MK-2206 (8-1 mol-mol),2.0492378318223508,2.114210259760499
PaTu 8988t,72193861,1.5880501840541692,1.9506740695584588
COR-L105,JQ-1-MK-0752 (1-1 mol-mol),0.9583306241234884,2.1655503637616205
MOLP-8,2742550,3.824247044326815,3.4445229215847557
BICR 31,10074640,3.67367044204876,3.2183649515015147
UACC-812,1750826,-1.5614417963348088,-1.3153302338714112
LS180,9907093,4.718701288752834,4.238514656088295
BICR 22,25062766,1.615874512669176,2.353488332031786
NCI-H2452,6852167,1.5258165813873172,2.9600268205825944
ML-1 [Human thyroid carcinoma],5328940,1.048806619411155,1.7913785766087686
PaTu 8988t,52912189,2.515835026596807,2.5670578478405717
KU-19-19,9935249,4.318045076797651,3.378757288711277
KU-19-19,57330099,3.159149106170822,4.259560133458485
SK-OV-3,17755052,2.097752569372091,2.1294455446575125
SK-OV-3,73707386,3.7899266428434233,2.1688038886824352
HEL,navitoclax-PLX-4032 (1-1 mol-mol),-1.2293549578890797,-0.029958846253720334
SK-HEP-1,216239,1.5998975447874937,2.3335996203370364
ML-1 [Human thyroid carcinoma],387447,-2.817858817217488,-3.604730270944436
RKO,3689413,3.093382349703003,-1.197439819106197
HARA [Human squamous cell lung carcinoma],11647372,1.8404588933860024,1.3516388837726934
K-562,44819697,-0.9868024060185686,-0.9047841754520561
LS411N,322968,4.732979049951269,2.6563664465001557
RCC10RGB,3689413,-2.0864832427963336,0.05183172037055127
MOLM-13,BRD-A02303741-carboplatin (1-1 mol-mol),3.787495781999856,3.446763472648359
COR-L105,409805,5.8843358134901775,4.985614666964113
ALL-SIL,11404337,-1.8413362349398936,-1.3739107895185378
Granta-519,135398738,2.4818536310203587,2.1774745118966847
IGROV-1,10385095,1.0670946713416192,1.3092806502326177
KU-19-19,5311,0.9327005340349652,1.6201699118939326
MOLP-8,6438330,1.5207659246126146,1.1480081931373365
SW948,5351362,1.282672018702937,1.4672298468797893
HuP-T3,54626689,4.821166418142214,4.685257528405102
HuP-T3,16013152,4.473149012747972,4.163950223803161
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054,0.9516770594459101
RKN,67156097,-0.5718675734992968,-0.5889704294192813
IA-LM,241158,3.7495123409873528,3.353191308064781
LCLC-97TM1,644241,3.02487415997038,1.9387051319542778
NCI-H2452,9823820,3.552631474664052,4.240204650130979
BFTC-909,2749,2.0212973698927184,2.133346423703136
Daudi,9956119,3.1347708383856827,2.566093747710008
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047,0.3762911836559883
ALL-SIL,136227924,2.439460537978413,2.069217688336839
HEL,44507138,3.4784823626806296,1.8869830499899378
Panc 02.03,3634881,5.203302993958793,3.421418824366407
HCC15,3038522,3.407637609998807,3.172462601432302
RERF-LC-MS,JQ-1-vorinostat (2-1 mol-mol),1.4753675236489834,1.409751734766833
SU-DHL-1,5311,0.6388765020007606,1.238142210844267
RKN,16038120,2.2721636156695357,1.002410504719055
Daudi,6917907,-7.619939635694887,-5.7476564685001
MOLP-8,3385,2.1758430637220334,2.902912840676313
COR-L95,2749,1.0184502693195283,1.5050367787056902
BICR 22,56946209,-6.158851096198738,-3.6655914687945
SU-DHL-6,72193861,0.720057034069739,0.24792649154606636
RCC10RGB,122327,5.581829763733156,5.010421286439813
Daudi,5284329,2.65655795986699,2.3203526036147837
WM115,72376,-0.2019485443349478,-1.8140079436452323
HCC1500,4378219,1.8377088226049565,2.13332484093875
SK-CO-1,246676,3.87632071272349,4.239408121676667
SK-HEP-1,docetaxel-tanespimycin (2-1 mol-mol),1.7150600920964667,-3.0875216544118875
IGROV-1,57519531,2.639098862164858,2.4710801258699124
P31/FUJ,serdemetan-SCH-529074 (1-1 mol-mol),2.3029277371957884,1.3810540319115399
MOLM-13,1714884,4.557672503718371,2.372247012954119
MOLM-13,JQ-1-vorinostat (2-1 mol-mol),-0.8524574918693427,-0.7207561500231153
Granta-519,72193861,-0.9369484536210768,0.04326378472274098
RKO,5311,2.326095881991792,0.7806949651312959
SK-HEP-1,4521392,4.36382839215776,4.410592918149145
COR-L105,3062316,-0.8702764318143076,1.2806811381997474
COR-L95,387447,-4.370301659619954,-4.281917764346157
COR-L105,10231331,1.4114577114599935,1.9307705970152313
SK-CO-1,637858,1.8597515079418403,2.101344905625761
SW1573,5282054,2.2636648441362417,3.8015887983158523
K-562,66577038,2.461713560075674,2.7806465951454853
Panc 02.03,984333,0.8671961837803726,0.8919426325979191
HCC1500,9967941,2.192170342398577,3.362820493811489
NCI-H1568,5281672,4.0091617833462125,4.55824230862778
K-562,11640390,3.4084234644631244,2.705393899192966
SW1271,60750,-2.442139934484719,-1.7403990163426417
HARA [Human squamous cell lung carcinoma],5280436,4.238746998760762,3.6574631976256784
MOLM-13,24889392,-6.717782140097413,3.6478768249401914
Granta-519,11364421,-8.40665244505035,-3.9630931385591475
LCLC-97TM1,11612883,2.215690343731866,2.569929846905066
ALL-SIL,serdemetan-SCH-529074 (1-1 mol-mol),2.0214253699045392,1.2771395725250927
PaTu 8902,1566236,3.6887913704860535,2.3727005064297266
MOLM-13,16741245,4.189200129622084,3.5537673524907216
SW48,6184667,4.015043076320991,3.043658166902581
RERF-LC-MS,66577038,3.051572744120707,3.056829188165446
K-562,71304818,1.450074212827562,2.0546661030922317
RCC10RGB,44489675,4.041451654117508,4.2833265855381155
LS411N,navitoclax-birinapant (1-1 mol-mol),3.012697957688565,1.2195797342519317
SW1271,10074640,2.938380325815859,3.221693467762808
RERF-LC-MS,11626560,1.1998891680987491,1.9541289989945907
PaTu 8988t,81146,4.470184859000855,4.5085373002927485
HCC15,11178236,-3.9629964965138584,-3.0484182231677504
SW48,navitoclax-pluripotin (1-1 mol-mol),-1.096538281516441,-0.8877461344478861
HCC15,11317348,1.1767586352696475,3.5822914581286027
P31/FUJ,9903786,1.0734919883099745,2.0824647817956388
IGROV-1,23582824,0.3287266354391525,0.8791630180551576
Granta-519,3465537,1.1430845598370274,2.0533571137850597
PaTu 8988t,984333,0.9294993195358888,0.8148249060757701
HCC1500,11396600,2.707080690171913,3.891545143725927
NCI-H1568,6252,-1.964470857288188,0.9592421995667874
NCI-H1568,7251185,1.379011815458227,2.6377169639859166
BFTC-909,UNC0638-navitoclax (1-1 mol-mol),2.418146384904106,1.7479528079600741
LCLC-97TM1,55508,4.820744956173848,3.262361093883641
PaTu 8902,9903786,4.041497343746548,2.8686263841684765
SW1271,12001922,2.1604198968714754,2.058606904736847
HEL,6505803,1.212867497705534,-1.0850824438045956
SK-HEP-1,216345,4.108495190728752,3.988555676134561
WM115,4705,2.3860154683324897,3.0415031138799318
NCI-H1568,JQ-1-vorinostat (2-1 mol-mol),1.325801474857881,1.1565792865530815
COR-L105,126941,-1.5036718028706904,-2.421603267240991
PaTu 8988t,9926054,1.9241127892750265,2.025223515459948
SW48,tretinoin-carboplatin (2-1 mol-mol),4.556026920056554,4.968387112681279
NCI-H2452,navitoclax-MST-312 (1-1 mol-mol),2.3760907472780137,1.1270480489962162
SK-HEP-1,374536,4.396616434658188,2.5326196775106613
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256,2.7684458359798003
NCI-H2452,208908,2.397298909776284,1.8747095727458472
SW948,24821094,3.757524617053942,2.6022041990410516
K-562,44491742,3.373435641850853,3.9081853526057047
RKO,24180719,5.308193040989237,3.460801666113815
MOLM-13,56946209,-5.150374128805616,-4.790791456392953
MDST8,54454,0.3151053774213321,2.4528438139531814
Daudi,969516,2.18084937908482,2.156532106194516
COR-L105,44607531,0.2442604090297878,1.5039143186489028
SaOS-2,54619267,4.116373312960232,4.204877899864352
MOLP-8,44607531,1.2227606502433142,1.20485630239229
ALL-SIL,11427553,-0.6859128537837271,1.254761959497859
NCI-H1568,11427553,2.9296384487881166,2.978606097841084
SK-HEP-1,6918638,1.490993863020431,0.6414815340360392
K-562,11175137,2.6421325977097663,2.224406728335956
MOLP-8,25126798,3.554030345273679,3.5015297365080498
MOLP-8,10427712,3.937375048887725,3.8989486467578076
BFTC-909,11404337,0.4468911705694049,-0.19597453979501278
Daudi,19582717,2.1579117268337975,2.5493931277001245
SW1573,9936388,3.0507391751654698,-1.1025687927381078
SW1271,156414,2.097129180606755,1.4800853008475061
Daudi,11213558,0.7122197709980888,1.3924694680632326
MOLM-13,135875424,3.721528356214304,3.1437678459695952
LS411N,3062316,3.313525141236135,0.889981396408893
Panc 02.03,6438330,3.381062774421129,2.294779228565072
MOLP-8,4705,2.7848528520877727,2.8651418966332862
SW48,675434,5.164587034175743,4.485925212559411
NCI-H1568,46215462,1.5662565779678703,2.0523277331051593
BICR 22,23635314,-3.9149935419765423,-0.018951829363787108
NCI-H1568,44607530,0.8979533446197012,1.9259097697810512
BFTC-909,89928392,2.1120581393996116,1.7652241481051556
NCI-H2452,8515,2.9816658051225344,4.265492032551812
WM115,252682,5.883677253194902,6.493636979265762
SaOS-2,11507802,0.9759404440699744,1.737708010750075
NCI-H1568,9935249,0.3822057580098375,3.0790516881943417
SU-DHL-1,selumetinib-vorinostat (8-1 mol-mol),1.570079304001321,1.7704765030400884
SW1271,65628,4.408026608161547,4.1882787556225844
MOLM-13,2742550,3.0943449980031845,3.1141248587869597
HuP-T3,56973724,4.820716068374067,3.310921122404628
P31/FUJ,5328940,0.1000739186855886,0.9090795111997757
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747,0.808203510606873
KU-19-19,9967941,2.4242338826427794,3.8737781809043756
COR-L95,selumetinib-decitabine (4-1 mol-mol),6.271791154986272,1.972042895301989
SK-CO-1,5328940,2.280320557186381,1.696253326075668
HARA [Human squamous cell lung carcinoma],6184667,2.5882672266365128,3.1608897708709636
COR-L95,1716436,2.176954941746147,2.8362373341799345
MDST8,46398810,3.011862004714757,2.560897810834463
SK-OV-3,654092,-0.1739817534251795,0.038776859383945
SW948,54613361,-2.2535675944820084,-0.3346475807643072
HuP-T3,25154868,5.141210696949765,4.581756076908809
SK-CO-1,selumetinib-PLX-4032 (8-1 mol-mol),0.4034815942312452,3.13591923667379
RKO,124202324,3.4391315101947386,1.5013590337262475
RCC10RGB,9444,4.509247284467684,4.173907079029292
P31/FUJ,135421197,1.0144502005310674,1.2344538046662317
MOLP-8,44487872,4.385798937588512,4.1321381421005325
PaTu 8902,448949,2.6032868845304606,2.269442212087492
MOLM-13,11427553,-2.505370137631637,1.2683124611241257
IA-LM,60750,4.549488262081028,-1.9121417599650365
MDST8,3825829,4.752817875520721,4.289578588546338
SW1573,JQ-1-navitoclax (2-1 mol-mol),0.4708104580132937,1.3154760043352716
BICR 22,navitoclax-MST-312 (1-1 mol-mol),0.8152867092510746,1.023855653510086
COR-L105,51037431,3.876010066295024,3.4434025680851557
RKO,31703,-1.8438289452025527,-1.319942584910091
HEL,5978,-0.5240559956879017,-3.0935665436468174
SW948,168312962,3.6749765666335903,1.3382623772147877
IGROV-1,72734382,4.633226130326536,4.4635038414151635
SW48,216468,-0.1130169029097753,2.9202120558045546
HuP-T3,216345,4.480282764347718,4.119719744434948
HCC15,439501,0.3030845703669018,-1.9523918536619405
P31/FUJ,638278,2.9129004591727057,2.79571827884288
BFTC-909,676352,2.5282943369079818,2.254683693340179
SK-HEP-1,60750,5.759979022694095,-2.1290715688151653
PaTu 8988t,4788,6.262210396704686,5.6700259736200325
Panc 02.03,JQ-1-navitoclax (2-1 mol-mol),1.014156743517759,0.8353610948522371
NCI-H2452,doxorubicin-navitoclax (2-1 mol-mol),-1.0690798948484177,-0.9122829017350882
HEL,24951314,0.022330385445513,0.3289505987853751
MOLM-13,46907787,-1.536709398859376,-0.8966354569326158
SaOS-2,54626689,4.533352391847383,4.6547972917024705
RERF-LC-MS,10410894,3.034247655874134,3.4777013266055707
RERF-LC-MS,9903786,2.6182355767545213,2.9960675575897
IGROV-1,107985,-2.8971910842184516,-3.4054054961410123
WM115,10231331,-3.458943295987183,1.557456833978149
Daudi,71466578,1.924283792281082,2.4752586771041445
KU-19-19,6610216,4.876021689690227,4.333427110434535
COR-L95,6918736,-0.04136223528326,-1.6417324002040683
MOLM-13,11625818,3.232701320691832,3.3364171292564593
Granta-519,16038120,-0.1772437220791911,0.0943422503622327
BICR 31,46907787,2.190433361645711,2.478305618122669
Daudi,702558,3.2750017094913657,3.9613211809481963
MOLP-8,24856436,-0.8263886484359759,-0.4359733390839648
MOLP-8,135440466,1.6989907480456066,1.5032034986635028
SK-HEP-1,46843906,3.844316747572769,3.379621733677737
RKO,54626689,4.750442055573677,4.28223811315152
HARA [Human squamous cell lung carcinoma],navitoclax-gemcitabine (1-1 mol-mol),-0.596107332987684,-1.0348990255123784
IGROV-1,11717001,4.394306548697183,3.845336440286948
Granta-519,5291,3.886616753428741,3.1828548258996894
HuP-T3,vorinostat-carboplatin (1-1 mol-mol),4.326832101925159,3.417700144823113
SW1271,262093,2.7991981503454495,2.9969768313351124
Granta-519,1566236,1.1036082649410253,1.2858511433844078
BICR 22,24753719,4.1427183131543615,4.108487837839158
Panc 02.03,9926054,1.881153725115377,2.0700281821394118
HEL,selumetinib-UNC0638 (4-1 mol-mol),4.439373718009897,2.053609267377352
HARA [Human squamous cell lung carcinoma],6918289,2.581505632245523,2.766673207029399
LS180,54619267,4.074522434074431,4.016987446941304
SK-OV-3,5281321,-0.7098099698865428,-0.9621655677775369
BICR 22,selumetinib-MK-2206 (8-1 mol-mol),1.8488971729777937,1.987400477545206
SK-CO-1,2729026,2.8886798476744246,2.7185746349849365
Granta-519,23582824,0.9303240666722092,0.7082378845802679
HuP-T3,JQ-1-navitoclax (2-1 mol-mol),2.3872748820971217,0.7983732529036034
WM115,24978538,1.155471911978994,1.5038361315620472
BFTC-909,navitoclax-gemcitabine (1-1 mol-mol),0.1512584221412147,-0.9643586450998711
NCI-H1568,11238147,2.925799577076833,3.1982049304593145
ALL-SIL,135398516,1.5622324093538014,1.258452327001296
COR-L95,135659046,3.614564650544248,3.507151537553608
SW1271,1285940,4.280510054640018,3.3057848512947716
SW1271,6505803,0.8186340021888412,-0.058919437091423645
SK-OV-3,SNX-2112-bortezomib (250-1 mol-mol),0.4595025269763413,-0.6440601700461828
RCC10RGB,UNC0638-navitoclax (1-1 mol-mol),1.9805139183388023,1.6448136552105408
IGROV-1,11626560,1.7276653519578558,1.9264914620806182
ML-1 [Human thyroid carcinoma],24748573,2.352453339172467,2.2475639244369225
P31/FUJ,3552672,1.950832295752278,2.1746393654239258
P31/FUJ,67291369,0.7371006748241407,0.7488201425228109
LCLC-97TM1,107970,2.3018486004849907,2.3230950240594024
SK-OV-3,44607531,1.947967745365508,1.2990314997750552
BFTC-909,9936388,1.702123766125507,-0.4414879073679126
ALL-SIL,8515,1.9161675301812888,3.05229394070569
LCLC-97TM1,25262965,-1.937189863749451,-1.4728234577373798
HuP-T3,ISOX-bortezomib (250-1 mol-mol),0.144245152578182,0.7044469433086169
MDST8,6914657,-1.2463021469195388,-3.691104221288268
RKO,SNX-2112-bortezomib (250-1 mol-mol),-2.626179791835481,-1.9810714515583434
HCC1500,53392493,1.8683885031226253,2.6477037350548525
MDST8,135411,0.5541309628089411,1.0567496142781647
RERF-LC-MS,1750826,-0.5689233588179538,-0.7775437366499726
LCLC-97TM1,5328940,1.525932870405189,1.5750881445593243
NCI-H2452,25195348,3.541594611208225,3.3689381948272437
ML-1 [Human thyroid carcinoma],71304818,3.0426605111728517,2.758850534487231
RKO,crizotinib-PLX-4032 (2-1 mol-mol),0.8147825419497507,1.1033427528977895
SaOS-2,53495165,-0.9847313398251484,0.5291488132566298
SW948,11626560,1.2721393744446543,1.431096698468725
LCLC-97TM1,tanespimycin-gemcitabine (1-1 mol-mol),-1.2417811136372243,-1.0458564812704834
HEL,25183872,-2.1054192111007657,-1.7358974264382276
RCC10RGB,89928392,1.8749323034057075,2.039356609587361
Panc 02.03,10074640,3.562403354758929,3.311964555641028
PaTu 8988t,57519531,4.351537289113079,2.648429072061179
SK-CO-1,5281321,-2.128194299198524,-0.5899172603420361
RERF-LC-MS,5311,1.7201713868016182,1.7635279878882606
HuP-T3,11427553,3.1840600229712037,3.011288603359262
ALL-SIL,4259181,-1.3200126273341632,-0.41682390477328424
HCC1500,11214940,3.550811671890936,1.9325584050026976
NCI-H2452,navitoclax-PLX-4032 (1-1 mol-mol),2.336639386671478,2.400965048877002
HCC1500,25195348,3.452030504957034,3.261497888174235
SW1271,52912189,0.6284206808713965,2.446660080209303
MOLP-8,984333,1.0413549547234568,-0.23093730571185117
SW948,72734382,3.6940713099503473,4.096230751460946
IGROV-1,46943432,4.105714883822214,2.307620880792428
BICR 31,25227462,0.4256700478941367,0.8447836913873945
SaOS-2,2126,4.6809882623674905,4.687907081116166
SaOS-2,11427553,2.020035940690151,2.7952172171340415
MOLM-13,6914657,-6.22505002098335,-5.113555796090264
NCI-H1568,24964624,2.125017418877952,2.636029357099257
HCC1500,11497983,4.502799578122533,4.017037129861534
K-562,23725625,5.2530061405843975,3.9604068804150088
SaOS-2,salermide-PLX-4032 (12-1 mol-mol),4.26549663284579,4.77824186047511
RKO,136227924,3.256787131627037,2.5026415886637188
IGROV-1,31703,-1.792518264692263,-0.8190036919556748
HEL,6438330,1.7062913765539824,1.364289067025362
RERF-LC-MS,25126798,3.475546322259903,3.9485615501523017
LCLC-97TM1,409805,4.11204743963536,4.490103110289911
Daudi,2708,2.1654486353587266,3.2250410196528656
SK-HEP-1,6914657,-2.911576812343612,-3.519423138640206
MOLM-13,36462,-3.0478349617512466,0.03707553840475251
COR-L105,208908,1.1794902635628597,1.8136488976102834
MOLP-8,44491742,4.067907034019371,3.8049834195928907
Panc 02.03,89183176,4.957506748320777,4.480256284237002
Daudi,3025986,-1.684737909075286,-1.7959932255562632
PaTu 8902,10302451,3.9687769441396608,2.9834958753053407
PaTu 8988t,9933475,2.2874108911255693,2.074370867894884
SW1573,5281321,-2.072955292880288,-1.0671308336571084
IA-LM,2733526,5.6911514373146135,3.957635832002043
Panc 02.03,6918837,-1.2317043962492993,-2.2108471203883573
NCI-H1568,19582717,3.4209569673427342,4.333622366652599
WM115,55508,6.132181701054794,3.7151329332647
MOLP-8,2871966,-0.632569947519592,-0.20906003364404258
ML-1 [Human thyroid carcinoma],decitabine-navitoclax (2-1 mol-mol),2.5515685650410216,2.2960226204965433
MOLP-8,decitabine-navitoclax (2-1 mol-mol),0.2255247501063145,-0.08010630554275472
HEL,6918837,-4.248380638359999,-4.249365688484139
RKN,alisertib-navitoclax (2-1 mol-mol),1.493636711316015,0.23794291149141722
BICR 22,136227924,2.105383482893856,2.60875208450684
SW48,135875424,3.469184081134181,3.7217962083988185
COR-L95,10127622,5.649647064343883,3.2292545635597274
SU-DHL-1,60750,-4.603947913298721,-2.1456437121042686
ML-1 [Human thyroid carcinoma],16065773,2.2629168527060117,2.6470745127797515
SaOS-2,446155,1.978878402700164,2.2205265339808533
Granta-519,tretinoin-carboplatin (2-1 mol-mol),6.438903911502162,3.1645900768582016
SK-CO-1,11625818,4.187860927408271,4.512014667326108
COR-L95,676352,2.06388279354012,2.0738573710210084
RKO,11719255,3.406006587740275,2.718017729245627
NCI-H1568,135875424,3.0063280878885967,3.899229857569675
IGROV-1,25195348,3.0698662305180275,3.5309436262725957
RERF-LC-MS,16659841,3.453543705685564,4.316822841132466
SW948,1641662,3.2658822910658905,3.31236485153719
BFTC-909,5351362,0.3148685714677321,1.702339581390181
COR-L95,24771867,5.320672645408192,0.5541879361220429
NCI-H2452,16725315,3.1677771909290184,4.044032848893426
WM115,9926054,3.0880179510914454,2.0949827509285295
IGROV-1,135875424,3.3275053166921347,3.871886274132743
LS411N,4259181,-1.386635238211632,-0.09373928686301185
SK-HEP-1,24821094,3.809459846332286,3.015938087414075
P31/FUJ,tanespimycin-gemcitabine (1-1 mol-mol),-1.9905845316732809,-2.249207522355971
ML-1 [Human thyroid carcinoma],17759555,4.838019485799326,3.5986200440398393
HCC1500,11364421,1.8102576985092016,-0.9893923997492172
WM115,11647372,-0.748702419415335,1.3327523054241996
IGROV-1,374536,0.7022324251593053,2.4218057119229237
K-562,5311,0.9288629076778604,0.6891137703211847
LS180,navitoclax-piperlongumine (1-1 mol-mol),3.251687407924036,1.4491394729424953
HARA [Human squamous cell lung carcinoma],375860,-0.967052520231088,-0.09019716723805951
Daudi,44607531,0.7322116783883826,1.6385325350199447
HARA [Human squamous cell lung carcinoma],9840324,5.741888919857564,5.870312895883718
SW1271,448949,2.9810988383972084,2.069872598899037
SU-DHL-1,42642645,0.6641769458510169,0.9704178181429657
ML-1 [Human thyroid carcinoma],168312962,4.623396193395582,2.802516408227995
SW48,53232,2.98078944705874,2.989121630623436
K-562,4096211,1.5585244853649294,1.3503920502264841
LS180,89183176,4.9114720653238315,4.518288035219253
SW1271,10427712,4.007366682408904,4.336777139312418
BICR 31,JQ-1-UNC0638 (2-1 mol-mol),1.590211689658008,1.7967515233431437
SK-OV-3,72193861,3.227068856168802,1.8692170659744523
K-562,148198,-4.073315546446919,-3.9617321201253755
ML-1 [Human thyroid carcinoma],25262965,-1.8922435286727564,-0.8146975066782864
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331,-0.4367064670493961
SW948,2729026,3.020599067804879,2.4917018633958095
SaOS-2,3552672,2.445112397338648,2.7317403670496856
K-562,6918638,0.0740833242167517,-0.28147485883544293
HCC15,67291369,1.6613409933263477,2.9170382739749723
LCLC-97TM1,11396600,3.6456493290211425,3.5887492587794094
HCC15,6438330,2.907250953014235,2.4027174859713054
SW48,123631,-2.3971553119638553,2.319510226739137
RERF-LC-MS,6918638,0.4520678244574614,0.8966915495189709
HCC15,54619238,5.509074276782743,4.744995735509724
HARA [Human squamous cell lung carcinoma],selumetinib-UNC0638 (4-1 mol-mol),6.072288250407716,3.0050560117621914
Granta-519,5351362,0.2173676915670352,0.9276639926286352
SW1271,219104,3.9142621703193625,3.8667076206889868
WM115,selumetinib-JQ-1 (4-1 mol-mol),-1.8046253833707984,1.270708586979266
SW948,11497983,1.2110688984787443,1.2446680960665015
Panc 02.03,11404337,1.528571500956484,-0.470685756742345
SK-OV-3,107985,-2.353051363092625,-3.3855473315282603
PaTu 8988t,selumetinib-GDC-0941 (4-1 mol-mol),1.0326932423441333,1.7313363470001213
HCC1500,56649450,4.199956636233384,3.3994721425260104
MDST8,54649381,4.2434412709491385,4.006199755014814
SK-CO-1,24772860,-2.764468608226056,-1.3952015851243413
SW1271,2708,3.697662973501111,4.803441683222653
COR-L105,25062766,2.3512127388642865,2.1604533881813754
BICR 22,9826308,0.9832071992526458,0.8242951905429392
SW48,navitoclax-piperlongumine (1-1 mol-mol),1.2226780800612655,1.7636658249960249
KU-19-19,11404337,0.0275069311149896,-0.35972402658431507
LS411N,decitabine-navitoclax (2-1 mol-mol),1.6875581183367745,1.0904686445544463
LS411N,452548,1.178688753001054,-0.9074574616662272
COR-L105,3025986,2.299444367217184,-0.6189404414957352
IGROV-1,25102847,1.7007012555618253,2.672822091147125
PaTu 8988t,24797083,1.3448554408655904,1.3493830433474594
IGROV-1,46398810,2.003787621940583,2.42738809991904
SaOS-2,2749,2.484303950908632,2.0629421425744274
WM115,7251185,2.999080033015298,2.6389986516935857
IA-LM,151289,3.753931026261757,0.8556434594565592
SW48,60168763,3.2354609354554924,2.7201711226690124
IGROV-1,168313016,4.807199318661473,4.83956258158843
MDST8,5351362,2.4401541198795726,1.6940582930199064
RKO,5291,3.391339544898264,3.506360916483641
LCLC-97TM1,23582824,0.7435680585464137,0.8660817287016614
BICR 22,16725315,5.207801943730372,4.1116296550804865
HCC1500,44632017,4.723480031494906,1.3681432254281172
MOLM-13,219104,1.3929442819191806,2.2977075471944617
SaOS-2,44202524,1.4210473732360835,1.7571043869576461
COR-L105,753704,5.105702577689745,5.059195548214625
BICR 22,216468,1.2752332856392885,2.9134286228776154
RERF-LC-MS,445643,4.345437949323675,3.8877375603843074
BICR 22,selumetinib-UNC0638 (4-1 mol-mol),2.123491609761504,2.92735837116766
HuP-T3,44607531,1.7591062122540748,1.6545097776211997
NCI-H1568,9915743,-0.8427224057935273,1.0297051377507123
ALL-SIL,126941,-2.455728969669062,-3.3673889176584284
IGROV-1,168313047,1.93821625738322,2.3975859362385954
LS180,100016,6.005443229591697,6.292934914709127
SaOS-2,60700,-2.625519230364934,-0.0869628384966266
KU-19-19,9907093,4.38040739031281,4.160157240290387
SaOS-2,9935249,3.097116977919543,3.2045216222727557
COR-L95,24821094,3.5692160345671335,2.720892275877258
Daudi,327653,2.694862581871668,2.660977890543911
SaOS-2,65628,4.208345318362158,4.305068310166955
SW1271,navitoclax-piperlongumine (1-1 mol-mol),2.304332277449707,1.8911783482780538
ML-1 [Human thyroid carcinoma],119182,-2.1546594526399647,0.10151926676183776
LS411N,24772860,-2.6286287692739587,-1.9965227555562826
HCC1500,15983966,1.4595203856942676,-0.699694084059899
COR-L95,46907787,3.807595772412777,1.2333501754782
BICR 22,24821094,3.82687279949815,1.6432707719267765
RERF-LC-MS,56946209,-3.4945734927118552,-3.6781059721253837
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448,1.1964742295106163
MDST8,49793307,-1.5088082080905487,-1.5972122706446519
RERF-LC-MS,tanespimycin-gemcitabine (1-1 mol-mol),-1.5952645398326415,-0.5768080174185506
SW1271,159324,2.241950485620868,3.23099424684684
LS180,doxorubicin-navitoclax (2-1 mol-mol),-2.003067068648065,-0.9656580971327676
HCC1500,135398516,0.4161092034804287,1.855137175363744
Granta-519,46901937,3.6488183223471022,1.90609146738832
RERF-LC-MS,5328940,2.240356815676024,1.6741612839693452
BFTC-909,navitoclax-sorafenib (1-1 mol-mol),2.944260401271062,1.9169634421489226
Granta-519,400769,-1.7592122365530554,-1.45344902427964
BICR 22,135421197,2.0438055763788556,2.5559909969432257
BICR 31,9967941,4.3746614656618865,3.9203704680447653
Daudi,89928392,0.010222000273875,0.2836645661403889
MOLM-13,151289,-0.2275053531847663,0.37441668450047827
IGROV-1,2874250,4.893662837169153,4.752724178098005
MOLM-13,4261,-0.2853779042398361,0.3592276706096371
MOLP-8,5280436,2.785612173209183,2.3765350485858305
RKN,11427553,3.6372919842764424,2.7490392390618803
LCLC-97TM1,2828334,6.057082646440782,6.000626013519219
Daudi,11640390,2.7767455060282873,2.4780171386632386
SW48,selumetinib-MK-2206 (8-1 mol-mol),-2.489387055809161,2.1886205970935553
RKN,51039095,3.7797830340785694,2.726671871858311
HuP-T3,46398810,2.968900053185397,2.416995875677221
SW948,60700,1.1260701186231294,-0.3661081163524227
LCLC-97TM1,168313047,1.50715487575417,2.3945407944582437
Panc 02.03,46174525,6.272327915554807,4.5659836810781185
SW948,72193861,0.8788999866892542,0.6783717633399763
HCC1500,6918638,0.5709126385335386,0.416468440898699
RERF-LC-MS,42642645,-0.4358765804877467,1.0965811286291816
LCLC-97TM1,selumetinib-vorinostat (8-1 mol-mol),2.6249327644586153,2.173415473329046
ALL-SIL,12001922,1.676377280214729,1.4380678314960986
NCI-H2452,441298,2.247705741320954,2.629105185100634
BICR 22,46191454,1.6809351488377804,1.5982928157068628
COR-L95,16013152,4.05038947229277,3.650508937116011
BFTC-909,72376,-1.4314875177558029,-1.434074480417633
SU-DHL-6,15983966,-6.405792257227171,-4.2655083253591615
K-562,11497983,3.839483588328175,0.9847622830382688
ML-1 [Human thyroid carcinoma],10184653,1.3933805894109417,1.9688783570980928
IGROV-1,4477,1.1767656777594142,0.4699896198338931
SK-CO-1,9444,4.465837668270579,4.181706239400038
SU-DHL-1,135999136,4.730243036337901,3.42927890259907
IGROV-1,54619267,3.9701367924453455,4.281961532194618
HARA [Human squamous cell lung carcinoma],6852167,2.790696024551457,3.1467156858732404
SW948,31703,0.6983000463207195,-0.6114434864494971
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028,-1.5411711954324812
SU-DHL-1,BRD-K03911514,2.3803066372148742,3.146264229642538
HCC1500,46398810,2.5427546617930905,2.585050863586269
LS180,tanespimycin-gemcitabine (1-1 mol-mol),-3.220136839114834,-1.1191280127613852
WM115,51039095,2.786212621210589,2.6528777189900223
Granta-519,JQ-1-carboplatin (1-1 mol-mol),-0.0687085528306087,-0.26739303352707816
HCC1500,24772860,0.2838196702204312,-1.7990581381731616
SU-DHL-1,71304818,1.6958772786188914,2.03168089407955
WM115,16736978,2.885535594388376,1.6609411774628589
NCI-H1568,54618305,4.1006341963066255,4.625988196518554
RCC10RGB,11404337,1.763382313076518,0.1644418729559178
BICR 31,navitoclax-MST-312 (1-1 mol-mol),1.028775915948256,1.0584568180591671
HCC15,17755052,4.876160174226561,2.1923787798177288
COR-L95,6610216,4.601423414679649,4.065209445889385
LCLC-97TM1,10296883,3.762301074740285,3.8285896675195024
Granta-519,753704,4.381381177541046,4.028420004295985
COR-L95,3825829,4.2210058836960265,3.6349145928168802
HCC15,51039095,2.370618956781999,2.8612916600342646
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404,3.0355113378692717
SK-OV-3,crizotinib-PLX-4032 (2-1 mol-mol),2.8845128579100456,1.9765480639001793
K-562,9915743,1.457381054045144,1.0448487143474767
Daudi,644241,1.4114598324864769,0.7570175997755187
COR-L105,6610355,4.615259996363044,4.690655727620248
NCI-H1568,400769,-0.2296701698466811,-0.4215992233316338
PaTu 8902,4096211,3.3878786245174917,2.1339395585653027
IGROV-1,6610355,3.969940996770339,4.604026066884013
NCI-H1568,15547703,3.0519937502167744,3.2729330925225537
BICR 22,11609586,1.2076158919216122,2.8930539897653405
NCI-H1568,6918736,-3.5744965026463893,-1.5242294553851148
Panc 02.03,2729026,3.1511226959620715,2.8376413290217384
RCC10RGB,73707438,4.14323951901879,4.200811203131317
SK-HEP-1,11609586,4.257559552037769,3.114413397590304
KU-19-19,piperlongumine-MST-312 (1-1 mol-mol),2.2377116602988187,2.056051393386549
WM115,9935249,2.3950107716018465,3.2509840622278454
ALL-SIL,9929138,4.286241964174987,4.949178643449853
SU-DHL-1,452548,-2.7499107831448257,-0.1306961867670763
ALL-SIL,JQ-1-MK-0752 (1-1 mol-mol),0.2899712696196563,-0.7007721222329351
COR-L95,262093,1.2094317801688714,2.689339709646408
LCLC-97TM1,4788,5.877974617736734,5.777732853462758
LCLC-97TM1,11455910,0.6647050862050086,0.9722106005254078
HARA [Human squamous cell lung carcinoma],5978,-4.046402058806829,-1.677698016322187
IGROV-1,3025944,3.9702787396819503,4.172273741167721
COR-L105,44486219,4.2268301570583,4.406677408857908
HEL,6852167,2.7971477189216207,1.5853963374849758
HARA [Human squamous cell lung carcinoma],6918837,-1.4537868658939308,-2.7339325385429056
BFTC-909,SNX-2112-bortezomib (250-1 mol-mol),0.3698834200349636,-1.1839655937774671
MOLP-8,24753719,3.861578571306771,3.5241393604169513
RKN,54649381,4.194319964969153,3.9401294979955197
NCI-H2452,5738263,2.391583749104638,3.5926897263571824
RERF-LC-MS,11612883,2.474683430971872,3.265391497114937
LS180,67156097,-0.3004464994297747,-0.9972087106981494
ALL-SIL,638278,2.4844738615144797,2.6367063219589038
NCI-H2452,navitoclax-sorafenib (1-1 mol-mol),1.6826538344111892,1.981275358615345
WM115,89928392,1.4475546317176564,1.575719054314462
NCI-H1568,4917,1.9457015565482707,3.16305841510484
Daudi,2746,0.9195319579001202,1.776903212931004
RERF-LC-MS,136227924,4.560045704487339,3.0561032175552914
SK-OV-3,400769,-0.3757443057400228,-0.34690513523598376
Daudi,2742550,2.6022450411597764,3.2352969440582764
SU-DHL-1,1242560,3.2887270842989285,3.1622121758044255
IGROV-1,1750826,-3.124548162001242,-0.895717491318491
IGROV-1,3025986,-1.046010021597061,-0.7793908155828114
SK-CO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.3873903217982155,2.216450281620042
COR-L95,11178236,-1.511835887926392,-3.20994179684777
MDST8,15953870,3.886262261351445,3.7850871456726534
P31/FUJ,71466578,3.434376258750051,2.58546554863597
SK-OV-3,navitoclax-pluripotin (1-1 mol-mol),-0.7992901012574275,-0.27356891095224894
HCC15,16038120,-0.3287102193479797,1.0613387186063772
SU-DHL-1,selumetinib-JQ-1 (4-1 mol-mol),2.388331941434094,1.1890893425232176
WM115,44607531,1.8052962391610108,1.602503939549903
SK-CO-1,322968,3.708989182542924,4.033424519476569
IGROV-1,1716436,3.2816872421007375,2.9937015843939423
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296,3.7784402040001623
SK-HEP-1,15953870,5.227718988850451,3.767619725275095
SW1271,10231331,-0.1974856956768426,1.4877101501159558
HuP-T3,168312962,3.781886601468438,2.3467024931712777
Granta-519,11238147,3.49055902156802,1.8570175279341945
SW1271,54678924,4.1367056407476595,2.122370967871032
Panc 02.03,89928392,1.630028817710481,1.8050215138755619
BICR 31,148198,-3.2373882564770513,-2.8255343668189625
IGROV-1,104842,-1.6690343627553987,-2.402863708835066
K-562,erlotinib-PLX-4032 (2-1 mol-mol),2.919036789421011,2.930001586853877
HCC1500,10184653,1.0749855490236058,1.0316881234107536
HCC15,44202524,2.021204517823952,2.3230243650464395
COR-L105,9866186,1.0648092573013754,0.9370412615950999
COR-L95,285033,-2.430535969260308,-2.354948941153912
COR-L95,23635314,-1.8010937940640896,-1.9513175637554971
SaOS-2,11364421,-5.8107581348158,-2.3383098836843166
BFTC-909,122327,4.590877432942681,4.867155485228284
IGROV-1,54618771,1.2456991772210466,1.2552687012485275
P31/FUJ,675434,4.075878142833804,4.054134498198369
HEL,tretinoin-navitoclax (4-1 mol-mol),-0.5211961958831923,0.31557518795642675
NCI-H2452,5328940,1.966899609603824,1.836171637275986
RCC10RGB,72376,3.207429090732714,-0.8519472729221728
LS411N,selumetinib-tretinoin (2-1 mol-mol),1.6361357934026397,2.207616233375151
NCI-H2452,4917,2.7944300449003907,3.2057987659723715
BICR 31,1716436,3.7157300626912617,3.015796782360518
MOLM-13,1239801,3.478439984806631,3.059092078252596
HuP-T3,10296883,4.266239948990751,4.051725520044085
PaTu 8988t,107970,2.530920724052233,2.285395657578629
ALL-SIL,675434,4.0400251875066715,3.874198931934718
PaTu 8988t,16736978,1.6582336139520693,1.73702625940864
LS180,5460769,0.3293841533128088,2.3332885032614503
MDST8,11612883,2.4942536836786635,3.028073488816692
COR-L95,46191454,2.009346014708409,1.2991192256783501
MOLM-13,451668,-3.798095624109847,-1.218382576248276
Daudi,168313016,3.9002026806644734,3.677404439541439
ALL-SIL,135411,-0.5620485907345016,-0.03720344423180982
RCC10RGB,46215462,3.684591481140594,2.2663868760771906
KU-19-19,4917,3.607977283390518,3.210656044828273
Panc 02.03,71751553,4.925944110140211,4.521586109127029
HCC1500,5281321,-4.561246998431513,-0.6139721243384835
LS411N,44202524,4.412838675121289,1.829638284310772
LS411N,637858,2.7012095970179635,1.448897435420685
ML-1 [Human thyroid carcinoma],46191454,1.5014607148772898,2.4654934043122863
SK-HEP-1,24797083,1.0035545042427043,1.3412454802427198
ALL-SIL,navitoclax-gemcitabine (1-1 mol-mol),-4.146952784268296,-2.908155288576554
HARA [Human squamous cell lung carcinoma],24951314,2.561199492034659,1.494216590971746
BICR 31,387447,-3.4745770631768553,-3.8188900936795314
SK-CO-1,452548,-1.5551413224098238,0.927032877234137
SW948,6914657,-4.288216532991124,-4.040269069987815
SK-HEP-1,216468,4.223762462623231,3.453035514108826
ALL-SIL,71466380,3.7861137397034255,3.556865016825805
ALL-SIL,66577038,2.592918053791083,2.594040263008468
K-562,46174525,4.631327159993839,2.8404319177256734
SK-HEP-1,11404337,1.0852289139958715,-0.17907507433632955
SW948,tanespimycin-gemcitabine (1-1 mol-mol),0.3148339676626304,-1.297655540613428
COR-L105,156414,4.037454349539868,1.393030468139157
P31/FUJ,5351362,0.932451869978648,1.0331345225730666
BICR 22,57519531,2.122776388957543,2.904095905142829
HARA [Human squamous cell lung carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.0458249521104828,2.096768491850935
SW48,156414,-3.5613148313114293,1.3898942848516256
BICR 31,24180719,3.9564262696237096,3.645016733572481
KU-19-19,11222830,1.7129831318158657,1.6541202152952528
HuP-T3,9911463,3.677427040789425,3.9748882713744274
Granta-519,56649450,2.820913380280981,2.6767374041878416
BICR 31,5328940,1.2878315189706533,1.8102947063251507
HARA [Human squamous cell lung carcinoma],navitoclax-birinapant (1-1 mol-mol),1.3986072497708624,2.039935976335905
IGROV-1,19582717,6.764352444432722,4.226148063629635
IGROV-1,24951314,0.9075718706849548,1.4791111393977519
Granta-519,9911830,2.3469616146388033,1.8511404435651924
RKO,3038522,3.342495330103654,2.954695037820537
P31/FUJ,135440466,3.423250795887436,1.6227855213065123
IGROV-1,6918878,1.6706182189896102,2.952297664639945
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448,-0.18196606420292213
SW1271,136227924,3.2074421772411372,2.954942875586853
IGROV-1,16722836,0.856484234547582,1.6422796517085059
WM115,piperlongumine-MST-312 (1-1 mol-mol),1.2080674757764085,1.8744902177798226
HARA [Human squamous cell lung carcinoma],3025986,-0.8541128463962537,-0.9006522294293606
IGROV-1,168313016,4.807199318661473,4.83956258158843
Panc 02.03,9935249,3.920507280118285,3.109141199077293
UACC-812,19582717,5.3439559865445245,4.053352133442662
SK-CO-1,54619267,3.100073010472608,4.122698847815653
LCLC-97TM1,56973724,2.3842885859021985,2.8147683730203763
P31/FUJ,44185566,1.65624467652309,1.4325176750384818
BICR 22,erlotinib-PLX-4032 (2-1 mol-mol),2.8586424250405784,1.9703546331424129
LS180,568763,0.2796957344404436,0.4800907107257933
HEL,5281321,0.1504430999261452,-2.4267835477369717
COR-L95,168313200,1.9910859109269063,2.5579854187307047
NCI-H2452,100016,6.6405878618594985,6.2952438251569
SK-OV-3,vorinostat-navitoclax (4-1 mol-mol),1.2421133926861518,1.4777753763386918
SK-HEP-1,71751553,4.559763777433237,4.585613400405426
COR-L105,6450551,3.13458936271996,3.3178199508206574
MOLP-8,227681,1.7901539797099055,2.4185466882950273
LCLC-97TM1,24951314,1.6929873886763296,1.093751042291315
LCLC-97TM1,20959075,-3.5903877814282836,-3.120875019350868
Panc 02.03,11964036,1.263021853424522,1.5083143166136441
Granta-519,54596558,4.099782953798094,4.0965510517598105
IA-LM,navitoclax-PLX-4032 (1-1 mol-mol),1.0143857311372344,2.0240882367137445
P31/FUJ,navitoclax-gemcitabine (1-1 mol-mol),-2.2174176001996626,-1.9265367072290274
IGROV-1,246676,4.485924799339535,4.233511783625888
HCC15,25126798,3.760529318413009,3.9467182677991604
P31/FUJ,67156097,-2.27730723064269,-2.234961796935489
KU-19-19,4788,5.856744699338042,5.768471432857979
MOLM-13,44507138,0.4726740823031857,1.7143692191581112
COR-L95,5281672,3.930459616892441,4.094736566775378
HEL,46191454,2.0114602406157487,-0.171568372631679
SaOS-2,25227462,1.0053365829052552,0.6166475777260537
NCI-H1568,327653,2.9538763640308403,3.2525298716952205
MOLM-13,126941,-4.1996343959718665,-2.9767618806186045
SW1573,23582824,0.5044187481506299,0.8363095619251335
SW1271,selumetinib-UNC0638 (4-1 mol-mol),0.1676161732677231,3.248252552566625
RKN,46199207,3.372714950884571,3.235440509701475
MOLP-8,2113511,4.489524818659998,4.484072030484491
K-562,selumetinib-decitabine (4-1 mol-mol),3.3977333997002215,0.7412580220851595
MOLM-13,9907093,2.467705892800055,3.3473877025100314
BICR 31,135398516,1.997761003126595,2.192015694896757
SW1271,216345,3.992520329028928,4.095099477483184
SW1271,49766530,-1.8216621121390524,-0.4285902887173146
BFTC-909,44819697,-0.8003395289407239,-0.25335623340493896
COR-L105,tretinoin-navitoclax (4-1 mol-mol),2.190606174961121,3.1025024897892437
COR-L95,24951314,1.2848618182948477,0.9849148048308998
Panc 02.03,11427553,3.85172253134883,3.117336961595539
RERF-LC-MS,11955716,-2.426679724944883,-1.5342264753861905
LCLC-97TM1,168312962,4.14705930417905,1.8190048365612212
LCLC-97TM1,984333,1.7706091320352773,1.1430347984763314
RERF-LC-MS,3689413,0.4263782886644774,0.34399628956620043
HARA [Human squamous cell lung carcinoma],613753,4.606319217012033,3.3449218416989326
HEL,72734382,4.138558929268269,3.4511287940708026
Daudi,5281672,3.0556000328651267,3.526323515850354
Granta-519,73707438,4.294812737502366,4.212965149590999
HARA [Human squamous cell lung carcinoma],23635314,-1.642514653884031,-1.9231124270465096
BFTC-909,3465537,1.8561429441463555,2.737068991208801
MDST8,53232,0.2243602329572143,2.536735064499913
PaTu 8988t,54618164,4.622822732421989,4.16005127109808
ALL-SIL,decitabine-navitoclax (2-1 mol-mol),-2.660613413513553,-1.9616079232874386
BICR 22,241158,4.423333712203234,3.7698341873958983
IGROV-1,25150857,3.031865110078871,2.484582988938136
MDST8,2729026,2.783400494590182,2.6968148312727016
IA-LM,56649450,5.159895082661475,3.054303115967977
RERF-LC-MS,44137675,3.373454428855253,3.8369816687572484
HCC1500,11612883,3.8728122953700113,2.8625990202444713
COR-L105,44491742,4.003695029376484,4.302609903960756
SU-DHL-1,17759555,3.5507610454949177,3.47737250429023
PaTu 8988t,2828334,6.317024230854033,6.141870130458159
PaTu 8988t,168312962,3.961414669504744,2.2453259531053216
NCI-H2452,15953870,1.9726746369071917,3.7214377879951197
LCLC-97TM1,54626689,4.751501808909531,4.539913619208959
PaTu 8902,136227331,5.567107594748722,3.981859693903691
HARA [Human squamous cell lung carcinoma],445643,3.755641736641804,3.8799994083993297
COR-L105,ISOX-bortezomib (250-1 mol-mol),0.2804376845822182,0.8042440284024663
ML-1 [Human thyroid carcinoma],selumetinib-UNC0638 (4-1 mol-mol),-2.912510210684258,3.4396948832194583
Daudi,11317348,0.8828508555827204,1.4218471440537201
IGROV-1,26596,2.910298792762654,-0.6900814895688018
K-562,2742550,1.8061055262772656,3.4082115532645783
IGROV-1,25062766,2.144848161581278,2.116685993415945
ML-1 [Human thyroid carcinoma],439501,-1.5032891627146094,-1.8314457219755418
IA-LM,navitoclax-MST-312 (1-1 mol-mol),0.5208691605540192,0.5528812530383921
SW948,123631,3.5700289871060327,1.8778366808904454
COR-L95,168312962,1.6965693753889812,1.5824535786812328
IGROV-1,9956119,3.7231415872817024,3.6938636686195228
RKO,doxorubicin-navitoclax (2-1 mol-mol),-1.0579033502847706,-1.7777620026765968
HCC15,23725625,4.984445415553906,5.081411915750933
KU-19-19,JQ-1-vorinostat (2-1 mol-mol),1.2174768050309406,1.1751907442154375
RKO,2708,5.0364138660049935,3.827945221398216
HARA [Human squamous cell lung carcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.215632811452015,2.3488224008192096
IA-LM,148198,-11.384967135346804,-2.944005034884252
PaTu 8902,44202524,5.539571067533291,2.2916736569570335
SK-OV-3,10127622,6.3662035368843535,4.256227318744495
PaTu 8988t,16038120,1.6913300198770496,1.1680713441940929
HCC1500,6610355,5.5539350619643395,4.637641165579539
RKO,9956119,3.3077949428120195,2.889023077360028
MDST8,8515,5.547245054967808,3.9384981997460073
HCC1500,5978,-3.1049031694332183,-1.4166244908307335
WM115,navitoclax-gemcitabine (1-1 mol-mol),-1.739473947075712,-1.633450251302793
BFTC-909,262093,3.5924629632259792,3.0714712355159635
RKO,23635314,-2.140231911981244,-3.110995551355225
MDST8,11626560,2.2403804115384207,1.9135068283816983
COR-L95,UNC0638-navitoclax (1-1 mol-mol),-0.3776689942774316,0.9360776501974404
COR-L95,44819697,-0.3616253875757693,-0.680764635230966
BICR 22,5351362,1.2051272382141311,1.8875571477818678
K-562,9967941,4.015535149970178,3.384913371444422
Panc 02.03,selumetinib-piperlongumine (8-1 mol-mol),3.9730948608994385,3.140290195656543
HARA [Human squamous cell lung carcinoma],42642645,0.3266919515257925,0.9378265944334472
UACC-812,25102847,4.053875686762356,2.3616601055578257
SK-OV-3,6610355,6.222226160480143,4.779911314458075
IA-LM,11152667,1.0642318645878492,-0.8261395186593138
BFTC-909,6918289,3.427790661189136,2.504199906994145
Granta-519,11167602,4.36712443545526,1.7374793382421239
BICR 22,60700,-0.4008092990404712,-0.1423009448769941
LS180,BRD-A02303741-carboplatin (1-1 mol-mol),4.457802595485306,4.0121221517349674
RERF-LC-MS,241158,4.36087401910034,4.0979321084424285
K-562,JQ-1-UNC0638 (2-1 mol-mol),0.4182690397422658,0.4350099230739696
HCC1500,24951314,1.2674136228128516,1.2842027866327763
K-562,65064,5.606410384518605,4.125081453792623
PaTu 8988t,6852167,4.186106645973286,2.9237540781867324
NCI-H1568,BRD-A02303741-navitoclax (2-1 mol-mol),5.689804602568574,2.3928842067962073
RERF-LC-MS,25154868,3.293982375318642,4.642107015964975
Daudi,11719255,1.9605498566152704,2.4800919560267003
LCLC-97TM1,selumetinib-piperlongumine (8-1 mol-mol),3.449521534433945,2.884930307130881
P31/FUJ,9907093,4.323796399268767,3.560058091769193
SK-HEP-1,56649450,4.110961369423777,3.5515506578635527
SW948,11238147,1.5812364597614252,2.499876779618393
MOLM-13,60700,-3.6931560077615337,-1.2667118248632174
SK-OV-3,54618164,4.236989567252486,4.197360276177933
WM115,53232,2.2909547616931243,2.8357165991571582
Granta-519,11213558,2.214733921051264,1.2743367492063529
HCC1500,12001922,1.110118640671234,1.8193285248205258
MDST8,12003241,0.3559193403256231,-1.1654020729787309
ML-1 [Human thyroid carcinoma],452548,-2.1962617612927375,0.7243010432366266
MOLP-8,44819697,-0.0313402586892576,-0.9061402471768685
COR-L95,136227924,2.879022500990784,2.381628498585441
Granta-519,135421197,0.2234065586927925,1.2217363918504827
MOLP-8,SNX-2112-bortezomib (250-1 mol-mol),-3.1816176018347018,-2.6019551888180854
SW48,6505803,-3.5264924347891897,-0.4759689204496017
IGROV-1,8515,2.1861539315976053,4.0537811392479695
ML-1 [Human thyroid carcinoma],10410894,4.287937298613586,3.6580508168478576
RCC10RGB,doxorubicin-navitoclax (2-1 mol-mol),1.2475465934468772,-0.5389005621699892
MOLM-13,25102847,-4.845176201807707,1.7917922515030553
SK-CO-1,selumetinib-JQ-1 (4-1 mol-mol),-1.696692082912101,1.2603445673392513
SW1271,53481919,3.611390941951582,3.822646384360687
RERF-LC-MS,24964624,3.0594292113466515,2.787427699281866
LCLC-97TM1,969516,2.175595213634207,2.7731269252377224
WM115,JQ-1-carboplatin (1-1 mol-mol),1.8205622185822876,2.419465408841073
RKN,49793307,-1.2643121180608,-2.6064471354818335
K-562,selumetinib-tretinoin (2-1 mol-mol),3.758766106216507,2.71728245628622
SU-DHL-1,15547703,1.7605543364675147,2.9994949146381464
COR-L95,11625818,4.182153411947424,4.043912673446596
BICR 22,12003241,-0.4808187565312439,-1.3364278557832676
LCLC-97TM1,124202324,2.4863882679536133,2.152671889457545
BICR 22,24797083,1.5794716057353129,1.5277607238303414
WM115,136227331,3.7917327546536983,3.9112000259011297
MOLP-8,23725625,3.090240324780466,3.405359790076695
NCI-H1568,3552672,1.826953477138791,2.9943470151313516
SU-DHL-1,selumetinib-navitoclax (8-1 mol-mol),2.4518113927127754,1.262297231916711
IA-LM,51039095,2.817946248906647,2.7999321338719425
K-562,11964036,1.6077176524784418,0.5839440186964263
HCC1500,5470400,-1.7385310235308598,-0.17148650219192707
SU-DHL-1,11396600,2.533401176626175,3.538024514527475
BFTC-909,216345,4.226804426652683,4.120044069140652
Panc 02.03,71304818,4.256945507775637,2.5304138977049306
Panc 02.03,219104,4.2068478561753375,4.008622138176675
SW948,23582824,0.2041553679799947,1.0563191932570593
NCI-H2452,5287620,-2.107035322199283,-2.080344059634221
SW1271,15953870,2.918493523161381,3.631130985046477
IGROV-1,119182,0.2112476135388779,-0.4383159745697547
SW1271,11656518,1.475105479065936,1.8951263605206108
Panc 02.03,49766530,0.9655059796360064,-0.3990476634679084
LS180,89928392,1.7442798189695845,1.5027778043199178
SW1573,53495165,2.229023421141798,0.823203654510399
WM115,16659841,5.127619480623103,3.726456376032534
SW1271,3552672,3.981050843991283,2.6644193218380887
SW948,9926054,1.8406028662949705,1.9183684360349418
MOLP-8,JQ-1-MK-0752 (1-1 mol-mol),-1.2157281413611027,0.18856143000594244
RCC10RGB,71466445,4.397911896340776,4.137189037222681
WM115,7326481,2.374260909001927,2.8197926300136986
SW948,44202524,1.7116279237548724,2.1539057985160106
RCC10RGB,46907787,5.224507823938942,2.3578773104053394
LS411N,9936388,1.997277136132151,-3.7318072660055095
SW1271,135423438,1.1699634662635283,2.2296708594462267
SK-OV-3,ISOX-bortezomib (250-1 mol-mol),1.1042689402938264,0.6064007520931292
COR-L105,123631,-0.3749766708664047,2.150241274772883
MOLM-13,52947716,-3.8827491455655694,-3.1030572587205993
HEL,36314,-3.7348038354216593,-2.68226008410878
KU-19-19,54454,2.6957608866389866,2.6140749224390656
Granta-519,BRD-A02303741-navitoclax (2-1 mol-mol),-0.3585433064620935,-0.016133277746549986
MOLM-13,71680916,4.890723285268907,3.7377767737264818
SW1573,65628,4.136448104244246,4.380808904327979
HuP-T3,11178236,-4.0067645508863174,-2.9619919447375724
WM115,11364421,-5.628114250516673,-0.7712572838022439
K-562,613753,3.252228295501032,2.9650764897675357
IGROV-1,24771867,1.9944882740161016,2.4485577301598
ALL-SIL,11152667,-2.075218964097288,-2.1394745014146124
BICR 31,3081361,0.7844567898788304,2.421618163953081
SK-HEP-1,piperlongumine-MST-312 (1-1 mol-mol),1.9419225552023804,1.8920160664905992
RCC10RGB,4788,6.17872638158586,5.865658198668257
Panc 02.03,11626560,2.1710424521283427,1.963273637602782
IA-LM,11175137,3.357915620650256,2.1912183682103903
RCC10RGB,11626560,2.6825909392900376,2.1547265196426024
SW1573,168313200,1.7327341920391253,3.2315499557608485
Granta-519,2828334,6.191507302277889,5.551590814406985
SK-CO-1,selumetinib-piperlongumine (8-1 mol-mol),0.2146036861774908,2.9974713486993276
MOLM-13,5460769,1.2989705913507943,2.2190715145798205
SU-DHL-1,216345,3.4378126257341406,3.2489927551735054
WM115,vorinostat-navitoclax (4-1 mol-mol),2.428259860783612,1.3779242388727733
MDST8,9926054,1.8075400364112937,2.168077360655388
WM115,676352,1.7628184284101875,1.9462462319051825
BFTC-909,55508,3.078625314561866,3.679071365537374
RKO,100016,5.817852214634293,5.204568585366827
MDST8,46943432,3.6174081091701886,2.559710880753399
SW48,5978,-4.7084088584036525,-2.0653303002036485
ALL-SIL,44491742,3.700418914769662,3.798857553471996
ALL-SIL,navitoclax-piperlongumine (1-1 mol-mol),-1.3160613464557556,-0.46979122909212007
SU-DHL-1,11178236,-5.1175240313736845,-3.379685219256958
BICR 31,11955716,-3.162575487986667,-1.2365569160728633
HARA [Human squamous cell lung carcinoma],11364421,-4.71423157944935,-1.5445712615740146
MOLP-8,374536,-0.3332412159105151,0.8344256748282655
BICR 31,66577038,3.1838871840280745,3.095097532654398
MDST8,409805,3.941558883413243,4.5573917282210346
K-562,6918878,0.8571724386049573,0.815084811478174
ML-1 [Human thyroid carcinoma],56973724,3.438642865372283,3.3776942767596374
COR-L95,crizotinib-PLX-4032 (2-1 mol-mol),1.858262555354691,1.6244683872298769
NCI-H1568,5281321,-2.717480517336961,-0.9730747598312519
LCLC-97TM1,374536,2.574075324433214,2.0039284691751345
HCC1500,docetaxel-tanespimycin (2-1 mol-mol),1.2750885769824285,-2.52047204736294
HCC15,66577038,3.417660968254761,3.0857555771334684
IA-LM,9911463,2.6703246121465436,3.5346063276911908
SW1271,1566236,1.9677070098040983,2.501911289543624
IGROV-1,11238147,2.1723642292765084,3.126229405097642
SK-OV-3,11364421,-1.984047807336832,-1.4931551696594323
SU-DHL-1,54613361,-0.1121754666598921,-0.6592432579267086
COR-L105,119182,0.6226208228567816,-0.46881586872721015
WM115,3384730,6.229532895174781,3.09762039722731
COR-L105,9967941,2.071649254258539,3.8771114491923124
RKO,72193861,0.7735395045157347,0.07441521985410784
COR-L95,753704,4.781559661696253,4.445351472514047
IGROV-1,49766530,-0.195540678413639,-0.12697571079397424
BFTC-909,8515,4.73152093133166,4.053414034003321
Granta-519,31703,-4.611611754102639,-2.7198627128184016
SW48,19582717,4.381046957550593,4.179221633849914
P31/FUJ,selumetinib-GDC-0941 (4-1 mol-mol),0.2780140376369148,0.8268555163359378
HCC15,15547703,3.515422457694346,3.2155480237419876
HARA [Human squamous cell lung carcinoma],36314,-5.79294260923826,-1.934531585320348
SU-DHL-1,BRD-K58730230,4.384837032763104,2.9338923033628364
HuP-T3,2858523,3.211348955084378,3.155547912131948
LCLC-97TM1,24901704,3.846855123751057,2.9717911314311976
NCI-H2452,44607530,1.9759156929339727,1.9270316195935187
HCC15,9936388,-3.3305479025951783,-1.512011247057123
RKO,46191454,0.9841477576830012,1.0115526856750114
SW1271,3081361,2.248142117307072,2.4690064632280193
HEL,100016,4.260371486080393,4.816886721556378
Panc 02.03,327653,3.634511095206161,3.2527747739475243
NCI-H2452,25062766,2.439590704022921,2.0313896993173164
SaOS-2,44607530,1.05170222821091,1.8762720618023638
HEL,5335621,4.9483155198907225,4.059604681513955
BFTC-909,6852167,2.133526407129769,3.0293477280935304
MOLM-13,638278,1.880317910461832,2.8727027771112166
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225,1.6703020718271666
SK-CO-1,387447,-5.86001644251988,-4.072398565294347
MOLP-8,10113978,2.697897563265303,2.3019757219281196
MOLP-8,216239,2.6519870661660803,1.8582900461326057
NCI-H1568,46174525,4.305444868539079,4.586052904059428
HCC15,navitoclax-pluripotin (1-1 mol-mol),-1.3512127688258049,-0.7510082498151057
LCLC-97TM1,44607530,2.097748917507136,1.7421530637550715
SaOS-2,9911463,4.168030006572111,3.7880007080063614
Daudi,24889392,0.6157424479011876,3.6107973015957713
PaTu 8902,51039095,3.3801139171258976,2.7678695894307555
Panc 02.03,navitoclax-piperlongumine (1-1 mol-mol),3.4917646743182216,1.773240135338268
COR-L95,JQ-1-UNC0638 (2-1 mol-mol),1.8178477009164715,1.3839966651456488
Daudi,387447,-5.635352264179238,-5.011870384253775
IGROV-1,5702613,4.420745339537274,3.052119674085197
LS180,375860,-0.0541765269880971,-0.18369715203883172
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334,-0.31230280387015397
MOLP-8,241158,1.846975252387852,2.6595527215132937
SW948,44819697,-1.5719383449848416,-0.4305448518442587
NCI-H2452,5951923,4.988154330604512,4.558186825444571
MOLM-13,54613361,-1.833470941599732,-0.8856050078337335
SW948,148198,-4.802987893737634,-3.4572002618178033
BFTC-909,4261,3.835594401773327,1.7318277079961195
Daudi,45100481,4.914271492759253,2.9840097089760462
MOLM-13,3384730,-1.9717967977442377,1.4009787633286996
IGROV-1,5566,3.174346862827938,3.1398780763426486
SU-DHL-1,10302451,2.2731723403274535,2.9982114625088276
NCI-H1568,SNX-2112-bortezomib (250-1 mol-mol),1.539717951588267,-0.8018567663364451
RKN,24797083,0.944322820476056,1.3340662787025521
SK-HEP-1,148198,-3.434194259121147,-3.253224895150938
SW48,16736978,1.8227831775957584,1.4553517971181826
HCC15,2708,6.122532058448304,4.896212642097731
SW48,5335621,4.0461877603353855,4.532739876131094
SW948,JQ-1-MK-0752 (1-1 mol-mol),3.431430026033012,1.246224128996384
NCI-H1568,71304818,2.2110745175145876,2.5522565171818843
COR-L105,5311,1.9211659995219237,1.753886224504633
SK-OV-3,5328940,3.4311724872159903,1.932434568708166
RCC10RGB,1716436,3.489109378341682,3.153167435919914
MDST8,6918878,1.145593411739036,3.099830604131543
RKO,11364421,1.233720517884939,-3.4370878761771397
P31/FUJ,65064,5.109694638799521,4.120958778769682
HARA [Human squamous cell lung carcinoma],BRD-K27188169-navitoclax (2-1 mol-mol),2.401020533417727,2.4778535854778085
PaTu 8902,3025944,5.120505038776715,4.2712625530911446
Panc 02.03,12001922,2.5444953584324193,1.9880051201273803
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249,2.053690253302099
ALL-SIL,54454,2.130103786841792,2.28484033545523
Daudi,11238147,1.1945947480643642,1.8892639306575012
WM115,148124,-1.9357807696466565,-1.7376511077194203
PaTu 8988t,25262965,-2.4539636298097376,-1.3796033595787953
IA-LM,49766530,-3.412847117105243,-1.6283169910726787
Granta-519,44185566,0.7632366174102183,1.4256877756527007
MOLP-8,44607530,1.0628729381864028,1.2947627879491281
K-562,409805,3.7514940654800064,4.006568548548678
BICR 31,89928392,2.942196417475874,1.8447093048725116
SW48,23725625,4.606874242451815,5.073090701842026
RCC10RGB,16038120,1.536821218292656,1.3759403549877953
MDST8,UNC0638-navitoclax (1-1 mol-mol),0.0251885834350385,1.5312710726667023
RKO,148198,-2.1467795088860875,-3.7341262593130553
SK-CO-1,409805,5.790109243945559,4.8674560491820875
HuP-T3,7251185,1.9415241444855404,2.6642502091401976
LS180,11612883,2.759028826688456,2.8512005210796683
WM115,11507802,3.278245549501506,1.9220773707162848
IA-LM,168313016,4.257474229118996,4.0963660273335964
ML-1 [Human thyroid carcinoma],5566,3.147714437598846,3.13770031637504
MOLM-13,crizotinib-PLX-4032 (2-1 mol-mol),0.492576617206884,0.92813268970304
SW48,10302451,2.1638159560649157,3.2642793728490602
Daudi,65064,2.8809848507042095,3.853367180477473
LS411N,11612883,3.0472980958623705,2.0945218965909236
NCI-H2452,11214940,1.2392722713501154,1.7295391734982402
ALL-SIL,984333,-1.3370961884574026,-0.7465331293224247
P31/FUJ,1641662,2.802136916275355,2.9207769942532913
MOLM-13,25183872,-2.142456248879295,-2.1979192631223157
K-562,969516,2.7986550178028216,2.3025200843825133
Granta-519,54143018,0.4327684951223574,-0.580642707838441
SU-DHL-1,44819697,-0.3444138900100821,-0.2128143389942674
HEL,selumetinib-vorinostat (8-1 mol-mol),2.406012225394231,1.3404677812923487
Daudi,9933475,1.2993243126142855,1.477050947739059
SK-CO-1,10427712,4.208191107568486,4.246916033032637
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225,3.5534008323469037
HEL,2841722,4.805306475973069,3.8215142983662593
COR-L105,9926054,1.7310748902984938,2.0668133640824315
RCC10RGB,15983966,2.263334704673794,-0.2468962215561627
COR-L105,JQ-1-carboplatin (1-1 mol-mol),-0.012244733852177,2.6251259628228922
IGROV-1,46174525,4.5083762186279595,4.482596218849007
BICR 31,11175137,2.7548462189262817,2.8384382766261065
COR-L105,11609586,4.426382611322312,3.012108552090609
COR-L105,tretinoin-carboplatin (2-1 mol-mol),4.8464312209914056,5.126285296302004
IGROV-1,107985,-2.8971910842184516,-3.4054054961410123
SW48,selumetinib-tretinoin (2-1 mol-mol),-3.039219122646087,3.213348777427114
IA-LM,71466380,4.547922152882383,4.359618578139626
Granta-519,navitoclax-sorafenib (1-1 mol-mol),-1.03945044820541,-0.2274757433281653
K-562,11612883,3.292128537791773,1.9592686206030543
HuP-T3,15953870,4.533958601099395,3.6978203114235657
NCI-H1568,219104,4.078417481216408,3.8078157239215438
RKO,65064,4.5178366082525,4.170363415762408
NCI-H1568,9911463,2.564901149372131,3.9349804025075885
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384,-0.48525122362711187
ALL-SIL,6852167,2.025737624061405,1.5724673025320732
Daudi,16065773,1.627011760718674,1.8380294796965924
MOLP-8,10410894,2.1334782114390425,2.5512524440775084
RERF-LC-MS,73707371,5.9060077591992375,5.095935290167931
RKN,1566236,1.687441004968786,2.4664002692565528
IGROV-1,439501,-2.1510551928674557,-1.9064117958009776
MOLM-13,57519531,1.2030375936335158,1.390519929614477
Granta-519,11625818,4.458439944218401,3.387201002182186
WM115,JQ-1-navitoclax (2-1 mol-mol),1.0904660510926631,0.9279856040483839
MOLP-8,3689413,-2.303477592076259,-1.3651584165217725
SK-HEP-1,54596558,4.485352352092043,4.268800422684225
SW1271,4705,3.86061099620112,3.4580749397524295
Granta-519,9927531,4.885085469625254,4.123952309508437
SU-DHL-1,11427553,0.3775832797434548,2.273386596700585
ALL-SIL,15953870,2.429039509996585,2.74889988428127
COR-L105,4259181,2.2372065992854133,0.5166760573738753
HCC15,17759555,4.480266922784899,3.6755031179930198
COR-L105,10184653,-3.6529884694455608,1.4784043997950147
RKO,72376,-2.4980018930037673,-2.804095975984923
RKN,vorinostat-carboplatin (1-1 mol-mol),3.833796397117187,3.204550308394975
RKO,613753,3.427719504210608,2.8277676048633626
LCLC-97TM1,10302451,3.3699574981481217,2.7684205489653113
PaTu 8988t,JQ-1-UNC0638 (2-1 mol-mol),3.720997870166264,1.7195491056585923
MOLP-8,3634881,2.730356562919761,2.6291781111333266
SW948,11612883,1.2539645440532456,2.3662500256062167
HCC1500,carboplatin-etoposide (40-17 mol-mol),4.564857215457985,2.4641854940306325
BFTC-909,10074640,3.0053798884123837,3.2908809061389066
LS411N,24901704,3.828527152917887,2.730093907926588
SW1271,51039095,2.010271277744507,2.763427013395709
K-562,9935249,0.8993678101188762,1.9688851166559018
COR-L105,462382,1.111643181026989,0.5661082427690602
Granta-519,10385095,0.7144131323279258,0.9498295082210899
COR-L105,5281321,-2.635307184860664,-1.1940044941672177
KU-19-19,selumetinib-piperlongumine (8-1 mol-mol),2.2054937321135775,3.3862059480469573
LS180,11234052,4.148077533652898,4.011322965969769
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556,-1.033691546082411
COR-L95,25154868,4.601001468087818,4.019431768470524
Daudi,3025944,3.5610963405625267,3.9076897002016135
SW48,24180125,2.6937498240420457,2.9492437686916286
SW948,navitoclax-birinapant (1-1 mol-mol),2.127959258569347,1.4238047993544183
PaTu 8902,168312962,5.583922762984923,2.0217973704582923
COR-L105,5280436,1.8180108392693488,3.8381072795489395
SU-DHL-1,44507138,1.5242294298964132,1.7747088007104452
MOLM-13,10302451,1.7245492330691454,2.743940383437131
HARA [Human squamous cell lung carcinoma],72376,-2.3262904878865083,-1.7228324795980186
SK-HEP-1,44607531,1.6636821475505756,1.5369192355893
IA-LM,15983966,2.169762444969255,-2.5977427691959867
IGROV-1,56946209,-4.416985130578084,-3.97998974791757
P31/FUJ,25126798,3.55669651950966,3.464686963334899
LS180,piperlongumine-MST-312 (1-1 mol-mol),1.6478111921038412,1.7265738466642653
BICR 31,15983966,1.7355748159582445,-0.18540575442002827
ML-1 [Human thyroid carcinoma],carboplatin-UNC0638 (2-1 mol-mol),3.254418532258765,3.6730417157413187
NCI-H1568,135421197,1.29303587511011,1.8471877589224315
HEL,374536,0.3200488785786777,0.7006767009990351
NCI-H1568,25161177,4.305259269080427,4.2547865653972226
Granta-519,24951314,0.3336244464551668,0.08390994669964073
LS180,400769,-0.7559227838025858,-0.5374279231434294
MDST8,44607531,3.32682409463767,1.7237487803346894
WM115,46843906,3.7194943725295992,3.230435567930022
RKN,24771867,0.8860225124393014,2.4741463926967113
HCC15,tanespimycin-gemcitabine (1-1 mol-mol),-1.7446538355575971,-0.9400692722641399
MDST8,72734382,4.130038178532864,4.7396976080537465
SK-CO-1,1750826,-0.0283504159212216,-0.5216737299085806
MOLP-8,10184653,1.0374255182903005,0.758970190381331
NCI-H1568,46398810,2.1853633940590966,2.6337509230956204
PaTu 8902,6438330,3.32865710338655,2.3626388308076716
K-562,60700,0.041873955903415,-0.9924383435291163
KU-19-19,23725625,4.865374475902274,5.272699094668895
BFTC-909,6438330,3.0201113942824436,2.527132645533301
Panc 02.03,JQ-1-vorinostat (2-1 mol-mol),1.3831414404100788,1.1954910280019613
HCC15,65064,4.883028365063005,5.037561515583789
HCC1500,285033,-0.4229420433590342,-1.643896437824369
LCLC-97TM1,navitoclax-pluripotin (1-1 mol-mol),-0.4086079898924854,-0.636992915407115
LCLC-97TM1,5479543,3.538440111241957,3.2688263727616778
PaTu 8988t,613753,3.3970334474933495,3.345043093512215
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346,-0.676023529444977
SW1271,2949965,2.7362256869687895,2.952991570996419
SaOS-2,4705,3.668938036329027,3.2263706519618602
KU-19-19,11364421,2.01242470272022,-1.020796550978805
SW1271,676352,2.2943086949623885,2.1008333496636555
RKN,24856436,1.2279395925477072,0.5364253375913336
SW48,159324,-1.9628962598081805,2.8553397775217877
ALL-SIL,568763,-1.7129740739789223,-0.6037274272197859
ML-1 [Human thyroid carcinoma],73707398,0.9772448893034968,1.5845082899902903
WM115,9907093,3.0763750955907883,4.290198441220593
SW948,637858,1.5262532123254355,1.4539455486911583
PaTu 8988t,24901704,4.232615528659116,3.3086850449426093
SU-DHL-1,11238147,0.4308170484254632,2.6737058923517463
BICR 22,alisertib-navitoclax (2-1 mol-mol),0.0230518675395602,0.669988655514702
COR-L105,3634881,3.59150153069964,3.39111068726879
BICR 31,49766530,2.6564815829329236,-0.361780167705567
SU-DHL-6,439501,-2.4303946334698057,-2.482301541294349
SK-CO-1,6438330,2.884853035173295,2.505399608666481
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526,-0.31849603039047164
SW948,23635314,-3.685869994463448,-2.2350708971389492
ML-1 [Human thyroid carcinoma],24951314,0.9772476096511332,1.8068625366375928
RCC10RGB,24753719,5.18895385781671,4.473287315681343
RKN,tanespimycin-gemcitabine (1-1 mol-mol),2.340236610046533,-0.48716152231778687
HCC15,53481919,4.945944641956239,3.986654534187606
HARA [Human squamous cell lung carcinoma],52947716,4.13690029570622,-0.1951530104527864
BICR 31,11612883,2.9886930364048387,3.032502830538697
HEL,20959075,-3.3486318540939535,-2.7960842615049586
SU-DHL-1,24964624,1.891650824203322,2.0445220043196555
K-562,11609586,2.0906528510972775,1.8094442189709798
KU-19-19,89183176,4.239044338938638,4.5937976017224855
MOLM-13,9927531,3.44947203831576,4.317558229980931
COR-L95,10302451,3.773437494355592,3.066829364386596
SW1271,10385095,1.244878723840673,1.3037115338771337
SK-HEP-1,navitoclax-MST-312 (1-1 mol-mol),0.5798914619314417,0.9966675028596522
IGROV-1,17755052,-1.0246415273055465,1.5250418868973012
Daudi,3634881,1.264969339465191,2.4488062090124516
MDST8,46224516,2.508010817025431,2.519164488791434
SK-OV-3,65064,5.055886881526936,4.876337304562783
IA-LM,11364421,2.389092199855664,-3.1630780386774484
P31/FUJ,6918878,-0.2487475841908946,0.5197520767583028
SaOS-2,426756,5.396474834861055,4.37623371548886
MOLP-8,25150857,0.9011737742745826,1.6982526421899293
BFTC-909,11167602,2.8757137848929006,2.6077983850182083
RKO,10302451,3.926970734642152,2.6234352822861307
HCC15,6252,2.2097348223357396,1.0270947518912523
PaTu 8988t,135421197,1.788370067257354,1.9083271116683103
SW48,42642645,-1.378549292450493,0.9417259195068738
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668,-2.5893931446627136
COR-L105,73707398,2.56355231698926,1.3954256518318715
Panc 02.03,3854666,5.373190444337423,2.465333312769275
WM115,11404337,-2.7813606850874595,-0.344792936267742
MDST8,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9743607330604616,3.3897685283924197
K-562,9803433,4.389269041756261,4.355719345039892
LCLC-97TM1,JQ-1-vorinostat (2-1 mol-mol),0.588169137305971,0.5970630251102521
SW48,11152667,-1.5089069748808788,-0.49796483070253045
MOLP-8,BRD-K55473186,4.200306440270822,4.0693529598857054
MOLP-8,3854666,0.8063321236158104,0.9648420615551059
WM115,156422,4.742483160763306,3.9132484031639425
BICR 22,10302451,3.218470138701286,2.080830573901154
P31/FUJ,3815108,3.712799909664185,2.0999147912895673
SK-CO-1,5280436,3.963354946284049,3.4898303018689414
SaOS-2,11625818,4.3669462586555055,4.45535052099408
SaOS-2,serdemetan-SCH-529074 (1-1 mol-mol),2.337619260674083,2.044520307567713
NCI-H1568,24856436,-0.7402646666066086,0.6820655035298654
MOLM-13,19582717,1.836192229041244,2.8725451668847524
SaOS-2,selumetinib-vorinostat (8-1 mol-mol),3.065255136374356,2.5633730977962865
LS411N,65064,5.143309491248943,4.753519976489352
HCC15,selumetinib-PLX-4032 (8-1 mol-mol),2.5653564815538075,3.6202091798485294
SW948,1716436,3.337695569228523,2.8539534184801365
HEL,60750,-4.342121097179363,-3.252457766771975
SW48,5738263,2.8832489904283207,3.455033198322448
HARA [Human squamous cell lung carcinoma],216468,1.0737616041415703,3.33517823734738
LS180,135984461,4.839780886141452,4.030643593521304
ML-1 [Human thyroid carcinoma],123631,2.4078761561490025,2.5165093077875
SW48,3634881,4.093042888484318,3.272340936017491
WM115,82146,3.7974591517158,3.846290349055256
MOLP-8,24901704,2.731912612856625,2.4749681607778484
SU-DHL-1,9826308,0.1808938529022712,0.5229191888920006
SK-HEP-1,60700,1.3088528574816594,0.02363311724319293
SW948,49793307,-5.1176222473357775,-3.202695648315936
BICR 31,selumetinib-decitabine (4-1 mol-mol),4.509241156469813,3.9064517828423204
P31/FUJ,15953870,2.7000087530897776,2.9639688526700767
SK-CO-1,24901704,3.265743022928408,3.390696176379473
K-562,selumetinib-UNC0638 (4-1 mol-mol),3.2530488329097698,2.2594189475487907
Panc 02.03,100016,6.582809568040202,6.363084624414964
RKO,168312962,-2.5117583451491012,0.8414153538306667
RCC10RGB,25126798,4.759098567819552,3.9043084391431604
SW1271,24964624,2.7126751219569147,2.483376726250656
ALL-SIL,9444,2.1167841583667277,3.765452679037156
SW1271,1641662,3.842487885295187,3.5638877526176627
BICR 22,676352,2.452861704781308,2.056715450004618
K-562,54596558,4.166105900128149,4.100777282179471
Panc 02.03,9933475,2.3025810529048205,1.9934739712821676
NCI-H2452,374536,-3.751500666928139,2.5581352470226473
SW48,9825149,0.0451584979105152,1.855823509669307
MDST8,3634881,2.8722303311625006,3.1898581524415914
SW1573,24180125,4.83914798243841,3.1461255206881718
WM115,42642645,1.5932691238490415,1.2236168210726661
SaOS-2,24753719,4.762341084721446,4.402461518476044
SK-CO-1,25062766,1.7088187930933407,2.134318493618613
Daudi,71466445,1.7957550148901065,2.1930653242852585
K-562,9903786,3.6050720376028105,2.097018109670182
MDST8,5281321,-0.743993786053836,-1.2141048996607426
WM115,216345,2.152490626678771,3.8610437169582132
RKO,salermide-PLX-4032 (12-1 mol-mol),6.251314610722333,4.741759479470276
Panc 02.03,44566777,1.8066319547984584,0.5741139714986457
Daudi,carboplatin-etoposide (40-17 mol-mol),-0.43265013296543,0.6690895289284822
SW48,1716436,3.2732206570492512,3.064370045093112
KU-19-19,serdemetan-SCH-529074 (1-1 mol-mol),2.9806718783116337,2.1936276644401933
COR-L95,5281321,-5.086788267908354,-1.4612142130791077
ML-1 [Human thyroid carcinoma],2126,5.801287401499987,4.720719251832758
LS180,5287620,-2.159393408078438,-1.7411136196370913
HCC15,24856436,0.7194572205096856,1.0003881892825326
HCC1500,JQ-1-UNC0638 (2-1 mol-mol),1.6511332544763542,1.2393309095853733
RKO,BRD-A02303741-carboplatin (1-1 mol-mol),3.1646455891745084,3.931040903296808
K-562,54613361,-1.429503199294265,-0.8104052736130792
PaTu 8988t,5311281,3.776140248734943,2.735850158348079
HCC15,10090485,4.457627969814505,4.135196900203932
LS411N,1242560,3.5784744482633526,3.11466742913167
P31/FUJ,JQ-1-carboplatin (1-1 mol-mol),-0.13727273351174,-0.4101184792982479
MDST8,3854666,1.4298592595361392,2.446479165979893
HEL,carboplatin-etoposide (40-17 mol-mol),1.8930260059492108,0.48307905881585717
BICR 22,doxorubicin-navitoclax (2-1 mol-mol),-2.5908889748637467,-0.5229531319808269
SaOS-2,448949,2.4147534872316916,1.9926776619300028
K-562,44607531,1.5533391017282614,1.505870297362506
RKO,656346,1.2468664563159324,0.3750237681301947
SW1271,54619267,4.215254166837184,4.2927078651109545
PaTu 8988t,107985,-3.7439330143768106,-3.521912950463902
Daudi,107985,-4.311158471957254,-4.148337191505002
K-562,89928392,1.1726799483120014,0.53524091694025
BICR 22,2828334,6.182973514514405,6.282420769995964
PaTu 8988t,462382,0.0850922030405946,0.6652084607214533
COR-L95,54619267,4.025082196689936,3.9293129795491155
SW48,44486219,4.521255071137468,4.204279862372995
MOLP-8,136227924,1.5113872866650588,2.371952687041537
SU-DHL-1,vorinostat-carboplatin (1-1 mol-mol),1.1997073903631768,2.935332938845773
LS180,176870,3.0513508415646644,3.2410257605847717
ML-1 [Human thyroid carcinoma],409805,4.766723032315811,5.099656965791721
NCI-H2452,60700,-2.076184021255351,-0.07257056420237047
ML-1 [Human thyroid carcinoma],3465537,2.728802739434878,2.4577180578406406
Daudi,2749,-0.7661278600765006,0.9028450272849423
SW1573,SNX-2112-bortezomib (250-1 mol-mol),0.5082376174745985,-0.9168052639205547
HCC15,11364421,-3.377820549130246,-1.1853589980730062
ALL-SIL,135984461,1.7193250250744925,2.594899213901791
HCC1500,1750826,-2.1124887265082255,-1.2160110517209328
RKN,53392493,3.005817826052642,2.7013302503783807
P31/FUJ,JQ-1-UNC0638 (2-1 mol-mol),-0.0749230690326744,-0.09443262829896543
BICR 22,5287969,-2.619429839358568,-1.8737029176307889
BFTC-909,24978538,2.589526114093726,1.4135329293547745
SK-HEP-1,2828334,6.264472809398218,6.153066193813673
Daudi,4705,2.565440722309658,2.865666408578938
HEL,11485656,1.96241131365886,1.6521677407710715
BICR 22,23582824,1.0399288647056628,1.0963315317840248
Daudi,doxorubicin-navitoclax (2-1 mol-mol),-4.527956590288398,-2.6580524349484813
HCC1500,navitoclax-gemcitabine (1-1 mol-mol),-1.5596806456791137,-0.9414427021839868
MOLP-8,11364421,-5.744944118703229,-4.055465358631649
COR-L105,374536,-3.312479831607182,2.401661575161195
SK-CO-1,56973724,0.9140094173628892,3.351691361976423
HCC1500,135440466,3.12374064827048,2.1460460580805862
COR-L105,24978538,1.189273057385404,1.562970904064983
SK-HEP-1,45279963,4.052806603396004,3.7963069939418244
K-562,11317348,0.8853213314815674,1.0469697304135441
RKN,6918837,-0.6134153399361431,-2.696677973359726
LCLC-97TM1,285033,-3.3608842191269104,-2.042583272136591
HCC15,11455910,-0.3399110905288865,1.3711042903103652
SK-HEP-1,176870,5.630942733934813,3.5936664769921163
RKN,23635314,-1.997093039658799,-1.4399477250458903
HuP-T3,selumetinib-BRD-A02303741 (4-1 mol-mol),4.443167910893738,3.496516619537614
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191,1.9829276011296735
SW948,969516,2.384481795832599,2.417211673601176
WM115,24180125,3.7433275341391057,2.9974872327384623
SK-HEP-1,135440466,3.4774178685499324,2.379226584406748
KU-19-19,11626560,2.7733848967135017,2.06742984947763
ML-1 [Human thyroid carcinoma],675434,4.374805668496918,4.712461326559647
LCLC-97TM1,44507138,1.7278080476353117,2.496621931850681
SK-OV-3,25150857,2.8200349544845045,2.5800816026216693
HCC15,44491742,4.47716804785037,4.291965985026434
NCI-H2452,carboplatin-etoposide (40-17 mol-mol),4.403260682335101,3.063937833692836
LCLC-97TM1,25150857,2.1625900659079296,2.2519360045847057
P31/FUJ,124202324,0.9428129005296164,1.16478350010228
IA-LM,BRD-A02303741-navitoclax (2-1 mol-mol),1.2493454608743932,2.208735004521111
COR-L95,6505803,0.0712785503404296,-0.19972239316789828
HCC15,24964624,3.0755429715166063,2.522466308364128
MOLP-8,11647372,0.2904161448795228,0.3388796721765905
BICR 31,11977753,-1.0341786941527915,-1.4315664935194297
HARA [Human squamous cell lung carcinoma],216345,4.215325728716343,4.243069914170021
HuP-T3,5282054,2.779269170716028,3.899224474203026
SW948,54618771,1.4567685239775812,0.8336319648478221
Granta-519,24797083,0.9051026865971544,1.002039690661548
SW48,73707398,0.6331221198690845,1.4878527316762835
BFTC-909,135411,0.8518885281649031,0.653441781594303
HCC1500,675434,3.977739266447536,4.485917691579985
SK-HEP-1,6918328,0.8938731782790444,0.2771640679317737
ML-1 [Human thyroid carcinoma],2113511,5.6174346670931286,5.672519297327941
LS180,159324,3.258862193159196,3.0652675649321117
HEL,168312962,0.5016152377841688,0.2535053147492784
SaOS-2,44607531,1.4975746891341548,1.492276035469017
IA-LM,vorinostat-navitoclax (4-1 mol-mol),2.163605213189375,1.087365586301296
MOLP-8,6610216,4.187822370904977,3.922413928437984
HCC1500,5278396,3.6802956879537856,3.5668664113857265
K-562,445643,4.07029800941494,3.5878353873047035
HARA [Human squamous cell lung carcinoma],11178236,-2.833191042701781,-3.0882839353056943
Panc 02.03,5351362,2.6810485074832,1.4706031058368974
BFTC-909,23725625,7.000464253417552,5.2844247044980674
SK-OV-3,8515,5.143916520422132,4.252949895810661
RKO,24779724,5.847036108864024,3.6973470433600397
MOLM-13,65064,3.286890258414819,4.275824025448253
P31/FUJ,9868037,1.2869642230829814,1.9411920978540909
MOLP-8,52912189,-0.8757353744499203,-0.0011506988156779541
HCC15,2113511,6.327015395869061,5.4791951400259835
IGROV-1,25183872,-0.4560099928976716,-0.4667045449957205
MOLM-13,44259,-1.8425758706378912,0.9071203545173687
P31/FUJ,9911830,2.020541196825024,2.0256914592066
NCI-H1568,11455910,-0.0792581795853734,1.3287415123896247
Granta-519,409805,2.9966967612339417,3.6016626453980054
IA-LM,7251185,3.003277248553597,2.0857473264458064
LCLC-97TM1,24771867,-3.13973757551719,1.3485310663564745
SaOS-2,387447,-3.480142635313653,-4.359364578992347
SW1573,JQ-1-carboplatin (1-1 mol-mol),2.7673375122522,2.590342537165194
HCC15,71466380,4.492977556176778,4.512876606428866
KU-19-19,11178236,-2.578122805273377,-3.2277287627088294
SK-HEP-1,107970,2.7276242080982405,2.4723784181565347
SW948,3503,2.019264798250741,2.3106028407255748
MOLM-13,11455910,-0.3133362084586128,0.4604344001620928
COR-L95,216239,1.9606601522489808,2.156830604219909
MOLM-13,20959075,-3.627453597088981,-3.153713326265828
SW1573,3543504,3.864321270652805,4.537048646706542
NCI-H2452,16722836,1.367876124233394,1.9477812123020934
LCLC-97TM1,2949965,2.4577774402858203,2.689381941418394
HARA [Human squamous cell lung carcinoma],5479543,3.520150804916199,3.6561893191462214
SK-HEP-1,9911463,4.3683168964450125,3.987660955050139
P31/FUJ,11404337,-0.879305702132212,-1.2185163698006258
RERF-LC-MS,23725625,5.011639185934848,5.266615051723846
LS411N,alisertib-navitoclax (2-1 mol-mol),1.9281713469171404,0.05264148363891619
SW48,126941,-4.535727103151088,-2.5387078755454833
BFTC-909,6184667,3.207156937684644,3.184150646127485
KU-19-19,2945648,2.475372674219151,3.092033087485738
HuP-T3,387447,-4.787053098216054,-3.944449842134269
Panc 02.03,44493528,4.298055948100647,4.4676634710980565
Daudi,4788,4.597613323137637,4.916439413682488
K-562,46907787,1.0881737362577,-0.2282507752418222
HCC15,6505803,-2.813846830430111,-0.8771702635696427
MOLM-13,3503,1.2246558483585983,1.8044625603882816
NCI-H1568,136227924,3.032081072579533,3.0514581807124546
RKO,9444,4.448790979485227,3.6130267449167133
Daudi,107970,1.216737596928884,1.813591183488565
Daudi,5311037,3.4563783042396015,2.9824044455878522
SW948,10184653,-0.1197105127119604,0.8805877644884024
HEL,89928392,0.5480178499310975,0.18858207143458638
SK-HEP-1,5566,3.210365271342881,3.098279462963614
NCI-H2452,44493528,4.324080951064212,4.516782118434594
SW948,24753719,4.222068008445673,3.5719010518371594
K-562,11717001,4.3318290739670555,3.9640527346862613
HCC15,11647372,2.6612404016221824,1.0947667745431013
COR-L95,11214940,4.129361910595318,1.9799227511601258
P31/FUJ,57330099,4.216278217816623,3.780390212463422
COR-L95,24889392,4.336996294263524,3.8190958304531666
ALL-SIL,16725315,3.2612856597636064,3.3578686091169025
SU-DHL-1,2749,0.1348057545057474,1.9823399253068164
IGROV-1,6918736,-0.950858733923241,-1.6475765773128348
HEL,46398810,0.908204113249262,1.964812716050937
COR-L105,969516,2.680370673187369,2.9565924090259488
MOLP-8,613000,0.7667530859484226,2.5624313876652356
HARA [Human squamous cell lung carcinoma],6252,0.9917938801151434,0.9361905629531785
SW948,375860,-0.5776308885037049,-0.2046765095263822
Granta-519,6438330,1.446800550416973,0.9924146836185378
SaOS-2,3384730,0.9471099210722488,2.99500824889995
COR-L105,navitoclax-pluripotin (1-1 mol-mol),-0.739242899323645,-0.5906549126000481
SW948,10127622,1.0689347689119728,2.8043723324834144
SK-OV-3,104842,-0.359869843998673,-2.549549733429188
HCC15,2733526,3.237047771361035,3.7018785666021596
ALL-SIL,9884685,1.523019065964201,-0.18584034437155336
HCC1500,31703,-0.1591983874970776,-0.6878837051280879
MOLP-8,24785538,-1.5077289265748457,0.08321503371429909
COR-L95,6918328,0.296514622397876,-0.8653695595682248
LS180,24964624,2.8898766327054153,2.3715378278865966
PaTu 8902,2945648,2.947030382730425,3.0232889518336914
IA-LM,16038120,1.0865848932778794,0.8448899164580994
Daudi,54619267,3.035333918034676,3.639619151799041
Daudi,5284373,1.725683673378691,2.2473420521540763
SW948,56946209,-4.45606402023299,-3.8789323363210584
SU-DHL-1,9956119,2.7884192993685666,3.4274835471828338
PaTu 8988t,3689413,2.4784022576221836,-0.013298746241306893
WM115,44241473,4.443917717257507,4.802936001178623
HEL,11507802,0.749942791895586,0.6813046721398008
LS180,25150857,2.6595729662678846,2.4295992259799175
ALL-SIL,11964036,0.9057184864624424,0.2972763546620179
SW1271,5351362,2.529410314371741,1.5634197487666677
KU-19-19,151289,4.45756440863607,1.1265659382750222
MDST8,24785538,2.8042557252914597,1.8960890353594337
LCLC-97TM1,11228183,2.6499520646531254,1.7737222137965873
NCI-H1568,10127622,5.078058454742808,4.016233549192103
RKN,676352,2.5860960344205175,2.1166710157781754
WM115,6505803,-4.475953396274594,-0.27291234194920216
MOLM-13,5278396,2.870927952465231,3.031498483266105
SW48,1641662,2.4016053281737544,3.5803820078280237
Panc 02.03,5329102,3.1751218779490404,2.1760614235589504
P31/FUJ,136227924,2.3905530687579497,2.3156378531276243
LCLC-97TM1,5281321,-1.0764177966981967,-1.1794528606717791
SU-DHL-1,23635314,-2.2508595154996844,-0.9686086016508894
SK-HEP-1,navitoclax-pluripotin (1-1 mol-mol),-0.7942291093316414,-0.6760903869684085
MOLM-13,44494015,-5.247330257185634,2.6066982378356336
SK-OV-3,carboplatin-UNC0638 (2-1 mol-mol),3.7911977444327034,3.559479285726519
HCC1500,46199207,3.053954841618667,3.278956761010996
NCI-H1568,6610355,3.436001375430949,4.6363649529942155
HCC15,54618164,4.329878027642837,4.0086662634846375
RKN,969516,2.6409066030454804,2.831175252630633
COR-L105,71680916,4.738410817171978,5.001720298692207
SU-DHL-6,3634881,2.3700422517918653,2.6179038342094794
Daudi,374536,1.069903440531545,1.223448922992204
K-562,322968,4.0833948777840225,2.5369179516830314
HCC15,tretinoin-navitoclax (4-1 mol-mol),0.5454082454604786,2.650838565031466
K-562,136227924,2.737847329779252,2.4449595245668947
HCC15,15953870,3.1000423449826275,3.6567060833874483
BICR 22,6505803,-0.8504421983690468,-0.5974766792377405
BICR 31,409805,3.7719372874267982,4.942282412628906
MOLM-13,navitoclax-pluripotin (1-1 mol-mol),-3.59227040291678,-2.099270381744594
KU-19-19,71304818,1.8280747292346609,2.559350603615454
SW1271,6917907,-6.616351101315701,-5.140656956984692
SW48,44589607,2.4172125993075335,3.0441976938671393
KU-19-19,3854666,3.1161318305167995,2.270284097537426
MOLP-8,11404337,-0.9705317414577028,-1.277275216643171
SK-OV-3,11152667,-0.6824217491873509,0.17249448267615985
LCLC-97TM1,72199292,1.0139745528188595,0.39911025849734216
SK-OV-3,5566,3.179406871626594,3.0059031612492735
SU-DHL-1,11683005,2.624367478757415,2.871516183352341
PaTu 8902,71466380,4.078142681912824,4.592614625493071
Daudi,56963564,0.012925039709307,-0.048777710106318324
HARA [Human squamous cell lung carcinoma],656346,-0.3153592740671193,0.8973864098540009
SU-DHL-1,25195348,1.1859308431356896,2.5357165419869276
RERF-LC-MS,11494412,1.0302757077826894,1.8944736288930124
IGROV-1,3634881,2.769147818550815,3.2454497017594157
SW48,445643,3.7110082204631545,3.878526862921977
IGROV-1,3854666,2.3355254440561137,2.224601301929646
BICR 31,tanespimycin-gemcitabine (1-1 mol-mol),0.6260798256664765,-0.4173448047314867
HARA [Human squamous cell lung carcinoma],49867926,4.231294833351195,4.291954579598407
PaTu 8902,387447,-3.44390255134181,-4.131003676672595
BICR 22,25150857,2.1797682691439233,2.40304876644432
SK-HEP-1,54618164,4.274964046269975,4.161319996016197
BICR 22,44493528,4.288893884195869,4.511659102199673
NCI-H1568,969516,2.3539842482072353,3.1879015501453605
HEL,52912189,-0.3930066433927971,0.06031975709242191
BICR 31,53392493,3.0187901836288824,2.8736225354912324
Panc 02.03,6610216,4.56797737488032,4.3139356179483626
PaTu 8988t,selumetinib-UNC0638 (4-1 mol-mol),4.596522805557342,3.2511317984395647
SaOS-2,445643,3.906030165734591,4.006632180398137
SU-DHL-1,9967941,3.123701665105139,3.3558631153119425
P31/FUJ,10113978,2.718593007254544,2.3086969548531586
K-562,54618771,1.1969173800987956,0.513547612934043
SW1271,445643,4.255849699563793,3.8447126580585977
SU-DHL-1,16741245,1.9818901112506189,3.722809136071553
Granta-519,selumetinib-GDC-0941 (4-1 mol-mol),1.138104902542422,0.1439171924874497
SU-DHL-1,9935249,2.376788737359572,2.699327789962374
HCC1500,doxorubicin-navitoclax (2-1 mol-mol),-1.8241267045237697,-1.1420697453975093
Daudi,11625818,2.088957631704298,3.310079513485728
IGROV-1,11213558,0.52356811652227,1.6937531297679704
HCC1500,selumetinib-MK-2206 (8-1 mol-mol),4.693148185456232,2.306881003360668
SaOS-2,9907093,3.731287417721421,4.224225679333802
COR-L105,54618771,2.0419110046350135,1.6905052274331067
RKO,9935249,5.020114551473781,1.6838444346625625
RCC10RGB,54649381,5.891551456540707,4.041092209044601
RCC10RGB,11228183,3.0224846047699288,3.041971874507314
BFTC-909,selumetinib-navitoclax (8-1 mol-mol),4.610305702630868,2.3731317865370354
ALL-SIL,11683005,2.0727325774258794,3.1262706485527434
RKN,9935249,4.428036529076262,3.17573009518442
SK-HEP-1,6918837,-2.2229066751457345,-2.397224689089626
Panc 02.03,36462,3.4500230117265933,2.416797605998747
SU-DHL-1,9866186,-0.7631869517914462,0.8899974265949335
LCLC-97TM1,448949,2.0046135576158637,2.0487770607945963
SW1271,2858523,3.03244629786768,3.1008399016586594
SaOS-2,46398810,2.449640817433895,2.7242109441352174
ML-1 [Human thyroid carcinoma],navitoclax-piperlongumine (1-1 mol-mol),1.771267146894677,2.169592744895661
COR-L105,16013152,4.074366111138725,4.230131222496808
SW1271,10127622,0.8769341404821704,3.6512758737219246
PaTu 8902,24951314,1.6215809376037376,1.5458281878068107
P31/FUJ,navitoclax-birinapant (1-1 mol-mol),-0.4716815446348188,-0.31870338291095673
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733,1.0010597638837029
Daudi,72199292,0.1565760694605324,0.6763381288013897
PaTu 8902,409805,5.142449436796194,4.9971128168570695
BFTC-909,16115403,-3.993091010962378,-3.8542107304325244
LS411N,serdemetan-SCH-529074 (1-1 mol-mol),2.4339981987212256,1.5067927938673022
NCI-H2452,6505803,0.3706171048891257,-0.15371180116407704
K-562,123631,1.7867714727142892,1.9060473806884244
SW948,selumetinib-vorinostat (8-1 mol-mol),-0.2109654118959779,1.6619475523106573
SW948,56963564,0.1376223024943695,0.23036086715413798
P31/FUJ,doxorubicin-navitoclax (2-1 mol-mol),-2.963925883799113,-2.5870862518347284
KU-19-19,25183872,1.353604037781074,-0.7048620527085778
K-562,462382,0.6666012292356907,0.5879120490920022
BICR 22,216239,3.622359576149126,2.5807485841575266
SW948,72376,-2.235310823117723,-2.7920754301575617
SK-HEP-1,16736978,1.840110323821058,1.9267771641900424
LS411N,135440466,2.8415058675889,2.332313244348524
BICR 31,2871966,0.8542621552894032,1.0088635311411855
NCI-H2452,5311281,2.597680352332147,2.430157066906602
HEL,25195348,3.2451646073619416,2.4032737274451548
MOLP-8,navitoclax-MST-312 (1-1 mol-mol),1.0636024254561756,0.5221052415199652
SW48,24856436,-0.3608375787119608,0.3460135476688901
COR-L95,23582824,1.713723586402061,0.5740644782881413
NCI-H2452,400769,-0.2625889565980605,-0.3272544132357116
Granta-519,6610355,5.056177796240837,3.7808143320082963
RKN,135984461,0.6080422026652917,3.8549556503283697
IGROV-1,9956119,3.7231415872817024,3.6938636686195228
SU-DHL-1,24856436,-0.2626900450765423,-0.4801723247058331
BICR 31,9911463,4.617619725588035,3.927425280006757
BICR 31,2742550,4.742856926113666,3.897615440330031
Daudi,6450551,1.0042642679666238,1.261910107319035
HEL,57519531,1.593967479342305,1.562862936163468
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638,0.41125033649356957
RKN,216345,4.602972623005823,4.017294110949428
SW48,46224516,2.362473255058207,2.3655111808819966
RKN,10184653,1.939164173873933,1.4766863631801492
MOLP-8,31703,-3.4249459011432912,-1.9113807904556481
HCC15,9911830,1.9028880277746671,2.6251810130615394
P31/FUJ,24180125,3.650250525491935,2.263587472996133
HCC1500,11427553,3.400784702269924,2.920081553891097
WM115,4378219,1.986798403927216,2.4489401366972747
MOLM-13,445643,3.334033231716822,3.375071042331977
HuP-T3,135440466,1.565116417651368,2.186951373398146
ML-1 [Human thyroid carcinoma],44491742,4.3341380025681175,4.3982723596937925
SaOS-2,5284616,3.138246393599145,2.274313659974084
LCLC-97TM1,156422,4.251965697410575,3.615854999023071
Granta-519,71680916,3.9040498639791226,3.954116943093699
SU-DHL-1,16725315,3.3729799888412257,4.1142953512704175
P31/FUJ,20959075,-3.3972839651855207,-3.0756189588302236
K-562,16720766,1.059873963232806,-0.26153487893784455
WM115,9915743,2.6223908273409515,1.207202308139129
COR-L105,11238147,3.8255779395664065,3.246316606923452
HCC15,6918878,1.2461206152093485,3.0174078197342915
SK-OV-3,11427553,3.3243369937323877,2.8973057152148023
RKN,6918736,-2.1202784612128416,-1.7363326182724939
NCI-H1568,10385095,0.5241849666466598,1.4416750432399286
LS180,6623618,2.712323731600185,2.265137066471611
COR-L105,BRD-A02303741-navitoclax (2-1 mol-mol),1.6973601808682428,2.824752579392891
COR-L95,5287620,-3.7742892062529183,-1.9992246057699885
Daudi,11977753,-5.803293235753203,-2.36540411420416
NCI-H1568,375860,-0.3746562160702436,-0.01764221307671035
Daudi,1242560,2.7879344365615633,3.0359589896984716
RKN,2729026,3.0549768432694377,2.785989650624789
SU-DHL-1,56963564,-1.155496663147979,0.6544152196611873
SK-HEP-1,42642645,1.5394057036271682,1.2775755483512972
COR-L105,9935249,3.5389604716579175,3.3252549679902628
SK-CO-1,107970,2.4721550322855843,2.108847813905603
RKO,5113032,5.90165838842917,4.5798671880126225
SW1573,135411,2.599466343128946,0.8259280198773327
WM115,selumetinib-GDC-0941 (4-1 mol-mol),-1.581349987351192,1.3677707269322084
RCC10RGB,6610355,5.214940260192328,4.896619580337487
BICR 31,5287620,-1.513974949921974,-1.570058739017456
HARA [Human squamous cell lung carcinoma],10427712,4.036967432982734,4.327163853233611
RERF-LC-MS,72376,-2.3536044208150644,-1.3587511048492305
UACC-812,7326481,2.606201441290427,3.0116037846237695
MOLP-8,11717001,3.6554432811683824,3.7904816512928834
P31/FUJ,1317464,4.709019850634407,3.0511411426653092
HARA [Human squamous cell lung carcinoma],9956119,4.138225192842101,3.8825492821414413
HARA [Human squamous cell lung carcinoma],5328940,0.878974684606101,1.7713219197184582
SaOS-2,44507138,2.054017263478066,2.47406215101976
IGROV-1,445091,5.8777802446160825,4.427736738205771
RERF-LC-MS,54613361,-1.445874788963763,0.08426606005804803
RERF-LC-MS,72193861,1.0218744083195843,1.950093339000983
RKN,vorinostat-navitoclax (4-1 mol-mol),2.458310168873828,1.5760773298808666
HEL,56963564,-0.4081404928481738,-0.21286010905308117
PaTu 8902,136227924,3.2072125986231117,3.062942162763248
SW1271,25183872,-0.9123448839798644,-0.9038402365824197
LS411N,navitoclax-MST-312 (1-1 mol-mol),1.1524396159944978,0.9616691045298732
IGROV-1,25154868,4.833387840688245,4.388876683379811
LS180,107970,2.4480125060803077,2.089625757803324
RERF-LC-MS,9840324,5.508232790936476,5.728401181530952
HARA [Human squamous cell lung carcinoma],55508,3.1590088041564752,3.6170988591186193
ML-1 [Human thyroid carcinoma],6918736,-3.4697519345619843,-1.2583728399191552
COR-L95,60700,-2.695152938475503,-1.1917626183185446
HCC15,24785538,0.0662714662573936,1.6047094166553078
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563,3.524978670496088
ALL-SIL,73707398,-0.324762560862376,0.5128593163108984
HuP-T3,23725625,5.187021863055133,5.222841789487968
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163,3.25710475268586
ML-1 [Human thyroid carcinoma],53481919,4.335778865313171,4.142252958975875
MDST8,6505803,-0.0816923181525763,0.2730601317125882
SK-OV-3,5351362,2.7626479495985765,1.5450727275081797
IGROV-1,36462,2.313632721410001,2.244860031269744
BICR 22,54618305,4.315554591509874,4.09002830624311
MDST8,5311281,0.3396864368094036,2.5383392512094067
MDST8,9866186,0.4787443726889831,1.150350674615445
COR-L105,9840324,5.89386509883338,5.8325538772563315
SU-DHL-6,9887053,3.723065049771557,2.7035817347183677
SU-DHL-1,10113978,2.4232665022526154,2.86844975934565
K-562,6610216,3.734328570580528,3.849725508891339
MOLM-13,9936388,-7.059788369591511,-5.441809221493824
Panc 02.03,vorinostat-navitoclax (4-1 mol-mol),1.4480782846728824,1.2487252674486273
WM115,135659046,3.4373276092449667,3.7444439554617386
HARA [Human squamous cell lung carcinoma],16736978,1.7495486591528322,1.8931409538562496
RCC10RGB,2708,5.228545547030361,5.134280408367855
MOLM-13,JQ-1-navitoclax (2-1 mol-mol),-1.828604943394028,-0.10888453037259435
HuP-T3,969516,2.913535439683091,2.803193545215402
P31/FUJ,135398744,5.7727848933678,4.579005883344632
SaOS-2,168312962,3.518591614256865,2.1501184888482983
BICR 31,docetaxel-tanespimycin (2-1 mol-mol),0.9040464385667872,-2.8844235269411564
Panc 02.03,11364421,0.2085573081853932,-0.32643124427575254
SU-DHL-1,3385,0.1709309619587451,3.293422544009066
COR-L105,3854666,3.5309487733662923,2.563978052534301
K-562,3025986,-1.372296763308674,-1.261511831545657
PaTu 8902,25183872,-0.4459453921876214,-0.5979469765880502
BICR 22,25022340,5.75714905141274,3.0831805212811845
SK-CO-1,71466445,5.862416915369376,3.8706528969804594
HEL,159324,1.7687894675630291,1.3981082312304267
P31/FUJ,135411,-0.6620772647112111,0.032628897570417224
K-562,11455910,-0.068399521398108,0.46247631138924944
BICR 31,doxorubicin-navitoclax (2-1 mol-mol),-0.8834140125072127,-0.8233443811093828
SaOS-2,135421197,3.6760992974277817,2.1610558090853407
RKO,54678924,1.753529637740366,1.534782196201443
LS180,9926054,2.059729849775666,2.032415877283343
PaTu 8902,3081361,4.091517551590367,2.5056020653125866
HCC15,54618305,4.644823264977023,4.448852510462734
SK-CO-1,135421197,1.070123520764916,1.9286651416784857
MOLP-8,5282054,2.3704039128819603,2.7697088478248078
Granta-519,2874250,5.483813332492178,4.117581508538914
SW948,15547703,2.460178853059974,2.935684079819824
RKN,11175137,3.1657803092866224,2.701049984483569
HCC1500,15547703,2.6330912213710693,3.265137922979035
PaTu 8988t,3503,2.8268609009838706,2.6382482336500566
P31/FUJ,JQ-1-navitoclax (2-1 mol-mol),-0.8945725612384452,-0.4792047018757934
NCI-H2452,409805,5.262030999116563,5.026625830869684
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062,4.914219875461272
K-562,107985,-3.1543528536618175,-4.06424768021668
RCC10RGB,6918837,-1.099435459858538,-2.212938430113533
HuP-T3,2746,4.662800576379415,3.40899853315758
Granta-519,135928012,3.1328015926823065,3.7665604357751126
HEL,2733487,3.1527152778808794,5.640341575469523
RCC10RGB,11175137,3.603105896683611,2.788131473299671
RKO,51039095,3.7257826703811014,2.423191945200359
WM115,3689413,-0.1044392328624619,0.024770674301131782
SaOS-2,25154868,5.397428200613107,4.4319080651938005
RKO,25195348,3.4491832635970585,2.5658681887744903
BFTC-909,49850262,4.237463012213885,3.970497487419183
SW48,168313047,2.500888470511616,2.277180207495465
WM115,444795,4.375682835505768,4.795310412300575
IGROV-1,5738263,4.037832478240785,3.447646965006121
MOLM-13,24748573,1.5626639761830592,1.6824095566399402
UACC-812,6917907,-5.293133909322777,-3.3761007812070547
IGROV-1,168313200,3.9938362637732983,3.013914772398871
PaTu 8988t,262093,3.2462588578894587,2.817395932009106
KU-19-19,selumetinib-navitoclax (8-1 mol-mol),1.098074451823129,2.3984878154466474
WM115,3543504,4.159835009416132,4.546791500994771
Panc 02.03,selumetinib-MK-2206 (8-1 mol-mol),1.9117134680972272,2.356271533654309
SU-DHL-1,9903786,2.5464454731205777,2.4837822439102126
ALL-SIL,6438330,0.5772640537372373,0.8430044699924031
SK-HEP-1,322968,4.726859452680793,4.068951819710804
ML-1 [Human thyroid carcinoma],1716436,2.512454049061402,3.102674915611855
WM115,2874250,4.6839306454467975,3.7739060409199254
HEL,327653,2.969363674974165,2.5776809339435283
SU-DHL-1,11625818,3.655247454502854,3.9362460668592734
UACC-812,49766530,0.2629782697340875,0.29964097616714386
SU-DHL-1,3815108,2.229733806447586,2.650768259913309
IA-LM,71466445,4.189377103287156,3.255762385528742
HuP-T3,1716436,3.1901993610711092,3.000821672144534
SW948,44566777,0.0218128389697893,0.7914749187178692
SaOS-2,24821094,3.1556587771151117,3.073648630350036
Panc 02.03,135875424,4.996461687769912,4.114926415504106
COR-L95,3136844,6.4544258549997675,4.010111105128401
ML-1 [Human thyroid carcinoma],72193861,1.5092085092070135,2.0343387615733017
LCLC-97TM1,3385,2.7516430893834696,3.576857585855351
K-562,135875424,2.7247406179323055,3.4197976585619743
LS411N,5329102,2.797825403975713,1.6724693594900566
MDST8,24964624,1.7196440159479949,2.604979783748941
KU-19-19,10090485,5.355458016675434,4.057172850348188
HuP-T3,vorinostat-navitoclax (4-1 mol-mol),1.7749149652569187,1.3052707791656888
RKO,89183176,-5.254565057669901,3.149888941646901
WM115,decitabine-navitoclax (2-1 mol-mol),3.441832187102982,2.099126194527053
Daudi,24775005,2.5651956502981093,3.3853433085697997
SW948,46215462,1.7533079238953375,1.562015793519785
BICR 31,6610216,4.499990209090508,4.3636945175755475
ALL-SIL,89928392,-0.8842785165403505,0.13777363990770022
MOLP-8,carboplatin-UNC0638 (2-1 mol-mol),1.5821453597747015,3.0275030605903352
SaOS-2,9933475,1.7767718055197024,1.8117485208175648
LCLC-97TM1,16722836,1.3652485758433368,1.492603047766108
LCLC-97TM1,49793307,-2.6941720612695814,-2.835715381910753
SW48,10127622,-3.686333454689576,3.385835537419174
Daudi,451668,-1.5751627659840317,-0.9756725555413273
NCI-H1568,135398516,0.1447365774963497,2.3977751133964484
MOLP-8,11178236,-5.22072808334844,-3.0001782075709746
NCI-H1568,46907787,2.5747387573296425,2.1759036497180513
PaTu 8988t,6914657,-5.535111189097384,-3.4726500214800033
Daudi,vorinostat-navitoclax (4-1 mol-mol),0.7138664459313301,-0.0057805905083146494
SW948,3025986,-0.0730103520402185,-0.9268199940667152
IGROV-1,11612883,1.8715405446213529,3.0617075573064567
RCC10RGB,3081361,3.5981013353753464,2.4110584021118537
MOLM-13,73707398,-1.293008226929777,0.39217233608199176
RCC10RGB,9915743,0.9759946846108524,1.5394547295862646
HCC1500,24771867,4.066345817331682,2.8372054941931135
K-562,44137675,5.346911467461658,3.387827311472866
BICR 22,89183176,4.4276408454646,4.1535864335523796
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305,-0.6750486998309367
BFTC-909,54619267,3.991913685478571,4.102161908210783
RKO,71304818,0.9175289508752972,2.1566699811569894
SW1271,selumetinib-navitoclax (8-1 mol-mol),0.9104447168636678,2.3253589232418768
BICR 31,25161177,4.144120396566418,4.365070980435516
SK-CO-1,6918328,0.4731277879927994,-0.12298416669606628
RERF-LC-MS,6914657,-3.1593675222943896,-3.5492421950773196
NCI-H1568,44185566,2.743919877007031,2.608193631195286
BICR 22,navitoclax-pluripotin (1-1 mol-mol),0.259222956634469,-1.154130177001781
COR-L95,6852167,3.112371536345172,2.3827241798932564
P31/FUJ,5113032,4.875284905433655,4.364814868418336
BFTC-909,24180125,2.699370118217823,2.9312331440761805
SU-DHL-1,6252,0.3334498529847555,0.13702671152713347
K-562,tanespimycin-gemcitabine (1-1 mol-mol),-1.5492083628260829,-1.9484402555051654
LCLC-97TM1,322968,2.924684365208183,3.4523586452877693
Daudi,60750,-4.624244800464318,-3.600624755855851
NCI-H1568,3385,5.30334090203815,4.152968489638333
COR-L95,5978,-2.5997235685562026,-2.4024285121694064
Daudi,24856436,-0.3602858360333429,-0.5101258105204669
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635,1.1114589823846004
MOLM-13,445455,3.1473640199222386,3.881992372261267
SW1573,135421197,1.3915330004591782,2.03776785857213
HCC1500,16065773,1.504426355167742,2.3056767666132836
HARA [Human squamous cell lung carcinoma],54454,2.560964814308564,2.7054726385287653
K-562,piperlongumine-MST-312 (1-1 mol-mol),1.115742811823549,1.4011170937818174
Daudi,9826308,0.3207715704810925,-0.23700411874404095
RKN,17759555,4.047966260499275,3.567081420730968
RKO,navitoclax-piperlongumine (1-1 mol-mol),3.004924162452904,0.9864139458383983
PaTu 8902,9911463,4.390925153080421,3.9133159435151708
LS180,54613361,-0.777399447336216,-0.14167852611098672
COR-L95,11396600,3.695258257335492,3.3673709304597654
SU-DHL-1,9911463,3.067527187401269,3.638789260711677
COR-L95,4477,0.8356196347588036,0.3430961062478987
SK-CO-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.065917743830426,3.7045726692162595
COR-L105,12001922,2.476912212032941,1.9309094152231137
NCI-H1568,25154868,2.392234118098981,4.47481285545611
P31/FUJ,24964624,0.604485461730223,1.2920524985653556
RKN,11507802,1.1392194525963166,1.7756532345153975
Granta-519,2746,3.996696473436098,1.6921467580055138
BICR 22,6918736,-3.590209831667407,-0.824372408355018
IGROV-1,135423438,0.764137689665023,2.3607359803383217
SaOS-2,5460769,2.263492155098724,2.7880166393505617
MDST8,3025944,3.984610722170807,4.16132449773572
HuP-T3,9935249,3.692881062494191,3.2994288887088006
BICR 31,54618164,5.999146696375086,4.227200961406622
MOLM-13,3552672,1.8354180523958712,2.339644378156661
ALL-SIL,24889392,1.2675997647257198,3.462816898701901
P31/FUJ,5470400,3.6840145170482383,-0.3533456033221172
RCC10RGB,68056272,3.770230744947895,4.040149361918464
K-562,135440466,2.878154323162211,2.082970029237818
KU-19-19,16038120,2.2784541929956563,1.3042372270255993
IGROV-1,969516,2.460805405371151,2.860621637421576
RCC10RGB,54596490,4.957303932772775,4.608160568383658
SW48,54618771,0.2213541125267267,1.2184793519101182
SK-CO-1,56963564,-1.3743653333208103,0.7868769342914402
HARA [Human squamous cell lung carcinoma],7326481,3.3732570103291657,2.99671010999376
SaOS-2,4096211,1.593922478920674,2.1789749242419068
WM115,11317348,4.689716075377342,3.2938212015768613
LCLC-97TM1,ISOX-bortezomib (250-1 mol-mol),0.9661454802906008,0.8379885724806662
LS411N,387447,-3.952629374311597,-4.184422131784888
SK-CO-1,11396600,4.255124433433546,3.8330517679240024
RKO,2828334,5.934464187728916,5.72774014801313
NCI-H2452,6184667,2.981030320075281,3.1955118473953927
MDST8,119182,-3.087899770061731,0.019007412354060477
NCI-H1568,5282054,2.3545727551586744,3.9063790684337083
SK-OV-3,selumetinib-UNC0638 (4-1 mol-mol),4.410799167981822,3.6489016225229283
HuP-T3,navitoclax-sorafenib (1-1 mol-mol),3.5500030348393667,1.8662822480931627
HARA [Human squamous cell lung carcinoma],56963564,-0.1933628562955875,0.6741424428300716
MOLM-13,5311,-0.2452037316548625,0.3934326908525754
Panc 02.03,119607,6.223236877281167,5.4763636654216326
P31/FUJ,5566,2.621678413077409,2.894759684815375
RKN,5311281,3.300248210659573,2.5258856831533705
HARA [Human squamous cell lung carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),2.096379077317258,2.770734689161468
K-562,11152667,-1.0937594737206502,-1.5773302451712221
WM115,241158,3.4880777915567496,4.014100032484619
HARA [Human squamous cell lung carcinoma],176870,3.342277724847585,3.5565196801393677
SW948,11707110,-5.12001559624384,1.3884292653953587
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308,-0.11045641962772264
RKO,3503,2.683687073265507,2.042009817032459
SW48,tretinoin-navitoclax (4-1 mol-mol),1.442618908951043,2.9330018743777795
HCC15,3081361,2.87617011057776,2.5338224603845187
SW1573,25102847,2.4268351657646874,2.5921266301301453
SW48,24785538,-2.175303706573729,1.5035722289466897
NCI-H2452,5329102,1.9284891088724192,2.031258979647649
NCI-H1568,56946209,-4.312547212322036,-3.6405205500286484
SU-DHL-1,23939,4.934189555353841,3.3854079786183893
IGROV-1,2708,4.438419625543199,5.137080706146003
COR-L105,JQ-1-UNC0638 (2-1 mol-mol),-0.3865258904960421,1.705761224928893
K-562,44489675,3.6585617881709585,3.847149958105725
SaOS-2,23582824,0.6839328831098858,0.48088147805520154
WM115,1242560,3.734530534800184,3.7257737527126538
BICR 22,89928392,1.801349914013067,1.731024424101813
MDST8,375860,-0.0509298762434446,-0.042622279490652615
WM115,387447,-5.543981096917634,-3.776207867600693
PaTu 8988t,46215462,1.6929329300119484,2.0435706518572325
SK-CO-1,25150857,2.4521914239487965,2.4903791334671985
RKO,46843906,3.289277038806309,1.5584534971197344
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021,0.5429832616795713
SU-DHL-1,3062316,2.138301047480956,0.4389869884327488
LS180,31703,-0.5385699496513472,-0.49192291601997284
NCI-H1568,54619267,3.44714412714971,4.197822681914459
NCI-H2452,BRD-A02303741-navitoclax (2-1 mol-mol),3.2540850576086644,2.7067675354446425
SK-HEP-1,5351362,3.433378240202124,1.5762663205219978
Granta-519,119607,5.75770191278477,4.281022701415756
HCC15,2729026,2.745990777117554,2.749059801451381
ML-1 [Human thyroid carcinoma],5746,-1.0436745341015816,1.6654740210691978
MOLP-8,24797083,1.4809895165463562,0.8674888890343301
MDST8,446155,3.7715450651151854,2.6955589236374324
SaOS-2,11317348,2.7618337203443377,3.765088914540722
SW948,67156097,-1.6378764151549952,-1.2679903802617403
ALL-SIL,448949,0.3821166271144734,1.2593381327568016
SW948,5287620,-5.231918659547503,-2.058043252884719
HCC1500,selumetinib-decitabine (4-1 mol-mol),6.513754829735322,3.6579571028557805
RKN,159324,4.081844329649501,3.17573009518442
SU-DHL-1,6917907,-5.829381256855267,-5.3073633271640075
BFTC-909,3825829,4.25128930140834,4.26621922786687
SK-CO-1,119607,5.49560679798916,5.318801469082124
LCLC-97TM1,6450551,2.230680139016655,2.3777458548477903
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404,0.768535957224659
HARA [Human squamous cell lung carcinoma],644241,2.250939574369427,2.2630539934059204
HCC1500,54626689,4.657243866783195,4.776122111960853
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903,3.5053648385492835
IGROV-1,9866186,0.4571266497661056,0.8337899226782699
K-562,24772860,-2.920105669473321,-2.550069905231286
SW1573,9956119,4.0915863238100645,3.7083614699842515
BFTC-909,5280436,4.2143472852581025,3.69944094291613
SK-OV-3,5282054,5.04615494272688,3.8636654930417813
SW1271,24180125,2.511417012575286,3.210367866989841
MDST8,doxorubicin-navitoclax (2-1 mol-mol),-1.1540260466133785,-1.0790248316750308
LS180,46398810,2.878388522539818,2.5123673653629717
P31/FUJ,2749,0.384854271149864,0.9418677435456742
NCI-H2452,5281321,-2.0767365956379944,-1.3461886136927999
SaOS-2,9927531,5.410264314347966,4.667862939188819
WM115,156414,1.595819692541897,1.5690258335628011
COR-L95,15983966,3.7167583960216897,-1.4727378365220654
SU-DHL-1,10322450,2.9485372728674473,3.5253100041675203
HuP-T3,66577038,3.287519898796673,3.0811758945202894
Daudi,6505803,0.7229387165377155,-0.9914412391523085
COR-L105,46926350,-4.1614749205792565,-3.824949545331565
HARA [Human squamous cell lung carcinoma],36462,1.692464431977034,2.200218794437612
MOLM-13,tretinoin-carboplatin (2-1 mol-mol),-0.195663512171335,3.1032375448918863
MDST8,24901704,2.355370692316459,3.4386249521527907
IA-LM,navitoclax-piperlongumine (1-1 mol-mol),0.8087427714288938,1.4982774662466836
NCI-H2452,25126798,3.2665335299764298,3.989436609236808
ALL-SIL,107985,-3.6188373708521495,-3.8807175694183305
P31/FUJ,5738263,2.6277017246063252,2.366688050292007
HCC1500,2742550,3.2494473825713026,3.8137672923417547
LCLC-97TM1,54618771,0.7707104681824843,1.068102549127997
MDST8,3062316,2.63216781392049,1.0812307661488663
K-562,100016,4.034095210213227,5.076283607519162
NCI-H2452,136227924,3.4253193575490695,3.152781484152765
IGROV-1,3025986,-1.046010021597061,-0.7793908155828114
IGROV-1,135875424,3.3275053166921347,3.871886274132743
RCC10RGB,400769,0.8506758933165035,-0.23786767105377327
HCC15,44241473,5.510013950441446,4.686159855490962
SK-CO-1,26596,-2.200264316257102,-0.96397633538189
HCC15,613000,1.6197134073445976,2.742771535008785
Granta-519,10427712,3.8202730219655496,3.756659394752601
HCC15,5479543,3.813478020040636,3.7258196643739616
PaTu 8902,135423438,1.708930423466824,2.711521541163023
Panc 02.03,24964624,3.328827283539013,2.701298564639749
LCLC-97TM1,25154868,4.98783448400422,4.3593624327330005
RERF-LC-MS,5113032,4.48589538963195,5.19007320866665
SK-CO-1,168313016,6.229837204453753,5.011209986945675
SW1573,9926054,3.1618263718643513,2.1728568422206043
MOLP-8,451668,-1.0880279758209197,-0.24619562577614915
Granta-519,doxorubicin-navitoclax (2-1 mol-mol),-4.791758111451553,-2.88708132152011
SW1271,46191454,0.8015154670027128,1.7242981722585051
IGROV-1,156414,1.4212019235656712,1.3359143972344043
IA-LM,vorinostat-carboplatin (1-1 mol-mol),4.059193114117947,2.5554037294517906
NCI-H1568,11647372,0.9090690740398496,1.5031487211980374
ALL-SIL,JQ-1-carboplatin (1-1 mol-mol),0.1765424524035188,-0.09958152240870356
HEL,5394,4.33544579006292,3.25602455035985
Daudi,23635314,-4.750280690911186,-2.5748442001286818
SK-OV-3,3543504,4.529917197725731,4.7093227317551865
NCI-H1568,51037431,4.33384460889792,3.190629662406767
SU-DHL-1,2708,2.612747958759665,4.487022365140282
SW48,151289,-0.0884278513227002,1.2545870285068619
SW1271,24772860,-2.1080107772753607,-1.4866050570925653
SW1271,675434,4.352597318848774,4.5743013607492955
Granta-519,44632017,0.2326960109936577,0.6590520720354957
SaOS-2,11955716,-1.373693500458253,-1.1824629357672563
KU-19-19,159324,4.255883770522122,3.378757288711277
SU-DHL-1,4261,-0.6665613942828803,0.9033072023590001
COR-L105,10302451,1.2881684147693646,3.090021004371727
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448,1.1964742295106163
ALL-SIL,4096211,-0.2650943934034739,0.8306074062971579
IGROV-1,216468,0.5330864756407336,3.1349551940066176
Daudi,46907787,-0.707382985228944,-0.33405883503943573
ALL-SIL,11175137,2.2895463411974597,1.6466305020026635
HuP-T3,7326481,3.4338903427833674,3.0936653990175063
SK-OV-3,11626560,2.736987670099794,1.917455333788557
NCI-H1568,5978,-3.194054905017319,-1.4718963049509335
P31/FUJ,25062766,0.5108470478058419,1.5671632581993094
LS180,4261,0.8191216854939201,1.2634621137497435
HEL,71304818,2.1837189642761645,1.9296170958226022
NCI-H1568,71466445,4.632148673172368,4.07571067280456
PaTu 8988t,5282054,4.412677005920707,3.735804109171639
SW1573,54686904,4.039437320121271,3.9185641847180634
RKO,53392493,2.7606647137416616,1.8476892944804937
PaTu 8902,156422,4.606541116596145,3.9470474788072174
COR-L105,54454,1.772071227552003,2.7673363600068743
KU-19-19,9926054,2.3371072555508445,2.0324479423401773
IA-LM,3136844,4.47285753340146,3.6830203305694873
Daudi,3854666,0.3283534306514684,0.7796282502566088
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422,0.15492248401397257
SU-DHL-1,72193861,-0.6645199564816581,1.4401035904564703
SW1573,navitoclax-gemcitabine (1-1 mol-mol),-2.643981149214972,-1.0687690272783192
SK-CO-1,44202524,0.5946445627983161,2.3761730726523833
K-562,1750826,1.7671131923879069,-2.7210678492229734
LCLC-97TM1,3854666,0.8191923722369518,1.6517784490038656
SK-HEP-1,4477,0.3599343153867445,0.5764708258964497
BICR 31,5282054,4.622453961920413,3.895357417380933
ALL-SIL,3025986,-1.187507928097146,-1.630403199683518
BFTC-909,3062316,2.03384364484094,0.975304170485381
ML-1 [Human thyroid carcinoma],135875424,5.514442636506433,4.130053776672689
Granta-519,444795,4.599812836973149,2.9877625295522865
UACC-812,piperlongumine-MST-312 (1-1 mol-mol),1.224354228260847,2.01169340832986
COR-L95,selumetinib-JQ-1 (4-1 mol-mol),4.793493423716469,1.0759714427757983
RKO,1566236,3.4833841973625725,1.9655723019212368
BICR 31,navitoclax-piperlongumine (1-1 mol-mol),2.358684882853314,1.7136228746365396
LS411N,carboplatin-UNC0638 (2-1 mol-mol),3.912215714956053,3.3774954276536295
ML-1 [Human thyroid carcinoma],JQ-1-carboplatin (1-1 mol-mol),0.7562453345428342,2.941166714592122
NCI-H1568,8515,2.0721444777555327,4.215632801932163
MOLM-13,24978538,-1.2743594434772367,0.049183918075773984
SW1573,23725625,4.357604161446221,5.081156697630921
HEL,15953870,2.2428109686656295,2.9481447873504436
Daudi,52947716,0.9938257746380776,-3.5769744009177167
BFTC-909,44259,1.3269924163099676,0.7195610590870778
MDST8,selumetinib-UNC0638 (4-1 mol-mol),2.2725517612456416,2.8016959641213264
SaOS-2,6918328,0.1895131607356872,0.009080259928718788
HARA [Human squamous cell lung carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),5.192132134204876,3.7723708782927354
NCI-H1568,3503,1.1278876480867208,2.3498101898119153
IGROV-1,72376,-2.111352545322758,-1.6879770905404266
SaOS-2,selumetinib-piperlongumine (8-1 mol-mol),3.928507120342424,3.339454194139851
SK-CO-1,654092,0.6285789884023978,-0.06784525429847241
SU-DHL-1,44589607,1.246014317818898,2.6322259100076537
PaTu 8988t,3552672,2.097731757890035,2.989250311380207
HCC15,5282054,3.6050373222028815,3.995748278703064
HARA [Human squamous cell lung carcinoma],1641662,3.0207416829742058,3.5938338723639887
WM115,16013152,3.8161355323039,4.160026826160975
ALL-SIL,54618305,4.365324809283883,3.514002526615991
SK-CO-1,25195348,3.743308569883415,3.356272984644235
BFTC-909,123631,2.8792987518934403,2.573632623720495
NCI-H2452,25022340,5.0430378131248785,2.9890091762995614
BICR 31,11719255,5.311316415457661,3.661944007698901
BICR 22,JQ-1-vorinostat (2-1 mol-mol),0.486661425618767,1.222899573418539
HuP-T3,568763,0.3762081962980199,0.4789634004277116
Panc 02.03,71680916,5.6819891784443595,4.798749454838172
SK-CO-1,44484440,3.788843022204708,3.072748217382603
HCC1500,60750,4.75355506285403,-1.5300602856968697
SK-CO-1,44607531,1.475264767684201,1.2680821184047346
MOLP-8,1317464,4.425962710369034,3.2550210244180766
BFTC-909,107985,-3.700699007813787,-3.258800903794715
SK-CO-1,3025986,-0.6416687634539443,-0.7169906199401018
BFTC-909,44493528,4.370300807083883,4.49290067696487
SW48,49850262,3.202043440642355,3.838389090717468
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026,1.218329891176337
MOLM-13,5746,-2.6320399073484633,-0.24909708656175872
NCI-H1568,36462,0.6787379731584755,2.2796966296728707
SW48,vorinostat-navitoclax (4-1 mol-mol),1.1280429303528072,1.2231433729209125
LCLC-97TM1,31703,-1.7062756219896058,-0.741477403353448
BFTC-909,54454,2.6967031082973527,2.545049079622734
BICR 31,5351362,2.0722735669158876,1.5940502358478497
ML-1 [Human thyroid carcinoma],20959075,-2.269435131540743,-2.5403143362175644
HEL,3543504,3.6690825601144064,3.7648934209849245
IGROV-1,11178236,-2.8618715106425725,-3.0763864537689996
SW48,176870,1.305545107688616,3.3536985515265814
LCLC-97TM1,3062316,0.5973926668956511,1.1949231596229526
HCC1500,6852167,3.541859976914812,2.7770031134594233
MOLM-13,54626689,4.673711949381485,4.035617706822531
RKO,11175137,2.9264569639519906,1.9851559389807218
SK-OV-3,carboplatin-etoposide (40-17 mol-mol),4.59219202218907,2.986779184873102
BFTC-909,73707398,1.325657316242966,1.2513338190632024
SK-HEP-1,11485656,3.3898088020096324,2.500407110731351
SW1271,637858,1.8302889918552376,1.904223132050239
P31/FUJ,151289,0.3376751835645198,0.33319504103514985
MOLM-13,6918289,0.5846893448973186,0.16805201667731445
RKO,4096211,2.0568907070726397,1.3453207414812869
HCC15,42611257,3.545791426903468,3.507655195759371
RKO,51037431,1.443783779144223,3.1550409592182684
RKN,1716436,3.648262431092988,3.0379984781744622
RKO,216345,4.0768365061219525,3.156501477237147
MOLP-8,54454,2.3030156333842533,2.25634694677885
HuP-T3,JQ-1-carboplatin (1-1 mol-mol),1.982980925186552,2.3974926901356377
SW1271,11719255,2.0964009449704335,3.545789533834233
SK-HEP-1,5328940,3.1706915881362097,1.7731603195329102
HEL,6914657,-6.908409772348001,-5.53524087466283
LCLC-97TM1,6918878,3.384977217975284,2.129616676048327
HuP-T3,46943432,3.2592232125577665,2.6589887757996835
KU-19-19,11152667,0.8748891502312,-0.20462429280941039
MOLP-8,5278396,3.6007551773478093,3.1729143753860387
MOLP-8,71304818,1.8062780808091792,2.136568026926585
BICR 22,selumetinib-navitoclax (8-1 mol-mol),1.8614529515345275,2.4622522763240497
SaOS-2,5280436,3.62212536353362,3.4810362892732116
IA-LM,71751553,4.579394980470846,4.0871701852881355
COR-L95,374536,2.031472802797221,1.4122594862741693
HCC1500,1716436,1.6304357372897462,2.7198349468230534
HARA [Human squamous cell lung carcinoma],10385095,1.0837341672046903,1.4123615043637359
SW1271,9967941,4.951865473173475,3.8191600655492044
KU-19-19,6918837,-3.3861016705907203,-2.582270817937462
LCLC-97TM1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.91566117969414,3.514473053768138
RCC10RGB,54626689,5.11978438920743,4.901119941634567
COR-L105,24964624,2.7213287093015848,2.5901742839926967
RERF-LC-MS,10184653,1.661334722418144,1.9144350386027353
COR-L105,9907093,4.049740181744662,4.401790522612364
WM115,4917,1.7802954819592542,2.849422969678303
Daudi,25262965,-3.918146889356354,-2.6835018397042667
RKN,9926054,2.8101544562472056,2.084785361843221
COR-L95,969516,2.641832541585458,2.6900201492918234
ML-1 [Human thyroid carcinoma],9868037,3.639883526106939,3.7614901718481177
LS180,60700,-0.831384616867798,-0.1447050961783074
HCC1500,25062766,2.7449885477672136,2.439678846647456
COR-L95,11640390,2.478695805138082,2.8923226962196127
HuP-T3,54618164,3.3933985234085755,4.157598852081494
SaOS-2,25105715,3.6317688538247968,3.4387431771145005
SW1271,5335621,2.365445027841909,4.724612452961518
NCI-H1568,72193861,1.9818580959671683,2.1691252066799596
HuP-T3,JQ-1-UNC0638 (2-1 mol-mol),1.1921000919454006,1.7371521623083028
SW1573,10385095,0.5068001344623563,1.395084965711232
ALL-SIL,2841722,3.706104916487932,3.7307715368348577
P31/FUJ,71466445,3.0287439983851225,2.3678876309961097
IA-LM,JQ-1-UNC0638 (2-1 mol-mol),3.2694867389724744,1.1651053693954978
COR-L105,4917,3.658916006838,3.105951916726799
RCC10RGB,9903786,5.708919982977709,3.0748334575771783
HuP-T3,25161177,3.646148401953212,4.2569830354616265
K-562,71466445,2.3693775657442373,2.404099139172828
K-562,11977753,-1.2336845020581693,-1.8813143982944052
LS180,16725315,4.563180557999628,4.448935945233473
NCI-H1568,66577038,1.9593359628641709,3.1394970403197973
SaOS-2,3465537,1.5281169625539155,2.235907906842386
ML-1 [Human thyroid carcinoma],11640390,3.608850000621235,3.8533561750774044
MOLM-13,17755052,0.2343645648969551,0.7227566232146486
RERF-LC-MS,67156097,-1.006688958645714,-0.9516878794838199
SW948,5470400,-3.941225454290086,-0.46325434268646054
HEL,44185566,1.408371464536178,1.8032810827951824
RCC10RGB,3503,3.522457107356278,2.5132815945179887
BICR 22,9866186,0.6641273098552615,1.0415887284388796
K-562,52947716,-5.609155633475852,-3.0095314724598086
SaOS-2,1641662,3.0320316508312883,3.3623441080770062
SW48,5460769,-0.8804369809799648,2.3214267853369175
MOLP-8,11625818,3.354870459420626,3.222553549053312
KU-19-19,3025986,-0.2897675094370045,-0.915234880391896
K-562,9444,4.095192274458736,3.616173253701739
IGROV-1,5329102,1.2794664511054334,1.987571123357046
LS411N,11427553,2.839596649209722,1.9792828716891182
SU-DHL-1,10385095,0.4695713178913991,1.3781811535934299
SW1573,124202324,3.209850220678193,2.6419859400692856
BFTC-909,2949965,3.0294119536880197,2.8100674421492253
Panc 02.03,44589607,4.606435993835204,3.1082066650821316
LS411N,25126798,4.124739072985443,3.702875325170885
RKN,24785538,4.869460471506453,1.919664302541048
SU-DHL-1,31703,-2.5255735182995203,-2.2215230283130394
KU-19-19,6505803,0.0199416611110358,-0.4425868881833893
MDST8,5281672,5.754114909876849,4.766100163613556
PaTu 8988t,9903786,4.140175125497243,2.9670866221021566
SK-CO-1,11717001,2.027201802005241,3.6899252518487717
K-562,navitoclax-sorafenib (1-1 mol-mol),1.3368563864105187,0.8745373100704065
HuP-T3,54454,3.567661200928428,2.666547639362978
MOLP-8,262093,0.615798330418347,1.6614382557765213
SW1573,6918328,0.8267852089643692,0.18504801731302664
LCLC-97TM1,73707398,0.638027637531153,1.3405083448543442
SaOS-2,11719255,3.097989779485228,3.445587985322884
SU-DHL-1,73707386,2.8817783064824773,1.9628245676680631
HARA [Human squamous cell lung carcinoma],2841722,4.596341456340547,4.406329619674461
LS180,9915743,2.834892961755663,0.1346311823244145
ML-1 [Human thyroid carcinoma],54143018,-0.4485048931823356,0.9356798173695009
BICR 22,4578,4.285603675470092,4.219270039665342
SaOS-2,24951314,1.4499530102948022,1.4902991135898631
RKN,6918328,0.5495182279950256,-0.007581002927462137
IGROV-1,66577038,3.2148239132520455,3.2482429496213463
COR-L105,15547703,4.316721747481802,3.2412981984494116
HCC1500,753704,5.032412058463686,4.950856643700249
RKO,44819697,-0.2126149769206573,-1.0962587802120702
HCC1500,16013152,3.952751911590144,4.037295000473231
SW948,89183176,3.757757719513151,3.324293290232639
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013,1.0849912033142313
ML-1 [Human thyroid carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),3.3397252964004593,2.8156179640445655
ML-1 [Human thyroid carcinoma],11427553,2.643507576643823,3.0301802898450165
IA-LM,44819697,3.529669119404179,-0.5978976780579927
PaTu 8988t,148198,-4.283282973565046,-3.6554606364628977
HCC1500,5287969,-0.1960949732639439,-1.4630882931374438
RERF-LC-MS,5460769,5.094680634820597,2.9735395932831405
BICR 22,10113978,3.5652875556244923,3.2647528275413524
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681,1.351064828912401
LCLC-97TM1,6184667,3.4160200622822736,2.967998955722482
SK-OV-3,44507138,1.930427516054787,2.5512611588601386
SW1271,54626689,4.884226988721356,4.532707220015749
COR-L105,25195348,2.918205578273492,3.4055590324322544
MOLM-13,49850262,2.0503909100702873,2.504450276581583
LS180,104842,-3.608354535822108,-2.4741608655886744
Granta-519,6184667,3.6411271735359207,2.2578400774186207
IGROV-1,49836020,5.658436828096057,2.488271631902728
HuP-T3,54619267,3.893027602521098,4.14871239904274
SW1271,409805,4.993473873943069,4.897318967842104
NCI-H2452,2749,1.5209092727807076,2.067724041362211
MOLP-8,JQ-1-carboplatin (1-1 mol-mol),-0.7588683882378918,-0.5719729285204673
SK-OV-3,119607,5.6958068077620405,5.373754083036414
Granta-519,JQ-1-navitoclax (2-1 mol-mol),-0.9470910727061151,-0.8659612995084636
SU-DHL-1,6184667,2.253300303827536,2.832543502215303
WM115,2871966,2.231269661110087,0.5811353204506821
SK-HEP-1,219104,4.349330089087446,3.9489586835114885
SW948,selumetinib-piperlongumine (8-1 mol-mol),0.6665506156446188,2.059226065134806
SW48,8515,2.6507036204950256,3.931394025865584
MOLM-13,241158,1.7093626682651633,2.625335230017841
RCC10RGB,71576739,5.1028364410536735,3.6701295312739375
LS411N,54619267,4.196494516067777,3.7633690903687524
Panc 02.03,637858,2.766769284687194,2.5063532889251894
P31/FUJ,25150857,2.053516150415863,1.5450317655431447
P31/FUJ,24951314,0.294555023880993,0.10268356371538889
SU-DHL-6,16736978,-0.092754907722646,0.7839196452469811
RKO,151289,1.190219151105647,0.6098207183973724
NCI-H1568,1716436,2.664872339798973,2.959331780756
SK-CO-1,doxorubicin-navitoclax (2-1 mol-mol),-2.167378618505947,-0.6561932705580326
LCLC-97TM1,49836020,1.9924259842665932,2.79214262872456
HARA [Human squamous cell lung carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),1.441529788664552,2.4748901061305766
HARA [Human squamous cell lung carcinoma],44137675,4.310894105428011,3.86695157728851
SW948,11647372,1.3621251009964823,0.3041684263992109
LCLC-97TM1,selumetinib-UNC0638 (4-1 mol-mol),3.547341579124928,2.7047282107901753
LCLC-97TM1,56963564,-0.6229750501206363,0.4585154834372164
IGROV-1,11427553,2.926316692603687,2.9384621058314075
HARA [Human squamous cell lung carcinoma],54618305,5.079823174852019,4.524686303185184
SW48,24951314,0.6660870475429757,1.1598653431275863
RCC10RGB,46398810,2.467266718263722,2.730520022350146
NCI-H1568,16720766,0.7309820541773976,0.69157161326586
K-562,decitabine-carboplatin (1-1 mol-mol),4.43725246072026,0.053780202533160903
HCC1500,6918878,3.8452122267855544,2.7252343765801315
MDST8,JQ-1-navitoclax (2-1 mol-mol),0.0958031568177067,0.6882239295696263
BFTC-909,BRD-K27188169-navitoclax (2-1 mol-mol),3.3946327784578245,2.337185627787858
NCI-H1568,9840324,5.648333485386012,5.831138782268439
SaOS-2,24772860,-2.2454069761524416,-1.9203168234275483
NCI-H1568,12003241,-1.4870303892505918,-0.6723547690289604
IGROV-1,135411,0.626702113064729,0.7940575936527466
SU-DHL-1,123631,2.2104669936854817,2.2778652957483754
BICR 31,676352,2.5344425849235472,2.0270782967126193
WM115,2828334,5.840169576442124,6.152993953048875
BICR 31,16722836,0.993439631718574,1.8646827535715462
LS180,71304818,2.5144465721497573,2.3691707616921143
HCC15,176870,4.3801450304989835,3.410778500578794
SaOS-2,44137675,2.8908105588075537,3.737776445628994
SW48,57519531,1.1891467216952898,2.458711893781887
LCLC-97TM1,46943432,0.977611384475134,1.8881859987291767
LCLC-97TM1,selumetinib-tretinoin (2-1 mol-mol),4.0009002077883755,3.415489956844738
MOLM-13,alisertib-navitoclax (2-1 mol-mol),-6.0299100304654365,-1.6105064844174222
UACC-812,52912189,-0.0403441295384107,2.8182520289194093
HEL,638278,3.1804055556137394,2.5317223647823583
ML-1 [Human thyroid carcinoma],135440466,2.0685655954708824,2.4377408805060043
UACC-812,45279963,4.1756281682233185,3.2583389140603454
MDST8,12001922,2.1068751805520423,1.8369787906497166
HuP-T3,11626560,2.4663043755994094,1.812313076529582
HCC15,9884685,1.2743229964902805,0.6134084647710849
Daudi,82146,3.751797413920901,2.782598241686019
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645,3.1407263490831343
BICR 22,969516,2.807563254821311,2.7717213480487755
RKO,6917907,-7.36544436443182,-4.908536007330318
LCLC-97TM1,BRD-A02303741-carboplatin (1-1 mol-mol),3.5226633114065407,4.0721440317996835
P31/FUJ,54649381,3.661627004097492,3.4922275260439255
P31/FUJ,15983966,-4.570279214878008,-3.812900065147522
COR-L105,49793307,-0.7736136433109717,-2.0688742627546137
HARA [Human squamous cell lung carcinoma],107970,2.425047737070786,2.3611465165568237
SK-CO-1,57330099,5.774767561552264,4.267856889902487
SW48,navitoclax-gemcitabine (1-1 mol-mol),-2.8390563906078543,-1.1436603801290854
Daudi,36462,-1.782907247885185,0.2461478066044361
SW1271,10077130,5.262255440725952,2.910370912659587
PaTu 8902,124202324,2.5191853508509823,2.521624062718967
SW1271,4261,2.1417567232825157,1.8852830192250558
SW1271,568763,-0.4148311333850545,0.4940055911971537
IGROV-1,44185566,2.2104732991243248,2.641154670810692
PaTu 8988t,piperlongumine-MST-312 (1-1 mol-mol),1.7723365960000816,2.011215176451958
RERF-LC-MS,54678924,1.4734481784853186,2.3065496076186545
SW1271,17759555,2.4829827438054104,3.6948132666684654
HCC1500,2871966,-1.8945265193529464,0.7591098531027487
RCC10RGB,119607,6.074674808773517,5.373537352580918
MOLP-8,5566,2.8349074996791295,2.97277236627109
K-562,24901704,1.0460453676907424,2.5942378363921508
SK-OV-3,44607530,2.4027946355264507,1.712248638987823
IGROV-1,44589607,3.0909001492794377,2.8335783919096684
SU-DHL-1,44185566,1.07324922266726,2.3082790810672824
MOLM-13,navitoclax-gemcitabine (1-1 mol-mol),-4.310291489660192,-2.2386361710303855
SaOS-2,42642645,-0.01972406793895,0.6808857867702568
SaOS-2,327653,4.165382989627235,3.3236021132396676
RERF-LC-MS,44491742,4.380479941679622,4.322581941902883
Granta-519,navitoclax-gemcitabine (1-1 mol-mol),-5.4729921992931665,-2.6175255923270675
K-562,3038522,1.918387146447148,2.769208828191344
HuP-T3,702558,5.633624519144866,5.42593466408955
ALL-SIL,2858523,2.9846374491002376,2.5889245110159567
WM115,44589607,3.0632481185375933,2.9571160482953154
LCLC-97TM1,11977753,-2.2409153175434953,-1.0653450092764174
Granta-519,7251185,1.138949301849667,1.5719799582430574
MOLM-13,446155,1.5984418257641329,2.126943770146652
SW1271,11455910,0.4702460968788743,1.2998219350519806
WM115,10184653,1.7306018843706388,1.292308670016014
SW1271,12003241,-1.4062779923685875,-1.0873496416784831
SU-DHL-1,3038522,3.3518104703058467,2.6251839981437852
RERF-LC-MS,44819697,-0.3406635094896507,-0.12450726826146145
SW948,tretinoin-navitoclax (4-1 mol-mol),4.012168549649723,2.1535453487825786
SK-OV-3,piperlongumine-MST-312 (1-1 mol-mol),2.5779047815349627,2.0049418282859377
RERF-LC-MS,3825829,3.876424055067748,4.142525486867412
SU-DHL-1,208908,2.168834483257838,1.9087450881959633
COR-L105,4378219,1.9356703916494296,2.679294040815939
SU-DHL-1,44489675,4.002710700308593,3.6060133818341735
BICR 31,5329102,1.5123342757929257,2.1228744795550916
BICR 22,72193861,1.1787223619968317,1.810093577683213
SK-CO-1,4259181,-0.2853622975740302,0.6915283013376282
RKN,5278396,4.050807510430523,3.5313026066252915
LS411N,3543504,6.407278726964401,3.9135528594878912
Granta-519,2749,-0.6711865738648753,0.8885142449024778
LCLC-97TM1,11222830,0.9756157307321038,1.6946666026478463
HCC1500,49766530,0.4188049276678212,0.1895689608574531
BICR 31,24821094,2.272776200428542,2.9227835170079457
LS411N,15953870,3.79326986504028,3.2436746586071536
KU-19-19,15547703,3.5460273004695364,3.3209939217887934
IGROV-1,10410894,3.2660402181528263,3.368290199065291
SK-HEP-1,9936388,2.725726666175631,0.6110714756575438
SU-DHL-1,68056272,2.8441937668208297,2.572713393686389
BICR 31,107970,2.625018410874988,2.4078648840877093
RCC10RGB,24978538,2.2083570886635258,1.4847478625319217
MOLP-8,42642645,0.4027543307161444,0.07856377420350723
IA-LM,6438330,0.5920782597943414,2.2016926730486968
HCC1500,25102847,3.871994319987046,2.4312025822116063
SK-CO-1,9903786,1.8148473241522671,2.9229420815585456
SK-HEP-1,51037431,1.9503987957256583,3.1699168337460297
SU-DHL-6,15547703,1.663295720719241,2.526215981096716
PaTu 8988t,42642645,1.5127014290808742,0.9586142865886466
Daudi,4578,4.14840859618435,3.715356538072377
HEL,73707398,1.0006953763352662,0.45124101508287906
RERF-LC-MS,3634881,4.923247717838372,3.300997033574244
HCC15,9907093,4.55737056946543,4.1809051180545
IGROV-1,16725315,4.890680859998698,4.40231224292975
COR-L105,navitoclax-PLX-4032 (1-1 mol-mol),0.9673135251369994,2.295358593643412
COR-L105,107970,2.936160881286492,2.4712427274062265
PaTu 8902,11485656,3.4031855994132663,2.471231631947291
BICR 31,5287969,-2.0848564793948423,-1.7550973700134285
SU-DHL-1,3503,1.2104794697541517,2.1283926644261584
WM115,selumetinib-MK-2206 (8-1 mol-mol),-1.676879875544035,2.1566469686355374
RCC10RGB,107970,3.009214725762471,2.5891052590186434
KU-19-19,51039095,3.4730458815699743,2.9696286758686337
KU-19-19,selumetinib-MK-2206 (8-1 mol-mol),2.230752575212941,2.43390026554835
IGROV-1,16038120,0.2864038103759729,1.1799962627950906
P31/FUJ,selumetinib-UNC0638 (4-1 mol-mol),1.8703414483738705,2.112685221352456
SK-OV-3,1323703,3.751791158325908,1.179633864092871
K-562,JQ-1-MK-0752 (1-1 mol-mol),2.296423482837328,0.7350651126376535
LS180,56946209,-4.291807545115399,-4.164772469342611
BICR 22,16741245,4.124711805224883,3.055450203888276
Granta-519,11396600,3.399615682634249,2.3835634539567745
LCLC-97TM1,4378219,2.0431586025336332,2.1319031565385527
COR-L95,piperlongumine-MST-312 (1-1 mol-mol),1.3307800151979865,1.7324174491096054
PaTu 8902,3062316,3.1999770976977966,0.7955222033347649
MOLM-13,9825149,-0.4975121245832732,1.6752361207286828
PaTu 8988t,36462,2.8739750906545263,2.467090082490359
WM115,4261,1.0617223830766982,1.544698752655627
BICR 31,54618771,0.3365869204450262,1.455801772514788
IGROV-1,6918837,-2.9804518885508635,-2.4065444723806624
SK-CO-1,49850262,4.729060483840123,3.7923022358270604
NCI-H1568,selumetinib-MK-2206 (8-1 mol-mol),2.137801357231392,2.6869084004609216
SK-CO-1,49793307,-2.625714785229563,-2.878585043578102
ALL-SIL,159324,0.7144692186053382,0.8344409105501082
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896,-0.09330373785421232
RERF-LC-MS,24821094,3.899392046553833,3.243511342683553
NCI-H1568,selumetinib-decitabine (4-1 mol-mol),4.70224066359239,3.9633338478887508
ALL-SIL,54613361,-1.2150310590443698,-0.9835163732816435
MDST8,54618771,1.2096098448968695,1.4063382366465715
MOLP-8,26596,-2.4791577040777812,-2.4058179734743037
RKO,4788,5.372325515812119,5.4169596447197
P31/FUJ,44589607,2.3901798108348533,1.6762181805789391
SK-OV-3,613753,3.56222269809742,3.2365320338540937
SW1271,navitoclax-sorafenib (1-1 mol-mol),2.5597569107989457,1.8523758113339255
SW1573,2858523,3.1892649395611556,3.081871112359691
LS180,72193861,-0.0461725132802377,1.6755239990234312
RKN,25126798,3.956068538327861,3.6931220868223686
MOLM-13,6917907,-6.412365954060792,-5.740435576169553
WM115,50905018,4.954075896774319,4.262672889510669
HCC1500,54619267,3.954111090910006,4.166848356941954
IGROV-1,6252,1.1284141516966473,0.8471790614729858
Granta-519,49766530,-2.591856607816134,-2.386539840679183
RKO,400769,-0.364727826621167,-0.771206677196527
SaOS-2,5113032,4.015669070835574,4.87587775725652
MOLM-13,JQ-1-carboplatin (1-1 mol-mol),-1.1937671788026978,-0.4943232646943543
BICR 31,400769,0.3553213589698107,-0.5527870575522474
HARA [Human squamous cell lung carcinoma],16720766,-0.0810608938508249,0.8923740307766761
MOLP-8,JQ-1-navitoclax (2-1 mol-mol),-1.8736660374722776,-0.12637339592185903
RKO,24901704,3.90150667551114,2.544538488507202
K-562,675434,4.134192231732703,4.21309691728591
PaTu 8902,vorinostat-carboplatin (1-1 mol-mol),3.3056109148195936,3.4512142470601948
IGROV-1,60700,0.4424479122017752,0.007133556445412319
RERF-LC-MS,439501,-1.3704502050640626,-2.0288295271122503
PaTu 8988t,3081361,3.3861147832051004,2.384124707262361
PaTu 8988t,11507802,1.1782523393568187,1.7788208355571458
RKN,25154868,3.091821445991922,4.611143459347467
SK-HEP-1,3384730,4.617019540739567,3.191799828489718
IGROV-1,135411,0.626702113064729,0.7940575936527466
RKN,44202524,1.6880658914716755,2.3033518336678513
MDST8,10127622,1.4568360900186117,3.6458908597930857
ALL-SIL,5978,-4.2912860791141725,-3.6655947507771645
LCLC-97TM1,25195348,3.14182472834864,3.35517915272796
MDST8,navitoclax-piperlongumine (1-1 mol-mol),-0.5700737020348542,1.3292858382541906
MOLP-8,2949965,2.304667717892232,2.3778299153535274
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047,0.3762911836559883
NCI-H2452,11485656,2.991875358712002,2.7147149315110495
Panc 02.03,2708,5.654354843286421,4.911791413519868
SaOS-2,15953870,3.7774839542606617,3.8041999106368234
LS411N,11238147,4.220683195687341,2.565396450368483
WM115,selumetinib-vorinostat (8-1 mol-mol),-1.5219389321344234,2.248705994821119
COR-L105,11404337,0.9270352493146456,-0.12330607614692961
RKO,20959075,-2.9107192765247536,-2.791736811876262
IGROV-1,452548,0.0422661560146271,0.623318352354204
SW1271,25062766,1.8071163488926476,2.0727472605261785
SK-OV-3,24180719,3.148638094054939,3.758987828330713
IA-LM,doxorubicin-navitoclax (2-1 mol-mol),-0.2967430289420483,-1.0281307445969932
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727,0.8032389722224584
Daudi,selumetinib-PLX-4032 (8-1 mol-mol),4.542051250808824,3.5351323813045985
NCI-H2452,25150857,3.315566378385427,2.744466462591937
P31/FUJ,carboplatin-UNC0638 (2-1 mol-mol),3.2617545834686155,2.8636950470950224
LS411N,216239,2.6090534487015953,2.0209467429067987
SW948,2828334,6.27053385486612,5.736767808152775
HEL,25262965,-1.9607005706581808,-1.998985643311751
SK-HEP-1,46398810,3.2056962377986333,2.7929696913491893
P31/FUJ,46191454,0.7861082656977861,0.1495671001341896
SaOS-2,11404337,-0.7935370479535776,-0.31113559190359563
LS411N,6918878,3.507421995092854,1.4249567017177152
COR-L95,5566,3.0030322186541754,2.7710409462370107
NCI-H1568,2729026,2.4592472427928795,2.8458468390627987
Granta-519,5566,3.1418180472473023,2.750690528183936
SW948,15953870,3.980690301912255,3.426559820005061
IA-LM,selumetinib-navitoclax (8-1 mol-mol),1.3709865001695822,1.8437248518011067
SaOS-2,tanespimycin-gemcitabine (1-1 mol-mol),-1.7775872222613356,-0.523002191000488
COR-L105,decitabine-navitoclax (2-1 mol-mol),1.4499610580472069,2.1790935407854715
PaTu 8988t,4096211,4.042256121680771,2.2545329247368833
HCC15,638278,3.5096393014384346,3.089149144139833
LS411N,44185566,2.59688005994845,1.9604144720985017
WM115,15547703,2.53174585982074,3.35550158687938
RERF-LC-MS,46907787,3.883745984979501,2.695756938466523
RERF-LC-MS,49793307,-1.4864117200972382,-2.156243766812023
LS411N,6918837,-3.511331359252859,-3.448311416912068
HEL,2729026,2.9938268289747394,2.267828459997819
SU-DHL-1,9911830,2.4926956672938543,2.1893870079264826
RKO,6505803,-0.9276151073099124,-0.8594016195366645
HEL,5351362,1.012542471793317,0.9565903432717476
SW48,448949,2.118847083295334,2.1203775501762334
LS411N,3854666,3.592971008902542,1.4834411493375717
Daudi,55283,2.1333092426313143,2.8021256240319197
WM115,568763,0.4176363376103466,0.4662021918968351
ALL-SIL,JQ-1-navitoclax (2-1 mol-mol),-1.241318632460125,-0.8680019932425561
K-562,54143018,0.8143265967368298,-0.34706209819515865
WM115,6914657,-1.139050920215431,-3.545935696308862
BICR 31,JQ-1-navitoclax (2-1 mol-mol),1.1041257622460865,0.9763505187212167
ML-1 [Human thyroid carcinoma],24821094,3.2142530929148982,3.0464985308294423
Daudi,57519531,1.0816397392331083,1.5867521115792842
MDST8,9840324,7.1320098113776185,5.865488502705626
ML-1 [Human thyroid carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.127776457092234,2.144915097542429
NCI-H2452,67156097,-0.4931697978204585,-0.5236948241575522
ALL-SIL,11507802,-0.6218585688390301,0.48551200875202405
MOLM-13,9926054,0.378361077880871,1.5076890635770344
LCLC-97TM1,676352,2.332754642745106,2.1042218810646944
SW48,6450551,-0.0066484474606689,2.796202137231088
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169,-0.739266986841609
MDST8,vorinostat-carboplatin (1-1 mol-mol),3.0562610561977004,3.4010587223387723
ML-1 [Human thyroid carcinoma],53232,3.218931075380609,2.8061488445983196
KU-19-19,46191454,1.4474607873871597,1.6840035919976188
BICR 31,135440466,1.3506373291640237,2.340375843791741
SW948,44632017,0.8619787858061628,1.2648308508755406
NCI-H2452,159324,4.677055932941875,3.4479255138598166
WM115,60700,0.0008203329731028,0.20165850631860568
HuP-T3,selumetinib-navitoclax (8-1 mol-mol),3.027921751084016,1.9037091535132127
RKN,9936388,2.306220468641662,-1.2448593060944868
MOLM-13,2945648,3.0282797197343374,2.1868239876828475
P31/FUJ,135875424,3.622681212031297,3.3703025056124982
LS180,navitoclax-gemcitabine (1-1 mol-mol),-2.7206195218400007,-0.8700602093662669
BFTC-909,24964624,2.4776408698208003,2.5118108067166167
HCC1500,3825829,4.205963950909598,4.054046883193916
P31/FUJ,selumetinib-MK-2206 (8-1 mol-mol),-0.6510792771612892,1.5192931544309483
SU-DHL-1,135984461,1.9491307161872016,3.853432097028799
NCI-H1568,409805,3.8387714265583592,4.8428424199713636
COR-L95,2945648,2.3261820103406183,2.472831181438895
LS180,selumetinib-tretinoin (2-1 mol-mol),1.4682365811163622,3.0711800413599137
IGROV-1,5746,1.9055212643377857,1.1872801492735932
BICR 22,selumetinib-decitabine (4-1 mol-mol),2.485402962452582,2.851706948858411
HCC1500,104842,-2.1208898309536073,-2.4820129420323096
IGROV-1,148198,-2.659972993252853,-3.3696251873092127
ML-1 [Human thyroid carcinoma],4259181,0.3770562232502641,0.4324128324967451
K-562,crizotinib-PLX-4032 (2-1 mol-mol),0.2702262717922032,1.1371695956694199
IA-LM,5746,4.310443233142937,1.26161706812702
WM115,10427712,3.357641117907952,4.446887407685467
WM115,31703,-1.493876478932265,-1.0600543542273275
K-562,10296883,3.719487542859837,3.4690519229532883
UACC-812,JQ-1-navitoclax (2-1 mol-mol),2.277260275544626,0.6048235374381065
SW1271,selumetinib-BRD-A02303741 (4-1 mol-mol),1.6288124556214316,4.005384921434488
IGROV-1,10184653,0.79276129336756,1.371297481378642
K-562,5287969,-0.8630520858269013,-2.032562678093371
MOLP-8,148198,-4.437033387624053,-3.832860003660345
BICR 22,navitoclax-gemcitabine (1-1 mol-mol),-3.257857035264034,-0.7175948069586923
BICR 31,24951314,2.26082148142024,1.7002878463229403
COR-L95,9887053,2.0711365362831193,3.3584048618136335
SK-CO-1,2841722,4.495379043063509,4.163267282626638
COR-L95,54618164,3.8157010413732406,4.020850471183318
ML-1 [Human thyroid carcinoma],107970,2.5074769228196025,2.510840087106747
SaOS-2,25262965,1.6840235781335875,-1.2618677120167086
MDST8,25150857,2.921484336528134,2.5025921663741197
SK-HEP-1,984333,0.8474815446030621,0.7877048302275022
COR-L105,5311037,4.270584574919318,3.9815026365153314
P31/FUJ,selumetinib-navitoclax (8-1 mol-mol),-1.1281624183387444,0.5076310146274114
LCLC-97TM1,3825829,3.858617243526108,4.043262545846038
SK-OV-3,24951314,1.413681041410239,1.580360541272392
NCI-H2452,9903786,2.1501841215173396,2.9780346359396295
PaTu 8902,56963564,4.5637436248697565,0.461897960710461
SaOS-2,262093,2.7398792490382244,2.9990366098432215
HARA [Human squamous cell lung carcinoma],4788,5.847017929418924,5.7396033203940116
BICR 31,3854666,2.26793763186435,2.2013467980407215
SK-OV-3,15953870,4.452396287203901,3.6986529009929394
HuP-T3,serdemetan-SCH-529074 (1-1 mol-mol),2.447475280373413,2.153680464572029
BICR 31,24785538,2.8976650742045127,1.9814394956730041
HuP-T3,9903786,4.0743016574038915,2.925581642114028
Granta-519,11175137,2.0306520437568767,1.7324890716197134
Granta-519,25105715,3.663648488967505,3.2294446190065225
NCI-H1568,49867930,4.553956635433513,4.764431253352667
HCC1500,16038120,1.5738549040879308,1.0203685021110322
LCLC-97TM1,227681,3.759896348853487,3.429112487455941
BFTC-909,49867926,6.076136735210805,4.404839773593258
ALL-SIL,5278396,3.0589186731365814,2.928815532190571
HCC15,2742550,3.2685764522673972,3.8495745232440397
RERF-LC-MS,44486219,4.018485879154908,4.3824277889288945
RERF-LC-MS,462382,0.9319597157341816,0.7887953067940096
SK-CO-1,selumetinib-UNC0638 (4-1 mol-mol),-0.0758878647184332,2.521879986015151
SW1573,3854666,2.927116287337192,2.5518375437013554
Daudi,9935249,-0.0031627785077317,1.3908410291455613
MOLM-13,10231331,1.9024628033326092,0.2550293628296276
SaOS-2,6918837,-2.9214939411920593,-2.3883681023062975
HCC1500,11507802,0.960722132601806,1.6204586335788542
WM115,doxorubicin-navitoclax (2-1 mol-mol),-1.5072575260972283,-1.1832711578584547
BFTC-909,navitoclax-birinapant (1-1 mol-mol),3.573845080821179,1.6260519147873587
LS180,9911830,2.83226076921101,2.586803409874837
RERF-LC-MS,11222830,1.7620759794741472,1.6038598476422807
MOLP-8,6252,-2.041702184925406,-1.1471652175909721
SW1271,5978,4.916909360273371,-1.970494762370447
MOLM-13,5479543,2.5400848053862264,2.5646859694858106
NCI-H2452,11612883,2.7546488169018963,3.170360552771726
NCI-H1568,44493528,4.1542795967274175,4.312811472468917
RKN,46398810,3.1612721401313792,2.6175385804280267
ML-1 [Human thyroid carcinoma],676352,2.608959843452948,2.2695995550686354
MOLM-13,ISOX-bortezomib (250-1 mol-mol),-0.222539624438373,-0.021499023408248684
ML-1 [Human thyroid carcinoma],31703,-3.706133682115605,-0.34664396703802625
SW1573,31703,0.7694714266266048,-0.5885952704877745
BFTC-909,11238147,5.503103761619835,2.9979777341202705
SK-HEP-1,637858,2.866868896175592,2.21751000444132
HARA [Human squamous cell lung carcinoma],12001922,1.8002757111950325,2.035345940659555
KU-19-19,2828334,6.071698785304069,6.114448772659694
SW48,JQ-1-carboplatin (1-1 mol-mol),0.1401684728057108,2.0614921377164506
RERF-LC-MS,2828334,5.9123201087220325,6.170026189932689
SK-HEP-1,vorinostat-carboplatin (1-1 mol-mol),4.117273876837617,3.488400121161031
PaTu 8902,54649381,5.340946431274584,3.945899932735818
RCC10RGB,11214940,1.429625683961422,2.2254614140126523
NCI-H1568,25195348,2.211268152441431,3.306485598939594
COR-L95,10184653,1.5221413196357014,0.8044239125097138
BFTC-909,3634881,3.6308731463535704,3.4548357536047467
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508,-0.5131482306282918
SaOS-2,24785538,-0.4134197784310965,2.063563048689937
RERF-LC-MS,4705,3.292681011259135,3.3719784871265905
MOLP-8,10127622,1.9499981558353492,3.2215221212072085
Daudi,11626560,0.3779689739853294,0.6816678554606374
MDST8,168312962,1.677679532849221,2.0735984702767216
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057,2.4256725866155433
MOLM-13,10113978,0.7724135376915046,2.1316789710299004
PaTu 8902,selumetinib-MK-2206 (8-1 mol-mol),3.282015538774474,2.398004547444273
HCC1500,216239,1.4805608336728902,2.291185465641491
RKN,5281321,-0.4803497212669658,-1.0698645005350025
PaTu 8902,11175137,3.538788964844938,2.730966723219942
Daudi,10113978,1.6179427120332186,2.224939186379983
K-562,26596,-3.6076758496321832,-2.247127060130662
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158,-0.0705656149379972
Daudi,5291,1.8632614405000685,3.1404965986276974
NCI-H1568,2874250,4.364133169191667,4.380803107897293
LS411N,984333,1.2324204412799928,0.62042807440965
PaTu 8902,11222830,2.39915227633331,1.792705557780029
MOLP-8,54678924,1.6307832002497362,1.3433109159296297
COR-L95,49793307,-5.549400502924621,-3.730701630975217
HCC1500,45279963,3.5713917460093434,3.570561489752334
WM115,54765302,3.574934655958074,4.203209878310713
SaOS-2,136227924,4.496792726095474,2.98960059351665
NCI-H2452,107970,2.3345640718356364,2.3798052854106793
LS411N,16720766,1.2713952174238143,0.3619239370970041
MOLM-13,navitoclax-PLX-4032 (1-1 mol-mol),-1.1656285238385289,0.30887384049710886
MOLM-13,216239,-5.069803023561943,1.6256407424510109
RERF-LC-MS,44241473,4.536869636330491,4.801261068624418
LCLC-97TM1,10074640,3.2021543880531156,3.195098584185303
Panc 02.03,10296883,4.297264305827386,3.8704260394013796
IA-LM,3689413,-4.432004355370191,-0.7278539331060483
RKO,375860,-0.2095842697906711,-0.39261144556020805
HuP-T3,676352,1.9029965224961456,2.0670812064834707
SW1271,5470400,4.349220092525355,0.3211014112424572
NCI-H2452,656346,1.056906556032961,1.0688231666388024
BICR 31,56649450,1.7574149169243078,3.391636370979695
RERF-LC-MS,24785538,0.8057743011820994,2.014412190331871
SaOS-2,9825149,0.8893885919981879,2.3118526265651798
HARA [Human squamous cell lung carcinoma],51039095,3.2872110498619573,2.9122776269587742
PaTu 8988t,carboplatin-etoposide (40-17 mol-mol),3.874190963823487,3.114128380402245
SK-CO-1,638278,3.4780853527987854,3.38407784714255
WM115,4096211,3.685037910266886,2.240326347195713
RKO,126941,-5.081226966265268,-2.756125983597205
RERF-LC-MS,54618771,0.9955970244631366,1.4341950993916794
Daudi,50905018,3.9297282000687312,3.6049724262304816
WM115,11609586,3.058244435077658,2.8667773994024843
BICR 31,9926054,1.721382648019371,2.028367700013747
RKO,24821094,3.7157598247146977,2.6352369451573123
IGROV-1,135440466,0.9791523710816318,2.284449928959934
NCI-H1568,44202524,1.0522971592210668,2.107188034949525
HuP-T3,9933475,3.0776536859408807,2.1169480054294887
COR-L105,carboplatin-UNC0638 (2-1 mol-mol),4.035332544942737,3.4046884038166905
BICR 22,11612883,2.729453217725868,2.5532073761790097
MDST8,25154868,3.4078840547236333,4.582161279087024
WM115,12001922,1.1273981641266086,1.914079242173176
SW48,2742550,3.28553671385033,3.8669062261279175
WM115,445091,3.8598878691820886,4.146971655053123
RKN,135875424,3.6230459419726526,3.9196156247928666
BFTC-909,2708,5.254338200716292,4.919034598552722
SaOS-2,2871966,1.7918423486815835,0.8893937978575795
SW1271,serdemetan-SCH-529074 (1-1 mol-mol),2.3446355759055684,2.1715976980065728
HCC15,44632017,0.3758817607479284,1.5370932664011645
COR-L95,2729026,2.664378744829576,2.5273224456398298
SaOS-2,1566236,1.7620742085681662,2.2028263101855194
BICR 22,11955716,-1.4294009955010087,-1.2447804469304142
BICR 31,2729026,2.966794528433677,2.7808553051282128
COR-L95,119182,-1.6347192148686482,-0.8393070028699499
LS180,5328940,1.742567210928755,1.6471998778083254
Panc 02.03,46398810,3.420081587494409,2.642201267237717
RCC10RGB,60700,3.171193268028763,0.42855640355383245
SU-DHL-6,451668,-1.4332734905345434,-1.0526418178239392
Granta-519,16219061,2.116318709414125,2.1506316840754294
ML-1 [Human thyroid carcinoma],42642645,0.1882919364816784,1.2178410784599025
HEL,53232,2.5038982548529747,2.5745844341402644
RKO,44507138,3.480554434186059,1.9679684127753878
NCI-H2452,3081361,2.98247650375621,2.8309716886537757
RERF-LC-MS,44202524,1.2785968032229695,2.067538374439409
RERF-LC-MS,16722836,2.4162442447682193,1.7736405236208177
HCC15,637858,3.032734575357801,2.367218380395635
IGROV-1,11396600,3.99372654279783,3.768558145610776
BICR 22,44202524,1.658152527320416,2.5446738362897943
MOLP-8,54618771,0.2679151571300236,0.45807538136437487
NCI-H2452,navitoclax-gemcitabine (1-1 mol-mol),1.5021089136928458,-1.4540628585296183
LCLC-97TM1,54678924,1.535359034662644,1.7754316726959107
BFTC-909,49793307,-2.946331542038894,-2.2111495930598846
KU-19-19,5738263,3.812580710038467,3.467883196462527
PaTu 8988t,24821094,3.93253598055128,2.9034632583226907
LS180,148198,-2.644013472885731,-3.312317407970722
HEL,409805,5.92709656224454,3.726172973384378
RKO,11612883,3.106052261550285,2.1326050616994237
SW1271,122327,4.37632222345113,4.808925965582315
MOLM-13,44241473,6.124350775268443,3.8552346382273455
HuP-T3,2126,5.715410620657667,4.946813439623798
K-562,5291,-1.1872539047134878,1.9698167515408027
RKN,5282054,3.624299707956654,3.8633545846327824
BICR 22,613000,2.6534426018316277,2.7995685531198653
HCC15,49850262,3.6300454046422774,3.868798604125179
SW948,613000,2.5939391420023212,2.6266139524509606
COR-L95,135440466,3.0574476104836914,1.8981354221181208
SK-HEP-1,262093,3.158620019748703,2.834391560208525
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967,0.8986239506299936
MOLM-13,123631,1.0914116119684203,1.9491543960786302
BICR 31,4378219,2.049792351388142,2.8638868599719007
LS411N,16722836,1.825979837410603,1.1416342086774
SU-DHL-1,10074640,2.3568880289385654,2.8062529669773313
ALL-SIL,6918328,-1.7903684912223865,-1.8331714852868806
SU-DHL-6,3384730,1.0298608560692932,1.5255177615601656
SU-DHL-6,11485656,1.7981230616770194,1.6210442307666912
ML-1 [Human thyroid carcinoma],24785538,0.9232201957937346,2.097459967237761
NCI-H1568,176870,1.641159934282528,3.3300716420089196
HEL,5280436,3.9989145330348896,2.605375035382275
BFTC-909,5328940,1.2290524134113243,2.048097186561546
SK-CO-1,151289,0.7492352886663923,1.1906455453544262
RERF-LC-MS,104842,-3.024577047260716,-2.600587480945646
PaTu 8988t,46843906,4.444995617536364,3.3346204837931
BICR 22,24856436,-0.0251718817877118,0.48845018064777257
HARA [Human squamous cell lung carcinoma],208908,3.016531266929929,1.8974926967854182
IA-LM,67156097,4.3159050642226,-1.325905931797698
HuP-T3,6438330,2.3942211080747837,2.413693638950358
HCC1500,10296883,3.843895309810077,4.0621157202118034
HARA [Human squamous cell lung carcinoma],3062316,1.9438846554207736,1.4209455431138014
SK-CO-1,56946209,-3.7989193199280016,-3.8048755259027107
Granta-519,148198,-4.763660659469611,-4.312591465921568
HEL,4917,2.9031193377759603,2.894704747340132
RCC10RGB,66577038,3.312011612499516,3.1931052775380753
Panc 02.03,3689413,0.2165954212360822,-0.04522276407240626
ML-1 [Human thyroid carcinoma],89928392,0.0943028098974214,1.9218732910194887
SW48,241158,3.5185545260205364,3.930696477420424
COR-L105,selumetinib-GDC-0941 (4-1 mol-mol),0.702191872416662,1.6984009201115111
HCC1500,navitoclax-birinapant (1-1 mol-mol),-3.387149505683513,1.2353145274764785
K-562,11167602,1.4540526159902811,1.9264995699274676
HEL,9911830,3.2406370139452134,1.2963584500246577
SW948,25150857,2.687963392787196,1.87298820901683
WM115,44137675,0.4260207876885596,3.8493966683566834
SaOS-2,4917,3.064827494863108,2.977245693365042
SaOS-2,3503,1.987605483793098,2.193272129604288
LCLC-97TM1,9840324,5.858053248657865,5.755027378385432
RKN,11178236,-3.061903912386503,-3.2160481857109864
COR-L95,46843906,2.16387123849571,2.404670954047125
K-562,46191454,1.7723208241237427,0.7950895088310354
LCLC-97TM1,5746,2.627938158922912,1.1275924704861564
RERF-LC-MS,613753,3.34976336152667,3.3509717954515135
HCC1500,9823820,4.617789125102065,3.902397234483348
PaTu 8902,49793307,-1.5016152541437175,-1.9869733392818292
LS411N,24964624,2.837560916730962,1.7745692723631092
Granta-519,42642645,-0.7384711962533689,-0.2867043042909174
Daudi,156414,0.7854974484116999,0.48949530133916874
HCC1500,9840324,5.570797833564005,5.773818881199491
HuP-T3,6914657,-2.995276103152913,-3.6471651591524945
SW48,11178236,-2.976969958039468,-3.0535878281535433
Granta-519,11214940,1.149911870185247,0.8294933996410364
Granta-519,72734382,4.317814968690637,3.3629662692959594
SK-HEP-1,selumetinib-JQ-1 (4-1 mol-mol),3.7826975046986697,1.7747208799853678
SK-HEP-1,15983966,0.8278271069258164,-0.8908130864719389
BICR 22,6610355,3.5129220888937622,4.268005199344897
HCC1500,44489675,3.6836892776405854,4.16220897248278
IA-LM,3634881,3.385658224323674,3.055498629926275
SaOS-2,JQ-1-vorinostat (2-1 mol-mol),0.950161902916163,1.1493277646748745
COR-L95,4788,5.892645370038274,5.458514400242414
NCI-H1568,11717001,4.19629869858104,3.6232581216917437
RKO,46224516,2.430810450928805,2.361151218750148
LS411N,6505803,-0.6536233604701492,-0.8986796200552728
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986,2.5929226433788317
HCC1500,16725315,3.090868252599208,4.279246788389949
Panc 02.03,5287620,-2.132468814908427,-2.098944559409587
ML-1 [Human thyroid carcinoma],5470400,0.2567315670041485,-0.13861649308234608
LS411N,5351362,1.130738510814583,1.4690287674772236
IA-LM,168312962,3.008218706470952,1.3682925606602356
SW48,9887053,1.6385742110161594,4.208711116780101
HCC15,2945648,3.8992008266513305,3.0636640720766546
WM115,10385095,0.3137764342063494,1.3925611997479401
SW48,11213558,0.38171338020492,1.6145133399737912
IGROV-1,9911830,1.9130562323799436,2.7859972508442272
HARA [Human squamous cell lung carcinoma],6918736,-1.65788247009277,-1.4993017080477324
LCLC-97TM1,5284616,3.038958191933125,2.5942143168628804
SW948,5311,0.5245292911924586,1.0373885333115
PaTu 8902,2949965,3.498586647815041,2.9804875786469385
PaTu 8988t,53232,5.050646647161413,2.798838488035523
ML-1 [Human thyroid carcinoma],navitoclax-pluripotin (1-1 mol-mol),-1.2739160400163367,-0.5907005732265924
P31/FUJ,2729026,1.895106624580685,2.114242040174222
SW48,568763,-0.0201118962331156,0.6151265453640969
SW48,selumetinib-GDC-0941 (4-1 mol-mol),-3.255152499343646,1.21765439173867
SK-CO-1,docetaxel-tanespimycin (2-1 mol-mol),-5.721099284006835,-3.1958750571648493
SK-CO-1,54454,2.352526453014332,2.745773422045675
MOLP-8,tretinoin-navitoclax (4-1 mol-mol),4.347252260304068,1.585036045376783
SW948,151289,0.9927868711009586,1.1881095164499427
RCC10RGB,676352,2.417271143726191,2.020248292373351
LCLC-97TM1,15953870,3.316413299321368,3.4037056577089317
HCC1500,252682,6.335850466863892,6.433083422519779
LS411N,doxorubicin-navitoclax (2-1 mol-mol),-0.6349980356208603,-1.086483700438351
SW1271,702558,5.67814751001827,5.203022414312154
HEL,3503,1.2339935625044716,1.5913270343281085
SW948,6918328,0.2458443826474451,-0.022341161185621784
ALL-SIL,124202324,0.3755400921280209,0.9282750024814392
SW1573,2729026,2.4001203305493397,2.7141496413445285
SW948,57330099,4.403961221202979,3.9540722280980805
UACC-812,42642645,2.375397400257474,1.190837766117667
LS411N,tanespimycin-gemcitabine (1-1 mol-mol),-0.1859317712708109,-1.4224335552508123
PaTu 8902,984333,1.3011106079808883,1.0223643557716253
P31/FUJ,135398516,1.7387657861081838,1.364548376900759
WM115,46224516,3.0669076127990276,2.286854161305383
SW1271,24771867,3.777194428597206,2.6651394346474677
HEL,73707438,4.0836720937600175,4.062489416200393
MOLM-13,16038120,-1.7825288578452578,0.10777085378375079
IGROV-1,10427712,3.944243047938238,4.32058165933701
LS180,3815108,3.93048377981505,2.612128147932811
HCC15,1750826,-0.4775912601104041,-0.6971131854000455
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045,3.4887543229761286
P31/FUJ,42642645,-1.1469220315427042,-0.41930612404441825
HEL,1750826,-3.7677259179114047,-2.775505325988119
NCI-H1568,25183872,-0.3156837582718859,-0.5920998613076476
SW48,54143018,-1.2192841502688678,0.8064501178328297
SaOS-2,441298,1.6833347099113902,2.3527198205610684
SU-DHL-1,119607,3.7964753700545546,4.862108176302435
LS180,654092,0.275565618798522,0.02548197245882041
RKO,6918736,-1.762610939534952,-2.0157956827535077
ML-1 [Human thyroid carcinoma],6918837,-4.218663166819277,-2.1064205218892145
SK-OV-3,168312962,4.003119281373622,2.5833146545587664
PaTu 8988t,3062316,1.6786738127042626,1.1518861614687395
P31/FUJ,5746,-1.0128835373821496,-0.14643005935942804
ALL-SIL,46943432,1.7359798293614472,0.7404047849624132
IGROV-1,119607,5.004384040905396,5.430779533369017
LS180,135440466,2.758543039731734,2.2553342933955167
HEL,15983966,-4.130179752932702,-3.620358890064086
SW948,11228183,2.319596035574442,1.0721348150418766
SK-CO-1,navitoclax-birinapant (1-1 mol-mol),0.739134837908099,1.6379144039086477
NCI-H2452,219104,4.089454197150707,3.9885490559391688
LCLC-97TM1,24856436,-0.9719468010392746,0.4565346219215396
WM115,1716436,2.084402062067542,2.835949457514157
WM115,54596558,3.929397107249587,4.206482850724326
HCC15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1827234466059498,1.6542745318439034
SW48,2828334,6.103861625006206,6.108717322654136
Granta-519,5335621,4.386788840750005,4.030621936391984
NCI-H2452,25105715,3.487348959516136,3.4574754955502454
LS411N,11152667,-0.1489697958567156,-0.9630290718570855
HCC1500,4259181,0.9827468065480526,0.08188445788248762
SW1271,1716436,3.164329770032204,3.0609549984093376
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671,-0.5596317612895735
KU-19-19,637858,2.3404288739792314,2.187381610558298
SK-OV-3,3081361,2.5908903164469317,2.4916614127307657
BICR 22,10322450,4.612637955736889,3.733215819900187
ALL-SIL,44819697,-2.9345943950607136,-1.7397703239629296
LS180,4259181,0.5796574720850999,0.391441134570362
IGROV-1,6918328,-0.5330006254346346,0.2736142315058619
RERF-LC-MS,11178236,-5.98494163410248,-2.72264895957938
SK-HEP-1,SNX-2112-bortezomib (250-1 mol-mol),0.9629137048911888,-0.969026689925144
IGROV-1,11485656,1.900409616013456,2.407133758040317
HARA [Human squamous cell lung carcinoma],5281321,-1.682952924947167,-0.9118978221766296
BICR 31,16065773,3.973194001978765,2.5990715834159692
IGROV-1,6252,1.1284141516966473,0.8471790614729858
SaOS-2,135398516,5.990406168261382,2.3303338904221405
RCC10RGB,11485656,3.364959979667133,2.7380317688499356
NCI-H1568,46926350,-5.085925204635643,-3.8705571429377517
LCLC-97TM1,123631,2.4246211789463445,2.2396855904637794
BFTC-909,44185566,2.75887016136311,2.848550071364312
BFTC-909,124202324,2.9321657702899295,2.7033957042864345
LS411N,4917,3.429074291339912,2.9853054316236
BICR 22,135440466,2.8663984884678513,2.0494792718028343
HCC1500,10127622,5.201205269222406,3.5283329238872074
WM115,24748573,1.2650334763374356,2.18593633071735
LS180,17755052,1.7669119525953814,1.5381097749668564
HEL,5278396,2.941082820113368,3.002418711545738
K-562,6917907,-5.621792844351372,-5.419150465542228
WM115,11175137,1.8074191527620995,2.5897036367602793
ALL-SIL,6610216,3.679901693613009,3.8405290166621797
IGROV-1,3815108,1.915722485757852,3.0543109622826496
IGROV-1,44491742,4.406671418311328,4.289477941259691
NCI-H2452,11647372,3.7610160121318055,1.3073619285213232
Granta-519,25262965,-5.6090339200635375,-2.3664819685428795
HuP-T3,5287969,-2.0305885584054693,-1.7775840559240164
Panc 02.03,4578,4.394890119629889,4.328310957660653
PaTu 8902,46199207,3.581196343990194,3.1023698419584314
MOLP-8,5329102,1.1360795478534944,1.2898984746896878
SW1573,24797083,0.9725439959134782,1.4505143028760248
COR-L105,11507802,4.378208095645504,1.800123068310688
SK-HEP-1,10385095,2.0924930980552148,1.3152015417780822
ML-1 [Human thyroid carcinoma],44185566,2.5450411112530475,2.86580721790983
MOLM-13,54618164,3.841266236609366,3.408754380541881
SW1573,5287620,-0.7347028317725576,-1.6081888748344446
Panc 02.03,24821094,4.183998590604807,3.2690282383277904
NCI-H2452,11977753,-3.0535753971711617,-1.4722971779833371
MDST8,selumetinib-tretinoin (2-1 mol-mol),2.2380074013059086,3.153521153181664
K-562,5278396,3.2143611477277325,3.2134056768834416
MDST8,46907787,1.4338285439483007,2.1873710003432176
MOLM-13,16219061,2.363003680724254,2.0284324094519897
IGROV-1,3854666,2.3355254440561137,2.224601301929646
LS180,11175137,3.0855574956004506,2.7575679969618268
PaTu 8902,24180125,3.5735575491444505,3.1785387434295838
Granta-519,135440466,3.2501433765769097,1.64119828020708
Granta-519,3634881,2.8250958488191533,2.407503776301685
BFTC-909,24785538,3.0409365635840433,2.1387979319908843
Daudi,9903786,1.3988461789185107,1.9352791214479312
IGROV-1,126941,-2.246216453812328,-2.678141869641396
HuP-T3,327653,2.4979616286385573,3.068965994206076
KU-19-19,24785538,4.6207321752497545,1.925791697597317
PaTu 8902,11238147,5.651020754323713,2.9214574433631975
P31/FUJ,24772860,-2.926152167827307,-2.915940245558141
SW48,969516,2.6010409472277303,2.9173902451373768
NCI-H2452,11656518,-0.3763326461825258,2.063284432510569
LS180,156422,4.137124258725139,3.8071708012747996
K-562,16038120,0.8140588279430221,0.39066243455087973
HEL,9956119,2.2634866876643924,2.7991465638165756
MOLP-8,16013152,3.9032026583920656,3.078220319647484
SaOS-2,7251185,2.1177882155213488,2.572510794560807
SW1271,16722836,1.1489272284540188,1.6102834131936858
SW1573,1750826,-4.895155026964416,-1.1766511710490648
COR-L105,6918878,5.053406021852451,3.264055212875698
HuP-T3,44566777,1.596285673654969,0.7223202183336218
RCC10RGB,11167602,3.5267453541831695,2.9464114042867022
KU-19-19,3689413,0.155027117273248,0.12707662537766284
LS180,262093,3.1953995116592826,2.9853657243089318
HEL,168313016,4.358661125075543,3.9332848849468807
LS411N,448949,2.5849168666236273,1.5085280563604355
RERF-LC-MS,11507802,1.168612691302407,1.7971954312957008
RKN,3025986,-0.1432368238740909,-0.42412828188698914
LS411N,5566,3.1552423609786153,2.8638436001120122
MOLM-13,168312962,1.173226591058953,0.7718069371139694
KU-19-19,16741245,1.8623441782077492,3.908170146986407
BICR 31,5746,2.9612823230829592,1.4546492759880985
RERF-LC-MS,448949,1.7883798522328354,2.230985748531059
Panc 02.03,piperlongumine-MST-312 (1-1 mol-mol),2.606918356339114,2.157971384463677
K-562,135411,0.731253239019591,0.19137868892665594
WM115,3825829,3.803690072721518,4.099975532781231
PaTu 8988t,1566236,2.792784501487116,2.371555144325845
SK-HEP-1,25102847,3.375423501622406,2.6260527620174026
RCC10RGB,4378219,3.5112219508307017,2.7028913846068985
IGROV-1,46907787,2.182756719431072,1.9102572095047154
ML-1 [Human thyroid carcinoma],176870,3.163449715300446,3.671260329391288
COR-L105,9903786,2.948812050867326,3.056823353602997
SK-HEP-1,5287969,-1.6185163943497696,-1.5437288860321206
LS411N,66577038,3.114674219164565,2.723996190455107
LS180,11152667,-1.0678137233062412,-0.22225511724056943
SW1573,10322450,3.835483834832597,4.224694437067911
ALL-SIL,4369359,5.632204520937589,1.7195750279322382
P31/FUJ,6918289,5.395091759648689,0.19790392533024115
NCI-H1568,carboplatin-etoposide (40-17 mol-mol),1.7182211320205656,2.7428385270057776
BICR 22,54626689,4.975060177279609,4.72371903869071
RKO,11455910,0.1271196393609195,0.39853977574540955
NCI-H1568,2749,1.8950065449811435,2.189171243100857
SK-HEP-1,2858523,3.173409588420467,3.109371965208443
HARA [Human squamous cell lung carcinoma],46907787,3.600628557962214,2.6097720180496045
NCI-H1568,16736978,1.0202421307584555,2.090487674737689
NCI-H1568,11640390,2.883529605834316,3.709166421543614
SaOS-2,375860,-0.2844076074043694,-0.1739153410304977
Granta-519,9549297,1.4990763156673828,1.5498391905966913
ML-1 [Human thyroid carcinoma],24772860,0.5673209260643837,-1.5258529610896796
MDST8,9915743,3.1722151191536607,1.3284955641349296
HCC1500,7251185,1.592161448601532,2.5214216425641456
PaTu 8902,654092,0.4014878659730266,-0.04642876552355208
HCC15,36462,0.276886424919507,2.3394796110613894
HEL,11222830,1.7664464656365049,1.16937036496084
LCLC-97TM1,6918328,0.5489211755624944,0.05065994952707694
SW1271,11427553,2.280233400826346,2.717654006019539
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673,-0.16967435134984948
SW1271,216239,2.3992651597700805,2.626696450200269
LS411N,52912189,2.124177170278397,0.6001265514729781
RKO,262093,2.7220373961576834,2.251263301522147
RKO,selumetinib-piperlongumine (8-1 mol-mol),2.2390647410806306,1.9914934561533275
SU-DHL-1,24180125,2.3898229933344193,2.5936670191671167
P31/FUJ,10231331,0.360402840185862,1.1260441552130431
COR-L95,navitoclax-PLX-4032 (1-1 mol-mol),-1.058390181093963,0.47896144219522413
HCC1500,4705,3.1720127097688073,2.969709773511363
ML-1 [Human thyroid carcinoma],16722836,0.1571893320134409,1.8458225112133269
ALL-SIL,49793307,-3.5976005593324607,-4.324547341268967
LS180,decitabine-carboplatin (1-1 mol-mol),4.499129095785504,4.170718357396649
BICR 31,selumetinib-PLX-4032 (8-1 mol-mol),3.623780948669338,3.486017383873827
HARA [Human squamous cell lung carcinoma],409805,4.942295126142001,4.948816644316835
ALL-SIL,44489675,3.868517697091687,3.6529289898691
COR-L95,9825149,1.4009706639997015,1.7889641198019672
SK-CO-1,25102847,2.4259034566713087,2.2502521754834235
COR-L95,36314,-2.5383774872687743,-1.8191770824202524
IGROV-1,1641662,3.5854177848263675,3.5455669220713215
BICR 31,16720766,0.8786813091838682,0.6923708937201936
BICR 22,51037431,2.6213243445689254,3.305585897215997
BICR 22,2742550,3.9616050819266326,3.6807617225079095
Panc 02.03,46843906,3.852893526574364,3.4013824184267976
NCI-H2452,2708,3.4614923437122704,4.967525370615515
RCC10RGB,15547703,6.556615668020641,3.464954281864069
RCC10RGB,5311,2.218274000934613,1.9185665285128517
ALL-SIL,erlotinib-PLX-4032 (2-1 mol-mol),2.6221278423473446,2.8477621890251488
LCLC-97TM1,24964624,2.5877637900313384,2.34775725210887
KU-19-19,107985,-2.420790531142743,-3.1646997432535238
PaTu 8902,67156097,4.866613623772486,-0.048126888712654955
KU-19-19,676352,2.681008284282423,2.123304115501437
NCI-H1568,67291369,4.628091486396258,2.9429252255314067
BFTC-909,54143018,0.6300785047889099,0.8746689222458793
BICR 22,5329102,1.9183442886017033,2.2331417389889343
LS180,JQ-1-carboplatin (1-1 mol-mol),1.5137098822728978,2.3694350095157777
SU-DHL-1,1641662,2.0867851207635044,3.2461714611724126
SU-DHL-1,54143018,-1.2287450259829942,0.5770381673579703
WM115,3552672,1.460151745141153,2.610404692793356
Granta-519,6505803,0.3707466177802866,-0.5731595013589744
BFTC-909,2733526,3.41724914482818,4.015331863597793
COR-L105,445643,5.447871607768224,4.029033250960005
SW1573,BRD-A02303741-navitoclax (2-1 mol-mol),1.994158389176884,2.8374932682352925
COR-L95,135421197,1.4504202802892363,1.6570833753725176
BICR 22,4096211,1.2113689067872688,2.4299377327267817
Daudi,241158,1.9180708700138325,2.4895415842684714
RKN,docetaxel-tanespimycin (2-1 mol-mol),1.659975764237714,-3.903624074447544
COR-L105,44543605,3.798835657012519,3.9324691694884844
NCI-H2452,1641662,5.47511848960003,3.677118456107524
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233,-1.1187693797121905
HARA [Human squamous cell lung carcinoma],9826308,0.352829852370258,0.38649700257453984
MOLM-13,44489367,5.70063080501961,4.363835773349636
MDST8,9936388,-2.5080849755955485,-0.2812689682956037
Panc 02.03,5311281,4.827416145020449,2.623433121456965
MOLM-13,carboplatin-etoposide (40-17 mol-mol),-1.2909434999313618,0.407505953139934
Panc 02.03,71466380,5.929652601038649,4.633707385412742
BICR 22,148198,-3.168643556299537,-3.0030454026918147
LS411N,salermide-PLX-4032 (12-1 mol-mol),5.97516001818146,4.57343592636252
SK-HEP-1,serdemetan-SCH-529074 (1-1 mol-mol),2.785522004432589,2.2314304031989103
MOLP-8,36462,-1.3356090090333852,0.41344623080189313
RKO,168313200,3.1169425006108455,2.892250787721963
SK-HEP-1,24951314,2.4991128927954063,1.4991760702648507
HARA [Human squamous cell lung carcinoma],654092,0.0602204093244996,-0.15947900227134726
COR-L105,71304818,2.509036292239667,2.714503393262392
LS180,11485656,2.0322073649322716,2.2589010193558465
SW1271,44185566,2.531281599529394,2.545383055068024
P31/FUJ,49836020,4.674155414221834,2.4407959632142253
UACC-812,carboplatin-etoposide (40-17 mol-mol),1.4623710182991412,2.1423027527638614
SW48,selumetinib-piperlongumine (8-1 mol-mol),-1.6389231751651676,2.7440626999084374
RERF-LC-MS,9933475,2.253072026550434,1.9561950824963177
SK-CO-1,24964624,3.1718881088721735,2.1504803458933215
Daudi,serdemetan-SCH-529074 (1-1 mol-mol),0.5315798853273473,1.5212971556106991
LCLC-97TM1,54619267,4.094508182091097,4.004638979414525
SW1271,53232,2.609582991635379,2.6794387300654687
COR-L95,5282054,2.7623794331923293,3.3464196373783066
LS180,navitoclax-MST-312 (1-1 mol-mol),2.264329466995316,1.0854017014339212
ALL-SIL,2749,0.4174204822378836,0.9904180040055748
MOLP-8,11455910,0.4759456923848041,0.63220251757698
SK-OV-3,5329102,2.1848030817162427,2.065146599847115
IGROV-1,5978,-1.5618214380165825,-1.9577572946424362
BICR 22,135411,0.5903998872112299,1.3592836871409224
NCI-H1568,6610216,3.52063980115584,4.312768326267659
SK-CO-1,176870,3.965368978694832,3.0641483196162214
BICR 22,selumetinib-GDC-0941 (4-1 mol-mol),0.9236459983080146,1.419692924323019
BFTC-909,doxorubicin-navitoclax (2-1 mol-mol),-1.537563048544383,-0.5956464504291974
IA-LM,9936388,2.150111055311291,-3.236177055795811
ALL-SIL,selumetinib-BRD-A02303741 (4-1 mol-mol),5.278969536899067,3.482071820370118
ML-1 [Human thyroid carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),-0.2880991888537167,3.6701487183176607
SW1573,navitoclax-MST-312 (1-1 mol-mol),-1.0459858342436132,0.9023844393139174
P31/FUJ,11214940,0.6332731592867608,1.0342732144287203
WM115,421610,3.513747492259629,3.2549629735254872
SaOS-2,227681,4.210698048028356,3.0400790137795566
BICR 22,25102847,3.5270600092516444,2.5271822019909203
BFTC-909,46199207,3.2760821272908753,3.330149458628839
IA-LM,25154868,2.8804249714329537,4.259035549999322
SaOS-2,5738263,2.656867973667437,3.3808221257540065
BICR 22,5738263,3.828959854789421,3.4719191413853197
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202,1.7274415316865523
SW48,SNX-2112-bortezomib (250-1 mol-mol),-3.704667477676808,-1.3845521273645591
Daudi,24771867,-1.2539165255857252,-0.9776252681833981
Daudi,446155,1.8075236258569949,2.498213414995185
LCLC-97TM1,56946209,-4.83981355951691,-3.953480399051508
BFTC-909,702558,5.601571619782522,5.29701991647611
LCLC-97TM1,24797083,1.6672233423539589,1.2845040821717846
IA-LM,2945648,2.6647419367463794,2.5676055670150877
LS180,11717001,4.39666521822979,3.5150148646887005
LS411N,42642645,1.4293896003043414,0.2757776480105141
SaOS-2,16038120,-0.4228492368909831,0.9781180175642601
HCC15,387447,-3.5284625014182556,-3.5268627835039768
K-562,24785538,3.0712560410264436,0.5356945003982666
PaTu 8902,6918289,3.1585202712855196,2.749065586776928
BICR 31,11404337,-0.6318210319309021,-0.2679384522676602
Daudi,navitoclax-PLX-4032 (1-1 mol-mol),2.817343533206949,0.5717186599966153
LCLC-97TM1,5460769,-2.8089441547625067,2.648881659744546
IA-LM,25150857,2.846024040084871,1.943990474520855
HCC15,56973724,1.575466068691269,3.497600620880237
ALL-SIL,3384730,0.9130815120154347,1.438837911303153
Daudi,426756,2.2442144831253383,3.5898742381183104
NCI-H2452,6918328,0.3371182351616307,0.2891460398546978
SW1271,11364421,-1.228057709924225,-2.1718007061426867
HCC1500,9911830,2.253316240952314,2.583918572551823
COR-L95,60750,-4.239654973449372,-2.121842530025644
COR-L105,675434,4.897128449999278,4.6636824186165065
RKN,5978,-1.5379865785523688,-1.9502971595990595
BICR 31,1641662,4.3069637553272715,3.599681904373637
SW48,5281321,-2.141746406212142,-1.055328349044055
SaOS-2,navitoclax-gemcitabine (1-1 mol-mol),-3.208051277471344,-1.5128182174477232
SW1271,vorinostat-navitoclax (4-1 mol-mol),2.219898250998274,1.3484379792333139
K-562,12003241,-5.632155645383806,-1.141972946462441
IGROV-1,11455910,-0.2792640061206097,1.3029300673083404
COR-L95,10410894,3.9632969340699735,3.2953708217510815
SW48,5351362,1.0988845715277948,1.7056706115666724
HuP-T3,9907093,4.467626530245781,4.307592722880473
IGROV-1,16065773,3.3717508464278585,2.5047677474328047
Panc 02.03,439501,0.4668648826805023,-2.0295736062467884
COR-L105,11427553,3.315123926488956,2.987936189673736
IGROV-1,119607,5.004384040905396,5.430779533369017
BICR 31,151289,1.9519908762907336,1.256399452474233
SK-CO-1,60700,-2.5556595153787915,-0.2595441799282751
ML-1 [Human thyroid carcinoma],2828334,6.601742138030732,6.213527672938612
BICR 31,3825829,4.543850483279072,4.161648448849857
SK-CO-1,65064,5.377201033407044,4.94083592403428
HuP-T3,613753,3.2946831222357233,3.3128114439008436
SK-HEP-1,89928392,1.6602086186634375,1.7108340295299596
NCI-H2452,5291,3.747673065274588,3.756643372752322
NCI-H2452,24964624,2.8171716992687967,2.5639717586313537
SU-DHL-1,654092,-1.6609972231677514,-0.029159908721537252
LCLC-97TM1,327653,3.202975625508304,3.162910624595341
LCLC-97TM1,11507802,1.3666879232460134,1.477403074142501
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578,1.029371928828607
BICR 31,selumetinib-UNC0638 (4-1 mol-mol),2.7430116861345977,3.1561715308037144
SK-CO-1,11222830,1.7982943188317977,1.733090384469907
WM115,24951314,1.781657055553587,1.4317554417204092
WM115,135421197,2.9135607351561883,2.1025747563045964
LCLC-97TM1,136227331,4.3740550996774745,3.9743816166829107
BICR 22,24951314,1.8959621159637303,1.6096792115205845
HCC15,15983966,-4.250826265389746,-0.6759952667516477
Daudi,24964624,0.5895170730703193,1.2114094875672614
SaOS-2,11257553,0.2323229130258903,1.4354346049436209
RKN,doxorubicin-navitoclax (2-1 mol-mol),-0.6554911641899885,-0.9447724936578774
RKN,46191454,2.1430961760764897,1.7182770153047162
ALL-SIL,navitoclax-sorafenib (1-1 mol-mol),-0.9804805399961952,-0.3555245576535425
HARA [Human squamous cell lung carcinoma],24180125,3.640570848683534,3.11886841755698
BICR 22,10410894,2.962619033825151,3.1863028010223804
NCI-H2452,168312962,2.634597095527088,2.5077782899376406
MOLM-13,452548,-4.1979459883625045,-2.9435864887428367
HARA [Human squamous cell lung carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-1.5170547368842298,-0.9350256621023192
SW1573,44185566,2.872643000979188,2.7642280577718163
SK-CO-1,5470400,-5.490738264790885,-1.2452034134450938
BICR 22,9933475,1.970614134756263,1.8071215410148929
BICR 31,24753719,4.233476426959058,4.43103272592114
HuP-T3,4261,3.8165819220848767,1.6588609668242467
COR-L105,7251185,3.034502689275401,2.814503833761643
ALL-SIL,selumetinib-MK-2206 (8-1 mol-mol),1.6757681784854677,1.3995145370979074
SW948,crizotinib-PLX-4032 (2-1 mol-mol),1.0252435682890393,1.6115750117516483
SK-OV-3,49793307,0.1269396758315965,-2.0269313682128303
ML-1 [Human thyroid carcinoma],11647372,1.3935699525801049,1.3110873851814313
KU-19-19,216345,3.688803948438149,4.157427168681072
LS411N,638278,3.5631537252490917,3.177776546867404
SK-CO-1,374536,2.850215581982446,1.6819176682476455
ML-1 [Human thyroid carcinoma],25126798,4.037868296097697,3.960758587698317
P31/FUJ,11178236,-2.454576103037029,-3.448633148577343
SW948,439501,-2.1692174321648174,-1.9732627004464351
NCI-H2452,9911830,3.1691750432917645,2.6878459543340596
IGROV-1,9911463,4.195269991960018,3.8514719536017132
PaTu 8988t,JQ-1-vorinostat (2-1 mol-mol),2.250446694675845,1.3851289478855842
KU-19-19,46199207,3.5920417522591723,3.2962081719775607
IA-LM,25102847,3.5065737869109017,2.6470859065991283
SaOS-2,10385095,0.9171223668306429,1.4274551338610524
SK-HEP-1,285033,-0.6546577384402199,-1.5961721760525303
WM115,1566236,3.8332358430398847,2.219359131102017
LS180,3025986,-0.3657173630682503,-0.8504877292333026
HCC1500,11625818,4.269459310239442,4.518510288234281
HCC15,44259,1.006506996100477,1.0838868621077447
RERF-LC-MS,285033,-2.0574538896256587,-1.612450453624959
IGROV-1,241158,3.288496474515495,3.9301929474425883
BFTC-909,6917907,-4.2174557642594035,-4.871145099341043
BICR 22,375860,-0.6251605141105395,0.09827968784266845
BICR 22,119607,5.438520616053313,5.078080115278388
RERF-LC-MS,676352,1.6328584527608256,2.163556024562205
HCC15,6918289,2.816502870816243,2.9191024395869336
RKN,241158,3.8611150596916577,3.9252108511760184
COR-L95,3634881,3.005165393659793,2.9394851935391904
IGROV-1,11626560,1.7276653519578558,1.9264914620806182
LS180,3385,1.8718372753364907,4.207377791445503
SU-DHL-1,56946209,-5.3778659012875325,-4.3310509132761705
Panc 02.03,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1370964450490924,3.7868687614736887
NCI-H2452,448949,2.771204919609998,2.193907955337875
SW1573,5113032,6.532830278238065,4.9766970430108755
SK-OV-3,11485656,3.3782074628341894,2.524480726211112
BICR 22,81146,6.036644504914818,4.809176395689226
P31/FUJ,76446078,4.256026108364254,2.928293685954905
Daudi,2113511,3.606563716227827,4.403523935602336
HuP-T3,5328940,2.3682781464336147,1.7206131673368648
RKO,6852167,3.601912647929868,1.9901164575048227
SK-HEP-1,1750826,-4.478019715406424,-1.4013545588800052
SU-DHL-1,25102847,1.7846654255237482,2.0405223922198545
KU-19-19,2749,1.0704171129437314,2.201153507795782
COR-L105,136227924,2.729950058152846,3.0151462195421095
RERF-LC-MS,crizotinib-PLX-4032 (2-1 mol-mol),1.247076899545937,1.965338547242763
RKO,25154868,3.654559992823761,4.284886030097503
HCC15,5113032,5.023051877119823,4.914040828264503
LCLC-97TM1,3815108,3.2576294300862867,2.782820300400503
SU-DHL-1,6610216,4.061950863639378,4.157835669530922
LS411N,136227924,3.1900427132689724,2.403435310302049
BFTC-909,selumetinib-piperlongumine (8-1 mol-mol),4.839600666891057,3.328463074117007
KU-19-19,51037431,1.6044173216619535,3.2046460170636215
MOLM-13,637858,0.5048034575879493,0.8595280636771159
SW948,5329102,1.476566645762777,1.8435257623720795
NCI-H1568,tretinoin-carboplatin (2-1 mol-mol),4.637834792559274,5.002302678862077
K-562,serdemetan-SCH-529074 (1-1 mol-mol),0.9314801413999184,1.6990027943593342
SW1573,1566236,3.3872191513469025,2.40971558334859
IGROV-1,46174525,4.5083762186279595,4.482596218849007
SW948,9956119,4.230492181635778,2.9250023508650065
SaOS-2,100016,6.565789067704999,6.142473927382841
WM115,11152667,0.9737214532192616,-0.6021663071524108
HCC1500,439501,-1.4156205398968564,-1.83220926769111
SU-DHL-1,selumetinib-UNC0638 (4-1 mol-mol),2.6727434521528894,2.362225981299562
NCI-H2452,49793307,-1.217787389832333,-2.1414902579313937
BICR 22,208908,1.938925459708866,1.558774313050386
KU-19-19,675434,4.307992798559183,4.437349209007164
SU-DHL-6,168312962,-0.817402334599034,0.781815392033967
RKO,4705,3.750134101835121,3.125501994652306
MOLM-13,72193861,-0.3301410770598842,0.1026286524833327
SU-DHL-6,11497983,-4.838706392617486,0.07470289663524309
IA-LM,6610355,7.432350505906943,4.45925802065435
SU-DHL-1,100016,4.0163007651424945,5.782301427588212
SW48,tanespimycin-gemcitabine (1-1 mol-mol),-4.429955017650206,-0.9449046212688269
BICR 31,11717001,4.942461846011657,4.102258899895742
MDST8,452548,1.517979290481689,0.5815572293906466
SaOS-2,vorinostat-carboplatin (1-1 mol-mol),3.1714498028608573,3.172459161869999
ML-1 [Human thyroid carcinoma],tretinoin-navitoclax (4-1 mol-mol),3.335416129341979,3.196738715950697
HCC15,216239,2.699139377969599,2.4664020017860775
SW948,54143018,1.1269042701713536,0.1405342323279287
PaTu 8988t,2871966,0.7913795837456433,0.5755477813481857
HARA [Human squamous cell lung carcinoma],24889392,3.022552356394008,4.466232276618252
MOLP-8,702558,5.64086941386953,4.090181542610859
SK-CO-1,9926054,2.0008566323964576,2.0340645053946496
NCI-H1568,208908,1.6425276108518176,2.00119251879815
BICR 31,11364421,0.6668909809197356,-0.6602125715152944
RKO,6438330,2.4839059464581785,1.876084072822742
HCC1500,11717001,5.16685929391629,3.859022857019988
NCI-H2452,5335621,2.361346054519045,4.757160632771556
SK-HEP-1,168313200,3.8713243832650335,3.244084355510203
MOLP-8,5281321,-3.090542457479921,-2.450204133372885
LS411N,5287620,-2.7795044954925423,-1.9548145113371178
BFTC-909,42611257,4.384387627976705,3.458877179674178
MDST8,135421197,2.23565927197073,2.179940646667187
LCLC-97TM1,navitoclax-MST-312 (1-1 mol-mol),1.32635815912294,1.0636430918709678
ML-1 [Human thyroid carcinoma],4261,2.09291450929782,1.907350854181452
SU-DHL-1,136227924,2.1802521862386395,2.785154535336437
HEL,9929138,6.278460484472286,4.875764320393936
BICR 22,100016,6.157225392196351,6.2797413096463925
BFTC-909,6610216,4.898578232775107,4.4156775634931495
ML-1 [Human thyroid carcinoma],327653,3.144384021244803,3.4285492846912184
P31/FUJ,2708,3.1798246734444535,3.482680758171448
SK-HEP-1,11222830,2.864448489509693,1.65176390144625
SW948,6450551,1.190778779915613,2.0246902834486287
P31/FUJ,3503,1.1912257572322915,1.7440024235299103
SU-DHL-6,11214940,-0.480666123434414,1.0560397280678968
Granta-519,3101542,4.848909880356854,1.755801840630469
COR-L105,JQ-1-vorinostat (2-1 mol-mol),0.2989866544918393,1.187188560739174
SK-OV-3,54613361,2.1799599530092597,0.24856178581320804
SaOS-2,navitoclax-MST-312 (1-1 mol-mol),0.5918912917357866,0.9147803024794636
PaTu 8902,9866186,4.760639543290191,0.8350542125222663
BFTC-909,selumetinib-UNC0638 (4-1 mol-mol),3.893293421232559,3.246644312530963
MOLP-8,445455,4.348825488954634,3.950918533419483
LS180,327653,3.1909584751660973,3.289770553831348
LS180,selumetinib-JQ-1 (4-1 mol-mol),-1.4901017430136672,1.0933674504199178
WM115,24889392,3.868386170167097,4.380923102224809
SK-CO-1,54618771,-0.118181134306818,1.0664351201108937
SaOS-2,9868037,3.691858985861763,3.560808561559295
Granta-519,navitoclax-PLX-4032 (1-1 mol-mol),-1.627997667174391,-0.4493223995763478
HCC15,10385095,2.335943691067567,1.3590810336869237
MOLP-8,2874250,4.289349020932475,3.9942073268830853
IA-LM,selumetinib-PLX-4032 (8-1 mol-mol),3.550842721167267,3.497960869358944
SU-DHL-1,44137675,2.905771721153928,3.295937940808314
SW948,16038120,-0.173493225813213,0.5944381953541148
SW1271,387447,-4.431171658059158,-4.17812398388858
HCC15,71304818,2.608087345638841,2.526264257309249
HuP-T3,navitoclax-pluripotin (1-1 mol-mol),0.368847097693027,-0.68375001986672
SW48,44259,-0.1330653223053438,1.1357714287951273
SK-CO-1,selumetinib-tretinoin (2-1 mol-mol),0.0609322450258742,2.1513809400948314
BFTC-909,216239,2.6603594422751136,2.4058216398856187
MDST8,9825149,2.535214047656483,2.4317135839139143
BICR 22,11625818,4.758067302616356,4.3498481586275854
LS411N,6852167,3.3651093558735035,2.1549231466620973
BICR 31,7251185,3.1852875333924415,2.885931262695121
ALL-SIL,25195348,0.8279476297727174,2.338694931210236
SaOS-2,73707438,3.8840228628110336,3.8347033830081885
Granta-519,selumetinib-MK-2206 (8-1 mol-mol),2.927373885066516,1.329194546338164
BFTC-909,17755052,1.7621152527207813,2.013456463845822
MOLP-8,vorinostat-carboplatin (1-1 mol-mol),1.858459936032215,2.071748299387971
SK-CO-1,3815108,2.810447278858876,2.6234478912694077
COR-L95,3025944,4.2211844332657344,4.02360014927801
RERF-LC-MS,9825149,2.3136516136403595,2.3677775370125795
KU-19-19,72376,-1.7461965003174784,-1.571996923269564
K-562,568763,0.3044566284292496,-0.10293965742826369
ML-1 [Human thyroid carcinoma],4521392,4.335063435629941,4.404550979754674
Granta-519,6917907,-6.07944377191165,-5.5865345497598495
SK-OV-3,4788,6.178998906779571,5.76443811258761
HARA [Human squamous cell lung carcinoma],3081361,3.3764732224556533,2.4609542805414724
RERF-LC-MS,6852167,1.8897499878184068,2.99122817297656
RCC10RGB,2746,4.042085650474663,3.522120247743593
SaOS-2,54143018,-0.9786223984268784,0.8201623212087396
HCC15,451668,4.7728580097586635,4.35380103138248
RKN,135999136,4.319110081529012,3.951542453804417
ALL-SIL,11228183,-1.4217334963731665,0.3823592565930849
RKO,568763,0.6942409100068829,-0.07131899492131187
SK-CO-1,71304818,2.179260281615582,2.451413465743894
SaOS-2,151289,0.9278405880660672,1.1111553006026784
BICR 22,tanespimycin-gemcitabine (1-1 mol-mol),-1.0672550933922087,-0.591835842964193
MDST8,241158,1.799926141571129,3.9326299678898176
BICR 22,11214940,1.8032425349242045,2.16425935603357
BICR 22,navitoclax-birinapant (1-1 mol-mol),0.9663061977057198,1.3338537836790598
LS411N,9825149,1.7370452341191267,2.1078570369289453
K-562,72193861,0.1570904811456113,0.2592258280599211
RKN,89928392,1.2442310560485252,1.6311840292641002
HARA [Human squamous cell lung carcinoma],25150857,2.860855820493058,2.6467331672142134
RERF-LC-MS,44493528,4.358183394704722,4.507443549731407
COR-L105,5738263,4.054674337055045,3.5114059136517004
P31/FUJ,5280436,3.1830796623136832,2.762093184765196
Daudi,JQ-1-navitoclax (2-1 mol-mol),-0.7335137922261505,-0.5267011785964322
LCLC-97TM1,135398516,2.1563049020997593,2.063774210525718
COR-L95,25102847,2.826830714185171,2.606121314510769
BICR 31,11427553,1.8414471938085448,3.0722353459620124
P31/FUJ,navitoclax-MST-312 (1-1 mol-mol),-0.1859808943498902,-0.05110939020821185
IGROV-1,15547703,3.339928221860449,3.2606816145955144
LS411N,navitoclax-PLX-4032 (1-1 mol-mol),1.1305163231038025,1.2963705411576982
LS411N,6918328,-0.170211770014818,-0.10443510943457954
Daudi,3136844,3.4483363469146098,3.45328835801649
MOLP-8,10302451,3.559537910744256,2.753187324660869
LCLC-97TM1,24772860,-2.203105978452304,-1.8910350471110735
SK-OV-3,selumetinib-GDC-0941 (4-1 mol-mol),2.556628673081414,1.7956346042179743
ML-1 [Human thyroid carcinoma],637858,1.1825057393141218,2.4188070825381818
SW1271,119182,-0.4023310904747799,-0.4107203647730993
RERF-LC-MS,135398516,2.452363199699896,2.1551050497996
SK-CO-1,44495899,4.504236306700641,2.9429416635843615
IGROV-1,10127622,3.2581804056600165,3.7302088700248923
SK-CO-1,44491742,5.1736211152382285,4.273340596576653
MOLM-13,4477,0.1750371811238646,0.6504802331287612
WM115,25183872,-1.8696572442850008,-0.8171491749981863
BFTC-909,JQ-1-navitoclax (2-1 mol-mol),1.710597904541152,0.837766801300333
LS180,JQ-1-MK-0752 (1-1 mol-mol),0.6783898145505391,1.1153237920581736
HCC1500,5335621,4.362965892261437,4.418580140033652
P31/FUJ,1716436,3.053886593694114,2.692872660453381
Daudi,9915743,0.3665260221427978,0.498409542750035
UACC-812,selumetinib-MK-2206 (8-1 mol-mol),1.487616505543695,2.010677740386775
SK-CO-1,5311281,1.7217135985324663,2.757679195883861
IGROV-1,3503,2.453392942972796,2.3608553436351696
SW948,17755052,0.6738246482480579,1.3797994867076304
Granta-519,5329102,1.3717145166802862,1.407622361989897
HCC15,25183872,1.7330298559310635,-0.2447651357744866
IGROV-1,23635314,-0.611739968448912,-1.4321063891096424
HuP-T3,46174525,5.4457837824532245,4.558947553327039
IGROV-1,46199207,3.293579955374855,3.277379879604108
NCI-H1568,11656518,0.902462789439692,2.070801180611623
SW1573,12001922,2.294011710402099,1.9982543627605391
HCC1500,navitoclax-sorafenib (1-1 mol-mol),-0.1825981932609776,1.008001371599878
ML-1 [Human thyroid carcinoma],6918289,2.565001109569917,2.908511080607338
SW948,2871966,1.833559506117821,-0.1876667118695545
RKO,42642645,1.3055497818976145,-0.2737933392226585
NCI-H2452,6450551,2.947106204512916,3.0105086097127356
P31/FUJ,10302451,4.186780329312711,2.8721979751784747
P31/FUJ,6918837,-4.676526715032863,-4.3177299041616015
HuP-T3,3552672,1.4793505278318,2.8801185632443964
BFTC-909,25105715,3.3944682152224455,3.5021335284619557
HEL,44197249,3.8651368484410056,2.4363442099995476
HCC15,JQ-1-MK-0752 (1-1 mol-mol),3.1823820949476564,1.9795910245002275
BICR 31,46215462,1.6669957894505008,2.0949672256548824
HuP-T3,9866186,1.729562359157257,0.6884860646771354
HuP-T3,11717001,4.25253085122872,3.9308117976829595
NCI-H1568,54618164,3.652866089784218,4.217652164654287
WM115,441298,3.225500618866892,2.4525152718071546
LS411N,71304818,3.0616651991102697,2.196781577040041
NCI-H1568,navitoclax-sorafenib (1-1 mol-mol),1.4784994486098395,1.5718864186006511
SK-HEP-1,10184653,3.249474772070569,1.6862435228555281
BICR 31,12003241,-1.4237270953299652,-0.8974723903614165
RERF-LC-MS,25150857,3.1332692975488934,2.708729573681378
COR-L95,24964624,2.1587115359420994,2.245248289287882
SU-DHL-1,44241473,4.633491620971472,4.652729367916116
HARA [Human squamous cell lung carcinoma],72193861,-0.0489023079435419,1.6910284867236913
ML-1 [Human thyroid carcinoma],11152667,-4.726499990059393,-0.0783137098842544
MOLP-8,6918878,0.495059053850733,0.5827855641500631
RCC10RGB,448949,3.406339167429426,2.1590209991683507
HCC1500,148124,1.3380754252474834,-1.1736400529648483
HCC1500,5280436,1.8565158203383687,3.7092654733035846
IGROV-1,10302451,0.4135234554742116,3.302908698115804
Granta-519,285033,-4.09305161448312,-3.182038989585467
HEL,JQ-1-navitoclax (2-1 mol-mol),-0.660921199279695,-0.6997894307574865
Granta-519,71304818,1.7993370678919798,1.904649568050408
NCI-H2452,3689413,1.184555113675537,-0.18891333529652332
IGROV-1,2708,4.438419625543199,5.137080706146003
SW1271,49850262,4.063818012025616,3.7437945996681288
LS180,6918736,-2.1262365465987907,-1.5866100099837204
PaTu 8902,10127622,6.3250626499292295,3.5635238128109292
SW1271,57519531,1.4534695216386555,2.663368077414942
HCC15,57519531,1.9577451103636032,2.548634569813261
SK-HEP-1,navitoclax-PLX-4032 (1-1 mol-mol),2.657614017988428,1.9328144133750818
SW48,44185566,0.7812235367324193,2.4509551828172493
Granta-519,navitoclax-birinapant (1-1 mol-mol),-1.2889388818955343,-0.4692394150425706
KU-19-19,241158,4.34083218708613,3.8930375897261684
NCI-H1568,11404337,-0.63897934294681,-0.0028466144551429805
Granta-519,219104,2.15431657191886,2.3378313299326314
SK-CO-1,5746,-2.8271360432483035,1.1214028537857408
WM115,6918837,-2.450050091846588,-2.502977771661954
SK-CO-1,11152667,-1.1935109806009474,-0.33572975881774686
SW1271,9825149,2.2012182796133084,2.3307485069705716
SaOS-2,208908,2.5337103611164893,2.2370241139135505
SW48,5470400,-1.7303817372543355,-0.30860350494080313
NCI-H1568,JQ-1-UNC0638 (2-1 mol-mol),1.923479920407172,1.7964413477979662
SW48,15547703,3.0370188863847414,3.3071713589800305
SW948,46907787,2.3709287142369555,0.3815615804122743
Daudi,5113032,4.739966647777949,4.521406917933418
SaOS-2,135984461,4.8186429168984475,3.7251514658572167
MDST8,168313047,3.800021027786958,2.565939685943326
RCC10RGB,11964036,2.4986740771219673,1.5483789683889333
SW1271,24785538,1.505278847517323,1.9659618866975261
BFTC-909,3676137,5.055523871435828,4.639762824223434
SW48,9868037,2.459515994210572,3.241954198954596
KU-19-19,10231331,0.2937024112037242,1.9444358389704188
ALL-SIL,54619267,3.6744484896003713,3.349841554626681
BICR 22,selumetinib-BRD-A02303741 (4-1 mol-mol),2.600469012399248,3.481084489096282
RCC10RGB,24951314,2.138755705452886,1.690410358582363
SU-DHL-6,26596,-1.882707371112463,-2.6529230747496397
COR-L105,46843906,1.9821208299636863,3.0730933912338143
RERF-LC-MS,4477,-0.1141702320643991,0.6095596442182728
MOLM-13,49766530,-2.4914272268054107,-1.9085670248507287
SK-CO-1,4917,2.9299888563447163,2.997769146517358
Daudi,72734382,3.17690285998388,3.3778751645167944
LCLC-97TM1,11625818,5.063433550011292,4.147871518858746
LS411N,vorinostat-navitoclax (4-1 mol-mol),1.2590657469614004,0.7989178656642371
ALL-SIL,451668,-1.1904263441284522,-1.6975727011335824
SK-CO-1,219104,3.537047767593632,4.034886705159903
NCI-H2452,65064,5.258935158123576,5.11880816952233
BICR 31,25062766,2.0025728701089904,2.0594947789230016
LCLC-97TM1,4261,1.8883571230172835,1.5412663266724718
BFTC-909,54618164,4.281231487810877,4.048763630798223
NCI-H2452,16736978,0.9447398024439234,1.954252332253254
NCI-H2452,selumetinib-BRD-A02303741 (4-1 mol-mol),6.449127799684226,3.858591113322217
ML-1 [Human thyroid carcinoma],selumetinib-decitabine (4-1 mol-mol),4.367801531941202,4.346165012499447
WM115,6917907,-5.049795628811172,-4.4066979173103284
HuP-T3,5746,1.6464242063318688,1.4647605569984765
MOLP-8,327653,2.384727852533787,2.554213927249524
SW48,72376,-3.1415011638088144,-2.026902496811219
SK-HEP-1,23582824,1.0257570544783106,0.8460190144728356
K-562,12001922,1.1213264373636214,1.6176435063789207
WM115,10410894,3.2188686198907743,3.3915066620108623
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681,1.351064828912401
ML-1 [Human thyroid carcinoma],49850262,3.5297334075235245,4.073379521985912
KU-19-19,44819697,-2.543386759740491,-0.5163331544383878
LS180,46199207,2.9384583216685023,3.236185478733028
LS411N,56946209,-3.80128700519076,-3.9436670651418155
LCLC-97TM1,6918289,3.014261251605047,2.5142612581702846
KU-19-19,107970,3.004209688555129,2.3797387017380776
MOLP-8,72376,-3.958595065171294,-3.4722810828772572
IGROV-1,5291,3.6852809555447985,3.794703834139323
Granta-519,46191454,0.5060764897707477,-0.20780855596700923
COR-L105,24901704,3.8942422617258714,3.4539304405273596
NCI-H2452,24797083,2.030715286150645,1.4748913145086124
NCI-H2452,124202324,3.032884210730814,2.729845524399782
LCLC-97TM1,4259181,-0.2611730486969081,0.029283138645776884
KU-19-19,73707440,5.592820593626321,4.0122293773933375
RKN,5460769,5.79272629497122,2.65761802322948
RKO,10184653,1.6814092199651305,1.2830075061278166
PaTu 8988t,24180125,3.300808715406375,3.0563557771054626
COR-L105,2858523,3.082532365215724,3.106281987198609
BICR 22,decitabine-navitoclax (2-1 mol-mol),1.4331437420597166,1.8383669955657513
LCLC-97TM1,16065773,3.044024356255971,2.517989814582136
MOLM-13,16115403,-5.622868208190141,-4.234059105431708
Daudi,104842,-7.567274671559235,-4.216541049512964
PaTu 8988t,3825829,4.270364787448243,4.079054501963742
HuP-T3,227681,2.514870644267688,3.4157991418271543
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524,1.6008410022277022
COR-L105,11964036,1.2117851204645589,1.5471755873963016
SW1271,135659046,3.922158232881772,3.7569165847177834
IGROV-1,4917,2.985904350427039,3.150910572880444
HCC15,9826308,1.2579647962340863,0.47277658627842156
SK-OV-3,46199207,3.479599233509405,3.3644654986107265
KU-19-19,2729026,3.069520174525383,2.725931375877359
COR-L105,25102847,1.810865395215699,2.8143793310704464
SW1573,9935249,2.8664920450292852,3.4368885393128195
COR-L95,1714884,3.7968274989469992,3.157601727999366
PaTu 8988t,7251185,3.286029674356028,2.7849424046984246
SK-CO-1,24856436,0.7128954142297991,0.3598140474228795
HCC1500,5738263,2.955373895930653,3.546200309850812
SU-DHL-1,6914657,-4.020831804674196,-4.770456370040826
SW48,638278,3.16751315896482,3.3316640990992856
LCLC-97TM1,135421197,1.517750954289076,1.6271458219570873
ML-1 [Human thyroid carcinoma],11404337,0.3501599152959295,0.028458824705873655
RERF-LC-MS,selumetinib-decitabine (4-1 mol-mol),3.240984973519631,4.422545164164717
NCI-H1568,6914657,-5.120590256929669,-3.4157732512167684
NCI-H2452,3676137,5.703513737309888,4.638775117507302
PaTu 8988t,11238147,3.9795465318298526,3.2713925649430706
RCC10RGB,5113032,2.807854627845623,5.082487734549442
IA-LM,44607531,1.5934898700442923,1.6443534735143495
MOLP-8,BRD-A02303741-carboplatin (1-1 mol-mol),5.885720002784475,3.708822485271445
SW1271,docetaxel-tanespimycin (2-1 mol-mol),1.954654024202385,-3.2727416553986917
RKN,3815108,2.827407220517517,2.8456971886762523
IGROV-1,448949,2.098499309472767,2.0128443325029064
BICR 31,5426,4.483861121335425,3.7233681500605673
SK-OV-3,322968,3.987773865251791,3.97707911743382
BFTC-909,15953870,3.192835350037467,3.621407466713531
BFTC-909,4378219,4.497242068417329,2.5149925179923667
COR-L95,54143018,1.379812266453913,0.30607860079762444
SU-DHL-1,11612883,2.467580560997241,2.732345495138337
COR-L105,alisertib-navitoclax (2-1 mol-mol),1.2187125492955395,0.8048100710929282
LS180,5978,-1.0800938866172374,-2.0416517927042035
NCI-H1568,44566777,1.438409258191859,0.8997676637311061
BICR 31,42642645,1.5553576315566706,1.0446913857881799
MOLM-13,654092,-2.113392174262404,-0.855804938809894
LS411N,124202324,2.3656166654970137,1.610122716820654
SU-DHL-1,5329102,0.4187283879213827,1.6880429657596283
Daudi,51037431,1.7669670215364446,2.945567270868103
RERF-LC-MS,45279963,3.7797867340420215,3.848152847786862
IGROV-1,49850262,4.068828647042517,3.7860402529089083
BICR 31,12001922,2.662375748901725,1.9832378836375173
IGROV-1,49793307,-2.5291790820063538,-2.3039375974982956
PaTu 8902,2828334,6.440933390339598,6.192934665441288
SU-DHL-1,24951314,0.6018835624310062,0.8742616744676017
MDST8,676352,2.6149374435458643,1.9690900282650567
HARA [Human squamous cell lung carcinoma],3503,1.5305596721968624,2.331894380702535
MOLP-8,44185566,2.3020252385384747,1.6125689686599514
RKN,44137675,5.459450119186335,3.807607259979393
SU-DHL-1,216239,2.4334915471860064,2.191628778578975
RCC10RGB,5328940,2.5920229504771264,1.786877386235254
MOLP-8,5351362,0.578803181676615,1.0301557724765014
KU-19-19,4521392,6.281175440463305,4.265853493962284
HuP-T3,219104,4.090562015064086,3.877104483564637
BICR 22,16722836,2.37465920140225,1.7638210696705001
Granta-519,54678924,3.4908303220152512,1.3309237517792638
SW948,5738263,3.889172676108031,2.818876072470776
SW1271,9549297,2.1335240165820606,2.6409255773606826
MOLM-13,5280436,3.611781786093365,2.5920826165481388
BICR 22,3062316,1.4778056821676904,-0.20262262410338328
HCC1500,46191454,2.281809335685502,1.7364685983820278
HARA [Human squamous cell lung carcinoma],445455,6.075035505832661,4.742802814133496
SW48,9549297,0.4487326680785643,2.2360060004402396
SK-OV-3,46843906,3.785109660734252,3.058067515896421
NCI-H2452,5351362,1.571040634520482,1.482225951610641
RKO,56946209,-3.445993729976747,-4.474221885688171
SaOS-2,56649450,2.657103116813459,3.3924229029584443
KU-19-19,doxorubicin-navitoclax (2-1 mol-mol),-0.7241135755509572,-0.8154692145667802
LS411N,23725625,5.218761480016774,3.955609946565949
RERF-LC-MS,4578,4.625372786711685,4.536780911715217
MOLM-13,11507802,1.0337656748409854,0.812362764785998
SW48,65064,5.106206142410259,4.92150717605546
HCC15,2828334,6.579413009448801,6.241053610773377
SaOS-2,4378219,3.572923749570723,2.4399936096887695
BFTC-909,23939,4.493588141952023,4.061338441020407
RCC10RGB,439501,-2.548266242367821,-1.82670381740984
SW1271,3815108,3.2377532103389832,2.922832685180282
P31/FUJ,5287620,-2.889875327880449,-2.2507105824391913
HARA [Human squamous cell lung carcinoma],448949,2.536052822584039,2.0934945374132465
LS411N,5281321,2.872375461605106,-1.9696472650749115
ML-1 [Human thyroid carcinoma],4917,3.4875612389510184,3.1555472737606385
MOLM-13,16736978,-0.7178102164081313,0.8678642712570137
HuP-T3,24964624,2.5347495437600753,2.407957882769041
SW1271,3038522,2.6397404309625574,3.3516096141586598
SK-OV-3,6852167,3.0870556066687076,2.9984506037417953
PaTu 8902,25262965,1.559985123462204,-0.9583723363717173
PaTu 8988t,89928392,1.7442497788257625,1.6072360243055825
RCC10RGB,5494449,5.764110819730859,3.0602675474317818
LS411N,JQ-1-carboplatin (1-1 mol-mol),1.929098606006951,0.5994195364664581
Daudi,5282054,2.334684985175564,2.551813400000226
SW1573,9866186,2.2605214925080035,1.0281459605021872
SK-HEP-1,16013152,4.2454363352103925,4.270994407517647
IGROV-1,11647372,-0.6595372928368528,1.1858495432004643
RKO,60700,-0.2024014556335324,-0.9731997837787247
SaOS-2,66577038,3.461550546017496,2.9534098048611725
BICR 22,6918638,0.0558003797401064,0.3865760920145269
NCI-H1568,6918878,3.5715267618547832,3.107767293366483
RKN,17755052,4.615024850417848,1.7772159901736497
RKO,10385095,1.2981289243482117,0.9611020459769328
NCI-H1568,25227462,1.3523005990409367,0.9370081354365115
IGROV-1,168313200,3.9938362637732983,3.013914772398871
LS180,52912189,2.5201251776162454,2.1082097652635516
SK-OV-3,446155,4.068831864004445,2.696730651760478
SaOS-2,2729026,3.0079080963172573,2.4968291436271235
COR-L105,24785538,1.9787344511962284,1.7917284444081552
WM115,9549297,1.875565618317202,2.6812864021556044
COR-L95,53392493,1.7864953470488698,2.0100513996457994
SaOS-2,219104,3.933074432676362,3.8234125474884895
WM115,3854666,2.6196721416111024,2.4009805833531614
PaTu 8902,11626560,1.9806688551606229,1.8953487778330769
P31/FUJ,24901704,1.8625310117446785,1.9836137105299314
IGROV-1,9911463,4.195269991960018,3.8514719536017132
LCLC-97TM1,216468,0.7418366776466117,2.523459280271488
MOLP-8,387447,-5.214034261316855,-4.649215172853825
RCC10RGB,16722836,2.017391543442539,1.9320846505223408
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574,0.9266083885498331
SW48,5311281,1.5627745937535438,2.497041130374072
MOLM-13,11497983,-4.003769607545663,-0.7312990265365683
KU-19-19,2858523,2.990442019675252,3.131354375191371
COR-L95,11626560,1.5180153972734145,1.5741895489609101
WM115,123631,1.7981952102566006,2.4774608477796787
RERF-LC-MS,2874250,4.628157945253743,4.602743817443208
MOLP-8,65064,3.020382379730844,4.095927196656509
RERF-LC-MS,3854666,0.8294073497518095,2.191939249754383
HCC15,3689413,0.3467742153458734,0.301054838990637
HCC15,25150857,2.8177810894811786,2.714117303454679
LCLC-97TM1,46174525,4.403281113181967,4.1177393377243625
SK-HEP-1,31703,0.3185055118054912,-0.7007901803313027
BICR 22,123631,2.0553358195001383,1.8763711685354416
Panc 02.03,selumetinib-PLX-4032 (8-1 mol-mol),3.6013795626113163,3.338876445149845
ML-1 [Human thyroid carcinoma],JQ-1-vorinostat (2-1 mol-mol),1.0159563388217403,1.2194713093141432
COR-L105,11213558,1.6245415685033464,1.760921977340931
COR-L105,3689413,-2.1605707630353708,0.6593200385167757
MOLP-8,4917,1.932746630984224,2.781627315518883
HEL,11238147,1.9261110470981635,1.8727303162431266
HCC15,46907787,1.7788170946404287,2.5314450481109176
HCC1500,3062316,2.994925150114549,1.5584421415072598
MOLP-8,9935249,-5.983061984872936,1.6143035254446187
IA-LM,135398516,1.3190430503048431,2.0649442027944263
NCI-H1568,6917907,-6.013699668749745,-4.5093908104521985
PaTu 8988t,25062766,2.121196656552597,2.264589698887739
HARA [Human squamous cell lung carcinoma],49793307,-3.043253960744797,-2.7040395215239625
BICR 22,JQ-1-carboplatin (1-1 mol-mol),2.1312623877062125,2.4186968600497516
HCC15,3825829,3.261310602619802,4.207261909864463
SaOS-2,36314,-6.649536011740597,-1.3706544823970492
BFTC-909,54613361,0.5481358040879688,0.24527724998890763
HCC1500,navitoclax-MST-312 (1-1 mol-mol),-1.0378024218006647,0.8930010791445915
KU-19-19,135999136,4.912207411852192,4.319091327606185
HCC15,126941,-2.714458984381298,-2.7276678797487945
K-562,387447,-4.172741798582805,-4.680119521019296
BFTC-909,400769,-0.3884900564724624,-0.4044669815095982
SW948,serdemetan-SCH-529074 (1-1 mol-mol),2.314613339768124,1.6589945611369592
K-562,19582717,3.29667086675107,2.916657971772504
LS180,676352,2.815097827506973,2.133998102707658
SK-CO-1,5278396,2.886619996042885,3.5832970129526944
SW1271,654092,-0.6724961197062129,-0.05580041896654944
BICR 31,984333,1.688597902845401,0.9085089495439267
ML-1 [Human thyroid carcinoma],3854666,0.5957604923029644,2.2674971789613307
PaTu 8902,6918328,0.0837665640709721,0.21983791806429395
KU-19-19,25126798,3.8528221502524262,3.698253983117712
SW48,BRD-K27188169-navitoclax (2-1 mol-mol),2.506636688150973,2.474651794428952
K-562,984333,1.160515473081413,-0.04775376312266029
BICR 22,4261,1.6582900308021409,1.6129717557078238
P31/FUJ,24753719,3.279397605233023,3.379602910482238
RKO,89928392,1.6264666324972337,0.485185190921589
ML-1 [Human thyroid carcinoma],11364421,-5.159158552339723,-0.5193119894505942
MOLP-8,2746,0.9128995235322724,1.9568028421223016
PaTu 8988t,44589607,3.069724280166482,2.928633067179924
Daudi,55508,3.074140286884227,2.909960597987409
IGROV-1,53232,2.4872106086763393,2.6507707211962583
HCC1500,11178236,-0.8618797474299623,-2.901007497605229
SW1573,11228183,1.3544411199442492,2.862632374573506
ALL-SIL,docetaxel-tanespimycin (2-1 mol-mol),-8.351495985477111,-5.200577598922292
HCC15,151289,0.5818248951012718,1.3717585412829019
RKN,navitoclax-sorafenib (1-1 mol-mol),2.725354143371073,1.8296314933763713
LCLC-97TM1,9956119,3.701469228999412,3.2101072232931505
LS180,65064,5.333283055182179,4.9854580398576225
Panc 02.03,1566236,1.9322803720882225,2.375294581937272
WM115,UNC0638-navitoclax (1-1 mol-mol),2.6292832027586783,1.5577880572847536
COR-L105,5311281,2.5909348271223833,2.5948787696565563
COR-L105,4261,1.037866526492344,1.8021681482259493
MOLM-13,6505803,-3.0527041000310255,-0.6204592000441128
SaOS-2,24797083,1.1743557883271736,1.2020181699040873
NCI-H1568,selumetinib-GDC-0941 (4-1 mol-mol),1.6241640738587435,1.7385803189718498
PaTu 8988t,44819697,-1.4855632158782932,-0.8479282849959939
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574,0.9266083885498331
MOLM-13,136227924,1.704251401840426,2.3608210182442195
K-562,11955716,-2.44804051648688,-2.035784857903329
PaTu 8988t,119607,6.161307312166748,5.4042617548328815
COR-L95,71466380,4.385390307812106,4.230206018104057
SW48,400769,-1.161678790289576,-0.5866394134195625
SK-HEP-1,54618771,0.9570801540222316,1.0529542098010365
Daudi,10410894,2.7348964142664096,2.74104828636359
P31/FUJ,8515,2.4023085754769133,3.1493974692209328
MOLP-8,12001922,1.340541943266141,1.8113175479712438
SaOS-2,24180125,2.5037581025896896,3.191795542413693
LCLC-97TM1,11497983,-3.4928977535107872,2.6042648582546275
KU-19-19,54618771,0.4920305765445359,1.32076804337908
BFTC-909,9826308,0.9467806471528852,0.9312407155549168
HEL,6252,-2.3526628041976547,-1.6786856099469964
PaTu 8902,1750826,3.002378182351502,-0.1527663671248482
HEL,375860,-0.4243086466742362,-0.3519541805202157
SK-CO-1,erlotinib-PLX-4032 (2-1 mol-mol),3.6761827416716737,2.8681545426659016
LCLC-97TM1,44137675,2.6535109564984403,3.5753458739474477
BFTC-909,4096211,2.208598833058293,2.048574475234222
SW948,piperlongumine-MST-312 (1-1 mol-mol),2.3670131047839496,1.699221057731283
MDST8,serdemetan-SCH-529074 (1-1 mol-mol),2.3277787595180417,2.0446370460847856
ML-1 [Human thyroid carcinoma],46215462,1.6577528274030604,2.008794086768694
SK-CO-1,10231331,-0.7210930575000714,1.673598722712693
RERF-LC-MS,9908783,5.63449812951243,5.0888219576199845
SW48,BRD-A02303741-navitoclax (2-1 mol-mol),2.3907101942881392,2.34826340848364
SaOS-2,navitoclax-birinapant (1-1 mol-mol),2.783475564423097,1.2909040036685466
SaOS-2,54618795,3.185724709117328,1.3629050163555212
PaTu 8988t,637858,2.5993481939897314,2.089516761017004
HEL,984333,-1.1600295079037413,-0.40568065399485254
HCC15,2841722,4.4106331963661285,4.436478045860843
SW948,676352,1.6772543111300298,1.973480398337
BICR 31,24964624,2.1782924417506235,2.53241286175149
MDST8,984333,1.6302493723588198,0.5356821378569733
SaOS-2,25102847,2.0054521503393956,2.6685755411253753
NCI-H1568,11396600,3.496587037401377,3.8653152734916465
SU-DHL-1,25126798,1.813712960287442,3.6191758722394956
MOLM-13,445091,4.269392983422825,3.7149465118631726
IA-LM,6918328,0.468629569752011,0.06316151505830846
RKO,16038120,2.1201165412688385,0.5389712062374078
Daudi,3689413,-4.376822515219121,-1.543602386420302
LS411N,1750826,2.0365622567800985,-1.8694208788353075
SU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.071258944893258,0.8951300219587324
LS411N,11640390,3.2208706785393972,2.6707604621607333
SK-OV-3,2729026,2.529477515357917,2.8099163833527774
BICR 22,1317464,3.72634745746102,2.8367393130292657
PaTu 8988t,6917907,-5.027469783550181,-3.677174577415621
BICR 22,168313200,4.032164885313491,2.9883977021105466
WM115,24180719,-0.1236916700903925,2.89188786320302
WM115,2708,4.839353437835411,4.884100807813947
Daudi,erlotinib-PLX-4032 (2-1 mol-mol),2.269531504347571,2.9614201745863795
SW948,135398516,1.5329637117305952,1.7137745877018842
SK-HEP-1,15547703,3.182423809990023,3.3737723385241294
HARA [Human squamous cell lung carcinoma],17755052,1.9898088824831797,1.986220506187217
SW1271,400769,-0.393739366900267,-0.43397668408669615
COR-L95,11657048,4.451680892653422,3.2348414642728596
KU-19-19,5470400,0.4514058362673593,-0.17951250407026653
SU-DHL-1,46199207,2.2603615990150803,2.9896452185331945
LCLC-97TM1,452548,-0.620032222833134,-0.09712828910195245
COR-L105,216345,3.681753487249753,4.131021440185938
SK-CO-1,6918736,-2.135863333000623,-1.2379643867565904
SK-CO-1,5351362,1.1244803572081656,1.7087016742817915
Granta-519,451668,1.0102660805443675,-0.7367985760961859
RCC10RGB,71751553,5.18764953581067,4.617575356910553
SW948,44137675,3.8395253943289553,3.3425819597937156
SaOS-2,JQ-1-navitoclax (2-1 mol-mol),0.6153479757572562,0.6528098665874872
LS411N,654092,0.6196619744838121,-0.5792660133141855
HCC15,11222830,1.5967166138936082,1.7093500993957098
RERF-LC-MS,54143018,1.1379926617289184,0.5525406648652289
HuP-T3,107970,2.2315719384591133,2.3393753158944888
MOLP-8,462382,0.932516774133838,0.6405331972071988
ML-1 [Human thyroid carcinoma],24889392,3.5627585346619712,4.27493156864452
COR-L105,448949,1.923777772079977,2.127673686205744
SU-DHL-6,5311,0.0847535344452709,0.38129213834691855
COR-L105,65064,5.250674314711081,5.268576389909408
RKO,9908783,5.5436232623995805,4.174480962248774
BICR 22,1566236,3.7080344976190434,2.72898848685255
SK-OV-3,2708,5.531711784720637,5.135502309470877
RERF-LC-MS,148198,-3.5927713028936834,-2.7446537568590794
K-562,10127622,4.587499993681003,3.5051655047524894
MDST8,3543504,4.366917593553272,4.683960504726488
NCI-H2452,675434,4.57874791360699,4.721887132361805
BICR 22,vorinostat-carboplatin (1-1 mol-mol),3.8807496375646937,3.1684970126550813
K-562,73707398,1.1020172598138147,0.5797348126541176
BICR 22,11178236,-2.3138277354389176,-2.963537480640361
KU-19-19,53232,3.650570649303299,2.8309282890808505
COR-L105,2126,5.6436039579971045,4.622386276666168
MOLP-8,alisertib-navitoclax (2-1 mol-mol),-4.498852011390448,-0.7057754987568414
WM115,984333,1.7219326558446977,0.9001010130076349
Daudi,6918878,-0.3078198284611306,0.47382641974414086
HCC15,16725315,4.804384009366738,4.3305835327697535
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398,-0.6051752896592738
ALL-SIL,56946209,-4.755076906810128,-4.981218930492626
P31/FUJ,25195348,1.3039046822632598,2.272588528346241
NCI-H1568,4261,1.7177455985107426,1.8751985282257413
BICR 22,11238147,2.160553784520482,2.6213026803961452
SW48,decitabine-navitoclax (2-1 mol-mol),-0.1693110303669234,2.242685326225991
LCLC-97TM1,25126798,4.007107372760091,3.7665939037127756
PaTu 8988t,11612883,3.2937262662044424,2.9604375733785027
SW48,44507138,1.5733509414979852,2.3333002750157075
SU-DHL-1,66577038,2.452346655400699,2.8612181500473013
ALL-SIL,60168763,4.204461937910143,2.1421938105753133
Daudi,25227462,-5.495402710114509,-2.1330589424487902
LCLC-97TM1,613000,2.0466318432711708,2.7199415297183105
LS411N,2828334,6.327786282136184,5.750173909902523
IGROV-1,9866186,0.4571266497661056,0.8337899226782699
SU-DHL-6,72376,-4.568822946856545,-3.520488752316392
P31/FUJ,984333,-0.8646677641211812,-0.35999855470562125
COR-L95,123631,2.8240072692867915,2.11180462144447
IGROV-1,11497983,4.37450324471555,4.3012985413141624
BFTC-909,5281672,4.401358042981416,4.494992473549441
PaTu 8902,44607530,2.9609228636650826,1.7537569158603008
HuP-T3,5566,3.0002994658008935,3.081243398334853
NCI-H2452,JQ-1-UNC0638 (2-1 mol-mol),2.3308008637008837,1.5411774518892996
IGROV-1,2729026,2.3541792737160296,2.6737999786624673
COR-L95,11222830,1.53452681839189,1.356041869380873
LCLC-97TM1,66577038,1.6013450181273698,2.9242650840711475
IGROV-1,24772860,-3.2892316801587835,-1.919862966119899
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005,-0.41246525561498404
HCC1500,navitoclax-pluripotin (1-1 mol-mol),-1.6377620908642292,-0.6384408601236733
NCI-H1568,54678924,1.274078635657008,2.1776800585108367
ML-1 [Human thyroid carcinoma],navitoclax-MST-312 (1-1 mol-mol),1.8932386957075495,1.0196800896985843
RCC10RGB,9908783,5.908182650801537,5.221525126363394
IA-LM,66577038,3.3956332242260765,2.8740514470250678
LCLC-97TM1,selumetinib-JQ-1 (4-1 mol-mol),1.553276046289172,0.9753668014737729
COR-L95,9935249,2.976260244275784,2.2336745758846677
SU-DHL-6,9868037,3.231553190440303,1.9691215520067855
RCC10RGB,11640390,5.2605770793622275,3.9093416533445735
Daudi,285033,-6.062056136351362,-3.2887694792261466
BICR 22,11626560,2.057582050988773,1.9480068931584231
NCI-H1568,60750,-4.838669884752028,-2.130449762649355
MOLM-13,2708,1.6215518677504634,3.528999597219812
LS411N,crizotinib-PLX-4032 (2-1 mol-mol),1.3060638395576354,1.3815285646730444
K-562,10385095,0.5975872383647969,0.9868375550754378
P31/FUJ,tretinoin-navitoclax (4-1 mol-mol),0.2737114955755992,0.32707178515044305
ALL-SIL,9887053,2.3955838154567703,2.656561188773274
RERF-LC-MS,151289,1.06337646711186,1.0540015082834706
LCLC-97TM1,71466445,2.7974721848465025,3.4660618211356713
RKO,15983966,1.976330033309676,-2.91510785811077
SU-DHL-6,54143018,-0.9166021499884252,-0.4662570669285242
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992,0.7986081053467196
MOLM-13,vorinostat-carboplatin (1-1 mol-mol),0.7090489644750352,2.0681361277863344
IGROV-1,49793307,-2.5291790820063538,-2.3039375974982956
COR-L105,crizotinib-PLX-4032 (2-1 mol-mol),2.1629523176516248,2.0102088601315655
SW48,9866186,-0.0602537260044697,0.8521905182995404
ALL-SIL,24753719,3.3195109491118635,3.2130144169882944
PaTu 8988t,409805,3.676693079768219,4.8440639656902205
BICR 22,11175137,1.6412636442827269,2.676906355372017
PaTu 8988t,vorinostat-navitoclax (4-1 mol-mol),3.0451026382172732,1.1300762543119902
MOLP-8,9887053,1.3364969406129874,2.735654573636221
Daudi,81146,4.468898659357518,3.3718967123576222
NCI-H2452,6438330,4.066979701794873,2.473565031378401
SU-DHL-6,73707438,4.161722925172636,3.963526375894403
SU-DHL-1,9825149,2.3972801394012415,1.5735929512857922
LCLC-97TM1,1242560,3.1698209685240832,3.425488181868816
RKO,44632017,0.9673312213076444,0.9283275826915346
ALL-SIL,10184653,0.3156525087572682,0.48511949002290033
MOLM-13,15953870,2.45012914744678,3.0329266750940578
WM115,docetaxel-tanespimycin (2-1 mol-mol),-3.9058848396527464,-2.5960954227950093
HARA [Human squamous cell lung carcinoma],3038522,4.1452744027346045,3.226797341969268
Daudi,9908783,4.64363842559646,3.705157872507053
BICR 22,2746,3.5358057095338404,3.395569367648385
SK-OV-3,9903786,2.611217845094376,3.112318263828363
Granta-519,446155,3.3236756015859266,2.176899004312887
HuP-T3,46843906,1.6260119885378777,3.2668397330523957
RCC10RGB,25102847,4.4790627708666255,2.926841143150691
SW1573,119607,3.675967979424282,5.463044769900617
NCI-H2452,36462,2.3648017756260327,2.550438311876736
RKO,9926054,1.883626680074333,1.733528283248791
UACC-812,11396600,4.679415745859403,3.7738466394548227
LCLC-97TM1,67291369,2.1623476689900527,2.1212968085506425
SaOS-2,9926054,1.5065280757428428,2.0481869436357862
SW1271,11485656,2.5257448561020053,2.1868467949802604
SU-DHL-1,65628,3.0805404655500843,4.108820568100324
RERF-LC-MS,24889392,5.73600211591012,4.40453138839707
IGROV-1,16720766,-0.0562020789376145,1.0716029857236449
SaOS-2,53392493,1.7453499080757628,2.527886197878676
BICR 31,JQ-1-MK-0752 (1-1 mol-mol),2.163474213011291,1.5511540175937608
LCLC-97TM1,71466578,4.4967812415195025,4.01340438702698
MOLM-13,135440466,-1.1165614244178856,1.6858499587468372
IA-LM,1566236,2.064855820915055,2.2960132818634102
SW948,3825829,4.076553662425885,3.6299151810336348
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361,4.284461624928843
WM115,322968,4.566671406107956,3.8263794004567906
RKN,637858,2.0099352926359533,2.1816426173133845
COR-L105,135398516,1.4567379833558207,2.2272056793649875
LS411N,15547703,3.407600768992332,2.811936685824541
SW948,6918878,-0.2941800388813576,1.6383037533003102
SK-OV-3,31703,-0.6007067740148971,-0.5426844163052972
BICR 31,16038120,0.7865824758597759,1.2595308014581992
SW1271,46943432,0.8939870827443378,2.563832414172937
Daudi,67291369,0.2775886597323658,0.9616874949219276
WM115,SNX-2112-bortezomib (250-1 mol-mol),-3.3081919953178507,-0.9075793606265026
BICR 31,11455910,2.0785566961581186,1.63872017068461
MOLM-13,25150857,2.0975264071969075,1.5121373092007813
COR-L105,46174525,5.553907170062061,4.720858507108485
COR-L105,piperlongumine-MST-312 (1-1 mol-mol),2.3163882961547086,2.01659311517519
SW48,serdemetan-SCH-529074 (1-1 mol-mol),1.5320240627835209,2.1439828594783297
IGROV-1,135398516,1.9751898057484376,2.1692196369656522
PaTu 8902,3689413,3.662647678116459,0.19616674022734737
Daudi,31703,-5.42156315939604,-2.745864762078833
IGROV-1,24785538,1.106246320450551,1.6166589033607972
Daudi,navitoclax-MST-312 (1-1 mol-mol),0.6762626360352524,0.030554092443597313
PaTu 8902,676352,2.5672836386659625,2.301504436056331
MOLM-13,426756,3.5583078181784504,3.6860119639426956
WM115,64971,1.594754361798162,2.820974612907841
SW1271,4521392,3.9428497415690713,4.256865757541183
HCC1500,19582717,3.689290387765622,4.040600151318227
BICR 22,71680916,5.5411632888305755,4.672623225868789
IA-LM,462382,0.6444148679919928,0.9815314884681287
P31/FUJ,24856436,-2.072993507389728,-0.6128572044355127
LS180,135411,0.2951252953722391,0.6592552515320402
MOLM-13,72376,-3.7215877343251456,-3.672143861056311
RKO,6610216,3.958403220086871,3.9471880287193124
RKN,452548,0.7515073582009456,-0.29664084513490213
P31/FUJ,navitoclax-sorafenib (1-1 mol-mol),0.3998417690889591,0.15724379626671495
SaOS-2,3038522,3.0360203721983257,2.8517103518668465
SK-HEP-1,409805,5.808157500863876,5.079218525442306
BFTC-909,44137675,3.23817368119839,3.7706007883023744
SW1573,25183872,-2.56928333929943,-0.5620433926487644
HCC1500,23582824,1.5666293035108128,0.6640403714925731
MOLM-13,11612883,-1.8374573083034769,1.702669775101622
MOLP-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1535423507469189,0.5995815729523629
ML-1 [Human thyroid carcinoma],445643,4.241689590807037,4.020565955271205
KU-19-19,135421197,1.2163789616721166,1.7968576958018787
SK-HEP-1,49766530,-2.8567737760804324,-0.518032742655929
Daudi,46843906,1.1534141628569738,1.2547489719280507
HARA [Human squamous cell lung carcinoma],322968,4.828098936758316,4.2356453166088155
IA-LM,11494412,5.732457488131999,0.8584487571801369
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826,0.6863988516746575
Granta-519,selumetinib-piperlongumine (8-1 mol-mol),3.4654025033242712,2.122200855900816
Granta-519,46943432,2.0409318821812477,0.742682573367901
MOLP-8,46174525,3.423634821116614,3.3689897848622095
RCC10RGB,19582717,5.580606305911862,4.396721693306165
NCI-H1568,71680916,4.3779497666633915,4.854805943739715
SW948,3689413,-2.2648112033429824,-0.6225575180916717
RCC10RGB,252682,6.528801566934436,6.4851771383147145
Daudi,135875424,2.734623655159311,3.09204147470637
K-562,4788,4.09681667300412,5.222598595003645
BFTC-909,66577038,2.856590203747272,3.0455844729441357
BICR 22,56649450,1.894872176339528,2.318344340131166
LCLC-97TM1,23635314,-2.2617116518456792,-2.1023681431061014
SaOS-2,16013152,4.240825830990255,4.194756088812565
MOLP-8,5738263,2.3540234006064424,2.664220369329223
IGROV-1,3552672,2.134472496867482,3.0410139936275336
BFTC-909,6505803,-2.7076869289136147,-0.2392114702338504
NCI-H2452,9952709,3.912471204941481,3.2930498659119185
SW48,4477,0.2937974315698831,0.6110228392083881
IGROV-1,10113978,2.874171865860951,3.560144182135158
Daudi,3465537,3.6729414318228697,2.073015331689594
HARA [Human squamous cell lung carcinoma],400769,-0.3643318812201842,-0.48141258047259294
WM115,60750,-0.3155979924811316,-2.0163453135052087
LCLC-97TM1,3552672,1.9872160910848609,2.8054707787228956
P31/FUJ,16720766,-1.2973124396101832,-0.44206294801296653
PaTu 8988t,16722836,1.7927006401716397,1.7734966746964742
RCC10RGB,24785538,4.443576486987547,2.0724278820994337
LCLC-97TM1,54454,2.264936650655555,2.8556292401771475
BFTC-909,44202524,2.4582417316930916,2.106811430264644
NCI-H2452,9956119,4.089312834038711,3.801576130270291
LCLC-97TM1,44589607,2.470818031732135,2.7245336693875766
K-562,9911463,2.5078915917546336,3.3039499390684925
RKO,12003241,-0.2410566552434749,-1.0679125031376384
SK-CO-1,9887053,2.665990529661509,4.279561542855639
HEL,9444,3.6260707724362113,3.57210435813441
RERF-LC-MS,54618164,3.9158352593779377,4.180087865121171
SW1271,vorinostat-carboplatin (1-1 mol-mol),3.5487525185295774,3.1385398480729374
MOLM-13,400769,-1.4398892181534526,-1.4329147130106623
RKO,54454,4.6965621210229225,2.5470953132183367
HEL,3815108,1.7280464955300685,2.047785253818795
HuP-T3,400769,-0.02490432142157,-0.36747331594207894
COR-L105,439501,-1.395093001857319,-1.576718163828306
P31/FUJ,11717001,4.27266863837082,3.4167916728233485
WM115,44566777,1.1755609042254629,0.7582572996776206
Daudi,9823820,1.816535221490948,2.5804232286745155
K-562,selumetinib-BRD-A02303741 (4-1 mol-mol),3.9452785747148233,4.169085102290298
SaOS-2,11178236,-4.192404287761835,-3.320938555059203
RKO,107970,2.3673735748138265,2.243414111745025
Granta-519,3384730,1.8851059301538475,1.4366166441325938
Daudi,3081361,1.2348545680767924,1.5971591446183746
COR-L105,11656518,2.8708923278875846,2.02099064174933
SK-HEP-1,4261,2.0689452694586596,1.8069191966496867
IA-LM,4261,0.3595729013120086,1.5285431626028794
SW1271,5282054,4.135247135343962,3.790229255536326
NCI-H1568,44491742,3.692908194165655,4.348557200760343
K-562,10074640,1.329135681779355,1.8147025864679598
IGROV-1,9908783,5.873270433212515,5.052372982203147
MDST8,24951314,1.0921901869172437,1.439254031942129
ALL-SIL,3081361,0.1962192778787347,1.6665333908939157
SaOS-2,4578,4.61303870633514,4.5274402970802665
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031,0.23124718063110258
SW1573,selumetinib-navitoclax (8-1 mol-mol),2.299465388888248,2.061234608097101
IA-LM,25227462,1.9658589227885097,0.3265334721434041
MOLP-8,71466578,1.6771539715617054,2.5432328954625665
HCC1500,11977753,-0.4307765862265268,-1.1523449188683865
BICR 31,vorinostat-carboplatin (1-1 mol-mol),4.357832771492993,3.314094996971071
BFTC-909,568763,0.745825262149274,0.732879467684208
HARA [Human squamous cell lung carcinoma],16741245,4.4624437574750955,3.723448810153386
RCC10RGB,613753,3.3201179844199498,3.391757208807739
BICR 22,421610,1.881248812005912,3.065220978937932
COR-L95,55508,1.7090560645840305,3.1612901206764343
SaOS-2,2945648,3.259308629519986,3.086692576406467
LCLC-97TM1,selumetinib-GDC-0941 (4-1 mol-mol),1.4589950943419845,1.6432317853818668
RKO,409805,3.580644131410829,4.081625760791052
COR-L95,53495165,-2.3377393798516395,-1.010162653066383
SK-HEP-1,25154868,3.1824362497542182,4.430311357176175
NCI-H2452,tanespimycin-gemcitabine (1-1 mol-mol),1.9681737644651764,-0.358474994947712
SaOS-2,5978,-3.9287237947590494,-1.9941205984979617
COR-L105,4096211,2.67395928769434,2.4295668588849137
LS180,15953870,3.325208983942858,3.45481822271276
Daudi,66577038,1.2731684674623205,2.6984741360471487
HARA [Human squamous cell lung carcinoma],carboplatin-etoposide (40-17 mol-mol),3.125998778003278,2.7622401868953346
RKO,6918328,0.803085247134139,-0.5800964580736412
SW48,4259181,-1.8199657809061969,0.41343983557786657
SK-CO-1,44185566,2.2410285456889176,2.5893509534220054
K-562,5978,-3.1400031562505393,-2.956358994008886
SaOS-2,613000,1.0847199338514617,2.74954764571129
LCLC-97TM1,9826308,0.172966057550933,0.5883047672711437
Granta-519,5311,0.5114694341413046,0.3864673108376788
SaOS-2,carboplatin-etoposide (40-17 mol-mol),1.667562518729443,2.5402349850676504
SW1573,4788,4.2029613497215195,5.776821247845685
PaTu 8988t,vorinostat-carboplatin (1-1 mol-mol),4.263432325084182,3.2768538841624797
WM115,2729026,3.0250773642114175,2.794105126334949
IGROV-1,23725625,5.712368491237602,4.921458836607317
ML-1 [Human thyroid carcinoma],8515,2.907082200923046,4.2864186048410104
SK-OV-3,24964624,2.562140083880341,2.57638527882289
HCC15,navitoclax-PLX-4032 (1-1 mol-mol),0.321962590188161,2.2939551376782465
MDST8,5278396,3.853168516309647,3.426575886201326
RKO,119607,4.75876667689532,4.564221633092043
MDST8,65064,4.754326425577863,5.022586192338615
MOLP-8,54596558,5.109397009340411,4.158350066949744
WM115,9911830,1.4636751787761997,2.608307511006992
SK-HEP-1,44486219,4.3977685724309215,4.400172191409514
BFTC-909,15983966,-4.834157449814871,-1.2229222142604081
SU-DHL-1,24901704,2.0463171426909086,2.630503832785908
NCI-H1568,3025944,3.938114410703908,4.2993915109324705
LS180,selumetinib-PLX-4032 (8-1 mol-mol),2.448756445045049,2.8915260833387766
ML-1 [Human thyroid carcinoma],4477,0.6808915512553289,0.6604825714690863
RCC10RGB,16725315,5.2458056955252275,4.3465429565760605
RKO,53495165,0.8925500623489324,-1.521850783129354
HCC1500,71304818,1.489157695167493,2.5105529921504406
COR-L95,135398738,4.3251787986630195,3.5488451060012784
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263,2.9078127530018367
SaOS-2,56949517,5.721423210410403,4.071669505312759
ALL-SIL,644241,-6.056766449232899,0.689859346710137
MOLM-13,42642645,-6.876168570605093,-0.4413410375952803
RCC10RGB,51039095,3.636696049778912,3.040440455961721
ALL-SIL,60700,-4.240130526526249,-1.909097131507087
PaTu 8902,15547703,4.581249636071297,3.437987274681857
BFTC-909,11609586,2.9417391320909134,3.102640724269462
SW48,11455910,-0.1633281652990052,1.3736387056982893
LS180,selumetinib-MK-2206 (8-1 mol-mol),1.4028786728536926,1.9343474491516222
HARA [Human squamous cell lung carcinoma],JQ-1-navitoclax (2-1 mol-mol),2.200588179814963,1.1723135806063454
MDST8,11364421,1.2673702676732186,-1.0246521330147715
BFTC-909,navitoclax-piperlongumine (1-1 mol-mol),2.723586959528991,1.7074836373811548
IGROV-1,23939,4.412541857664819,3.9611343512234742
HCC15,11626560,0.3588759938830249,1.95228682444743
MOLP-8,1750826,-2.6273703880538166,-3.0860749714303006
RKN,crizotinib-PLX-4032 (2-1 mol-mol),3.0048201060690314,1.818698747937884
SaOS-2,3634881,3.4478485283346454,3.1417536333082694
KU-19-19,65064,5.4276979548790285,5.051189487933593
SK-OV-3,53392493,2.9853646548342767,2.6933723452293985
BFTC-909,44607531,1.7004331217528663,1.4576584979147162
RKO,9915743,2.8851858618766957,0.574753317730816
WM115,969516,2.5733075045080405,3.0372836870767386
MOLM-13,navitoclax-MST-312 (1-1 mol-mol),-0.7732876947237494,-0.1103987007582104
HCC15,1641662,2.7903081608832743,3.6201220481292675
PaTu 8988t,24856436,-1.0780184146975675,0.752114719237778
BICR 22,151289,1.1052603945032196,1.474300829629249
RKN,10302451,3.971829298943927,3.2503373219015743
Daudi,9840324,5.326423492349393,5.5521411041193085
Granta-519,24978538,-1.4483375486726318,-0.9326055542520738
IA-LM,969516,4.593397144463051,2.6127105939139916
LS411N,16741245,4.421981695824733,3.442495550802432
SaOS-2,241158,3.6917409878316136,3.6427313646050727
HCC1500,49846579,-4.075833194843517,0.6964228009191302
LS411N,11626560,1.8283516183370416,0.9885956711562587
NCI-H1568,2746,2.7741418395417163,3.32724823100354
PaTu 8988t,375860,0.0559535091713014,0.06419730704397276
BICR 22,613753,3.418897622092284,2.750740055350174
ALL-SIL,52912189,0.8155728349845486,-0.00023355106147437632
BICR 31,erlotinib-PLX-4032 (2-1 mol-mol),1.9143994783784697,2.910219827017857
BICR 22,3634881,3.8771660288779457,3.066447848266356
RKO,3543504,4.836700902585943,3.6889166633488752
Granta-519,6918837,-5.331886820340028,-4.76142644891374
SW48,56963564,-0.9893979738252238,0.7227378873999768
Daudi,4259181,-0.0890599021012781,-0.4100718190554124
Granta-519,7326481,2.8185757173328927,2.521906346406784
SK-OV-3,4096211,3.632564776557465,2.2135195603879434
HARA [Human squamous cell lung carcinoma],11317348,1.2268055094863417,3.639153543184304
SK-OV-3,24856436,1.946601057004947,0.8781206005326356
Daudi,613753,2.7401651571031618,2.7119476771944226
ALL-SIL,navitoclax-pluripotin (1-1 mol-mol),-6.100095381264916,-2.3784906887249355
BFTC-909,452548,0.7682850038212578,0.3238977533586235
P31/FUJ,409805,3.653161003579303,3.7618012569016446
IGROV-1,11404337,-0.7659238947812715,-0.14249168559967487
SU-DHL-1,24753719,3.670729792524347,3.891270696080606
BICR 22,24901704,3.9299918475898408,3.362662612489639
ML-1 [Human thyroid carcinoma],9911463,4.5829335325836436,4.11992842018737
NCI-H1568,135411,0.4069452326541798,0.9470325914011687
ML-1 [Human thyroid carcinoma],SNX-2112-bortezomib (250-1 mol-mol),0.4585620616557309,-0.6091548853680877
K-562,126941,-4.461586339574126,-2.998361084176927
Panc 02.03,2113511,6.868929428825361,5.767784992196623
NCI-H2452,44241473,5.273016525632626,4.89964499937139
RERF-LC-MS,135984461,4.284403636339015,4.204399102405373
KU-19-19,5329102,2.6076401407195355,2.1201057192463337
SaOS-2,49867930,4.412008076102657,4.722063376877021
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555,2.0547186955884915
IGROV-1,54618771,1.2456991772210466,1.2552687012485275
BICR 22,7251185,3.2802016727508105,2.689300066124361
WM115,11178236,-3.130587173648645,-2.8983685009308227
BICR 31,168312962,4.404506435623785,2.612661112809923
BICR 31,135421197,2.236076370585341,2.3000621706721556
K-562,72734382,4.39493075447737,3.594434552991564
Daudi,4521392,3.754955104648716,3.9685693932062684
NCI-H1568,9903786,2.4011050725962115,3.2059489568640758
Panc 02.03,1242560,3.876690059869664,3.743249430657383
SaOS-2,24771867,1.911103494547597,2.8010463985277902
NCI-H1568,46224516,1.8217130718981496,2.8349705828473915
HuP-T3,637858,1.096014734488476,1.9632353491188113
HARA [Human squamous cell lung carcinoma],10184653,0.92256613856931,1.732240918767325
HCC15,9825149,1.99442718669858,2.364919127044307
ML-1 [Human thyroid carcinoma],1285940,4.2577484489413004,3.926973995964667
LS180,9967941,3.3265068520356227,3.5792538096856994
BICR 22,15953870,4.283514914534557,3.6163847806308076
ML-1 [Human thyroid carcinoma],124202324,2.283804161098842,2.7483260528408726
P31/FUJ,49766530,-2.577046245506879,-1.9518768024341295
COR-L95,erlotinib-PLX-4032 (2-1 mol-mol),3.78665088959685,3.045983152055391
IGROV-1,5470400,-0.2457809435208252,-0.5395300988339069
K-562,3025944,3.938999685525622,3.9813064268599327
ML-1 [Human thyroid carcinoma],5282054,2.990899024296238,3.96516397093188
Panc 02.03,1641662,3.717230762709902,3.6022524169437524
UACC-812,selumetinib-JQ-1 (4-1 mol-mol),2.304813012505874,1.552261808509089
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858,-0.32115151651598445
SK-CO-1,613753,3.569116813952151,3.153298516073871
RKO,navitoclax-gemcitabine (1-1 mol-mol),-2.8709534482220196,-1.9207744945372596
LS411N,73707398,1.3643081745247092,0.86400072368136
RKN,60700,0.8209474049972991,-0.11743378751025638
P31/FUJ,52912189,-0.0654684439378525,0.281250690664577
Granta-519,49793307,-5.0235824363471675,-4.46685911245357
LS180,439501,-1.9142457865624176,-1.8207084619166052
BICR 22,19582717,3.5857042125142247,4.240649893769986
P31/FUJ,11612883,1.4537759753270971,1.9283193684827957
RCC10RGB,135423438,4.4299924289236055,2.8583099711417397
HCC1500,piperlongumine-MST-312 (1-1 mol-mol),1.4293216638390454,1.9503833163537163
IGROV-1,24797083,1.5319862293819655,1.3920657903930913
WM115,11657048,4.298694485616108,3.818217279408648
SaOS-2,5328940,1.8581375817896455,1.693732106626629
K-562,11427553,0.716330793964625,1.8602988651923764
BFTC-909,60700,0.4554202898414442,0.08835324070412286
HARA [Human squamous cell lung carcinoma],24964624,2.781169175627229,2.5007957680706085
HARA [Human squamous cell lung carcinoma],44259,0.8184068416156438,1.2290303911706482
HEL,656346,0.4971755704716853,0.37998421163168394
ML-1 [Human thyroid carcinoma],3384730,3.994618489141425,3.3522160687105753
SK-HEP-1,25126798,3.9918710327668503,4.009494713356893
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933,0.8208057903956572
HCC1500,568763,-0.919346546730658,0.5768926978599005
SW948,selumetinib-tretinoin (2-1 mol-mol),-0.8554904901249896,2.4709194606665985
NCI-H2452,71466578,5.120149615089657,4.980000389986266
COR-L105,2871966,0.4959639880090196,0.8365790743307074
SW948,5746,1.511438037719251,0.7498604936990438
WM115,10172275,3.759074377781229,3.537847890174033
PaTu 8988t,11964036,2.992263460840089,1.6374544524035373
SW948,16219061,3.499504842183279,2.567846769201133
LCLC-97TM1,53495165,-0.6427926162361222,-0.4232115784959001
UACC-812,3081361,1.9829916627298712,1.8809004822306685
SaOS-2,5287969,-1.655987163162804,-1.8889924904479696
IGROV-1,25183872,-0.4560099928976716,-0.4667045449957205
IGROV-1,44607530,1.2936443589937894,1.6142187927585097
BICR 31,salermide-PLX-4032 (12-1 mol-mol),5.564689341846323,5.029078737670856
SK-HEP-1,57519531,4.12625544642691,2.447617357210556
BICR 22,119182,-2.736639797021525,-0.021380998024104612
PaTu 8902,4521392,4.129468839379376,4.330066291345876
LCLC-97TM1,60700,-0.7670870439402468,-0.2764503355117487
ALL-SIL,44607531,0.7892287314343482,1.0519883394253802
SW48,16720766,-1.213948450866439,0.6750945110132317
LCLC-97TM1,9911463,3.937478558519083,3.591784782421269
SW1271,6918289,2.985913038733717,2.6955867269931786
SK-HEP-1,25183872,-0.6604608842788147,-0.6757926860164032
P31/FUJ,5311281,0.8046363155731003,1.7721940934697418
MOLM-13,107970,2.204740997332017,1.9449869018100012
PaTu 8902,44607531,2.4953979740561136,1.4795676022322533
BFTC-909,5978,-2.385180460490498,-1.7174321279187474
IGROV-1,9926054,1.8111808945519428,2.0700745522430752
MOLM-13,JQ-1-UNC0638 (2-1 mol-mol),-0.7004023711482303,-0.17534870609792705
SaOS-2,44632017,0.980304929421305,1.3808538820811713
WM115,23582824,-1.5173797182891284,0.7605212392766407
RKO,5746,2.147448518007633,0.4207935319551415
SU-DHL-1,docetaxel-tanespimycin (2-1 mol-mol),-2.528242404368283,-4.119617954608209
COR-L95,11234052,4.796206825131301,3.8500477076672865
HuP-T3,navitoclax-gemcitabine (1-1 mol-mol),2.4880623143443965,-0.40214473869864376
MOLM-13,46199207,1.8343479247638497,2.8985837741947
SK-CO-1,216345,2.2578794962248403,3.764499396275795
LS180,24951314,1.284825385865239,1.3230432200488633
SW1573,71680916,4.0865163925225385,4.853600071017434
LS180,11427553,3.214146965067504,2.841833883690401
HuP-T3,17755052,3.4304742988115366,1.7939595628811953
IGROV-1,44607530,1.2936443589937894,1.6142187927585097
HCC1500,11964036,2.769497384705972,1.3365524762599856
LS180,446155,1.950458971830876,2.843458604870725
SK-OV-3,10385095,3.0219456492917485,1.3089604285075622
BFTC-909,serdemetan-SCH-529074 (1-1 mol-mol),2.384231187993096,2.289764511446799
LS180,23635314,-2.728761007932067,-1.6817778082876438
ALL-SIL,25262965,-0.0785584741633136,-2.1311567733656704
MOLM-13,9956119,3.465056755214706,2.680119398533869
Panc 02.03,54619267,4.6873070757127335,4.220329489138252
MDST8,45100481,5.670163105184411,4.431434274632516
P31/FUJ,11427553,0.2126015278922564,1.5310460118514493
RKO,navitoclax-sorafenib (1-1 mol-mol),2.2009176263452983,1.075562287427398
SW1271,123631,1.9601206845091983,2.569303630502613
HARA [Human squamous cell lung carcinoma],5738263,3.6004475982525825,3.5585809874802545
SW1573,11626560,2.096503053081923,2.0096407384750683
COR-L105,11717001,4.401406695561914,4.105486126746168
COR-L95,JQ-1-carboplatin (1-1 mol-mol),1.8062318254958765,1.491793608891282
IGROV-1,135984461,4.285945029851472,4.1031515960476765
HuP-T3,16725315,3.145396972494799,4.2369826709108995
SK-OV-3,5278396,4.0115131897954175,3.596299208684303
HARA [Human squamous cell lung carcinoma],9907093,5.03391680027973,4.27171242604281
RKN,piperlongumine-MST-312 (1-1 mol-mol),1.5374075036414252,1.8508262435096114
HCC1500,7326481,2.1911838281348897,3.0129301988304853
ML-1 [Human thyroid carcinoma],6918328,-0.1732040518011542,0.5376093257458087
RKO,11485656,2.16906736756012,1.6928388958731002
HCC1500,17755052,3.708779056995352,1.5446179742357435
RKN,16720766,0.5941206863048918,0.7154692608517403
SK-OV-3,49766530,0.1985460846164677,-0.26719896058368603
NCI-H1568,11178236,-4.756412327662482,-3.061904560065406
K-562,613000,2.5009117496842292,2.5835785652851575
SK-HEP-1,doxorubicin-navitoclax (2-1 mol-mol),-0.2519782158989084,-0.8396077264615113
Daudi,49867930,3.141108082189553,3.8326218794117115
P31/FUJ,451668,0.4769801026955246,-0.9129051237854572
SU-DHL-6,2708,3.434249932793118,3.2517191417239797
RKN,11497983,4.544575984994342,4.0441246262759
IGROV-1,23582824,0.3287266354391525,0.8791630180551576
HCC15,2858523,2.7763462118547833,3.0960674482502224
RERF-LC-MS,3025986,-0.71270364092759,-0.5690068095662332
LS180,984333,1.4840791700280882,0.9302820306052887
COR-L95,24901704,3.9540534266274183,2.9247616657118867
NCI-H2452,selumetinib-JQ-1 (4-1 mol-mol),2.500134928300083,1.7519473797192953
MOLM-13,piperlongumine-MST-312 (1-1 mol-mol),1.1119295359137316,1.2174646182472895
COR-L95,409805,3.71634228772174,4.099443835813187
PaTu 8902,9823820,4.420414335239228,4.21605158375178
Granta-519,24821094,2.4908648032560183,2.506288613684231
SU-DHL-1,26596,-2.3613305357908625,-0.953796958895931
RKN,285033,-0.0275118271199953,-2.003498712277094
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505,0.7696998683387348
WM115,ISOX-bortezomib (250-1 mol-mol),0.2831832229570691,0.5960325152391842
NCI-H2452,9936388,2.1806204942966803,-0.47245611571535856
LS411N,54618771,1.0517408544895162,1.2240326910669068
RKN,72193861,2.3331130274465313,1.8136669807267136
MDST8,46843906,2.4704071908178844,3.377152062832033
HCC15,11485656,2.480533785053976,2.330100410372395
MDST8,11977753,-2.9914432786855305,-1.7399518040994661
PaTu 8902,168313047,2.1566405666580963,2.3782465444131797
MOLP-8,135928012,3.056644501758044,3.842217997168539
ML-1 [Human thyroid carcinoma],25062766,2.2645177949682775,2.1339766086843106
MOLP-8,10074640,3.1436066614625173,2.7156081137441657
HCC15,12001922,1.9087360775911748,1.8968219332222784
LCLC-97TM1,3025986,-2.553955076787079,-0.8584075939190775
BFTC-909,2842253,5.585220688564769,5.382561094413509
RKO,216239,1.9979551619375524,1.9553922068201022
HARA [Human squamous cell lung carcinoma],241158,4.240217877475157,4.07540472706473
RERF-LC-MS,JQ-1-carboplatin (1-1 mol-mol),4.276053499927872,2.5684294102899914
Granta-519,135398516,2.1425852334349575,1.098030658388552
KU-19-19,10385095,1.1563887024661463,1.3808309843107167
LS411N,navitoclax-gemcitabine (1-1 mol-mol),0.4425335439188313,-1.2501373736732018
SU-DHL-1,9803433,4.734138876460479,4.530021039421346
HCC15,135999136,4.472611779685761,3.9298174709755322
SW48,11238147,3.1100916590750045,3.069442579431873
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784,-0.8089175496133304
BICR 22,409805,3.8456212820768214,4.876069667262429
SW948,selumetinib-GDC-0941 (4-1 mol-mol),-3.896690328067956,0.8003945914203764
P31/FUJ,24785538,-0.2737810661065927,0.40482606576096286
Panc 02.03,176870,4.923826321280428,3.2886613028725087
RCC10RGB,322968,3.1449149812629877,3.814640789498672
HCC15,107970,2.678547076190946,2.4393968320470303
SW1271,71304818,2.7682192858067385,2.5566228131936093
LS180,3634881,3.5372782333734696,3.3493622258508706
COR-L105,11214940,1.6414587299435788,1.9040312337733578
SW1271,5287620,-1.7165830209074355,-1.551427275587256
HCC1500,navitoclax-piperlongumine (1-1 mol-mol),-1.489158158277352,1.2912974495906429
COR-L95,49766530,-0.268325836176492,-0.8548170877386516
P31/FUJ,6450551,0.3392586382091512,1.4144552775671797
PaTu 8902,5566,3.0665407385312182,3.015404625678852
SW1271,6610216,4.395476769861187,4.46751480885799
IA-LM,4477,0.1872236957364025,0.4498302621455613
BICR 31,6917907,-2.0849244140580683,-4.585229221939417
Daudi,56949517,3.615784656128556,3.5911367729770767
SW948,selumetinib-navitoclax (8-1 mol-mol),-0.0800083599001994,1.6815867166979583
Granta-519,156414,1.3767921664113123,0.36144394376765226
SW1573,60700,0.5293530759970745,-0.2721210211371619
PaTu 8902,11404337,0.5155229173062875,-0.22394240102679006
BICR 22,52947716,-3.710960782083666,-0.3254965833997136
HARA [Human squamous cell lung carcinoma],5311,2.3146371221244184,1.5369963004654068
ML-1 [Human thyroid carcinoma],135398516,0.6909808613935852,2.412373906243066
SW48,216239,2.7420558854204105,2.4123723541010893
HCC15,136227924,3.0147456858017923,3.083574958714969
MDST8,400769,0.2052239388954162,-0.4445964188900141
IA-LM,navitoclax-sorafenib (1-1 mol-mol),0.7106711881893861,1.5383933847945033
RCC10RGB,4917,3.4531775579708044,3.1958684224116705
RERF-LC-MS,73707398,2.0319367406190483,1.5594285297603023
LS180,4917,2.9590600733191272,2.992270659795253
Granta-519,46926350,-4.5411361861126,-4.840993232457898
BICR 22,1716436,3.778329286476686,2.9827724770084934
LCLC-97TM1,55283,2.725406070596606,2.919393530474539
LS411N,BRD-K27188169-navitoclax (2-1 mol-mol),3.592750133273901,1.939677144580495
RKN,168312962,-2.199105388969794,2.4709892413149315
MOLM-13,54619267,3.3881439662249657,3.293324798108005
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711,-1.8560096120984806
COR-L95,1239801,5.40725658561935,3.6609741153174955
IGROV-1,10184653,0.79276129336756,1.371297481378642
HCC1500,16741245,3.4170657459529865,3.8377687461071464
LS411N,44491742,5.693616041532359,4.050274667108325
HARA [Human squamous cell lung carcinoma],5282054,3.837128949835148,4.0070396737056395
Granta-519,24753719,3.151565571990212,3.2870031456256026
MDST8,decitabine-navitoclax (2-1 mol-mol),-0.200661322464638,2.0309503536516216
RKO,107985,-4.24085601271806,-3.5488252391490245
HEL,322968,3.0393820993226535,2.380494010166647
Granta-519,46224516,0.9242838162777752,1.7474060167036725
LCLC-97TM1,9823820,4.2474508710721315,3.578566220882904
MOLP-8,23582824,0.4015956903029024,0.7770573231710606
NCI-H2452,60750,1.245026450810127,-2.3200389544632807
NCI-H2452,piperlongumine-MST-312 (1-1 mol-mol),2.5229701837483263,2.033692122305073
COR-L95,54596558,4.049100773357865,4.336980112947329
SW948,135398738,3.916695667859345,3.0835599829722993
SK-CO-1,9936388,-6.4137542305703015,-1.0309161094274497
Daudi,60700,-3.752408099295295,-1.801286565356513
COR-L105,11612883,3.356288934915157,3.1064214771158873
PaTu 8988t,10302451,4.044762571435361,3.3543679738772827
SK-CO-1,44507138,1.8454813707467936,2.6066641598645703
COR-L95,44486219,4.398500193784116,4.1693875652400685
LS180,1242560,3.670855291471482,3.6272738881624953
PaTu 8988t,25102847,3.84691315859083,2.672854719997288
SU-DHL-1,1750826,-3.9186889861650713,-1.035850866672126
IGROV-1,4261,1.934016649932683,1.4711353105587393
IGROV-1,9903786,1.7387584479757865,2.7666239537128523
IGROV-1,9935249,3.330117761231163,3.2233843191007328
COR-L95,446155,4.383849487789403,2.6245797379110907
COR-L95,9967941,2.195306027237361,3.018101670050457
BICR 31,49793307,-0.900639036765476,-2.102288410525748
Daudi,52912189,-0.5619081020202099,-0.0668933592672869
MOLP-8,9911463,4.2009596294807245,3.0342806328327065
LS180,44589607,3.154958497437342,2.9670173088524803
Daudi,24821094,0.7293316215174883,2.5830811279622092
RKN,12003241,-0.3350096455718494,-1.517531292427839
LS411N,148198,-2.2204558676981576,-3.446187021769252
RERF-LC-MS,446155,1.000000375050646,2.6304220673605476
MOLM-13,10127622,2.24693559354045,2.414993157614775
SU-DHL-1,decitabine-carboplatin (1-1 mol-mol),1.7663528844174463,3.1865208747474236
P31/FUJ,72734382,3.508076038929844,3.550198397940761
SU-DHL-1,568763,-0.4525318049600722,0.7410564670701097
SaOS-2,11977753,-0.3684170228919589,-1.3381076830132352
SaOS-2,969516,2.4754458532868067,2.8717523951454704
SU-DHL-1,54619238,4.649416356939895,4.300712760132832
SK-OV-3,6623618,3.404966669354166,2.5909061273651566
WM115,9952709,2.366340614566085,3.1496692829993562
Panc 02.03,10184653,2.526680989613479,1.3224450004842527
SW1271,3634881,2.897813479014186,3.2814014889107663
P31/FUJ,72376,-3.3088434861533704,-3.428021560611454
P31/FUJ,46907787,-0.8407426122417735,-0.6900721934903242
IA-LM,5351362,3.020488284300014,1.207471042780768
NCI-H2452,676352,2.443862996701222,1.9835241120721596
SU-DHL-1,56973724,1.0008411647005613,2.4144137877983094
PaTu 8902,1716436,3.3992265902353425,3.0941495246754367
ML-1 [Human thyroid carcinoma],10074640,3.5607250325369812,3.258761751589316
MOLM-13,11717001,3.6418982852877457,3.3457488256911923
MOLP-8,613753,2.6774354597179,2.8131281275394473
IGROV-1,44137675,1.8406125640672395,3.5953789890030556
P31/FUJ,6914657,-6.361388893160888,-5.311012595717598
LS180,60750,-4.478139976515186,-2.055087655746098
SW1271,3062316,-1.9256219632112692,1.2897121028739005
RCC10RGB,219104,3.453227771477981,3.95451262033731
HuP-T3,6917907,-1.7519392074642692,-4.301072109856856
SU-DHL-1,11656518,1.4392799669460994,0.8690458787122514
MDST8,54626689,6.955475194588027,4.731110320362027
SW48,10410894,3.4061289364485794,3.208126373732306
HEL,72193861,0.4910118925931417,0.021933978664295396
Panc 02.03,65064,5.367712415574159,5.1543481793060195
BFTC-909,984333,1.0937084793466407,0.9001982264918698
IGROV-1,426756,6.142776526139055,4.402996869120184
RKN,11152667,0.0617927102225113,-0.6100228812460964
BICR 22,3025944,4.210034761741456,4.0410755915822865
SU-DHL-1,11640390,4.597120644825806,3.289572771903033
RKO,44589607,3.597229089573096,2.0535774199077874
IGROV-1,56963564,1.8260986108097368,0.3788742404140937
Daudi,24180719,3.437659555986817,3.36573262562309
BICR 31,45279963,4.353781648061694,3.9357439647142125
KU-19-19,445455,4.442962740031222,4.626940778905714
Panc 02.03,5281672,4.500820026656837,4.654893192956606
Granta-519,675434,3.9057117034292976,3.9377938919292124
WM115,46398810,3.009678027858605,2.5898962776318184
BICR 31,119607,5.814089022953436,5.469635384465172
IGROV-1,23635314,-0.611739968448912,-1.4321063891096424
HEL,44819697,-3.010940469478465,-1.2067836604050548
ALL-SIL,5282054,2.788902246408387,2.603657778299535
WM115,5328940,2.031963430852867,1.878341144933659
BICR 22,11455910,2.0554057071158303,1.5031607104718665
COR-L105,serdemetan-SCH-529074 (1-1 mol-mol),2.960742836944571,2.126537118971975
P31/FUJ,4259181,-1.476581151251805,-0.3224771812922259
MOLP-8,54619267,3.766514987830834,3.711273376729215
P31/FUJ,44489367,5.126164790260484,4.207845902741316
RKN,11625818,5.974552631000589,4.327047548174665
SK-CO-1,alisertib-navitoclax (2-1 mol-mol),-2.923852550533504,0.3758150772071065
BICR 31,5470400,2.045329114611378,-0.5482037435977711
LCLC-97TM1,5738263,3.894572665100205,3.361061759744428
SW48,2729026,2.3283979545053155,2.726309188589418
HARA [Human squamous cell lung carcinoma],123631,2.9564926917309635,2.4084130434487214
COR-L105,11167602,4.878993593502554,2.695095430613666
HCC15,9549297,1.5760835884765407,2.8344170236760267
HuP-T3,448949,2.1685596620814565,2.2378730121521087
Granta-519,9915743,0.9460784198503543,-0.0066411347477023696
MOLP-8,51039095,1.4019996450160122,2.295539843736862
COR-L105,56649450,3.0558986692826595,3.6026435676359916
WM115,16038120,1.6321211746217177,1.1763214271678064
K-562,31703,-1.219746708928784,-1.7797797346690307
ML-1 [Human thyroid carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),1.7858982688933729,2.173182979841807
SU-DHL-1,11609586,1.5538406664396571,2.4176579184956486
BICR 31,3025944,4.108701914406302,4.31655642981897
SW48,66577038,3.1598846844687545,3.0586128803340773
Daudi,24180125,1.1000611971852634,2.1014060789598785
SK-CO-1,6184667,4.676967004326267,3.283069812136187
Daudi,SNX-2112-bortezomib (250-1 mol-mol),-4.343389130323972,-2.517620104898828
SU-DHL-1,67291369,2.039504043535649,2.0110855193076826
IGROV-1,3815108,1.915722485757852,3.0543109622826496
ML-1 [Human thyroid carcinoma],2708,2.4589573831191633,5.056609916889946
SW1271,selumetinib-GDC-0941 (4-1 mol-mol),0.8746912096343703,1.8441811530315904
LCLC-97TM1,68056272,3.7652459105524585,3.5156539566662217
NCI-H1568,9926054,1.8156743035592564,2.026230326989727
SU-DHL-1,2113511,3.6581551041454823,4.888237777460232
HCC15,3503,1.8764785687467953,2.524038694372083
SaOS-2,3062316,2.2990980703822115,1.0919217075336891
K-562,16736978,2.075477087199636,0.958715630272559
SU-DHL-1,selumetinib-decitabine (4-1 mol-mol),2.598187269312087,2.3474798322921697
RKN,135440466,3.1815161125023033,2.303892453651358
SK-CO-1,89928392,1.2451759556756246,1.6841381090368392
NCI-H1568,54596558,4.146513733670967,4.492630420470886
LCLC-97TM1,4477,1.1810793422928998,0.622929692213221
LS180,16741245,4.152630132762677,3.69740641770214
SK-CO-1,decitabine-navitoclax (2-1 mol-mol),-0.6610169057545121,1.6950279645048294
BFTC-909,159324,4.114702101808939,3.436477061549245
PaTu 8988t,2113511,6.37119394515457,5.453206848513862
ML-1 [Human thyroid carcinoma],alisertib-navitoclax (2-1 mol-mol),-1.2100779480376045,0.6637891117268443
IGROV-1,5291,3.6852809555447985,3.794703834139323
PaTu 8902,16038120,1.215016097060631,1.1354838348801177
ALL-SIL,10302451,-1.1728976190372558,2.5550544696773296
UACC-812,tretinoin-navitoclax (4-1 mol-mol),2.4411364981876043,2.6391743110255703
LS180,vorinostat-navitoclax (4-1 mol-mol),1.6395407762655403,1.0094348143203418
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668,-2.5893931446627136
P31/FUJ,vorinostat-navitoclax (4-1 mol-mol),-0.3847698718995038,0.04594021575004782
ML-1 [Human thyroid carcinoma],7251185,4.28899372473645,2.883274383905771
SW948,7326481,3.486606738365962,2.988772237700436
HCC15,44507138,1.6295786006094204,2.749824067913059
RERF-LC-MS,16725315,4.583339442818838,4.548267557658505
P31/FUJ,148198,-3.664233852608881,-4.112753052043704
HEL,49850262,3.2265871136708997,2.6717941710222046
HARA [Human squamous cell lung carcinoma],25126798,3.0348047735223935,3.9042891523087593
BFTC-909,60750,-1.7298046099952136,-2.0030751777765645
SW48,doxorubicin-navitoclax (2-1 mol-mol),-4.619867397585904,-1.3347883376559793
NCI-H1568,675434,4.067969537829177,4.601574538093174
COR-L95,19582717,3.635233206850296,3.6444722679789705
COR-L95,148198,-4.800055382400855,-3.3750833284324933
BICR 22,44819697,0.2156040754176,0.47431751740113987
SK-OV-3,46224516,3.444215787907748,2.789537596480903
HCC15,5281672,5.6563329698974965,4.627884420117887
HEL,6918328,-0.4966077251990671,-1.1823850502813122
NCI-H1568,24785538,0.5698046292147018,1.5058042135539162
RKN,23582824,1.7370647325872666,0.7763866219790355
PaTu 8988t,navitoclax-gemcitabine (1-1 mol-mol),-0.4570432900108468,-1.4775297204055837
SU-DHL-1,322968,2.585334286015635,3.2318967726729153
BICR 31,24797083,1.8361324304615187,1.4658340715350633
SK-HEP-1,3062316,3.432714145613195,1.443262551371067
PaTu 8902,2729026,2.7803221257085884,2.861331409462037
SK-OV-3,11609586,4.251063762376387,3.000157895486719
HARA [Human squamous cell lung carcinoma],3025944,5.227932597847333,4.277730088066291
ML-1 [Human thyroid carcinoma],156414,1.0547615836858202,1.8222718185487665
Granta-519,44607530,1.7224857333943702,1.4259675364653344
NCI-H1568,15953870,3.42403550557497,3.645400905880403
RCC10RGB,carboplatin-UNC0638 (2-1 mol-mol),3.3801418218563337,3.272421808596931
MOLM-13,erlotinib-PLX-4032 (2-1 mol-mol),1.7877509525982431,2.6737710024420402
MOLP-8,252682,6.161004481234046,6.313297702185576
SW1573,126941,-1.0305779796426808,-2.7688562025914845
BICR 31,9927531,5.661036072082279,4.953626966635803
RCC10RGB,441298,3.7731685554529384,2.710579482977562
MOLM-13,387447,-5.119095777855545,-5.0260942449681725
Granta-519,216345,1.0997896286755158,2.8523526204015326
LCLC-97TM1,107985,-4.222636663811031,-3.502860993504742
LS180,3384730,2.894746509752001,2.853528758469667
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233,-1.0929082095562965
ML-1 [Human thyroid carcinoma],2746,-1.478438692576885,3.4695470349228708
KU-19-19,44493528,4.383684457454455,4.298374993051522
LS411N,53232,4.5193815700089655,2.9174230520869515
ML-1 [Human thyroid carcinoma],46907787,2.3673247902218804,2.605175615825406
LS411N,6438330,3.3380693145982816,2.2747324113938334
HARA [Human squamous cell lung carcinoma],5284616,3.060508834181737,2.7506603844209767
NCI-H1568,JQ-1-carboplatin (1-1 mol-mol),3.4150339974619457,2.771523094238384
BFTC-909,16725315,4.495652912061774,4.297615432278059
RKN,124202324,3.704376342602573,2.4509449672254506
LCLC-97TM1,10127622,3.458194652659875,3.765339455473529
SW948,vorinostat-carboplatin (1-1 mol-mol),1.7834644899516086,2.5500964430487714
SaOS-2,5494449,1.7356769079300427,2.6666721046827275
HEL,702558,3.166026376934585,3.992283124977371
KU-19-19,11612883,2.975593545287462,3.100900336927247
BICR 31,6914657,-2.1990076047646703,-3.4607545918269604
PaTu 8988t,2858523,3.414247843041017,3.030523335654525
SW48,9911830,1.5953282800372102,2.5544753913148512
Daudi,11178236,-7.583909031047052,-4.411085215743914
Granta-519,44819697,-1.094231558387569,-1.3682529563777301
MDST8,2828334,6.077771510152207,6.255240223597266
RKN,9911463,4.114615883902867,4.0173939536878835
RCC10RGB,JQ-1-vorinostat (2-1 mol-mol),1.4034358595851535,1.2870838937915563
SaOS-2,9903786,2.3206358959344264,2.807341262549068
RKO,44607530,2.6096687798301677,1.6571025518230318
SK-CO-1,11455910,1.152685438196598,1.3623976861086637
SK-OV-3,25183872,-0.070614613180641,-0.4157463932942116
WM115,25227462,1.5125525407178182,0.2875637152807123
HCC15,2126,5.047391044285817,4.729587794644049
HARA [Human squamous cell lung carcinoma],9823820,4.297752192216693,4.240789839910222
HuP-T3,11238147,3.6375005285241033,2.973610736051142
SU-DHL-1,168313047,2.0629090722275945,2.135835635921804
BICR 22,5335621,5.24838502551373,4.4138971091209145
SK-OV-3,135398516,2.140261030425796,2.2118051870430517
ML-1 [Human thyroid carcinoma],6852167,2.7131700239928316,3.1913390848859677
RKO,11214940,1.6564081526645635,1.3847602342003353
SW948,9935249,-1.8483271913214137,2.1432505030530553
NCI-H1568,2871966,-1.5477941874243064,0.9176992321138117
WM115,54626689,3.4845925362433,4.6116632100429715
IGROV-1,46398810,2.003787621940583,2.42738809991904
NCI-H1568,alisertib-navitoclax (2-1 mol-mol),0.1984676648447771,0.5009344811650458
RCC10RGB,selumetinib-UNC0638 (4-1 mol-mol),4.208062457345683,3.6967025274097494
SW1271,selumetinib-PLX-4032 (8-1 mol-mol),0.5021040652093107,3.0599889026506975
BFTC-909,3025944,6.464154930724253,4.298781302730178
BFTC-909,10113978,3.8739618499623094,3.548653628436835
LS180,docetaxel-tanespimycin (2-1 mol-mol),-5.0888233311005795,-3.432413205385256
BFTC-909,24748573,2.672786285704278,2.1758100121865116
MDST8,23582824,0.3553467044538872,0.7310064781764462
MDST8,navitoclax-MST-312 (1-1 mol-mol),0.0883996467230522,0.9360460973045366
SW948,53392493,1.921137473015096,2.037519062671741
LCLC-97TM1,5287620,-2.537847801025228,-2.03766961818707
HCC1500,3552672,1.623977684405255,2.9344239702382016
SW1271,2113511,4.856200971437617,5.524763828311299
RKO,11238147,3.3996395604326977,2.3389334460092788
MDST8,56963564,1.9609696235744132,0.6386924153858634
HEL,JQ-1-vorinostat (2-1 mol-mol),-0.5678151706430512,-0.7475216885092961
MDST8,73707398,0.930898424190815,1.6382200360210633
SaOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.0166144741288403,1.6218737179395666
COR-L95,serdemetan-SCH-529074 (1-1 mol-mol),-0.7704324455951623,1.8248729387587141
HCC1500,107970,1.6380228058856745,2.2377586911781826
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911,3.0693780674480426
ML-1 [Human thyroid carcinoma],5335621,2.3456257872682933,4.8093825538059285
MDST8,11222830,1.739834123793711,1.5727153266849723
MOLM-13,11364421,-4.614262921489179,-4.53416379833725
MDST8,89928392,1.3331112546959425,1.8383010127620865
SW1271,doxorubicin-navitoclax (2-1 mol-mol),-1.1619625703073235,-0.8791069327740234
RERF-LC-MS,148124,-5.592640359076286,-2.2944197321077153
PaTu 8988t,219104,4.30352428274638,3.732184542189805
SaOS-2,16659841,3.6368059645085737,3.751887568116436
HuP-T3,selumetinib-vorinostat (8-1 mol-mol),2.242647534898157,2.472618941009531
ALL-SIL,25183872,-1.1896517316661384,-2.2958376060962937
HuP-T3,3503,2.6961085729175465,2.4585893051095082
SaOS-2,148124,-5.379251304292956,-2.2451755405726157
SW48,25102847,1.5289459974072863,2.540654831423167
PaTu 8902,6852167,4.282216220168943,2.7089545178854353
ALL-SIL,11396600,2.960335319566646,2.585900386639089
LS411N,54649381,4.0879656113234315,3.3501348274270244
LCLC-97TM1,56649450,1.9268896253969057,3.2799664210796893
Panc 02.03,42642645,1.4849485241267697,1.1547629382936022
PaTu 8902,5328940,2.100447742300893,1.6587435401833426
Daudi,10127622,5.05479511248997,3.531773368932534
SaOS-2,15983966,-4.612114381732812,-1.3409169272562935
SK-CO-1,selumetinib-decitabine (4-1 mol-mol),0.410871863589865,2.9899320929913467
MOLP-8,11214940,2.188017762346292,1.4030273342871673
SW48,44607531,-0.0703962424187993,1.4763591830475389
IA-LM,637858,2.795809218533269,1.462109670779263
LS180,119182,-2.2864715680735603,-0.43810829343247654
SK-CO-1,135411,-1.9906675184189948,1.0756545960705637
SW1271,15983966,-1.9627382742922743,-2.074308943400358
LCLC-97TM1,11485656,2.4293249862604913,2.1391312699547087
Daudi,135984461,3.9990978127252728,2.783509596363241
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662,1.514461166926586
SW1271,24180719,4.447587763279296,3.2275389976572524
RERF-LC-MS,4917,3.617944790726347,3.2327815883840088
HARA [Human squamous cell lung carcinoma],1242560,4.08747373250943,3.64248338098955
COR-L105,44185566,3.03526972595121,2.808327789121526
MOLP-8,8515,3.727464051425151,3.1118301559639288
Daudi,11656518,1.0836561052202376,0.6458456408478825
MDST8,10302451,4.267643132743765,3.0180116710821276
Panc 02.03,tretinoin-navitoclax (4-1 mol-mol),6.083694650761559,3.0742921769390135
MOLP-8,135398738,4.11621412508813,2.3481011693662124
RCC10RGB,568763,0.4218853975706897,0.7007520015666941
SW1271,285033,0.340737243750418,-1.8868762025815888
Granta-519,67156097,-3.3327998752636483,-2.2589717431564513
WM115,11964036,0.4423113132234746,1.5001141062119165
SK-CO-1,156414,0.1991331726980137,1.0201387990571797
BICR 22,568763,1.1340411223212885,0.9327572423301058
P31/FUJ,176870,1.9707243184949097,2.354588738778321
SW1271,24748573,2.5868513601661336,2.2043352917630754
MOLP-8,72199292,1.2541603744267094,0.5613245733071013
RKO,5282054,3.8735499096789856,2.9011403034255436
RKO,selumetinib-decitabine (4-1 mol-mol),2.541552473841643,1.4999098048381654
HCC1500,16722836,2.402902940836366,1.808794670494769
Panc 02.03,46199207,3.8452319744534886,3.3508117886485995
PaTu 8988t,71304818,2.8353343090304257,2.4620303038144145
IGROV-1,241158,3.288496474515495,3.9301929474425883
Daudi,71751553,3.830487233171358,3.7378643826493207
COR-L95,46174525,3.763282126483136,3.8177271276436913
NCI-H2452,2126,4.762499509878762,4.603627593030643
HCC15,11228183,0.6025691709173914,2.5323588330939892
HCC1500,11404337,-1.1638452247583002,-0.3122924467286943
PaTu 8988t,16725315,5.4103858057829095,4.269742904128143
MDST8,4378219,1.9480435949418269,2.7529690558154756
IGROV-1,5351362,1.961059142684053,1.5230721694614586
HuP-T3,44489675,3.6946366435409352,4.0898356161094656
SW1271,4259181,0.7411137136724786,0.23182189415531287
RKO,5978,-3.7617282032773582,-2.8527516776689943
MOLM-13,11485656,-3.968420003132376,1.752338987174455
K-562,24821094,1.908113699718487,2.8825265396118103
SW1573,89183176,3.862510153781557,4.442011844050556
K-562,24180719,3.2747438118023533,3.5077812370878623
LS411N,4788,5.997281207159956,5.786202288539669
IGROV-1,66577038,3.2148239132520455,3.2482429496213463
SaOS-2,selumetinib-BRD-A02303741 (4-1 mol-mol),7.165298435960504,4.611846678560698
Daudi,9549297,1.403366421117492,1.7289093245158005
UACC-812,11427553,3.574449796486334,3.0466780082437537
MOLM-13,52912189,-1.0667663091505395,0.007068985429099914
HCC1500,selumetinib-JQ-1 (4-1 mol-mol),2.938993597127826,1.3579519591095766
SW948,erlotinib-PLX-4032 (2-1 mol-mol),3.457135081619971,3.1079804328914222
PaTu 8988t,selumetinib-JQ-1 (4-1 mol-mol),1.6621315506186802,1.758771666834611
IGROV-1,24821094,1.720998716331183,3.094545867208243
Granta-519,11427553,-0.9723301484726812,1.3439340135081443
MOLM-13,208908,2.7636340376000317,1.823389225925372
IGROV-1,9915743,-0.4757488934941289,1.1352927303967488
Panc 02.03,241158,4.402915180139186,4.077853086417421
IGROV-1,24748573,-1.0654275876710166,2.1502151282662023
COR-L105,5287969,-1.8496230723467,-1.7027835685321973
MOLP-8,10296883,2.725727750190508,3.022163952683776
SW948,241158,4.5321951743877005,3.421167444318624
ML-1 [Human thyroid carcinoma],216239,2.965937740464059,2.6158906633614016
MOLM-13,navitoclax-piperlongumine (1-1 mol-mol),-1.0908841522604569,0.28335773808067244
SU-DHL-6,10302451,3.370117636140473,2.64065533746215
IGROV-1,9936388,2.10108466287406,-1.0080455805804374
HCC15,72376,-1.512462057486854,-1.8683277011321489
COR-L95,6450551,2.8920154707175776,2.080209891229614
NCI-H1568,5738263,3.2402226460817323,3.5616516703854857
RKO,54619267,4.028311361432676,3.6845742736107803
RERF-LC-MS,4261,2.068565192175152,1.8783582127446092
K-562,73707371,5.645446798773975,3.648090778773613
SK-HEP-1,carboplatin-etoposide (40-17 mol-mol),5.6878657292744075,2.7867570302405973
P31/FUJ,ISOX-bortezomib (250-1 mol-mol),-0.0400156428773503,0.022096075120615087
WM115,122327,3.780637240577924,4.744089523854145
WM115,25150857,2.4679229997528394,2.295484377191612
SK-CO-1,11178236,-3.2010052407962215,-2.944854990378331
RKN,753704,4.966407297087677,5.056761212554317
BFTC-909,selumetinib-PLX-4032 (8-1 mol-mol),5.555922755682714,3.612527301544921
SW1271,227681,3.2917347097405725,3.2986526030815413
MDST8,568763,0.1407924711645573,0.6192645962905678
BICR 31,5566,3.2898773587253096,3.104235485316351
HARA [Human squamous cell lung carcinoma],3385,4.962584280578164,4.344741032750665
RERF-LC-MS,6450551,1.967154760545028,2.870301747350721
IGROV-1,2874250,4.893662837169153,4.752724178098005
ML-1 [Human thyroid carcinoma],ISOX-bortezomib (250-1 mol-mol),0.9716953544539896,0.8467962071295163
HCC15,56946209,-3.385198311974778,-3.7938400887381483
BFTC-909,136227924,2.3418993883842134,2.9058439198962294
Granta-519,1750826,-3.7858867937492984,-3.374514324828567
P31/FUJ,11625818,3.2136174191857174,3.43826713358068
COR-L105,10322450,4.112392966182136,4.305298908229748
HCC1500,5566,2.905130044911903,2.871485525437896
SW48,51039095,1.7096770563148074,2.7685363140914796
SW1271,8515,5.208985199998064,3.997296411963731
KU-19-19,73707398,1.7453733414385195,1.3974905819785786
K-562,11707110,1.6681367726124623,1.5867673299412812
COR-L95,16065773,1.8842547212847705,2.2819859472902255
LS411N,docetaxel-tanespimycin (2-1 mol-mol),0.1660438979420715,-4.11443634667599
IA-LM,11178236,-6.720771550362321,-3.2431100569937614
MOLP-8,54596490,4.413151323823571,4.0331014447931715
ALL-SIL,44202524,-0.4119558263455749,1.4052533836266878
WM115,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.6716900719045018,3.38034693045589
MDST8,6918328,-0.3527629143091293,0.08616767592927438
BICR 31,104842,-0.0442586507462943,-2.298639985634015
BICR 31,6852167,2.001013365002547,2.79353064503813
MDST8,vorinostat-navitoclax (4-1 mol-mol),-0.0959848783200281,1.0498778540644353
IA-LM,24821094,3.0699000024292293,2.907833327583792
IGROV-1,73707398,0.8848064516600974,1.3051500570258667
SaOS-2,46191454,1.8159544721998524,1.7789765307266632
NCI-H2452,selumetinib-GDC-0941 (4-1 mol-mol),2.2378905262634343,1.7388561831575402
LS411N,25150857,2.959758413524705,1.9106632110759574
HuP-T3,11175137,3.603877049706456,2.6320504495472337
LS411N,135984461,5.061110843141604,3.0720921449324736
IGROV-1,4261,1.934016649932683,1.4711353105587393
SK-CO-1,BRD-K27188169-navitoclax (2-1 mol-mol),1.3228586557967312,2.6456669917904527
HCC1500,9952709,2.298703589628035,3.140757066457665
SK-OV-3,176870,3.5610869734905255,3.4624300805327097
PaTu 8902,9952709,4.3707417693645745,3.0124633165910133
P31/FUJ,56973724,0.796880831995934,1.7257992699822902
RKO,2729026,2.3662843020346753,2.3139359518969584
RKO,387447,-4.452540898932811,-4.564997670067368
SK-CO-1,135398738,3.5773200936681584,4.493138779121333
BFTC-909,3552672,4.498195948808332,2.9851506597898565
Panc 02.03,7251185,3.0530850004567767,2.840840452232739
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024,-0.21070989570654686
RERF-LC-MS,serdemetan-SCH-529074 (1-1 mol-mol),2.886633168137992,2.308074317196044
Panc 02.03,53392493,3.617637281515077,2.9684660066432604
LCLC-97TM1,446155,3.780165105352184,2.771389693761942
BICR 31,23725625,6.004496967521932,5.229283676045639
RCC10RGB,11612883,4.41570881394896,3.0749265654480644
WM115,5280436,2.216411919293008,3.795963541152355
RKO,selumetinib-JQ-1 (4-1 mol-mol),0.7539248953092096,0.769561244079677
NCI-H1568,10184653,1.3826991243685076,1.5335266413264805
LS180,10427712,4.740953715848998,4.2987110285060375
SU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),3.662871226226577,2.067074731865563
ML-1 [Human thyroid carcinoma],56963564,0.9868520726565888,0.6204265795035191
HuP-T3,12003241,-0.2833744856936582,-1.0344493002345885
Daudi,9884685,-1.7998414591903729,-0.12407445378900549
SK-CO-1,44259,0.6005082969424771,0.9787121262617369
MDST8,10231331,0.2022855962524302,1.8255254405183217
SK-CO-1,4261,0.7789911540114764,1.4544991025571177
P31/FUJ,10074640,2.9862675466657764,2.707239720517086
SK-CO-1,12001922,1.782153173177779,1.9791748052136553
SaOS-2,16720766,-1.9505026731708328,0.22425165247073844
RCC10RGB,216239,3.3222265979679375,2.789623471191062
BICR 31,navitoclax-pluripotin (1-1 mol-mol),-0.5418229135264367,-0.629069777439963
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133,0.8488187548745902
COR-L105,72734382,5.425179503032161,4.7451763651480094
LS180,11640390,3.36619781023128,3.513306776004016
K-562,25262965,-1.232298297425116,-2.450117630800377
IA-LM,piperlongumine-MST-312 (1-1 mol-mol),2.1673101171047513,1.5367056604317975
LCLC-97TM1,135411,0.5874500365845237,0.5265671069516903
SU-DHL-1,46398810,1.696894130738712,2.235235224245878
P31/FUJ,6610216,4.336076332167018,3.842356812630487
BICR 22,5291,3.723640910280853,3.6951453567328745
HEL,44632017,1.0842639602191189,0.8281329312097963
Granta-519,4261,1.1412453306659267,0.15830888199413862
Granta-519,56963564,-0.5609340564012296,-0.2500872055283059
MDST8,53392493,2.9375507482716334,2.717300198257016
LS411N,44819697,-0.923326266781905,-0.6154258816723065
NCI-H2452,selumetinib-decitabine (4-1 mol-mol),5.979248786857892,4.371835030842147
NCI-H1568,5291,3.770643134542437,3.818761876375802
BFTC-909,11612883,3.5324782187628827,2.9354819426164744
RCC10RGB,11955716,4.4260489213830425,-1.350432328863294
SW1271,11626560,1.376954486231794,1.9670141080012993
SW48,46943432,0.8743166493146273,2.3345243526224806
HEL,3062316,2.2727573444408633,-0.19313355639859023
MDST8,JQ-1-carboplatin (1-1 mol-mol),1.720719180230483,2.4198988837952498
RCC10RGB,5329102,2.357265375302505,2.3359892711180787
ALL-SIL,9866186,-0.4181259896802407,0.10509040395568445
NCI-H1568,selumetinib-navitoclax (8-1 mol-mol),2.553812274921004,2.1117268862256977
HEL,23635314,-2.6594801266287154,-2.6706742868119857
Daudi,10074640,1.7373836938395748,2.753088864530521
RKO,26596,-1.341584325458414,-2.146819661965682
WM115,11167602,1.5239005360441813,2.8454908055696064
IGROV-1,2746,2.8413672686351212,3.373014510275744
Daudi,24978538,2.467871482925033,-0.14312329967722148
RKO,2858523,3.1569923390566332,3.048448064251693
LS411N,15983966,2.6804451752833978,-2.9915486843402874
SK-OV-3,452548,0.7579906967862455,0.5877398995215211
MOLP-8,25262965,-4.805551534468427,-2.1162457739337572
LCLC-97TM1,46215462,1.4949685345148778,1.77147244665813
BICR 22,439501,-2.4052901035443,-2.0563423268300287
SW48,10184653,-2.0074491437034094,1.1784925037247893
P31/FUJ,168313016,4.690131242833582,3.724762389517881
NCI-H1568,selumetinib-tretinoin (2-1 mol-mol),5.145646184067631,3.7626547914990005
SK-OV-3,selumetinib-JQ-1 (4-1 mol-mol),5.055306733015199,1.7123370196107897
LS411N,54613361,3.867376577775082,-0.44793739919922126
COR-L105,24772860,-1.435746068442861,-1.5275337752004738
K-562,11222830,1.892206265748428,1.2531447337855068
Daudi,10385095,0.347773175212431,0.7658164131507716
HCC1500,44137675,4.199849963716895,3.552285684619715
SW1573,11404337,-1.3449252751203844,-0.06654154966367307
SK-HEP-1,46191454,1.8876467264614776,1.76118719495021
P31/FUJ,135999136,4.068676884464422,2.6139591665127044
RCC10RGB,25150857,2.370598483016253,2.771834351424486
NCI-H2452,57330099,4.302779847582817,4.341863966653721
IGROV-1,10127622,3.2581804056600165,3.7302088700248923
COR-L105,5282054,3.9571885951378505,4.15316306349666
LCLC-97TM1,53481919,3.8027519676947232,3.7343630375326757
NCI-H2452,3025986,-0.5496531660815697,-0.5390508906893484
WM115,11955716,-2.4505472507691013,-1.3702696944968518
BFTC-909,637858,2.264716830291231,2.3198621133415718
COR-L105,selumetinib-JQ-1 (4-1 mol-mol),0.4359614379036839,1.7206038133193948
Daudi,1641662,2.995591169153073,2.8712987762632567
MOLP-8,446155,0.367312642153156,2.4069260542008
RERF-LC-MS,135999136,4.400683337930441,4.299753171971029
WM115,5738263,3.851280366828244,3.6458094250793183
MOLM-13,65628,2.9573007313246924,3.3767514565957217
HEL,9936388,-3.337900467930123,-5.899984346772584
SW48,104842,-4.777281812432541,-2.5519732280141256
MOLP-8,ISOX-bortezomib (250-1 mol-mol),0.0006851036189058,0.24006288462337808
Granta-519,11626560,0.2073830225530282,0.5586076039251872
SK-CO-1,969516,2.7975557975376035,2.955208793761939
SW948,11640390,3.051257470103826,2.539022177691553
HCC15,10302451,3.767869991537956,3.101105499303773
MDST8,crizotinib-PLX-4032 (2-1 mol-mol),1.604281792595084,2.054234804592554
PaTu 8988t,46943432,6.478561461465468,2.8041348427432173
K-562,208908,1.7214906675478436,2.143963847986968
NCI-H1568,11612883,2.467781963295413,2.9676827484350525
LCLC-97TM1,9884685,-0.6945268748645868,0.6151549738156803
Granta-519,6918328,-2.2526378564537355,-1.7831019052733246
Granta-519,5470400,-3.2597420844446163,-0.15840998936368014
LS180,10231331,0.7625893939503741,0.9350373413086907
SW1271,46199207,3.134892747913181,3.110888003473694
HEL,11404337,-0.835651629585067,-1.1098410632636158
Daudi,216345,1.872370108624604,2.735355179588747
MOLM-13,decitabine-navitoclax (2-1 mol-mol),-5.337552823003331,-0.6642419099693312
RKN,54613361,0.2026815444056028,0.07024847713844035
LS180,452548,0.7544699085550369,0.5616056340076715
RKN,44493528,4.408823872302737,4.4965372872479215
SK-HEP-1,11238147,2.1467729161342524,3.063134156751389
MOLP-8,tanespimycin-gemcitabine (1-1 mol-mol),-4.944533339092102,-2.238870537339433
COR-L95,11364421,1.7062947816433405,-2.306260695766794
KU-19-19,452548,1.4010535434747853,0.6107597120047366
COR-L95,tretinoin-carboplatin (2-1 mol-mol),4.531796019532578,4.152155062984015
IGROV-1,44819697,-0.8326420176056434,-0.30231545042468605
MOLM-13,salermide-PLX-4032 (12-1 mol-mol),4.733891503361179,4.389782086691321
RERF-LC-MS,2729026,3.1361811776879644,2.9036463538384396
RKN,4788,5.902938799554125,5.777672920066961
K-562,216239,1.6121414929675577,1.8499814901410045
HARA [Human squamous cell lung carcinoma],2729026,2.992927693558788,2.7003398241048693
IGROV-1,2746,2.8413672686351212,3.373014510275744
IGROV-1,637858,1.814476597989254,2.0254701236303485
HuP-T3,11214940,1.8541641961456377,1.972117505344274
IGROV-1,46907787,2.182756719431072,1.9102572095047154
P31/FUJ,445643,6.117258311867223,3.36966153359116
Granta-519,3854666,0.1662242620713641,0.8684533063537155
MOLM-13,tretinoin-navitoclax (4-1 mol-mol),-1.997886556177749,0.4478908185666042
LCLC-97TM1,135440466,1.105929023295497,2.163837515701527
RERF-LC-MS,56649450,3.38813984116235,3.6855795587482874
SK-CO-1,11612883,2.4661452350243493,2.857348967791973
SK-HEP-1,44137675,4.549525792934436,3.8722046048347734
HCC15,72193870,4.3690783386047025,2.4295466475553957
HCC1500,2746,2.6069735713089006,3.1019593942038877
MOLM-13,decitabine-carboplatin (1-1 mol-mol),-2.1020710624228833,-0.4571217505756707
Daudi,11222830,0.8543881776084605,1.3192629211801903
WM115,2749,6.3303951951253445,2.0106703332460047
K-562,9840324,5.675524269237515,5.652377677972665
MDST8,10113978,3.624916965791189,3.2819917288985603
NCI-H2452,44507138,2.753685109279225,2.7325118692893255
MOLM-13,5282054,3.1361279245897857,2.9605185659269284
BICR 31,9911830,2.2138272662609064,2.7558293320053218
HEL,6917907,-5.38656193144065,-5.636981656321544
IGROV-1,2858523,3.196384505087132,3.0074301539774746
MOLP-8,322968,-1.2094679469942695,2.2926343532875135
BICR 22,3503,2.960513829073252,2.4611503253342373
ALL-SIL,10113978,1.6173510565910796,2.162633637387413
HARA [Human squamous cell lung carcinoma],navitoclax-sorafenib (1-1 mol-mol),1.2625473684238606,2.0280292794203847
RERF-LC-MS,119182,-0.645974794966856,-0.20064094585632433
LS411N,4261,1.591263829932159,1.2823587855624548
SW948,4096211,1.12279899109382,1.688974260232038
K-562,11485656,1.7795111963017332,1.8078083983387532
MOLM-13,53232,2.182263698942312,2.756379937086493
ML-1 [Human thyroid carcinoma],44819697,3.711954604060423,-0.26777284167547144
IGROV-1,3689413,-0.3633634632064185,0.20390496186348567
RCC10RGB,12001922,2.277970650057297,2.024850730532816
RERF-LC-MS,246676,4.480243243269967,4.622246914734724
HCC15,374536,0.7951987879889547,2.632710632949498
MOLP-8,11977753,-4.876868381891939,-2.4398524727685116
Panc 02.03,2874250,4.438896474206821,4.872146455241466
COR-L95,613753,3.031049367391043,3.0001493336577862
SW1573,9840324,5.095993559480237,5.847171461068772
SW48,24901704,1.780712261537264,3.260420365915722
BICR 22,6918328,0.5113628660513942,0.08393610816090506
Daudi,54613361,-0.5183638298018372,-1.1230887155198928
LCLC-97TM1,25102847,2.141917897082315,2.4522331420624335
HuP-T3,3081361,3.872954779649628,2.1894907560459043
LS180,969516,2.6818241036299275,2.8114022301342065
SW1271,2945648,2.4921907486938646,3.0197407308050814
BICR 31,25126798,3.691910729857057,3.891842058529376
KU-19-19,SNX-2112-bortezomib (250-1 mol-mol),-1.0111363937138018,-0.9539938676958283
Daudi,262093,0.7533038243356376,1.6182640371609625
RKN,20959075,-2.033811748726601,-2.8142555538969067
KU-19-19,702558,5.449368171937104,5.149780757776203
SaOS-2,2842253,6.143936300195383,5.510190658145924
RERF-LC-MS,26596,-1.2372341703529914,-1.0606462494918245
PaTu 8988t,5329102,3.3339986936080717,2.1144657394566333
ML-1 [Human thyroid carcinoma],44607531,1.8496707927685447,1.5781627768524737
SaOS-2,73707398,0.8491853151273433,1.3985399866804586
K-562,JQ-1-carboplatin (1-1 mol-mol),0.3966707315482991,0.10162068264567681
SaOS-2,984333,4.259432573695519,0.7415171536533548
LCLC-97TM1,53232,3.007779101776312,3.046250924449555
KU-19-19,3503,3.0769201112014803,2.3355332078265474
WM115,57330099,5.984461482923693,4.242625192033307
HARA [Human squamous cell lung carcinoma],82146,4.619283658647928,3.719496230381616
LCLC-97TM1,44491742,4.237702230509644,4.150023221891389
SK-CO-1,9915743,2.0474134916136184,0.38660564920253576
HCC15,73707398,1.6988346513711203,1.6779381248876504
HCC15,4477,-0.3802251277588812,0.5056152935545668
BICR 22,26596,-1.8883514509946957,-0.9126265694149198
SaOS-2,445091,4.479630914494518,4.430335190483126
HCC1500,3503,2.0705498046235817,2.2051592468834773
SK-CO-1,salermide-PLX-4032 (12-1 mol-mol),5.553578625312618,4.748619100022727
RCC10RGB,71304818,3.488257335656729,2.75843672620267
RKO,241158,4.5302703569847305,3.0801698266518036
SW1271,168313016,5.582938604018868,4.8323623012040455
SW948,10385095,1.3660359707166476,1.4810517496298785
RERF-LC-MS,3543504,3.1700226881436193,4.574385138217539
LS180,5311,1.1738972820475675,1.289688671332822
RERF-LC-MS,5291,3.9873816513243785,3.831162937228894
RCC10RGB,53481919,4.9196370953200805,4.241553784486509
Daudi,44241473,5.233980827552566,3.7724191320359286
Panc 02.03,10127622,3.4148938287456776,3.797158263859625
BICR 31,49836020,4.313223650735915,2.582151428106093
Daudi,54618305,3.9105424608095847,3.932010380985507
SK-HEP-1,5746,3.319924463812582,1.209887444609642
ALL-SIL,67156097,-2.3407546390754037,-2.625786972476165
ML-1 [Human thyroid carcinoma],24797083,1.931228349809168,1.6822740297082261
P31/FUJ,613753,2.9305719806169432,2.872236502984296
PaTu 8988t,1641662,3.634680635371761,3.4100330212459085
SU-DHL-1,15953870,1.992339234699044,2.842097809415264
COR-L95,decitabine-navitoclax (2-1 mol-mol),-0.2234984214129892,0.6779701496531071
SW1573,JQ-1-UNC0638 (2-1 mol-mol),2.8948762578833667,1.8096906270127888
P31/FUJ,navitoclax-PLX-4032 (1-1 mol-mol),0.0164871875305551,0.23315346712057508
Daudi,vorinostat-carboplatin (1-1 mol-mol),1.6612162447966572,1.8684712730610007
SK-CO-1,11364421,1.7180407971266538,-0.10756427606758225
COR-L105,16722836,1.79329711252707,1.8602124545417382
IGROV-1,439501,-2.1510551928674557,-1.9064117958009776
ALL-SIL,50905018,3.9646846974495418,3.45847388166444
SW48,25126798,2.5731969050098993,3.8079571611962306
PaTu 8988t,10113978,4.3652834043747335,3.112268423965556
SK-OV-3,12003241,-1.2313805329375749,-1.0539653943334228
Daudi,1317464,3.6966432302020817,3.1245250584798976
WM115,5978,4.185238310426041,-1.6148069798420874
RKN,carboplatin-etoposide (40-17 mol-mol),3.53893718453625,2.951280830709836
ALL-SIL,24785538,-0.5874123218373029,0.22025319230491472
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034,1.0558958858560086
IGROV-1,9967941,2.9735049794712545,3.694129530235999
SK-HEP-1,11977753,-1.1270659898133608,-1.542314803000817
COR-L105,676352,1.9469411585028615,2.1784553036118792
MDST8,11485656,2.867381561993162,2.4105252622747586
SW1271,selumetinib-piperlongumine (8-1 mol-mol),2.3808052258502705,3.015710343480708
SW48,6918736,-2.164113269607571,-1.4816648617024348
SK-HEP-1,445455,4.37046727572682,4.707072186133367
Daudi,4096211,1.4831417361144643,1.0399423554509684
LCLC-97TM1,16038120,-0.9192372639718316,0.8571660399154579
BFTC-909,3384730,4.46542670181497,3.1251483010913144
K-562,36462,1.3855340321895664,1.1982736452445573
SK-HEP-1,5329102,2.506246240472525,2.0656771587935587
WM115,25161177,2.874219730459086,4.113830963749465
HCC1500,119607,4.730010050453825,5.172593944131872
IGROV-1,24964624,0.5052308994941754,2.283020793972891
HCC15,421610,3.960173561996767,3.4076790002896034
ALL-SIL,4788,4.920956242868583,4.740779649301877
IGROV-1,49766530,-0.195540678413639,-0.12697571079397424
SK-HEP-1,11175137,3.0126176485486114,2.8096540850671063
MOLM-13,selumetinib-piperlongumine (8-1 mol-mol),2.118239948342191,1.5336003357698087
K-562,54678924,1.7343444538293111,1.5207244418733352
ML-1 [Human thyroid carcinoma],5281321,-2.300928121678764,-1.061619037067827
ML-1 [Human thyroid carcinoma],11167602,2.9640815113410923,2.77523968071978
COR-L105,6505803,1.059348129706536,-0.4675830490032602
P31/FUJ,25183872,-2.108478877482417,-2.2188530162581714
Daudi,navitoclax-birinapant (1-1 mol-mol),2.1928151248147194,0.01138442925925096
NCI-H1568,9444,4.259676436179719,4.191614486483701
NCI-H2452,selumetinib-MK-2206 (8-1 mol-mol),2.148853035614541,2.3580311447249
KU-19-19,19582717,2.992815973528006,4.421818518932472
RKN,36462,2.460575122343829,2.3930458536794617
P31/FUJ,3062316,2.2346133515561415,0.7712028787223077
MOLM-13,36314,-7.769941141611737,-1.4770695841133417
HEL,44484440,3.2564839193688524,2.610154684365625
RERF-LC-MS,168313016,4.277512101574917,5.0936504296553045
HCC1500,637858,1.1010846881251866,2.0938004270573987
COR-L105,11178236,-3.064044900311784,-3.1006485328480715
IGROV-1,44202524,1.8303703172382677,2.367386691159152
LS180,alisertib-navitoclax (2-1 mol-mol),1.1962644272537857,0.38713540239672434
MOLP-8,11175137,1.914718066408171,1.8150223458129806
LCLC-97TM1,1641662,3.5570250788057187,3.4161757680880527
SK-HEP-1,46199207,3.772137058295689,3.347028107260474
SW1573,6917907,-6.296104468024424,-4.569876911915228
HEL,89183176,1.9576500820122449,3.129046378199497
SU-DHL-6,49793307,-4.306431914357451,-4.392616228984976
K-562,6918837,-4.262812875828109,-3.868538344431379
Daudi,44493528,3.680262260756896,4.042335001256971
RERF-LC-MS,5311281,3.366561586065275,2.6575633365655564
IGROV-1,675434,4.336225379212549,4.610988885656843
NCI-H1568,216345,3.8344110950672823,4.113962414778777
SU-DHL-1,9926054,1.6936537424309908,1.8919890770402303
Panc 02.03,9911830,3.8856260346392903,2.656543901182815
HCC1500,2729026,1.749867272011919,2.7029134421306136
ALL-SIL,42642645,-2.33031271995146,-0.13138713782975586
Daudi,9911463,2.4252044126403915,2.9936003209108186
NCI-H1568,45279963,3.534456091536717,3.757305198718604
RKO,135999136,6.045591123054076,3.080157224807071
SW948,JQ-1-UNC0638 (2-1 mol-mol),0.5184819522178918,1.0763021282851197
SW948,9903786,1.6902329933335576,2.7443713867151582
RCC10RGB,9956119,4.44093701823858,3.6528298619354644
SW1271,25154868,5.0403607075499375,4.489035623413505
K-562,65628,4.517417686157834,3.472073174779355
SU-DHL-1,613753,2.797885663964736,2.9480280147632816
SW48,ISOX-bortezomib (250-1 mol-mol),0.0957852828937709,0.788725171207648
HCC1500,44566777,0.0909506116020526,0.7877497337064757
NCI-H1568,54454,3.61375646412465,2.72398326035851
SW948,44507138,2.949706410080911,2.7336165530120713
SK-CO-1,17759555,4.047587343089958,3.8064507047911764
HEL,568763,0.2288469977463405,-0.35701817875683406
BFTC-909,3815108,3.5118939741133075,2.9957446239299306
ALL-SIL,24901704,-0.1489296834412312,2.1942626407376324
MOLP-8,piperlongumine-MST-312 (1-1 mol-mol),0.7424689739493265,1.1899342833396847
KU-19-19,24772860,-1.0696999794461075,-1.9135292675772397
MOLP-8,9866186,-0.5209158528959533,0.3510187850093328
NCI-H1568,JQ-1-MK-0752 (1-1 mol-mol),3.5105249308751363,1.6084819950955365
HuP-T3,71304818,3.5647709327393287,2.6695929083503205
MOLM-13,11683005,2.7238157220539345,3.144455628861695
HEL,54618771,0.7283869495698151,-0.12243587897110304
RKO,selumetinib-PLX-4032 (8-1 mol-mol),1.8013466074828854,3.989806948522735
WM115,selumetinib-PLX-4032 (8-1 mol-mol),-2.130332393585934,2.2192843206949946
NCI-H1568,25150857,2.4294918673251416,2.6027093356108217
RKN,6438330,1.1013294242613172,2.408093935978532
HCC15,644241,2.326085716096255,2.2437377964958403
LS180,2708,3.937371430907984,4.994067595275329
LS180,51037431,3.4786862718788747,3.2589951198130978
K-562,16741245,3.9224206604880583,3.6566976677271925
RERF-LC-MS,44185566,3.014427147988128,2.891578028860362
SW48,navitoclax-MST-312 (1-1 mol-mol),0.8806321220589545,1.0213853710618368
RKN,5566,3.4992110401170944,3.134979145651643
LS411N,navitoclax-piperlongumine (1-1 mol-mol),2.36008373550467,1.2581812813307978
MOLP-8,216345,2.155670358283386,2.701323838338039
HCC1500,BRD-A02303741-navitoclax (2-1 mol-mol),0.0071603230581946,1.5659984172277737
HARA [Human squamous cell lung carcinoma],alisertib-navitoclax (2-1 mol-mol),-2.092897901371494,0.7246828124149259
PaTu 8902,46224516,2.4477060426075723,2.596104951547106
RCC10RGB,241158,4.984223152954295,4.097227583488907
HCC15,11612883,1.9950389922708311,2.8765116081625184
HCC15,969516,3.14053560758236,2.9485739106178777
LS180,9866186,-0.1716689837079009,0.7493757052968651
Granta-519,decitabine-carboplatin (1-1 mol-mol),2.1725621434549582,-0.10260413388459547
RCC10RGB,24964624,2.93015987785669,2.689027810729516
MDST8,216345,3.5638732818875094,3.6245959931798915
RCC10RGB,10302451,3.839480938635774,3.213657873068163
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084,6.030557937328601
WM115,44491742,3.78432787650886,4.3384389133997505
SU-DHL-1,selumetinib-piperlongumine (8-1 mol-mol),2.378072265787347,2.412144913261024
KU-19-19,262093,2.7281718696395303,3.0753614927810173
ML-1 [Human thyroid carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),2.7869393467132344,3.0405797694168815
COR-L105,1242560,3.3237423881291233,3.7836310885461812
MDST8,16736978,0.980275670291684,2.0218208100950683
NCI-H1568,16722836,1.2045551605263336,1.8077353148877282
WM115,5282054,2.577591804396212,4.047630246082462
IGROV-1,25195348,3.0698662305180275,3.5309436262725957
PaTu 8902,148198,-2.774580136562139,-3.2548638608678404
HEL,26596,-1.8679385890512872,-2.590254659297463
Daudi,25126798,3.548189682848153,3.3517643348448813
PaTu 8902,selumetinib-piperlongumine (8-1 mol-mol),5.497989392681889,3.148476748513109
SaOS-2,decitabine-navitoclax (2-1 mol-mol),2.350842092351968,1.7005742459335067
PaTu 8988t,56946209,-4.946927234389905,-3.7483221075547424
SK-CO-1,2945648,3.4071568821077993,3.1165008692375475
SK-CO-1,JQ-1-navitoclax (2-1 mol-mol),0.4682346666935782,0.7543194897737944
BFTC-909,3136844,3.2427360302120403,4.426686701969123
IA-LM,71304818,3.3887828048220094,2.475492945405421
NCI-H2452,122327,4.606448802646307,4.86605614772674
LS180,12003241,-0.6460664270988897,-1.1931174671699978
SK-HEP-1,16741245,3.65273757252914,3.7416685775727045
RCC10RGB,6918638,2.235907203261483,0.8812975079364728
WM115,16065773,1.4979025411384967,2.4741213905567334
HARA [Human squamous cell lung carcinoma],9825149,2.481612932411,2.321902134572262
Daudi,54678924,0.8831010429483725,1.1245284242679057
MOLP-8,9903786,1.299688823902182,2.0237998593578337
ML-1 [Human thyroid carcinoma],24180719,3.042356764984187,3.6624378330584206
WM115,219104,4.514482202684108,3.9433260492413598
Daudi,25150857,0.8259987709661276,1.6446195453622743
KU-19-19,selumetinib-BRD-A02303741 (4-1 mol-mol),2.399823528664379,4.123241632783745
BICR 22,25262965,-4.220207088048826,-0.9604933372938496
BICR 22,25126798,3.759096897040898,3.6313628237431703
HCC15,11717001,5.339668805105819,3.9796301190713206
Panc 02.03,JQ-1-MK-0752 (1-1 mol-mol),2.226829891800918,1.8145091099522417
BICR 31,6918328,1.2499033439512497,0.184769917726331
COR-L95,25150857,1.208080540357677,2.2195564607851015
ALL-SIL,104842,-6.679847729141338,-4.611815122257447
ML-1 [Human thyroid carcinoma],6450551,2.5869852554462622,3.072254120441213
MOLP-8,crizotinib-PLX-4032 (2-1 mol-mol),0.0452912472141007,1.0508245924838033
IGROV-1,11612883,1.8715405446213529,3.0617075573064567
HEL,9926054,1.596813412273358,1.283356126810991
HCC15,11404337,-0.219975280966356,-0.08860720787621976
LS411N,168313047,3.2811764574410893,2.335870235997189
HuP-T3,168313200,4.289513738947004,2.983095430833135
RKO,216468,3.08027711257304,1.632412991869439
HCC15,5566,3.133848096057735,3.006818221149511
SaOS-2,2130404,2.752105467907615,3.5363461248833925
PaTu 8902,6623618,2.257974787323956,2.3427249961230494
Granta-519,45279963,2.8131243875516097,3.066619559768766
BICR 31,6918638,1.4401869695378149,0.5373698953289007
IGROV-1,2729026,2.3541792737160296,2.6737999786624673
SaOS-2,decitabine-carboplatin (1-1 mol-mol),4.9062736540715735,4.335808683250277
PaTu 8988t,126941,-4.347732149803542,-2.755312748134642
BICR 31,44607531,1.4420456412349776,1.4854896552355175
RKO,227681,3.9032876810461814,2.8711994194498924
Granta-519,5278396,3.331153353007608,2.9928462297614065
MOLM-13,11214940,0.2452206847669268,1.381508598948324
Granta-519,6914657,-5.464946920891912,-5.401026165553041
SW1271,72199292,4.741032264194907,0.3214650743001185
LCLC-97TM1,3676137,5.47833794075875,4.614130930074685
BICR 31,6505803,0.2507928346620714,-0.3923973660606472
NCI-H2452,9927531,4.529523169776047,4.8443280167237335
HEL,107970,2.2652057864285893,2.007434166338665
P31/FUJ,73707398,-0.9687174770786582,0.37495669710378793
SK-CO-1,3634881,3.2176217097393867,3.1797031017534834
ALL-SIL,71680916,4.0231197218666015,4.106528318658932
IA-LM,carboplatin-etoposide (40-17 mol-mol),4.857587432381165,2.8999056852311127
NCI-H2452,54678924,3.78052585603054,2.3675313072297657
HARA [Human squamous cell lung carcinoma],20959075,-3.3968163713216657,-2.8086532786100893
RKN,9840324,5.059199694090175,5.7673636272131015
LS411N,25195348,3.7393125277208608,3.347443227771631
ML-1 [Human thyroid carcinoma],171352865,2.7298814774275435,3.537858614964864
BICR 31,11497983,4.106423080888053,4.573618304057944
RKN,3825829,4.2934517576030276,3.896054622178909
Panc 02.03,104842,-1.6275579890051994,-2.564063122301113
SK-HEP-1,4378219,1.9889575503272792,2.5766563449737867
NCI-H1568,11609586,2.169671625299293,3.013048553812885
NCI-H2452,24772860,-2.067021978185303,-1.9095842765377646
HCC1500,2828334,6.090675120485649,6.1147490017249915
ML-1 [Human thyroid carcinoma],15983966,-5.2151360937473,-0.4269119890931192
HCC15,selumetinib-navitoclax (8-1 mol-mol),-1.9070047094364015,1.8568146412669022
ML-1 [Human thyroid carcinoma],5291,4.042812106600411,3.853332387001207
SK-CO-1,426756,3.753929508081783,4.282935185587163
SaOS-2,46215462,2.3169135098646483,1.9174470927815614
IGROV-1,216468,0.5330864756407336,3.1349551940066176
RERF-LC-MS,25262965,-1.1343637554659964,-1.5682698022203019
NCI-H1568,53392493,1.829675716879907,2.665710838065645
WM115,6438330,2.009543324889134,2.372327548671564
P31/FUJ,9908783,6.361014450142155,4.3333124892448405
HCC1500,5291,3.388112901698238,3.629098763910648
HCC1500,216345,2.2086555393223293,3.7874627002399506
SK-CO-1,16722836,1.1930735523198912,1.7943567595811423
MDST8,2858523,3.149165485885388,3.112795966889037
IA-LM,44486219,4.346993548383093,4.1830669656906005
P31/FUJ,10427712,4.089067276268696,3.7015159439560468
K-562,24771867,1.7261535062160185,-0.866222028137907
SW948,2742550,2.6149964231270166,3.430434439566028
COR-L95,2113511,4.880906118348224,5.293670872145485
BFTC-909,82146,3.493415453952883,3.7681179680986894
BICR 31,4261,2.904745052497421,2.0120155357147094
BFTC-909,119607,6.015893315993201,5.398089943406376
MDST8,JQ-1-MK-0752 (1-1 mol-mol),1.445543393100169,1.6460813663473548
Granta-519,262093,1.5974758737964725,1.4209071195362788
COR-L105,4521392,4.261553030698096,4.396328508384328
HuP-T3,52912189,2.4400429797195065,1.9238703401666686
HCC15,168313016,4.627209757330862,4.9717863477535875
MDST8,15983966,1.9809932367095728,-0.24786997971986607
Granta-519,9866186,-0.14818829969678,0.1286119650651562
SK-HEP-1,462382,1.018219313736715,0.7706588645843824
Daudi,7251185,0.6493905196982933,1.2966737446830066
HEL,3385,2.274300648457042,2.7047910307955174
NCI-H2452,44185566,2.4757676958398824,2.850514890851969
SW1573,9884685,-1.2788581073527363,1.0202728202631113
RKN,6505803,1.4092626649390017,-0.037433286615544216
COR-L105,selumetinib-piperlongumine (8-1 mol-mol),1.184006147072735,3.5368753118939753
RERF-LC-MS,11427553,2.91041132641442,2.966696544036887
SW948,107985,-3.1361927230844255,-3.5016601516288794
IGROV-1,24951314,0.9075718706849548,1.4791111393977519
IGROV-1,753704,6.461140333581179,5.010315971281263
LCLC-97TM1,54143018,-1.232378656007133,0.3468081145386672
SU-DHL-1,16038120,-4.191759239414132,0.3460598228319447
SK-HEP-1,65064,5.472205201006758,5.151206252213326
COR-L105,2733526,5.6711261994322,3.826580952286176
HuP-T3,56649450,4.499318873015619,3.3136704289338126
SW48,16741245,3.865069024996995,4.119700218430443
HCC15,89183176,3.7013914070621903,4.395183294767738
SU-DHL-1,135928012,2.7237506411412427,3.9804661187198476
HCC1500,24901704,3.772063812557438,3.2057128577915104
K-562,6505803,-1.797722788015983,-0.62113224146459
P31/FUJ,docetaxel-tanespimycin (2-1 mol-mol),-5.9377835284500895,-4.867768493470181
ALL-SIL,9936388,-6.364749169872344,-5.572091120710429
P31/FUJ,5284616,2.141886646431612,-0.22637313935069248
RKN,654092,-2.299209260296745,-0.09296154445908124
SW48,piperlongumine-MST-312 (1-1 mol-mol),1.3077982167208542,1.8231784464075724
Panc 02.03,462382,1.1832417961450334,0.7625717311380223
P31/FUJ,11609586,2.709581392176905,1.4286404645773283
COR-L105,322968,4.452130073523545,4.186892917394645
RKO,135398516,4.318914396092429,1.7824800451131606
Panc 02.03,44185566,3.1312758482446976,2.7866070824280302
NCI-H1568,72376,-1.5373297187690371,-1.6631169508086225
Daudi,11494412,-0.3802447608890573,0.6208607420019046
SW48,erlotinib-PLX-4032 (2-1 mol-mol),3.2399078814474924,2.979683092211042
SW1271,2126,5.27764055734565,4.674691773267673
RERF-LC-MS,10296883,4.230661493555322,4.0849525535253735
SK-CO-1,53232,1.9491581074450712,2.921294616889926
HCC1500,11222830,1.0956735100670385,1.6078641252922403
SK-CO-1,vorinostat-navitoclax (4-1 mol-mol),1.5116374119241311,1.1834212472609102
LCLC-97TM1,16219061,3.747043694071086,3.2433844011492297
HCC15,3543504,4.297283358198234,4.457651347477645
SW1271,6918837,-1.9255423784418917,-2.638793811976393
SaOS-2,53301938,5.583232766578932,3.677929625796768
UACC-812,9866186,1.6792636289805696,1.2486363652230257
RKO,5278396,3.510721289362286,3.1285490044482787
K-562,16722836,1.308803334400655,0.9067959809809537
HEL,selumetinib-tretinoin (2-1 mol-mol),7.234386750467808,2.1543724573283876
P31/FUJ,9935249,2.700947453739227,1.2353743613001005
IGROV-1,5351362,1.961059142684053,1.5230721694614586
IGROV-1,44819697,-0.8326420176056434,-0.30231545042468605
HCC1500,5746,0.8617369744590151,1.0339516907828417
BICR 31,15547703,3.2095649219178006,3.267569576791078
P31/FUJ,72193861,-0.3659416399435479,0.0033404401488806236
PaTu 8902,24964624,3.11499425545507,2.5430091900682568
BICR 31,vorinostat-navitoclax (4-1 mol-mol),1.4356739307232549,1.1833569589412252
SK-OV-3,24901704,3.989938255280614,3.3896377938646727
LCLC-97TM1,2113511,6.012866888022406,5.597424897103798
SaOS-2,3081361,3.085781742119062,2.193467563152613
IGROV-1,15983966,1.7101486625531308,-0.9508504724994747
MDST8,6852167,1.3374988720553735,2.7257791454607245
MOLM-13,67291369,-0.0488061328139809,0.7645042875944921
K-562,JQ-1-vorinostat (2-1 mol-mol),0.1257253367868581,-0.5237200486328291
MOLP-8,9926054,1.7939353525170396,1.597389430339296
SU-DHL-1,168312962,-2.257405592485961,1.2723097021321197
LCLC-97TM1,219104,3.650486733954163,3.637089187584392
HuP-T3,984333,1.5721860041126483,0.8401082981335893
Panc 02.03,4477,0.984097917718396,0.43978726763304654
Daudi,selumetinib-piperlongumine (8-1 mol-mol),2.587128104626929,2.278951057925598
IGROV-1,9929138,6.483056540257463,5.755071002980173
SaOS-2,11175137,1.9690729540796783,2.4991760931954348
LCLC-97TM1,9915743,-0.0836077976930932,0.6351228672272835
PaTu 8988t,9907093,4.39010034793255,4.3672373701344185
LS180,73707398,1.191690395470446,1.2579154874660012
ML-1 [Human thyroid carcinoma],25102847,2.935986325205898,2.832085507679223
Daudi,11960529,3.700971671461623,3.2356346692007976
RKO,4259181,-0.4049041326260317,-0.18596050949572984
MOLM-13,31703,-4.683228669920675,-2.591443371408094
SW1271,4477,0.3648589081307944,0.6076221023753956
HuP-T3,216239,2.9976543037230665,2.5493345382281887
HCC15,9903786,1.5576741113339283,2.9957662918477466
IA-LM,selumetinib-JQ-1 (4-1 mol-mol),2.5487957947561544,0.6628311255022826
Daudi,1239801,3.0112900662314717,2.980358545958942
PaTu 8988t,25126798,4.088623680113087,3.805886446904548
RKN,227681,3.7901732699912585,3.364064160623004
K-562,216468,1.7844503846326911,1.2329253921010417
NCI-H1568,11234052,4.07711650557102,4.306053904012304
RERF-LC-MS,17755052,1.8057357372617977,1.9889971946270217
HEL,135999136,1.6019096984193502,2.4204608599873527
HEL,9887053,3.0781159437380974,2.649219248109336
RKO,11625818,4.5581118700811105,3.393625380382214
HuP-T3,322968,2.6241189840020787,3.7797126563692824
BFTC-909,11317348,4.568727931072339,3.4136574081362334
SW48,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.5460315373913385,3.588055328618357
MDST8,1716436,1.1500764778734351,2.5735037790343434
ALL-SIL,16741245,1.8101156107911176,3.3100149093610525
Granta-519,16722836,1.0937584859115594,0.6745182580933172
PaTu 8902,10385095,2.391345219233966,1.4847990520603875
WM115,3038522,1.9104775831242309,2.9811148369398732
HCC15,decitabine-carboplatin (1-1 mol-mol),4.946381859305088,4.429547749865453
RKO,11497983,5.954072388877685,0.8838356713991561
BICR 31,46174525,4.37434163277974,4.5698776706113335
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356,1.672708809765638
PaTu 8902,73707398,2.5949502925816397,1.534143774721056
MOLP-8,1641662,3.485304007232308,2.927779021177332
HuP-T3,11640390,3.629059315953643,3.693688174053213
HARA [Human squamous cell lung carcinoma],53481919,4.643044937502802,4.0271660486262695
LS411N,49850262,4.021647044836445,2.8697227176907334
HARA [Human squamous cell lung carcinoma],9952709,3.695976506837269,3.294602239530443
SW1573,24951314,1.273840217876839,1.444032612576635
RKO,441298,2.3183923582018107,2.2232853407719957
COR-L95,5335621,4.389010810876702,4.210598254402333
MOLM-13,selumetinib-UNC0638 (4-1 mol-mol),2.1826018630699746,2.262987914197242
MOLM-13,24785538,0.0261170120397283,0.0758494348614092
Granta-519,374536,-1.3755413186728007,1.150829631022536
HuP-T3,9911830,2.533690069517969,2.778793479084265
HCC15,11640390,4.25082988279064,3.5568597345745037
Daudi,375860,-0.7416229308895455,-0.33493473818470526
BFTC-909,16722836,1.424017650466323,1.7540484795346873
BICR 31,selumetinib-JQ-1 (4-1 mol-mol),1.6620620003816966,1.4691980226132149
BICR 31,crizotinib-PLX-4032 (2-1 mol-mol),1.5274046089824267,2.075208128053565
LS411N,46398810,3.253541487295017,2.049155591608768
SW948,carboplatin-etoposide (40-17 mol-mol),4.008054530018911,2.661273321431281
HARA [Human squamous cell lung carcinoma],24748573,1.9169510591730587,2.3746674179767204
BICR 31,136227924,2.8140968842668923,2.942680441554197
SK-CO-1,24753719,4.51149350773187,4.377672253794485
LS411N,JQ-1-MK-0752 (1-1 mol-mol),1.615286960946078,1.1836661070141055
SW1271,57330099,4.656552081384507,4.259710799122263
ALL-SIL,60750,-4.149254188873004,-3.605177960209885
MDST8,42642645,1.1052716804296012,1.341769583318828
ALL-SIL,25062766,1.575972356073685,1.466589502105542
LCLC-97TM1,salermide-PLX-4032 (12-1 mol-mol),6.666218718302321,4.866968838106723
SW948,11455910,0.6774609071475187,0.9701792415921073
SK-CO-1,11485656,2.076616779710352,2.4179534678674233
P31/FUJ,387447,-5.269499156732966,-5.147315798539224
SaOS-2,54765302,6.138432086002101,4.022088407746871
KU-19-19,3384730,2.4463371108200995,3.0505217559438442
SW48,56946209,-4.8342224094221455,-4.212185079792902
RERF-LC-MS,71304818,2.1402027844306986,2.6195579523437282
SaOS-2,5351362,1.054118918695375,1.5351326177476223
SW1271,60700,-2.0966401571631805,-0.16483100495654626
SK-OV-3,12001922,2.3689117655248197,2.036633609149696
BICR 22,11222830,2.7513096778080293,1.8098388640112772
HEL,637858,1.821308587756956,0.8751812325445942
LS411N,11609586,3.7769222068832384,2.031858536382714
PaTu 8988t,crizotinib-PLX-4032 (2-1 mol-mol),2.4555083865109197,2.0783721096330803
SW1573,53392493,3.256582971351183,2.677521502573878
IGROV-1,71466380,4.863636874274779,4.474542635633177
SK-HEP-1,119607,5.888068080296772,5.479532960867004
K-562,5329102,1.5928854941533903,1.5012658708438666
RERF-LC-MS,24901704,2.6292316786888295,3.5078324797369955
RKO,54649381,4.449908747747005,3.4651970928098854
KU-19-19,6438330,3.038685724131264,2.049142713456271
RERF-LC-MS,6917907,-5.461995819879327,-4.816681382280577
Daudi,6852167,0.8630196090584432,1.4834208457635123
RKN,2708,5.19327789915259,4.991990948358184
SK-CO-1,51039095,2.6345691844177006,2.960887946451144
HEL,9935249,3.1121102066484827,1.3981082312304267
Daudi,6184667,1.7615544136572183,2.2135700854279947
ML-1 [Human thyroid carcinoma],24964624,3.117302997790913,2.8040834774491885
SK-HEP-1,selumetinib-vorinostat (8-1 mol-mol),2.40344777828312,2.4117145931402497
LCLC-97TM1,5978,-5.540378308178224,-1.8134232477819037
SaOS-2,135999136,4.306712196094447,3.709852967955093
IGROV-1,5311,1.0068816368200209,1.4883649963058938
PaTu 8902,10184653,3.3664490630517023,1.1644745603543176
IGROV-1,54678924,1.4704159748793169,2.257635956571808
HARA [Human squamous cell lung carcinoma],54613361,-1.6613115011598742,0.17307995842517498
IGROV-1,16720766,-0.0562020789376145,1.0716029857236449
RCC10RGB,31703,2.24368059098483,-0.3302571987558678
SW48,4261,1.3708847234833408,1.6019270080137782
LCLC-97TM1,navitoclax-gemcitabine (1-1 mol-mol),-2.1258188281402757,-0.8784649865333631
Granta-519,11494412,-1.422706675432074,0.3817911303302827
BFTC-909,10302451,3.622269240471498,3.112559940664637
HARA [Human squamous cell lung carcinoma],452548,-0.3270885928487969,0.32284606607033567
SU-DHL-1,11497983,5.985793176782232,3.174101042553742
HEL,44486219,4.241945120616936,3.65576459927798
HuP-T3,9926054,1.9266750805140576,1.9594511028678465
Granta-519,5281672,3.715092894597705,3.946938362121121
NCI-H2452,568763,0.2251625503779925,0.6423526710981872
Daudi,15547703,2.9729250708388815,2.5101464516558694
RERF-LC-MS,1566236,3.687566928717542,2.5605427902052544
SW48,3689413,2.066117060158584,0.29140964317144336
RKN,11396600,3.670395083293249,3.549517823693678
COR-L95,25227462,1.0954609187473372,-0.037258716546209276
P31/FUJ,11497983,-3.9754433923569295,-0.6299150450362556
COR-L105,11977753,-3.381629820862821,-1.060103214913224
SaOS-2,10302451,5.268852772808677,3.4982239297662234
WM115,25126798,4.207732195436686,3.890873052317404
HEL,6918736,-2.4872933380365483,-2.2141702850441134
ALL-SIL,vorinostat-carboplatin (1-1 mol-mol),1.2348853562201922,1.7168999279147414
MDST8,selumetinib-JQ-1 (4-1 mol-mol),-0.5732607032642526,1.4069922934114965
BICR 31,11626560,1.5769037831027732,2.117411315681723
SaOS-2,53481919,3.9662352208904,4.0202160284728
NCI-H2452,4378219,4.095695943124218,2.6903730916355393
RKO,135440466,3.093117295091816,2.0460108204311482
ALL-SIL,selumetinib-decitabine (4-1 mol-mol),-0.1840409792284095,-0.2975263522726184
IGROV-1,4521392,5.131794979216607,4.195859275452879
WM115,6610355,3.646348527159068,4.639070745128614
IA-LM,46199207,3.643614442277753,3.2338949709215417
RERF-LC-MS,navitoclax-MST-312 (1-1 mol-mol),2.0546989000241367,1.137690032527539
RERF-LC-MS,4259181,-1.273108977623296,0.5132668106129095
COR-L95,selumetinib-PLX-4032 (8-1 mol-mol),5.035796466628604,3.519350665609522
LCLC-97TM1,9866186,0.636434294421894,0.7775234632604328
LS180,selumetinib-BRD-A02303741 (4-1 mol-mol),2.497004756461055,3.4516082583545202
BICR 31,285033,-1.6333817403557132,-1.4259736496339641
SW1573,24821094,3.391149888356164,3.2905403921454495
RERF-LC-MS,984333,0.876742343627688,1.0924649119342487
SW1573,2828334,5.538488922798482,6.27670116926833
BFTC-909,11214940,1.666026285351028,1.7879539285002466
MOLM-13,SNX-2112-bortezomib (250-1 mol-mol),-3.9385993868290665,-2.780861047050674
ML-1 [Human thyroid carcinoma],55508,1.8303716396385248,3.8470586880363293
MOLM-13,16722836,-1.8349401857846608,0.7185168171952979
MOLP-8,135398516,0.6877200142840878,1.4582757099325807
NCI-H1568,56649450,2.3390116545362956,3.4442424148693878
COR-L105,5329102,2.9490674090485007,2.180070133929101
BICR 22,104842,-5.460039616101889,-2.3208262435310525
ALL-SIL,44507138,0.0905903694215729,1.4210768779222673
COR-L105,navitoclax-piperlongumine (1-1 mol-mol),1.1506089120324992,2.200978384713916
Daudi,252682,5.82526834825694,6.280040998667911
SK-CO-1,24785538,-2.301834394825824,1.795751777221566
HCC15,4788,6.208189927463216,5.631556743397573
HARA [Human squamous cell lung carcinoma],54686904,4.432396143260886,3.8724319857962426
SK-HEP-1,5282054,5.2464488654660935,4.118160293505218
K-562,2729026,2.90327889883348,2.4579197722957957
HEL,docetaxel-tanespimycin (2-1 mol-mol),-3.324993936619335,-5.002987395239014
IGROV-1,135398744,6.402844237905131,6.625605548328045
Panc 02.03,44819697,-0.6097657869730747,-0.106630194831588
COR-L95,6252,1.2572884944075156,-0.3288613630638213
HARA [Human squamous cell lung carcinoma],613000,1.7145271439199108,2.7694735172394744
HARA [Human squamous cell lung carcinoma],54143018,-1.1176720961651934,0.5226133576281202
RKO,135411,0.3039750611139232,0.12964446971624285
SW1271,5284616,3.4240840801047825,2.6806441595781756
Daudi,9803433,4.921870042846492,4.130880756961273
HuP-T3,1566236,2.433067651410228,2.346693174394485
NCI-H1568,11364421,1.3511041801335055,-0.7563056460638716
SaOS-2,54678924,2.353285364311993,2.1382915550048205
NCI-H1568,6438330,1.052967118553252,2.302277780375759
SaOS-2,56946209,-2.927880316628738,-3.4447582358636333
MDST8,71304818,3.102141708789901,2.497776597806442
MDST8,16722836,1.8236379945665244,1.7054083088812042
COR-L95,5460769,3.3963309413836815,2.6452312013112946
SW1573,5328940,2.8151731448483424,2.03249169709534
P31/FUJ,44486219,4.066329818545256,3.5810408544813765
SK-CO-1,44819697,-0.0659450585917303,0.006307588447307053
NCI-H1568,3689413,-2.0602171008804935,0.3239998293350749
SW48,4788,5.795432827385499,5.677056695075407
IGROV-1,11625818,2.877471533668122,4.483061927301121
HEL,5282054,3.8014373831294073,2.577473508919005
Granta-519,2858523,3.0573334835342725,2.780970170689027
Granta-519,2708,2.6467102550113357,3.2195350497722224
SaOS-2,10074640,3.1546787022314264,3.179781608273814
Granta-519,alisertib-navitoclax (2-1 mol-mol),-1.8552810437041576,-1.5626538313283307
NCI-H1568,462382,0.4864277786958156,0.7818226964446704
PaTu 8902,6450551,4.419968438595772,2.6559577307863225
NCI-H1568,89183176,4.755399227223714,4.550973333927804
SK-HEP-1,89183176,6.199387598364303,4.568963238144002
COR-L95,3689413,-1.01311028513846,-0.3677589195832802
SW48,322968,2.620984302451229,3.7344454619100644
NCI-H1568,2113511,4.994259934049027,5.5441285109624
RERF-LC-MS,10074640,3.277461458690314,3.2338152769145023
P31/FUJ,11485656,1.9746673234827223,1.581199784791209
NCI-H2452,24978538,1.4440845227299357,1.582846312663116
SW948,46398810,1.81837356763434,2.219532320197143
SW948,navitoclax-pluripotin (1-1 mol-mol),-1.6002032912556945,-0.8566698984262269
SW48,5280436,3.9386259808510737,3.6050789479930336
NCI-H1568,16013152,3.794215458313736,4.146806064105545
K-562,JQ-1-navitoclax (2-1 mol-mol),0.4672607120603991,0.27435719165843186
SaOS-2,72193861,0.3662001709486771,1.4455274067533586
SW1271,6623618,2.240401111492455,2.281593649999127
BICR 31,11964036,0.7129684858082154,1.3170453918854894
MOLM-13,71466445,2.28410988708537,2.0841139017334065
SW1271,5280436,5.166796757102748,3.716183088159852
Daudi,crizotinib-PLX-4032 (2-1 mol-mol),0.8611087114550048,1.0993282564521072
SK-HEP-1,5470400,0.5577708849126581,0.17653024446307924
SW1271,73707398,1.637161284255629,1.2817941084446876
Panc 02.03,24771867,4.320948526904658,3.271396737055669
K-562,11494412,-0.907204058397288,0.6294760445621579
HuP-T3,4477,0.7500067469313434,0.6320317980675473
WM115,44489675,3.6522428576041888,4.099017867449386
IGROV-1,10074640,3.2681490579824426,3.155200994027916
LCLC-97TM1,387447,-4.752686001320434,-3.9566735837431475
NCI-H2452,136227331,4.192235498443636,3.972614980583209
BICR 22,44566777,0.9464577594296588,0.7657030445005135
Daudi,44462760,2.2846011846998184,2.4526191020198658
HuP-T3,11222830,1.7699584455080513,1.5351410359941815
BFTC-909,10184653,1.6906150005550105,1.6146371360334424
COR-L105,navitoclax-sorafenib (1-1 mol-mol),1.5234919165461795,1.907312880730733
SK-CO-1,5460769,-0.7722931098274061,3.1530635387822974
IGROV-1,9884685,-0.088911709267569,0.8377935348219152
SW948,10074640,3.6458957710098927,3.1769299058537057
RCC10RGB,2729026,3.187414345119047,2.8873264894789044
SU-DHL-1,25105715,2.6102250612439857,3.3211793018306435
SaOS-2,2708,4.307882235107384,4.838485236285851
SW48,11485656,-1.6768123952056315,2.268317402250638
LS411N,5738263,3.6843208102291127,2.9687829210410115
LCLC-97TM1,89928392,0.9843618500255806,1.3451557321121936
IGROV-1,5328940,0.347812751869877,1.8569330540365891
BFTC-909,carboplatin-UNC0638 (2-1 mol-mol),3.28125381181505,3.306688522711962
MOLP-8,6184667,3.7618917164892296,2.1778044354298243
HEL,9907093,4.271492923268933,3.515561971429751
SU-DHL-1,409805,5.150132871505728,4.43082371723725
IGROV-1,5287620,-1.5394168430569777,-1.5773345963411503
HCC15,6184667,2.403880665872793,3.431405360963635
ML-1 [Human thyroid carcinoma],119607,6.010030667993389,5.3803819122988195
BFTC-909,11152667,-0.3524603871752078,-0.17908090110877103
BICR 22,10427712,4.255154443676342,4.120646923735731
RCC10RGB,73707398,3.9170227295506304,1.562028527807048
SK-HEP-1,4788,5.857315027837397,5.801842963708728
SaOS-2,11167602,3.026359974607451,2.766519838162008
IGROV-1,3825829,4.144093606877803,4.050375676881746
Daudi,53232,2.2893399383043116,2.4405728803282143
HARA [Human squamous cell lung carcinoma],2828334,6.6956020196427115,6.104752467298185
LS180,5470400,-3.6342626980574657,-1.447590237909433
NCI-H1568,322968,3.6220797151302673,3.828394107985464
SU-DHL-1,25150857,1.7165355924738273,2.2945292433051128
NCI-H2452,9926054,2.7849990975548726,2.0926186737684622
RKO,5280436,4.655813696583822,2.8720278281329596
Panc 02.03,25126798,4.246913180768056,3.964910244061425
BICR 22,5460769,-1.4539525700949456,2.698695501715397
RERF-LC-MS,4521392,4.229663793191115,4.329039501983147
COR-L95,65628,4.016533332946612,3.6964398871418003
ML-1 [Human thyroid carcinoma],72199292,2.652505906746634,0.4087848490804263
BFTC-909,11507802,1.7199271215311116,1.8333484519170802
HCC15,16115403,-5.315255617661217,-4.1722841991695425
Panc 02.03,24797083,1.7288458125332262,1.49964417526696
Granta-519,16065773,1.8580334509866892,2.0582704993076657
MOLP-8,67291369,0.6739245689833524,0.973105919983834
LCLC-97TM1,71304818,2.70820846116735,2.3658752733354276
COR-L105,10113978,3.5062120769458907,3.1713320918593713
IA-LM,selumetinib-GDC-0941 (4-1 mol-mol),3.6293192218894017,1.744048180805837
ALL-SIL,5460769,0.8731159867521163,1.6208861684672622
MOLM-13,89928392,-0.0278317389216686,0.3710280371491031
ALL-SIL,selumetinib-PLX-4032 (8-1 mol-mol),4.528203505983491,3.2547781811433856
SaOS-2,6852167,2.181246544986129,2.698913070074688
SK-CO-1,135999136,4.853872243910513,4.272646300869922
LCLC-97TM1,5329102,1.5800226001590805,1.8198425226411614
RCC10RGB,3825829,4.92777419243283,4.250847086284583
WM115,16722836,2.5522609953991577,1.7599194702092964
KU-19-19,6610355,5.477302473020379,4.441520618886899
HCC15,5311281,-0.1593612251340344,2.4642783244291424
WM115,11656518,-0.7680829336702796,1.6970535132186202
IGROV-1,675434,4.336225379212549,4.610988885656843
BICR 31,322968,4.229982613329669,4.20750227879972
LCLC-97TM1,serdemetan-SCH-529074 (1-1 mol-mol),1.7773916595129422,1.8022169675447848
MOLM-13,409805,3.504188648592109,3.587327713300165
NCI-H2452,68056272,5.088176766324353,3.795376538616752
HuP-T3,JQ-1-vorinostat (2-1 mol-mol),0.3185506624165122,1.1869425247523053
RERF-LC-MS,25102847,0.6953191965745218,2.644289119424761
SU-DHL-1,5278396,2.36959409949266,3.3604238949488563
HCC1500,9935249,2.2800833668468266,3.1363509199958544
HEL,46907787,-1.2802643066913908,-0.809839187247249
Daudi,64971,1.9256728094608813,1.7941002108298036
KU-19-19,168313047,3.3084179069540696,2.348224589650652
HCC1500,9903786,4.21203406645071,3.1411876823271867
BFTC-909,3689413,0.9841636034152118,-0.016665083301619796
MDST8,9911830,3.786562744766562,2.540476910723915
WM115,262093,2.5199436905866905,2.9193167301312837
IGROV-1,5311281,3.3250623444804206,2.5509606637575413
ALL-SIL,4261,-0.4593745111072439,0.3993555442177631
ML-1 [Human thyroid carcinoma],25183872,1.7816002858265556,-0.3370714289152052
NCI-H1568,25105715,3.512540774448481,3.536545665082227
COR-L95,12001922,1.5177554079359803,1.928663575452799
Granta-519,25154868,5.041568583050757,3.9843779905986207
MOLP-8,navitoclax-piperlongumine (1-1 mol-mol),0.7236562214911971,0.5799634421000431
SK-HEP-1,3503,1.99172511033101,2.391671124487503
BICR 22,2749,1.4483580801045477,2.4725876120260026
SU-DHL-1,10231331,2.149159497852676,1.2806970886134967
SU-DHL-1,132496,3.861580575323874,3.1521148704658217
NCI-H1568,11955716,5.84501437277453,-1.3640325030931155
COR-L105,11647372,1.8386560750541856,1.2613345990742444
PaTu 8988t,702558,5.248840045640507,5.333318966317775
RKO,219104,3.7756995047121658,2.7388046681790614
RERF-LC-MS,119607,4.38818595494476,5.452477726065588
SK-OV-3,969516,2.624811361400939,2.9629440442143395
SU-DHL-1,67156097,-2.1897423830418155,-0.0035213959235419834
HARA [Human squamous cell lung carcinoma],25262965,-0.7160848382234604,-1.3225371766433671
MDST8,10296883,3.644541291105843,3.987631175936402
BICR 31,135411,1.1842135795155395,0.8866107894838323
NCI-H1568,17755052,1.5920713080731803,2.0929420275164063
K-562,selumetinib-JQ-1 (4-1 mol-mol),0.1487830644360653,-0.14351658726620284
Granta-519,3062316,1.222650334372554,0.012338805713403107
MOLM-13,11609586,0.2693262849825738,1.6063474679624594
MDST8,65628,4.39024768664476,4.489427668629076
LS411N,11222830,1.85641131377126,1.806821870313641
P31/FUJ,5278396,3.2564464707559786,3.0742162640704986
NCI-H2452,selumetinib-piperlongumine (8-1 mol-mol),3.871574708601934,3.5883875188397782
HCC1500,11228183,-3.1075364778620544,2.414136568862057
Panc 02.03,3503,2.8594786206641514,2.3091797148727164
MOLM-13,12001922,1.648284949914827,1.6671024060094854
Daudi,decitabine-navitoclax (2-1 mol-mol),0.1880854613737136,-0.9503656990372464
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179,-1.1015716082756046
KU-19-19,selumetinib-UNC0638 (4-1 mol-mol),2.3716952230277313,3.4494353435981715
RCC10RGB,135875424,5.859031260595621,4.155322117597971
LS180,44491742,4.531352051294965,4.171424046616825
Daudi,salermide-PLX-4032 (12-1 mol-mol),4.83725960729828,4.650089537296748
SW948,5460769,-0.6640669541383749,2.993848367966005
BFTC-909,9866186,1.150003196853964,1.032445269593031
KU-19-19,docetaxel-tanespimycin (2-1 mol-mol),1.4200175787881737,-2.7583339743326674
Daudi,322968,1.8489038189519929,2.248308901421626
LS180,135999136,4.321194581518088,4.09994066158735
MOLP-8,4259181,0.2540996075245788,-0.23766622528403236
SaOS-2,UNC0638-navitoclax (1-1 mol-mol),2.2506963685809676,1.4041444187997474
BICR 31,17755052,0.616652074058669,1.7689824073605036
Daudi,10427712,3.475831712716563,3.757490805299458
ALL-SIL,6252,-2.462384672511242,-2.4236485507966155
IGROV-1,57330099,4.391385744785918,4.030676549023622
ML-1 [Human thyroid carcinoma],5311,0.3887425314777955,1.7911301748765047
LS411N,5746,2.615146419652584,1.1064102234251156
WM115,11625818,2.666283825244439,4.7639056882041935
SK-CO-1,17755052,1.6143754050867285,1.7748502064703178
BFTC-909,4788,5.986704833543041,5.825540357919368
BFTC-909,613000,3.1980696015333137,2.8092615629761157
RCC10RGB,9933475,1.608288384582936,2.0423033190030346
COR-L95,11964036,1.1862097811542611,0.9619998385456227
IGROV-1,12003241,-2.0122972114546904,-1.0946002226754457
ML-1 [Human thyroid carcinoma],67156097,-0.9782117982072136,-0.24686464094778418
SK-CO-1,navitoclax-PLX-4032 (1-1 mol-mol),0.9904814430420492,1.716988330003252
LS411N,676352,3.0047981548436873,1.8932065289891427
NCI-H1568,6918638,-0.3782949656582497,0.635900090425142
HCC15,654092,-0.5163256778254894,-0.04423958360057195
MOLM-13,72193870,3.075841334601934,1.7400735929612667
ML-1 [Human thyroid carcinoma],24180125,2.9342502769836263,3.113824638828465
SK-HEP-1,1716436,3.791424957504218,2.915851670476972
IGROV-1,637858,1.814476597989254,2.0254701236303485
IA-LM,44137675,5.685431340913792,3.5835322413278488
RKO,49793307,-1.4433237106321422,-3.387770091651608
Panc 02.03,1750826,-0.0877771412327358,-0.9714197631507553
P31/FUJ,216239,3.114152508734425,1.8806873518324807
BICR 22,9911463,4.403388511465592,3.7988903882594336
LS180,3503,2.1233569957286673,2.383791679130947
NCI-H1568,135440466,1.9451121966001212,2.2008979858094944
LS180,6917907,-5.898955627831861,-5.316232397802607
NCI-H2452,3503,2.8949427881039367,2.5023475067968755
LCLC-97TM1,9952709,3.284131025623194,2.870375823460393
MOLM-13,168313047,1.872191765635252,1.943372060939602
RKN,65064,4.855719732775604,4.854577992999291
SK-CO-1,1716436,3.109025551437123,2.831118016703959
Panc 02.03,322968,4.613737356937267,4.073088532241409
SU-DHL-1,16115403,-5.307217729681928,-4.561779287188103
Daudi,5738263,2.220866513982768,2.373882326463208
SW48,10074640,2.891302128524984,3.121468771767023
SW48,3552672,5.820012420560967,3.0202575155088316
Daudi,568763,-0.9358982895655849,-0.0650914065315831
HCC1500,11234052,4.300499145525321,4.196530793977838
WM115,16741245,4.109793610684897,3.5391442484475544
SK-CO-1,6917907,-6.103253673111458,-5.092896545411618
SW48,100016,6.031440310304127,6.101006318328301
SW948,12003241,-1.7903806895013192,-0.5157660032105702
SK-HEP-1,9840324,5.848573782723059,5.807224746716701
ALL-SIL,5328940,-0.9694628184696558,0.9755484719445298
BICR 22,2858523,3.373464702278958,3.0924005495880618
NCI-H2452,17755052,2.4746667711045514,2.0556265283373403
HEL,tanespimycin-gemcitabine (1-1 mol-mol),-4.465092392275179,-2.748862195723858
P31/FUJ,654092,-2.277731190350674,-0.998263596945882
HCC15,selumetinib-BRD-A02303741 (4-1 mol-mol),4.266961603535723,4.283678472743583
BICR 22,16736978,1.4452527998079976,1.9841549673692216
HARA [Human squamous cell lung carcinoma],107985,-4.031127583701494,-3.5363817814601752
RKN,SNX-2112-bortezomib (250-1 mol-mol),-0.3229299326159797,-1.3888874429021043
ALL-SIL,9843750,4.4328493438561845,2.8025131072589056
IGROV-1,168313047,1.93821625738322,2.3975859362385954
Panc 02.03,selumetinib-navitoclax (8-1 mol-mol),2.257139592520967,1.8743561243091054
RCC10RGB,24797083,3.688734393817597,1.8516820449358038
IGROV-1,67291369,1.8066430555976296,2.689770400632035
SK-HEP-1,135875424,4.97106166770821,3.8934004495825354
SK-OV-3,676352,2.4999853996447423,2.1570642124915254
IGROV-1,3689413,-0.3633634632064185,0.20390496186348567
MOLM-13,2126,3.944929409626795,3.618491813229174
SW1271,25150857,2.216244024484901,2.4897852220373693
P31/FUJ,piperlongumine-MST-312 (1-1 mol-mol),1.5235846843184453,1.3761998389346564
Granta-519,3689413,-2.6080640580656977,-1.5756589059882318
UACC-812,11955716,-3.4049141440551765,-0.9450431877311702
WM115,6918638,1.2765614986990457,0.6293177906487298
MOLM-13,119182,-3.013346002661584,-2.7387951438787645
HuP-T3,25150857,2.779922499061356,2.4924240319615976
RKN,400769,-0.3685197718994141,-0.5495081431487998
RCC10RGB,navitoclax-birinapant (1-1 mol-mol),2.5525116990099015,1.1182344780042097
COR-L95,9927531,5.207677506691081,4.381458505578142
RKO,439501,-1.8401322759847645,-2.2697140974690027
COR-L105,135875424,4.584511127602178,4.167930281266573
MDST8,67156097,-2.036194319435593,0.10062739709164109
SK-CO-1,11640390,3.1287755311468715,3.363677819804114
NCI-H2452,9915743,1.4140850498548845,1.4751153518416789
COR-L95,54626689,4.626807564914302,4.354380959808953
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887,1.0577269723381093
SW48,15983966,-4.810478602921179,-0.767339376374805
RERF-LC-MS,53495165,1.4938275665549956,0.7133759734004981
SW1573,10026128,4.237670104162456,3.4576040367120884
BICR 22,5328940,1.2238467278980267,1.6487971501786842
IGROV-1,25150857,3.031865110078871,2.484582988938136
SW48,54649381,3.6753624817280706,3.8452987565844747
RKN,11485656,2.343665915939472,2.3954257519458957
IGROV-1,216239,2.21703825410177,2.4082261550866075
ALL-SIL,selumetinib-JQ-1 (4-1 mol-mol),0.7996490760807272,-0.3361664523310701
SaOS-2,675434,4.709862103920263,4.64587666891168
WM115,439501,-0.2667789802830004,-1.6969385722800532
RKO,11152667,-2.010180339323448,-1.3214478239340897
BICR 22,702558,5.841545864846151,5.071160981983414
SW948,navitoclax-piperlongumine (1-1 mol-mol),1.2480624926894286,1.115960509319642
IGROV-1,52912189,2.3966568144845666,2.13162294633244
SU-DHL-1,219104,2.7039031158758395,3.295983028955722
SW1271,19582717,5.373754052547774,4.373854923311311
IGROV-1,119182,0.2112476135388779,-0.4383159745697547
SW1573,25150857,3.3863948467965717,2.6016611756463406
LCLC-97TM1,1566236,1.804143498427706,2.069441131071329
SW48,6252,-1.782590172996294,1.0235004993373609
MOLP-8,168313200,3.062868142984741,2.593199311647091
SU-DHL-6,969516,2.321858620209541,2.1871361643424745
K-562,44632017,0.5936262556123562,1.1747169140004863
BFTC-909,56973724,3.22598802973391,3.15782472591553
NCI-H1568,24180125,3.319632294157453,2.920865050319082
HCC15,JQ-1-vorinostat (2-1 mol-mol),0.768732947542672,1.3484802372230584
RKO,15547703,3.988071110220001,2.636142259808599
COR-L105,446155,1.2274898824574871,2.831042797889446
WM115,25062766,1.993857010637035,1.9728978128172725
HCC15,42642645,-0.8684016042996798,1.138281004181336
IGROV-1,3136844,5.214591389089975,4.549405959703979
COR-L95,16659841,4.2643844802603725,3.346616726256691
NCI-H1568,107985,-3.6136890416333665,-3.2203312520342378
HEL,9967941,3.646907071964301,3.1578786096241087
NCI-H1568,5311,0.289477139532769,1.610158339669199
HCC1500,24964624,2.92457410282952,2.588447435819987
LCLC-97TM1,44185566,1.2712415312804253,2.294090335717546
HARA [Human squamous cell lung carcinoma],4259181,-0.0825087225465529,0.16388198336313534
RKO,135421197,1.472175761257966,1.428210652369543
BICR 22,UNC0638-navitoclax (1-1 mol-mol),4.356226198213725,1.5321389750179852
WM115,vorinostat-carboplatin (1-1 mol-mol),3.7982137973374104,3.4648835505241093
K-562,docetaxel-tanespimycin (2-1 mol-mol),-6.155798984221324,-4.320190458504981
P31/FUJ,119607,5.165578068786105,4.449999084856591
SW1271,44507138,3.04083255973368,2.5946929789456705
MOLP-8,72734382,2.92105223846654,3.3474583792685326
COR-L95,selumetinib-tretinoin (2-1 mol-mol),5.25273224867287,2.9546011562214347
RKN,12001922,2.582060834791438,1.9728811309945988
MOLM-13,3025986,-2.268401268397509,-1.7527996659284057
ML-1 [Human thyroid carcinoma],54613361,1.1529799235720395,0.29546957462266465
HARA [Human squamous cell lung carcinoma],65064,5.174523602274789,5.066629043732875
BICR 22,387447,-3.632542993789297,-3.1302525503242373
SU-DHL-1,navitoclax-pluripotin (1-1 mol-mol),0.447892144567538,-1.9288326750935958
BFTC-909,selumetinib-vorinostat (8-1 mol-mol),1.99531584260594,2.675024526260133
MDST8,44819697,0.5968481057166135,0.011690554332663946
COR-L95,54613361,1.8571878459944453,-0.2692633353338378
PaTu 8988t,25183872,-1.065851307698322,-0.7558214874550917
HCC1500,969516,2.5012208253247374,2.886430278932295
LS411N,51039095,3.380080993968732,2.7730606024967033
IA-LM,10385095,1.8174613436578264,1.2500420702476436
Daudi,JQ-1-vorinostat (2-1 mol-mol),-1.994208072819334,-0.48656348315862874
MOLP-8,44589607,1.928632926439859,1.8284258196392011
UACC-812,JQ-1-UNC0638 (2-1 mol-mol),0.7883661966359787,1.6270356327255049
SK-HEP-1,5311,2.3418360503567386,1.726050813260448
NCI-H2452,24889392,3.037712354939189,4.590640078132353
SU-DHL-1,4378219,1.8683369375684944,2.1488861146437666
NCI-H2452,2858523,2.6943426896823284,3.1070012003439142
ML-1 [Human thyroid carcinoma],decitabine-carboplatin (1-1 mol-mol),4.481069697343496,4.622407591413894
IA-LM,119607,5.918153428689206,4.688981747242064
ML-1 [Human thyroid carcinoma],11214940,1.6315509593699482,1.94122101238891
COR-L105,46224516,3.053099263199949,2.7122614849954005
SW948,3062316,3.151526592835161,1.445357159684332
BICR 22,6610216,4.672862717569176,4.117619801014925
SW948,16736978,1.371465793072688,1.4545270735367515
IGROV-1,2828334,6.070696247039626,6.169976079333005
RCC10RGB,44185566,3.1564704709707856,2.7909850158311595
Granta-519,135999136,4.28714374371566,2.3826851642391227
BFTC-909,654092,0.6323398211983356,-0.13525597832795877
SW48,selumetinib-PLX-4032 (8-1 mol-mol),-2.238777477327049,3.159290485051564
P31/FUJ,17755052,1.7010190253681206,1.0319020095372362
SU-DHL-1,2945648,2.120687124348465,2.7783471405951405
LCLC-97TM1,16720766,-2.0806199642234704,0.549709794018034
HCC15,3025944,3.8616867083103648,4.298240006071382
LCLC-97TM1,53392493,1.9813066602409652,2.3937205700592084
WM115,selumetinib-piperlongumine (8-1 mol-mol),-2.154986024806584,2.688933297831389
COR-L95,675434,4.0325297307826125,4.44083644139888
SaOS-2,11213558,1.0641156085827448,1.6805729291881113
Daudi,JQ-1-carboplatin (1-1 mol-mol),-0.7509851402821236,-0.08573569115643602
KU-19-19,1716436,3.531012736022478,3.042042132031308
SU-DHL-1,11485656,1.6397040363022437,2.0362000485699774
SK-CO-1,16736978,2.1510378918389415,1.6139422683062958
SW1573,selumetinib-JQ-1 (4-1 mol-mol),1.6562897469951037,2.0611047474703628
HCC1500,136227924,2.675203690625814,2.9319363988360942
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557,0.7172988321314179
RKN,BRD-A02303741-carboplatin (1-1 mol-mol),5.528038962892509,4.186116886291286
PaTu 8902,selumetinib-PLX-4032 (8-1 mol-mol),5.82901614817581,3.293579440157137
Daudi,219104,1.6178665476553538,2.316909869746441
WM115,5284373,2.6004259651165644,2.8959866937803485
SU-DHL-6,216345,3.116690602340157,2.9935261252719245
HuP-T3,5460769,4.291069487745317,2.8736794280762927
HARA [Human squamous cell lung carcinoma],54619238,4.4726064543510144,4.857968192935869
Daudi,8515,3.193004700442435,3.215597360438279
HCC15,3815108,3.1337581441750277,3.0461661070788506
IGROV-1,5280436,3.2616766817665086,3.555995529565654
COR-L95,107970,2.0048060228155333,2.2223161626291716
BICR 31,25150857,2.3687059872087217,2.7826650533916983
IA-LM,6918837,-2.975709639111599,-3.007212034398588
WM115,3025986,-1.3268545497049868,-0.41693646238718673
WM115,BRD-A02303741-navitoclax (2-1 mol-mol),3.3998938295257632,2.577585183229001
SW48,17759555,2.861947497664063,3.3938467537743304
SK-CO-1,selumetinib-vorinostat (8-1 mol-mol),-0.8201042282991368,1.6154012029553482
SW1271,9956119,4.3828310926576375,3.6643794548530315
ML-1 [Human thyroid carcinoma],piperlongumine-MST-312 (1-1 mol-mol),2.022291985496103,2.123716488447175
MDST8,24772860,-2.900176299695688,-1.6543643109049893
SaOS-2,4259181,-0.1317601722396107,0.2164388410411802
PaTu 8988t,5746,3.0775825889142543,1.4649548001732895
SaOS-2,4521392,4.5837419847316845,4.411844051565384
SaOS-2,445455,5.662681927298568,4.811610973166878
IGROV-1,148198,-2.659972993252853,-3.3696251873092127
SK-CO-1,11404337,-0.5084033800481932,-0.36532599500657964
Granta-519,4578,4.680400709321271,3.891649863388688
RKO,4261,2.924548439505643,0.9020541874627722
MOLP-8,54618164,3.908946135671936,3.626426074568016
HCC15,24978538,-1.0517559532383662,1.6403659005161941
COR-L105,2945648,3.0602962908492386,2.979660620202168
RCC10RGB,salermide-PLX-4032 (12-1 mol-mol),5.5053951487435775,5.00784375536418
NCI-H2452,4705,3.641149380662554,3.4014289285634347
SK-CO-1,54143018,-0.6826828748975821,0.7446374931642952
MDST8,26596,-1.25574590011264,-0.39122121003121907
NCI-H2452,54454,2.511734775409603,2.5724407642177005
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487,1.6601583538166027
RERF-LC-MS,16038120,1.5599846769821624,1.175011122225894
SK-OV-3,44185566,3.1295797630764266,2.7112505791276145
BICR 31,148124,2.7085675831815292,-1.2981596308078633
P31/FUJ,439501,-2.3575947617146475,-2.5769805185926056
BICR 22,11152667,-1.8276171650012312,-0.44599287292280515
COR-L95,56973724,4.268430703602559,2.5364762799559655
RERF-LC-MS,54626689,4.221264321270605,4.649503738306175
IGROV-1,1641662,3.5854177848263675,3.5455669220713215
MOLM-13,613753,2.871004682812888,2.988360639202059
IGROV-1,11404337,-0.7659238947812715,-0.14249168559967487
SW48,219104,2.280685064057957,3.8080050780069414
Panc 02.03,crizotinib-PLX-4032 (2-1 mol-mol),2.31663341207245,1.976587498035837
Granta-519,9935249,0.0212855082517002,1.2715885630996109
MOLM-13,2749,0.3899767988765278,0.8451153137751553
WM115,1750826,-0.9273267035114736,-1.1868999597652392
SK-OV-3,2858523,3.2787147644650716,3.1764224514404584
COR-L95,selumetinib-GDC-0941 (4-1 mol-mol),2.521789990361809,1.4607630193299277
ML-1 [Human thyroid carcinoma],969516,2.8184901812435923,3.1050075283406344
SW948,25183872,-1.604238480901096,-0.7749611521791858
HARA [Human squamous cell lung carcinoma],decitabine-navitoclax (2-1 mol-mol),1.7884131125603568,2.1982647740024173
IGROV-1,6914657,-4.141311308759326,-4.096062004156778
SW1573,salermide-PLX-4032 (12-1 mol-mol),4.9189296859442315,5.135193610395245
HCC15,6610216,4.23435184261858,4.300601856904466
NCI-H1568,10074640,3.1711026687004855,3.285737949831455
SW48,4917,2.351047632498956,3.0130841001804862
MOLP-8,46215462,1.266580776259001,1.3318553209651685
WM115,erlotinib-PLX-4032 (2-1 mol-mol),0.1999561238865428,2.6435194326033
COR-L105,387447,-4.5302496546864885,-4.111658953888323
MOLP-8,44462760,3.111101001788515,2.657714035756626
BICR 31,44819697,0.4590360698509347,-0.13561666515250062
HuP-T3,9956119,4.370077084995815,3.5913965498866753
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585,0.5852035977635663
KU-19-19,66577038,3.864819378735941,3.0153820273909546
BICR 22,5746,-1.0393569299451335,1.3254545022131428
HARA [Human squamous cell lung carcinoma],6438330,2.871193568039211,2.263142256150994
SW48,67156097,-2.150931452918296,-0.24846722215474962
SaOS-2,25150857,2.491525195617086,2.3748500504455223
NCI-H1568,613753,3.056586098825006,3.2805913751878317
LS180,44137675,2.850653785387247,3.631313227338056
RKN,11364421,-3.590581417405073,-2.327874135521339
HuP-T3,23582824,1.5911146583975455,0.9068460187397437
SW48,446155,2.2181780639059907,2.9290418773468274
SU-DHL-1,44202524,0.8334918459072751,1.774425090318511
RERF-LC-MS,11404337,1.609147033115388,-0.06928060876115447
K-562,44486219,4.057183894108205,4.067077942423433
PaTu 8902,serdemetan-SCH-529074 (1-1 mol-mol),2.396607903766339,2.176522829118138
PaTu 8988t,46199207,3.796589685342678,3.2262064714871217
LS180,11964036,0.9251272605785624,1.2254683998559788
SW948,8515,3.759025323790885,3.706739983183545
SaOS-2,374536,3.743747938767685,2.324754395277774
SW948,135875424,4.663257041681152,3.4031904970706948
SK-HEP-1,72376,-0.6035227354554765,-1.5216139990322939
SK-CO-1,1242560,3.64748499205759,3.758891257909304
SW48,selumetinib-vorinostat (8-1 mol-mol),-2.7312432821532724,2.3308081133873393
MOLP-8,3025986,-4.599162344151263,-1.7134565093139347
SW48,25150857,2.2099211562472125,2.327686293798827
ML-1 [Human thyroid carcinoma],10127622,2.646237824428173,4.244856457942389
LCLC-97TM1,3465537,1.1142431298706064,2.512360232356137
NCI-H1568,9887053,3.9549233487650666,4.079573719238591
SW48,5746,-2.6538895977275745,0.9523891379190621
LS180,44484440,3.4848015178596343,3.2806654682511027
Daudi,25183872,-3.2629659020313393,-2.0849978889076057
IGROV-1,984333,0.6618578113050116,0.4678212342190562
COR-L95,135999136,4.28146486500778,3.4499778634203886
RERF-LC-MS,4788,5.0822281264538365,5.831143240371023
HuP-T3,2828334,6.159425491986346,6.134795859775866
RKN,3854666,2.132003481112045,2.057166924222465
HARA [Human squamous cell lung carcinoma],676352,2.7556636695973515,2.183495748596303
PaTu 8902,54639665,4.483683562011812,3.2179613302997887
ALL-SIL,24180125,1.6553840753953686,2.2984891973977195
SK-CO-1,12003241,-0.9578793579943758,-0.7680816745874718
BFTC-909,104842,-1.584917163766509,-2.497676893422885
HARA [Human squamous cell lung carcinoma],60750,0.0702005032300629,-2.124534956540761
MOLP-8,24772860,-3.493237790177901,-2.9088123961663013
SK-OV-3,49836020,-5.2191550029019025,2.2788677139320144
K-562,46199207,1.8646546122938352,2.787124148333074
SaOS-2,BRD9876-MK-1775 (4-1 mol-mol),1.220945840769529,0.6745295768819163
MOLM-13,6450551,0.4092106163446157,1.299005819310622
BICR 31,1566236,4.637821170940002,2.7192971840399935
SW1271,54454,2.1914366041236204,2.4857277689317505
HCC1500,selumetinib-PLX-4032 (8-1 mol-mol),4.771751115117369,3.2655316185852827
SaOS-2,9952709,3.1448975558697545,3.167546585082763
HuP-T3,54618771,0.8132197250487964,1.3190635715714984
IGROV-1,6918736,-0.950858733923241,-1.6475765773128348
ML-1 [Human thyroid carcinoma],654092,0.5372247724983673,-0.07430748089481748
Granta-519,53392493,1.7904738197895116,1.7296062028754597
NCI-H2452,445643,4.078319116283011,3.9759889427162447
HuP-T3,5281321,0.1098786391841839,-0.8722838786640655
NCI-H2452,654092,0.1220899319284023,-0.1799149868137912
ML-1 [Human thyroid carcinoma],135423438,1.332992654992983,2.6110235120702363
MOLM-13,56973724,0.5307136138302019,1.4335060817143357
BICR 31,439501,-2.4499261286992007,-1.981104618797662
MOLP-8,44495899,4.403173191891281,2.312421011768316
Daudi,44632017,0.5148090574579154,0.9131231300991722
SaOS-2,selumetinib-JQ-1 (4-1 mol-mol),2.075892545487755,1.858537048337723
SU-DHL-1,10077130,2.6641926349973875,2.1203509148491313
SaOS-2,9549297,2.000544043325996,2.864264709158272
LCLC-97TM1,24785538,-0.7280489014481334,1.3216905335382196
HuP-T3,10302451,3.3244038223924868,2.773564009496186
Panc 02.03,73707398,1.687012904299387,1.560335438516091
SW948,25161177,4.032512886861284,3.8312854156129243
COR-L105,17755052,1.2153053156846572,1.9697402236632786
HCC1500,11719255,2.4435237001116685,3.1947810166485824
RERF-LC-MS,5287620,-3.2415128958876123,-2.07521292872766
WM115,72193861,3.0084505907765795,1.8381310826057216
K-562,2113511,5.3605896450220785,4.972457256258397
RERF-LC-MS,24772860,-2.3078196081029136,-1.852943518032386
SK-CO-1,navitoclax-gemcitabine (1-1 mol-mol),-3.3609230620799595,-0.37353982144392406
HCC15,piperlongumine-MST-312 (1-1 mol-mol),2.732022929511258,2.010705010666238
MOLP-8,15547703,2.3372930335131663,2.496511491637939
LS180,4378219,2.066313424484697,2.4733113376086373
SW1271,168313047,1.8206519834924395,2.318939111197659
RKO,123631,2.6120370559458155,2.0070987900213044
NCI-H2452,3011155,5.255477653901917,4.430236298483589
Daudi,16722836,0.8830828668869325,0.7580042944377545
PaTu 8988t,6505803,-0.6279165545759258,-0.4876486768009664
SW1573,5280436,3.0542460563059253,3.5660094677533056
MOLM-13,262093,0.9014616367149992,1.6587572333142788
IGROV-1,BRD-K55473186,4.387806234483854,4.089121377783784
SU-DHL-1,selumetinib-MK-2206 (8-1 mol-mol),2.1944562589821226,1.8561766128763244
SW948,5287969,-2.4513180825948515,-1.7631560838270581
P31/FUJ,54619267,3.5260071244925575,3.5901633324823035
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202,1.7274415316865523
SW1271,11396600,3.626770708484224,3.676272031324812
IA-LM,676352,2.5463710414635696,2.153719256406403
SW48,148198,-2.7635683141359277,-3.4976999961104642
K-562,6918328,-1.3297822316036851,-0.646497613136439
HARA [Human squamous cell lung carcinoma],25105715,3.4880191589222966,3.548094411655755
Daudi,135423438,1.6157885595086947,1.5066098222867366
Daudi,6438330,0.2626238759101729,0.9009055227438951
Daudi,44543605,5.193449926403497,3.5189312585822377
SaOS-2,71751553,4.337892909522829,4.647594960822145
MOLP-8,23939,4.352572888875192,3.551931392055897
SW48,2858523,2.8468158768410965,2.9545710457962455
SK-HEP-1,selumetinib-piperlongumine (8-1 mol-mol),4.719630045140052,3.3217227515929992
COR-L105,9911463,4.222864246171191,4.012972097832909
SW1271,11167602,2.369450835450289,2.7525560172830255
SW48,135928012,3.696922095661256,4.169031728741921
Granta-519,53232,4.0944047749373915,2.3243634884846975
COR-L95,2871966,-0.8178907803151099,0.16249548448156492
MOLM-13,17759555,3.648246486561575,3.1280701768662595
COR-L95,tretinoin-navitoclax (4-1 mol-mol),0.626714074175952,1.4924589225002438
SK-OV-3,44589607,4.1377534493712265,3.1135479122402048
RERF-LC-MS,44543605,4.169252612552019,3.865257819948776
Granta-519,49836020,3.8229564713378057,2.8798604319807093
SW948,5278396,3.777624651516773,3.154870469835667
HCC15,400769,-0.8695567043490428,-0.289918392174437
ALL-SIL,3038522,2.34327176020718,2.3539125240599557
SW948,135440466,1.4177296224023617,2.0902730102154443
PaTu 8902,400769,0.6580342998730634,-0.4779083674530017
IGROV-1,5746,1.9055212643377857,1.1872801492735932
COR-L95,25195348,4.044301101066811,2.9487483304312643
BICR 22,24180125,3.296229177015365,2.9471086337896795
SW1271,carboplatin-UNC0638 (2-1 mol-mol),2.98870654666586,3.472889622559369
RKO,73707398,0.9128481241529548,0.610370174981226
BICR 22,selumetinib-vorinostat (8-1 mol-mol),2.1163342168700936,2.245268780517695
HCC1500,decitabine-navitoclax (2-1 mol-mol),-0.2719438923490784,1.071845945002114
IGROV-1,15953870,2.712793598656007,3.703804828106351
WM115,71466445,4.303064097958205,4.2591568310888395
COR-L105,9956119,4.279642090153805,3.7074126615823517
BICR 22,168312962,0.5954564951508424,1.2619482896223946
SK-OV-3,navitoclax-piperlongumine (1-1 mol-mol),3.1171344026711147,1.7585254756374011
LCLC-97TM1,46843906,2.6060669508648675,2.327125723540653
HCC15,9840324,6.2076616503129,5.814186009126278
RKN,24964624,2.2448388370498704,2.564264632401726
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907,2.0858823025117106
K-562,10410894,3.650757753763785,2.8479743352662283
SW48,124202324,1.4616392816877528,2.3413467956747183
IA-LM,15547703,3.104636726250569,3.0206013195854196
SU-DHL-1,decitabine-navitoclax (2-1 mol-mol),1.6803027957585963,0.5251742203366596
ML-1 [Human thyroid carcinoma],15547703,3.133536230544004,3.478878982566099
MDST8,49850262,3.692937134795778,3.939162920167104
UACC-812,52947716,-6.767186414102593,-1.4796003734105088
ML-1 [Human thyroid carcinoma],9911830,3.383108057822615,2.880453912191715
HEL,11427553,2.263048189869726,1.3227962328451408
IGROV-1,5281321,-1.4962463697398798,-1.292575032624836
IGROV-1,135421197,1.96820638017286,1.7559993558303173
LCLC-97TM1,104842,-3.469971777740615,-2.4782963137792864
RCC10RGB,374536,3.743226525407361,2.6277596513600785
COR-L95,107985,-2.989419812710682,-3.368325690194475
RCC10RGB,72199289,4.762339751475906,3.559346197697134
NCI-H1568,11485656,1.8106242285910237,2.2753827639573307
MOLP-8,9549297,1.4376511571672042,1.8792191693293037
Daudi,24951314,0.2263717121921743,0.2602417936525153
BFTC-909,7326481,3.4905195575106527,3.089960286933833
BFTC-909,6623618,2.802037410677928,2.344631386774461
HuP-T3,5287620,-3.5836939395445913,-2.0290332778696323
COR-L95,568763,-0.4949329271490838,0.21446750699785933
SaOS-2,216239,3.028726771334262,2.5471905646534716
RKN,navitoclax-piperlongumine (1-1 mol-mol),2.28018118974292,1.8813051195697579
Daudi,5311281,1.0302556341787754,1.9211874079313298
LS411N,3503,3.033347172376105,2.3334498218996127
BICR 22,4705,3.4365696424802477,2.6999942187235035
Granta-519,6918638,-1.0102021398050984,-0.8980597409353228
HARA [Human squamous cell lung carcinoma],11175137,1.814800704414418,2.7247998033214746
SW48,54618164,3.7830586534540616,3.930775546386855
MOLM-13,25105715,3.5182090361281326,3.01761406291532
Daudi,11175137,1.084300991963852,1.6820263099896036
SW1573,42642645,1.1024283721976142,1.0398868528605794
P31/FUJ,11364421,-5.080526011220062,-4.291883529905291
MOLP-8,12003241,-1.4499361325619826,-1.5777063430950584
Granta-519,10410894,1.4137063553430784,2.6782707232153093
RCC10RGB,57519531,5.003664553369681,3.1195953091858994
HEL,11625818,4.404342627749774,3.6105574465279373
SK-HEP-1,1242560,3.752923936287399,3.61026020551107
SW48,3062316,-0.5038339303633423,1.2417486375171713
HEL,219104,3.0071408108258253,2.417923979079587
SK-CO-1,3025944,4.807689572392986,4.132480952391145
SK-OV-3,52912189,0.2062426244094619,2.469098079712146
COR-L105,51039095,3.4251018662752073,3.120206965776575
HEL,65064,3.1933308972510113,3.9115172429301395
Daudi,9929138,3.458684768924583,4.857214284058724
SK-OV-3,11404337,1.4011927232423718,0.10272377019612022
ML-1 [Human thyroid carcinoma],7326481,3.5221044039257037,3.1519114477249617
MDST8,11178236,-3.494725666780331,-3.181548733758656
HCC1500,ISOX-bortezomib (250-1 mol-mol),0.4566996929358766,0.6124784523371086
WM115,119182,-0.4924283039006125,-0.685772989457689
COR-L95,56649450,4.0191520211736895,2.5893653605894644
HCC15,5278396,3.283293724206623,3.5930858174065956
LS180,54143018,-0.5111931850291043,0.45487651943566526
MOLM-13,10427712,3.427914513597021,3.7267326568072825
NCI-H2452,1566236,3.5735792412039022,2.4138026654625278
ALL-SIL,452548,-3.3771532504793194,-3.4006799459278683
KU-19-19,409805,5.730069773001202,5.035063311343244
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407,0.947843939549972
HARA [Human squamous cell lung carcinoma],17759555,3.7036804092868847,3.686882053910007
SW948,11955716,-2.1355637415890323,-1.8974142327165047
RERF-LC-MS,11609586,3.546222239883878,3.0205757080678963
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045,3.4887543229761286
WM115,5311,1.988201906885666,1.5891279007364256
HCC1500,5311,1.250436307916732,1.4586057642282055
KU-19-19,5282054,4.451216911386669,4.032358858144896
PaTu 8902,4788,6.453607861068675,5.738816049279212
PaTu 8902,4261,2.3507697687761224,1.5506905589107072
SW48,68056272,2.992212540747962,3.750117029491976
HCC1500,56963564,1.3630245510511625,0.6388618506056731
Panc 02.03,25183872,-0.079390979301081,-0.7530116951461266
LS411N,11964036,1.3999141622104765,0.4684138260005921
BFTC-909,135440466,2.535274686795805,2.1961967605340256
SW48,selumetinib-UNC0638 (4-1 mol-mol),-2.2763178570350857,2.9995537326278394
ML-1 [Human thyroid carcinoma],54619267,4.278122085164484,4.2108892398762485
LS180,25183872,-0.6080839156226316,-0.26993648686170924
PaTu 8902,71304818,2.9919229428361263,2.610509730850431
BICR 22,216345,4.525930969601246,3.9805029083900005
NCI-H1568,374536,1.2941902477204823,2.588380604121832
LCLC-97TM1,135423438,1.8911988038183152,2.075417491246935
NCI-H1568,56963564,0.2273202395709376,0.5555991259792684
K-562,9927531,3.3022164605184763,4.359361566545744
SW948,2858523,3.1308292618704905,3.0225349346303507
COR-L95,ISOX-bortezomib (250-1 mol-mol),0.3297770164947888,0.2532252217920395
SK-OV-3,5287620,-0.5544150043477152,-1.9127142975296891
ML-1 [Human thyroid carcinoma],3676137,5.53606210778591,4.678814379808424
NCI-H1568,5311037,3.1621369524545155,3.922594988385015
WM115,15953870,3.7155207356015207,3.7308623943433172
Daudi,445643,2.8458589584694307,3.610269732393135
BICR 22,navitoclax-piperlongumine (1-1 mol-mol),2.368049525679639,1.7474429861255734
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164,-0.022084834422752962
NCI-H2452,156414,1.7996451609117237,1.7398772436816943
Daudi,53301938,4.372641532954565,0.062439967949183245
PaTu 8902,9907093,4.385383441203628,4.309170170073849
SW48,136227924,1.7122170056378203,2.971864920358476
P31/FUJ,4096211,0.7441609883240002,0.9161070898522674
IGROV-1,6610355,3.969940996770339,4.604026066884013
PaTu 8902,4917,3.0649190232675525,3.1314505739139453
IGROV-1,613753,3.483244781428779,3.3478026862097967
SU-DHL-1,3136844,3.883215489826005,4.009659064227317
HEL,446155,2.11086977892158,1.802738363523349
HuP-T3,46907787,1.2763139172323097,2.18008602937836
ALL-SIL,2729026,2.163276094007301,2.1900345729566966
NCI-H2452,54613361,3.2620625907056744,0.19863720880543626
BICR 22,448949,3.2035793217055124,2.040740857801117
SW948,5280436,1.724516723779293,3.190954910711846
BICR 31,25154868,5.458998944130281,4.7095789814443485
LCLC-97TM1,44632017,0.6758650901814578,1.2706850625017456
PaTu 8988t,docetaxel-tanespimycin (2-1 mol-mol),-5.646992799561264,-3.3293607005269634
SK-HEP-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.819431075997551,3.641358841529454
HARA [Human squamous cell lung carcinoma],4261,3.400371454492322,1.6862220649150772
HARA [Human squamous cell lung carcinoma],salermide-PLX-4032 (12-1 mol-mol),5.233652502193764,4.820112623446238
ML-1 [Human thyroid carcinoma],9866186,0.3108629746931657,1.0823346290692757
SW948,409805,5.995103866916248,4.0842912957716715
P31/FUJ,16736978,2.2012912480094444,0.7504439999098338
SK-CO-1,crizotinib-PLX-4032 (2-1 mol-mol),1.4696043946454187,1.9172259571885328
PaTu 8902,19582717,4.67665303596855,4.301153541936863
SaOS-2,24775005,3.5680490412807555,3.630079559878485
Granta-519,327653,2.833903719231272,2.5666524074078394
ALL-SIL,446155,2.369103686447931,1.8543261723901814
HCC1500,445643,3.796669497386567,3.9250835483668087
COR-L95,7326481,3.0640813007839105,2.8997320311424875
Granta-519,selumetinib-navitoclax (8-1 mol-mol),0.4649117531552323,0.3125350695713195
LS180,53232,2.536426383073758,2.9454244157590073
P31/FUJ,10127622,1.4388313131004449,3.1149919759092963
HARA [Human squamous cell lung carcinoma],vorinostat-carboplatin (1-1 mol-mol),4.151404263307493,3.432529929803509
WM115,alisertib-navitoclax (2-1 mol-mol),1.935725956121268,0.7679940297943709
SaOS-2,11214940,4.2656495802712735,1.7907771845018434
RKO,637858,2.400395947377078,1.211588708974532
NCI-H2452,3552672,4.527548939486843,2.8921723224659
Daudi,168312962,0.2834059413422853,0.4931125964153182
P31/FUJ,216468,2.1049028903625673,0.9079380498933968
MOLP-8,11656518,1.844531268869525,1.1014234416595576
MOLP-8,5426,4.334733303826167,2.234878772581438
SW48,54454,2.31662951125423,2.8792737503309285
K-562,4521392,4.220123235241678,3.916237388550351
SU-DHL-1,selumetinib-PLX-4032 (8-1 mol-mol),2.801448892460394,2.7567492927064787
RKO,1641662,3.3091455873155367,3.0338784761886957
BICR 31,135875424,5.0736941678127945,4.164832972576348
SW1573,BRD-K27188169-navitoclax (2-1 mol-mol),1.518643472033959,2.452164437651612
Daudi,44607530,0.9746569917988196,1.4349619754645146
SK-HEP-1,25150857,3.0587845310763297,2.6098818045112444
COR-L105,tanespimycin-gemcitabine (1-1 mol-mol),0.318019061549867,-0.60091214798846
Granta-519,23635314,-4.977140911540282,-2.588616327693738
LCLC-97TM1,24753719,4.6973214087473405,3.9499388531729993
P31/FUJ,11640390,3.1324724534083277,2.523212042292375
HCC15,navitoclax-MST-312 (1-1 mol-mol),-0.227842438558318,1.2076718298562483
K-562,6450551,-0.0734681627771844,1.5545761226410422
Daudi,56946209,-7.191237665956405,-4.582830008423333
Panc 02.03,25154868,5.464083731960118,4.545393629190253
P31/FUJ,5311,0.3390662723443479,0.32292837216147374
SaOS-2,11485656,2.155652122560971,2.512915722213922
IGROV-1,3025944,3.9702787396819503,4.172273741167721
COR-L95,docetaxel-tanespimycin (2-1 mol-mol),-3.340788273550256,-3.4285809293365457
PaTu 8988t,11494412,2.1257430484232525,1.8143959192772399
IGROV-1,53495165,1.3981720287668329,0.7395224239416884
LCLC-97TM1,42642645,0.0997949580151915,0.7007013875289715
HCC1500,36314,3.7134374865247017,-0.368249396536915
NCI-H2452,3815108,3.5712952235347455,3.03247656256444
WM115,11214940,3.8761690772861126,1.7226514562071042
SW48,676352,1.4830170410483523,2.1443089568157383
MOLM-13,25262965,-3.0495150612642465,-2.072641650037139
ALL-SIL,tanespimycin-gemcitabine (1-1 mol-mol),-4.457360880270642,-2.6608430517518786
Panc 02.03,148198,-4.053337817942692,-3.1468982953152005
SW1573,71466380,3.629171273590213,4.624536737809948
SU-DHL-1,151289,-1.0536473601541108,0.7682793813498993
SK-OV-3,JQ-1-vorinostat (2-1 mol-mol),1.4863340037373012,1.1490871207862883
COR-L105,285033,-1.0049053408998423,-1.3015502509268158
SU-DHL-1,SNX-2112-bortezomib (250-1 mol-mol),-2.738100295775396,-2.6590445921216794
Daudi,135440466,1.490781603812653,1.9133448811049911
NCI-H2452,6918878,3.5446658281374277,3.3217352994941534
PaTu 8902,123631,3.453096327622384,2.435313907098058
COR-L95,15547703,3.222652754514603,2.9591141791702937
NCI-H1568,123631,1.2596294102093508,2.280154427330981
P31/FUJ,216345,2.9363986514954203,2.835044578409187
HEL,4261,0.4865008011530605,0.5110753366212337
SK-HEP-1,5280436,-0.1709015599208282,3.682227343613879
SaOS-2,25062766,1.5016836694759386,1.9196486308156082
RERF-LC-MS,51037431,2.0455212647735364,3.2639604946172374
HCC15,11656518,2.9308462534519024,2.206213646789358
RKO,10127622,3.209405126939437,3.36408529063397
COR-L105,9927531,5.197941564874311,5.011648188280219
NCI-H2452,6623618,2.534886377212576,2.650013606831048
SK-HEP-1,16725315,5.326615386804391,4.269524863905874
SW1271,11152667,-1.5987482479879582,-0.2949751100532284
PaTu 8902,selumetinib-GDC-0941 (4-1 mol-mol),3.4038309056959424,1.4798030814734917
SU-DHL-6,3825829,3.5283611337160155,3.3083992483614297
RCC10RGB,11656518,3.9855029209510215,2.2600891042180926
SaOS-2,67156097,-1.585481519484996,-0.9220799711524333
BFTC-909,5566,2.8568699448622263,3.1670143742258854
SW948,4788,6.033471365822279,5.798546022148864
LCLC-97TM1,1750826,-2.0890062190589544,-1.3992224179560342
MDST8,3689413,-1.6812703512916511,-0.2604426866754163
SW48,9926054,0.5681768331785455,1.971391901764471
MOLP-8,selumetinib-JQ-1 (4-1 mol-mol),-0.4981022967817401,-0.2918548365811533
SU-DHL-1,262093,1.7952973078733698,2.1995372164014277
BFTC-909,439501,-2.4866456286351095,-1.9627901897808726
HCC15,123631,2.7523193051058974,2.509259994139936
P31/FUJ,60750,-3.4241008025920396,-3.464651116850995
Daudi,9927531,3.2507934675389447,3.9443372683335314
MOLM-13,5281672,4.456656164404507,4.146778535909436
IGROV-1,11222830,1.5703285223102077,1.6840690809101444
SK-CO-1,5311,2.0479844637297617,1.540365413537908
COR-L105,15953870,3.0827686267342957,3.681451500697601
PaTu 8988t,9866186,1.4965239773376473,0.9095015770867653
IGROV-1,124202324,2.2563058955522157,2.2596011761485273
PaTu 8988t,9936388,-7.900053622036252,-0.8545297863360204
HCC1500,11152667,3.4439033763408644,0.31761139336717686
MDST8,54618305,4.422279328619345,4.465210628709241
MOLM-13,3825829,3.189823245525434,3.286942308599949
BICR 22,3081361,1.798482521796042,1.9025877866321783
SW1271,3854666,4.252835819462087,2.1492293976989965
HuP-T3,285033,-3.1273004056463916,-1.5377186394225903
COR-L105,navitoclax-birinapant (1-1 mol-mol),1.1502985438361142,2.2999499578134364
SK-OV-3,6610216,4.5015440272840275,4.3685993907626655
ML-1 [Human thyroid carcinoma],56946209,-4.214217670545523,-3.4678960403444727
SU-DHL-1,10090485,4.45721233802345,3.5684879046811875
COR-L105,54765302,4.547071050564395,4.299188033935126
SaOS-2,44491742,4.263847553999534,4.4447118459621
RCC10RGB,BRD-K55473186,4.42890698658841,4.236216089220697
SW1271,2742550,3.530952260660614,4.097387175912738
Daudi,148198,-7.679285276133229,-4.262284150767412
RKN,104842,-2.3241286690000265,-2.91825910118602
SK-CO-1,3689413,1.2567954519757167,0.5945529067228352
Panc 02.03,24180719,3.694319415808187,3.740162265213155
MDST8,637858,1.7716899628344815,2.153644967582236
BICR 22,11404337,-1.5250786338229352,-0.03711036107982352
NCI-H1568,82146,4.486561599154294,3.9537067054268493
LCLC-97TM1,52912189,1.3140510236946998,1.6330648306167737
BFTC-909,6918328,0.6354681535452512,0.12078174378701599
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907,2.0858823025117106
SW48,10385095,0.7767009249070084,1.2902838639706813
RKO,56649450,4.8662264096692684,2.920432516877045
SW948,45279963,3.8052773477912782,3.289836689482396
RCC10RGB,3038522,2.595581097335362,3.4253629543054274
BICR 31,3689413,0.760898743899782,0.37001053102263043
RERF-LC-MS,5282054,4.065617468844444,4.0434827722386295
K-562,selumetinib-PLX-4032 (8-1 mol-mol),4.219594820991848,3.6177719401857775
K-562,25161177,2.405708421255354,3.7140706890698265
ALL-SIL,11497983,-4.396279985993102,-0.5819302054303993
SW1271,446155,1.3369653200346725,2.6574890900122345
HARA [Human squamous cell lung carcinoma],568763,1.3363257274557196,0.5060120896418863
Daudi,10296883,2.545577320776033,3.1592023236353453
COR-L105,52912189,0.1952406080619365,2.303112365006024
RERF-LC-MS,36314,3.6884025033565897,-1.278646443252006
SU-DHL-1,25062766,2.372674975426994,1.8818706423494103
BICR 22,126941,-2.054722221433598,-1.7774001350745567
P31/FUJ,46398810,1.6622931867453647,1.759088375802867
K-562,15953870,3.5143251027161613,3.091808174463838
MOLP-8,89183176,2.6780353354925706,2.806641271127548
MOLM-13,9967941,3.903949930542719,3.0897798963754086
ML-1 [Human thyroid carcinoma],57519531,1.467564757525082,2.634000849827607
SW1271,5291,3.239071539524422,3.740570891395954
K-562,56963564,-0.0263606087054764,-0.20815854774270603
LCLC-97TM1,54613361,-0.0023609252607709,-0.0369094935148514
Granta-519,24771867,-1.6352261980607803,-1.5172322161109955
RERF-LC-MS,5287969,-2.0564845219287555,-1.7520421730750624
SW48,alisertib-navitoclax (2-1 mol-mol),-4.705705243079418,0.616929707773211
IGROV-1,168312962,3.022863957843741,2.126383507735494
SaOS-2,6505803,-1.001039194104569,-0.4254001951762879
Panc 02.03,5460769,1.6540560754425335,2.8887205496315005
RCC10RGB,vorinostat-navitoclax (4-1 mol-mol),1.2015093799520282,1.4465085133984215
ML-1 [Human thyroid carcinoma],11175137,2.0792526924223735,2.657812493623432
Granta-519,crizotinib-PLX-4032 (2-1 mol-mol),0.3086247100875356,0.9126286666710491
HCC15,135440466,1.473766152733558,2.380279003200493
Panc 02.03,448949,3.46549633046868,2.2723332987829856
SW48,119182,-2.1563748503052103,-0.8010811746946735
SK-OV-3,36462,2.5052417836250496,2.4774895977945306
LS411N,46199207,3.2917214979820506,3.208191309219819
Daudi,71466380,2.956949879575845,3.9862600348727657
RCC10RGB,44566777,1.0790521939265936,0.8708752848458761
P31/FUJ,446155,2.867326521256313,2.128087291699528
SW948,navitoclax-PLX-4032 (1-1 mol-mol),3.63435849770784,1.5363637802082968
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736,0.5940378759571702
BICR 31,71576739,4.400142576070014,3.9403785928055464
SW1573,6623618,2.3278245092002936,2.4287770646469555
ALL-SIL,969516,2.19071597716798,2.063586536895604
COR-L105,241158,4.618729119434587,4.094716223080481
Daudi,24797083,-0.0937737057199073,0.7122664491452825
HEL,5566,2.9283259495001133,2.9326689659246084
BICR 22,44137675,4.05989667865121,3.466272732685174
Granta-519,3503,1.8528122642218805,1.6102352204719228
WM115,5287969,-2.3112325385791093,-1.6173801627734858
NCI-H2452,3062316,-0.5574526988915461,1.4128764549439685
PaTu 8988t,12003241,-0.7673639150441187,-1.208673034144396
SK-CO-1,44589607,2.7511810771029213,2.942542576258861
RKN,23939,4.640348748177221,3.92687234644857
IGROV-1,72734382,4.633226130326536,4.4635038414151635
BICR 22,46215462,1.5294433170369757,2.13285194065121
MOLM-13,2949965,3.7040534246432624,2.089943556396501
HCC1500,46215462,1.5254849350202837,1.8648346716130337
K-562,25183872,-1.1768480549542706,-1.3084692437569683
HARA [Human squamous cell lung carcinoma],5470400,2.3733756266777037,-0.3661580065528638
IGROV-1,3081361,0.99973562532788,2.3027074237930676
NCI-H1568,9908783,4.863315848037401,5.262693681911173
HEL,vorinostat-carboplatin (1-1 mol-mol),1.771793472925216,1.6976037315659238
SW48,25195348,3.355247289110599,3.2328629790760086
HCC1500,135411,2.801194317933856,1.0040477707997992
BFTC-909,10410894,3.671861694905457,3.424051154523018
COR-L105,2708,5.5167338716905885,4.9699226844195525
SW1271,9927531,4.558020454092029,4.741447826477668
NCI-H1568,44462760,4.02669785413772,3.886641395211206
COR-L95,11612883,2.9601999054336106,2.3936427702282623
KU-19-19,selumetinib-tretinoin (2-1 mol-mol),2.7257099010203047,3.6232866313026353
SaOS-2,46199207,3.779046434903352,3.2117754329145862
MDST8,15547703,1.8320295844693912,3.3648447723161237
SK-HEP-1,23725625,4.972795252846745,5.162288123833705
HuP-T3,JQ-1-MK-0752 (1-1 mol-mol),1.9324342474715044,1.4895515608193313
SaOS-2,doxorubicin-navitoclax (2-1 mol-mol),-1.9339656168793864,-1.3953103092848724
HCC1500,24797083,1.1358144177435396,1.380469269331683
MOLM-13,11647372,-0.8512376057901615,0.4095766639805271
Daudi,navitoclax-sorafenib (1-1 mol-mol),1.4462190868370148,0.29849439532234484
K-562,5335621,4.97915810125604,4.065385803348706
COR-L95,2858523,3.028185885315027,2.8849882870366135
HCC1500,9911463,3.4774936591741703,3.9393654553491064
RKO,452548,0.942587279069954,-1.5608127481843201
MOLP-8,126941,4.086011311839599,-2.4582220921628974
P31/FUJ,3384730,-0.5934712638177775,1.4377320195088341
LCLC-97TM1,16725315,3.732120983026874,4.3791273735073295
HuP-T3,60700,1.2793809884126126,-0.24072944589935846
SaOS-2,9956119,4.053594307296879,3.535503080743876
HEL,alisertib-navitoclax (2-1 mol-mol),-1.6663288612486489,-1.2759399818981143
SK-CO-1,46199207,2.9466484543003197,3.3217492690407067
SK-OV-3,11175137,3.182781765506491,2.762028055650802
LS180,11222830,1.8684195070218452,1.6261429044094962
SW1573,selumetinib-MK-2206 (8-1 mol-mol),4.390623431255029,2.498045928026375
K-562,23582824,1.4169931108164455,0.8174774390560124
COR-L95,3025986,-1.3264557881304966,-0.9261998231973217
NCI-H2452,16065773,1.9140766169124153,2.7148271728805877
MOLM-13,54454,1.7928295036604598,2.3341375735038543
LS180,119607,5.442141379439383,5.164965798383139
Granta-519,644241,4.377614733152813,0.9770375851556556
IGROV-1,46199207,3.293579955374855,3.277379879604108
IGROV-1,3038522,3.6829378423722416,3.067426668202332
HuP-T3,135875424,4.261865095251217,4.1552044523604295
IGROV-1,89928392,1.4824233552493276,1.4294661646462787
KU-19-19,5280436,3.7375704611092657,3.618791610839703
SW1573,54678924,1.9184875438403524,2.6069380577975836
K-562,selumetinib-MK-2206 (8-1 mol-mol),2.367030654184624,1.7159590759034518
SK-HEP-1,11364421,3.0648019303900624,-1.95969517281625
P31/FUJ,11507802,-0.4015560413947272,0.7767165096003924
MDST8,selumetinib-PLX-4032 (8-1 mol-mol),6.148002129111475,2.465144210475217
NCI-H1568,89928392,1.1949851991515912,1.7877329794384849
WM115,11222830,1.2308018153574234,1.7171446739306284
SU-DHL-6,9908783,5.938767725153886,4.004649639679283
HCC1500,25150857,1.1801270031504156,2.610755861833535
ML-1 [Human thyroid carcinoma],9915743,-0.6180546405493912,1.483728769892833
NCI-H1568,4521392,3.7910777113602303,4.203746647220027
COR-L95,25183872,0.0728708482253017,-0.9942862237809755
IGROV-1,227681,3.5439813498262347,3.3366371887172748
PaTu 8902,6918878,3.691618711508776,3.032343630218079
K-562,1242560,3.4884556471232293,3.0274295806306304
BICR 31,53495165,2.344314514368125,0.5248056410168936
BFTC-909,tretinoin-navitoclax (4-1 mol-mol),5.193173988671874,3.2200695045710406
BICR 22,17755052,1.4011116930942769,1.761433631356934
Daudi,17755052,0.1512024273398794,0.8552516766342322
HEL,67156097,-1.6398778776875675,-1.828142900564933
BICR 31,44486219,4.3544536670303025,4.244443120621228
SU-DHL-1,119182,-1.9070320733957784,-0.6285690672880445
WM115,135440466,3.0586385090162085,2.280511076479689
IGROV-1,11152667,-1.4116509977729443,-0.31935735731425263
BICR 31,10385095,1.3759128494100044,1.4497944206568305
RKO,969516,2.537841036798478,2.3295345082695547
Granta-519,123631,2.886011281362197,1.9550407116188353
HEL,4477,0.140225607998234,0.3763863469972062
HCC15,568763,0.562622735167329,0.6661299165266996
HCC1500,9926054,1.7367797854287812,2.101838245289254
HCC15,vorinostat-navitoclax (4-1 mol-mol),-0.4329287763165494,1.4220189072044622
SW948,444795,4.960330673315111,3.6751842526628
SW948,119607,5.410714093672246,4.63124229408463
RERF-LC-MS,9936388,-8.273067767637817,-0.4946447903435572
SW1271,alisertib-navitoclax (2-1 mol-mol),1.9083065334137317,0.6295365628487543
KU-19-19,4261,0.7367611445661113,1.8453209543719062
SU-DHL-6,387447,-5.553627026103078,-4.667939597949047
SK-HEP-1,3825829,4.395950359013269,4.1938046893061
COR-L95,9903786,3.7357721387912513,2.7627654315564185
SK-HEP-1,44185566,3.236949395761265,2.796007726934354
COR-L95,73707398,1.0347493154641954,0.7851685941775056
SW1271,66577038,2.7134536861777807,3.0372641345289213
RERF-LC-MS,36462,1.1230283698314445,2.3763003015716793
LS180,5278396,3.460947025625347,3.4498422675640597
Daudi,3062316,-6.775500959037878,0.5700508817344941
K-562,107970,1.9304513771469212,2.056707876059741
HCC1500,3854666,1.4433352503078565,1.9569419360992335
LCLC-97TM1,JQ-1-navitoclax (2-1 mol-mol),0.3092105032557149,0.7535703618004088
HCC1500,11455910,0.2448151005088887,1.2580317247785984
MOLP-8,46907787,-2.434163875600539,-0.8854115565081225
LS180,crizotinib-PLX-4032 (2-1 mol-mol),2.1034358212812867,1.93066506324005
RERF-LC-MS,53392493,1.949934555719578,2.9865928130087163
MDST8,6610216,4.3863838734153,4.378037985715667
COR-L105,navitoclax-MST-312 (1-1 mol-mol),1.0518954464197996,1.3196557605124983
LS411N,216345,4.369072592416217,3.5717745156894343
SW948,JQ-1-carboplatin (1-1 mol-mol),1.423261364200352,0.8100273590700305
SW48,2841722,4.762546821441249,4.232996432049811
SW48,9956119,3.393025538441131,3.5626615696917012
PaTu 8988t,44607531,1.764787957031886,1.7151442136619974
HCC15,16741245,4.574628343563009,3.6992592610166066
SW948,89928392,1.4444572178844948,0.8870319164226568
SK-OV-3,25126798,3.9960730178767,3.9002133121871747
RKN,54143018,1.3184566027416504,0.683343353057458
NCI-H2452,24180719,2.8480667171601852,3.5684159113193563
COR-L95,9915743,0.942320604231091,0.4337021518775501
LCLC-97TM1,decitabine-navitoclax (2-1 mol-mol),2.9245922441873717,2.1331477402283334
LS411N,selumetinib-PLX-4032 (8-1 mol-mol),1.7092095935664802,3.425453626452068
ALL-SIL,387447,-4.904935645240703,-5.130804003587488
SW1271,54649381,4.56488530045006,3.9353712150362314
KU-19-19,4259181,2.3072251676522835,0.35518697035226215
SW948,25105715,3.628389782970242,3.2681577394641805
SK-CO-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.470227169685732,-1.1724436106222056
LS180,19582717,2.9052461851112565,4.200620102473115
Daudi,676352,1.3635905677607614,1.6206108355966113
SW948,SNX-2112-bortezomib (250-1 mol-mol),-2.424265268462928,-1.5810886869520018
ML-1 [Human thyroid carcinoma],375860,0.003862862725961,0.003758018010736265
SW48,9915743,2.691515978939234,0.8469461633686299
MDST8,BRD-A02303741-navitoclax (2-1 mol-mol),1.0671280155352338,2.1040878218619934
P31/FUJ,navitoclax-piperlongumine (1-1 mol-mol),-0.4738069202441977,0.06580864440501365
SK-CO-1,navitoclax-piperlongumine (1-1 mol-mol),0.7177098692298883,1.4380011036602602
Granta-519,3025944,4.149663954634143,3.688888863625682
ML-1 [Human thyroid carcinoma],46174525,4.296155307906125,4.56351720151103
SW1271,2841722,4.036476035404804,4.297390302898221
SW948,53232,2.3961531254319466,2.968921942703456
SK-CO-1,25183872,-2.2315902989777725,-0.5058133829135605
KU-19-19,vorinostat-navitoclax (4-1 mol-mol),1.414230786423441,1.2341494090935377
SK-CO-1,selumetinib-MK-2206 (8-1 mol-mol),-0.5781899978856783,1.649044183632137
P31/FUJ,6918328,-1.424420935100909,-1.7816215659827734
HuP-T3,71680916,4.329506074723249,4.868657453720926
P31/FUJ,262093,1.035147161622815,1.6829546411773206
SaOS-2,11228183,2.7080984165628754,2.480930523415166
NCI-H1568,6852167,2.376266672184036,2.9360261337826183
RKO,4477,1.7070595719756474,0.4615932626676795
Granta-519,46199207,2.493616790778817,2.6549024544911735
IGROV-1,5470400,-0.2457809435208252,-0.5395300988339069
IGROV-1,409805,5.990596261907717,5.0859923261478475
PaTu 8902,15983966,2.4191743534269463,-0.9375504724622202
RERF-LC-MS,31703,0.0184985959907658,-0.3665715773914846
NCI-H2452,SNX-2112-bortezomib (250-1 mol-mol),-1.5822620251622193,-1.2679203734661437
P31/FUJ,46224516,2.421293495972869,2.061451893426157
BFTC-909,10127622,5.216996592058982,4.155054312720369
HuP-T3,55508,4.397520768584908,3.6238264862614615
HuP-T3,10385095,0.7178899916931367,1.3642683581848516
RKO,16013152,4.038378204585466,3.4649116907743536
RCC10RGB,6918328,1.0053978601828475,0.7364403854169
SW948,9444,4.221430823371368,3.8462209783630654
WM115,53392493,1.845382538513501,2.6346265907392903
HCC15,44185566,3.08334642122707,2.6320050081289366
LS180,JQ-1-navitoclax (2-1 mol-mol),0.8160001924760493,0.67919478159092
UACC-812,25262965,-4.249514707304517,-1.0893424748894518
WM115,51037431,2.6247692404465868,3.2794902145153593
SW948,5311281,0.0185560472432188,2.6912655212112293
HCC15,44607531,1.6724658843452191,1.6511966790730113
MOLP-8,6450551,1.973885798572914,1.4089014281751713
MOLP-8,7251185,0.7855879803762651,1.7127070920723921
SaOS-2,5479543,4.655800274360292,3.627828212882747
IGROV-1,4917,2.985904350427039,3.150910572880444
Daudi,3825829,3.2006002080342544,3.121498690547961
UACC-812,148198,-2.7739066615342236,-3.6207198727951555
Granta-519,1242560,3.55554960326222,3.137530751840018
HARA [Human squamous cell lung carcinoma],60700,-1.6734694813518207,-0.2418956687227368
HEL,17759555,4.966386069896687,3.1824492268724667
SW1271,119607,6.141140067390372,5.2579604052481015
Daudi,3038522,1.648170780235362,2.4751770303378406
PaTu 8988t,969516,4.442820223092304,2.9403867100709946
HuP-T3,4521392,4.351966444408677,4.214397437290114
BFTC-909,2113511,5.65564772398506,5.6578015431330035
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731,3.2716617617675245
SW1271,24856436,1.0602186643720275,0.6983462088263314
HEL,24180125,3.3188099636510495,2.3654925426556828
WM115,10077130,4.784184630126653,3.165097937898348
SK-HEP-1,5281321,-2.075735756673856,-1.0350218335023025
UACC-812,10184653,-4.111635019949291,0.5204368405404329
BICR 31,55283,4.60336009153674,2.711868240479171
MOLM-13,11178236,-3.317575610691226,-3.7168299081256255
COR-L105,57519531,4.553300256365288,2.7422488742521876
ML-1 [Human thyroid carcinoma],3815108,2.9979183689426723,2.9688772759575333
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997,0.9751096534230161
ML-1 [Human thyroid carcinoma],vorinostat-carboplatin (1-1 mol-mol),2.0705525470951587,3.424287512262777
ALL-SIL,11317348,-1.373590167325895,0.8729403358434488
LS411N,6914657,-4.299110458286086,-3.9871064856010365
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476,-0.8401626792960216
HARA [Human squamous cell lung carcinoma],1716436,3.773793106717324,2.8810259871455823
LS180,57519531,1.9809210286085912,2.395857688578856
LCLC-97TM1,60750,-0.9490237417659374,-1.850851601728476
SU-DHL-1,49850262,3.2383746822480384,3.3201595229672964
SK-OV-3,9911830,2.8997016876614863,2.7843503348247003
PaTu 8988t,alisertib-navitoclax (2-1 mol-mol),4.265397677389301,0.43409965687083163
RERF-LC-MS,15983966,-4.090154567310139,-0.44537138448001556
SK-HEP-1,selumetinib-MK-2206 (8-1 mol-mol),4.11054762578972,2.6671284164485445
RERF-LC-MS,24951314,1.4075693116182684,1.6964274326081283
SK-HEP-1,11494412,3.332434654266433,1.6877156760616752
BICR 31,51039095,3.0794813668201546,2.9766063010798325
Panc 02.03,11178236,-2.8028080099743624,-3.093664481802426
SU-DHL-1,24772860,-2.736237819232434,-1.9974296590357283
Daudi,6610216,3.2134188501838494,3.8760586501640306
NCI-H2452,53392493,2.782389188766079,2.899846232635129
NCI-H1568,445091,4.097432324473231,4.357323428289345
K-562,9926054,1.8612748023096723,1.5968543013820702
HCC1500,24978538,-1.6021545775061432,0.8989369081717871
COR-L95,25126798,4.203058281978897,3.634541509193893
LS180,44819697,-0.9723932292423276,-0.27189623715126976
BICR 22,5281321,-1.7077192732848236,-0.8982121249857751
PaTu 8902,656346,4.145274855759625,1.091690674941902
BFTC-909,42642645,1.561027146692027,1.2333329818957055
IGROV-1,49836020,5.658436828096057,2.488271631902728
Daudi,168313200,1.4988300519601074,2.6877267390167936
MOLM-13,24779724,4.7751629548446894,2.9226532854675105
IA-LM,docetaxel-tanespimycin (2-1 mol-mol),3.5360773084497494,-3.1997309955587747
K-562,doxorubicin-navitoclax (2-1 mol-mol),-1.4702798280033291,-1.8276021280604635
RKN,2828334,5.965623907482328,6.073251972991796
NCI-H2452,5280436,4.838161671645799,3.7937489023537228
HARA [Human squamous cell lung carcinoma],25062766,2.285935640348263,2.2192400362695066
BICR 22,637858,2.779101364791116,2.208338253399865
RERF-LC-MS,56963564,0.3267097404636779,0.750291464324617
RCC10RGB,2949965,2.9970768068045577,3.0964908872984847
WM115,10074640,2.7921613557017473,3.126283868514972
KU-19-19,25154868,3.204596310046931,4.4473636286115035
BICR 22,49793307,-5.020228152199773,-1.9728561028762521
SU-DHL-1,5460769,-0.475427190707336,2.380850755227536
NCI-H2452,9868037,3.199558399493599,3.7026157111507394
SaOS-2,9823820,4.1201217228566565,4.151998710921356
SU-DHL-1,9444,2.825333870881758,3.4912851097140516
HCC1500,53495165,1.6495193303321407,0.42455851217516766
RCC10RGB,9952709,4.37754893062567,3.314084818547304
Granta-519,73707398,-0.348610297970246,0.22489188166387308
HARA [Human squamous cell lung carcinoma],44632017,0.7187380309890276,1.5691515479506932
MOLM-13,26596,-2.2068545341754295,-2.5525615224266205
K-562,52912189,0.5484446218637569,0.03143476314947707
MOLP-8,doxorubicin-navitoclax (2-1 mol-mol),-3.5664947897809207,-1.7442302400202134
IGROV-1,375860,0.7731558163124775,-0.050244392066920725
IA-LM,11964036,4.998383188027045,0.9937819302737385
MDST8,387447,-2.914953377887094,-3.831876240986813
IA-LM,9915743,1.455667571666015,1.2702329546129512
LS180,6918328,-0.1069758097146191,0.001059275082999116
PaTu 8988t,6610216,5.064895456595333,4.355225940618373
SU-DHL-1,104842,-6.410970225096146,-3.5518297229668705
P31/FUJ,56946209,-4.67609529352027,-4.827486021725015
SW948,6917907,-5.884345700630281,-4.70673328392165
BICR 22,53232,4.030024483575548,2.704083648090199
PaTu 8902,568763,1.8312011651342244,0.4997797774820287
ALL-SIL,6505803,0.7073572306495796,-0.6622440866709295
SW1271,selumetinib-JQ-1 (4-1 mol-mol),-0.3516238001186607,1.7272640681893774
LS411N,10302451,4.220534629483678,2.7456204683324206
RKN,11238147,3.9265768628415487,2.8678259949919727
PaTu 8902,135440466,3.176809791892748,2.2673267760188414
MOLM-13,119607,3.836878131829583,4.462326216446609
HEL,11612883,1.9962168488272864,1.8333300849022678
COR-L95,11485656,1.8696119642586884,2.0151901056050754
MDST8,675434,4.4652962141660595,4.721570765852157
IGROV-1,11507802,1.5049911819213722,1.7036640170659783
SK-HEP-1,2708,5.260013220141412,4.811617993485569
LCLC-97TM1,BRD-K27188169-navitoclax (2-1 mol-mol),5.367919613117806,2.39760965434779
SU-DHL-1,5738263,2.757121948334044,3.1337746311548873
Granta-519,54626689,4.523537450364534,4.074628789695716
SW948,135421197,1.7477185084776832,1.5930856899991692
SW1573,ISOX-bortezomib (250-1 mol-mol),0.8486273919193054,0.6038289198821775
BFTC-909,tanespimycin-gemcitabine (1-1 mol-mol),0.2587370636739561,-0.4992726781353728
BICR 22,4917,3.6655313291566327,3.0819696975569024
HARA [Human squamous cell lung carcinoma],2130404,2.6459509712703246,3.2408111090816227
MOLP-8,16736978,0.6033273838828506,1.304687693277363
SW948,11396600,3.556168564723583,3.018247322201846
IGROV-1,2113511,5.982902824257526,5.721841787840134
Panc 02.03,16725315,5.289216895099664,4.319743034666365
K-562,9549297,1.810271401171294,1.6453143513008908
SU-DHL-1,60700,-3.861884777487788,-1.2175873910682313
MDST8,89183176,5.515733421140453,4.435432135633213
PaTu 8988t,selumetinib-decitabine (4-1 mol-mol),5.718429611668687,3.9633611418598393
WM115,10113978,3.3670712397266698,3.4572038639351597
SW48,25154868,5.084018259884556,4.334701465673749
Granta-519,107985,-5.079154139769343,-4.192646196482326
IA-LM,15953870,4.160803294534019,3.692253159996178
RKO,19582717,4.345992572306107,3.147420378499841
WM115,selumetinib-decitabine (4-1 mol-mol),-1.8184529973078083,3.351065048060001
ALL-SIL,2742550,3.1857763586562577,3.150825826541239
COR-L95,375860,0.21091681928276,0.239500836070805
Daudi,JQ-1-MK-0752 (1-1 mol-mol),-0.2875395851345496,-0.017469053453829833
COR-L95,702558,5.203109308170341,4.703285194162881
ALL-SIL,5329102,0.5818325089631969,1.3417364328446926
MDST8,9911463,4.372295154952754,3.8461883311095657
LS411N,44607531,1.9881484499388475,1.4264783372198473
Daudi,68056272,2.8001037652797818,2.835212961540662
MOLP-8,4521392,3.737637773211522,4.082168582813741
MDST8,20959075,-2.855250986095604,-2.6543048516869696
IA-LM,400769,-0.2498086542393983,-0.6269692913409481
IA-LM,16722836,2.5380745713557893,1.316394899581307
HCC15,445091,5.451686926059382,4.3710762021429925
HCC15,11507802,1.1916077520331714,1.9671780230354121
MOLM-13,9903786,0.7109980532390177,1.825525348225841
SW948,24901704,3.213341299668661,2.7284113539889905
ML-1 [Human thyroid carcinoma],46224516,1.5473988782080883,2.9138245885293226
SU-DHL-1,10427712,3.576020229714379,3.992196119735708
ML-1 [Human thyroid carcinoma],107985,-3.3059977696559204,-3.0774175288434837
SK-CO-1,piperlongumine-MST-312 (1-1 mol-mol),2.091052840490691,1.9941997602031987
Granta-519,51039095,1.7779321154646133,2.0080925019512756
RERF-LC-MS,65628,5.693639897620667,4.503214696478555
SaOS-2,2828334,6.074749772556143,6.285196095818957
SW48,3815108,2.5063295630391806,2.8791297634747726
SK-CO-1,11626560,0.3943389380121196,2.0215051085232636
HEL,107985,-3.965696416470184,-3.9835356770624433
KU-19-19,60700,0.8700483452505813,0.06671013615650792
Daudi,5280436,1.0789231424034973,2.2700657147145007
MOLP-8,54613361,-0.8734170036218252,-0.6358835413311632
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844,-1.9842768808270705
SK-CO-1,24978538,-0.5683899539074425,1.0985806742052557
SU-DHL-1,54649381,3.644517842316546,3.743929285345162
SU-DHL-1,44493528,3.922242735424854,4.350046135824067
P31/FUJ,5282054,2.945149434876345,2.736607069581859
SK-OV-3,49850262,4.3958011115665006,4.087992332954165
IA-LM,10184653,0.8510906912410041,1.627225096934594
NCI-H1568,36314,4.092621701538515,-0.5553661571959908
BICR 22,46843906,2.889476079217857,3.175492511440059
SU-DHL-6,9444,3.111459322097769,3.49460452076068
ALL-SIL,10410894,2.969142576372873,2.6219157079652775
ALL-SIL,9549297,0.2429486516660708,1.5818365600408502
Daudi,46926350,-6.041265180126537,-4.832562264422804
RKO,1750826,1.760307875609834,-2.468199239802057
PaTu 8988t,4477,0.4312443696129938,0.7163229604234005
Granta-519,5282054,2.5814189459390957,2.5812699111617206
SaOS-2,carboplatin-UNC0638 (2-1 mol-mol),3.570952437368873,3.2737911149163774
IA-LM,16065773,2.795317455347302,2.5855419069383054
RCC10RGB,156422,4.423389512885201,4.429460757635458
IGROV-1,11214940,1.360660548899077,1.8197937209888602
Panc 02.03,16720766,4.473005389666903,0.892039912957374
Granta-519,3081361,1.7559432073327723,1.3463263739686575
MOLP-8,52947716,-7.872176911001468,-2.5200353132744264
KU-19-19,5281321,2.871465791170073,-0.8888408946579769
IGROV-1,5282054,3.614574021382022,3.92756007038955
MDST8,4261,1.8348924416255383,1.80359676249407
MOLP-8,100016,7.090961588333011,5.018615031847256
Granta-519,168313200,2.290121636997186,2.644508423255206
HCC1500,462382,0.0787876699821948,0.6440213531403629
IGROV-1,10113978,2.874171865860951,3.560144182135158
IGROV-1,BRD-K55473186,4.387806234483854,4.089121377783784
HARA [Human squamous cell lung carcinoma],5291,4.037970789679042,3.7768778946559207
P31/FUJ,10410894,5.368264014178215,2.5754070396773194
BFTC-909,3025986,-2.0399601309440336,-0.6155602436537982
MOLP-8,24771867,-5.187641849515016,-1.0764101268011697
BICR 31,11214940,4.966543096658616,1.8132501726706796
Panc 02.03,selumetinib-JQ-1 (4-1 mol-mol),2.589155616289617,1.6297316102167207
UACC-812,9936388,-5.022392750910281,-1.4210545604247833
ALL-SIL,24772860,-3.38763553354356,-2.7955885132404976
MOLP-8,11626560,-0.689912231097504,0.8592702749717042
HARA [Human squamous cell lung carcinoma],selumetinib-JQ-1 (4-1 mol-mol),3.6659251122276015,1.9199659966488587
BICR 22,navitoclax-PLX-4032 (1-1 mol-mol),4.097608134933257,1.5518383530514765
SW948,262093,3.1804911198162036,2.474333894971542
SW948,216239,1.8650010893863176,2.240594266480361
SW948,11364421,-5.809742751249139,-2.999714120330845
HEL,10302451,3.814274659252608,2.450821266175375
K-562,46398810,1.812730009869126,2.0745409494194447
Daudi,216239,1.5780166370194677,1.6709808733660867
LS411N,10231331,0.2083934704449227,1.504080538054518
MOLP-8,46926350,-5.986975596425451,-4.3139644006172935
SK-HEP-1,11964036,3.325100881793091,1.6975847064585974
Granta-519,11485656,1.6660529916447626,1.477222840983059
K-562,2871966,0.96376622724181,-0.2360846326055092
P31/FUJ,54454,2.7341923640247123,2.4631340409432076
SW48,54613361,-1.8010952783890095,-0.22422817778243534
NCI-H2452,46843906,4.012061875028764,3.4475169080934585
HEL,135875424,2.9448279330391927,3.311297195390307
HARA [Human squamous cell lung carcinoma],16725315,4.551171651287005,4.405335951862548
SW1573,serdemetan-SCH-529074 (1-1 mol-mol),2.68378670703322,2.200849789090904
ML-1 [Human thyroid carcinoma],51039095,1.326261900002616,2.9625590105153203
P31/FUJ,decitabine-navitoclax (2-1 mol-mol),-1.2834649241305407,-0.46622803250108114
HCC1500,54678924,1.846277418486191,1.9491113555844717
SU-DHL-1,UNC0638-navitoclax (1-1 mol-mol),-6.722227351020971,0.6306255222418421
MOLP-8,9927531,5.438833274000949,4.1657480659509405
PaTu 8902,selumetinib-vorinostat (8-1 mol-mol),2.5580221704247403,2.1418633277262895
HCC15,9952709,3.084010703088348,3.095751666931631
K-562,3503,1.244026999465694,2.1925637709104397
SaOS-2,3689413,0.0712794264513353,-0.25314652520509234
MDST8,10427712,3.921886084986449,4.480921147377875
HARA [Human squamous cell lung carcinoma],11238147,2.905443405294126,3.1323707985072122
SU-DHL-1,1716436,3.093009546519781,2.504857544429031
PaTu 8902,25105715,3.5553172149604375,3.4761821662676162
HuP-T3,24771867,4.228511460696379,2.5747921814055417
RKN,31703,-0.7196573309741882,-0.9638719724132772
MDST8,60700,1.1908209554887386,0.07071743657984977
SW948,carboplatin-UNC0638 (2-1 mol-mol),3.7515115045005913,3.507123853823308
HEL,54454,2.1583735480761437,2.314900663866508
NCI-H1568,UNC0638-navitoclax (1-1 mol-mol),3.297813275168301,1.8241374276378155
BICR 31,alisertib-navitoclax (2-1 mol-mol),3.3923193563221257,0.6818563534985959
SU-DHL-1,135875424,2.8587183873170847,3.451208180684016
SU-DHL-1,36462,-1.6063137198477124,0.9227923685749047
MOLM-13,73707386,2.881964792667641,2.2026465340357935
P31/FUJ,3854666,0.6136756098719494,0.8674491952091619
ML-1 [Human thyroid carcinoma],6505803,-0.5261965004955029,0.08876844398394193
MOLM-13,159324,-0.2587959593058327,1.593744969438343
SW948,19582717,2.742329976582949,3.223180971644674
SK-CO-1,444795,5.109688629113172,4.732356023353659
Daudi,400769,-1.3686052359334673,-1.4590393197741625
SK-HEP-1,10296883,4.4971190241998835,4.019679535400274
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688,-1.4876474519578347
LS180,17759555,2.746757712453425,3.4952849891571036
MOLM-13,156414,-0.1970532812518614,0.616166811325234
ALL-SIL,72376,-2.2514410459425043,-3.5401681313147675
BICR 31,selumetinib-MK-2206 (8-1 mol-mol),1.335551689205146,2.287086815339202
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683,-0.37521663975358344
HCC1500,51039095,2.9997605815390935,2.839369285416808
WM115,44185566,3.0030021210520794,2.7016276854005743
COR-L105,4705,0.5312031062005766,3.358401485113531
Granta-519,8515,3.731909716775835,3.1331479907394977
ALL-SIL,11234052,3.5011978223530926,2.9102872238276087
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636,-0.12217833403096767
ML-1 [Human thyroid carcinoma],44632017,3.256506939906626,1.6864593275223092
Granta-519,613753,3.0344429390603493,2.8401081623268523
HuP-T3,5329102,2.4996480668272527,1.988554542635018
SU-DHL-1,2828334,5.462697908299577,6.189512641193889
SK-OV-3,51039095,2.3576173335626147,2.960087316776611
UACC-812,5470400,-2.2578344499942418,-0.48699906918623
HCC15,9935249,4.091947122155354,3.0025240243739533
UACC-812,JQ-1-vorinostat (2-1 mol-mol),-0.5213031534169104,1.1111800122149464
SW1271,322968,3.7653444240208263,3.8658276314363604
COR-L105,54678924,1.4327429630461548,2.339472977452862
Panc 02.03,31703,0.91391851070637,-0.5408573019767459
NCI-H1568,5329102,1.5348278867114138,2.240366785499042
Granta-519,9887053,0.035640336798207,2.6089269638298656
IA-LM,6610216,4.173583896241699,4.07126199548481
NCI-H1568,119182,-0.8732650634834633,-0.686628923009378
IGROV-1,159324,2.8766947154825044,3.2233843191007328
NCI-H1568,5566,2.911706555521376,3.1310265553059464
Granta-519,ISOX-bortezomib (250-1 mol-mol),-0.0076351128807997,-0.3423453966263412
NCI-H2452,10385095,2.425738192808243,1.3940856581101915
HuP-T3,16065773,2.155269900494742,2.746431524196814
SW948,448949,1.5714288146717783,1.7278270429109706
NCI-H2452,107985,-2.625758680845612,-3.389453927938863
RCC10RGB,1750826,-3.277944046627699,-1.834700326266465
Granta-519,16736978,1.0160166250823044,0.7852963889407135
HEL,104842,-4.135712202151618,-4.0355246258265325
MOLP-8,71466445,1.892906464336944,2.365868270460249
MDST8,262093,2.389063867163299,2.423430174656888
COR-L95,4259181,0.8580425806970188,-0.05305982736581243
Daudi,45279963,2.6753649589319854,3.0696752363363395
IGROV-1,656346,1.6285470744333117,0.9172691307372155
SK-HEP-1,10427712,4.527720982072863,4.417065705834467
SaOS-2,11647372,0.6261520317366223,1.2560110674959795
COR-L105,53495165,0.9627099148057476,0.489857284842733
Granta-519,11404337,-2.8078628280004048,-1.3402618533060546
SW1573,25154868,3.281093993360062,4.647402709068162
RCC10RGB,crizotinib-PLX-4032 (2-1 mol-mol),2.89623675646366,2.0977388605681018
BICR 31,3503,3.4488620791118993,2.6032000328423495
SK-CO-1,3062316,0.5910144260309655,1.3065673010171246
RKN,6917907,-6.438038185084336,-4.886724068111845
LS411N,23635314,4.011909681168236,-2.513402595600516
WM115,11234052,4.1182935305671435,4.29146018253575
Granta-519,tanespimycin-gemcitabine (1-1 mol-mol),-7.490554088908799,-2.0553077612915107
SW948,JQ-1-navitoclax (2-1 mol-mol),0.5901277786092829,0.672501325843937
RERF-LC-MS,11485656,1.5190166417661397,2.5265270766109693
PaTu 8988t,46224516,2.924922546378164,2.701647919702947
Granta-519,JQ-1-vorinostat (2-1 mol-mol),0.0738956362017292,-0.526148986473036
SK-CO-1,5287620,-2.837552470898679,-1.9476109633907115
PaTu 8988t,24772860,-1.5593380796956875,-2.081260820103689
PaTu 8988t,6184667,3.5063575702163345,3.3835017409733323
BICR 22,36462,0.4717839486114671,2.4092062409677846
RKN,16722836,2.340122812915413,1.7715750064781168
Panc 02.03,54618164,4.482290203520866,4.234987105313044
BFTC-909,2841722,4.3094465275997536,4.351868217755273
COR-L105,2746,3.1035280268076217,3.392891126669793
IGROV-1,9929138,6.483056540257463,5.755071002980173
HCC1500,2708,5.151987441269929,5.159151253786441
MOLM-13,11238147,1.4582306649534449,1.9811314810880574
RERF-LC-MS,11364421,-3.8493036468537265,-0.8162332390279144
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015,6.362552942100975
RERF-LC-MS,16736978,2.30801467798398,2.0647196955349565
LS180,44241473,4.435457667187811,4.675199741936405
SW48,16722836,0.2197322523934369,1.5215073487530204
NCI-H2452,9444,3.5242093703527697,4.408039558910023
SU-DHL-1,5284616,2.4488241799592143,0.9098306607371702
K-562,54454,3.689215856042272,2.7043864725329185
HEL,2945648,2.719646445320408,2.1189827667709067
ML-1 [Human thyroid carcinoma],selumetinib-JQ-1 (4-1 mol-mol),1.6383064835611996,1.6303444734577976
HuP-T3,9936388,0.6940852338085793,-0.47508822264988
LCLC-97TM1,10427712,4.124790087544491,4.068153297882825
SK-CO-1,navitoclax-sorafenib (1-1 mol-mol),1.5561836215711824,1.4528882021376928
SW1271,135398738,5.657599080768866,4.367581545637031
RKN,216468,4.351451769225332,3.3657532042171043
SW1271,46224516,1.263100640010589,2.5235990733553955
SK-OV-3,60750,-4.210978436614257,-2.1239381777631334
SU-DHL-1,11455910,0.1271925880707346,1.1156888646315148
Granta-519,25161177,3.429453868131532,3.482427015370236
PaTu 8902,SNX-2112-bortezomib (250-1 mol-mol),1.6303309640570394,-1.1958735828567137
COR-L105,erlotinib-PLX-4032 (2-1 mol-mol),-0.0740461614956173,3.2287637162589964
UACC-812,16065773,1.9582746458630844,2.44735405052321
MOLP-8,2858523,3.112163707938977,2.8429269884395474
ML-1 [Human thyroid carcinoma],6252,2.036085666454029,1.4816148800699878
IGROV-1,6505803,-0.2382223795960626,-0.3013979829039265
HEL,24772860,-2.0205510075596425,-2.7748743068052915
HCC15,4917,3.2753021602409267,3.217931676809741
HEL,ISOX-bortezomib (250-1 mol-mol),0.0125517502363375,0.04617768929928236
P31/FUJ,6184667,2.9500590386465393,2.1894633585756744
MOLP-8,46843906,0.174682801852784,1.4935602717703518
NCI-H2452,54618305,4.302077073898344,4.499889710657926
BICR 22,8515,4.348804794701894,3.946557483706826
COR-L105,24821094,-1.121187296223131,3.036588531411066
HCC1500,4788,5.676843976237076,5.610435924039349
SK-HEP-1,2746,4.04921422913523,3.5063006621330093
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791,-0.38650109090028645
COR-L95,46199207,3.11604668311128,3.0213537212048247
MOLM-13,1641662,2.418131669664625,2.6513368772047836
WM115,135984461,4.094268409164816,4.098167573909102
LS411N,10127622,0.4126946340819594,2.5345710280093234
HARA [Human squamous cell lung carcinoma],11497983,-2.5330413808054333,4.279391774461777
ALL-SIL,11364421,-5.245070547120315,-4.800300963180482
NCI-H1568,44607531,1.2688225542701184,1.5863229653618183
SW1573,navitoclax-pluripotin (1-1 mol-mol),-0.8972243214684317,-0.6933246999573128
SW948,104842,-0.6555530305877334,-2.4627099796255423
SK-CO-1,46907787,4.316773762169295,2.05008036679342
HuP-T3,104842,-2.1883971380944054,-2.780329250474896
IGROV-1,11178236,-2.8618715106425725,-3.0763864537689996
HCC1500,71751553,4.671922723370954,4.697749781437759
SW1271,54618771,-0.1319273231055389,1.4386199135213413
ML-1 [Human thyroid carcinoma],9952709,4.669340472029816,3.212991936055417
IGROV-1,654092,-1.340387623873854,-0.05737214387753925
HCC1500,44819697,2.691999336982048,0.2014247839923233
HEL,44137675,4.224171499328968,3.237861767149114
MOLM-13,tanespimycin-gemcitabine (1-1 mol-mol),-4.499081483016427,-1.917581727943371
COR-L95,5328940,2.113977806947162,1.6123744255361132
SK-OV-3,3825829,4.139200001280225,4.17850617853912
Panc 02.03,216468,3.8655539989600176,3.4789712949461467
SW948,25195348,3.534636067330416,3.292474734526834
MOLM-13,9444,3.2439366633039426,3.566090007494921
NCI-H1568,24821094,1.7576462865100984,2.9787236695451016
MOLP-8,1566236,0.7132031003128095,1.7277459395523393
HuP-T3,11455910,1.0919804440303738,1.487110260670565
MDST8,44185566,3.0590843033834116,2.63930289248223
NCI-H2452,216345,4.1608899350266615,4.15778587042613
SaOS-2,23635314,-2.530968731721941,-1.3767056580735775
MOLP-8,selumetinib-MK-2206 (8-1 mol-mol),0.6863734484808788,1.515865906787409
LS180,168312962,-1.039638615515642,1.710194505165374
BFTC-909,crizotinib-PLX-4032 (2-1 mol-mol),2.7598509436067906,1.9556708405506027
BICR 22,322968,4.6496227244818416,3.741336385126924
NCI-H1568,vorinostat-carboplatin (1-1 mol-mol),1.5719417416558872,3.3399922288325516
RKO,6918837,-1.4612228483082623,-3.815374125388201
MDST8,selumetinib-navitoclax (8-1 mol-mol),0.5901837965573531,2.126767278663321
SW48,613753,3.5910736246612323,3.1749297366923277
IGROV-1,44507138,2.359177395411688,2.774715187469184
WM115,52947716,-6.8465929822900815,-0.4662687026805218
RKN,73707398,1.136221501718042,1.2628596698284835
HCC1500,4477,0.2789780560390432,0.529310283957313
Granta-519,11719255,2.4006867045586953,2.3824310689671826
HCC1500,6918736,0.2919336581768246,-1.590445291624456
IGROV-1,4477,1.1767656777594142,0.4699896198338931
IA-LM,11609586,4.073174168632335,2.276019118775291
NCI-H2452,11404337,-0.3859535574072682,0.033506455130575305
Daudi,136227924,1.3476403322374937,2.1122354545784687
SK-OV-3,387447,-3.0618968905277164,-3.9837101070877607
MOLM-13,3854666,0.5101644656521153,0.7684896936095807
RKN,46843906,3.906010302389018,3.158800672077738
ALL-SIL,1641662,2.105441320822025,2.6733355692744465
MOLP-8,46199207,3.622115707782432,2.867490605362091
HEL,17755052,2.5427584711612554,0.7833198897169018
MOLP-8,9915743,0.5160575940701332,0.25204912249701883
NCI-H2452,135398516,0.2354885350790482,2.5045540142332934
NCI-H2452,JQ-1-vorinostat (2-1 mol-mol),1.361868366541758,1.4578126762332715
SW1573,9911463,3.734935340044018,4.003719578999765
P31/FUJ,selumetinib-vorinostat (8-1 mol-mol),0.1511350548351421,1.4430581492891423
IGROV-1,23725625,5.712368491237602,4.921458836607317
IGROV-1,54143018,0.8385018685685798,0.7229026271283336
WM115,135875424,2.968517855352779,4.042009473856072
SW948,16659841,2.968981271202921,2.8258916265500766
SW48,25183872,-1.521332471338628,-0.7146561534348074
ALL-SIL,selumetinib-GDC-0941 (4-1 mol-mol),1.4850584156304236,1.141219193260344
RKN,selumetinib-JQ-1 (4-1 mol-mol),2.2117221190324323,1.7429572656765058
COR-L105,UNC0638-navitoclax (1-1 mol-mol),1.0855753959105363,1.8074204111719632
WM115,5284616,2.9108529677003565,2.6067235384889336
SW948,4705,1.720002028261835,2.776027261993329
HCC1500,71680916,4.362866442203444,4.768343959704697
PaTu 8902,17755052,3.1533076581920936,2.0065117340934755
COR-L95,11427553,2.745819698220539,2.302520333625534
MOLP-8,11707110,-0.9708482925672104,0.9221325507134327
HCC15,5351362,1.1207822529279785,1.800104642610713
SaOS-2,11234052,4.364959006359101,4.008711451163773
SK-OV-3,6918837,-1.7709381590236568,-2.439785015451135
RKN,10113978,4.430129932581481,3.3960859308002735
Panc 02.03,5566,2.8367562997211815,3.0039193378540574
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858,1.9221163850582315
Granta-519,4096211,0.4087245803445845,1.0186274295570452
SK-HEP-1,72193861,3.0367238048594603,1.9962415191272809
SW948,9933475,1.7222383900333498,1.653502846662513
SW48,9936388,-6.68623848822316,-1.4124541528209464
NCI-H1568,11222830,1.5738139714037271,1.660394625578053
IGROV-1,24856436,0.4840146383282276,0.5212209908101816
SW1271,25105715,2.9104912505007143,3.4266320050689183
IA-LM,11238147,3.064975348903814,2.491000687552545
PaTu 8988t,23635314,0.3317794086663004,-1.6644460603330784
Granta-519,3136844,3.153984140395424,3.455118885852146
COR-L105,24951314,2.139685821030411,1.5998848995520711
IGROV-1,135398744,6.402844237905131,6.625605548328045
LCLC-97TM1,156414,1.5907536031970133,1.3006550751282842
BICR 22,46926350,-6.042960620867506,-3.8110148180362127
Granta-519,387447,-5.4996124066637435,-5.031952193908236
BFTC-909,51039095,2.7594177275421403,2.8775027113589875
Panc 02.03,5746,2.615751109567445,1.3942246099050302
SW948,71466380,3.8629020707603914,4.167625687414802
SW1573,tanespimycin-gemcitabine (1-1 mol-mol),5.2364436023498815,-0.2388142740481848
COR-L105,24856436,1.5602990639828938,0.48541467402675453
K-562,327653,3.3038748071855175,2.8179635271714996
Daudi,16725315,3.035985748437892,3.5606144340062014
LCLC-97TM1,6917907,-8.098980466082804,-5.315681079695144
NCI-H2452,4261,1.8682088943565944,1.9504090211859095
SU-DHL-6,241158,1.5794519300851928,2.5899626634395743
IGROV-1,9840324,5.720969888694302,5.843081806372021
COR-L95,10074640,3.0551355702246292,2.9731710201057275
ALL-SIL,navitoclax-birinapant (1-1 mol-mol),-2.9890180212020265,-0.524244533387116
BICR 31,5460769,3.9433617709959696,2.9349310244689364
WM115,navitoclax-pluripotin (1-1 mol-mol),-1.858334672155358,-0.45726758050734806
ALL-SIL,171352865,4.1926931777749346,2.24392693866236
PaTu 8988t,5351362,2.286773409161727,1.5554715190690542
COR-L105,54618164,4.149947168538197,4.1487505262911855
K-562,168312962,1.3008721680360658,0.4232628665544397
NCI-H2452,3634881,3.1517111283550854,3.405337293379874
SW48,crizotinib-PLX-4032 (2-1 mol-mol),0.8715368349247399,1.8323177479336439
LS411N,2858523,3.1062955336512603,3.0510249566550027
NCI-H1568,65628,3.926137474064237,4.485583927523295
SW1573,25126798,4.147065453172024,3.9068119112858777
SU-DHL-1,9868037,1.568771805047012,2.8122898677218884
HCC15,46174525,4.292402667650191,4.575740084858905
HCC15,54626689,4.436341034968849,4.663852548831818
K-562,241158,3.183928650435804,2.968140718782148
HEL,400769,-1.0010167847558078,-1.3393205417826912
MOLP-8,24180125,2.8280981087253605,2.3011561928390005
LCLC-97TM1,6918837,-2.241539398034031,-3.0884073126501175
SW948,52947716,2.6983492764143984,-0.6931662332812398
HuP-T3,11609586,3.0975126346448056,2.9134881838558986
ML-1 [Human thyroid carcinoma],44589607,3.064794245292079,3.3317222423730555
K-562,9911830,-1.954559593888618,1.727121260285034
Panc 02.03,54454,5.027619058009229,2.7380819218539028
Daudi,9967941,1.9498714635628245,3.048044788722339
SK-CO-1,46224516,2.9108482414820833,2.465280883968387
IGROV-1,56963564,1.8260986108097368,0.3788742404140937
PaTu 8902,119607,6.110313748168657,5.32524657426558
SK-OV-3,1750826,-0.3132155362058529,-1.3271562185613937
NCI-H1568,11507802,1.223292685938289,1.8379231889611731
SU-DHL-1,6918736,-2.1290482192432396,-1.7544638983197631
MOLM-13,6252,-1.803091878000868,-1.5419267380330104
HuP-T3,16659841,4.694527425679891,4.232623111621417
COR-L105,135440466,2.282908830244017,2.4447197935750173
COR-L105,36462,5.237060103367249,2.5296616695949345
LS180,16038120,0.768362963165676,1.0046515801642315
COR-L95,11719255,2.8113582651389684,2.758661418473718
K-562,71466380,4.109476883218819,3.960497577085182
LS411N,selumetinib-GDC-0941 (4-1 mol-mol),0.0319239505994205,1.3840868754605067
LCLC-97TM1,65064,4.239331302053654,4.911327046331679
ALL-SIL,11626560,-1.2475078800938888,0.6969058706317697
IGROV-1,9903786,1.7387584479757865,2.7666239537128523
HARA [Human squamous cell lung carcinoma],119607,5.240910567943734,5.286418626006668
UACC-812,3025944,3.7003704595595894,4.0940687277519
HCC15,52912189,2.9796194932949875,2.3863353391769557
SK-CO-1,24951314,2.193758155281627,1.6047976854027095
IGROV-1,208908,2.822483792004996,1.9303790645205174
BICR 31,2945648,3.0787524499283023,2.924536092413321
WM115,11485656,3.738489726762909,2.5985175089590133
IGROV-1,126941,-2.246216453812328,-2.678141869641396
KU-19-19,135411,0.3258457054887789,0.7568229821018805
PaTu 8988t,tanespimycin-gemcitabine (1-1 mol-mol),0.132721029617077,-0.7705806737844624
P31/FUJ,BRD-K27188169-navitoclax (2-1 mol-mol),0.0086353275600694,0.7761412209687211
MOLP-8,25105715,3.7016775455761968,3.0498197316538445
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266,-0.9646876389943604
NCI-H1568,25126798,3.633705991567496,3.922136927127038
LCLC-97TM1,3689413,0.1289764847745495,-0.1785790332074424
SW48,5311,0.4861581581750583,1.3845435552394454
LS180,409805,6.164182483443964,5.115694580786109
ALL-SIL,17759555,3.7861470032844418,3.354764291140609
K-562,7326481,2.6072018104551824,2.4282376591168866
SK-CO-1,8515,5.207883928071115,4.029759619082404
NCI-H1568,439501,-2.6831567396736022,-1.7468832570668562
BICR 31,3634881,3.594506321194918,3.3235104282010486
KU-19-19,656346,4.826208082880011,0.9457533721931525
SW1271,10410894,3.9794007270318903,3.275835864521462
ML-1 [Human thyroid carcinoma],3689413,0.6725245747839163,0.2252697730857468
SK-HEP-1,16722836,2.576451725849178,1.7567271042267762
RERF-LC-MS,10113978,3.210216765519601,3.569558064788775
LS180,54454,2.0147485365690945,2.852062592985783
NCI-H1568,9866186,-0.23967308205821,1.027752132073273
IGROV-1,10302451,0.4135234554742116,3.302908698115804
PaTu 8988t,9935249,3.4642640806067897,3.3502164713253695
HuP-T3,65064,5.168937665689206,5.031574441574726
UACC-812,JQ-1-carboplatin (1-1 mol-mol),1.7132070182589942,2.4124514144055236
LCLC-97TM1,44543605,5.020704141539917,4.014638416610322
KU-19-19,3062316,3.300727237006398,0.9906480338507236
IA-LM,54143018,6.360653223606267,-0.00552707898456607
HCC15,JQ-1-carboplatin (1-1 mol-mol),2.0328384477438477,2.3921965594096166
PaTu 8988t,11497983,4.771256524847766,4.53137755141774
IA-LM,7326481,3.2597510497719964,3.013467730762606
MOLP-8,57519531,1.794840771759573,1.719345792593388
Panc 02.03,387447,-4.21908064053878,-4.033759915141152
Panc 02.03,9866186,1.4364847380387245,0.9203933152973143
BFTC-909,56946209,-2.8280109825858943,-3.8047731788816446
K-562,46843906,1.6079735978006011,1.6080408496590537
IGROV-1,3038522,3.6829378423722416,3.067426668202332
COR-L95,9933475,1.8209744616881691,1.7896357537824332
NCI-H1568,54613361,-1.9115789745186575,-0.011722123293430387
PaTu 8988t,11178236,-5.843883599227575,-3.499865590058808
IGROV-1,24856436,0.4840146383282276,0.5212209908101816
HEL,5746,-1.0378501544368317,-0.47927814710885835
LS180,216345,2.343571728213523,3.791855380573994
MOLM-13,11234052,1.8885372726820036,3.0551632217034186
IGROV-1,656346,1.6285470744333117,0.9172691307372155
IGROV-1,613753,3.483244781428779,3.3478026862097967
RERF-LC-MS,44632017,0.7768655843829712,1.5308346886411208
LCLC-97TM1,10113978,4.598206277837053,3.021915200872342
LS180,136227924,2.415770069388299,3.1436918362773043
Granta-519,5978,-7.678617575463935,-2.9966298529106217
MOLM-13,2828334,5.861258184508348,5.650770067866907
ALL-SIL,3815108,1.81429533281988,2.090009181542769
NCI-H2452,serdemetan-SCH-529074 (1-1 mol-mol),2.3569369644908535,2.2128469897461995
LS180,10385095,1.937933801431244,1.392034750163191
SW1271,7326481,3.1173859417421985,2.9857437562164746
COR-L105,176870,-0.2151307909405896,3.5896642363895923
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296,3.7784402040001623
HEL,6918878,-0.4197772532459504,0.5199650688492193
RCC10RGB,44589607,3.0966280095343777,3.2681533512455077
RKN,ISOX-bortezomib (250-1 mol-mol),1.0286936108605995,0.5571242633938691
SW48,89183176,5.513741245898386,4.320117388630616
KU-19-19,168312962,-2.211081322704064,2.306065729530666
LCLC-97TM1,11656518,-4.424964199082896,1.9038966688035794
ML-1 [Human thyroid carcinoma],426756,5.157831333984941,4.301435900012323
SW48,decitabine-carboplatin (1-1 mol-mol),4.347409294464919,4.180680621957965
WM115,6918328,0.4200257259119496,0.21130072114214188
RKO,44491742,4.905526099010324,3.9050732531883843
SU-DHL-1,5280436,3.4353188558540895,3.3157991191363965
SW1271,BRD-K27188169-navitoclax (2-1 mol-mol),3.98136464619854,2.733541679228004
P31/FUJ,702558,3.294053878414949,3.8859873019814835
MDST8,322968,3.292336134337166,3.833854476869183
MOLP-8,66577038,2.4807994544381997,2.6727413794714034
NCI-H2452,216239,2.289885444542123,2.3873894254785886
LS411N,24951314,1.1768436480242177,0.5865384716050889
HCC15,5291,3.948819619575577,3.75453229553045
RERF-LC-MS,11152667,0.0782441689403026,-0.3297329322043466
NCI-H1568,285033,-1.965656578387781,-1.621245090738113
K-562,119607,4.708269214175102,4.572519846158281
MOLM-13,6918328,-1.6668605659600593,-1.297090899556932
HuP-T3,51039095,3.318948357155543,3.053029457503199
COR-L105,3025944,3.915005293474353,4.286838662566259
SK-CO-1,carboplatin-UNC0638 (2-1 mol-mol),2.9632424574107157,3.302565696544518
NCI-H2452,42642645,0.8357005775142816,1.1292815784004864
PaTu 8988t,67156097,0.822255948885768,-0.713104652373101
P31/FUJ,44507138,1.0120664141515707,1.562841752071882
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623,1.0021920280176262
COR-L95,vorinostat-navitoclax (4-1 mol-mol),-0.3281165082224372,0.6349008741518759
HCC15,10074640,3.1199478074334106,3.282753732126237
IGROV-1,53392493,2.352084848618059,2.5170664773420874
SK-HEP-1,135398516,1.8011759760648425,2.2149042489831534
HCC1500,tretinoin-navitoclax (4-1 mol-mol),-0.6846797821009611,1.9272868106811705
IGROV-1,1242560,3.902441161940491,3.735910289756535
IGROV-1,24901704,3.0789156375765936,3.5450309172648753
RERF-LC-MS,23635314,-3.639251677232653,-1.8198911835020783
KU-19-19,56946209,-3.434845070293707,-4.101314028300243
SK-CO-1,11427553,2.3636745936222177,2.8982438428604747
SU-DHL-1,erlotinib-PLX-4032 (2-1 mol-mol),3.622151043319632,2.0792989798777852
Panc 02.03,6852167,4.143336119644561,2.8700422681534934
NCI-H1568,26596,-1.690126811671561,-0.7470550355200846
ALL-SIL,100016,4.099229681419155,4.9400938428942895
SW1271,navitoclax-pluripotin (1-1 mol-mol),-0.6532328489926583,-0.8902593083199843
BICR 22,219104,4.618531153522784,3.9463321207370767
HuP-T3,4378219,2.0668857590794767,2.641790532093357
IGROV-1,11647372,-0.6595372928368528,1.1858495432004643
BICR 31,46843906,2.802485697538939,3.0924265170987013
SW1573,navitoclax-piperlongumine (1-1 mol-mol),1.792577527221854,2.251182259811646
HARA [Human squamous cell lung carcinoma],44202524,1.300312464104863,2.1001718998311176
PaTu 8902,65064,4.553320484088526,4.95683050414069
NCI-H1568,10410894,1.924104691976128,3.412609862720535
SU-DHL-1,72376,-3.386078956410557,-2.09209572828197
BFTC-909,JQ-1-UNC0638 (2-1 mol-mol),2.2684379316791112,1.661630709396845
NCI-H1568,16659841,3.88074746768202,4.1582919603674515
LS180,selumetinib-vorinostat (8-1 mol-mol),0.5678514609289822,1.8527636559935505
LS411N,54618164,4.167426775220608,3.8011596314073524
MOLP-8,5287969,-2.4943575090146903,-2.256731697729651
Granta-519,24856436,-2.399051702227432,-0.6563548898867164
SK-OV-3,JQ-1-navitoclax (2-1 mol-mol),0.6239682404577798,0.9731280587101706
BICR 22,3689413,1.1307119933583345,0.07630573307247909
SW948,11494412,0.3616963479580831,1.2286178587815346
RCC10RGB,3552672,3.073432883089278,2.9697911282103724
LCLC-97TM1,72376,-4.375427192181232,-2.2572139043024784
SW948,11234052,4.776317924055416,3.2169589743123526
P31/FUJ,89928392,-0.2575535361410093,0.26183230983807143
SK-HEP-1,ISOX-bortezomib (250-1 mol-mol),0.2987916672751671,0.5105965822569193
MDST8,piperlongumine-MST-312 (1-1 mol-mol),2.167739236118489,1.9494881371328228
HuP-T3,selumetinib-JQ-1 (4-1 mol-mol),1.2883856318712232,1.5304446355047474
NCI-H2452,2742550,5.209305166760603,4.110896150423143
SW48,9884685,-1.5395746259931604,0.6483584701025187
SU-DHL-1,16722836,1.4294085247204618,1.6666652331062648
MOLP-8,11640390,2.6566405323234057,2.0685427492444033
RKN,5113032,5.131058822839954,5.037365811155485
Panc 02.03,5311,2.7910052639268415,1.5902544140262227
HuP-T3,36462,3.380707637397105,2.5664992790895944
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342,-0.3809091289433145
K-562,6852167,3.2696177089982807,1.8252650060025974
KU-19-19,16725315,4.810213458660102,4.344040343498563
Daudi,44819697,-3.048561633253287,-1.956427088342906
NCI-H2452,73707398,1.4673083704761625,1.3531757088695597
SU-DHL-1,6438330,0.8462618394668467,1.625170463504099
PaTu 8902,carboplatin-etoposide (40-17 mol-mol),6.0931927841576385,3.20245749581169
IGROV-1,400769,-0.5589612210030486,-0.4622747788433413
PaTu 8988t,6918736,-0.015847459349983,-1.6743830663347878
NCI-H2452,12003241,-1.7557808561862691,-1.0033237388377465
SW48,89928392,0.7467993581529679,1.6654279403529986
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203,4.067687821762609
NCI-H2452,71466380,5.164331301376758,4.778507974093168
Panc 02.03,4917,3.7856869354758342,3.175137259221242
SW48,25062766,1.0755009410821956,2.2198700045479494
IGROV-1,4259181,0.1937358171291443,0.15288196952912805
BICR 31,46926350,-4.294934659479777,-3.67792384775642
Granta-519,72199292,2.8103945289975623,0.35586383353158313
HARA [Human squamous cell lung carcinoma],216239,2.4828561148565256,2.073782855649304
MOLM-13,11222830,0.9845802392597008,1.2676095509326222
SK-HEP-1,676352,1.798347685811885,2.1624462578079022
SK-CO-1,36314,-5.371942323616045,-1.694943810065447
P31/FUJ,71466380,4.574945433624961,3.7590951524014313
PaTu 8988t,11427553,3.005069211450264,2.839905805306917
ML-1 [Human thyroid carcinoma],1566236,3.1920996771286783,2.6652534925080626
NCI-H1568,151289,0.8908355813530987,1.1650090204161976
SW48,216345,1.323366684487305,3.742986700542575
SK-HEP-1,44819697,-0.1381867301228731,-0.38421717515724757
BFTC-909,24951314,2.3445794180209565,1.5595100876042196
SK-CO-1,107985,-2.728069079888901,-3.5713883837477636
BICR 22,168313016,4.910867780923905,5.001326643263609
SW48,3025986,-2.1875732043663048,-0.6419233293913799
HEL,SNX-2112-bortezomib (250-1 mol-mol),-2.046606544409741,-2.8805861555035803
UACC-812,erlotinib-PLX-4032 (2-1 mol-mol),1.674253271447935,2.7591456385717175
HCC15,446155,0.1844871361320988,2.877614273028602
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512,0.8717015358574427
BFTC-909,56963564,-0.1720168824982637,0.6237259551643749
MOLP-8,151289,0.9447515089929442,0.5501718324901588
HEL,11609586,2.7821230127549663,1.5199261417708256
ML-1 [Human thyroid carcinoma],66577038,3.490614785347513,3.1719721114747053
SW948,46174525,3.747184504681747,3.7025201267391297
HCC15,11964036,0.8100768326008368,1.4411959944263588
SK-OV-3,53232,3.610813443380856,3.0034179958738485
NCI-H2452,9884685,3.2183676658345868,0.9831532699179053
RKO,navitoclax-MST-312 (1-1 mol-mol),1.4157691797100402,0.5339662749767254
K-562,44241473,4.342180714885996,4.172201764358962
HCC1500,65628,4.452955395596753,4.623049998670608
MOLM-13,24771867,-2.755307399303063,-1.504533495178521
RERF-LC-MS,168312962,0.3496483928324376,2.6623420085142504
SU-DHL-1,carboplatin-UNC0638 (2-1 mol-mol),2.541711165237938,2.9145416274176115
NCI-H1568,44589607,2.521775448277625,3.158378711938356
ALL-SIL,selumetinib-UNC0638 (4-1 mol-mol),2.881146238835363,2.3081554487511102
Granta-519,5280436,1.7342596657129103,2.6112832742378633
NCI-H1568,72199292,0.3941551729128716,0.24675449489181525
SK-CO-1,439501,-2.410857533331093,-1.9110719612885592
Daudi,selumetinib-decitabine (4-1 mol-mol),-0.4974612156096017,0.21774635586826727
PaTu 8902,3038522,3.855914834510199,3.0728854634673137
SU-DHL-1,159324,0.2044468524757833,2.699327789962374
BFTC-909,46398810,2.674147192871529,2.7583327698225317
LCLC-97TM1,148198,-1.8422045751990368,-3.333348955769402
MOLM-13,selumetinib-MK-2206 (8-1 mol-mol),0.4118015123896347,1.2813441679145692
LS180,5351362,1.0497784443121565,1.4461131605239235
NCI-H1568,5311281,2.6261557759532974,2.3712153789640062
SW1271,44589607,3.6432775089048888,2.956357521782422
RKO,54143018,-0.3751060369564643,-0.006235883575485195
COR-L105,44607530,0.5885750535327339,1.6419209746443895
RKO,navitoclax-pluripotin (1-1 mol-mol),0.0128409422156563,-1.5985450808689463
Granta-519,serdemetan-SCH-529074 (1-1 mol-mol),-1.751418488769959,1.4395974686467772
SW948,387447,-4.931777613053621,-3.978024157813546
BICR 31,168313016,4.3680397842259095,4.866378431775711
LS411N,36314,3.823716751686664,-1.2827420122513837
IA-LM,JQ-1-vorinostat (2-1 mol-mol),1.5927237168826456,0.346371721303923
MDST8,67291369,1.5579520311273356,2.9741572019450864
RERF-LC-MS,3062316,3.070306969339253,1.7439069301436902
COR-L95,doxorubicin-navitoclax (2-1 mol-mol),-3.6271325367233977,-1.7139686256465478
ML-1 [Human thyroid carcinoma],navitoclax-gemcitabine (1-1 mol-mol),0.4874661343054459,-1.0362276197644398
WM115,JQ-1-vorinostat (2-1 mol-mol),1.1090035526940631,1.1780136956629363
MOLP-8,11964036,0.2292639686830329,0.46702734068543433
RKN,66577038,3.4891743358782104,3.1933726986233455
PaTu 8988t,5978,-2.779195325360685,-1.7822364204712806
RKO,8515,4.32265921632429,3.341561214173706
SU-DHL-1,46907787,0.92481130470373,1.5443644147584847
COR-L95,216468,4.837628080392179,1.7082769199990986
SW948,462382,0.505941174695894,1.0737680472177287
NCI-H1568,448949,1.6827994040181535,2.1444201892501322
ML-1 [Human thyroid carcinoma],11626560,2.2482240841306123,1.9804835410263946
NCI-H2452,10184653,1.4868368660739673,1.7391530552573178
NCI-H2452,1285940,4.318373702463549,3.8529515836581605
SW48,52912189,0.0060801339095902,2.260313728625675
RERF-LC-MS,46926350,-4.177207395055215,-3.7388514566297597
P31/FUJ,5978,-3.805650321394954,-2.7326757071867878
Daudi,4917,1.6956741153412938,2.7341776717469255
LS411N,44507138,1.8249335905604152,2.4085002713641512
RERF-LC-MS,10231331,0.9954911948227504,2.110334811470231
HCC15,4261,-0.2961876318733478,1.9312170871203296
P31/FUJ,16722836,0.3472605187822769,0.6301448234077118
MOLP-8,45279963,3.839697844480557,3.025905819623402
NCI-H2452,446155,1.665772886963468,2.555292390191214
NCI-H2452,11609586,3.752552997604344,3.041974233636633
ML-1 [Human thyroid carcinoma],54618771,2.3801125351223105,1.505475429103356
IA-LM,9933475,1.89794527933904,1.931967390385389
MOLP-8,4477,0.6768027916096236,0.5720873921337912
IGROV-1,42642645,0.3750175292659389,1.1722186176257043
IGROV-1,6852167,1.5305143027352028,2.9153480234562
Daudi,5287969,-2.32062356362434,-2.278473771082429
WM115,44607530,1.3586937130527126,1.6662560962105541
SU-DHL-6,5291,3.0098231219330422,3.292292773698099
IA-LM,53392493,3.818463276064527,2.161634132044621
MOLP-8,5328940,1.3442597724286955,0.930234675779258
NCI-H1568,11626560,1.7284579168385834,2.121569393752286
NCI-H1568,9967941,2.084939505363619,3.6217816003002357
BICR 31,24856436,1.9770307243044476,0.7152291571390417
LS411N,6918289,4.168112514533401,2.329533316589424
SK-CO-1,49766530,2.416603727276247,-0.15246931689157603
LS180,15547703,3.0095925001469577,3.0852505209594216
SK-CO-1,24771867,2.6665073598645086,2.7409877400545417
MOLP-8,17755052,-0.3093261728985458,1.0547088945747485
HARA [Human squamous cell lung carcinoma],SNX-2112-bortezomib (250-1 mol-mol),-1.7614271905544292,-1.2780030893188183
NCI-H2452,6610216,4.12804282735119,4.509101083420174
RERF-LC-MS,16065773,2.958049600168222,2.5759740138370883
SaOS-2,6610216,4.351676798413151,4.292967741790299
RERF-LC-MS,navitoclax-sorafenib (1-1 mol-mol),1.552996311194731,1.9172198044900197
COR-L95,BRD-A02303741-carboplatin (1-1 mol-mol),4.777626447761979,3.849826719698947
NCI-H1568,3854666,0.7326561551321923,2.275193746915126
SU-DHL-1,11404337,-0.9851913382580488,-0.8104112839542975
HARA [Human squamous cell lung carcinoma],2708,4.268843127757034,4.984511984580385
K-562,2746,2.4328857060914797,2.1104915958764225
Daudi,16038120,0.2901991168563289,0.27050438480699635
MOLM-13,71466380,3.777949844495899,3.72600971812005
Panc 02.03,11955716,-1.8470517927785437,-1.5144644239107248
LCLC-97TM1,2858523,3.382646598163124,3.093729681844243
SK-HEP-1,11234052,4.66363668535284,4.358419088713971
HCC1500,322968,2.559368987278369,3.6301615765987476
COR-L95,24772860,-0.7858558168975444,-2.0764890432914633
RKN,selumetinib-navitoclax (8-1 mol-mol),4.166323835760914,2.089655317173246
SW1271,89928392,3.428275427880058,1.5225898249960763
RCC10RGB,24821094,3.8097926200280225,3.255147730729884
HEL,24753719,3.7144242054355985,3.243672092901727
K-562,445091,4.14956176193418,4.019068788774175
HEL,136227924,2.725456875957553,2.247017813774073
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256,2.7684458359798003
LCLC-97TM1,159324,3.194316902825419,2.526011426442366
RERF-LC-MS,57519531,1.5399611647939,2.5994238913967864
RKO,JQ-1-navitoclax (2-1 mol-mol),1.6431758808285295,0.08541731147618963
SW1573,navitoclax-birinapant (1-1 mol-mol),1.5026164736180645,1.3972216365126613
HCC1500,51037431,2.242858518427135,3.461381495415078
ALL-SIL,12003241,-5.746631994241774,-1.7873872604627064
P31/FUJ,44819697,-1.8374306821299025,-1.3189577476098449
SU-DHL-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.4382165085850405,-1.595640454603815
MDST8,107970,2.8941750874079744,2.4424196625610506
SK-OV-3,3503,3.0304882575129497,2.3984020075363666
HuP-T3,selumetinib-piperlongumine (8-1 mol-mol),4.093853736240695,3.197242034600289
HCC1500,9927531,5.051014893697188,4.603755674837699
NCI-H2452,selumetinib-tretinoin (2-1 mol-mol),6.004763322543325,3.950020316196035
HCC15,5328940,2.162982624771584,1.8293627229594707
Panc 02.03,11626927,4.481877662185247,2.869205212388429
SU-DHL-1,navitoclax-gemcitabine (1-1 mol-mol),-3.283553666087357,-2.1487493863376788
SU-DHL-6,2749,-0.5951367082815587,0.9712471419772924
HARA [Human squamous cell lung carcinoma],15547703,3.5023955614710633,3.2183769143652516
MDST8,135398516,1.8788362071916904,2.176333376810784
MOLM-13,5328940,0.1532905912336842,0.7049444097639974
WM115,4477,-0.2872762876800434,0.5653331482969475
ALL-SIL,5746,-1.6673474530311534,-0.7900341689998008
PaTu 8902,25150857,2.644837375624729,2.565204394603822
MDST8,219104,3.7181204954875864,3.833091972479325
Daudi,11228183,2.4864875823277557,0.5857903481669606
ML-1 [Human thyroid carcinoma],613753,2.773006926215127,3.417306580728948
Daudi,984333,-2.2486456844128333,-0.34200614132275264
Granta-519,12003241,-2.1147517064841925,-1.824371745402712
Granta-519,BRD-A02303741-carboplatin (1-1 mol-mol),4.5159158584764745,3.961451012576984
SW48,387447,-4.885505238560258,-3.822831830822866
COR-L105,36314,4.185071185075879,-1.0727362645864378
HuP-T3,4705,2.7233440783632608,3.064443994734181
Panc 02.03,54678924,2.4878586568917536,2.227692966855333
SW1573,16065773,3.287625611468905,2.559698266228019
ML-1 [Human thyroid carcinoma],15953870,3.8046885468141016,3.6204859695815976
COR-L95,10385095,1.3959867651371194,1.2544786335054854
P31/FUJ,2945648,2.3869646223252365,2.1409385534999292
PaTu 8902,55283,3.4956890773009097,2.7042988929788567
COR-L105,89183176,5.033590250009003,4.649833853849788
HEL,navitoclax-MST-312 (1-1 mol-mol),-0.4450786060493964,0.11467270618133739
HCC1500,445091,4.393350110080019,4.308984640535558
SK-CO-1,11175137,2.477148698701912,2.8391653356092807
SK-CO-1,navitoclax-MST-312 (1-1 mol-mol),0.863563965470539,1.157678450679789
BFTC-909,54618771,2.8225313881877545,1.2515024691823224
HCC1500,73707398,0.9868057798362108,1.4371364722043385
WM115,135398516,0.1940094116062491,2.137684438250395
SW948,11977753,-4.015233583581633,-1.2618424159897428
KU-19-19,446155,2.785852834205258,2.771586544779964
BFTC-909,3854666,1.1654585644167257,2.36175487263876
ALL-SIL,327653,2.0915878780614623,2.5332764316748198
RERF-LC-MS,2749,2.1448012118135176,2.119159574932923
SK-CO-1,3503,2.662166466999906,2.451017375761018
IA-LM,60700,0.8821511316384938,-0.13518983579234556
Panc 02.03,10302451,3.706546166543765,2.9897979289383385
SaOS-2,45279963,3.893370234288743,3.4813695708715535
HARA [Human squamous cell lung carcinoma],2858523,2.980861882613042,3.085484709091287
RKO,tanespimycin-gemcitabine (1-1 mol-mol),-1.448163850865836,-1.8964193356123764
K-562,11626560,-0.7477726232652755,0.9166712092924512
PaTu 8902,252682,7.782026892174048,6.531782711051212
HARA [Human squamous cell lung carcinoma],24856436,-1.2762108597510684,0.7196721778525169
HCC1500,9887053,4.8738692747205175,4.086327897099439
IGROV-1,11717001,4.394306548697183,3.845336440286948
NCI-H2452,9911463,3.657985193851277,4.083720988901251
HuP-T3,11707110,2.782188957571083,0.1653754270963088
COR-L105,5287620,-2.2558017577268665,-1.5444332950819086
K-562,9907093,4.115761716505682,3.583222637524614
SW1573,53245473,3.5468633352222287,2.879066330294121
COR-L95,100016,6.620829555802918,5.629890138031515
Granta-519,11178236,-5.517610268531398,-4.111076794688302
IA-LM,3503,2.293282991199797,2.3269789242911942
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943,-0.15257012207461865
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005,-0.41246525561498404
MOLM-13,23635314,-2.1464398793300408,-3.0438573235789153
WM115,45100481,5.666571363096329,4.105259578727475
ALL-SIL,doxorubicin-navitoclax (2-1 mol-mol),-2.2880067679034526,-3.059234792001264
COR-L105,5351362,1.5942690709113274,1.5847916791585235
IGROV-1,6610216,4.310938387105607,4.340934058643816
SK-CO-1,4521392,4.292734672993078,4.231218034898226
RERF-LC-MS,53232,1.207294902086358,2.8948157796334084
NCI-H2452,16038120,1.767482091574877,1.1642956088129295
LS180,107985,-4.080313435814333,-3.2814631865270685
SU-DHL-1,24785538,0.8988368126388477,1.2038339047407072
IGROV-1,11977753,-2.2284230058029433,-1.372718786368373
ML-1 [Human thyroid carcinoma],6623618,2.7004595127938686,2.536004871350315
SW48,24964624,1.8073600797801577,2.518468356636152
RKO,9911830,2.9376280530386123,2.0211895144474403
SU-DHL-1,navitoclax-PLX-4032 (1-1 mol-mol),4.469831301175806,0.9312832789248737
Panc 02.03,navitoclax-pluripotin (1-1 mol-mol),3.190516365419919,-0.6602631586266828
HEL,5287620,-1.51108604946339,-2.123437028601215
MDST8,11964036,-0.5107320494490124,1.6807033974712309
HCC1500,10385095,0.8648832931247582,1.4823390701521435
SW48,702558,4.851481027043998,5.072741525908279
BICR 22,15547703,3.054989624104991,3.217191803029227
LCLC-97TM1,375860,-0.9613247940016756,-0.23993628670224518
BICR 22,5566,3.0896765386345244,2.9460148888547417
SW948,36462,2.9711779559511604,1.9339338073695524
SaOS-2,135411,0.7043200334589346,0.8044034417665687
SW1271,24889392,3.729104653817525,4.321834302477058
K-562,4917,1.7461656699737091,2.933647294268188
MOLM-13,11964036,-0.3903680086882432,0.18968199990062065
SU-DHL-1,9907093,3.802209526559384,3.9865235398908014
MOLP-8,44507138,3.0437239609683515,1.8099325198986795
HCC15,441298,2.404091830829315,2.6211347486566097
IGROV-1,246676,4.485924799339535,4.233511783625888
IGROV-1,3136844,5.214591389089975,4.549405959703979
Daudi,119182,-1.0022442636317743,-3.0822777604018587
SK-CO-1,2742550,3.074063089907043,3.9474022415462566
COR-L95,5291,3.794551144961864,3.5156249726148467
ML-1 [Human thyroid carcinoma],6184667,3.426764234055379,3.2720033987850896
WM115,16219061,2.9198343751130036,3.501919636022748
RERF-LC-MS,2871966,0.0193381278585586,1.0465299916228716
SW1271,44607531,2.0262821909932964,1.7639108984436676
NCI-H2452,53495165,2.6100799702143824,0.604858588078446
SaOS-2,3825829,3.573326366415088,4.135701386098457
HEL,1242560,2.170830105823081,2.8899345156987897
SU-DHL-1,selumetinib-tretinoin (2-1 mol-mol),1.6823534410792318,2.3786425039974697
MOLM-13,135423438,-5.2048777869707035,1.304692261312539
RKO,3815108,2.4813915623878264,2.371426422906434
SK-CO-1,57519531,1.3464743023672243,2.782745607567399
SU-DHL-1,2729026,1.1961155288156848,2.621116293469453
MOLP-8,57330099,4.408814311331857,3.7310404716582286
SK-HEP-1,25262965,-1.9202339310426983,-1.5341660097050172
HCC15,71466445,3.952377160133232,3.4997882048345548
Daudi,49793307,-5.375388093698208,-4.094452621993199
RCC10RGB,52947716,3.397847809230189,0.4855724919146373
COR-L95,selumetinib-vorinostat (8-1 mol-mol),2.598334256861724,2.410758856820125
MOLM-13,10074640,2.6694741782411975,2.471620506173474
HCC1500,16736978,0.2362509616809698,1.307583459785965
WM115,11228183,1.7654096487865938,2.683124772325355
Granta-519,25150857,0.8022216450857215,1.8091319440720717
RERF-LC-MS,2858523,3.0171071482923826,3.1308134656737536
K-562,71466578,3.85538032532176,2.6529120920135894
RKO,135875424,3.829354185480349,3.3234811065390666
HEL,4096211,2.9626104821001524,0.9917481772900142
LCLC-97TM1,67156097,-2.339870774569048,-1.1750321830027142
COR-L95,3503,2.5200783295079834,2.4087143791670864
SW48,11609586,2.634017068041322,2.7166647677207254
SU-DHL-1,375860,-0.8487932986720208,-0.0699427523769863
SU-DHL-1,5351362,0.9282229173955964,1.6375035452536075
SK-OV-3,6917907,1.1533351492785058,-4.791615425681716
PaTu 8988t,65064,5.1728218990125,4.642937970206622
RKN,3503,2.6546301780010144,2.3376644209890927
IA-LM,23582824,0.7235929041173603,0.8282503180849494
IGROV-1,54143018,0.8385018685685798,0.7229026271283336
Daudi,11214940,1.5157277988308535,1.1399199755811047
SW948,4261,0.2066749270482282,1.1410059258430247
HuP-T3,15547703,4.355520728687953,3.1435748029773922
NCI-H2452,24748573,1.1942514329138498,2.428955282035153
IGROV-1,159324,2.8766947154825044,3.2233843191007328
MOLP-8,JQ-1-vorinostat (2-1 mol-mol),-1.65297675500665,-0.689157576257827
MOLP-8,navitoclax-birinapant (1-1 mol-mol),3.3062400198752195,0.7968387075681281
SU-DHL-1,3465537,3.713885766889003,2.2859215102896315
NCI-H1568,60700,-0.8736945480852499,0.06366768383168817
P31/FUJ,3689413,-2.495432751898851,-1.3376493259539795
PaTu 8902,16722836,2.3982166809874768,1.7394903134284576
SW1271,452548,-0.0979853591066759,-0.11286138530927672
HCC1500,9444,4.370086947523025,4.2276342773654525
IA-LM,navitoclax-pluripotin (1-1 mol-mol),-1.626939018948189,-0.7482872876583779
MDST8,44137675,1.8173250203578384,3.9849068642072525
IGROV-1,5460769,1.6083174601829917,2.748117465139342
SK-CO-1,10302451,2.4520332675877605,3.145421632407683
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386,0.48260356740918253
SU-DHL-1,3384730,1.173741268518712,2.4217967948168853
LS411N,11178236,-2.533537215148808,-2.8882078243518094
COR-L105,216239,2.81147830727615,2.545362307538077
MDST8,1750826,-3.2078848487443716,-1.825756264093218
HARA [Human squamous cell lung carcinoma],tanespimycin-gemcitabine (1-1 mol-mol),0.469334809183726,-0.7354141976973249
SW1573,3025986,2.659291536752942,-0.4138828745248017
SK-OV-3,73707398,1.4890038437616029,1.4932280846753687
LCLC-97TM1,12003241,-0.8351557307101188,-0.9134620578698724
BFTC-909,1750826,-0.1726466566192349,-1.595235377911572
WM115,44819697,0.4217395821242636,-0.1358116320044298
Daudi,57330099,4.348234162675926,3.648664862647675
HCC15,6852167,3.485797740848402,2.9225941618401676
IGROV-1,23939,4.412541857664819,3.9611343512234742
Daudi,carboplatin-UNC0638 (2-1 mol-mol),1.637238274504332,2.7370190150396927
MDST8,159324,4.143261975826356,3.0105796539109395
IGROV-1,9840324,5.720969888694302,5.843081806372021
LCLC-97TM1,36314,-6.600382606146434,-1.1721139232114548
UACC-812,11494412,1.976870257251046,1.9189282688887337
LS180,24785538,2.36344296814186,1.6713693783018757
SW1271,46398810,2.1181317502001864,2.580091377580899
COR-L95,8515,4.297389552329342,3.554697057357457
HEL,67291369,-0.0398574366947598,0.8655673911236044
WM115,65064,5.519507799834776,4.7813419411711156
K-562,11178236,-5.937287665657859,-3.4168517311843773
MOLM-13,46398810,-0.3461491770759903,1.740939281100473
Daudi,49836020,3.49644839546437,2.9490458544287517
SaOS-2,135659046,3.828911922642458,3.984447968140719
MOLM-13,156422,2.6570896066322054,2.9007884014216008
IGROV-1,11222830,1.5703285223102077,1.6840690809101444
MOLM-13,3062316,-0.5121609334560062,0.6668108670909149
RCC10RGB,24775005,3.7293513155953737,3.693208995760072
Daudi,135411,0.411387979123234,-0.16195086776050743
HEL,6623618,1.8836955043929509,2.167120026170398
IGROV-1,5702613,4.420745339537274,3.052119674085197
BICR 31,3025986,-1.7152493432112506,-0.609991931556288
ALL-SIL,crizotinib-PLX-4032 (2-1 mol-mol),-0.8453908934030238,0.8551863230189132
HuP-T3,46926350,-3.9956296104835447,-3.816125759668032
SW948,11964036,0.9329377934210036,0.5647998102223447
HEL,navitoclax-pluripotin (1-1 mol-mol),-0.6457207254934652,-2.359746661377783
BICR 31,168313200,4.293337148285007,3.1155364300599473
LCLC-97TM1,613753,3.2994086878019693,3.1099239957351275
NCI-H1568,2858523,2.9099207435493306,3.1631188273710102
K-562,selumetinib-piperlongumine (8-1 mol-mol),3.695022326832345,2.2357087564779308
WM115,168312962,-0.8720769549309708,2.6464365405170294
COR-L105,3136844,4.323289843330604,4.504496526540542
SaOS-2,24964624,2.194529135867758,2.635080888638427
IGROV-1,322968,4.140599241163106,3.7603739231454636
SU-DHL-1,44259,0.9870469643742532,0.761847165637475
HuP-T3,erlotinib-PLX-4032 (2-1 mol-mol),4.371591161861475,2.8287381155327496
Daudi,7326481,2.37278983949268,2.6556774386949984
HCC1500,5284616,3.2143502285360395,1.88470447157798
Granta-519,6918736,-3.0470654964091346,-2.5174926311602595
K-562,53232,2.317344808959498,2.7617852060909787
KU-19-19,6914657,-4.990300196809823,-4.049500340335508
Granta-519,72376,-3.0273971733074463,-3.583204804737923
SW948,54678924,1.3690911042909353,1.7295596112387859
HARA [Human squamous cell lung carcinoma],135999136,4.433628677785179,4.133018107174835
SU-DHL-1,2858523,2.096941494706986,2.771588945709734
HCC15,11427553,0.4296382841284133,2.79703455450298
HCC1500,UNC0638-navitoclax (1-1 mol-mol),-0.3841073877308503,1.412675167213212
PaTu 8902,9444,4.223556509018044,4.295790007399429
Granta-519,10074640,3.4462174196318864,2.667264982308448
NCI-H2452,11213558,2.927858740250081,2.044956465864002
HARA [Human squamous cell lung carcinoma],10302451,4.803964333247322,3.3448875709798824
SU-DHL-1,17755052,1.573040093702568,1.2438163859221765
HCC1500,44185566,2.7833515387265435,2.4645347204301538
BFTC-909,107970,2.2861723254681774,2.5344163444072954
WM115,46191454,1.770414974730312,1.8958502744331858
Panc 02.03,selumetinib-decitabine (4-1 mol-mol),4.111945447475948,3.573324991895973
SW948,JQ-1-vorinostat (2-1 mol-mol),0.5761489017255973,0.1692247286310276
SW48,984333,0.702746968378095,0.6960891878968625
MOLM-13,4378219,1.3750720877022855,1.7837262514894967
SK-CO-1,104842,-6.47047720162668,-2.6013437426859367
HARA [Human squamous cell lung carcinoma],135440466,2.4398826683273165,2.282522729505568
SU-DHL-1,753704,3.8222320630358344,4.699326016550631
NCI-H2452,11640390,3.686004280320225,3.8849644914366603
IA-LM,44185566,3.1900951690600596,1.860827826247711
SW948,24748573,3.0928652753553685,1.8535379284147175
HCC15,16722836,0.9313515315756092,1.8465691531624508
SK-CO-1,2858523,3.0692168261278345,2.933606815619752
BICR 22,984333,1.5288435331300914,0.5313076693130535
WM115,46907787,1.8634039559333693,2.185204888868775
K-562,135398516,2.1877631842117315,1.6323656669903244
PaTu 8988t,navitoclax-pluripotin (1-1 mol-mol),-0.085365931635351,-0.7314804974450759
SW1271,56649450,5.123918884487689,3.61562949949091
MOLM-13,73707438,4.222752629567675,4.070600917173523
BICR 31,navitoclax-PLX-4032 (1-1 mol-mol),3.597223758742863,2.074275588100866
IGROV-1,9908783,5.873270433212515,5.052372982203147
COR-L105,100016,7.1590039780101895,6.267654176410442
MOLP-8,2733487,6.371854996101937,5.459890318420523
HuP-T3,40482356,5.071639396405957,4.242891295523811
Daudi,10231331,6.134507235467236,0.9910158162378014
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013,1.0849912033142313
ALL-SIL,135398738,2.8388897343309214,1.9221290521080103
Granta-519,15953870,3.078322892664931,2.776777111786204
SW1573,16722836,2.4665820842388606,1.7356471119233745
RKN,262093,2.5285063130840344,2.945807886525409
COR-L105,16736978,0.0668136597141226,1.9181087641254815
SU-DHL-1,3854666,0.5155348387571919,1.9636542155435097
SaOS-2,docetaxel-tanespimycin (2-1 mol-mol),-4.954749121249774,-2.6244992809368246
HCC15,1242560,4.141842055686159,3.6931878460627705
Daudi,227681,2.3413610492173533,2.4150680773546647
BICR 22,9825149,1.9632507246672848,2.140312211791212
KU-19-19,57519531,2.7709295903751987,2.6818556585369815
HEL,675434,4.82305615478698,4.098495999658184
LCLC-97TM1,9927531,5.703886109604247,4.8185737496281185
HCC1500,60700,0.3261825799377537,-0.3122237393323609
SK-HEP-1,3025986,-0.7748266135658505,-0.7170375020645142
LS180,5281321,-2.3743222213125703,-1.1270714534416886
RERF-LC-MS,11234052,4.094456859515875,4.4002595076626525
COR-L95,JQ-1-navitoclax (2-1 mol-mol),-0.0986281743436248,0.3984279155362507
RERF-LC-MS,753704,5.128075002459309,5.0603641505676435
ALL-SIL,71304818,1.8469641946240791,1.8800407408012425
LCLC-97TM1,2733526,4.142341185184233,3.713650720502482
SW1271,6918328,0.5991052607451842,-0.04840520872361905
SW1271,24901704,3.681572165465946,3.177487719984008
Granta-519,11656518,1.6452745070498538,0.10726564036848846
NCI-H2452,3025944,3.797054601848671,4.296218348613091
COR-L95,navitoclax-sorafenib (1-1 mol-mol),-0.3721439158461418,0.8983535879715927
RKN,24951314,1.3743916622304369,1.3910661941348497
SW1271,25126798,3.686543071113652,3.786245642724532
IGROV-1,6450551,2.579641476451469,2.799216977446231
IGROV-1,54454,2.453541831966438,2.6735071520264673
COR-L95,9936388,1.0197606854481494,-3.2879668464546215
Daudi,42611257,3.0497080994784307,3.1219022294324708
BICR 22,54618771,-1.5156377594303725,1.2085238404758873
LCLC-97TM1,23939,4.339779460008714,3.7657482605830084
NCI-H2452,46191454,2.4313233431346366,2.022073758374108
COR-L105,42642645,1.1549939076973508,1.1589093996797473
MOLP-8,11609586,0.3617141221652126,1.753956452589033
BICR 31,613753,3.1747241586791772,3.3131178685061666
SU-DHL-1,5328940,1.3431964509037,1.5910761024142877
HARA [Human squamous cell lung carcinoma],5287620,-1.762699468398793,-1.8519525344316077
SW48,carboplatin-UNC0638 (2-1 mol-mol),2.888292790339682,3.221331249546596
BFTC-909,11455910,1.958059547603208,1.7055072918096021
RERF-LC-MS,322968,4.758979615786181,4.2320058423844555
KU-19-19,5351362,1.814646406429004,1.4426441264841232
MOLM-13,54649381,3.864277780400009,3.3139637140189984
RKO,selumetinib-MK-2206 (8-1 mol-mol),2.0156387563640337,1.5618070661999832
NCI-H2452,72199292,1.1345413256627164,0.04659756973782932
MOLP-8,676352,1.5936675202889017,1.8429932816118306
HCC1500,676352,1.5631676801704226,2.118589621935145
COR-L95,51037431,4.395819234826154,3.0339650000840535
Daudi,5328940,0.4604914818199462,0.9158269943988231
SU-DHL-1,ISOX-bortezomib (250-1 mol-mol),0.1782734065105105,0.25131369601605663
IA-LM,168313200,3.804941602819176,2.847112929836483
RERF-LC-MS,navitoclax-gemcitabine (1-1 mol-mol),-4.0027913936317026,-1.259738453411778
RKO,119182,-2.4803685643523,-1.1479558734787967
Panc 02.03,selumetinib-vorinostat (8-1 mol-mol),2.158693436679715,2.573826668781746
PaTu 8988t,25227462,0.2940996568558364,0.397649664172122
SU-DHL-1,9929138,3.6810672504095385,5.07616311149232
SU-DHL-1,12003241,0.0778318253848937,-1.0966324954459992
RKN,15547703,3.1395613683678287,3.25165668668492
MDST8,selumetinib-vorinostat (8-1 mol-mol),1.0590621941896752,2.137650718705445
MOLP-8,375860,-0.9263291950812266,-0.5106975146587823
PaTu 8988t,11234052,5.58672838892775,4.2033253693449515
LS411N,piperlongumine-MST-312 (1-1 mol-mol),2.10220496247882,1.7179544607057764
SK-CO-1,126941,-2.257482818819106,-2.159529084200833
KU-19-19,selumetinib-GDC-0941 (4-1 mol-mol),1.3867335606828617,1.7953838406243736
LS180,3038522,3.8311766422201727,3.1701735995714664
SW948,1566236,2.0550116218076235,1.8764849166205222
Granta-519,89928392,0.2978525114312038,0.11924039670864628
MOLP-8,19582717,2.2376953494036624,2.828726536416278
HCC1500,vorinostat-navitoclax (4-1 mol-mol),-0.8820209164506474,0.7941021085057466
K-562,2874250,4.395305106833161,4.188032067562894
SU-DHL-1,11234052,1.0073590907004168,3.6330197344039603
BICR 22,73707398,1.4183060149157571,1.4538531233987175
COR-L95,46926350,-4.41571269577794,-4.184358839510975
Daudi,25154868,2.925803317483448,3.8567743325162143
HEL,16725315,4.4825385691379145,3.470550829482842
IGROV-1,67291369,1.8066430555976296,2.689770400632035
PaTu 8988t,11404337,-0.5897258437911538,-0.11334762887720312
SK-CO-1,9911463,3.850014047184169,3.991827767634733
LS411N,89928392,2.6081309937571655,0.6365732290899407
SW948,374536,1.478775672326772,1.6124753167477666
Daudi,3543504,2.1992036346279997,3.4628049605593434
NCI-H2452,5746,2.2152642195731818,1.3868993230831759
K-562,451668,2.928523807666895,-0.6998052939103913
RERF-LC-MS,71680916,4.2559060280924665,4.95792078282238
BFTC-909,5311281,3.2468587214362175,2.398718757616976
HCC15,54649381,3.779002151510325,4.015868441000311
SaOS-2,6252,5.899001284083339,1.2262051514531442
SK-CO-1,2828334,6.603893313093487,6.089071543538879
HARA [Human squamous cell lung carcinoma],8515,3.1956320485149265,4.275221057599449
RKN,56946209,-4.407104587623599,-3.932831361341424
P31/FUJ,54618164,3.783909273991047,3.606938221450802
P31/FUJ,46943432,0.8368365469264624,0.9215195569084996
SU-DHL-1,24180719,4.350105317542874,2.5926120650686033
SK-CO-1,10113978,3.831664495659769,3.419788767594414
Granta-519,16659841,3.0104726191973756,2.325861047948163
HCC15,5329102,1.9423862085433257,2.1415333011600484
RKO,9903786,4.184024439899693,2.2905546354101047
Daudi,76446078,6.274042769130843,3.1220332142024914
SU-DHL-1,5113032,6.615586057729586,4.839902355072409
ML-1 [Human thyroid carcinoma],carboplatin-etoposide (40-17 mol-mol),0.3624432437862623,3.261347628324774
IA-LM,219104,4.299166533144503,3.116699218670862
P31/FUJ,5329102,0.6917422477571054,1.2760096950902118
PaTu 8988t,5278396,4.086122365965545,3.493991845631316
LCLC-97TM1,8515,3.105500626842055,3.7822481764214477
ALL-SIL,36314,-6.574209880787115,-3.4906722917545356
HEL,JQ-1-MK-0752 (1-1 mol-mol),-0.9106796249442436,0.054413813181309424
SU-DHL-1,252682,6.908372017357921,6.4172112177332075
MOLM-13,24753719,4.086009941734247,3.228853109440436
LS411N,119607,5.818355117504778,4.675793751042419
MOLM-13,66577038,2.3893764671204853,2.4271840034424192
HCC1500,25183872,-1.4621663438631347,-0.7207915506013023
KU-19-19,6917907,-4.52253618895935,-5.296280108971554
MOLM-13,11396600,-0.7885098330267027,2.8146908862330093
SW1271,25195348,2.4923805554625407,3.128708839582095
NCI-H2452,15983966,-3.826639310361129,-1.0945819299514
BICR 22,6184667,3.547514920621151,2.9603917245370353
IGROV-1,11396600,3.99372654279783,3.768558145610776
PaTu 8902,24748573,3.607230896648149,2.5016960130256445
MDST8,54613361,0.3905773320508885,0.2609296314213694
SW948,136227924,2.9576701343794145,2.6034868965300206
HEL,135411,-2.1892340188273836,-0.16113030809312004
RKN,322968,3.2277505791227776,3.8377263288964905
HARA [Human squamous cell lung carcinoma],15953870,3.428154571209005,3.615583802948897
RCC10RGB,alisertib-navitoclax (2-1 mol-mol),1.3902469753656497,0.9261101110643943
COR-L105,444795,5.02091820523187,4.9568950651614685
RERF-LC-MS,11175137,3.6286013190581503,2.777590710414125
RKN,54619267,4.894700718514424,4.11233091835593
MDST8,54143018,0.2489025697900608,1.1114793821675883
LCLC-97TM1,4917,2.8423920861921803,3.053697987577371
Granta-519,60700,-4.015034522335836,-1.6295225060039706
MOLP-8,56649450,1.2499213171679169,2.611527187872606
RERF-LC-MS,11719255,3.775646564562419,3.6590092750415453
BFTC-909,12001922,1.803559970478093,2.0587091109428446
MOLP-8,3384730,1.892166165987978,1.6073289854107538
RKO,176870,5.862868084879783,2.833860330431583
HCC1500,SNX-2112-bortezomib (250-1 mol-mol),0.5561082321817433,-1.0598320274466841
PaTu 8988t,navitoclax-MST-312 (1-1 mol-mol),1.1129030049458837,1.0074830845881766
IGROV-1,24772860,-3.2892316801587835,-1.919862966119899
IA-LM,6450551,2.2909353415785403,1.7602204627642521
HARA [Human squamous cell lung carcinoma],441298,0.3301976976056055,2.693469014499575
BFTC-909,6252,5.031852570794812,0.9560385368028608
BICR 31,9907093,4.585915925811977,4.3133749527027945
MDST8,285033,-1.9150900594470792,-1.471936580096659
MOLM-13,375860,-1.005106987112833,-0.4932642157560709
P31/FUJ,16725315,4.109597365862544,3.5119634864291824
IGROV-1,216345,3.498629789107092,3.7489676682799655
SW1271,208908,1.7498569635536685,2.1500795984652696
COR-L95,11507802,0.9381723124038672,1.31866253020043
RERF-LC-MS,6918328,0.3946668064090056,0.2976379280352862
NCI-H1568,426756,4.294080241318686,4.382845378683599
K-562,67156097,-2.769244311294464,-2.119217563766268
LS411N,2729026,2.9791300415919646,2.3711919215258486
SK-HEP-1,2729026,3.094345392685322,2.8411314065941666
Panc 02.03,54618771,1.0884531427161812,1.2311279099529235
MDST8,5282054,3.0885738072945776,3.7925268704301294
HARA [Human squamous cell lung carcinoma],31703,-1.5277652674394486,-0.47653203981076026
HEL,54143018,-0.2807045945993052,-0.7366715757395929
COR-L105,5278396,3.038896363429305,3.6568491691685647
SU-DHL-6,6450551,1.9173550036200224,1.5148224151095484
LCLC-97TM1,1716436,2.9898763561132276,3.0545296642619597
K-562,54619267,3.679496217482672,3.6189698261580645
Granta-519,1641662,2.857235389717828,2.815178057793227
PaTu 8902,219104,4.25826825351418,3.9300240127187465
NCI-H2452,24779724,6.409137734448782,4.386685667523403
RCC10RGB,2126,5.809199309072596,5.003752683067397
HuP-T3,24753719,4.122061219367772,4.337779603340744
RKN,44197249,3.9607888926275217,4.098052687087646
SU-DHL-1,44543605,4.013392575246718,3.7737302936680845
HEL,11455910,0.7002369428142345,0.1711257080953199
SK-HEP-1,5281672,4.68841423543723,4.5434051467428205
SW1271,navitoclax-gemcitabine (1-1 mol-mol),-0.9038417813496232,-1.2638329358699496
BICR 31,23582824,0.6119811525421108,0.7752237993382836
SW48,57330099,4.121753491452113,4.120650478176089
MOLP-8,3825829,4.0673932001437,3.3825809789962187
Granta-519,5746,-3.467826904777232,-0.7686689533107343
K-562,46215462,1.6076592131491731,1.3517019854451275
Daudi,alisertib-navitoclax (2-1 mol-mol),-1.1022910082635888,-1.3629204832365023
MOLM-13,6852167,0.0474303723036755,1.549334770812491
PaTu 8902,44819697,-0.6077719001286086,-0.4748833967189614
P31/FUJ,selumetinib-BRD-A02303741 (4-1 mol-mol),2.927335699972257,3.1885098074407185
HCC15,135875424,4.57405525423842,3.9220698938791627
BFTC-909,6918736,-1.9066217610366931,-1.3699897675417454
MOLP-8,25195348,2.8158250690550215,2.6890585156996276
KU-19-19,11175137,2.6409229524549858,2.7005076113438364
MOLP-8,selumetinib-vorinostat (8-1 mol-mol),0.5192774432453199,1.6932587523259002
SU-DHL-1,15983966,-4.109397573586815,-1.3451484127720355
Granta-519,4705,3.4024179319436483,2.9653512811813254
SaOS-2,6450551,2.5324870379200113,2.8272444815541804
SU-DHL-1,6918837,-2.995399398295858,-3.8213884321372005
RKN,selumetinib-BRD-A02303741 (4-1 mol-mol),7.036223119013143,3.953637889222603
SW1573,159324,2.9705070550476274,3.4368885393128195
LS180,11625818,4.457813695022962,4.259391018176187
Granta-519,10296883,3.749738066673353,3.0608708308606003
Panc 02.03,285033,-1.023489563814438,-1.6612157061947364
SU-DHL-1,11175137,1.828860424721981,2.5128438833108215
HEL,124202324,1.0355607531680788,1.074517697884641
NCI-H1568,702558,5.469457182473135,5.247994849522034
IGROV-1,46191454,1.3777495915525844,1.8059670541081718
WM115,55283,3.7426713954425415,2.772551212061879
SW948,7251185,1.827873481109932,1.8726212910501443
MDST8,4521392,4.294685623216763,4.3105368182739605
HuP-T3,selumetinib-GDC-0941 (4-1 mol-mol),0.9673243203252392,1.5049466570810832
LS180,11455910,2.088798844266998,0.9523106820541092
NCI-H2452,151289,3.721937933525537,1.100893951871683
LCLC-97TM1,11214940,1.4536772193180694,1.742395685776637
RKO,25062766,2.7314931301361476,1.7225895411167194
SU-DHL-1,navitoclax-piperlongumine (1-1 mol-mol),1.5701555779120346,1.253534945633231
COR-L105,3385,6.244906352702261,4.319914153601903
IGROV-1,375860,0.7731558163124775,-0.050244392066920725
SU-DHL-1,9936388,0.846879508636978,-2.409452435209954
MOLP-8,11955716,-2.2423093620343666,-2.2483365739134005
IGROV-1,11455910,-0.2792640061206097,1.3029300673083404
HEL,216468,1.594172428774628,0.7338749550629761
K-562,216345,3.9110155346915088,3.3438190308340716
SK-HEP-1,6450551,3.663777137244395,2.9841445327091685
Daudi,5460769,0.2326576177581661,1.802015493610792
BICR 22,1750826,0.8880077925102622,-1.0071875938826278
RERF-LC-MS,11238147,2.4729298726299147,3.039975755108588
BFTC-909,54649381,4.487285574329416,4.021090664602341
RERF-LC-MS,9926054,1.8051014319834384,2.128668106466532
IA-LM,1750826,-4.675530321169698,-2.455209821734993
BICR 22,46398810,2.733805979632988,2.604357446903935
WM115,445643,3.76443753653658,3.795789534099933
LS411N,3689413,2.701640891749041,-0.7174322044131641
SW48,71304818,2.1411626536950323,2.4740489572722657
HuP-T3,5291,4.150853397708747,3.7574225482877766
SW48,9911463,3.374803590447597,3.865236619784168
Daudi,16219061,1.2860438148144782,1.9532155623096676
SaOS-2,9911830,2.995519789289086,2.645128012716979
BFTC-909,5329102,1.9658448878596055,2.0187352211686873
NCI-H1568,53495165,-0.6133813456223128,0.6440519557289562
BICR 22,6918878,1.3704913724877863,2.985202357661314
SK-OV-3,4259181,0.9080230343390464,0.2839007004863107
HCC15,BRD-A02303741-navitoclax (2-1 mol-mol),0.3796712498058268,2.8034935256585367
BFTC-909,445091,4.3207806819680625,4.506989007335908
WM115,2130404,3.451007656106494,3.290819173214207
RCC10RGB,11152667,2.8531679730856268,-0.2315545308970372
HEL,5460769,3.63888115942649,2.1854669956519386
HEL,969516,2.4495484774391296,2.168973479471831
MDST8,11152667,-1.6082048518025778,-0.2030716191487222
WM115,54596490,4.400808012137458,4.139359289779946
NCI-H2452,1716436,2.783046357832639,3.2386864254326326
MOLM-13,4917,2.9272389210025955,2.846768392746163
ALL-SIL,119182,-4.503247338331098,-3.532916739276711
MDST8,3552672,1.9687663546279843,2.799298298949603
HCC15,16720766,-0.3160262480808965,0.6689618900579536
ML-1 [Human thyroid carcinoma],12001922,2.2640831281012916,1.9256645585794883
MOLM-13,12003241,-3.578107028375036,-1.2241479084950913
SW948,24856436,-0.402936098482521,0.423351330961326
HCC1500,44202524,3.676243999694772,2.301939097713733
Daudi,4261,-0.6156785773872924,0.2838541401641509
MDST8,11507802,0.9258202338292296,1.7970048474083082
BFTC-909,54626689,4.365294423210906,4.66675693806661
NCI-H1568,16741245,4.262204040009308,3.858311406695992
HCC1500,25154868,1.8923567203600569,4.490915141038742
HCC15,navitoclax-piperlongumine (1-1 mol-mol),-0.4364560874228035,1.7723299191573922
COR-L105,3825829,4.424164708702568,4.235780574897515
HEL,10074640,3.098757234686198,1.602609918697941
RKO,44202524,1.4476976505001866,1.8924820701938563
SK-HEP-1,6852167,5.53454213252302,2.832647807899515
